data_2mwn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mwn _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 N--CA 1.462 0.129 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -43.41 98.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.582 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.87 -37.27 90.45 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.457 -0.371 . . . . 0.0 110.035 178.632 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 89.1 t . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.736 0.303 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.56 153.62 27.22 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.202 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.22 134.29 47.16 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.054 0.221 . . . . 0.0 111.471 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -139.82 128.42 23.03 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.663 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.556 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.58 107.17 13.16 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 123.685 1.707 . . . . 0.0 109.358 178.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.609 ' O ' ' N ' ' B' ' 328' ' ' ARG . 28.7 m -118.96 160.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.174 -176.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -104.78 144.93 31.08 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' B' ' 326' ' ' VAL . 60.6 tt0 . . . . . 0 C--N 1.315 -0.923 0 CA-C-O 122.126 0.965 . . . . 0.0 112.596 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' B' ' 317' ' ' GLU . 12.2 t . . . . . 0 N--CA 1.44 -0.965 0 CA-C-O 119.156 -0.45 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -44.74 144.75 3.23 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.634 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 10.5 ttm-85 -151.58 -173.06 4.4 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 119.48 -0.888 . . . . 0.0 108.682 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.81 120.79 12.83 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 32.0 tp -98.17 158.74 15.38 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.214 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -143.0 108.76 0.53 Allowed Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.0 mm -87.97 124.34 41.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.725 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.5 p -118.47 138.34 52.56 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.426 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.617 ' NZ ' ' CE1' ' B' ' 395' ' ' TYR . 1.1 mtmm -57.68 14.55 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.813 0.34 . . . . 0.0 111.306 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.725 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.1 pt-20 -144.96 -3.56 0.77 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.625 ' N ' ' HG1' ' B' ' 333' ' ' THR . 0.1 OUTLIER -175.15 177.7 1.86 Allowed 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.351 1.072 . . . . 0.0 112.991 -176.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.613 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.3 t -132.8 145.56 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 CA-C-N 113.093 -1.867 . . . . 0.0 106.236 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.5 ptt? -152.88 151.83 30.83 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.334 -175.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 5.4 mmt-85 -96.96 106.68 19.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.277 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -95.73 149.44 4.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.517 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' B' ' 343' ' ' LYS . 41.0 t0 -86.64 89.95 8.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.673 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.7 OUTLIER -35.88 -27.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.6 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 31.6 mttm -71.21 -44.16 65.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.582 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.54 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -113.61 -17.34 12.18 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' B' ' 344' ' ' THR . 6.8 tttm 77.26 0.22 2.96 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.406 ' CG ' ' OG1' ' B' ' 344' ' ' THR . 8.0 pt-20 -82.84 157.98 22.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 89.8 t -87.29 131.94 33.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.331 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 6.7 mt -102.64 -30.67 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.498 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.484 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.8 tt0 -138.13 158.31 44.57 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.662 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -144.48 149.75 36.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.258 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.13 123.14 3.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.318 177.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.5 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.48 139.58 3.67 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.513 0.673 . . . . 0.0 111.627 -178.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.6 tt -82.26 -36.64 26.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 19.6 m -71.74 7.37 1.53 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.882 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.4 m-20 -108.51 -5.02 16.75 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.825 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 72.1 mt -60.81 144.19 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.725 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -107.42 -46.18 3.91 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 7.5 ptt180 -171.54 136.03 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.474 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 7.5 p90 -119.31 176.45 5.32 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.315 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.7 98.27 1.64 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.188 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.38 145.77 31.84 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.741 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -134.23 174.17 4.97 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -77.57 -7.87 16.91 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.027 1.818 . . . . 0.0 112.123 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' B' ' 382' ' ' THR . 10.4 mtpt -130.86 -21.49 2.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.016 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.56 ' HA ' ' H ' ' B' ' 382' ' ' THR . 58.1 p -152.21 167.15 29.52 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.526 0.679 . . . . 0.0 111.874 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.458 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -138.55 156.74 47.23 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.826 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.437 ' OG1' ' OG ' ' B' ' 379' ' ' SER . 31.8 m -148.56 154.72 40.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.146 -1.022 . . . . 0.0 113.185 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' B' ' 367' ' ' THR . 7.4 mt -125.89 139.64 53.3 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.142 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.9 t0 -117.72 95.58 5.0 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.485 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 17.3 t80 -137.33 94.48 2.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.89 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.87 11.97 2.01 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.6 t0 -41.41 -16.12 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.067 -0.566 . . . . 0.0 111.797 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.556 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.59 -37.03 65.06 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.515 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.3 OUTLIER -125.93 -93.06 0.49 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.853 -1.521 . . . . 0.0 106.946 176.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.515 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 8.2 t70 -128.96 96.41 4.34 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.56 -2.64 53.27 Favored Glycine 0 C--N 1.312 -0.775 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.292 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.67 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.26 107.13 16.39 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . 0.413 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.7 OUTLIER -114.65 120.43 40.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.737 176.03 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.662 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 35.1 t -138.73 163.59 31.76 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.581 0.705 . . . . 0.0 112.78 -177.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.662 ' N ' ' HG ' ' B' ' 379' ' ' SER . 1.2 m -151.08 175.41 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.792 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -100.78 125.57 47.27 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.96 0.885 . . . . 0.0 110.931 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.575 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -155.28 136.49 13.93 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.753 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.32 17.01 4.68 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.143 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . 0.575 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.4 OUTLIER -143.99 84.04 1.76 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.022 175.112 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.99 -58.84 1.94 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.458 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.4 pt-20 -44.41 -20.21 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.748 -0.726 . . . . 0.0 111.038 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.437 ' N ' ' C ' ' B' ' 385' ' ' GLY . 63.6 mt-30 -83.04 -39.71 20.87 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.1 mt -76.39 -42.22 36.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.683 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.47 -42.53 61.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.267 -1.333 . . . . 0.0 113.718 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.458 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 12.2 pt20 -63.88 -34.76 78.66 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.04 0.924 . . . . 0.0 110.98 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.599 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.84 -53.47 10.14 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 113.877 -1.51 . . . . 0.0 108.765 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.599 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.4 mt -48.67 -55.29 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 176.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.79 -33.68 49.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.708 -2.042 . . . . 0.0 110.552 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.96 -18.0 62.06 Favored Glycine 0 CA--C 1.507 -0.456 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.617 ' CE1' ' NZ ' ' B' ' 334' ' ' LYS . 5.3 m-30 -86.84 -37.18 17.99 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -13.39 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 122.153 0.978 . . . . 0.0 109.284 176.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.82 -22.69 45.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.506 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.8 mt -91.89 -61.88 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 113.895 -1.502 . . . . 0.0 112.033 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.44 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.85 -20.51 27.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.374 -1.739 . . . . 0.0 112.307 -176.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.44 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.83 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.463 0.187 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -42.94 98.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.24 -36.86 90.59 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 . . . . . 0 C--N 1.327 -0.379 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.707 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.775 0.322 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.55 153.56 23.96 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.15 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -129.95 134.58 47.55 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.153 0.283 . . . . 0.0 111.496 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -139.84 128.52 23.13 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.582 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.557 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.86 107.27 13.53 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.745 1.736 . . . . 0.0 109.334 178.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.614 ' O ' ' N ' ' B' ' 328' ' ' ARG . 30.7 m -118.74 160.57 18.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 112.63 -2.077 . . . . 0.0 110.096 -176.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -102.94 145.53 29.7 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' B' ' 326' ' ' VAL . 31.0 tt0 . . . . . 0 C--N 1.315 -0.897 0 CA-C-O 122.164 0.983 . . . . 0.0 112.575 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t . . . . . 0 N--CA 1.44 -0.952 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' B' ' 326' ' ' VAL . 63.9 Cg_exo -44.15 144.06 3.03 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 N-CA-C 108.085 -1.544 . . . . 0.0 108.085 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.63 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 8.4 ttm180 -150.26 -173.3 4.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.8 120.65 12.72 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 31.3 tp -98.45 158.43 15.6 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.09 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.45 108.4 0.52 Allowed Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 29.7 mm -87.98 123.02 40.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.724 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.37 138.25 51.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.418 ' O ' HG21 ' B' ' 399' ' ' ILE . 1.2 ttmt -57.86 15.2 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.173 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.724 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.0 pt-20 -144.99 -4.25 0.74 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.62 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.6 177.22 2.17 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 122.448 1.118 . . . . 0.0 112.892 -176.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.613 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.8 t -132.32 145.25 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-N 113.132 -1.849 . . . . 0.0 106.201 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.1 ptt? -152.77 151.01 29.99 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 117.089 -1.845 . . . . 0.0 114.419 -175.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . 0.51 ' NH2' ' NE2' ' B' ' 349' ' ' GLN . 61.4 mtm180 -96.01 106.91 19.13 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.443 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.46 149.81 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.284 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.0 t0 -87.83 91.57 8.8 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.712 -178.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.37 -28.46 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.62 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.5 mttp -75.54 -44.0 45.76 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.714 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.739 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 1.3 p -108.63 -13.07 14.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 30.7 tttp 67.38 -0.67 1.76 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 109.986 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.739 ' H ' ' HG1' ' B' ' 344' ' ' THR . 2.7 mt-10 -85.99 152.56 22.82 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.317 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 87.5 t -81.36 133.6 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.498 0.666 . . . . 0.0 112.299 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 56.1 mt -103.21 -30.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.369 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.51 ' NE2' ' NH2' ' B' ' 339' ' ' ARG . 19.7 tt0 -140.23 157.86 44.93 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.678 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 44.9 mt-10 -143.32 150.15 38.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.349 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.562 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.49 124.02 4.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.118 177.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.492 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -45.59 140.44 3.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.439 0.638 . . . . 0.0 111.566 -178.557 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' B' ' 355' ' ' ASN . 2.0 tt -84.2 -36.12 23.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -73.74 9.39 1.48 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.889 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.57 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 1.0 OUTLIER -111.04 -7.21 14.53 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.055 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.75 146.6 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.686 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 10.0 tttm -107.78 -46.35 3.82 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.3 ptt-85 -172.05 135.91 0.83 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.461 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 8.7 p90 -119.53 175.94 5.6 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.288 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.37 99.49 1.62 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.085 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.63 146.83 30.98 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.747 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.537 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -134.55 173.75 5.43 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -77.49 -7.98 17.03 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.119 1.879 . . . . 0.0 112.038 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' B' ' 382' ' ' THR . 4.1 mtpp -130.87 -21.16 2.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.038 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.564 ' HA ' ' H ' ' B' ' 382' ' ' THR . 58.6 p -152.13 167.7 27.66 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.566 0.698 . . . . 0.0 111.942 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.456 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -139.06 156.64 47.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.651 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.436 ' OG1' ' OG ' ' B' ' 379' ' ' SER . 27.9 m -148.53 154.74 40.2 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.151 -174.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.422 ' N ' ' CG2' ' B' ' 367' ' ' THR . 7.0 mt -126.12 140.03 52.9 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.08 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.0 t0 -117.75 95.84 5.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.533 176.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 27.6 t80 -137.93 94.72 2.93 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.89 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.8 12.02 2.02 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.9 t0 -41.39 -16.43 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.045 -0.577 . . . . 0.0 111.829 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.548 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.46 -37.25 64.99 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.51 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.2 pt20 -125.85 -92.74 0.5 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.941 -1.482 . . . . 0.0 107.222 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.51 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.6 t70 -129.14 96.3 4.29 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.24 -2.91 54.24 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.376 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.681 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.57 106.75 16.37 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -175.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . 0.41 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.8 OUTLIER -114.3 120.13 39.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.717 176.106 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.666 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 35.4 t -138.66 163.45 32.06 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.673 0.749 . . . . 0.0 112.773 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.666 ' N ' ' HG ' ' B' ' 379' ' ' SER . 1.3 m -150.62 175.61 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.93 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -101.42 124.89 47.83 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.938 0.875 . . . . 0.0 110.807 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.564 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.95 136.68 14.4 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.772 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.41 17.2 4.63 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.271 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.03 83.92 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.989 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.02 -59.15 1.9 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.497 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.6 pt-20 -44.33 -20.69 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.758 -0.721 . . . . 0.0 111.009 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 22.9 mt-30 -82.43 -39.59 22.39 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.0 mt -76.55 -42.01 34.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.661 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.87 -42.71 60.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.651 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 5.1 pp0? -63.76 -34.3 77.58 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.055 0.931 . . . . 0.0 110.969 -177.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.31 -53.4 9.77 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.705 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.597 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -48.77 -55.38 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.06 -34.53 43.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.737 -2.029 . . . . 0.0 110.593 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.46 -18.06 62.98 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.499 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.4 m-30 -86.7 -37.0 18.37 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -13.29 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.097 0.951 . . . . 0.0 109.221 176.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.39 -22.62 47.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.563 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 67.2 mt -91.99 -61.96 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.057 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.441 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.81 -20.28 27.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.396 -1.729 . . . . 0.0 112.335 -176.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.441 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.858 -1.067 . . . . 0.0 110.731 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 CA--C 1.518 -0.256 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -39.26 80.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.724 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.35 -43.21 99.4 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 C--N 1.326 -0.423 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.397 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.832 0.348 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.09 153.43 26.94 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.229 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -130.47 134.26 46.95 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.113 0.258 . . . . 0.0 111.423 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -139.31 129.01 24.63 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.625 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.561 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.52 105.9 13.04 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 123.749 1.737 . . . . 0.0 109.42 178.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' B' ' 328' ' ' ARG . 30.8 m -117.36 160.82 16.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 112.703 -2.044 . . . . 0.0 110.078 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -102.55 145.5 29.52 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.526 ' CD ' ' HE ' ' B' ' 339' ' ' ARG . 26.6 tt0 . . . . . 0 C--N 1.315 -0.929 0 CA-C-O 121.955 0.884 . . . . 0.0 112.627 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' B' ' 317' ' ' GLU . 6.5 t . . . . . 0 N--CA 1.438 -1.049 0 CA-C-O 119.116 -0.468 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' B' ' 326' ' ' VAL . 66.5 Cg_exo -43.9 143.89 2.81 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 N-CA-C 108.196 -1.502 . . . . 0.0 108.196 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.622 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 15.7 ttt180 -149.71 -173.33 4.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 119.476 -0.89 . . . . 0.0 108.699 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.662 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -141.83 120.73 12.77 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 32.2 tp -98.5 158.11 15.8 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.177 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.52 108.46 0.53 Allowed Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 29.5 mm -88.1 123.04 40.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.711 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.47 138.43 51.86 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.424 ' NZ ' ' CZ ' ' B' ' 395' ' ' TYR . 0.0 OUTLIER -58.15 16.0 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.191 0.307 . . . . 0.0 111.268 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.711 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -145.48 -4.76 0.68 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.482 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.42 177.14 2.26 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 122.368 1.08 . . . . 0.0 112.883 -176.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.1 t -132.01 145.14 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 CA-C-N 113.13 -1.85 . . . . 0.0 106.33 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.474 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.2 ptt? -152.79 150.84 29.79 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 117.124 -1.831 . . . . 0.0 114.519 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . 0.526 ' HE ' ' CD ' ' B' ' 317' ' ' GLU . 0.2 OUTLIER -96.3 106.79 19.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.496 176.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.662 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.16 149.98 4.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.244 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.1 t0 -87.87 91.6 8.82 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.736 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.36 -28.45 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.685 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' B' ' 341' ' ' ASP . 44.4 mttt -75.5 -43.9 46.62 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.69 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.557 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.76 -13.33 14.8 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -177.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 20.6 tttt 67.77 -0.87 1.83 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.942 0.401 . . . . 0.0 109.943 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.462 ' H ' ' C ' ' B' ' 344' ' ' THR . 4.1 mt-10 -86.05 152.59 22.77 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 87.7 t -81.37 134.05 27.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.5 0.667 . . . . 0.0 112.237 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 7.4 mt -104.11 -30.69 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.186 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.474 ' O ' ' CB ' ' B' ' 338' ' ' MET . 15.6 tt0 -139.04 157.4 46.05 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.554 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -143.64 149.84 37.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.232 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.15 123.98 4.1 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.976 177.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.521 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -44.86 141.77 2.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.388 0.613 . . . . 0.0 111.661 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' B' ' 355' ' ' ASN . 2.0 tt -85.25 -36.27 21.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -73.91 9.99 1.32 Allowed 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.908 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.574 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.1 m-20 -111.81 -7.04 14.22 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.973 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 80.1 mt -56.44 147.04 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.748 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . 0.514 ' NZ ' ' OH ' ' B' ' 373' ' ' TYR . 9.4 tttp -107.71 -46.29 3.84 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 6.0 ptt180 -172.77 135.71 0.67 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.432 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 10.4 p90 -119.28 175.78 5.64 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.226 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.14 100.38 1.7 Allowed 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.84 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -82.86 142.56 31.4 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.66 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.538 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -130.27 174.51 4.55 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -77.82 -8.31 16.77 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.145 1.896 . . . . 0.0 112.063 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' B' ' 382' ' ' THR . 3.2 mttp -130.33 -20.81 2.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.965 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.565 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.1 p -152.03 167.69 27.61 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.55 0.691 . . . . 0.0 111.951 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.43 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -138.87 156.39 47.33 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.541 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.42 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 24.7 m -148.46 154.53 39.98 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.021 -1.072 . . . . 0.0 113.107 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.5 mt -125.61 140.0 53.11 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.336 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.9 t0 -117.36 95.61 5.04 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.892 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 29.7 t80 -137.99 95.24 3.0 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.955 176.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.77 12.38 1.96 Allowed Glycine 0 C--O 1.225 -0.419 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 10.0 t0 -41.88 -16.35 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.935 -0.633 . . . . 0.0 112.07 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.27 -38.09 65.45 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.496 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.32 -92.17 0.52 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.881 -1.509 . . . . 0.0 107.553 176.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.496 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 15.1 t0 -130.06 96.27 4.15 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.82 -3.58 54.88 Favored Glycine 0 C--N 1.303 -1.287 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.425 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.5 106.99 16.5 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -175.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -115.09 120.45 39.85 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.691 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.1 t -138.54 163.28 32.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.5 m -149.98 176.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.367 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -102.13 124.24 47.39 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-O 122.012 0.911 . . . . 0.0 110.829 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.565 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.55 137.19 15.17 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.929 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.15 17.69 4.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.23 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.18 83.64 1.74 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.973 174.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.42 -58.52 1.95 Allowed Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.449 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.3 pt-20 -44.82 -20.08 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.783 -0.708 . . . . 0.0 111.03 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.433 ' N ' ' C ' ' B' ' 385' ' ' GLY . 4.1 mm-40 -83.37 -38.87 21.42 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.8 mt -76.91 -41.99 32.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.623 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.95 -42.51 60.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.566 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.449 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -63.65 -34.2 77.31 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.064 0.935 . . . . 0.0 111.091 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.22 -53.26 10.17 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.738 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.597 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -49.02 -55.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.13 -34.44 44.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.663 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.68 -18.01 62.63 Favored Glycine 0 CA--C 1.505 -0.56 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.4 m-30 -86.65 -37.04 18.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.322 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -13.34 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-O 122.121 0.962 . . . . 0.0 109.288 176.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.36 -22.65 47.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.715 -1.584 . . . . 0.0 109.512 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 67.3 mt -92.05 -61.95 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.119 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.82 -20.11 26.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 113.394 -1.73 . . . . 0.0 112.373 -176.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--O 1.219 -0.508 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.723 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 CA--C 1.52 -0.18 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -41.42 93.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.586 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.27 -41.48 98.35 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.15 178.687 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 73.9 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.839 0.352 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.87 153.18 25.8 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.082 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -129.49 135.64 48.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.452 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -138.5 129.83 27.33 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.588 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.57 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.42 101.39 10.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 123.869 1.795 . . . . 0.0 109.541 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' B' ' 328' ' ' ARG . 31.4 m -112.88 157.79 13.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 112.654 -2.066 . . . . 0.0 109.986 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -99.57 144.14 29.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' B' ' 326' ' ' VAL . 38.8 tt0 . . . . . 0 C--N 1.314 -0.961 0 CA-C-O 122.091 0.948 . . . . 0.0 112.714 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' B' ' 327' ' ' PRO . 11.2 t . . . . . 0 N--CA 1.439 -0.984 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.859 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.44 ' C ' ' O ' ' B' ' 326' ' ' VAL . 76.7 Cg_exo -43.13 142.86 2.25 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 N-CA-C 107.915 -1.61 . . . . 0.0 107.915 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' B' ' 315' ' ' VAL . 2.0 tpt180 -146.7 -173.16 4.14 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -145.93 122.92 11.38 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 26.7 tp -102.5 158.39 16.25 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.01 107.51 0.52 Allowed Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 31.5 mm -88.62 122.72 40.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.747 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.5 p -117.66 137.78 52.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.429 ' O ' HG21 ' B' ' 399' ' ' ILE . 18.9 pttm -57.54 13.78 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.059 0.457 . . . . 0.0 111.727 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.747 ' H ' ' C ' ' B' ' 333' ' ' THR . 15.8 pt-20 -144.25 -2.69 0.87 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.839 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.83 179.05 2.08 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.318 1.056 . . . . 0.0 112.989 -177.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.612 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 15.0 t -137.13 144.33 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 CA-C-N 113.266 -1.788 . . . . 0.0 106.752 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 4.2 ptt? -153.44 150.12 28.46 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 117.053 -1.859 . . . . 0.0 114.263 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 6.5 mmt-85 -94.9 107.19 19.22 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.665 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.63 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.53 149.7 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.275 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.1 t0 -89.92 92.18 8.9 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.765 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.58 -28.7 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.697 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 20.2 mttp -75.42 -43.6 48.98 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.705 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.556 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.39 -12.58 14.72 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm 66.76 -0.52 1.59 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.032 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.5 mt-10 -84.9 153.17 23.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.274 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 74.2 t -83.17 134.35 27.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.481 0.658 . . . . 0.0 112.334 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 21.6 mm -102.89 -31.85 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.353 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' B' ' 338' ' ' MET . 17.1 tt0 -137.64 156.89 47.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.703 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -146.42 148.78 32.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.348 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.556 ' O ' ' N ' ' B' ' 337' ' ' VAL . 67.0 t-105 -163.73 135.74 4.95 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.905 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.519 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -53.87 138.25 36.71 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.344 -178.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.7 tt -78.26 -35.38 48.23 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -75.59 11.72 1.23 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.999 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -115.58 -4.01 12.28 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.139 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 75.8 mt -57.7 149.39 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.097 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 10.8 tptt -107.33 -44.71 4.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.1 ptt180 -175.88 136.22 0.31 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.407 177.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.457 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.3 p90 -118.84 174.54 6.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.344 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.31 99.21 1.76 Allowed 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 119.233 -0.987 . . . . 0.0 112.002 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.53 144.25 31.45 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.773 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.539 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -131.9 174.27 4.9 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -77.31 -8.94 17.57 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.14 1.893 . . . . 0.0 112.102 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 17.1 mttt -130.69 -21.37 2.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.97 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.567 ' HA ' ' H ' ' B' ' 382' ' ' THR . 78.7 p -149.85 168.88 22.48 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.487 0.661 . . . . 0.0 111.938 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.452 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -141.16 156.87 45.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.796 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.448 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 44.8 m -147.78 156.85 43.17 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.093 -1.043 . . . . 0.0 112.913 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.448 ' N ' ' CG2' ' B' ' 367' ' ' THR . 5.9 mt -130.04 140.65 50.82 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.546 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.4 t0 -117.28 95.86 5.16 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.697 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.6 p90 -136.56 93.64 2.9 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.443 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.45 12.36 1.82 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . 0.401 ' CG ' ' OH ' ' B' ' 377' ' ' TYR . 8.3 t0 -41.84 -15.78 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.034 -0.583 . . . . 0.0 111.756 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.6 -37.27 65.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.515 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.89 -92.78 0.5 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.132 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.515 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.0 t70 -129.05 96.27 4.29 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.38 -3.03 55.6 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.306 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.682 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.95 106.06 16.86 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -175.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.14 125.86 51.89 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.736 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.584 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 46.6 t -138.38 163.67 31.27 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.532 0.682 . . . . 0.0 112.559 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.584 ' N ' ' HG ' ' B' ' 379' ' ' SER . 1.6 m -148.89 175.02 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.883 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.07 125.41 48.76 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.897 0.855 . . . . 0.0 111.098 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.618 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -154.54 136.44 14.56 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.814 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.78 16.85 4.4 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.243 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . 0.618 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.2 OUTLIER -143.97 84.0 1.76 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.938 175.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.79 -58.24 2.05 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.6 pt-20 -44.79 -20.69 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.811 -0.695 . . . . 0.0 110.962 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' B' ' 385' ' ' GLY . 68.9 mt-30 -82.11 -39.29 23.55 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 45.9 mt -77.05 -42.43 31.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.614 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.63 -42.38 61.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.569 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 5.1 pp0? -63.77 -34.91 78.96 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.1 0.952 . . . . 0.0 110.95 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.601 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.01 -53.78 10.28 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.723 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.601 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -48.97 -56.06 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 176.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.41 -33.74 45.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 112.874 -1.966 . . . . 0.0 110.671 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.18 -17.81 62.05 Favored Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.3 m-30 -87.04 -36.92 17.91 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -13.31 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 122.203 1.002 . . . . 0.0 109.285 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.6 -22.68 46.67 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.459 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 69.2 mt -91.82 -62.01 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 113.894 -1.503 . . . . 0.0 112.038 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.444 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.22 -20.58 27.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 113.449 -1.705 . . . . 0.0 112.323 -177.061 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.444 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.222 -0.384 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.812 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 CA--C 1.521 -0.145 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.431 ' CD2' ' HG ' ' B' ' 362' ' ' SER . 0.1 OUTLIER -59.34 -41.19 88.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.432 179.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.68 -41.82 99.66 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.508 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 90.0 mt-10 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.042 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.846 0.355 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.76 153.4 26.57 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.166 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -129.73 134.52 47.66 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.085 0.24 . . . . 0.0 111.475 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -139.33 128.72 24.21 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.612 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.561 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.3 105.86 12.83 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 123.733 1.73 . . . . 0.0 109.446 178.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.622 ' O ' ' N ' ' B' ' 328' ' ' ARG . 29.5 m -118.34 161.95 16.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 112.709 -2.041 . . . . 0.0 110.145 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -103.41 145.3 30.19 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' B' ' 326' ' ' VAL . 44.4 tt0 . . . . . 0 C--N 1.314 -0.951 0 CA-C-O 121.972 0.891 . . . . 0.0 112.462 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.2 t . . . . . 0 N--CA 1.443 -0.824 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' B' ' 326' ' ' VAL . 70.0 Cg_exo -43.9 144.44 2.51 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 N-CA-C 108.166 -1.513 . . . . 0.0 108.166 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' B' ' 315' ' ' VAL . 7.3 ttm-85 -151.44 -172.61 4.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.708 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -142.1 122.39 13.93 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 31.2 tp -100.41 158.58 15.8 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.32 108.3 0.52 Allowed Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.1 mm -88.09 123.4 40.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.723 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.83 138.51 52.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.617 ' NZ ' ' CE1' ' B' ' 395' ' ' TYR . 0.4 OUTLIER -57.76 15.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.311 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' B' ' 333' ' ' THR . 10.9 pt-20 -144.88 -4.65 0.74 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.701 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.08 177.84 2.25 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 122.398 1.094 . . . . 0.0 112.947 -176.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.8 t -132.94 145.22 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 CA-C-N 113.113 -1.858 . . . . 0.0 106.219 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.474 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.4 ptt? -153.05 151.34 30.12 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 117.258 -1.777 . . . . 0.0 114.429 -175.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -96.24 106.85 19.12 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.456 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.641 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -97.07 149.7 4.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.235 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 343' ' ' LYS . 25.5 t0 -88.47 91.98 9.01 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.773 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.42 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.734 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 61.8 mttt -76.12 -44.08 40.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.756 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.551 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -108.72 -12.59 14.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 32.4 tttp 66.9 -0.53 1.63 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.955 0.407 . . . . 0.0 109.976 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.3 mt-10 -85.37 153.0 22.82 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.284 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 83.4 t -81.9 133.47 29.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.524 0.678 . . . . 0.0 112.314 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 11.6 mt -103.4 -31.86 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.449 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.474 ' O ' ' CB ' ' B' ' 338' ' ' MET . 24.4 tt0 -136.6 158.48 44.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.782 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 39.1 mt-10 -144.97 149.3 34.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.286 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.562 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.88 124.74 3.94 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.151 177.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.534 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -46.59 140.37 4.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.435 0.636 . . . . 0.0 111.527 -178.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' B' ' 355' ' ' ASN . 2.0 tt -83.74 -36.04 23.96 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.2 t -74.18 9.82 1.48 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.913 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.569 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 1.0 OUTLIER -111.64 -7.98 14.24 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.052 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 81.4 mt -56.01 146.92 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.692 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -107.86 -46.08 3.86 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.493 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 2.2 ptt-85 -172.55 136.38 0.75 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.47 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 8.3 p90 -119.44 176.49 5.33 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.275 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.39 99.2 1.75 Allowed 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.041 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.97 140.15 34.15 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.68 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.531 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -128.32 174.5 4.36 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.79 -7.78 16.66 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.118 1.878 . . . . 0.0 112.193 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.1 mttp -130.91 -20.39 2.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.04 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.572 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.5 p -152.85 166.49 32.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.423 0.63 . . . . 0.0 111.931 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.453 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -137.04 156.52 48.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.61 179.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.436 ' OG1' ' OG ' ' B' ' 379' ' ' SER . 25.3 m -148.54 154.58 39.98 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.104 -1.038 . . . . 0.0 113.091 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.422 ' N ' ' CG2' ' B' ' 367' ' ' THR . 7.0 mt -125.66 139.45 53.55 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.118 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.8 t0 -117.07 95.83 5.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.457 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 33.4 t80 -137.77 94.51 2.91 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.896 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.67 12.12 2.03 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . 0.525 ' CG ' ' HH ' ' B' ' 377' ' ' TYR . 9.0 t0 -41.47 -16.0 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.035 -0.582 . . . . 0.0 111.826 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.52 -37.33 65.24 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.513 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.69 -92.84 0.5 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.513 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.3 t70 -128.88 96.34 4.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.11 -2.97 54.66 Favored Glycine 0 C--N 1.315 -0.629 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.243 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.07 106.4 15.69 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . 0.415 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.8 OUTLIER -113.88 120.4 40.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.598 176.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.648 ' HG ' ' H ' ' B' ' 380' ' ' VAL . 37.3 t -138.88 164.59 29.27 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.651 0.738 . . . . 0.0 112.757 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.648 ' H ' ' HG ' ' B' ' 379' ' ' SER . 1.0 OUTLIER -151.07 174.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.858 179.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.39 124.59 46.07 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.973 0.892 . . . . 0.0 111.024 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.572 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.82 137.69 14.42 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.824 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 383' ' ' THR . . . . . 0.439 ' N ' ' OE2' ' B' ' 384' ' ' GLU . 0.8 OUTLIER -85.43 -1.2 56.79 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.972 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . 0.531 ' CD ' ' HG1' ' B' ' 382' ' ' THR . 0.0 OUTLIER -123.81 84.05 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.096 0.95 . . . . 0.0 108.727 175.25 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.99 -59.54 1.86 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.4 pt-20 -45.59 -21.04 0.08 Allowed 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 114.697 -0.752 . . . . 0.0 111.074 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.406 ' N ' ' C ' ' B' ' 385' ' ' GLY . 68.6 mt-30 -81.04 -38.62 27.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.3 mt -77.36 -41.97 30.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.588 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -74.18 -42.68 59.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.507 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.65 -34.59 78.19 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.991 0.9 . . . . 0.0 111.035 -177.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.598 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.94 -53.45 10.08 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.781 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.598 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -48.89 -55.55 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 176.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -51.96 -34.06 40.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.764 -2.017 . . . . 0.0 110.569 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.06 -18.12 61.66 Favored Glycine 0 CA--C 1.506 -0.524 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.617 ' CE1' ' NZ ' ' B' ' 334' ' ' LYS . 5.4 m-30 -86.68 -36.88 18.47 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -13.36 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 122.108 0.956 . . . . 0.0 109.189 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.34 -22.68 47.67 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.506 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.99 -61.92 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 113.869 -1.514 . . . . 0.0 112.022 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.442 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.9 -20.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 113.415 -1.721 . . . . 0.0 112.311 -176.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.221 -0.437 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.775 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 CA--C 1.521 -0.159 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -40.98 86.32 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.8 -41.63 99.65 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.513 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.1 mt-10 . . . . . 0 C--N 1.327 -0.398 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.784 0.326 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.13 153.4 23.21 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.132 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -128.14 135.29 49.57 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -140.06 128.79 23.14 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.598 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.557 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.86 107.45 13.68 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 123.728 1.728 . . . . 0.0 109.349 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.631 ' O ' ' N ' ' B' ' 328' ' ' ARG . 28.0 m -119.88 159.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 112.647 -2.07 . . . . 0.0 110.066 -177.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -100.79 145.05 29.01 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' B' ' 326' ' ' VAL . 47.1 tt0 . . . . . 0 C--N 1.312 -1.023 0 CA-C-O 121.995 0.903 . . . . 0.0 112.617 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.0 t . . . . . 0 N--CA 1.441 -0.911 0 CA-C-O 119.092 -0.48 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.411 ' C ' ' O ' ' B' ' 326' ' ' VAL . 67.0 Cg_exo -44.33 143.74 3.45 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 N-CA-C 108.093 -1.541 . . . . 0.0 108.093 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.631 ' N ' ' O ' ' B' ' 315' ' ' VAL . 0.3 OUTLIER -149.99 -172.92 4.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.759 -177.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.646 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -142.31 122.05 13.45 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 30.3 tp -100.37 158.3 15.99 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.118 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.94 108.11 0.52 Allowed Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.99 121.63 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.719 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.3 p -115.83 138.62 50.97 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.404 ' O ' HG22 ' B' ' 399' ' ' ILE . 74.2 mttt -57.92 14.95 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.364 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.719 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.4 pt-20 -145.14 -3.79 0.74 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.476 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.5 178.42 1.97 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.343 1.068 . . . . 0.0 112.993 -176.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.7 t -134.38 145.0 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 113.147 -1.842 . . . . 0.0 106.308 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.48 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.5 ptt? -152.8 151.99 31.09 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 117.145 -1.822 . . . . 0.0 114.546 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 6.5 mmt-85 -96.28 107.36 19.7 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.466 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.646 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.06 149.8 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.219 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' B' ' 343' ' ' LYS . 0.3 OUTLIER -87.94 92.0 8.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.859 -178.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -36.55 -27.34 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.637 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' B' ' 341' ' ' ASP . 54.3 mttt -74.79 -42.61 57.79 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.731 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 341' ' ' ASP . 64.5 p -112.0 -16.91 12.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' B' ' 344' ' ' THR . 5.8 ttmm 73.73 1.8 4.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.94 0.4 . . . . 0.0 110.174 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.485 ' H ' ' HG1' ' B' ' 344' ' ' THR . 5.5 pt-20 -86.52 158.65 19.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 89.4 t -88.4 132.78 32.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.567 0.698 . . . . 0.0 112.36 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.21 -31.34 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.241 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.0 tt0 -136.74 157.5 46.61 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.601 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -144.25 149.65 36.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.003 -0.998 . . . . 0.0 111.215 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.61 124.52 4.02 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.125 177.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.534 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -46.73 140.47 4.53 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.358 0.599 . . . . 0.0 111.511 -178.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.9 tt -83.79 -35.74 24.09 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.6 t -74.52 10.22 1.43 Allowed 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.909 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.573 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.8 m-20 -112.11 -7.63 14.06 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.004 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 80.8 mt -55.98 147.4 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.775 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.77 -45.44 4.01 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.7 ptt-85 -173.9 135.93 0.51 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.459 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 8.8 p90 -118.74 176.54 5.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.206 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.43 99.42 1.6 Allowed 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.887 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.21 147.22 30.09 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.699 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.538 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -135.63 173.87 5.2 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -77.35 -8.36 17.31 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.113 1.875 . . . . 0.0 112.15 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' B' ' 382' ' ' THR . 3.9 mttp -130.66 -20.55 2.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.977 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.556 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.6 p -152.69 167.29 29.43 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.59 0.71 . . . . 0.0 111.993 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.45 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -138.81 156.92 46.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.638 179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.432 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 24.3 m -148.53 155.73 41.52 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.041 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.432 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.8 mt -126.29 139.73 53.08 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.375 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.1 t0 -116.96 95.75 5.15 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.68 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 32.6 t80 -138.1 94.87 2.93 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.971 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.12 12.04 1.94 Allowed Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . 0.521 ' CG ' ' HH ' ' B' ' 377' ' ' TYR . 9.4 t0 -41.79 -16.37 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.044 -0.578 . . . . 0.0 111.778 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.0 m-85 -54.33 -37.27 64.67 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.503 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.98 -92.37 0.51 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.335 176.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.503 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.7 t70 -129.78 96.28 4.19 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 174.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.15 -3.52 54.27 Favored Glycine 0 C--N 1.31 -0.872 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.313 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.25 106.33 15.79 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.06 120.43 40.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.703 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.641 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 34.5 t -138.43 163.67 31.32 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.674 0.75 . . . . 0.0 112.952 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.641 ' N ' ' HG ' ' B' ' 379' ' ' SER . 1.6 m -150.42 175.56 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.199 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -101.23 125.06 47.82 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.968 0.89 . . . . 0.0 110.899 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.61 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -155.08 136.23 13.92 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.878 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.09 17.07 4.44 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . 0.61 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.5 OUTLIER -144.13 83.69 1.74 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.044 174.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.25 -57.72 2.08 Favored Glycine 0 C--N 1.317 -0.51 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.451 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.5 pt-20 -45.26 -20.27 0.05 Allowed 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 114.898 -0.651 . . . . 0.0 110.991 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.425 ' N ' ' C ' ' B' ' 385' ' ' GLY . 6.7 mm-40 -83.36 -38.55 21.87 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.0 mt -77.23 -41.89 30.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.538 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.88 -42.46 60.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.344 -1.298 . . . . 0.0 113.509 -177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.451 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -64.08 -34.14 77.37 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.051 0.929 . . . . 0.0 111.022 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.07 -53.43 9.98 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.898 -1.501 . . . . 0.0 108.725 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.597 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -49.16 -55.55 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -51.89 -34.15 39.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 112.756 -2.02 . . . . 0.0 110.69 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.8 -18.11 62.19 Favored Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.5 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.5 m-30 -86.66 -36.98 18.43 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -13.29 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 CA-C-O 122.114 0.959 . . . . 0.0 109.282 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.67 -22.77 46.29 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.519 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 69.3 mt -91.9 -61.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.052 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.97 -20.34 27.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 113.458 -1.701 . . . . 0.0 112.329 -176.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.463 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.767 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -40.56 91.27 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.92 -38.19 95.61 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.508 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 91.4 mt-10 . . . . . 0 C--N 1.328 -0.346 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 74.0 t . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.735 0.302 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.59 153.25 24.44 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -129.72 135.68 48.76 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.058 0.224 . . . . 0.0 111.434 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -139.2 129.49 25.47 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.648 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.559 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.37 104.45 12.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.933 1.825 . . . . 0.0 109.403 178.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.645 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.6 m -115.6 160.93 14.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 112.583 -2.099 . . . . 0.0 110.101 -176.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -103.89 144.49 31.43 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' B' ' 326' ' ' VAL . 27.1 tt0 . . . . . 0 C--N 1.317 -0.825 0 CA-C-O 122.088 0.947 . . . . 0.0 112.767 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' B' ' 317' ' ' GLU . 9.4 t . . . . . 0 N--CA 1.439 -0.993 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' B' ' 326' ' ' VAL . 65.5 Cg_exo -44.49 145.32 2.63 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 N-CA-C 108.121 -1.53 . . . . 0.0 108.121 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' B' ' 315' ' ' VAL . 9.9 ttm-85 -150.13 -173.21 4.37 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.787 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.64 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -143.89 122.1 12.24 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 26.2 tp -101.34 158.01 16.36 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.53 107.51 0.51 Allowed Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.8 mm -88.22 124.0 41.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.742 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.6 p -118.23 137.74 52.81 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.425 ' O ' HG21 ' B' ' 399' ' ' ILE . 5.5 pttp -56.93 12.8 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.908 0.385 . . . . 0.0 111.724 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.742 ' H ' ' C ' ' B' ' 333' ' ' THR . 10.8 pt-20 -144.06 -2.49 0.9 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.712 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.2 OUTLIER -174.03 -179.28 1.66 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.357 1.075 . . . . 0.0 113.372 -177.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.597 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.6 t -137.95 144.84 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.106 0 CA-C-N 113.257 -1.792 . . . . 0.0 107.036 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.447 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 5.8 ptp -153.03 151.33 30.13 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 117.178 -1.809 . . . . 0.0 114.347 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . 0.51 ' NH1' ' OE2' ' B' ' 317' ' ' GLU . 38.8 mtm180 -96.15 107.67 20.02 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.539 176.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.64 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.76 149.03 5.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.43 -178.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' B' ' 344' ' ' THR . 44.6 t0 -88.75 90.5 8.43 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.962 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.79 -28.39 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.66 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.3 mttp -68.99 -43.98 73.77 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.441 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.721 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 0.4 OUTLIER -115.73 -16.39 11.24 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' B' ' 344' ' ' THR . 2.7 tttp 77.11 -0.75 2.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.013 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.721 ' H ' ' HG1' ' B' ' 344' ' ' THR . 8.7 pt-20 -80.12 158.01 26.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 86.4 t -88.64 133.77 30.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.432 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 61.0 mt -102.18 -29.36 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.3 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.447 ' O ' ' CB ' ' B' ' 338' ' ' MET . 17.6 tt0 -143.46 157.89 44.09 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.938 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . 0.408 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 36.3 mt-10 -146.13 149.45 34.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.996 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.576 ' O ' ' N ' ' B' ' 337' ' ' VAL . 70.1 t-105 -161.14 136.78 7.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.994 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.475 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -55.71 137.95 48.5 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.515 0.674 . . . . 0.0 111.554 -179.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.6 tt -78.66 -35.38 45.36 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 354' ' ' THR . . . . . 0.436 ' C ' HD21 ' B' ' 355' ' ' ASN . 4.9 t -75.37 11.22 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.874 177.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' B' ' 353' ' ' LEU . 0.9 OUTLIER -115.08 -3.71 12.57 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.289 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 75.6 mt -58.71 148.92 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.854 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 6.9 tttp -106.96 -45.36 4.18 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.492 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 1.7 ptt180 -174.84 136.41 0.41 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.518 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.485 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 6.8 p90 -118.71 175.46 5.73 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.246 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.34 97.7 1.65 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.909 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.81 142.29 33.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.785 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -129.91 174.08 5.02 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -77.43 -8.47 17.26 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.156 1.904 . . . . 0.0 112.121 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' B' ' 382' ' ' THR . 20.3 mtpt -130.66 -21.84 2.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.855 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.567 ' HA ' ' H ' ' B' ' 382' ' ' THR . 86.3 p -149.81 169.74 20.39 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.507 0.67 . . . . 0.0 111.743 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.441 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -142.35 156.43 45.23 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.885 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.684 ' HG1' ' HG ' ' B' ' 379' ' ' SER . 44.0 m -147.77 156.76 43.08 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.711 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.447 ' N ' ' CG2' ' B' ' 367' ' ' THR . 5.7 mt -129.92 142.45 50.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.495 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.2 t0 -119.14 95.64 4.9 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.743 176.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 12.6 p90 -136.07 93.43 2.91 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.235 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.95 11.7 1.8 Allowed Glycine 0 N--CA 1.462 0.391 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -41.74 -15.53 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.21 -0.495 . . . . 0.0 111.856 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.9 -36.55 65.3 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.533 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.06 -93.25 0.49 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.533 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.8 t0 -129.01 96.43 4.34 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.8 -1.81 55.17 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.315 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.31 105.96 17.04 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -175.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.96 125.77 51.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.645 176.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.684 ' HG ' ' HG1' ' B' ' 367' ' ' THR . 35.8 t -138.19 164.12 30.0 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.575 0.702 . . . . 0.0 112.458 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -150.39 174.08 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.867 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -100.92 126.17 47.54 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.954 0.883 . . . . 0.0 111.072 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.596 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -154.93 136.49 14.26 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.404 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.02 16.66 4.77 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.142 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . 0.596 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.2 OUTLIER -143.55 84.33 1.8 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.119 174.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.88 -59.15 1.91 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.504 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 15.4 pt-20 -44.17 -20.72 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.625 -0.787 . . . . 0.0 111.029 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 5.0 mm-40 -82.85 -38.7 22.64 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 47.1 mt -77.23 -42.38 31.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.526 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.41 -42.9 61.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.676 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.54 -34.81 78.61 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 122.093 0.949 . . . . 0.0 110.892 -177.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.596 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.06 -53.89 9.94 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.771 -1.559 . . . . 0.0 108.713 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.596 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.9 mt -48.83 -55.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.62 -33.75 48.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.742 -2.026 . . . . 0.0 110.639 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.13 -17.93 61.89 Favored Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.3 m-30 -87.1 -36.66 17.98 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -13.2 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 122.178 0.99 . . . . 0.0 109.264 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -22.61 46.45 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.503 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.4 mt -91.63 -62.07 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 113.899 -1.5 . . . . 0.0 112.067 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.21 -20.69 27.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.437 -177.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.487 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.89 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.01 -41.22 96.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.569 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.39 -37.91 93.91 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.779 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 97.2 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.753 0.311 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.27 152.91 29.25 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.138 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -130.58 134.3 46.89 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.994 0.184 . . . . 0.0 111.413 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -137.59 130.14 29.73 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.565 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.57 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -83.98 101.78 11.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 123.965 1.84 . . . . 0.0 109.309 178.189 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.662 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.7 m -112.16 161.93 10.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 112.645 -2.071 . . . . 0.0 110.175 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -105.04 145.97 29.74 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' B' ' 326' ' ' VAL . 24.4 tt0 . . . . . 0 C--N 1.315 -0.923 0 CA-C-O 122.037 0.922 . . . . 0.0 112.665 -178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.6 t . . . . . 0 N--CA 1.439 -1.019 0 CA-C-O 119.1 -0.476 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.425 ' C ' ' O ' ' B' ' 326' ' ' VAL . 66.2 Cg_exo -44.58 145.62 2.57 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 N-CA-C 107.956 -1.594 . . . . 0.0 107.956 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.662 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.8 ttt180 -149.91 -174.1 4.61 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.725 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.35 123.44 12.87 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.081 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 26.7 tp -102.13 159.03 15.74 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.07 108.07 0.52 Allowed Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.8 mm -89.04 123.7 41.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.746 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.48 138.1 52.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.411 ' O ' HG22 ' B' ' 399' ' ' ILE . 0.0 OUTLIER -57.63 13.84 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.114 0.483 . . . . 0.0 111.793 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.746 ' H ' ' C ' ' B' ' 333' ' ' THR . 8.9 pt-20 -144.4 -3.16 0.84 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.868 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.88 178.52 2.17 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 122.272 1.034 . . . . 0.0 113.003 -177.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.5 t -135.79 145.96 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-N 113.4 -1.727 . . . . 0.0 106.573 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.466 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 2.2 ptt? -153.93 150.31 28.2 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 117.044 -1.863 . . . . 0.0 114.262 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 3.2 mtp85 -94.89 107.6 19.63 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.669 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.11 149.94 5.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.371 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' B' ' 344' ' ' THR . 3.2 t70 -90.46 92.62 8.96 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.755 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.7 OUTLIER -35.87 -28.76 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.626 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' B' ' 341' ' ' ASP . 41.9 mttt -73.2 -43.49 61.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.691 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.7 p -111.43 -12.82 13.96 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt 67.63 -0.85 1.79 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 109.999 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.541 ' H ' ' HG1' ' B' ' 344' ' ' THR . 2.3 mt-10 -84.55 151.97 24.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.311 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 77.7 t -82.94 135.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.526 0.679 . . . . 0.0 112.308 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 70.9 mt -103.82 -30.99 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.438 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.466 ' O ' ' CB ' ' B' ' 338' ' ' MET . 7.2 tt0 -138.85 156.04 47.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.584 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -145.51 149.6 34.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.336 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.552 ' O ' ' N ' ' B' ' 337' ' ' VAL . 64.1 t-105 -161.83 134.95 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.838 177.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.508 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.52 138.77 27.06 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.477 -178.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.8 tt -79.08 -35.74 41.95 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 4.7 t -74.86 11.24 1.12 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.895 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.508 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.5 m-20 -114.75 -4.16 12.74 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.14 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 73.5 mt -57.86 147.97 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.088 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 8.1 tttp -105.9 -45.48 4.36 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.8 ptt180 -174.69 136.4 0.43 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.462 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.44 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 10.1 p90 -119.45 173.14 7.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.174 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.0 99.11 1.8 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.086 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.16 148.6 30.85 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.951 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -136.69 173.43 5.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -76.82 -8.81 18.12 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.122 1.882 . . . . 0.0 112.073 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' B' ' 382' ' ' THR . 12.6 mtpp -130.68 -21.64 2.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.968 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.569 ' HA ' ' H ' ' B' ' 382' ' ' THR . 89.8 p -150.35 169.23 21.91 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.606 0.717 . . . . 0.0 111.852 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.463 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -141.78 156.88 45.56 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.888 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 34.2 m -148.06 156.68 42.91 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.091 -1.043 . . . . 0.0 112.809 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.445 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.0 mt -129.21 144.51 51.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.567 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 22.2 t0 -120.51 95.82 4.88 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.837 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.0 p90 -136.71 93.71 2.9 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.369 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.81 12.51 1.72 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -41.9 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.159 -0.521 . . . . 0.0 111.719 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.62 -37.32 65.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.518 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.77 -92.8 0.5 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.934 -1.484 . . . . 0.0 107.097 176.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.518 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.6 t70 -129.12 96.34 4.3 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.24 -2.81 55.75 Favored Glycine 0 C--N 1.312 -0.75 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.217 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.686 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.96 106.3 17.04 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -175.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.81 125.57 51.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.747 175.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.56 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 35.9 t -138.49 162.63 34.03 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.482 0.658 . . . . 0.0 112.646 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.56 ' N ' ' HG ' ' B' ' 379' ' ' SER . 1.7 m -149.05 172.6 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.022 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -99.23 126.3 45.01 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.886 0.851 . . . . 0.0 111.074 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.701 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -155.02 135.97 13.76 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.698 179.265 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.57 17.95 3.6 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.178 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . 0.701 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.3 OUTLIER -144.05 83.89 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.049 175.007 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.91 -59.34 1.89 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.9 pt-20 -45.01 -19.85 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 114.754 -0.723 . . . . 0.0 111.016 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.436 ' N ' ' C ' ' B' ' 385' ' ' GLY . 24.3 mt-30 -82.96 -39.56 21.23 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' B' ' 385' ' ' GLY . 40.6 mt -76.95 -41.86 32.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.731 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -74.11 -41.97 60.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.651 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.438 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -63.93 -34.77 78.71 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.059 0.933 . . . . 0.0 111.023 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.6 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.92 -53.82 10.31 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.813 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.6 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.11 -55.98 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.74 45.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.663 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.19 -17.79 62.07 Favored Glycine 0 CA--C 1.506 -0.469 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.3 m-30 -87.11 -37.0 17.78 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -13.27 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-O 122.187 0.994 . . . . 0.0 109.281 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.64 -22.67 46.54 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.473 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.4 mt -91.76 -62.07 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 113.897 -1.502 . . . . 0.0 112.035 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.445 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.3 -20.51 27.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.396 -177.075 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.445 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.877 -1.059 . . . . 0.0 110.797 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.462 0.135 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -38.61 77.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.513 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.32 97.99 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 89.1 mt-10 . . . . . 0 C--N 1.328 -0.345 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.718 0.294 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.47 153.19 27.78 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.192 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -130.09 134.39 47.33 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 123.059 0.224 . . . . 0.0 111.465 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -138.74 129.02 25.68 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.499 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.563 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.23 105.05 13.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.834 1.778 . . . . 0.0 109.446 178.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.631 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.6 m -115.79 160.92 14.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 112.596 -2.093 . . . . 0.0 110.1 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -103.52 145.67 29.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' B' ' 326' ' ' VAL . 25.3 tt0 . . . . . 0 C--N 1.315 -0.925 0 CA-C-O 122.071 0.938 . . . . 0.0 112.601 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' B' ' 317' ' ' GLU . 5.2 t . . . . . 0 N--CA 1.44 -0.953 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' B' ' 326' ' ' VAL . 63.1 Cg_exo -44.27 145.18 2.49 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.107 -1.536 . . . . 0.0 108.107 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.631 ' N ' ' O ' ' B' ' 315' ' ' VAL . 10.6 ttm-85 -149.96 -173.5 4.45 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 119.498 -0.881 . . . . 0.0 108.658 -177.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.4 121.7 12.29 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 28.0 tp -100.15 158.31 15.95 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.81 108.38 0.54 Allowed Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 31.0 mm -88.75 124.61 41.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.724 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.94 138.13 53.0 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.443 ' NZ ' ' CZ ' ' B' ' 395' ' ' TYR . 0.0 OUTLIER -57.34 14.71 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.74 0.305 . . . . 0.0 111.301 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.724 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -145.15 -3.66 0.75 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.497 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.81 179.98 1.88 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.287 1.041 . . . . 0.0 113.073 -176.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.67 146.53 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 CA-C-N 113.293 -1.776 . . . . 0.0 106.493 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.466 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 2.0 ptt? -154.56 150.33 27.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 117.086 -1.845 . . . . 0.0 114.303 -176.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . 0.649 ' NH2' ' CG ' ' B' ' 378' ' ' TYR . 18.3 mtt-85 -95.12 107.94 20.03 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.561 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.6 149.74 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.259 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' B' ' 344' ' ' THR . 24.7 t0 -88.97 91.91 9.02 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.724 -178.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 1.0 OUTLIER -35.38 -28.63 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.692 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 341' ' ' ASP . 32.9 mttt -75.64 -43.81 45.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.749 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.554 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -108.9 -12.64 14.86 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -177.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt 66.81 -0.29 1.68 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.017 0.436 . . . . 0.0 109.994 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.5 mt-10 -85.45 153.59 22.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.314 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 81.6 t -83.4 134.31 27.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.493 0.663 . . . . 0.0 112.363 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 66.4 mt -102.72 -30.15 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.335 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.647 ' NE2' HH21 ' B' ' 339' ' ' ARG . 38.5 tt0 -140.41 156.84 46.25 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.627 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -145.27 149.7 35.34 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.387 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.577 ' O ' ' N ' ' B' ' 337' ' ' VAL . 70.9 t-105 -160.93 135.37 7.23 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.696 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.502 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -54.84 138.53 42.54 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.461 0.648 . . . . 0.0 111.492 -178.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.6 tt -78.57 -35.58 45.7 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 21.8 m -73.68 8.81 1.69 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.882 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' B' ' 353' ' ' LEU . 0.9 OUTLIER -112.75 -2.35 14.48 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.147 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.32 146.82 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.211 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . 0.455 ' NZ ' ' CE1' ' B' ' 373' ' ' TYR . 4.9 tttt -106.62 -45.24 4.28 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 0.1 OUTLIER -174.88 136.08 0.39 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.388 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.458 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.1 p90 -119.72 175.33 5.92 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.212 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.62 99.99 1.6 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.239 -0.984 . . . . 0.0 112.057 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.09 143.81 32.17 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.752 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.544 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -131.0 174.05 5.15 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -77.11 -9.05 17.84 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.043 1.829 . . . . 0.0 112.036 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.0 mttt -130.79 -21.1 2.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.972 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.575 ' HA ' ' H ' ' B' ' 382' ' ' THR . 78.6 p -149.81 169.54 20.86 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.513 0.673 . . . . 0.0 111.866 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.464 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.2 OUTLIER -141.09 156.32 46.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.583 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.442 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 54.8 m -146.31 156.89 43.67 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.885 -174.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.442 ' N ' ' CG2' ' B' ' 367' ' ' THR . 5.7 mt -130.79 139.68 50.23 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.54 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 22.5 t0 -116.6 95.86 5.24 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.779 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.2 p90 -135.93 94.01 3.0 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.532 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.77 12.51 1.73 Allowed Glycine 0 C--O 1.225 -0.427 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -41.74 -16.13 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.054 -0.573 . . . . 0.0 111.774 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.554 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.42 -37.28 64.93 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.518 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.98 -92.38 0.51 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.942 -1.481 . . . . 0.0 107.183 176.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.518 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.6 t0 -129.47 96.42 4.27 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.14 -3.46 55.67 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.149 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.697 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.03 106.7 17.38 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -175.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . 0.649 ' CG ' ' NH2' ' B' ' 339' ' ' ARG . 0.3 OUTLIER -120.04 127.4 52.55 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.835 175.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.624 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 33.1 t -138.64 166.52 24.14 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.621 0.724 . . . . 0.0 112.61 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.624 ' N ' ' HG ' ' B' ' 379' ' ' SER . 1.6 m -149.18 174.26 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.893 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -101.14 125.38 47.75 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.964 0.888 . . . . 0.0 111.092 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.642 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -154.83 136.82 14.62 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.84 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.27 16.88 4.77 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.211 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . 0.642 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.2 OUTLIER -144.07 83.88 1.75 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.021 174.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.38 -57.44 2.1 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.8 pt-20 -45.04 -20.2 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 114.82 -0.69 . . . . 0.0 111.091 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.426 ' N ' ' C ' ' B' ' 385' ' ' GLY . 4.6 mm-40 -83.05 -39.16 21.58 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' B' ' 385' ' ' GLY . 49.1 mt -76.58 -42.55 34.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.634 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.46 -42.53 61.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.306 -1.315 . . . . 0.0 113.604 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.453 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 12.3 pt20 -63.56 -34.72 78.43 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.001 0.905 . . . . 0.0 111.04 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.598 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.33 -53.6 10.4 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.85 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.598 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -49.02 -55.61 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -53.14 -33.61 53.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.684 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.05 -17.71 62.46 Favored Glycine 0 CA--C 1.505 -0.538 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.2 m-30 -87.07 -37.15 17.7 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -13.36 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-O 122.211 1.005 . . . . 0.0 109.371 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.01 -22.62 45.23 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.525 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 71.4 mt -91.76 -62.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.998 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.444 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.31 -20.75 27.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.322 -176.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.444 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.79 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 CA--C 1.522 -0.133 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -39.22 79.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.462 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.06 -43.86 98.16 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.516 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 88.8 mt-10 . . . . . 0 C--N 1.328 -0.335 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 71.3 t . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.778 0.323 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.28 153.26 25.1 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.1 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -129.39 135.44 48.71 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -139.1 129.43 25.55 Favored 'General case' 0 C--N 1.347 0.485 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.522 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.561 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.33 105.73 13.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 123.825 1.774 . . . . 0.0 109.402 178.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' B' ' 328' ' ' ARG . 33.0 m -116.98 161.11 15.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 112.564 -2.107 . . . . 0.0 110.122 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -103.5 145.34 30.15 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' B' ' 339' ' ' ARG . 27.1 tt0 . . . . . 0 C--N 1.314 -0.943 0 CA-C-O 122.119 0.961 . . . . 0.0 112.606 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t . . . . . 0 N--CA 1.441 -0.903 0 CA-C-O 119.143 -0.456 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' B' ' 326' ' ' VAL . 62.4 Cg_exo -44.76 145.56 2.77 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 N-CA-C 108.029 -1.566 . . . . 0.0 108.029 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.649 ' N ' ' O ' ' B' ' 315' ' ' VAL . 4.2 ttm180 -150.59 -173.45 4.47 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 119.518 -0.873 . . . . 0.0 108.76 -177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.65 122.38 12.62 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 27.7 tp -101.69 157.87 16.52 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.29 107.92 0.53 Allowed Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 31.1 mm -88.56 124.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.727 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.4 p -118.44 138.2 52.63 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.417 ' O ' HG23 ' B' ' 399' ' ' ILE . 1.0 OUTLIER -57.34 14.58 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.872 0.368 . . . . 0.0 111.331 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.727 ' H ' ' C ' ' B' ' 333' ' ' THR . 12.9 pt-20 -145.37 -2.88 0.75 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.459 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.88 179.66 1.93 Allowed 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.322 1.058 . . . . 0.0 113.088 -176.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.593 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.1 t -137.36 146.43 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 113.276 -1.784 . . . . 0.0 106.535 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.468 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 4.0 ptt? -154.76 149.63 26.7 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 117.056 -1.857 . . . . 0.0 114.274 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . 0.528 ' NH2' ' OE2' ' B' ' 317' ' ' GLU . 15.6 mtp180 -94.55 107.73 19.71 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.633 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.89 149.88 5.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.207 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 28.7 t0 -89.45 92.02 8.95 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.729 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.49 -28.79 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.745 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.7 mttm -75.21 -43.61 50.88 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.732 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.73 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 1.2 p -109.32 -12.34 14.77 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm 66.58 -1.09 1.37 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 109.962 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.73 ' H ' ' HG1' ' B' ' 344' ' ' THR . 2.4 mt-10 -84.55 153.33 23.32 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.36 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 82.3 t -83.29 135.16 25.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.497 0.665 . . . . 0.0 112.285 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 67.2 mt -103.54 -30.17 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.407 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.468 ' O ' ' CB ' ' B' ' 338' ' ' MET . 23.5 tt0 -140.6 156.46 46.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.675 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -145.66 149.87 35.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.517 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.548 ' O ' ' N ' ' B' ' 337' ' ' VAL . 65.3 t-105 -162.82 134.87 5.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.711 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.514 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -53.13 139.39 28.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.496 0.665 . . . . 0.0 111.425 -178.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.6 tt -78.77 -36.04 43.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 21.6 m -73.16 9.13 1.33 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.901 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.499 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.2 m-20 -113.52 -1.99 13.98 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.157 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 66.1 mt -61.17 145.6 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.182 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 5.6 tttt -104.38 -45.72 4.59 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.515 0.674 . . . . 0.0 109.21 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.7 ptt180 -174.92 136.19 0.39 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.45 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.4 p90 -118.89 174.71 6.13 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.227 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.64 99.38 1.72 Allowed 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 119.28 -0.968 . . . . 0.0 112.11 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.83 146.99 30.62 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.856 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.537 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -135.35 173.64 5.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -77.02 -8.15 17.6 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.003 1.802 . . . . 0.0 112.221 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' B' ' 382' ' ' THR . 23.0 mttt -131.02 -21.91 2.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.048 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.583 ' HA ' ' H ' ' B' ' 382' ' ' THR . 79.0 p -150.33 168.88 22.79 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.6 0.714 . . . . 0.0 111.895 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.453 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -141.09 156.79 45.93 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.75 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 39.7 m -147.54 156.55 42.94 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.942 -174.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.445 ' N ' ' CG2' ' B' ' 367' ' ' THR . 5.6 mt -129.56 141.87 50.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.628 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 21.1 t0 -118.19 95.59 4.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.677 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.3 p90 -136.23 93.98 2.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.657 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.49 12.45 1.8 Allowed Glycine 0 C--O 1.226 -0.349 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.2 t0 -41.79 -16.15 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.12 -0.54 . . . . 0.0 111.721 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.5 -37.38 65.24 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.519 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.5 OUTLIER -125.76 -92.5 0.51 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.169 176.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.519 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.6 t70 -129.41 96.3 4.25 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.37 -3.01 55.61 Favored Glycine 0 C--N 1.313 -0.714 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.217 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.689 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.93 106.16 16.92 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -175.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.54 126.66 52.96 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.77 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.688 ' HG ' ' H ' ' B' ' 380' ' ' VAL . 47.2 t -138.47 164.55 29.1 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.6 0.714 . . . . 0.0 112.679 -177.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.688 ' H ' ' HG ' ' B' ' 379' ' ' SER . 1.7 m -149.64 174.13 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.971 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -100.91 125.12 47.44 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.94 0.876 . . . . 0.0 111.128 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.682 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -155.41 137.45 14.62 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.827 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 383' ' ' THR . . . . . 0.415 ' N ' ' OE2' ' B' ' 384' ' ' GLU . 0.8 OUTLIER -84.83 -1.13 56.06 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.975 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . 0.682 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.0 OUTLIER -123.93 84.0 2.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.038 0.923 . . . . 0.0 108.71 175.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.24 -58.5 1.97 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.507 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.8 pt-20 -46.81 -20.6 0.14 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 114.696 -0.752 . . . . 0.0 110.982 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -80.95 -39.09 26.64 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.49 ' N ' ' O ' ' B' ' 385' ' ' GLY . 49.4 mt -77.06 -42.42 31.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.615 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.97 -42.4 60.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.308 -1.314 . . . . 0.0 113.506 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.57 -34.74 78.47 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.049 0.928 . . . . 0.0 111.047 -177.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.599 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.25 -53.49 10.74 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.894 -1.503 . . . . 0.0 108.815 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.599 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.9 mt -48.94 -55.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.84 -34.06 52.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 112.732 -2.031 . . . . 0.0 110.651 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.95 -17.58 62.91 Favored Glycine 0 CA--C 1.505 -0.543 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.2 m-30 -87.14 -37.2 17.57 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -13.16 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 CA-C-O 122.1 0.952 . . . . 0.0 109.236 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -79.26 -22.73 44.32 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.51 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.62 -61.76 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 114.001 -1.454 . . . . 0.0 112.051 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.75 -20.51 27.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.419 -1.719 . . . . 0.0 112.375 -176.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 N--CA 1.467 0.424 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.802 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 CA--C 1.52 -0.194 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -39.1 80.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.636 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.41 -43.3 99.25 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.979 0.419 . . . . 0.0 109.97 178.402 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 68.9 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.773 0.321 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.07 153.3 24.84 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -130.2 135.17 47.86 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.012 0.195 . . . . 0.0 111.514 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -138.14 130.0 28.35 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.519 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.562 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -83.49 103.56 12.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 123.92 1.819 . . . . 0.0 109.308 178.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.7 m -113.7 162.05 12.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 112.579 -2.101 . . . . 0.0 110.309 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -105.32 147.1 28.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' B' ' 326' ' ' VAL . 26.3 tt0 . . . . . 0 C--N 1.312 -1.059 0 CA-C-O 122.02 0.914 . . . . 0.0 112.639 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t . . . . . 0 N--CA 1.44 -0.95 0 CA-C-O 119.166 -0.445 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.426 ' C ' ' O ' ' B' ' 326' ' ' VAL . 61.2 Cg_exo -44.8 145.95 2.6 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 N-CA-C 108.07 -1.55 . . . . 0.0 108.07 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.67 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.2 ttt180 -149.92 -174.21 4.64 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 119.529 -0.868 . . . . 0.0 108.689 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.616 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.34 122.64 12.29 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -176.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 25.8 tp -102.12 158.13 16.39 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.16 108.1 0.54 Allowed Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 31.3 mm -88.64 123.97 41.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.741 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.8 p -118.52 137.45 53.2 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.409 ' O ' HG22 ' B' ' 399' ' ' ILE . 0.2 OUTLIER -56.99 13.65 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.944 0.402 . . . . 0.0 111.667 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.741 ' H ' ' C ' ' B' ' 333' ' ' THR . 7.9 pt-20 -144.61 -2.68 0.84 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.711 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.89 179.0 2.06 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.404 1.097 . . . . 0.0 113.072 -176.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.602 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.3 t -136.84 146.17 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 CA-C-N 113.252 -1.795 . . . . 0.0 106.4 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.466 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 4.0 ptt? -154.24 150.08 27.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 117.153 -1.819 . . . . 0.0 114.409 -176.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -95.08 107.86 19.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.54 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.7 t -99.49 150.22 5.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.304 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 344' ' ' THR . 32.8 t0 -90.72 92.35 8.78 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.767 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.54 -28.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.599 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' B' ' 341' ' ' ASP . 20.5 mttp -74.66 -43.56 54.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.688 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.735 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 1.2 p -109.45 -12.53 14.7 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.34 -1.21 1.27 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.035 0.445 . . . . 0.0 110.023 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.735 ' H ' ' HG1' ' B' ' 344' ' ' THR . 2.6 mt-10 -84.79 152.1 23.89 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.332 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 76.7 t -82.76 134.75 26.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.51 0.671 . . . . 0.0 112.305 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . 0.436 HG21 HD12 ' B' ' 348' ' ' ILE . 20.9 mm -102.71 -31.12 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.276 178.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.466 ' O ' ' CB ' ' B' ' 338' ' ' MET . 17.1 tt0 -139.79 156.86 46.53 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.611 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -145.75 149.41 34.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.249 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.539 ' O ' ' N ' ' B' ' 337' ' ' VAL . 64.2 t-105 -162.08 135.05 6.02 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.057 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.514 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.39 139.42 24.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.432 0.634 . . . . 0.0 111.379 -178.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' B' ' 355' ' ' ASN . 2.0 tt -79.57 -35.79 39.2 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.53 11.08 1.09 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.825 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.514 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -114.41 -4.5 12.94 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.027 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 69.6 mt -57.62 147.8 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.468 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 11.7 tptt -105.46 -45.7 4.38 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.502 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.6 ptt180 -175.38 135.98 0.34 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.428 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 12.2 p90 -118.91 173.66 6.75 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.172 -177.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.46 99.74 1.77 Allowed 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.018 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.04 147.66 30.05 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.783 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.535 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -135.99 173.56 5.51 Favored Pre-proline 0 N--CA 1.453 -0.282 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -77.06 -8.68 17.77 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.133 1.888 . . . . 0.0 112.022 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 20.6 mtpt -130.77 -21.38 2.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.96 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.567 ' HA ' ' H ' ' B' ' 382' ' ' THR . 88.9 p -150.47 169.57 21.16 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.574 0.702 . . . . 0.0 111.932 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.452 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -142.12 156.61 45.38 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.566 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.442 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 44.1 m -147.3 156.72 43.18 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.877 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.442 ' N ' ' CG2' ' B' ' 367' ' ' THR . 5.7 mt -129.78 141.35 50.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.544 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 21.9 t0 -117.66 95.72 5.07 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.722 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 8.1 p90 -136.78 94.27 2.96 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.581 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 133.02 12.77 1.64 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.5 t0 -42.08 -15.92 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.979 -0.61 . . . . 0.0 111.852 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.41 -37.68 65.36 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.513 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.57 -92.11 0.52 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.356 176.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.513 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.4 t70 -129.91 96.16 4.14 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -99.93 -3.52 55.88 Favored Glycine 0 C--N 1.311 -0.812 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.261 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.69 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.09 106.17 17.03 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -175.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.69 126.07 51.82 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.647 176.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.672 ' HG ' ' H ' ' B' ' 380' ' ' VAL . 47.1 t -138.55 163.45 31.97 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.676 0.751 . . . . 0.0 112.849 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.672 ' H ' ' HG ' ' B' ' 379' ' ' SER . 1.7 m -149.51 172.89 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.196 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -99.45 125.91 45.27 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.764 0.792 . . . . 0.0 111.192 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.567 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.59 136.28 14.38 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.976 -1.465 . . . . 0.0 109.868 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 383' ' ' THR . . . . . 0.451 ' H ' ' HG1' ' B' ' 383' ' ' THR . 0.7 OUTLIER -86.67 16.63 4.54 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.185 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . 0.464 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.4 OUTLIER -144.08 83.54 1.74 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.943 174.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -57.89 2.06 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.531 ' O ' ' NE2' ' B' ' 390' ' ' GLN . 7.4 pt-20 -45.12 -20.58 0.05 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 114.905 -0.648 . . . . 0.0 110.964 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.422 ' N ' ' C ' ' B' ' 385' ' ' GLY . 5.6 mm-40 -82.26 -39.27 23.23 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' B' ' 385' ' ' GLY . 47.5 mt -76.54 -42.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.609 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.33 -42.36 62.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.559 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' B' ' 386' ' ' GLU . 2.2 pt20 -63.56 -34.88 78.79 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 122.082 0.944 . . . . 0.0 111.029 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.593 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.85 -53.49 11.29 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.819 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.593 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.35 -55.98 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.37 -33.74 44.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 112.761 -2.018 . . . . 0.0 110.701 177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.26 -17.8 61.92 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.4 m-30 -87.15 -36.96 17.76 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -13.19 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 CA-C-O 122.175 0.988 . . . . 0.0 109.297 176.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.56 -22.65 46.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.475 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.1 mt -91.8 -61.98 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.067 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.54 -20.41 27.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.338 -1.756 . . . . 0.0 112.315 -176.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.494 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.793 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 N--CA 1.461 0.089 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -41.17 87.66 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.99 -44.36 97.28 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.515 ' OE2' ' CD2' ' B' ' 377' ' ' TYR . 85.6 mt-10 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 120.995 0.426 . . . . 0.0 109.933 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 72.2 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.794 0.33 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.47 153.04 25.6 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.064 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -128.87 135.18 48.73 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.125 0.266 . . . . 0.0 111.42 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -139.15 129.52 25.59 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.795 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.563 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.47 104.86 12.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 123.717 1.723 . . . . 0.0 109.154 178.242 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' B' ' 328' ' ' ARG . 34.1 m -120.82 156.02 24.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 112.815 -1.993 . . . . 0.0 110.278 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -93.37 138.34 31.8 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.27 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' B' ' 326' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.314 -0.973 0 CA-C-O 121.918 0.866 . . . . 0.0 112.881 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.0 t . . . . . 0 N--CA 1.445 -0.678 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.482 ' C ' ' O ' ' B' ' 326' ' ' VAL . 78.1 Cg_exo -37.89 140.26 0.29 Allowed 'Trans proline' 0 CA--C 1.506 -0.882 0 N-CA-C 108.535 -1.371 . . . . 0.0 108.535 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' B' ' 315' ' ' VAL . 1.6 tpt180 -152.98 -172.22 4.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.574 -0.85 . . . . 0.0 108.731 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.628 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.33 123.63 13.82 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 27.7 tp -103.11 158.27 16.42 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.151 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.24 107.71 0.52 Allowed Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 31.6 mm -88.33 123.03 40.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.746 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.2 p -117.28 138.02 52.02 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.414 ' O ' HG23 ' B' ' 399' ' ' ILE . 8.9 pttm -57.26 13.6 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.015 0.436 . . . . 0.0 111.779 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.746 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.5 pt-20 -144.45 -2.69 0.85 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.955 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.97 178.89 2.06 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 122.315 1.055 . . . . 0.0 113.059 -177.051 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.609 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.47 146.09 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.042 0 CA-C-N 113.312 -1.767 . . . . 0.0 106.587 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.467 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 2.3 ptt? -154.06 149.84 27.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 117.09 -1.844 . . . . 0.0 114.324 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -94.51 107.7 19.66 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.645 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.628 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.34 149.84 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.124 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' B' ' 344' ' ' THR . 32.0 t0 -89.53 92.6 9.17 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.884 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.56 -28.58 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.732 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 14.8 mttp -75.0 -43.79 51.86 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.73 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.554 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.41 -12.84 14.68 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 11.5 tttt 66.54 -0.75 1.45 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.048 0.452 . . . . 0.0 110.049 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.8 mt-10 -85.15 152.22 23.53 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.311 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 82.5 t -83.83 135.14 25.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.528 0.68 . . . . 0.0 112.253 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -104.55 -30.93 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.414 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.467 ' O ' ' CB ' ' B' ' 338' ' ' MET . 7.4 tt0 -138.01 154.9 49.29 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.516 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -145.32 149.83 35.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.37 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.549 ' O ' ' N ' ' B' ' 337' ' ' VAL . 63.0 t-105 -161.99 135.06 6.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.753 177.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.78 139.1 27.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.424 0.631 . . . . 0.0 111.32 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.8 tt -79.47 -35.6 40.06 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.83 11.28 1.11 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.888 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.7 m-20 -114.65 -4.19 12.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.191 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 74.0 mt -57.99 148.53 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.155 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 10.3 tttt -106.42 -45.12 4.35 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.1 ptt180 -175.64 136.52 0.33 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.365 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.45 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.5 p90 -119.53 174.14 6.57 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.224 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.02 98.83 1.78 Allowed 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.039 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.68 147.09 30.78 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.803 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -136.36 173.78 5.22 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -77.24 -8.26 17.4 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.038 1.825 . . . . 0.0 112.205 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.6 mttt -130.6 -21.43 2.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.073 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.563 ' HA ' ' H ' ' B' ' 382' ' ' THR . 94.4 p -151.74 168.75 24.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.658 0.742 . . . . 0.0 111.858 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.456 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -140.64 157.07 45.99 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.84 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.453 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 62.7 m -146.79 158.64 43.96 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.848 -174.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.453 ' N ' ' CG2' ' B' ' 367' ' ' THR . 5.6 mt -132.41 140.11 48.32 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.519 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 19.7 t0 -117.0 96.03 5.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.634 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' B' ' 370' ' ' PHE . 5.9 p90 -137.25 94.11 2.9 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.555 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.58 12.68 1.74 Allowed Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 8.8 t0 -41.97 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.108 -0.546 . . . . 0.0 111.682 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.3 m-85 -54.43 -37.24 64.9 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.51 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -126.09 -92.67 0.5 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.093 176.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.51 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.3 t70 -129.32 96.21 4.24 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -99.98 -3.13 55.96 Favored Glycine 0 C--N 1.315 -0.605 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.223 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.25 105.68 16.79 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -175.581 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.18 127.68 54.35 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.557 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.532 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 22.6 t -137.48 157.83 45.71 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.313 0.578 . . . . 0.0 112.23 -177.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.532 ' N ' ' HG ' ' B' ' 379' ' ' SER . 2.5 m -142.09 171.86 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.047 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -100.84 125.99 47.4 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.964 0.887 . . . . 0.0 110.991 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.667 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -156.01 137.59 14.13 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.876 179.046 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.43 15.54 6.44 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.132 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . 0.667 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.2 OUTLIER -143.93 84.54 1.78 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.065 175.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -56.35 2.32 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.4 pt-20 -45.07 -20.18 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 114.797 -0.702 . . . . 0.0 111.025 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' B' ' 385' ' ' GLY . 2.5 mm-40 -82.96 -39.39 21.46 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' B' ' 385' ' ' GLY . 46.3 mt -76.85 -42.44 33.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.669 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.37 -42.18 62.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.665 -177.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.436 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -63.93 -34.89 78.99 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.032 0.92 . . . . 0.0 110.965 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.599 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.8 -53.69 10.84 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.783 -179.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.599 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.14 -56.1 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.59 -33.8 47.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 112.819 -1.991 . . . . 0.0 110.662 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.98 -17.87 62.29 Favored Glycine 0 CA--C 1.507 -0.444 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.3 m-30 -87.01 -36.79 18.02 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -13.21 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-O 122.157 0.98 . . . . 0.0 109.258 176.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.64 -22.54 46.74 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.712 -1.585 . . . . 0.0 109.459 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.8 mt -91.82 -62.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.968 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.442 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.43 -20.43 27.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.347 -177.026 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.442 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.765 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -42.67 94.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.708 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.22 92.86 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 C--N 1.326 -0.42 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.683 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.776 0.322 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.58 153.45 26.28 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.221 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -130.04 134.08 47.16 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.042 0.214 . . . . 0.0 111.46 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -139.26 128.48 23.99 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.656 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.558 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.84 107.15 13.4 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 123.769 1.747 . . . . 0.0 109.396 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' B' ' 328' ' ' ARG . 30.3 m -119.13 160.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.096 -176.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -102.11 145.25 29.62 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.524 ' CD ' ' HE ' ' B' ' 339' ' ' ARG . 26.6 tt0 . . . . . 0 C--N 1.312 -1.038 0 CA-C-O 122.005 0.907 . . . . 0.0 112.708 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' B' ' 317' ' ' GLU . 5.7 t . . . . . 0 N--CA 1.44 -0.965 0 CA-C-O 119.112 -0.471 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' B' ' 326' ' ' VAL . 68.1 Cg_exo -44.18 144.14 3.01 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 N-CA-C 108.096 -1.54 . . . . 0.0 108.096 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.626 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 13.9 ttt180 -150.41 -173.23 4.39 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.71 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -141.41 120.76 13.11 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.103 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 32.0 tp -98.67 158.17 15.79 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.223 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.56 108.5 0.53 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 29.4 mm -87.98 123.58 40.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.724 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.98 138.05 52.45 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.423 ' O ' HG21 ' B' ' 399' ' ' ILE . 0.0 OUTLIER -57.55 14.65 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.697 0.284 . . . . 0.0 111.442 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.724 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.5 pt-20 -144.53 -4.36 0.78 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.561 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.48 177.35 2.19 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.412 1.101 . . . . 0.0 112.915 -176.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.0 t -132.5 145.4 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 113.148 -1.842 . . . . 0.0 106.401 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.2 ptt? -152.93 150.61 29.44 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 117.199 -1.801 . . . . 0.0 114.568 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . 0.524 ' HE ' ' CD ' ' B' ' 317' ' ' GLU . 0.4 OUTLIER -96.24 106.86 19.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.515 176.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.13 150.1 4.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.299 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.5 t0 -87.97 91.62 8.83 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.694 -178.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.43 -28.32 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.619 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 24.0 mttp -75.52 -43.94 46.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.725 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.556 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.61 -13.7 14.77 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 15.3 tttt 68.0 -0.41 2.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.98 0.419 . . . . 0.0 109.933 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.9 mt-10 -86.66 152.9 22.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 89.7 t -81.61 133.96 28.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.5 0.667 . . . . 0.0 112.276 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 1.2 mm -104.14 -30.76 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.225 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' B' ' 338' ' ' MET . 15.7 tt0 -138.74 157.23 46.47 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.489 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -143.4 150.55 39.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.233 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.52 124.31 4.01 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.942 177.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.529 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -45.69 140.92 3.14 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.42 0.628 . . . . 0.0 111.612 -178.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' B' ' 355' ' ' ASN . 2.0 tt -84.36 -36.32 22.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 354' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' B' ' 400' ' ' LEU . 6.0 t -73.5 9.54 1.33 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.906 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.571 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 1.0 OUTLIER -111.13 -7.28 14.49 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.0 178.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 78.0 mt -56.91 146.41 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 120.444 -0.503 . . . . 0.0 111.766 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . 0.512 ' NZ ' ' OH ' ' B' ' 373' ' ' TYR . 9.0 tttp -107.6 -46.03 3.92 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.5 ptt-85 -172.97 135.76 0.63 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.454 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.1 p90 -119.15 176.56 5.25 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.186 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.37 98.94 1.59 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 119.176 -1.009 . . . . 0.0 111.877 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.64 145.73 31.52 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.563 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.537 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -134.09 173.73 5.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.735 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.38 -8.21 17.23 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.175 1.917 . . . . 0.0 112.069 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' B' ' 382' ' ' THR . 26.0 mttt -130.51 -21.3 2.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.942 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.566 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.3 p -151.94 167.79 27.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.601 0.715 . . . . 0.0 111.883 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.439 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -139.19 156.49 47.07 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.549 179.557 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.432 ' OG1' ' OG ' ' B' ' 379' ' ' SER . 25.1 m -148.43 154.81 40.39 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 118.947 -1.101 . . . . 0.0 113.068 -174.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.419 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.6 mt -125.64 140.09 53.02 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.329 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 9.7 t0 -117.56 95.5 4.98 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.875 176.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 27.6 t80 -137.75 95.16 3.0 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.89 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.96 12.17 1.96 Allowed Glycine 0 C--O 1.225 -0.413 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.6 t0 -41.73 -16.36 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.911 -0.645 . . . . 0.0 112.057 -178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.539 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.0 m-85 -54.35 -37.83 65.37 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.502 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.66 -92.16 0.51 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.522 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.502 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 7.5 t0 -130.02 96.29 4.16 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.14 -3.31 54.39 Favored Glycine 0 C--N 1.306 -1.131 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.405 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.68 107.11 16.71 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -175.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -115.39 120.66 40.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.742 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.586 ' HG ' ' H ' ' B' ' 380' ' ' VAL . 35.2 t -138.49 163.35 32.19 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.788 0.804 . . . . 0.0 113.103 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.586 ' H ' ' HG ' ' B' ' 379' ' ' SER . 1.6 m -149.97 175.56 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.299 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -101.74 124.4 47.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.039 0.923 . . . . 0.0 110.728 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.566 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.46 136.86 14.97 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.883 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.62 17.59 4.55 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.251 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . 0.517 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.4 OUTLIER -144.16 83.58 1.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.949 174.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -58.85 1.92 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.0 pt-20 -44.49 -20.08 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.904 -0.648 . . . . 0.0 111.022 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.437 ' N ' ' C ' ' B' ' 385' ' ' GLY . 23.5 mt-30 -83.13 -39.55 20.93 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.9 mt -76.54 -42.02 34.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.654 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.63 -42.69 61.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.503 -177.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -63.63 -34.62 78.24 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 122.036 0.922 . . . . 0.0 111.05 -177.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.596 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.96 -53.16 10.7 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.811 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.596 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -49.12 -55.12 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.19 -34.32 44.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.657 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.86 -17.99 62.31 Favored Glycine 0 CA--C 1.504 -0.611 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.4 m-30 -86.72 -36.65 18.54 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -13.02 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-O 122.123 0.963 . . . . 0.0 109.226 176.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.51 -23.07 43.18 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.465 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . 0.419 ' O ' ' CD1' ' B' ' 400' ' ' LEU . 74.2 mt -90.34 -59.95 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.573 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.493 ' O ' ' C ' ' B' ' 400' ' ' LEU . 0.7 OUTLIER -69.1 -19.58 23.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.266 -177.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.493 ' C ' ' O ' ' B' ' 399' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.381 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.463 0.186 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -37.35 64.61 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.12 -50.68 61.19 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 120.986 0.422 . . . . 0.0 110.023 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 74.9 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.761 0.315 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.5 153.65 24.78 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.113 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -127.7 135.42 50.16 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.158 0.286 . . . . 0.0 111.587 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -139.96 127.36 21.4 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.572 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.555 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.77 107.72 13.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 123.751 1.739 . . . . 0.0 109.314 178.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' B' ' 328' ' ' ARG . 31.3 m -120.18 162.6 18.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 112.658 -2.065 . . . . 0.0 110.097 -176.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -104.0 145.61 29.9 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' B' ' 326' ' ' VAL . 44.0 tt0 . . . . . 0 C--N 1.314 -0.951 0 CA-C-O 122.033 0.92 . . . . 0.0 112.627 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' B' ' 317' ' ' GLU . 14.4 t . . . . . 0 N--CA 1.44 -0.929 0 CA-C-O 119.113 -0.47 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.409 ' C ' ' O ' ' B' ' 326' ' ' VAL . 68.0 Cg_exo -44.39 144.11 3.28 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.629 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 11.2 ttm-85 -150.08 -173.59 4.48 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.696 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.16 120.49 13.07 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.145 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 31.7 tp -99.04 157.9 16.03 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.249 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.2 108.04 0.52 Allowed Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.7 mm -87.82 122.91 40.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.715 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.9 p -117.09 138.55 51.55 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.414 ' O ' HG21 ' B' ' 399' ' ' ILE . 1.0 OUTLIER -57.79 15.83 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.747 0.308 . . . . 0.0 111.354 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.715 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.1 pt-20 -145.72 -4.5 0.66 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.528 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.46 177.39 2.19 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.362 1.077 . . . . 0.0 113.011 -176.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.61 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 9.9 t -132.81 145.29 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 CA-C-N 113.16 -1.836 . . . . 0.0 106.254 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.475 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.0 OUTLIER -152.54 150.88 30.04 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 117.143 -1.823 . . . . 0.0 114.468 -175.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . 0.506 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 62.6 mtm180 -96.13 106.77 19.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.524 176.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.7 t -96.76 150.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.278 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' B' ' 344' ' ' THR . 28.8 t0 -88.04 91.74 8.88 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.76 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.48 -28.38 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.617 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.8 mttm -75.18 -43.78 50.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.691 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.7 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 1.3 p -108.77 -13.98 14.68 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 14.7 tttp 68.29 -0.77 2.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.026 0.441 . . . . 0.0 109.958 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.7 ' H ' ' HG1' ' B' ' 344' ' ' THR . 3.9 mt-10 -86.3 152.83 22.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.35 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 86.6 t -81.6 133.55 29.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.485 0.66 . . . . 0.0 112.178 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 11.9 mt -102.98 -31.02 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.319 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.506 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 21.8 tt0 -139.58 158.15 44.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.595 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -143.06 150.08 39.06 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.135 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.556 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.0 122.38 4.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.938 177.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.551 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -44.93 139.79 2.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.443 0.639 . . . . 0.0 111.624 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.7 tt -82.24 -37.28 26.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 19.7 m -70.67 6.76 1.32 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.799 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.587 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 0.9 OUTLIER -108.37 -4.84 17.06 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.106 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.9 144.42 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.753 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -107.3 -45.95 3.99 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 7.2 ptt180 -172.43 135.7 0.74 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.443 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.6 p90 -119.08 176.35 5.34 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.208 -177.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.24 99.21 1.62 Allowed 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.961 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.25 145.4 30.96 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.573 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -133.71 173.96 5.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -77.39 -7.95 17.12 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.136 1.891 . . . . 0.0 112.131 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' B' ' 382' ' ' THR . 4.0 mtpp -130.61 -21.27 2.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.046 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.565 ' HA ' ' H ' ' B' ' 382' ' ' THR . 61.1 p -152.25 167.36 28.85 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.528 0.68 . . . . 0.0 111.903 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.437 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -138.79 156.63 47.18 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.504 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.428 ' OG1' ' OG ' ' B' ' 379' ' ' SER . 24.2 m -148.57 154.47 39.81 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.014 -1.075 . . . . 0.0 113.02 -174.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.8 mt -125.32 140.77 52.53 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.355 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.8 t0 -118.06 95.6 4.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.464 -0.895 . . . . 0.0 110.821 176.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 18.6 t80 -137.38 94.85 2.98 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.936 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.01 12.41 1.91 Allowed Glycine 0 C--O 1.226 -0.405 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.2 t0 -41.89 -16.12 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.02 -0.59 . . . . 0.0 111.887 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.542 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.34 -37.94 65.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.501 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.32 -92.37 0.51 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.895 -1.502 . . . . 0.0 107.358 176.691 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.501 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 7.8 t70 -129.93 96.16 4.14 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.16 -2.92 54.48 Favored Glycine 0 C--N 1.31 -0.883 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.28 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.673 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.45 107.06 16.5 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -175.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . 0.422 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.7 OUTLIER -114.71 120.95 41.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.677 175.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.608 ' HG ' ' H ' ' B' ' 380' ' ' VAL . 35.7 t -138.67 163.21 32.69 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.608 ' H ' ' HG ' ' B' ' 379' ' ' SER . 0.8 OUTLIER -149.95 175.18 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.209 178.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -101.44 124.57 47.32 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.955 0.883 . . . . 0.0 110.863 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.565 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.88 136.91 14.66 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.937 179.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.75 17.42 4.77 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.207 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.06 83.88 1.75 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.902 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.96 -58.19 2.04 Favored Glycine 0 C--O 1.223 -0.578 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.5 pt-20 -44.58 -20.06 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.814 -0.693 . . . . 0.0 111.083 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.439 ' N ' ' C ' ' B' ' 385' ' ' GLY . 41.5 mt-30 -83.04 -39.78 20.78 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' B' ' 385' ' ' GLY . 50.2 mt -76.74 -41.99 33.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.611 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.68 -42.37 61.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.293 -1.321 . . . . 0.0 113.532 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.462 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.3 pt20 -64.02 -34.65 78.5 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.076 0.941 . . . . 0.0 111.063 -177.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.598 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.96 -53.11 10.8 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.753 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.598 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -49.09 -55.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.98 -33.69 52.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.736 -2.029 . . . . 0.0 110.511 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.06 -17.71 62.45 Favored Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.3 m-30 -86.91 -37.18 17.88 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -13.15 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.112 0.958 . . . . 0.0 109.297 176.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.96 -22.67 45.33 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.437 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 69.6 mt -91.95 -61.9 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.126 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.441 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.64 -20.37 27.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.324 -176.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.441 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.637 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 N--CA 1.463 0.199 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.03 -43.26 99.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.619 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.26 89.2 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.724 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 85.3 t . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.781 0.324 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.68 153.29 26.64 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.202 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -130.09 134.64 47.49 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.052 0.22 . . . . 0.0 111.436 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -138.93 129.3 25.69 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.533 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.573 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.39 102.32 10.41 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 123.902 1.811 . . . . 0.0 109.503 178.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.613 ' O ' ' N ' ' B' ' 328' ' ' ARG . 26.2 m -114.33 158.08 14.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 112.76 -2.018 . . . . 0.0 110.187 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -98.35 145.22 26.91 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' B' ' 326' ' ' VAL . 30.1 tt0 . . . . . 0 C--N 1.31 -1.121 0 CA-C-O 121.927 0.87 . . . . 0.0 112.435 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.6 t . . . . . 0 N--CA 1.44 -0.952 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.417 ' C ' ' O ' ' B' ' 326' ' ' VAL . 71.2 Cg_exo -44.14 143.03 3.63 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 N-CA-C 107.939 -1.6 . . . . 0.0 107.939 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.617 HH21 ' CD1' ' B' ' 348' ' ' ILE . 2.2 tpt180 -148.52 -172.59 4.12 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.629 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.66 121.11 11.0 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 31.9 tp -99.4 158.61 15.6 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.198 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.34 108.34 0.52 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 29.9 mm -88.19 123.26 40.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.718 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.88 138.37 52.17 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.412 ' O ' HG21 ' B' ' 399' ' ' ILE . 1.0 OUTLIER -58.06 15.73 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.752 0.31 . . . . 0.0 111.251 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.718 ' H ' ' C ' ' B' ' 333' ' ' THR . 11.2 pt-20 -145.12 -4.75 0.71 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.525 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.62 177.28 2.15 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.425 1.107 . . . . 0.0 112.89 -176.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.61 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.9 t -132.56 145.3 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 CA-C-N 113.065 -1.88 . . . . 0.0 106.315 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.472 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.2 ptt? -152.63 150.61 29.67 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 117.175 -1.81 . . . . 0.0 114.423 -175.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . 0.507 ' NH1' ' OE1' ' B' ' 317' ' ' GLU . 26.3 mtm105 -95.74 107.01 19.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.481 176.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.629 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -96.57 150.04 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.274 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.6 t0 -88.19 91.4 8.77 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.668 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.4 -28.49 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.678 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.9 mttm -75.19 -43.96 49.18 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.704 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.74 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 1.3 p -108.95 -13.27 14.76 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 17.4 tttp 67.72 -0.9 1.8 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 109.988 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.74 ' H ' ' HG1' ' B' ' 344' ' ' THR . 3.5 mt-10 -85.69 152.07 23.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.346 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 85.6 t -81.38 133.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.514 0.673 . . . . 0.0 112.209 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . 0.617 ' CD1' HH21 ' B' ' 328' ' ' ARG . 48.8 mt -103.83 -30.24 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.335 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.472 ' O ' ' CB ' ' B' ' 338' ' ' MET . 21.4 tt0 -139.72 157.41 45.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.639 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -143.35 149.98 38.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.321 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.554 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.87 124.12 4.27 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.102 177.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.516 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.54 140.63 3.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.394 0.616 . . . . 0.0 111.606 -178.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' B' ' 355' ' ' ASN . 2.0 tt -84.16 -35.89 23.26 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -74.26 9.87 1.49 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.824 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.575 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.0 m-20 -111.46 -7.56 14.34 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.069 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 81.3 mt -55.95 146.9 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.805 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -107.83 -45.9 3.9 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.502 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.9 ptt-85 -173.02 135.72 0.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.457 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.0 p90 -119.61 176.28 5.45 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.195 -177.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.93 99.59 1.54 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.017 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.34 147.7 30.97 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.574 -1.193 . . . . 0.0 110.682 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.541 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -135.32 174.17 4.9 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -77.81 -8.13 16.74 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.137 1.892 . . . . 0.0 112.122 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' B' ' 382' ' ' THR . 5.6 mttm -130.74 -20.36 2.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.056 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.566 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.1 p -153.11 167.98 27.43 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.594 0.711 . . . . 0.0 111.934 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.437 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -139.42 156.46 46.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.618 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.424 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 26.0 m -148.51 154.81 40.32 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.03 -1.068 . . . . 0.0 113.081 -174.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.424 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.8 mt -125.82 140.0 53.03 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.362 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.6 t0 -117.4 95.6 5.04 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.654 176.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 30.5 t80 -137.93 94.94 2.95 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.985 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.85 12.11 1.99 Allowed Glycine 0 C--O 1.224 -0.51 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.3 t0 -41.61 -16.42 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.977 -0.612 . . . . 0.0 111.745 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.38 -37.33 64.88 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.513 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.06 -92.31 0.51 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.283 176.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.513 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.5 t70 -129.59 96.36 4.24 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.5 -3.34 53.28 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.21 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.677 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.21 106.79 16.11 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . 0.4 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.9 OUTLIER -114.53 120.3 39.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.748 176.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 34.8 t -138.68 163.91 30.9 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.54 175.81 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.15 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.76 124.29 47.15 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.904 0.859 . . . . 0.0 110.754 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.566 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.69 136.85 14.77 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.87 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.74 17.42 4.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.247 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . 0.552 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.1 OUTLIER -144.06 83.74 1.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.996 175.031 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.53 -58.24 1.97 Allowed Glycine 0 C--N 1.317 -0.498 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.1 pt-20 -44.81 -20.17 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 114.949 -0.625 . . . . 0.0 111.032 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 6.7 mm-40 -83.47 -38.87 21.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.2 mt -76.68 -42.2 34.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.613 177.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.69 -42.58 61.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.363 -1.289 . . . . 0.0 113.541 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.443 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.9 pt20 -63.55 -34.45 77.83 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.051 0.929 . . . . 0.0 111.069 -177.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.599 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.02 -53.32 10.29 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.81 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.599 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.6 mt -49.21 -55.09 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 176.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.38 -34.1 46.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.55 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.79 -17.95 62.54 Favored Glycine 0 CA--C 1.506 -0.529 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.5 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.4 m-30 -86.91 -36.93 18.1 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -13.29 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 CA-C-O 122.151 0.976 . . . . 0.0 109.283 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.49 -22.62 47.19 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.741 -1.572 . . . . 0.0 109.447 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.7 mt -91.94 -61.85 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.901 -1.499 . . . . 0.0 112.037 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -65.12 -20.17 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.357 -176.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.454 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.838 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 CA--C 1.519 -0.243 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.84 -40.33 83.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.3 -42.03 99.72 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.491 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.4 mt-10 . . . . . 0 C--N 1.327 -0.381 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.772 0.32 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.02 153.7 25.22 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.099 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -127.79 135.57 50.28 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.1 0.25 . . . . 0.0 111.56 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -140.31 128.11 21.86 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.568 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.557 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.58 107.99 13.84 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 123.653 1.692 . . . . 0.0 109.477 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' B' ' 328' ' ' ARG . 31.1 m -119.85 161.28 19.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 112.706 -2.043 . . . . 0.0 110.072 -176.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -102.58 146.02 28.78 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' B' ' 326' ' ' VAL . 20.5 tt0 . . . . . 0 C--N 1.313 -0.99 0 CA-C-O 121.993 0.902 . . . . 0.0 112.275 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.2 t . . . . . 0 N--CA 1.442 -0.873 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' B' ' 326' ' ' VAL . 64.0 Cg_exo -44.87 145.09 3.13 Favored 'Trans proline' 0 C--N 1.32 -0.937 0 N-CA-C 108.088 -1.543 . . . . 0.0 108.088 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.632 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 12.5 ttm-85 -151.68 -172.89 4.35 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.62 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.21 121.13 13.59 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 31.9 tp -99.17 157.95 16.01 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -178.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.01 108.04 0.52 Allowed Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.96 122.19 39.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.737 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.2 p -116.56 138.2 51.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.43 ' O ' HG21 ' B' ' 399' ' ' ILE . 22.1 pttm -57.59 14.09 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.031 0.443 . . . . 0.0 111.647 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.737 ' H ' ' C ' ' B' ' 333' ' ' THR . 16.2 pt-20 -144.2 -3.63 0.84 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.758 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.618 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.59 178.18 1.98 Allowed 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.386 1.089 . . . . 0.0 112.898 -176.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.618 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.0 t -134.18 144.72 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 113.106 -1.861 . . . . 0.0 106.386 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.488 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.6 ptt? -152.71 151.46 30.56 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 117.175 -1.81 . . . . 0.0 114.42 -175.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.18 106.69 18.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.385 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.651 ' N ' ' O ' ' B' ' 329' ' ' LEU . 3.0 t -96.1 149.26 4.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.293 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' B' ' 343' ' ' LYS . 46.0 t0 -87.26 90.49 8.38 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.854 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.8 OUTLIER -35.84 -28.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.686 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' B' ' 341' ' ' ASP . 15.9 mttp -70.49 -44.01 68.55 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.613 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.624 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 0.5 OUTLIER -114.21 -17.55 11.84 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' B' ' 344' ' ' THR . 8.3 tttp 77.46 -0.0 2.87 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.624 ' H ' ' HG1' ' B' ' 344' ' ' THR . 8.1 pt-20 -82.47 157.82 23.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 90.3 t -87.38 131.69 34.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.363 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 59.3 mt -101.35 -29.99 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.455 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.488 ' O ' ' CB ' ' B' ' 338' ' ' MET . 18.0 tt0 -140.81 158.23 44.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.626 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -143.79 151.25 39.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.232 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -160.31 124.83 3.75 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.19 177.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.539 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -47.09 139.42 5.86 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.448 0.642 . . . . 0.0 111.493 -178.803 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.9 tt -82.99 -35.67 25.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.2 t -74.15 9.69 1.52 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.935 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.57 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.1 m-20 -111.29 -7.67 14.4 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.992 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 78.9 mt -56.55 146.69 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.826 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -107.76 -45.12 4.08 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.503 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 10.3 ptt180 -173.79 136.1 0.54 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.476 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 7.9 p90 -119.09 177.24 4.94 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.23 -177.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.58 99.23 1.57 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.101 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.13 147.13 30.21 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.647 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.554 ' HG ' ' H ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -135.69 173.71 5.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -76.98 -8.39 17.74 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.088 1.858 . . . . 0.0 112.297 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.9 mttm -130.66 -20.76 2.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.057 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.56 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.3 p -152.47 167.67 28.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.572 0.701 . . . . 0.0 111.852 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.443 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -139.2 156.79 46.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.815 179.619 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.437 ' OG1' ' OG ' ' B' ' 379' ' ' SER . 24.9 m -148.65 155.52 41.16 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.11 -1.036 . . . . 0.0 113.17 -174.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.432 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.8 mt -126.05 140.15 52.83 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.168 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 9.2 t0 -117.69 95.6 5.01 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.547 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 31.0 t80 -137.63 94.71 2.95 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.937 176.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.85 12.17 1.98 Allowed Glycine 0 C--O 1.225 -0.421 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.7 t0 -41.6 -16.16 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.953 -0.624 . . . . 0.0 111.818 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.45 -37.44 65.19 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.514 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.87 -92.59 0.5 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.909 -1.496 . . . . 0.0 107.187 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.514 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.5 t70 -129.34 96.18 4.23 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.24 -3.37 54.05 Favored Glycine 0 C--N 1.311 -0.851 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.256 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.02 106.73 15.9 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -175.605 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . 0.403 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.9 OUTLIER -114.05 120.38 40.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.759 175.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.636 ' HG ' ' H ' ' B' ' 380' ' ' VAL . 34.7 t -138.46 163.87 30.83 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.679 0.752 . . . . 0.0 112.909 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.636 ' H ' ' HG ' ' B' ' 379' ' ' SER . 1.6 m -150.76 175.56 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.101 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -101.53 125.08 48.13 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.12 0.962 . . . . 0.0 110.799 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.56 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.22 136.51 14.0 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.831 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.22 17.35 4.38 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.175 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.04 83.94 1.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.936 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.98 -58.78 1.95 Allowed Glycine 0 C--O 1.223 -0.557 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.501 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.7 pt-20 -44.45 -20.87 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 114.787 -0.706 . . . . 0.0 111.027 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' B' ' 385' ' ' GLY . 22.3 mt-30 -82.37 -39.35 22.86 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 51.6 mt -76.59 -42.2 34.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.579 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.89 -42.57 60.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.534 -177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 5.0 pp0? -63.81 -34.44 77.91 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.075 0.941 . . . . 0.0 111.105 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.6 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.05 -53.42 10.02 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.73 -179.581 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.6 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -48.97 -55.56 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -51.96 -34.01 40.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.777 -2.01 . . . . 0.0 110.635 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.89 -18.16 61.9 Favored Glycine 0 CA--C 1.506 -0.491 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.5 m-30 -86.79 -36.82 18.34 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -13.3 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 CA-C-O 122.195 0.998 . . . . 0.0 109.29 176.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.42 -22.6 47.5 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.512 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.5 mt -91.9 -62.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.003 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.44 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.68 -20.24 26.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.359 -1.746 . . . . 0.0 112.393 -176.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.44 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.715 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 CA--C 1.521 -0.152 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.08 -43.75 98.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.79 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.35 -36.08 81.92 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.752 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 95.2 t . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.736 0.303 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.58 153.59 27.31 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -129.58 134.13 47.56 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.14 0.275 . . . . 0.0 111.45 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -138.93 128.01 23.88 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.615 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.561 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.06 106.09 12.78 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 123.762 1.744 . . . . 0.0 109.284 178.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' B' ' 328' ' ' ARG . 28.5 m -118.55 162.68 16.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 112.669 -2.059 . . . . 0.0 110.12 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -103.83 145.98 29.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' B' ' 326' ' ' VAL . 38.1 tt0 . . . . . 0 C--N 1.314 -0.942 0 CA-C-O 122.059 0.933 . . . . 0.0 112.538 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' B' ' 317' ' ' GLU . 19.6 t . . . . . 0 N--CA 1.44 -0.967 0 CA-C-O 119.158 -0.449 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' B' ' 326' ' ' VAL . 67.8 Cg_exo -44.52 144.73 3.01 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 N-CA-C 108.117 -1.532 . . . . 0.0 108.117 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.636 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 8.1 ttm180 -151.18 -173.09 4.39 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 119.577 -0.849 . . . . 0.0 108.712 -177.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.12 121.47 13.99 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 33.3 tp -99.41 158.42 15.74 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.213 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.83 108.44 0.52 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.0 mm -87.91 123.96 40.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.73 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.42 138.38 52.5 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.417 ' O ' HG22 ' B' ' 399' ' ' ILE . 0.5 OUTLIER -57.83 14.71 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.122 0.487 . . . . 0.0 111.562 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.73 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.2 pt-20 -144.59 -4.11 0.78 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.805 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.13 176.77 2.03 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.323 1.059 . . . . 0.0 112.989 -176.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.615 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 9.5 t -132.58 145.8 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 CA-C-N 113.209 -1.814 . . . . 0.0 106.269 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.477 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.2 ptt? -152.66 151.16 30.25 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 117.167 -1.813 . . . . 0.0 114.549 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . 0.554 ' NH1' ' NE2' ' B' ' 349' ' ' GLN . 2.7 mtm180 -95.76 106.8 18.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.436 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.46 149.5 4.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.29 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' B' ' 343' ' ' LYS . 42.9 t0 -87.63 90.83 8.52 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.862 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.8 OUTLIER -36.24 -27.27 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.654 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.1 mttp -70.64 -43.17 69.78 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.672 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.533 ' N ' ' O ' ' B' ' 341' ' ' ASP . 26.6 p -115.59 -17.86 11.05 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' B' ' 344' ' ' THR . 10.3 tttm 78.16 1.19 2.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 110.126 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -84.97 156.98 20.93 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 91.7 t -86.69 132.87 31.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.508 0.67 . . . . 0.0 112.394 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 22.0 mm -102.6 -30.6 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.267 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.554 ' NE2' ' NH1' ' B' ' 339' ' ' ARG . 2.7 tt0 -140.45 157.87 44.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.622 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -142.28 150.29 40.67 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.19 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -157.16 122.32 4.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.136 177.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.528 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -45.48 138.95 4.02 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.403 0.621 . . . . 0.0 111.503 -178.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.7 tt -81.66 -36.99 28.18 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 17.4 m -70.97 6.9 1.34 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.892 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.569 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.7 m-20 -108.55 -4.95 16.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.93 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 70.8 mt -60.65 144.16 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.743 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -107.3 -45.63 4.06 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.4 ptt-85 -172.43 135.77 0.74 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.451 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 8.7 p90 -118.95 175.51 5.72 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.119 -177.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.87 98.94 1.66 Allowed 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 119.199 -1.001 . . . . 0.0 111.891 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.16 149.54 29.07 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.839 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.522 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -137.86 174.99 3.72 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -78.42 -7.0 15.83 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.266 1.977 . . . . 0.0 112.134 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' B' ' 382' ' ' THR . 47.6 mttt -130.84 -22.53 2.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.001 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.55 ' HA ' ' H ' ' B' ' 382' ' ' THR . 63.8 p -152.74 165.94 33.74 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.653 0.74 . . . . 0.0 111.85 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.431 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -137.36 156.98 47.58 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.737 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.441 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 27.7 m -148.52 156.29 42.25 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.065 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.441 ' N ' ' CG2' ' B' ' 367' ' ' THR . 7.1 mt -126.71 141.45 51.84 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.435 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.4 t0 -118.44 95.41 4.86 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.691 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 17.6 t80 -137.18 94.85 3.0 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.951 176.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.79 12.24 1.98 Allowed Glycine 0 C--O 1.225 -0.412 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -41.73 -16.15 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.857 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.52 -37.51 65.45 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.506 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.82 -92.27 0.51 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.958 -1.473 . . . . 0.0 107.345 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.506 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 12.9 t0 -129.75 96.37 4.22 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.46 -2.7 53.56 Favored Glycine 0 C--N 1.311 -0.82 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.271 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.81 106.87 16.67 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -175.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.11 122.69 46.87 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.663 176.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 34.3 t -139.03 163.69 31.73 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.35 173.66 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.113 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -99.92 125.29 45.89 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.976 0.893 . . . . 0.0 110.872 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.55 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.21 136.39 13.91 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.912 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.09 16.83 4.66 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.296 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.19 84.1 1.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.992 175.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.76 -58.26 2.05 Favored Glycine 0 C--N 1.317 -0.487 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.9 pt-20 -44.73 -20.09 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 114.893 -0.653 . . . . 0.0 111.047 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.434 ' N ' ' C ' ' B' ' 385' ' ' GLY . 46.7 mt-30 -82.89 -39.76 21.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' B' ' 385' ' ' GLY . 51.4 mt -76.66 -41.84 34.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.687 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.86 -42.19 61.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.362 -1.29 . . . . 0.0 113.604 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.462 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.4 pt20 -64.19 -34.44 78.08 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.06 0.933 . . . . 0.0 111.047 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.598 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.09 -53.47 9.87 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.759 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.598 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -48.93 -55.28 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.6 -33.9 48.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 112.801 -2.0 . . . . 0.0 110.506 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.75 -17.98 62.55 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.4 m-30 -86.91 -37.07 17.98 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -13.14 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.911 0 CA-C-O 122.102 0.953 . . . . 0.0 109.325 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.04 -22.6 45.15 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.507 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.9 mt -91.83 -61.96 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-N 113.865 -1.516 . . . . 0.0 112.105 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.54 -20.54 27.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.38 -176.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.462 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.801 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.463 0.206 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -39.34 81.73 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.57 -45.52 96.15 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.518 ' OE2' ' CD2' ' B' ' 377' ' ' TYR . 82.5 mt-10 . . . . . 0 C--O 1.222 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 69.2 t . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 120.835 0.35 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.44 153.1 25.49 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.081 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -128.99 134.76 48.29 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.037 0.211 . . . . 0.0 111.405 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -138.35 129.76 27.55 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.763 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.568 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.12 104.02 12.16 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 123.666 1.698 . . . . 0.0 109.283 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.598 ' O ' ' N ' ' B' ' 328' ' ' ARG . 34.7 m -120.27 157.27 22.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 112.867 -1.97 . . . . 0.0 110.167 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' B' ' 380' ' ' VAL . 7.0 mtmt -96.6 139.5 32.59 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.454 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.529 ' OE1' ' NE ' ' B' ' 339' ' ' ARG . 3.2 tt0 . . . . . 0 C--N 1.316 -0.866 0 CA-C-O 122.007 0.908 . . . . 0.0 113.061 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' B' ' 327' ' ' PRO . 3.4 t . . . . . 0 N--CA 1.444 -0.743 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.542 ' O ' ' NE ' ' B' ' 328' ' ' ARG . 80.1 Cg_exo -38.05 144.62 0.17 Allowed 'Trans proline' 0 CA--C 1.508 -0.816 0 N-CA-C 108.701 -1.307 . . . . 0.0 108.701 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' B' ' 315' ' ' VAL . 0.3 OUTLIER -157.15 -171.54 3.67 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.82 -176.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.643 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -142.81 124.38 14.88 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 27.9 tp -103.95 158.18 16.59 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.41 107.84 0.52 Allowed Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 31.6 mm -88.35 123.59 40.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.745 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.4 p -118.19 137.91 52.67 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.43 ' O ' HG21 ' B' ' 399' ' ' ILE . 20.9 pttm -57.36 13.64 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.004 0.43 . . . . 0.0 111.793 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.745 ' H ' ' C ' ' B' ' 333' ' ' THR . 12.7 pt-20 -144.32 -2.85 0.86 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.991 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.643 ' H ' ' HG1' ' B' ' 333' ' ' THR . 0.1 OUTLIER -173.9 178.72 2.12 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.307 1.051 . . . . 0.0 112.982 -177.07 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.601 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.38 145.6 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-N 113.338 -1.756 . . . . 0.0 106.682 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.473 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 3.2 ptt? -153.95 149.49 27.33 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 117.062 -1.855 . . . . 0.0 114.356 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . 0.529 ' NE ' ' OE1' ' B' ' 317' ' ' GLU . 12.1 mtp180 -94.14 107.65 19.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.666 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -98.73 149.71 5.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.2 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.9 t0 -89.6 92.27 9.02 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.815 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 341' ' ' ASP . 1.1 tt0 -35.46 -28.83 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.65 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' B' ' 341' ' ' ASP . 14.8 mttp -75.17 -43.62 51.19 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.704 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.61 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 1.2 p -109.2 -12.55 14.78 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt 66.67 -1.15 1.38 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.029 0.442 . . . . 0.0 109.961 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.61 ' H ' ' HG1' ' B' ' 344' ' ' THR . 2.5 mt-10 -84.71 153.53 23.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.322 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 79.2 t -82.83 135.29 25.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.454 0.645 . . . . 0.0 112.288 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 66.0 mt -103.67 -30.39 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.424 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.473 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.9 tt0 -140.55 156.63 46.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.715 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -145.74 149.61 34.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.495 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' B' ' 337' ' ' VAL . 63.5 t-105 -162.79 135.15 5.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.892 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.503 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.57 138.75 27.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.411 -178.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.9 tt -79.03 -35.82 42.05 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.64 10.92 1.16 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.98 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.503 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.4 m-20 -114.23 -4.43 13.06 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.217 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 71.6 mt -57.48 147.81 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.068 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 26.8 tttt -105.84 -45.84 4.28 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 0.2 OUTLIER -174.45 136.3 0.46 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.405 177.272 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.439 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 10.0 p90 -119.99 173.64 6.95 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.256 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.73 99.72 1.73 Allowed 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 119.153 -1.019 . . . . 0.0 112.252 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.49 144.29 31.45 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.797 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.549 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -132.14 174.28 4.89 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -77.66 -8.63 17.06 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.165 1.91 . . . . 0.0 112.019 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.0 mtpp -130.95 -19.24 2.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.121 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.592 ' HA ' ' H ' ' B' ' 382' ' ' THR . 92.8 p -152.78 168.5 25.5 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.552 0.691 . . . . 0.0 112.062 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.452 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.2 OUTLIER -140.84 156.94 46.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.914 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.461 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 64.1 m -147.3 158.99 44.17 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.003 -174.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.461 ' N ' ' CG2' ' B' ' 367' ' ' THR . 5.8 mt -133.23 140.29 47.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.515 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 19.5 t0 -117.33 96.13 5.28 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.615 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 9.5 p90 -136.9 93.92 2.9 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.352 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.66 12.49 1.76 Allowed Glycine 0 C--O 1.227 -0.294 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -41.73 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.18 -0.51 . . . . 0.0 111.769 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.562 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.46 -37.44 65.2 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.51 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.5 OUTLIER -125.76 -92.87 0.5 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.111 176.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.51 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.4 t0 -129.05 96.27 4.29 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.13 -2.66 55.87 Favored Glycine 0 C--N 1.312 -0.78 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.245 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.38 105.44 16.71 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.79 127.44 54.34 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.541 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 23.2 t -137.67 158.35 44.55 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.348 0.594 . . . . 0.0 112.349 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.541 ' N ' ' HG ' ' B' ' 379' ' ' SER . 2.4 m -141.72 172.63 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.004 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -103.35 124.62 49.03 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.896 0.855 . . . . 0.0 110.796 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.592 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.89 139.17 16.64 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.183 179.336 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.09 16.08 6.58 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.313 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.98 84.48 1.78 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.075 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.37 -56.93 2.18 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.7 pt-20 -44.98 -20.22 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 114.615 -0.792 . . . . 0.0 110.945 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' B' ' 385' ' ' GLY . 3.2 mm-40 -82.62 -39.76 21.71 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' B' ' 385' ' ' GLY . 45.0 mt -76.6 -42.38 34.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.763 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.4 -42.01 62.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.255 -1.339 . . . . 0.0 113.68 -177.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.437 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -64.06 -34.83 78.92 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.975 -177.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.596 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.85 -53.75 10.61 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.664 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.596 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.2 -55.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.7 -33.69 48.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.852 -1.976 . . . . 0.0 110.697 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.01 -17.84 62.3 Favored Glycine 0 CA--C 1.506 -0.471 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -178.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.3 m-30 -87.04 -36.99 17.88 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -13.18 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 CA-C-O 122.18 0.99 . . . . 0.0 109.236 176.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.48 -22.62 47.23 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.511 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.7 mt -91.78 -62.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.978 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.441 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.39 -20.56 27.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.379 -177.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.441 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.82 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 CA--C 1.52 -0.186 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -39.63 80.03 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.09 -43.4 98.8 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.484 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.6 mt-10 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.475 -0.362 . . . . 0.0 110.036 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.797 0.332 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.03 153.59 27.87 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.162 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -129.54 134.36 47.72 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.042 0.214 . . . . 0.0 111.439 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -139.22 127.78 23.09 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.596 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.56 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.75 106.85 13.07 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 123.712 1.72 . . . . 0.0 109.272 178.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.622 ' O ' ' N ' ' B' ' 328' ' ' ARG . 28.0 m -119.8 162.82 17.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 112.755 -2.02 . . . . 0.0 110.187 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -103.72 145.58 29.86 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' B' ' 326' ' ' VAL . 44.2 tt0 . . . . . 0 C--N 1.315 -0.905 0 CA-C-O 122.023 0.916 . . . . 0.0 112.558 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.7 t . . . . . 0 N--CA 1.442 -0.86 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' B' ' 326' ' ' VAL . 68.9 Cg_exo -43.9 144.51 2.47 Favored 'Trans proline' 0 C--N 1.321 -0.917 0 N-CA-C 108.209 -1.496 . . . . 0.0 108.209 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.631 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 7.6 ttm180 -151.55 -173.02 4.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 119.496 -0.881 . . . . 0.0 108.628 -177.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.636 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.68 121.32 13.38 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.113 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 31.5 tp -99.47 158.72 15.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.175 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.95 108.7 0.53 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.2 mm -87.91 124.4 41.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.737 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.5 p -118.59 138.25 52.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.327 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.431 ' O ' HG23 ' B' ' 399' ' ' ILE . 4.1 ptpp? -57.96 14.4 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.115 0.484 . . . . 0.0 111.769 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.737 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -144.66 -3.06 0.81 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.981 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.62 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.64 176.95 1.82 Allowed 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.43 1.11 . . . . 0.0 112.833 -176.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.62 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.4 t -132.28 145.84 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-N 113.071 -1.877 . . . . 0.0 106.215 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.477 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 0.9 OUTLIER -152.63 150.78 29.86 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 117.179 -1.808 . . . . 0.0 114.415 -175.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . 0.516 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 60.0 mtm180 -95.85 106.94 19.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.397 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.65 149.93 4.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.278 -178.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.0 t0 -88.07 91.6 8.83 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.736 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.9 OUTLIER -35.42 -28.38 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.671 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' B' ' 341' ' ' ASP . 28.1 mttp -75.39 -43.92 47.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.641 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.558 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.68 -13.47 14.79 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm 67.71 -1.11 1.74 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' B' ' 344' ' ' THR . 4.4 mt-10 -85.95 152.08 23.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.337 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 86.9 t -80.99 133.26 29.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.527 0.68 . . . . 0.0 112.176 -178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 55.0 mt -102.91 -30.29 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.323 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.516 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 22.1 tt0 -140.27 158.06 44.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 45.6 mt-10 -142.85 150.69 40.22 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.296 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.02 122.47 4.23 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.227 177.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.511 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.01 140.1 2.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.51 0.672 . . . . 0.0 111.632 -178.755 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.5 tt -82.46 -36.48 26.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 354' ' ' THR . . . . . 0.475 ' CG2' ' O ' ' B' ' 354' ' ' THR . 99.5 m -71.17 7.07 1.36 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.831 177.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.571 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.2 m-20 -108.12 -5.26 17.06 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.828 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 72.1 mt -61.19 143.23 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.672 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -107.3 -45.29 4.13 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.501 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.0 ptt-85 -172.17 136.27 0.83 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.474 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 7.8 p90 -119.14 176.33 5.36 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.234 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.63 98.62 1.67 Allowed 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 119.066 -1.054 . . . . 0.0 112.044 -178.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.81 145.01 31.64 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.747 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.532 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -133.76 174.15 5.02 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -77.69 -7.61 16.7 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.12 1.88 . . . . 0.0 112.158 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.4 mtpt -130.86 -21.42 2.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.011 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.556 ' HA ' ' H ' ' B' ' 382' ' ' THR . 61.3 p -152.65 166.63 31.51 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.56 0.695 . . . . 0.0 111.908 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.453 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -137.68 156.84 47.58 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.823 179.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.433 ' OG1' ' OG ' ' B' ' 379' ' ' SER . 29.1 m -148.81 155.06 40.4 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.215 -174.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.425 ' N ' ' CG2' ' B' ' 367' ' ' THR . 7.4 mt -125.81 139.83 53.17 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.181 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.1 t0 -117.6 95.65 5.04 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.569 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 15.1 t80 -137.45 94.43 2.92 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.955 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.92 11.98 2.0 Allowed Glycine 0 C--O 1.225 -0.407 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 8.9 t0 -41.47 -16.01 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.087 -0.556 . . . . 0.0 111.777 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.56 -37.08 65.03 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.517 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.0 -92.94 0.49 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.876 -1.511 . . . . 0.0 107.072 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.517 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 16.3 t0 -128.9 96.38 4.34 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.53 -2.9 53.38 Favored Glycine 0 C--N 1.313 -0.7 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.339 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -83.79 106.65 15.66 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -175.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . 0.426 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.6 OUTLIER -114.06 120.8 41.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.6 176.066 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.664 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 38.4 t -138.88 164.09 30.6 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.587 0.708 . . . . 0.0 112.818 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.664 ' N ' ' HG ' ' B' ' 379' ' ' SER . 0.9 OUTLIER -150.84 174.1 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.874 179.079 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -100.47 125.49 46.78 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 122.0 0.905 . . . . 0.0 110.835 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.556 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.56 136.78 13.88 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.832 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.25 17.0 4.62 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.147 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . 0.502 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.3 OUTLIER -144.01 84.19 1.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.092 175.121 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.88 -58.45 2.01 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.463 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.2 pt-20 -44.3 -20.19 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 114.814 -0.693 . . . . 0.0 111.026 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' B' ' 385' ' ' GLY . 67.5 mt-30 -82.75 -40.15 20.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.578 0.704 . . . . 0.0 109.102 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' B' ' 385' ' ' GLY . 49.5 mt -76.41 -42.04 35.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.719 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.46 -42.32 62.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.6 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.463 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -64.14 -34.79 78.87 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.023 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.64 -53.67 9.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.727 -179.509 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.597 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -48.59 -55.7 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 176.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.8 45.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 112.761 -2.018 . . . . 0.0 110.578 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.12 -17.83 62.11 Favored Glycine 0 CA--C 1.505 -0.539 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.1 m-30 -86.88 -36.45 18.41 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -13.23 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 CA-C-O 122.166 0.984 . . . . 0.0 109.308 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.77 -22.62 42.96 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.52 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 74.8 mt -91.23 -62.15 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.17 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.431 HG23 ' O ' ' B' ' 334' ' ' LYS . 0.9 OUTLIER -61.4 -25.84 37.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 113.409 -1.723 . . . . 0.0 112.291 -176.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 C--O 1.218 -0.581 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.693 -179.703 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 N--CA 1.463 0.191 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -43.38 96.59 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.7 -36.42 89.67 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.516 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 92.6 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.326 -0.437 . . . . 0.0 109.843 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 70.8 t . . . . . 0 CA--C 1.529 0.164 0 CA-C-O 120.738 0.304 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.83 153.26 24.65 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.123 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -129.69 135.45 48.51 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.03 0.206 . . . . 0.0 111.483 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -138.83 129.89 26.7 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.565 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.561 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.61 104.72 13.09 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 123.918 1.818 . . . . 0.0 109.368 178.368 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 315' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.9 m -115.71 161.19 14.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 112.523 -2.126 . . . . 0.0 110.086 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -103.57 145.0 30.69 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 317' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' B' ' 326' ' ' VAL . 27.8 tt0 . . . . . 0 C--N 1.316 -0.88 0 CA-C-O 122.102 0.953 . . . . 0.0 112.729 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 326' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' B' ' 317' ' ' GLU . 9.5 t . . . . . 0 N--CA 1.44 -0.967 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 327' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' B' ' 326' ' ' VAL . 61.0 Cg_exo -44.56 145.22 2.76 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 N-CA-C 108.099 -1.539 . . . . 0.0 108.099 178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 328' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' B' ' 315' ' ' VAL . 5.6 ttm-85 -150.2 -173.21 4.37 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.776 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 329' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.95 122.72 12.64 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.07 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 26.4 tp -101.96 158.32 16.22 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.44 107.94 0.53 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.8 mm -88.46 123.83 41.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 333' ' ' THR . . . . . 0.745 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.6 p -118.31 137.75 52.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 334' ' ' LYS . . . . . 0.42 ' O ' HG23 ' B' ' 399' ' ' ILE . 0.0 OUTLIER -57.26 13.23 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.05 0.452 . . . . 0.0 111.741 -179.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 335' ' ' GLU . . . . . 0.745 ' H ' ' C ' ' B' ' 333' ' ' THR . 11.3 pt-20 -144.15 -2.52 0.89 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.844 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 336' ' ' CYS . . . . . 0.611 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.86 179.36 2.0 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 122.158 0.98 . . . . 0.0 113.045 -177.194 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 337' ' ' VAL . . . . . 0.611 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.3 t -137.08 145.31 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 CA-C-N 113.365 -1.743 . . . . 0.0 106.677 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 338' ' ' MET . . . . . 0.479 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 3.9 ptt? -154.08 149.95 27.69 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 117.028 -1.869 . . . . 0.0 114.318 -176.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 339' ' ' ARG . . . . . 0.497 ' NH1' ' OE2' ' B' ' 317' ' ' GLU . 44.7 mtm180 -94.66 107.79 19.78 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.778 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 340' ' ' VAL . . . . . 0.626 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.24 149.84 5.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.228 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 344' ' ' THR . 29.0 t0 -89.93 92.15 8.89 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.784 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.51 -28.95 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.76 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 343' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 35.8 mttt -74.7 -43.67 53.97 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.672 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 344' ' ' THR . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.3 -12.72 14.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 7.4 tttp 66.73 -0.91 1.46 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.977 0.418 . . . . 0.0 109.918 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 346' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.6 mt-10 -84.88 152.73 23.36 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.388 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 81.9 t -82.92 135.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.449 0.642 . . . . 0.0 112.352 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mt -104.03 -30.13 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.386 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 349' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' B' ' 338' ' ' MET . 6.9 tt0 -140.49 156.05 46.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.677 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -145.66 149.43 34.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.451 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 351' ' ' TRP . . . . . 0.554 ' O ' ' N ' ' B' ' 337' ' ' VAL . 68.6 t-105 -162.34 135.95 6.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.828 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 352' ' ' SER . . . . . 0.509 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -54.01 138.32 37.51 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.541 -178.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.8 tt -78.51 -35.69 45.97 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.97 11.1 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.97 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 355' ' ' ASN . . . . . 0.509 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -115.04 -3.99 12.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.171 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.12 148.54 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.951 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 357' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 11.5 tptt -106.45 -45.64 4.21 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.2 ptt180 -174.88 136.3 0.4 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.399 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 359' ' ' TRP . . . . . 0.462 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 8.6 p90 -118.74 174.53 6.22 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.35 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -156.88 97.99 1.73 Allowed 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.936 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -79.77 147.85 31.69 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.855 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 362' ' ' SER . . . . . 0.535 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -136.21 173.04 6.06 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -76.63 -8.61 18.26 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.033 1.822 . . . . 0.0 112.092 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 6.4 mttm -130.79 -22.08 2.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.96 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 365' ' ' SER . . . . . 0.569 ' HA ' ' H ' ' B' ' 382' ' ' THR . 89.8 p -149.73 170.02 19.7 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.617 0.723 . . . . 0.0 111.815 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 366' ' ' PHE . . . . . 0.468 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -142.79 156.56 44.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.802 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 367' ' ' THR . . . . . 0.442 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 33.9 m -148.1 156.44 42.61 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.734 -174.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 368' ' ' LEU . . . . . 0.442 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.0 mt -129.11 143.4 50.85 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.479 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.7 t0 -119.74 95.86 4.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.652 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 370' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 10.3 p90 -136.6 93.52 2.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.371 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 371' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.58 12.22 1.81 Allowed Glycine 0 C--O 1.226 -0.397 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -41.77 -15.74 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.117 -0.542 . . . . 0.0 111.776 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 373' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.61 -37.3 65.42 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 374' ' ' GLN . . . . . 0.514 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.85 -92.94 0.5 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 375' ' ' ASP . . . . . 0.514 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.5 t70 -129.02 96.4 4.33 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.5 -2.45 55.49 Favored Glycine 0 C--N 1.311 -0.859 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.218 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 377' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.32 106.11 17.15 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -175.547 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.21 125.98 52.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.783 175.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 379' ' ' SER . . . . . 0.674 ' HG ' ' H ' ' B' ' 380' ' ' VAL . 35.9 t -138.19 164.27 29.62 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.519 0.676 . . . . 0.0 112.667 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 380' ' ' VAL . . . . . 0.674 ' H ' ' HG ' ' B' ' 379' ' ' SER . 1.8 m -150.4 172.89 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.942 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -99.77 126.51 45.85 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.891 0.853 . . . . 0.0 111.114 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 382' ' ' THR . . . . . 0.569 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.11 136.05 13.73 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.651 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.27 16.66 4.22 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.103 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.95 84.04 1.77 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.91 175.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.9 -58.84 1.95 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 386' ' ' GLU . . . . . 0.509 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.1 pt-20 -44.66 -20.73 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.746 -0.727 . . . . 0.0 110.976 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 387' ' ' GLN . . . . . 0.429 ' N ' ' C ' ' B' ' 385' ' ' GLY . 78.2 mt-30 -82.06 -39.38 23.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 48.1 mt -76.93 -42.33 32.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.712 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.87 -42.29 60.96 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.185 -1.37 . . . . 0.0 113.618 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 390' ' ' GLN . . . . . 0.509 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.79 -34.99 79.13 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.116 0.96 . . . . 0.0 110.992 -177.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 391' ' ' LEU . . . . . 0.599 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.93 -53.59 10.91 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.814 -179.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 392' ' ' ILE . . . . . 0.599 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.09 -56.12 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.29 -33.77 43.67 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.792 -2.004 . . . . 0.0 110.743 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 394' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.2 -17.86 61.92 Favored Glycine 0 CA--C 1.507 -0.454 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 395' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.3 m-30 -87.15 -36.95 17.77 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -13.33 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 122.237 1.017 . . . . 0.0 109.365 176.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.54 -22.7 46.89 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.513 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.5 mt -91.8 -62.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 113.899 -1.501 . . . . 0.0 112.042 -178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 399' ' ' ILE . . . . . 0.443 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.29 -20.6 27.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 113.404 -1.725 . . . . 0.0 112.384 -177.048 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 400' ' ' LEU . . . . . 0.443 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.773 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.2 mt -100.2 150.85 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.543 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.71 -67.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.895 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 13' ' ' SER . 8.3 mt-30 -120.95 -21.61 6.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.518 ' C ' ' O ' ' A' ' 10' ' ' GLN . 15.6 mtm -14.47 -63.54 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 124.2 0.937 . . . . 0.0 112.044 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -41.96 -62.73 0.86 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.101 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -65.24 -27.86 68.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.71 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.54 ' H ' ' HG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -70.01 -24.54 63.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.966 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -98.97 -36.87 9.6 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -43.41 98.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.582 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.87 -37.27 90.45 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.74 -40.6 72.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.457 -0.371 . . . . 0.0 110.035 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.546 ' CG ' ' HG1' ' B' ' 367' ' ' THR . 9.9 mtp -54.49 -31.81 56.69 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.936 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.9 -28.8 17.51 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.335 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.521 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.4 mm? -73.59 -11.32 60.39 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.287 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.55 ' CD2' ' HG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -89.58 -11.26 43.22 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.55 ' HG1' ' CD2' ' A' ' 22' ' ' LEU . 2.9 m -113.4 -14.97 12.71 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.961 0.41 . . . . 0.0 110.267 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.46 -74.1 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.179 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.94 -36.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.188 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 26' ' ' LEU . 8.4 mp -63.05 -99.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.548 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.67 -82.71 0.27 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.453 ' C ' ' H ' ' A' ' 30' ' ' THR . 63.6 t -136.47 -1.53 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.744 0.307 . . . . 0.0 110.665 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' O ' ' OXT' ' A' ' 30' ' ' THR . 45.7 t0 48.13 15.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.671 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 28' ' ' VAL . 41.8 p . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.554 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -137.15 -145.47 4.96 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 89.1 t -40.8 138.31 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 110.703 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.56 153.62 27.22 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.202 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.22 134.29 47.16 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.054 0.221 . . . . 0.0 111.471 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -139.82 128.42 23.03 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.663 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.556 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.58 107.17 13.16 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 123.685 1.707 . . . . 0.0 109.358 178.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.609 ' O ' ' N ' ' B' ' 328' ' ' ARG . 28.7 m -118.96 160.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.174 -176.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -104.78 144.93 31.08 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' B' ' 326' ' ' VAL . 60.6 tt0 -134.04 152.38 51.82 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 122.126 0.965 . . . . 0.0 112.596 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 6.7 tptm -81.24 102.37 10.32 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.163 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 35.2 mmt -96.81 178.78 5.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.067 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.66 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -99.38 150.52 22.06 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.067 178.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 117.02 -23.34 10.0 Favored Glycine 0 C--N 1.315 -0.59 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -138.56 -142.27 0.16 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.285 -0.457 . . . . 0.0 110.646 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.525 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.4 OUTLIER -141.28 -17.88 0.8 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.532 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.1 -176.79 4.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.935 0.398 . . . . 0.0 110.956 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 29.0 mt -90.17 162.78 15.1 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.192 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' B' ' 317' ' ' GLU . 12.2 t -121.58 123.81 27.41 Favored Pre-proline 0 N--CA 1.44 -0.965 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.088 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -44.74 144.75 3.23 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.634 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 10.5 ttm-85 -151.58 -173.06 4.4 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 119.48 -0.888 . . . . 0.0 108.682 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.81 120.79 12.83 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 32.0 tp -98.17 158.74 15.38 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.214 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -143.0 108.76 0.53 Allowed Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.0 mm -87.97 124.34 41.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.725 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.5 p -118.47 138.34 52.56 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.426 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.617 ' NZ ' ' CE1' ' B' ' 395' ' ' TYR . 1.1 mtmm -57.68 14.55 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.813 0.34 . . . . 0.0 111.306 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.725 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.1 pt-20 -144.96 -3.56 0.77 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.625 ' N ' ' HG1' ' B' ' 333' ' ' THR . 0.1 OUTLIER -175.15 177.7 1.86 Allowed 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.351 1.072 . . . . 0.0 112.991 -176.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.613 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.3 t -132.8 145.56 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 CA-C-N 113.093 -1.867 . . . . 0.0 106.236 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.5 ptt? -152.88 151.83 30.83 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.334 -175.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 5.4 mmt-85 -96.96 106.68 19.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.277 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -95.73 149.44 4.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.517 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' B' ' 343' ' ' LYS . 41.0 t0 -86.64 89.95 8.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.673 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.7 OUTLIER -35.88 -27.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.6 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 31.6 mttm -71.21 -44.16 65.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.582 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.54 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -113.61 -17.34 12.18 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' B' ' 344' ' ' THR . 6.8 tttm 77.26 0.22 2.96 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.406 ' CG ' ' OG1' ' B' ' 344' ' ' THR . 8.0 pt-20 -82.84 157.98 22.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 89.8 t -87.29 131.94 33.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.331 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 6.7 mt -102.64 -30.67 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.498 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.484 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.8 tt0 -138.13 158.31 44.57 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.662 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -144.48 149.75 36.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.258 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.13 123.14 3.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.318 177.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.5 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.48 139.58 3.67 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.513 0.673 . . . . 0.0 111.627 -178.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.6 tt -82.26 -36.64 26.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 19.6 m -71.74 7.37 1.53 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.882 177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.4 m-20 -108.51 -5.02 16.75 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.825 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 72.1 mt -60.81 144.19 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.725 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -107.42 -46.18 3.91 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 7.5 ptt180 -171.54 136.03 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.474 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 7.5 p90 -119.31 176.45 5.32 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.315 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.7 98.27 1.64 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.188 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.38 145.77 31.84 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.741 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -134.23 174.17 4.97 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -77.57 -7.87 16.91 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.027 1.818 . . . . 0.0 112.123 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' B' ' 382' ' ' THR . 10.4 mtpt -130.86 -21.49 2.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.016 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.56 ' HA ' ' H ' ' B' ' 382' ' ' THR . 58.1 p -152.21 167.15 29.52 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.526 0.679 . . . . 0.0 111.874 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.458 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -138.55 156.74 47.23 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.826 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.546 ' HG1' ' CG ' ' A' ' 19' ' ' MET . 31.8 m -148.56 154.72 40.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.146 -1.022 . . . . 0.0 113.185 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' B' ' 367' ' ' THR . 7.4 mt -125.89 139.64 53.3 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.142 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.9 t0 -117.72 95.58 5.0 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.485 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 17.3 t80 -137.33 94.48 2.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.89 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.87 11.97 2.01 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.6 t0 -41.41 -16.12 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.067 -0.566 . . . . 0.0 111.797 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.556 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.59 -37.03 65.06 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.515 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.3 OUTLIER -125.93 -93.06 0.49 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.853 -1.521 . . . . 0.0 106.946 176.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.515 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 8.2 t70 -128.96 96.41 4.34 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.56 -2.64 53.27 Favored Glycine 0 C--N 1.312 -0.775 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.292 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.67 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.26 107.13 16.39 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . 0.413 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.7 OUTLIER -114.65 120.43 40.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.737 176.03 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.662 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 35.1 t -138.73 163.59 31.76 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.581 0.705 . . . . 0.0 112.78 -177.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.662 ' N ' ' HG ' ' B' ' 379' ' ' SER . 1.2 m -151.08 175.41 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.792 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -100.78 125.57 47.27 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.96 0.885 . . . . 0.0 110.931 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.575 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -155.28 136.49 13.93 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.753 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.32 17.01 4.68 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.143 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . 0.575 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.4 OUTLIER -143.99 84.04 1.76 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.022 175.112 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.99 -58.84 1.94 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.458 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.4 pt-20 -44.41 -20.21 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.748 -0.726 . . . . 0.0 111.038 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.437 ' N ' ' C ' ' B' ' 385' ' ' GLY . 63.6 mt-30 -83.04 -39.71 20.87 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.1 mt -76.39 -42.22 36.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.683 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.47 -42.53 61.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.267 -1.333 . . . . 0.0 113.718 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.458 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 12.2 pt20 -63.88 -34.76 78.66 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.04 0.924 . . . . 0.0 110.98 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.599 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.84 -53.47 10.14 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 113.877 -1.51 . . . . 0.0 108.765 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.599 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.4 mt -48.67 -55.29 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 176.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.79 -33.68 49.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.708 -2.042 . . . . 0.0 110.552 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.96 -18.0 62.06 Favored Glycine 0 CA--C 1.507 -0.456 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.617 ' CE1' ' NZ ' ' B' ' 334' ' ' LYS . 5.3 m-30 -86.84 -37.18 17.99 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -13.39 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 122.153 0.978 . . . . 0.0 109.284 176.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.82 -22.69 45.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.506 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.8 mt -91.89 -61.88 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 113.895 -1.502 . . . . 0.0 112.033 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.44 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.85 -20.51 27.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.374 -1.739 . . . . 0.0 112.307 -176.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.44 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.83 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.441 ' CG1' ' SD ' ' A' ' 11' ' ' MET . 2.1 mp -101.07 151.96 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.631 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.18 -43.62 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.092 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.506 ' C ' ' HG1' ' A' ' 14' ' ' THR . 37.4 mt-30 -120.78 -24.67 5.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.934 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.487 ' C ' ' O ' ' A' ' 10' ' ' GLN . 58.2 mtp -19.42 -64.72 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 124.109 0.88 . . . . 0.0 112.02 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.412 ' C ' ' O ' ' A' ' 11' ' ' MET . 11.4 m-85 -41.09 -62.1 0.89 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.081 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' GLN . 2.9 t -64.51 -33.79 76.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.813 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.506 ' HG1' ' C ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -61.78 -27.25 68.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -96.79 -38.58 9.82 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -42.94 98.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.24 -36.86 90.59 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.47 -39.79 70.69 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.506 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 4.8 mtp -55.62 -30.61 61.23 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.893 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.11 -26.71 17.45 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.262 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.529 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 3.8 mm? -76.17 -6.5 51.56 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.234 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -93.85 -10.55 33.61 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.178 0.513 . . . . 0.0 109.811 179.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 25' ' ' SER . 44.3 m -123.29 -24.61 4.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.153 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 7.0 mp0 42.64 17.22 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.286 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.3 OUTLIER 74.97 -60.33 0.52 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.024 178.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.5 ' N ' ' OG ' ' A' ' 25' ' ' SER . 1.4 mp -89.37 -23.74 22.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.476 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.5 11.1 59.84 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 29' ' ' ASP . 3.8 p -45.01 -41.42 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.156 0.503 . . . . 0.0 110.821 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.467 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 2.0 t70 40.96 86.71 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.531 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.631 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . 0.427 ' O ' ' OH ' ' B' ' 395' ' ' TYR . . . 41.1 -108.72 0.13 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 94.8 t -86.47 136.41 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.322 . . . . 0.0 110.702 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.55 153.56 23.96 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.15 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -129.95 134.58 47.55 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.153 0.283 . . . . 0.0 111.496 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -139.84 128.52 23.13 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.582 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.557 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.86 107.27 13.53 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.745 1.736 . . . . 0.0 109.334 178.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.614 ' O ' ' N ' ' B' ' 328' ' ' ARG . 30.7 m -118.74 160.57 18.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 112.63 -2.077 . . . . 0.0 110.096 -176.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -102.94 145.53 29.7 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' B' ' 326' ' ' VAL . 31.0 tt0 -133.18 149.95 52.02 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.164 0.983 . . . . 0.0 112.575 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -81.68 101.87 10.34 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.157 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 38.1 mmt -95.05 178.89 5.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.072 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.674 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.36 150.93 22.51 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.103 178.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.12 -22.53 12.23 Favored Glycine 0 C--N 1.315 -0.586 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.19 -141.63 0.17 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.642 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -142.48 -21.1 0.68 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.523 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.3 -176.31 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.924 0.392 . . . . 0.0 111.001 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 32.9 mt -91.24 164.63 13.82 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.161 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t -122.84 122.34 27.13 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.154 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.404 ' C ' ' O ' ' B' ' 326' ' ' VAL . 63.9 Cg_exo -44.15 144.06 3.03 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 N-CA-C 108.085 -1.544 . . . . 0.0 108.085 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.63 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 8.4 ttm180 -150.26 -173.3 4.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.8 120.65 12.72 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 31.3 tp -98.45 158.43 15.6 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.09 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.45 108.4 0.52 Allowed Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 29.7 mm -87.98 123.02 40.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.724 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.37 138.25 51.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.418 ' O ' HG21 ' B' ' 399' ' ' ILE . 1.2 ttmt -57.86 15.2 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.173 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.724 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.0 pt-20 -144.99 -4.25 0.74 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.62 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.6 177.22 2.17 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 122.448 1.118 . . . . 0.0 112.892 -176.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.613 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.8 t -132.32 145.25 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-N 113.132 -1.849 . . . . 0.0 106.201 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.476 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.1 ptt? -152.77 151.01 29.99 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 117.089 -1.845 . . . . 0.0 114.419 -175.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . 0.51 ' NH2' ' NE2' ' B' ' 349' ' ' GLN . 61.4 mtm180 -96.01 106.91 19.13 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.443 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.46 149.81 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.284 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.0 t0 -87.83 91.57 8.8 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.712 -178.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.37 -28.46 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.62 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.5 mttp -75.54 -44.0 45.76 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.714 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.739 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 1.3 p -108.63 -13.07 14.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 30.7 tttp 67.38 -0.67 1.76 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 109.986 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.739 ' H ' ' HG1' ' B' ' 344' ' ' THR . 2.7 mt-10 -85.99 152.56 22.82 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.317 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 87.5 t -81.36 133.6 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.498 0.666 . . . . 0.0 112.299 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 56.1 mt -103.21 -30.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.369 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.51 ' NE2' ' NH2' ' B' ' 339' ' ' ARG . 19.7 tt0 -140.23 157.86 44.93 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.678 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 44.9 mt-10 -143.32 150.15 38.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.349 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.562 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.49 124.02 4.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.118 177.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.492 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -45.59 140.44 3.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.439 0.638 . . . . 0.0 111.566 -178.557 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' B' ' 355' ' ' ASN . 2.0 tt -84.2 -36.12 23.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -73.74 9.39 1.48 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.889 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.57 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 1.0 OUTLIER -111.04 -7.21 14.53 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.055 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.75 146.6 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.686 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 10.0 tttm -107.78 -46.35 3.82 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.3 ptt-85 -172.05 135.91 0.83 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.461 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 8.7 p90 -119.53 175.94 5.6 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.288 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.37 99.49 1.62 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.085 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.63 146.83 30.98 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.747 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.537 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -134.55 173.75 5.43 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -77.49 -7.98 17.03 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.119 1.879 . . . . 0.0 112.038 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' B' ' 382' ' ' THR . 4.1 mtpp -130.87 -21.16 2.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.038 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.564 ' HA ' ' H ' ' B' ' 382' ' ' THR . 58.6 p -152.13 167.7 27.66 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.566 0.698 . . . . 0.0 111.942 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.456 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -139.06 156.64 47.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.651 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.436 ' OG1' ' OG ' ' B' ' 379' ' ' SER . 27.9 m -148.53 154.74 40.2 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.151 -174.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.422 ' N ' ' CG2' ' B' ' 367' ' ' THR . 7.0 mt -126.12 140.03 52.9 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.08 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.0 t0 -117.75 95.84 5.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.533 176.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 27.6 t80 -137.93 94.72 2.93 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.89 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.8 12.02 2.02 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.9 t0 -41.39 -16.43 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.045 -0.577 . . . . 0.0 111.829 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.548 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.46 -37.25 64.99 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.51 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.2 pt20 -125.85 -92.74 0.5 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.941 -1.482 . . . . 0.0 107.222 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.51 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.6 t70 -129.14 96.3 4.29 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.24 -2.91 54.24 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.376 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.681 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.57 106.75 16.37 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -175.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . 0.41 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.8 OUTLIER -114.3 120.13 39.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.717 176.106 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.666 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 35.4 t -138.66 163.45 32.06 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.673 0.749 . . . . 0.0 112.773 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.666 ' N ' ' HG ' ' B' ' 379' ' ' SER . 1.3 m -150.62 175.61 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.93 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -101.42 124.89 47.83 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.938 0.875 . . . . 0.0 110.807 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.564 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.95 136.68 14.4 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.772 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.41 17.2 4.63 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.271 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.03 83.92 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.989 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.02 -59.15 1.9 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.497 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.6 pt-20 -44.33 -20.69 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.758 -0.721 . . . . 0.0 111.009 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 22.9 mt-30 -82.43 -39.59 22.39 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.0 mt -76.55 -42.01 34.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.661 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.87 -42.71 60.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.651 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 5.1 pp0? -63.76 -34.3 77.58 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.055 0.931 . . . . 0.0 110.969 -177.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.31 -53.4 9.77 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.705 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.597 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -48.77 -55.38 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.06 -34.53 43.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.737 -2.029 . . . . 0.0 110.593 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.46 -18.06 62.98 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.499 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.4 m-30 -86.7 -37.0 18.37 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -13.29 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.097 0.951 . . . . 0.0 109.221 176.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.39 -22.62 47.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.563 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 67.2 mt -91.99 -61.96 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.057 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.441 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.81 -20.28 27.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.396 -1.729 . . . . 0.0 112.335 -176.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.441 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.858 -1.067 . . . . 0.0 110.731 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.5 mt -78.21 152.49 5.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.323 0.582 . . . . 0.0 110.748 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.48 -41.05 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.374 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 11' ' ' MET . 8.9 mt-30 -69.41 -55.14 11.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.756 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.494 ' C ' ' O ' ' A' ' 10' ' ' GLN . 40.1 mtp -17.91 -71.8 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.475 0 O-C-N 124.264 0.977 . . . . 0.0 112.157 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -42.99 -60.95 1.43 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.917 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -59.15 -37.1 76.49 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.878 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.419 ' H ' ' HG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -55.52 -47.0 76.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 110.838 -179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.57 -41.05 55.76 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -39.26 80.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.724 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.35 -43.21 99.4 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.87 -38.29 90.48 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.504 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 3.9 mtp -58.32 -32.39 68.44 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.296 -0.562 . . . . 0.0 109.882 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.17 -29.06 12.66 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.249 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.1 mm? -75.15 -9.3 58.42 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.295 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.46 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -93.16 -9.42 39.43 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 25' ' ' SER . 22.0 m -131.61 -2.41 3.8 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.318 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 14.7 mp0 42.27 -91.62 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.902 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -141.36 -10.54 0.95 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.332 -178.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mp -45.64 -74.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.669 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.3 79.44 1.41 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.472 ' CG1' ' N ' ' A' ' 29' ' ' ASP . 58.7 t -95.51 -110.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.679 0.276 . . . . 0.0 110.458 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.472 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 30.5 t70 55.09 60.26 3.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.519 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.579 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.44 -154.36 52.93 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.6 t -40.62 138.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.832 0.348 . . . . 0.0 110.731 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.09 153.43 26.94 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.229 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -130.47 134.26 46.95 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.113 0.258 . . . . 0.0 111.423 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -139.31 129.01 24.63 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.625 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.561 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.52 105.9 13.04 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 123.749 1.737 . . . . 0.0 109.42 178.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' B' ' 328' ' ' ARG . 30.8 m -117.36 160.82 16.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 112.703 -2.044 . . . . 0.0 110.078 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -102.55 145.5 29.52 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.526 ' CD ' ' HE ' ' B' ' 339' ' ' ARG . 26.6 tt0 -132.92 149.5 52.24 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.955 0.884 . . . . 0.0 112.627 -178.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 6.1 tptm -81.83 100.76 9.76 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.425 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.603 ' SD ' ' NZ ' ' B' ' 320' ' ' LYS . 38.7 mmt -93.62 178.68 5.62 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.115 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.603 ' NZ ' ' SD ' ' B' ' 319' ' ' MET . 0.0 OUTLIER -101.34 157.59 16.68 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.101 179.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 107.98 -21.74 28.94 Favored Glycine 0 C--N 1.312 -0.804 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.12 -140.21 0.16 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.45 -0.375 . . . . 0.0 110.603 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.517 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.1 OUTLIER -145.83 -17.91 0.46 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.56 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.63 -176.62 4.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.966 0.412 . . . . 0.0 110.937 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 34.3 mt -90.85 164.81 13.92 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.4 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' B' ' 317' ' ' GLU . 6.5 t -124.44 122.72 25.88 Favored Pre-proline 0 N--CA 1.438 -1.049 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.038 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' B' ' 326' ' ' VAL . 66.5 Cg_exo -43.9 143.89 2.81 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 N-CA-C 108.196 -1.502 . . . . 0.0 108.196 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.622 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 15.7 ttt180 -149.71 -173.33 4.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 119.476 -0.89 . . . . 0.0 108.699 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.662 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -141.83 120.73 12.77 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 32.2 tp -98.5 158.11 15.8 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.177 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.52 108.46 0.53 Allowed Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 29.5 mm -88.1 123.04 40.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.711 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.47 138.43 51.86 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.424 ' NZ ' ' CZ ' ' B' ' 395' ' ' TYR . 0.0 OUTLIER -58.15 16.0 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.191 0.307 . . . . 0.0 111.268 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.711 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -145.48 -4.76 0.68 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.482 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.42 177.14 2.26 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 122.368 1.08 . . . . 0.0 112.883 -176.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.1 t -132.01 145.14 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 CA-C-N 113.13 -1.85 . . . . 0.0 106.33 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.474 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.2 ptt? -152.79 150.84 29.79 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 117.124 -1.831 . . . . 0.0 114.519 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . 0.526 ' HE ' ' CD ' ' B' ' 317' ' ' GLU . 0.2 OUTLIER -96.3 106.79 19.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.496 176.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.662 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.16 149.98 4.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.244 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.1 t0 -87.87 91.6 8.82 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.736 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.36 -28.45 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.685 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' B' ' 341' ' ' ASP . 44.4 mttt -75.5 -43.9 46.62 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.69 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.557 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.76 -13.33 14.8 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -177.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 20.6 tttt 67.77 -0.87 1.83 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.942 0.401 . . . . 0.0 109.943 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.462 ' H ' ' C ' ' B' ' 344' ' ' THR . 4.1 mt-10 -86.05 152.59 22.77 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 87.7 t -81.37 134.05 27.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.5 0.667 . . . . 0.0 112.237 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 7.4 mt -104.11 -30.69 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.186 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.474 ' O ' ' CB ' ' B' ' 338' ' ' MET . 15.6 tt0 -139.04 157.4 46.05 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.554 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -143.64 149.84 37.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.232 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.15 123.98 4.1 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.976 177.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.521 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -44.86 141.77 2.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.388 0.613 . . . . 0.0 111.661 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' B' ' 355' ' ' ASN . 2.0 tt -85.25 -36.27 21.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -73.91 9.99 1.32 Allowed 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.908 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.574 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.1 m-20 -111.81 -7.04 14.22 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.973 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 80.1 mt -56.44 147.04 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.748 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . 0.514 ' NZ ' ' OH ' ' B' ' 373' ' ' TYR . 9.4 tttp -107.71 -46.29 3.84 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 6.0 ptt180 -172.77 135.71 0.67 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.432 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 10.4 p90 -119.28 175.78 5.64 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.226 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.14 100.38 1.7 Allowed 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.84 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -82.86 142.56 31.4 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.66 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.538 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -130.27 174.51 4.55 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -77.82 -8.31 16.77 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.145 1.896 . . . . 0.0 112.063 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' B' ' 382' ' ' THR . 3.2 mttp -130.33 -20.81 2.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.965 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.565 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.1 p -152.03 167.69 27.61 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.55 0.691 . . . . 0.0 111.951 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.43 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -138.87 156.39 47.33 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.541 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.42 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 24.7 m -148.46 154.53 39.98 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.021 -1.072 . . . . 0.0 113.107 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.5 mt -125.61 140.0 53.11 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.336 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.9 t0 -117.36 95.61 5.04 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.892 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 29.7 t80 -137.99 95.24 3.0 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.955 176.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.77 12.38 1.96 Allowed Glycine 0 C--O 1.225 -0.419 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 10.0 t0 -41.88 -16.35 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.935 -0.633 . . . . 0.0 112.07 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.27 -38.09 65.45 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.496 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.32 -92.17 0.52 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.881 -1.509 . . . . 0.0 107.553 176.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.496 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 15.1 t0 -130.06 96.27 4.15 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.82 -3.58 54.88 Favored Glycine 0 C--N 1.303 -1.287 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.425 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.5 106.99 16.5 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -175.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -115.09 120.45 39.85 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.691 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.504 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.1 t -138.54 163.28 32.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.5 m -149.98 176.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.367 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -102.13 124.24 47.39 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-O 122.012 0.911 . . . . 0.0 110.829 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.565 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.55 137.19 15.17 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.929 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.15 17.69 4.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.23 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.18 83.64 1.74 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.973 174.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.42 -58.52 1.95 Allowed Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.449 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.3 pt-20 -44.82 -20.08 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.783 -0.708 . . . . 0.0 111.03 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.433 ' N ' ' C ' ' B' ' 385' ' ' GLY . 4.1 mm-40 -83.37 -38.87 21.42 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.8 mt -76.91 -41.99 32.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.623 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.95 -42.51 60.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.566 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.449 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -63.65 -34.2 77.31 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.064 0.935 . . . . 0.0 111.091 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.22 -53.26 10.17 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.738 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.597 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -49.02 -55.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.13 -34.44 44.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.663 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.68 -18.01 62.63 Favored Glycine 0 CA--C 1.505 -0.56 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.4 m-30 -86.65 -37.04 18.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.322 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -13.34 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-O 122.121 0.962 . . . . 0.0 109.288 176.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.36 -22.65 47.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.715 -1.584 . . . . 0.0 109.512 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 67.3 mt -92.05 -61.95 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.119 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.82 -20.11 26.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 113.394 -1.73 . . . . 0.0 112.373 -176.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--O 1.219 -0.508 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.723 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 9' ' ' ASP . 9.9 p30 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.61 10.86 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.436 0.636 . . . . 0.0 110.727 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -103.74 -31.95 9.59 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.399 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.502 ' O ' ' C ' ' A' ' 11' ' ' MET . 23.6 mt-30 -100.17 -35.16 9.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.599 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.502 ' C ' ' O ' ' A' ' 10' ' ' GLN . 24.6 mtp -18.33 -74.12 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 124.026 0.829 . . . . 0.0 112.163 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 11' ' ' MET . 10.0 m-85 -40.44 -62.51 0.76 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.118 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 10' ' ' GLN . 5.5 t -58.3 -32.85 68.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.796 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.449 ' HG1' ' C ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -60.41 -47.15 87.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.975 0.416 . . . . 0.0 110.975 -179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.84 -41.25 53.01 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -41.42 93.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.586 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.27 -41.48 98.35 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.22 -39.61 89.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.15 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.528 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 5.9 mtp -56.61 -31.72 64.57 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.664 -0.414 . . . . 0.0 109.993 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.46 -28.55 20.69 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.15 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.529 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.1 mm? -79.72 -0.15 32.97 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.422 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.499 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -101.75 -9.91 20.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 109.726 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 25' ' ' SER . 5.2 m -123.58 -9.23 7.94 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.992 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 12.9 mp0 40.98 -95.08 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.899 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -143.52 -162.58 1.48 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.361 -178.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.518 ' N ' ' OG ' ' A' ' 25' ' ' SER . 8.4 mp -68.82 -100.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.507 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.57 -33.44 2.31 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 29' ' ' ASP . 58.7 t -147.55 -112.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 110.43 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.468 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 20.3 t70 -98.91 -111.4 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.603 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.463 ' N ' ' CG ' ' A' ' 29' ' ' ASP . 81.6 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.629 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . 0.431 ' CE1' ' OH ' ' B' ' 395' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 135.8 -91.03 0.22 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.57 134.21 66.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.839 0.352 . . . . 0.0 110.765 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.87 153.18 25.8 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.082 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -129.49 135.64 48.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.452 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -138.5 129.83 27.33 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.588 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.57 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.42 101.39 10.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 123.869 1.795 . . . . 0.0 109.541 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' B' ' 328' ' ' ARG . 31.4 m -112.88 157.79 13.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 112.654 -2.066 . . . . 0.0 109.986 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -99.57 144.14 29.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' B' ' 326' ' ' VAL . 38.8 tt0 -131.14 151.34 51.56 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 122.091 0.948 . . . . 0.0 112.714 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -81.23 102.57 10.44 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.975 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 34.1 mmt -98.65 178.65 4.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.039 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.662 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -99.87 151.33 21.42 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.009 178.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 117.4 -23.13 9.87 Favored Glycine 0 C--N 1.316 -0.57 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -140.18 -146.64 0.2 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.553 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.18 -18.08 1.79 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.521 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.86 -176.67 4.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.89 0.376 . . . . 0.0 110.919 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 35.2 mt -90.52 166.25 13.33 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.213 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' B' ' 327' ' ' PRO . 11.2 t -124.4 126.73 25.43 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.859 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.44 ' C ' ' O ' ' B' ' 326' ' ' VAL . 76.7 Cg_exo -43.13 142.86 2.25 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 N-CA-C 107.915 -1.61 . . . . 0.0 107.915 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' B' ' 315' ' ' VAL . 2.0 tpt180 -146.7 -173.16 4.14 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -145.93 122.92 11.38 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 26.7 tp -102.5 158.39 16.25 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.01 107.51 0.52 Allowed Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 31.5 mm -88.62 122.72 40.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.747 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.5 p -117.66 137.78 52.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.429 ' O ' HG21 ' B' ' 399' ' ' ILE . 18.9 pttm -57.54 13.78 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.059 0.457 . . . . 0.0 111.727 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.747 ' H ' ' C ' ' B' ' 333' ' ' THR . 15.8 pt-20 -144.25 -2.69 0.87 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.839 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.83 179.05 2.08 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.318 1.056 . . . . 0.0 112.989 -177.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.612 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 15.0 t -137.13 144.33 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 CA-C-N 113.266 -1.788 . . . . 0.0 106.752 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 4.2 ptt? -153.44 150.12 28.46 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 117.053 -1.859 . . . . 0.0 114.263 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 6.5 mmt-85 -94.9 107.19 19.22 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.665 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.63 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.53 149.7 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.275 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.1 t0 -89.92 92.18 8.9 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.765 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.58 -28.7 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.697 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 20.2 mttp -75.42 -43.6 48.98 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.705 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.556 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.39 -12.58 14.72 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm 66.76 -0.52 1.59 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.032 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.5 mt-10 -84.9 153.17 23.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.274 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 74.2 t -83.17 134.35 27.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.481 0.658 . . . . 0.0 112.334 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 21.6 mm -102.89 -31.85 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.353 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' B' ' 338' ' ' MET . 17.1 tt0 -137.64 156.89 47.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.703 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -146.42 148.78 32.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.348 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.556 ' O ' ' N ' ' B' ' 337' ' ' VAL . 67.0 t-105 -163.73 135.74 4.95 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.905 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.519 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -53.87 138.25 36.71 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.344 -178.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.7 tt -78.26 -35.38 48.23 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -75.59 11.72 1.23 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.999 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -115.58 -4.01 12.28 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.139 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 75.8 mt -57.7 149.39 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.097 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 10.8 tptt -107.33 -44.71 4.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.1 ptt180 -175.88 136.22 0.31 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.407 177.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.457 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.3 p90 -118.84 174.54 6.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.344 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.31 99.21 1.76 Allowed 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 119.233 -0.987 . . . . 0.0 112.002 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.53 144.25 31.45 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.773 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.539 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -131.9 174.27 4.9 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -77.31 -8.94 17.57 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.14 1.893 . . . . 0.0 112.102 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 17.1 mttt -130.69 -21.37 2.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.97 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.567 ' HA ' ' H ' ' B' ' 382' ' ' THR . 78.7 p -149.85 168.88 22.48 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.487 0.661 . . . . 0.0 111.938 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.452 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -141.16 156.87 45.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.796 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.448 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 44.8 m -147.78 156.85 43.17 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.093 -1.043 . . . . 0.0 112.913 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.448 ' N ' ' CG2' ' B' ' 367' ' ' THR . 5.9 mt -130.04 140.65 50.82 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.546 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.4 t0 -117.28 95.86 5.16 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.697 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.6 p90 -136.56 93.64 2.9 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.443 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.45 12.36 1.82 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . 0.401 ' CG ' ' OH ' ' B' ' 377' ' ' TYR . 8.3 t0 -41.84 -15.78 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.034 -0.583 . . . . 0.0 111.756 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.6 -37.27 65.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.515 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.89 -92.78 0.5 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.132 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.515 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.0 t70 -129.05 96.27 4.29 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.38 -3.03 55.6 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.306 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.682 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.95 106.06 16.86 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -175.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.14 125.86 51.89 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.736 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.584 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 46.6 t -138.38 163.67 31.27 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.532 0.682 . . . . 0.0 112.559 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.584 ' N ' ' HG ' ' B' ' 379' ' ' SER . 1.6 m -148.89 175.02 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.883 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.07 125.41 48.76 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.897 0.855 . . . . 0.0 111.098 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.618 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -154.54 136.44 14.56 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.814 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.78 16.85 4.4 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.243 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . 0.618 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.2 OUTLIER -143.97 84.0 1.76 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.938 175.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.79 -58.24 2.05 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.6 pt-20 -44.79 -20.69 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.811 -0.695 . . . . 0.0 110.962 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' B' ' 385' ' ' GLY . 68.9 mt-30 -82.11 -39.29 23.55 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 45.9 mt -77.05 -42.43 31.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.614 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.63 -42.38 61.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.569 -177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 5.1 pp0? -63.77 -34.91 78.96 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.1 0.952 . . . . 0.0 110.95 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.601 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.01 -53.78 10.28 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.723 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.601 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -48.97 -56.06 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 176.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.41 -33.74 45.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 112.874 -1.966 . . . . 0.0 110.671 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.18 -17.81 62.05 Favored Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.3 m-30 -87.04 -36.92 17.91 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -13.31 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 122.203 1.002 . . . . 0.0 109.285 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.6 -22.68 46.67 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.459 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 69.2 mt -91.82 -62.01 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 113.894 -1.503 . . . . 0.0 112.038 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.444 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.22 -20.58 27.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 113.449 -1.705 . . . . 0.0 112.323 -177.061 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.444 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.222 -0.384 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.812 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.435 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 76.7 mt 55.57 7.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.354 0.597 . . . . 0.0 110.608 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.6 OUTLIER -140.79 -35.26 0.49 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.314 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' SER . 12.5 mt-30 -101.06 -53.72 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.807 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.486 ' C ' ' O ' ' A' ' 10' ' ' GLN . 7.8 mmm -19.83 -71.4 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 124.146 0.903 . . . . 0.0 112.156 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -43.9 -58.41 2.78 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.065 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -60.77 -35.89 77.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.814 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.477 ' H ' ' HG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -56.8 -46.26 81.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.836 -179.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.59 -38.97 58.67 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.431 ' CD2' ' HG ' ' B' ' 362' ' ' SER . 0.1 OUTLIER -59.34 -41.19 88.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.432 179.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.68 -41.82 99.66 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.508 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 90.0 mt-10 -65.76 -38.94 90.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.042 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.525 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 9.9 mtp -55.92 -33.91 65.11 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.855 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.26 -31.3 13.78 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.398 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.4 mm? -73.37 -12.29 60.77 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.266 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.509 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -87.88 -11.66 47.07 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 m -111.19 -17.63 13.16 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.085 0.469 . . . . 0.0 110.106 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.82 -73.77 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.189 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.637 ' HG ' ' N ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -169.8 -162.47 0.33 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.19 -178.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.637 ' N ' ' HG ' ' A' ' 25' ' ' SER . 5.2 mp -48.35 -44.93 34.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.707 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.13 -57.72 4.85 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.7 t -149.8 -41.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.926 0.393 . . . . 0.0 110.817 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -173.21 26.56 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.793 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.428 ' O ' ' O ' ' B' ' 319' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.563 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -82.05 -149.18 7.33 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 98.6 t -40.8 137.18 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 0.0 110.69 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.76 153.4 26.57 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.166 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -129.73 134.52 47.66 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.085 0.24 . . . . 0.0 111.475 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -139.33 128.72 24.21 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.612 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.561 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.3 105.86 12.83 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 123.733 1.73 . . . . 0.0 109.446 178.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.622 ' O ' ' N ' ' B' ' 328' ' ' ARG . 29.5 m -118.34 161.95 16.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 112.709 -2.041 . . . . 0.0 110.145 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -103.41 145.3 30.19 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.499 ' O ' ' SD ' ' B' ' 319' ' ' MET . 44.4 tt0 -135.11 151.93 51.17 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.972 0.891 . . . . 0.0 112.462 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . 0.529 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 5.7 tptm -79.21 101.1 7.79 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.475 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.676 ' N ' ' SD ' ' B' ' 319' ' ' MET . 0.0 OUTLIER -91.25 179.0 5.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.911 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.661 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.61 149.25 24.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.007 178.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.96 -25.12 9.65 Favored Glycine 0 C--N 1.313 -0.7 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -133.47 -142.58 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.45 -0.375 . . . . 0.0 110.537 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.529 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.8 OUTLIER -142.61 -14.55 0.75 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.808 0.337 . . . . 0.0 110.574 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.665 ' H ' ' CD ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -94.14 -176.4 3.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.188 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 28.4 mt -92.04 160.96 14.98 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.206 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.2 t -122.58 126.97 25.98 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.018 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' B' ' 326' ' ' VAL . 70.0 Cg_exo -43.9 144.44 2.51 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 N-CA-C 108.166 -1.513 . . . . 0.0 108.166 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' B' ' 315' ' ' VAL . 7.3 ttm-85 -151.44 -172.61 4.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.708 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -142.1 122.39 13.93 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 31.2 tp -100.41 158.58 15.8 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.32 108.3 0.52 Allowed Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.1 mm -88.09 123.4 40.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.723 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.83 138.51 52.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.617 ' NZ ' ' CE1' ' B' ' 395' ' ' TYR . 0.4 OUTLIER -57.76 15.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.311 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' B' ' 333' ' ' THR . 10.9 pt-20 -144.88 -4.65 0.74 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.701 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.08 177.84 2.25 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 122.398 1.094 . . . . 0.0 112.947 -176.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.8 t -132.94 145.22 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 CA-C-N 113.113 -1.858 . . . . 0.0 106.219 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.474 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.4 ptt? -153.05 151.34 30.12 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 117.258 -1.777 . . . . 0.0 114.429 -175.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -96.24 106.85 19.12 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.456 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.641 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -97.07 149.7 4.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.235 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 343' ' ' LYS . 25.5 t0 -88.47 91.98 9.01 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.773 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.42 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.734 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 61.8 mttt -76.12 -44.08 40.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.756 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.551 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -108.72 -12.59 14.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 32.4 tttp 66.9 -0.53 1.63 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.955 0.407 . . . . 0.0 109.976 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.3 mt-10 -85.37 153.0 22.82 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.284 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 83.4 t -81.9 133.47 29.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.524 0.678 . . . . 0.0 112.314 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 11.6 mt -103.4 -31.86 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.449 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.474 ' O ' ' CB ' ' B' ' 338' ' ' MET . 24.4 tt0 -136.6 158.48 44.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.782 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 39.1 mt-10 -144.97 149.3 34.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.286 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.562 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.88 124.74 3.94 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.151 177.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.534 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -46.59 140.37 4.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.435 0.636 . . . . 0.0 111.527 -178.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' B' ' 355' ' ' ASN . 2.0 tt -83.74 -36.04 23.96 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.2 t -74.18 9.82 1.48 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.913 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.569 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 1.0 OUTLIER -111.64 -7.98 14.24 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.052 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 81.4 mt -56.01 146.92 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.692 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -107.86 -46.08 3.86 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.493 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 2.2 ptt-85 -172.55 136.38 0.75 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.47 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 8.3 p90 -119.44 176.49 5.33 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.275 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.39 99.2 1.75 Allowed 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.041 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.97 140.15 34.15 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.68 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.531 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -128.32 174.5 4.36 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.79 -7.78 16.66 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.118 1.878 . . . . 0.0 112.193 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.1 mttp -130.91 -20.39 2.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.04 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.572 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.5 p -152.85 166.49 32.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.423 0.63 . . . . 0.0 111.931 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.453 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -137.04 156.52 48.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.61 179.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.436 ' OG1' ' OG ' ' B' ' 379' ' ' SER . 25.3 m -148.54 154.58 39.98 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.104 -1.038 . . . . 0.0 113.091 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.422 ' N ' ' CG2' ' B' ' 367' ' ' THR . 7.0 mt -125.66 139.45 53.55 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.118 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.8 t0 -117.07 95.83 5.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.457 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 33.4 t80 -137.77 94.51 2.91 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.896 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.67 12.12 2.03 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . 0.525 ' CG ' ' HH ' ' B' ' 377' ' ' TYR . 9.0 t0 -41.47 -16.0 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.035 -0.582 . . . . 0.0 111.826 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.52 -37.33 65.24 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.513 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.69 -92.84 0.5 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.513 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.3 t70 -128.88 96.34 4.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.11 -2.97 54.66 Favored Glycine 0 C--N 1.315 -0.629 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.243 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.07 106.4 15.69 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . 0.415 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.8 OUTLIER -113.88 120.4 40.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.598 176.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.648 ' HG ' ' H ' ' B' ' 380' ' ' VAL . 37.3 t -138.88 164.59 29.27 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.651 0.738 . . . . 0.0 112.757 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.648 ' H ' ' HG ' ' B' ' 379' ' ' SER . 1.0 OUTLIER -151.07 174.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.858 179.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.39 124.59 46.07 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.973 0.892 . . . . 0.0 111.024 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.572 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.82 137.69 14.42 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.824 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 383' ' ' THR . . . . . 0.439 ' N ' ' OE2' ' B' ' 384' ' ' GLU . 0.8 OUTLIER -85.43 -1.2 56.79 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.972 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . 0.531 ' CD ' ' HG1' ' B' ' 382' ' ' THR . 0.0 OUTLIER -123.81 84.05 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.096 0.95 . . . . 0.0 108.727 175.25 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.99 -59.54 1.86 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.4 pt-20 -45.59 -21.04 0.08 Allowed 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 114.697 -0.752 . . . . 0.0 111.074 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.406 ' N ' ' C ' ' B' ' 385' ' ' GLY . 68.6 mt-30 -81.04 -38.62 27.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.3 mt -77.36 -41.97 30.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.588 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -74.18 -42.68 59.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.507 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.65 -34.59 78.19 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.991 0.9 . . . . 0.0 111.035 -177.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.598 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.94 -53.45 10.08 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.781 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.598 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -48.89 -55.55 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 176.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -51.96 -34.06 40.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.764 -2.017 . . . . 0.0 110.569 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.06 -18.12 61.66 Favored Glycine 0 CA--C 1.506 -0.524 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.617 ' CE1' ' NZ ' ' B' ' 334' ' ' LYS . 5.4 m-30 -86.68 -36.88 18.47 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -13.36 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 122.108 0.956 . . . . 0.0 109.189 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.34 -22.68 47.67 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.506 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.99 -61.92 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 113.869 -1.514 . . . . 0.0 112.022 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.442 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.9 -20.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 113.415 -1.721 . . . . 0.0 112.311 -176.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.221 -0.437 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.775 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mt -96.07 152.55 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.11 0.481 . . . . 0.0 110.626 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -171.38 -36.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.076 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 13' ' ' SER . 38.4 mt-30 -72.72 -54.33 9.25 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.787 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.483 ' C ' ' O ' ' A' ' 10' ' ' GLN . 49.3 mtp -20.07 -70.13 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 124.238 0.961 . . . . 0.0 112.044 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -42.95 -59.89 1.83 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.006 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -60.53 -37.33 80.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.899 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.74 -46.02 77.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.65 -39.93 56.92 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -40.98 86.32 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.8 -41.63 99.65 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.513 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.1 mt-10 -65.8 -38.21 88.37 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.522 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 8.2 mtp -57.71 -33.58 68.55 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.962 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.54 -29.42 10.62 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.365 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.4 mm? -76.34 -9.18 58.45 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.399 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.519 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -91.82 -10.7 38.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.007 0.432 . . . . 0.0 110.027 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 m -115.78 -15.36 11.31 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.085 0.469 . . . . 0.0 110.25 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -49.64 -74.05 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.264 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -178.0 -45.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.268 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.27 -98.89 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.515 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 46.66 91.57 0.01 OUTLIER Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 29' ' ' ASP . 91.1 t -78.53 -107.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.752 0.311 . . . . 0.0 110.469 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.483 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.6 OUTLIER 55.52 95.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.598 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.466 ' CB ' ' O ' ' A' ' 29' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.575 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 135.96 -73.4 0.44 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 77.8 t -130.12 133.5 64.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.784 0.326 . . . . 0.0 110.835 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.13 153.4 23.21 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.132 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -128.14 135.29 49.57 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -140.06 128.79 23.14 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.598 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.557 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.86 107.45 13.68 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 123.728 1.728 . . . . 0.0 109.349 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.631 ' O ' ' N ' ' B' ' 328' ' ' ARG . 28.0 m -119.88 159.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 112.647 -2.07 . . . . 0.0 110.066 -177.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -100.79 145.05 29.01 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' B' ' 326' ' ' VAL . 47.1 tt0 -131.67 150.96 51.97 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.995 0.903 . . . . 0.0 112.617 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -80.17 101.51 8.86 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.308 -1.315 . . . . 0.0 111.256 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 35.0 mmt -97.6 178.67 5.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.169 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.557 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.0 157.88 16.42 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.85 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 109.96 -22.61 23.1 Favored Glycine 0 C--N 1.309 -0.971 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -136.64 -138.69 0.15 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.347 -0.426 . . . . 0.0 110.605 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.79 -16.35 0.47 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.631 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -94.21 -174.46 3.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.924 0.392 . . . . 0.0 110.947 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 32.1 mt -91.93 162.56 14.36 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.25 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.0 t -122.24 126.6 26.19 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.055 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.411 ' C ' ' O ' ' B' ' 326' ' ' VAL . 67.0 Cg_exo -44.33 143.74 3.45 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 N-CA-C 108.093 -1.541 . . . . 0.0 108.093 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.631 ' N ' ' O ' ' B' ' 315' ' ' VAL . 0.3 OUTLIER -149.99 -172.92 4.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.759 -177.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.646 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -142.31 122.05 13.45 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 30.3 tp -100.37 158.3 15.99 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.118 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.94 108.11 0.52 Allowed Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.99 121.63 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.719 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.3 p -115.83 138.62 50.97 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.404 ' O ' HG22 ' B' ' 399' ' ' ILE . 74.2 mttt -57.92 14.95 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.364 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.719 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.4 pt-20 -145.14 -3.79 0.74 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.476 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.5 178.42 1.97 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.343 1.068 . . . . 0.0 112.993 -176.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.7 t -134.38 145.0 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 113.147 -1.842 . . . . 0.0 106.308 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.48 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.5 ptt? -152.8 151.99 31.09 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 117.145 -1.822 . . . . 0.0 114.546 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 6.5 mmt-85 -96.28 107.36 19.7 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.466 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.646 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.06 149.8 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.219 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' B' ' 343' ' ' LYS . 0.3 OUTLIER -87.94 92.0 8.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.859 -178.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -36.55 -27.34 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.637 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' B' ' 341' ' ' ASP . 54.3 mttt -74.79 -42.61 57.79 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.731 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 341' ' ' ASP . 64.5 p -112.0 -16.91 12.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' B' ' 344' ' ' THR . 5.8 ttmm 73.73 1.8 4.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.94 0.4 . . . . 0.0 110.174 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.485 ' H ' ' HG1' ' B' ' 344' ' ' THR . 5.5 pt-20 -86.52 158.65 19.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 89.4 t -88.4 132.78 32.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.567 0.698 . . . . 0.0 112.36 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.21 -31.34 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.241 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.0 tt0 -136.74 157.5 46.61 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.601 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -144.25 149.65 36.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.003 -0.998 . . . . 0.0 111.215 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.61 124.52 4.02 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.125 177.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.534 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -46.73 140.47 4.53 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.358 0.599 . . . . 0.0 111.511 -178.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.9 tt -83.79 -35.74 24.09 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.6 t -74.52 10.22 1.43 Allowed 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.909 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.573 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.8 m-20 -112.11 -7.63 14.06 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.004 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 80.8 mt -55.98 147.4 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.775 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.77 -45.44 4.01 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.7 ptt-85 -173.9 135.93 0.51 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.459 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 8.8 p90 -118.74 176.54 5.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.206 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.43 99.42 1.6 Allowed 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.887 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.21 147.22 30.09 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.699 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.538 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -135.63 173.87 5.2 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -77.35 -8.36 17.31 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.113 1.875 . . . . 0.0 112.15 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' B' ' 382' ' ' THR . 3.9 mttp -130.66 -20.55 2.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.977 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.556 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.6 p -152.69 167.29 29.43 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.59 0.71 . . . . 0.0 111.993 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.45 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -138.81 156.92 46.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.638 179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.432 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 24.3 m -148.53 155.73 41.52 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.041 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.432 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.8 mt -126.29 139.73 53.08 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.375 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.1 t0 -116.96 95.75 5.15 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.68 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 32.6 t80 -138.1 94.87 2.93 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.971 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.12 12.04 1.94 Allowed Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . 0.521 ' CG ' ' HH ' ' B' ' 377' ' ' TYR . 9.4 t0 -41.79 -16.37 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.044 -0.578 . . . . 0.0 111.778 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.0 m-85 -54.33 -37.27 64.67 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.503 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.98 -92.37 0.51 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.335 176.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.503 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.7 t70 -129.78 96.28 4.19 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 174.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.15 -3.52 54.27 Favored Glycine 0 C--N 1.31 -0.872 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.313 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.25 106.33 15.79 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.06 120.43 40.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.703 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.641 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 34.5 t -138.43 163.67 31.32 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.674 0.75 . . . . 0.0 112.952 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.641 ' N ' ' HG ' ' B' ' 379' ' ' SER . 1.6 m -150.42 175.56 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.199 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -101.23 125.06 47.82 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.968 0.89 . . . . 0.0 110.899 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.61 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -155.08 136.23 13.92 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.878 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.09 17.07 4.44 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . 0.61 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.5 OUTLIER -144.13 83.69 1.74 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.044 174.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.25 -57.72 2.08 Favored Glycine 0 C--N 1.317 -0.51 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.451 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.5 pt-20 -45.26 -20.27 0.05 Allowed 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 114.898 -0.651 . . . . 0.0 110.991 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.425 ' N ' ' C ' ' B' ' 385' ' ' GLY . 6.7 mm-40 -83.36 -38.55 21.87 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.0 mt -77.23 -41.89 30.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.538 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.88 -42.46 60.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.344 -1.298 . . . . 0.0 113.509 -177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.451 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -64.08 -34.14 77.37 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.051 0.929 . . . . 0.0 111.022 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.07 -53.43 9.98 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.898 -1.501 . . . . 0.0 108.725 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.597 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -49.16 -55.55 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -51.89 -34.15 39.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 112.756 -2.02 . . . . 0.0 110.69 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.8 -18.11 62.19 Favored Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.5 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.5 m-30 -86.66 -36.98 18.43 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -13.29 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 CA-C-O 122.114 0.959 . . . . 0.0 109.282 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.67 -22.77 46.29 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.519 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 69.3 mt -91.9 -61.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.052 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.97 -20.34 27.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 113.458 -1.701 . . . . 0.0 112.329 -176.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.463 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.767 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.48 ' O ' ' SD ' ' A' ' 11' ' ' MET . 10.0 p-10 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.596 ' CG1' ' H ' ' A' ' 9' ' ' ASP . 0.9 OUTLIER -155.8 -166.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.532 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.596 ' H ' ' CG1' ' A' ' 8' ' ' ILE . 6.7 t70 68.89 -54.16 0.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.951 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 13' ' ' SER . 8.9 mt-30 -74.19 -56.35 5.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.614 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.492 ' C ' ' O ' ' A' ' 10' ' ' GLN . 48.5 mtp -20.54 -70.87 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 O-C-N 124.183 0.927 . . . . 0.0 111.941 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' MET . 16.9 m-85 -38.88 -57.1 1.28 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.227 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -68.41 -36.16 78.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.705 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.75 -24.99 66.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.095 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.14 -38.42 9.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -40.56 91.27 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.92 -38.19 95.61 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.508 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 91.4 mt-10 -69.74 -37.87 76.64 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.509 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 9.0 mtp -58.34 -32.36 68.45 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.921 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.504 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 0.2 OUTLIER -52.01 -27.3 13.07 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.418 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 4.2 mm? -77.44 -11.16 59.81 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.437 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.497 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -86.04 -9.42 56.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.14 0.495 . . . . 0.0 109.901 179.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 24' ' ' GLN . 1.3 m -120.25 -42.77 2.55 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.114 0.483 . . . . 0.0 110.737 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 26' ' ' LEU . 1.4 tt0 47.53 -178.23 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.714 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 26' ' ' LEU . 1.5 t 37.44 -90.13 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.219 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 24' ' ' GLN . 4.5 mm? -42.68 -34.89 0.98 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.527 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 40.56 71.9 0.27 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 28' ' ' VAL . 92.5 t -69.76 -2.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.339 . . . . 0.0 110.565 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.65 22.18 3.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.402 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.504 ' HG1' ' CG ' ' A' ' 20' ' ' ASP . 1.8 m . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.57 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . 0.409 ' O ' ' N ' ' B' ' 310' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 68.22 -65.61 0.38 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' B' ' 308' ' ' TYR . 74.0 t -126.56 133.45 68.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.735 0.302 . . . . 0.0 110.755 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.59 153.25 24.44 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -129.72 135.68 48.76 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.058 0.224 . . . . 0.0 111.434 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -139.2 129.49 25.47 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.648 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.559 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.37 104.45 12.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.933 1.825 . . . . 0.0 109.403 178.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.645 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.6 m -115.6 160.93 14.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 112.583 -2.099 . . . . 0.0 110.101 -176.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -103.89 144.49 31.43 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' B' ' 326' ' ' VAL . 27.1 tt0 -132.66 152.77 51.59 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.088 0.947 . . . . 0.0 112.767 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . 0.447 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 6.0 tptm -81.37 103.25 10.99 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.891 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 33.7 mmt -99.71 178.78 4.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.118 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.659 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -99.77 150.38 22.39 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.238 178.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 118.22 -23.84 9.0 Favored Glycine 0 C--N 1.315 -0.607 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -139.0 -142.82 0.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.265 -0.467 . . . . 0.0 110.59 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.447 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.2 OUTLIER -139.25 -20.32 0.96 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.428 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.48 ' HD2' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -88.99 -176.85 5.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 110.92 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 31.6 mt -89.77 165.24 14.28 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.147 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' B' ' 317' ' ' GLU . 9.4 t -123.67 126.21 25.81 Favored Pre-proline 0 N--CA 1.439 -0.993 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.056 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' B' ' 326' ' ' VAL . 65.5 Cg_exo -44.49 145.32 2.63 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 N-CA-C 108.121 -1.53 . . . . 0.0 108.121 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' B' ' 315' ' ' VAL . 9.9 ttm-85 -150.13 -173.21 4.37 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.787 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.64 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -143.89 122.1 12.24 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 26.2 tp -101.34 158.01 16.36 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.53 107.51 0.51 Allowed Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.8 mm -88.22 124.0 41.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.742 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.6 p -118.23 137.74 52.81 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.425 ' O ' HG21 ' B' ' 399' ' ' ILE . 5.5 pttp -56.93 12.8 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.908 0.385 . . . . 0.0 111.724 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.742 ' H ' ' C ' ' B' ' 333' ' ' THR . 10.8 pt-20 -144.06 -2.49 0.9 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.712 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.2 OUTLIER -174.03 -179.28 1.66 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.357 1.075 . . . . 0.0 113.372 -177.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.597 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.6 t -137.95 144.84 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.106 0 CA-C-N 113.257 -1.792 . . . . 0.0 107.036 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.447 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 5.8 ptp -153.03 151.33 30.13 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 117.178 -1.809 . . . . 0.0 114.347 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . 0.51 ' NH1' ' OE2' ' B' ' 317' ' ' GLU . 38.8 mtm180 -96.15 107.67 20.02 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.539 176.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.64 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.76 149.03 5.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.43 -178.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' B' ' 344' ' ' THR . 44.6 t0 -88.75 90.5 8.43 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.962 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.79 -28.39 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.66 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.3 mttp -68.99 -43.98 73.77 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.441 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.721 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 0.4 OUTLIER -115.73 -16.39 11.24 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' B' ' 344' ' ' THR . 2.7 tttp 77.11 -0.75 2.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.013 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.721 ' H ' ' HG1' ' B' ' 344' ' ' THR . 8.7 pt-20 -80.12 158.01 26.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 86.4 t -88.64 133.77 30.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.432 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 61.0 mt -102.18 -29.36 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.3 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.447 ' O ' ' CB ' ' B' ' 338' ' ' MET . 17.6 tt0 -143.46 157.89 44.09 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.938 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . 0.408 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 36.3 mt-10 -146.13 149.45 34.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.996 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.576 ' O ' ' N ' ' B' ' 337' ' ' VAL . 70.1 t-105 -161.14 136.78 7.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.994 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.475 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -55.71 137.95 48.5 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.515 0.674 . . . . 0.0 111.554 -179.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.6 tt -78.66 -35.38 45.36 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 354' ' ' THR . . . . . 0.436 ' C ' HD21 ' B' ' 355' ' ' ASN . 4.9 t -75.37 11.22 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.874 177.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' B' ' 353' ' ' LEU . 0.9 OUTLIER -115.08 -3.71 12.57 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.289 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 75.6 mt -58.71 148.92 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.854 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 6.9 tttp -106.96 -45.36 4.18 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.492 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 1.7 ptt180 -174.84 136.41 0.41 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.518 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.485 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 6.8 p90 -118.71 175.46 5.73 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.246 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.34 97.7 1.65 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.909 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.81 142.29 33.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.785 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -129.91 174.08 5.02 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -77.43 -8.47 17.26 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.156 1.904 . . . . 0.0 112.121 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' B' ' 382' ' ' THR . 20.3 mtpt -130.66 -21.84 2.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.855 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.567 ' HA ' ' H ' ' B' ' 382' ' ' THR . 86.3 p -149.81 169.74 20.39 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.507 0.67 . . . . 0.0 111.743 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.441 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -142.35 156.43 45.23 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.885 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.684 ' HG1' ' HG ' ' B' ' 379' ' ' SER . 44.0 m -147.77 156.76 43.08 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.711 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.447 ' N ' ' CG2' ' B' ' 367' ' ' THR . 5.7 mt -129.92 142.45 50.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.495 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.2 t0 -119.14 95.64 4.9 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.743 176.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 12.6 p90 -136.07 93.43 2.91 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.235 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.95 11.7 1.8 Allowed Glycine 0 N--CA 1.462 0.391 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -41.74 -15.53 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.21 -0.495 . . . . 0.0 111.856 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.9 -36.55 65.3 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.533 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.06 -93.25 0.49 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.533 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.8 t0 -129.01 96.43 4.34 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.8 -1.81 55.17 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.315 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.31 105.96 17.04 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -175.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.96 125.77 51.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.645 176.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.684 ' HG ' ' HG1' ' B' ' 367' ' ' THR . 35.8 t -138.19 164.12 30.0 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.575 0.702 . . . . 0.0 112.458 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -150.39 174.08 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.867 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -100.92 126.17 47.54 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.954 0.883 . . . . 0.0 111.072 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.596 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -154.93 136.49 14.26 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.404 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.02 16.66 4.77 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.142 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . 0.596 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.2 OUTLIER -143.55 84.33 1.8 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.119 174.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.88 -59.15 1.91 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.504 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 15.4 pt-20 -44.17 -20.72 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.625 -0.787 . . . . 0.0 111.029 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 5.0 mm-40 -82.85 -38.7 22.64 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 47.1 mt -77.23 -42.38 31.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.526 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.41 -42.9 61.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.676 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.54 -34.81 78.61 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 122.093 0.949 . . . . 0.0 110.892 -177.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.596 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.06 -53.89 9.94 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.771 -1.559 . . . . 0.0 108.713 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.596 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.9 mt -48.83 -55.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.62 -33.75 48.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.742 -2.026 . . . . 0.0 110.639 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.13 -17.93 61.89 Favored Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.3 m-30 -87.1 -36.66 17.98 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -13.2 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 122.178 0.99 . . . . 0.0 109.264 176.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -22.61 46.45 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.503 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.4 mt -91.63 -62.07 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 113.899 -1.5 . . . . 0.0 112.067 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.21 -20.69 27.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.437 -177.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.487 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.89 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.589 ' N ' ' SD ' ' A' ' 11' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.3 mt 52.33 11.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.211 0.529 . . . . 0.0 110.667 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -124.73 -33.13 3.01 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.49 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.473 ' O ' ' C ' ' A' ' 11' ' ' MET . 78.6 mt-30 -126.72 -36.14 2.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.63 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' A' ' 7' ' ' ASP . 20.3 mtm -22.73 -70.9 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 123.981 0.801 . . . . 0.0 112.049 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 11' ' ' MET . 10.9 m-85 -36.48 -56.16 0.81 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.146 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 10' ' ' GLN . 2.0 t -69.82 -28.71 65.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.912 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 11' ' ' MET . 0.2 OUTLIER -72.54 -17.37 61.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -110.69 -41.31 4.33 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.01 -41.22 96.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.569 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.39 -37.91 93.91 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -69.84 -39.3 76.5 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.53 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 4.4 mtp -56.56 -31.75 64.49 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.959 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.4 -27.8 17.25 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.329 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.54 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.1 mm? -75.95 -9.02 58.27 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.251 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.447 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -93.05 -9.06 41.03 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.244 0.545 . . . . 0.0 109.8 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 25' ' ' SER . 21.3 m -133.71 -3.17 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.044 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 12.1 mp0 39.85 -92.18 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.933 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -142.14 -7.86 0.91 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.299 -178.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -40.33 -84.49 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.647 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.08 -95.52 0.12 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 29' ' ' ASP . 47.4 t -142.83 -113.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.694 0.283 . . . . 0.0 110.452 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.463 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 8.2 t70 -97.16 44.79 1.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.624 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.534 -179.979 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' B' ' 309' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' B' ' 308' ' ' TYR . . . 43.31 -168.52 0.01 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 97.2 t -41.6 137.62 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 0.0 110.809 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.27 152.91 29.25 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.138 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -130.58 134.3 46.89 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.994 0.184 . . . . 0.0 111.413 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -137.59 130.14 29.73 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.565 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.57 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -83.98 101.78 11.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 123.965 1.84 . . . . 0.0 109.309 178.189 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.662 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.7 m -112.16 161.93 10.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 112.645 -2.071 . . . . 0.0 110.175 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -105.04 145.97 29.74 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' B' ' 326' ' ' VAL . 24.4 tt0 -133.62 151.43 51.68 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 122.037 0.922 . . . . 0.0 112.665 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -81.82 101.77 10.39 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.176 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 33.6 mmt -98.76 178.62 4.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.029 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.564 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.43 158.16 16.27 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.733 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 110.88 -22.95 20.58 Favored Glycine 0 C--N 1.308 -0.988 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -136.51 -139.65 0.16 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.255 -0.472 . . . . 0.0 110.634 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.98 -18.4 0.58 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.473 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.494 ' HD2' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -93.82 -176.52 4.07 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.031 0.443 . . . . 0.0 110.968 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 30.7 mt -87.87 165.6 15.16 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.174 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.6 t -124.21 124.12 25.91 Favored Pre-proline 0 N--CA 1.439 -1.019 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.887 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.425 ' C ' ' O ' ' B' ' 326' ' ' VAL . 66.2 Cg_exo -44.58 145.62 2.57 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 N-CA-C 107.956 -1.594 . . . . 0.0 107.956 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.662 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.8 ttt180 -149.91 -174.1 4.61 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.725 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.35 123.44 12.87 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.081 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 26.7 tp -102.13 159.03 15.74 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.07 108.07 0.52 Allowed Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.8 mm -89.04 123.7 41.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.746 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.48 138.1 52.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.411 ' O ' HG22 ' B' ' 399' ' ' ILE . 0.0 OUTLIER -57.63 13.84 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.114 0.483 . . . . 0.0 111.793 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.746 ' H ' ' C ' ' B' ' 333' ' ' THR . 8.9 pt-20 -144.4 -3.16 0.84 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.868 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.88 178.52 2.17 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 122.272 1.034 . . . . 0.0 113.003 -177.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.5 t -135.79 145.96 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-N 113.4 -1.727 . . . . 0.0 106.573 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.466 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 2.2 ptt? -153.93 150.31 28.2 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 117.044 -1.863 . . . . 0.0 114.262 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 3.2 mtp85 -94.89 107.6 19.63 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.669 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.11 149.94 5.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.371 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' B' ' 344' ' ' THR . 3.2 t70 -90.46 92.62 8.96 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.755 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.7 OUTLIER -35.87 -28.76 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.626 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' B' ' 341' ' ' ASP . 41.9 mttt -73.2 -43.49 61.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.691 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.7 p -111.43 -12.82 13.96 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt 67.63 -0.85 1.79 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 109.999 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.541 ' H ' ' HG1' ' B' ' 344' ' ' THR . 2.3 mt-10 -84.55 151.97 24.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.311 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 77.7 t -82.94 135.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.526 0.679 . . . . 0.0 112.308 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 70.9 mt -103.82 -30.99 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.438 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.466 ' O ' ' CB ' ' B' ' 338' ' ' MET . 7.2 tt0 -138.85 156.04 47.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.584 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -145.51 149.6 34.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.336 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.552 ' O ' ' N ' ' B' ' 337' ' ' VAL . 64.1 t-105 -161.83 134.95 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.838 177.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.508 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.52 138.77 27.06 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.477 -178.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.8 tt -79.08 -35.74 41.95 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 4.7 t -74.86 11.24 1.12 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.895 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.508 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.5 m-20 -114.75 -4.16 12.74 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.14 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 73.5 mt -57.86 147.97 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.088 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 8.1 tttp -105.9 -45.48 4.36 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.8 ptt180 -174.69 136.4 0.43 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.462 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.44 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 10.1 p90 -119.45 173.14 7.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.174 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.0 99.11 1.8 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.086 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.16 148.6 30.85 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.951 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -136.69 173.43 5.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -76.82 -8.81 18.12 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.122 1.882 . . . . 0.0 112.073 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' B' ' 382' ' ' THR . 12.6 mtpp -130.68 -21.64 2.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.968 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.569 ' HA ' ' H ' ' B' ' 382' ' ' THR . 89.8 p -150.35 169.23 21.91 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.606 0.717 . . . . 0.0 111.852 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.463 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -141.78 156.88 45.56 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.888 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.461 ' OG1' ' SD ' ' A' ' 19' ' ' MET . 34.2 m -148.06 156.68 42.91 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.091 -1.043 . . . . 0.0 112.809 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.445 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.0 mt -129.21 144.51 51.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.567 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 22.2 t0 -120.51 95.82 4.88 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.837 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.0 p90 -136.71 93.71 2.9 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.369 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.81 12.51 1.72 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -41.9 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.159 -0.521 . . . . 0.0 111.719 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.62 -37.32 65.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.518 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.77 -92.8 0.5 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.934 -1.484 . . . . 0.0 107.097 176.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.518 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.6 t70 -129.12 96.34 4.3 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.24 -2.81 55.75 Favored Glycine 0 C--N 1.312 -0.75 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.217 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.686 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.96 106.3 17.04 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -175.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.81 125.57 51.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.747 175.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.56 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 35.9 t -138.49 162.63 34.03 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.482 0.658 . . . . 0.0 112.646 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.56 ' N ' ' HG ' ' B' ' 379' ' ' SER . 1.7 m -149.05 172.6 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.022 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -99.23 126.3 45.01 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.886 0.851 . . . . 0.0 111.074 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.701 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -155.02 135.97 13.76 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.698 179.265 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.57 17.95 3.6 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.178 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . 0.701 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.3 OUTLIER -144.05 83.89 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.049 175.007 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.91 -59.34 1.89 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.9 pt-20 -45.01 -19.85 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 114.754 -0.723 . . . . 0.0 111.016 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.436 ' N ' ' C ' ' B' ' 385' ' ' GLY . 24.3 mt-30 -82.96 -39.56 21.23 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' B' ' 385' ' ' GLY . 40.6 mt -76.95 -41.86 32.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.731 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -74.11 -41.97 60.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.651 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.438 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -63.93 -34.77 78.71 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.059 0.933 . . . . 0.0 111.023 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.6 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.92 -53.82 10.31 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.813 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.6 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.11 -55.98 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.74 45.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.663 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.19 -17.79 62.07 Favored Glycine 0 CA--C 1.506 -0.469 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.3 m-30 -87.11 -37.0 17.78 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -13.27 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-O 122.187 0.994 . . . . 0.0 109.281 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.64 -22.67 46.54 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.473 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.4 mt -91.76 -62.07 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 113.897 -1.502 . . . . 0.0 112.035 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.445 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.3 -20.51 27.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.396 -177.075 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.445 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.877 -1.059 . . . . 0.0 110.797 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.1 mt -78.78 10.37 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.325 0.583 . . . . 0.0 110.739 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.81 -32.28 8.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.315 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 11' ' ' MET . 23.5 mt-30 -101.06 -35.11 9.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.546 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.487 ' C ' ' O ' ' A' ' 10' ' ' GLN . 6.1 mmm -18.97 -72.59 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 124.153 0.908 . . . . 0.0 112.146 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -42.76 -62.63 0.95 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.968 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 10' ' ' GLN . 6.4 t -56.6 -35.4 68.22 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.811 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -47.94 79.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.031 0.444 . . . . 0.0 110.773 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.49 -41.56 46.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -38.61 77.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.513 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.32 97.99 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 89.1 mt-10 -63.67 -36.42 83.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.523 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 4.7 mtp -61.82 -31.88 72.16 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.883 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.63 -28.78 15.4 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.23 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -75.12 -9.41 58.51 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.311 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.458 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -93.18 -8.88 41.18 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.119 0.485 . . . . 0.0 109.82 179.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 25' ' ' SER . 24.4 m -131.95 -1.52 3.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.803 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 14.9 mp0 41.58 -91.21 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.894 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -140.71 -11.18 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.417 -178.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tp -47.02 -36.49 7.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.757 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 41.29 80.43 0.04 OUTLIER Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 29' ' ' ASP . 3.8 m -88.94 -109.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.724 0.297 . . . . 0.0 110.444 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.458 ' H ' ' CG2' ' A' ' 28' ' ' VAL . 4.8 t70 51.41 81.38 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.659 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.578 -179.922 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' B' ' 309' ' ' GLY . 1.7 p90 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 308' ' ' TYR . . . -60.21 -135.53 0.01 OUTLIER Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.5 t -40.8 137.14 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.718 0.294 . . . . 0.0 110.805 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.47 153.19 27.78 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.192 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -130.09 134.39 47.33 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 123.059 0.224 . . . . 0.0 111.465 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -138.74 129.02 25.68 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.499 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.563 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.23 105.05 13.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.834 1.778 . . . . 0.0 109.446 178.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.631 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.6 m -115.79 160.92 14.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 112.596 -2.093 . . . . 0.0 110.1 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -103.52 145.67 29.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' B' ' 326' ' ' VAL . 25.3 tt0 -132.46 150.64 52.12 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 122.071 0.938 . . . . 0.0 112.601 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 6.2 tptm -82.37 101.45 10.61 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.205 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.601 ' SD ' ' NZ ' ' B' ' 320' ' ' LYS . 38.3 mmt -94.91 179.09 5.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.173 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.601 ' NZ ' ' SD ' ' B' ' 319' ' ' MET . 0.0 OUTLIER -101.48 157.92 16.45 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.89 179.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 108.51 -21.88 27.52 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 -141.66 0.16 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.561 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.523 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.7 OUTLIER -143.57 -18.86 0.61 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.482 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -176.52 4.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.976 0.417 . . . . 0.0 110.911 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 31.7 mt -91.85 165.02 13.46 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.219 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' B' ' 317' ' ' GLU . 5.2 t -123.88 123.71 26.16 Favored Pre-proline 0 N--CA 1.44 -0.953 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.909 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.418 ' C ' ' O ' ' B' ' 326' ' ' VAL . 63.1 Cg_exo -44.27 145.18 2.49 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.107 -1.536 . . . . 0.0 108.107 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.631 ' N ' ' O ' ' B' ' 315' ' ' VAL . 10.6 ttm-85 -149.96 -173.5 4.45 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 119.498 -0.881 . . . . 0.0 108.658 -177.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.4 121.7 12.29 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 28.0 tp -100.15 158.31 15.95 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.81 108.38 0.54 Allowed Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 31.0 mm -88.75 124.61 41.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.724 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.94 138.13 53.0 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.443 ' NZ ' ' CZ ' ' B' ' 395' ' ' TYR . 0.0 OUTLIER -57.34 14.71 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.74 0.305 . . . . 0.0 111.301 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.724 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -145.15 -3.66 0.75 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.497 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.81 179.98 1.88 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.287 1.041 . . . . 0.0 113.073 -176.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.67 146.53 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 CA-C-N 113.293 -1.776 . . . . 0.0 106.493 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.466 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 2.0 ptt? -154.56 150.33 27.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 117.086 -1.845 . . . . 0.0 114.303 -176.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . 0.649 ' NH2' ' CG ' ' B' ' 378' ' ' TYR . 18.3 mtt-85 -95.12 107.94 20.03 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.561 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.6 149.74 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.259 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' B' ' 344' ' ' THR . 24.7 t0 -88.97 91.91 9.02 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.724 -178.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 1.0 OUTLIER -35.38 -28.63 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.692 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 341' ' ' ASP . 32.9 mttt -75.64 -43.81 45.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.749 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.554 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -108.9 -12.64 14.86 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -177.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt 66.81 -0.29 1.68 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.017 0.436 . . . . 0.0 109.994 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.5 mt-10 -85.45 153.59 22.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.314 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 81.6 t -83.4 134.31 27.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.493 0.663 . . . . 0.0 112.363 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 66.4 mt -102.72 -30.15 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.335 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.647 ' NE2' HH21 ' B' ' 339' ' ' ARG . 38.5 tt0 -140.41 156.84 46.25 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.627 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -145.27 149.7 35.34 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.387 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.577 ' O ' ' N ' ' B' ' 337' ' ' VAL . 70.9 t-105 -160.93 135.37 7.23 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.696 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.502 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -54.84 138.53 42.54 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.461 0.648 . . . . 0.0 111.492 -178.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.6 tt -78.57 -35.58 45.7 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 21.8 m -73.68 8.81 1.69 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.882 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' B' ' 353' ' ' LEU . 0.9 OUTLIER -112.75 -2.35 14.48 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.147 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.32 146.82 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.211 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . 0.455 ' NZ ' ' CE1' ' B' ' 373' ' ' TYR . 4.9 tttt -106.62 -45.24 4.28 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 0.1 OUTLIER -174.88 136.08 0.39 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.388 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.458 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.1 p90 -119.72 175.33 5.92 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.212 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.62 99.99 1.6 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.239 -0.984 . . . . 0.0 112.057 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.09 143.81 32.17 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.752 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.544 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -131.0 174.05 5.15 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -77.11 -9.05 17.84 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.043 1.829 . . . . 0.0 112.036 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.0 mttt -130.79 -21.1 2.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.972 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.575 ' HA ' ' H ' ' B' ' 382' ' ' THR . 78.6 p -149.81 169.54 20.86 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.513 0.673 . . . . 0.0 111.866 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.464 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.2 OUTLIER -141.09 156.32 46.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.583 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.442 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 54.8 m -146.31 156.89 43.67 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.885 -174.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.442 ' N ' ' CG2' ' B' ' 367' ' ' THR . 5.7 mt -130.79 139.68 50.23 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.54 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 22.5 t0 -116.6 95.86 5.24 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.779 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.2 p90 -135.93 94.01 3.0 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.532 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.77 12.51 1.73 Allowed Glycine 0 C--O 1.225 -0.427 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -41.74 -16.13 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.054 -0.573 . . . . 0.0 111.774 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.554 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.42 -37.28 64.93 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.518 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.98 -92.38 0.51 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.942 -1.481 . . . . 0.0 107.183 176.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.518 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.6 t0 -129.47 96.42 4.27 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.14 -3.46 55.67 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.149 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.697 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.03 106.7 17.38 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -175.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . 0.649 ' CG ' ' NH2' ' B' ' 339' ' ' ARG . 0.3 OUTLIER -120.04 127.4 52.55 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.835 175.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.624 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 33.1 t -138.64 166.52 24.14 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.621 0.724 . . . . 0.0 112.61 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.624 ' N ' ' HG ' ' B' ' 379' ' ' SER . 1.6 m -149.18 174.26 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.893 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -101.14 125.38 47.75 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.964 0.888 . . . . 0.0 111.092 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.642 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -154.83 136.82 14.62 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.84 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.27 16.88 4.77 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.211 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . 0.642 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.2 OUTLIER -144.07 83.88 1.75 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.021 174.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.38 -57.44 2.1 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.8 pt-20 -45.04 -20.2 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 114.82 -0.69 . . . . 0.0 111.091 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.426 ' N ' ' C ' ' B' ' 385' ' ' GLY . 4.6 mm-40 -83.05 -39.16 21.58 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' B' ' 385' ' ' GLY . 49.1 mt -76.58 -42.55 34.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.634 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.46 -42.53 61.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.306 -1.315 . . . . 0.0 113.604 -177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.453 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 12.3 pt20 -63.56 -34.72 78.43 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.001 0.905 . . . . 0.0 111.04 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.598 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.33 -53.6 10.4 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.85 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.598 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -49.02 -55.61 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -53.14 -33.61 53.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.684 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.05 -17.71 62.46 Favored Glycine 0 CA--C 1.505 -0.538 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.2 m-30 -87.07 -37.15 17.7 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -13.36 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-O 122.211 1.005 . . . . 0.0 109.371 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.01 -22.62 45.23 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.525 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 71.4 mt -91.76 -62.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.998 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.444 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.31 -20.75 27.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.322 -176.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.444 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.79 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' A' ' 9' ' ' ASP . 13.1 p30 . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.9 mt -72.68 10.87 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.4 0.619 . . . . 0.0 110.698 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -103.54 -32.01 9.66 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.394 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.502 ' O ' ' C ' ' A' ' 11' ' ' MET . 23.6 mt-30 -100.39 -35.23 9.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.578 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.502 ' C ' ' O ' ' A' ' 10' ' ' GLN . 24.6 mtp -18.18 -73.67 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 124.122 0.889 . . . . 0.0 112.159 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' MET . 10.1 m-85 -40.66 -63.38 0.66 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.998 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 10' ' ' GLN . 5.1 t -57.15 -34.45 68.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.845 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -46.77 86.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.39 -42.24 37.1 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -39.22 79.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.462 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.06 -43.86 98.16 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 88.8 mt-10 -62.97 -37.45 87.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.532 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 6.4 mtp -60.85 -33.22 72.72 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.003 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.16 -29.96 15.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.169 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.464 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 4.2 mm? -75.69 -13.97 60.33 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.294 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.495 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -86.38 -12.88 48.01 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.977 0.417 . . . . 0.0 109.932 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 24' ' ' GLN . 1.4 m -124.98 -27.51 3.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.958 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.7 OUTLIER 39.37 -161.13 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.367 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -26.95 66.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.19 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 26' ' ' LEU . 4.4 mm? -47.51 -35.79 9.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.939 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -45.37 -31.63 3.45 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.63 -22.62 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.642 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.65 -1.23 53.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.557 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.578 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . 0.414 ' O ' ' OH ' ' B' ' 395' ' ' TYR . 1.6 p90 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -77.19 -40.18 25.05 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 71.3 t -126.33 133.99 67.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.778 0.323 . . . . 0.0 110.822 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.28 153.26 25.1 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.1 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -129.39 135.44 48.71 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -139.1 129.43 25.55 Favored 'General case' 0 C--N 1.347 0.485 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.522 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.561 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.33 105.73 13.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 123.825 1.774 . . . . 0.0 109.402 178.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' B' ' 328' ' ' ARG . 33.0 m -116.98 161.11 15.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 112.564 -2.107 . . . . 0.0 110.122 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -103.5 145.34 30.15 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' B' ' 339' ' ' ARG . 27.1 tt0 -132.76 152.04 51.86 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.119 0.961 . . . . 0.0 112.606 -178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 6.8 tptm -82.19 101.92 10.77 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.118 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.54 ' SD ' ' NH2' ' B' ' 328' ' ' ARG . 36.6 mmt -95.92 179.31 5.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.067 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.554 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.18 157.99 16.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.849 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 108.55 -21.3 28.51 Favored Glycine 0 C--N 1.308 -1.003 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.38 -141.23 0.15 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.299 -0.451 . . . . 0.0 110.609 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.532 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.4 OUTLIER -143.24 -21.73 0.62 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.486 179.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.48 ' HD2' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -86.91 -176.61 5.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.944 0.402 . . . . 0.0 110.99 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 28.1 mt -91.79 165.15 13.42 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.202 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t -124.31 125.8 25.62 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.971 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.42 ' C ' ' O ' ' B' ' 326' ' ' VAL . 62.4 Cg_exo -44.76 145.56 2.77 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 N-CA-C 108.029 -1.566 . . . . 0.0 108.029 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.649 ' N ' ' O ' ' B' ' 315' ' ' VAL . 4.2 ttm180 -150.59 -173.45 4.47 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 119.518 -0.873 . . . . 0.0 108.76 -177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.65 122.38 12.62 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 27.7 tp -101.69 157.87 16.52 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.29 107.92 0.53 Allowed Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 31.1 mm -88.56 124.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.727 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.4 p -118.44 138.2 52.63 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.417 ' O ' HG23 ' B' ' 399' ' ' ILE . 1.0 OUTLIER -57.34 14.58 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.872 0.368 . . . . 0.0 111.331 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.727 ' H ' ' C ' ' B' ' 333' ' ' THR . 12.9 pt-20 -145.37 -2.88 0.75 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.459 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.88 179.66 1.93 Allowed 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.322 1.058 . . . . 0.0 113.088 -176.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.593 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.1 t -137.36 146.43 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 113.276 -1.784 . . . . 0.0 106.535 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.468 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 4.0 ptt? -154.76 149.63 26.7 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 117.056 -1.857 . . . . 0.0 114.274 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . 0.528 ' NH2' ' OE2' ' B' ' 317' ' ' GLU . 15.6 mtp180 -94.55 107.73 19.71 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.633 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.89 149.88 5.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.207 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 28.7 t0 -89.45 92.02 8.95 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.729 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.49 -28.79 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.745 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.7 mttm -75.21 -43.61 50.88 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.732 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.73 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 1.2 p -109.32 -12.34 14.77 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm 66.58 -1.09 1.37 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 109.962 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.73 ' H ' ' HG1' ' B' ' 344' ' ' THR . 2.4 mt-10 -84.55 153.33 23.32 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.36 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 82.3 t -83.29 135.16 25.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.497 0.665 . . . . 0.0 112.285 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 67.2 mt -103.54 -30.17 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.407 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.468 ' O ' ' CB ' ' B' ' 338' ' ' MET . 23.5 tt0 -140.6 156.46 46.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.675 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -145.66 149.87 35.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.517 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.548 ' O ' ' N ' ' B' ' 337' ' ' VAL . 65.3 t-105 -162.82 134.87 5.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.711 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.514 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -53.13 139.39 28.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.496 0.665 . . . . 0.0 111.425 -178.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.6 tt -78.77 -36.04 43.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 21.6 m -73.16 9.13 1.33 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.901 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.499 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.2 m-20 -113.52 -1.99 13.98 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.157 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 66.1 mt -61.17 145.6 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.182 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 5.6 tttt -104.38 -45.72 4.59 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.515 0.674 . . . . 0.0 109.21 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.7 ptt180 -174.92 136.19 0.39 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.45 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.4 p90 -118.89 174.71 6.13 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.227 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.64 99.38 1.72 Allowed 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 119.28 -0.968 . . . . 0.0 112.11 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.83 146.99 30.62 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.856 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.537 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -135.35 173.64 5.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -77.02 -8.15 17.6 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.003 1.802 . . . . 0.0 112.221 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' B' ' 382' ' ' THR . 23.0 mttt -131.02 -21.91 2.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.048 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.583 ' HA ' ' H ' ' B' ' 382' ' ' THR . 79.0 p -150.33 168.88 22.79 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.6 0.714 . . . . 0.0 111.895 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.453 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -141.09 156.79 45.93 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.75 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 39.7 m -147.54 156.55 42.94 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.942 -174.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.445 ' N ' ' CG2' ' B' ' 367' ' ' THR . 5.6 mt -129.56 141.87 50.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.628 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 21.1 t0 -118.19 95.59 4.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.677 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.3 p90 -136.23 93.98 2.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.657 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.49 12.45 1.8 Allowed Glycine 0 C--O 1.226 -0.349 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.2 t0 -41.79 -16.15 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.12 -0.54 . . . . 0.0 111.721 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.5 -37.38 65.24 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.519 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.5 OUTLIER -125.76 -92.5 0.51 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.169 176.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.519 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.6 t70 -129.41 96.3 4.25 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.37 -3.01 55.61 Favored Glycine 0 C--N 1.313 -0.714 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.217 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.689 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.93 106.16 16.92 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -175.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.54 126.66 52.96 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.77 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.688 ' HG ' ' H ' ' B' ' 380' ' ' VAL . 47.2 t -138.47 164.55 29.1 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.6 0.714 . . . . 0.0 112.679 -177.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.688 ' H ' ' HG ' ' B' ' 379' ' ' SER . 1.7 m -149.64 174.13 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.971 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -100.91 125.12 47.44 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.94 0.876 . . . . 0.0 111.128 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.682 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -155.41 137.45 14.62 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.827 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 383' ' ' THR . . . . . 0.415 ' N ' ' OE2' ' B' ' 384' ' ' GLU . 0.8 OUTLIER -84.83 -1.13 56.06 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.975 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . 0.682 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.0 OUTLIER -123.93 84.0 2.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.038 0.923 . . . . 0.0 108.71 175.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.24 -58.5 1.97 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.507 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.8 pt-20 -46.81 -20.6 0.14 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 114.696 -0.752 . . . . 0.0 110.982 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -80.95 -39.09 26.64 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.49 ' N ' ' O ' ' B' ' 385' ' ' GLY . 49.4 mt -77.06 -42.42 31.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.615 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.97 -42.4 60.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.308 -1.314 . . . . 0.0 113.506 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.57 -34.74 78.47 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.049 0.928 . . . . 0.0 111.047 -177.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.599 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.25 -53.49 10.74 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.894 -1.503 . . . . 0.0 108.815 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.599 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.9 mt -48.94 -55.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.84 -34.06 52.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 112.732 -2.031 . . . . 0.0 110.651 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.95 -17.58 62.91 Favored Glycine 0 CA--C 1.505 -0.543 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.2 m-30 -87.14 -37.2 17.57 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -13.16 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 CA-C-O 122.1 0.952 . . . . 0.0 109.236 176.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -79.26 -22.73 44.32 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.51 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 70.9 mt -91.62 -61.76 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 114.001 -1.454 . . . . 0.0 112.051 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.75 -20.51 27.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.419 -1.719 . . . . 0.0 112.375 -176.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 N--CA 1.467 0.424 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.802 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 8' ' ' ILE . 61.0 m-20 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 7' ' ' ASP . 15.1 mt 58.4 151.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.688 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.91 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.146 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.529 ' O ' ' C ' ' A' ' 11' ' ' MET . 20.8 mt-30 -96.6 -47.55 5.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.849 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.529 ' C ' ' O ' ' A' ' 10' ' ' GLN . 24.7 mtp -11.45 -77.73 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.46 0 O-C-N 124.326 1.016 . . . . 0.0 112.209 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 11' ' ' MET . 11.9 m-85 -41.2 -62.67 0.8 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.045 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 10' ' ' GLN . 1.2 t -58.41 -34.26 70.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.912 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -58.69 -47.04 85.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.43 -42.7 43.18 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -39.1 80.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.636 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.41 -43.3 99.25 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.46 -37.63 88.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.979 0.419 . . . . 0.0 109.97 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.515 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 4.4 mtp -60.03 -32.14 70.62 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.027 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.58 -29.17 16.26 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.287 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.544 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -74.11 -10.45 59.64 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.286 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.445 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -92.37 -9.17 42.75 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.122 0.487 . . . . 0.0 109.723 179.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' SER . 22.9 m -134.15 -2.06 2.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.62 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 13.1 mp0 40.94 -91.94 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.729 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -140.85 -9.89 1.02 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.316 -178.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mp -46.27 -73.51 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.669 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.63 89.59 0.4 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.453 ' O ' ' CG1' ' A' ' 28' ' ' VAL . 53.4 t -75.12 -3.27 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.883 0.373 . . . . 0.0 110.526 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 61.9 t0 46.55 69.69 0.46 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.629 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.545 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' B' ' 310' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 68.57 -65.96 0.42 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' B' ' 308' ' ' TYR . 68.9 t -126.31 133.43 68.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.773 0.321 . . . . 0.0 110.715 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.07 153.3 24.84 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -130.2 135.17 47.86 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.012 0.195 . . . . 0.0 111.514 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -138.14 130.0 28.35 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.519 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.562 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -83.49 103.56 12.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 123.92 1.819 . . . . 0.0 109.308 178.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.7 m -113.7 162.05 12.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 112.579 -2.101 . . . . 0.0 110.309 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -105.32 147.1 28.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' B' ' 326' ' ' VAL . 26.3 tt0 -134.74 152.73 51.99 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.02 0.914 . . . . 0.0 112.639 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 7.1 tptm -84.27 102.11 12.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.422 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 38.7 mmt -94.66 179.09 5.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.188 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.679 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -100.72 151.25 21.88 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.091 178.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.05 -22.16 12.66 Favored Glycine 0 C--N 1.315 -0.637 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.99 -146.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.548 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.53 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.5 OUTLIER -137.52 -20.01 1.2 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.572 179.608 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.26 -176.67 5.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 111.024 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 28.9 mt -93.13 166.29 12.41 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.348 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t -124.4 124.75 25.73 Favored Pre-proline 0 N--CA 1.44 -0.95 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.888 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.426 ' C ' ' O ' ' B' ' 326' ' ' VAL . 61.2 Cg_exo -44.8 145.95 2.6 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 N-CA-C 108.07 -1.55 . . . . 0.0 108.07 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.67 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.2 ttt180 -149.92 -174.21 4.64 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 119.529 -0.868 . . . . 0.0 108.689 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.616 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.34 122.64 12.29 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -176.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 25.8 tp -102.12 158.13 16.39 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.16 108.1 0.54 Allowed Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 31.3 mm -88.64 123.97 41.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.741 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.8 p -118.52 137.45 53.2 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.409 ' O ' HG22 ' B' ' 399' ' ' ILE . 0.2 OUTLIER -56.99 13.65 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.944 0.402 . . . . 0.0 111.667 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.741 ' H ' ' C ' ' B' ' 333' ' ' THR . 7.9 pt-20 -144.61 -2.68 0.84 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.711 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.89 179.0 2.06 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.404 1.097 . . . . 0.0 113.072 -176.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.602 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.3 t -136.84 146.17 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 CA-C-N 113.252 -1.795 . . . . 0.0 106.4 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.466 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 4.0 ptt? -154.24 150.08 27.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 117.153 -1.819 . . . . 0.0 114.409 -176.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -95.08 107.86 19.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.54 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.7 t -99.49 150.22 5.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.304 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 344' ' ' THR . 32.8 t0 -90.72 92.35 8.78 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.767 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.54 -28.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.599 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' B' ' 341' ' ' ASP . 20.5 mttp -74.66 -43.56 54.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.688 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.735 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 1.2 p -109.45 -12.53 14.7 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.34 -1.21 1.27 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.035 0.445 . . . . 0.0 110.023 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.735 ' H ' ' HG1' ' B' ' 344' ' ' THR . 2.6 mt-10 -84.79 152.1 23.89 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.332 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 76.7 t -82.76 134.75 26.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.51 0.671 . . . . 0.0 112.305 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . 0.436 HG21 HD12 ' B' ' 348' ' ' ILE . 20.9 mm -102.71 -31.12 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.276 178.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.466 ' O ' ' CB ' ' B' ' 338' ' ' MET . 17.1 tt0 -139.79 156.86 46.53 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.611 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -145.75 149.41 34.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.249 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.539 ' O ' ' N ' ' B' ' 337' ' ' VAL . 64.2 t-105 -162.08 135.05 6.02 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.057 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.514 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.39 139.42 24.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.432 0.634 . . . . 0.0 111.379 -178.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' B' ' 355' ' ' ASN . 2.0 tt -79.57 -35.79 39.2 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.53 11.08 1.09 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.825 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.514 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -114.41 -4.5 12.94 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.027 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 69.6 mt -57.62 147.8 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.468 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 11.7 tptt -105.46 -45.7 4.38 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.502 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.6 ptt180 -175.38 135.98 0.34 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.428 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 12.2 p90 -118.91 173.66 6.75 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.172 -177.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.46 99.74 1.77 Allowed 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.018 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.04 147.66 30.05 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.783 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.535 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -135.99 173.56 5.51 Favored Pre-proline 0 N--CA 1.453 -0.282 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -77.06 -8.68 17.77 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.133 1.888 . . . . 0.0 112.022 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 20.6 mtpt -130.77 -21.38 2.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.96 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.567 ' HA ' ' H ' ' B' ' 382' ' ' THR . 88.9 p -150.47 169.57 21.16 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.574 0.702 . . . . 0.0 111.932 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.452 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -142.12 156.61 45.38 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.566 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.442 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 44.1 m -147.3 156.72 43.18 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.877 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.442 ' N ' ' CG2' ' B' ' 367' ' ' THR . 5.7 mt -129.78 141.35 50.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.544 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 21.9 t0 -117.66 95.72 5.07 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.722 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 8.1 p90 -136.78 94.27 2.96 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.581 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 133.02 12.77 1.64 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.5 t0 -42.08 -15.92 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.979 -0.61 . . . . 0.0 111.852 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.41 -37.68 65.36 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.513 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.57 -92.11 0.52 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.356 176.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.513 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.4 t70 -129.91 96.16 4.14 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -99.93 -3.52 55.88 Favored Glycine 0 C--N 1.311 -0.812 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.261 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.69 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.09 106.17 17.03 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -175.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.69 126.07 51.82 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.647 176.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.672 ' HG ' ' H ' ' B' ' 380' ' ' VAL . 47.1 t -138.55 163.45 31.97 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.676 0.751 . . . . 0.0 112.849 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.672 ' H ' ' HG ' ' B' ' 379' ' ' SER . 1.7 m -149.51 172.89 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.196 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -99.45 125.91 45.27 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.764 0.792 . . . . 0.0 111.192 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.567 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.59 136.28 14.38 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.976 -1.465 . . . . 0.0 109.868 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 383' ' ' THR . . . . . 0.451 ' H ' ' HG1' ' B' ' 383' ' ' THR . 0.7 OUTLIER -86.67 16.63 4.54 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.185 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . 0.464 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.4 OUTLIER -144.08 83.54 1.74 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.943 174.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -57.89 2.06 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.531 ' O ' ' NE2' ' B' ' 390' ' ' GLN . 7.4 pt-20 -45.12 -20.58 0.05 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 114.905 -0.648 . . . . 0.0 110.964 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.422 ' N ' ' C ' ' B' ' 385' ' ' GLY . 5.6 mm-40 -82.26 -39.27 23.23 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' B' ' 385' ' ' GLY . 47.5 mt -76.54 -42.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.609 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.33 -42.36 62.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.559 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' B' ' 386' ' ' GLU . 2.2 pt20 -63.56 -34.88 78.79 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 122.082 0.944 . . . . 0.0 111.029 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.593 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.85 -53.49 11.29 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.819 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.593 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.35 -55.98 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.37 -33.74 44.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 112.761 -2.018 . . . . 0.0 110.701 177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.26 -17.8 61.92 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.4 m-30 -87.15 -36.96 17.76 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -13.19 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 CA-C-O 122.175 0.988 . . . . 0.0 109.297 176.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.56 -22.65 46.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.475 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.1 mt -91.8 -61.98 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.067 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.54 -20.41 27.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.338 -1.756 . . . . 0.0 112.315 -176.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.494 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.793 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' ILE . 1.2 m-20 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 7' ' ' ASP . 5.5 mt 57.64 151.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.664 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.12 -28.0 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.051 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.509 ' O ' ' C ' ' A' ' 11' ' ' MET . 18.0 mt-30 -85.69 -44.46 12.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.864 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.536 ' O ' ' N ' ' A' ' 14' ' ' THR . 15.7 mtp -15.73 -80.19 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 124.252 0.97 . . . . 0.0 111.986 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.444 ' C ' ' O ' ' A' ' 11' ' ' MET . 11.0 m-85 -38.01 -63.53 0.47 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.1 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 10' ' ' GLN . 1.1 t -56.17 -27.42 54.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.85 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 11' ' ' MET . 0.2 OUTLIER -65.4 -49.47 69.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.7 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.27 -43.38 33.51 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -41.17 87.66 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.99 -44.36 97.28 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.515 ' OE2' ' CD2' ' B' ' 377' ' ' TYR . 85.6 mt-10 -62.77 -34.03 76.39 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 120.995 0.426 . . . . 0.0 109.933 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.553 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 7.3 mtp -69.49 -33.11 72.38 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.061 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -54.68 -20.44 8.23 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.107 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.518 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -72.12 -37.91 69.38 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.177 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 pp -100.48 6.6 44.36 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 25' ' ' SER . 1.3 m -126.03 -26.5 3.41 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.069 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 8.7 mp0 37.29 -91.54 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.88 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -141.81 -7.71 0.95 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.23 -178.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -64.23 -89.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.699 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.62 33.44 26.25 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 29' ' ' ASP . 51.7 t -101.64 -112.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.729 0.3 . . . . 0.0 110.452 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.473 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 27.3 t70 42.0 24.06 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.646 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' VAL . 2.5 m . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.6 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' B' ' 310' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 63.0 -73.68 0.03 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' B' ' 308' ' ' TYR . 72.2 t -126.48 134.13 67.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.794 0.33 . . . . 0.0 110.776 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.47 153.04 25.6 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.064 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -128.87 135.18 48.73 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.125 0.266 . . . . 0.0 111.42 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -139.15 129.52 25.59 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.795 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.563 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.47 104.86 12.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 123.717 1.723 . . . . 0.0 109.154 178.242 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' B' ' 328' ' ' ARG . 34.1 m -120.82 156.02 24.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 112.815 -1.993 . . . . 0.0 110.278 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -93.37 138.34 31.8 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.27 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' B' ' 326' ' ' VAL . 1.0 OUTLIER -125.67 152.5 45.15 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.918 0.866 . . . . 0.0 112.881 -178.04 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . 0.435 ' N ' HD23 ' B' ' 325' ' ' LEU . 6.3 tptm -75.81 102.66 5.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.245 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 35.8 mmt -102.29 179.42 4.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.023 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.674 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -96.5 146.19 25.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.998 178.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 123.54 -26.18 6.06 Favored Glycine 0 C--N 1.313 -0.744 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -140.76 -142.81 0.15 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.527 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.43 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.5 OUTLIER -136.94 -19.37 1.31 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.567 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -178.82 5.43 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.936 0.398 . . . . 0.0 110.937 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . 0.435 HD23 ' N ' ' B' ' 318' ' ' LYS . 13.5 mt -85.88 161.2 19.17 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.379 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.0 t -122.89 130.74 24.5 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.172 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.482 ' C ' ' O ' ' B' ' 326' ' ' VAL . 78.1 Cg_exo -37.89 140.26 0.29 Allowed 'Trans proline' 0 CA--C 1.506 -0.882 0 N-CA-C 108.535 -1.371 . . . . 0.0 108.535 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' B' ' 315' ' ' VAL . 1.6 tpt180 -152.98 -172.22 4.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.574 -0.85 . . . . 0.0 108.731 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.628 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.33 123.63 13.82 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 27.7 tp -103.11 158.27 16.42 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.151 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.24 107.71 0.52 Allowed Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 31.6 mm -88.33 123.03 40.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.746 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.2 p -117.28 138.02 52.02 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.414 ' O ' HG23 ' B' ' 399' ' ' ILE . 8.9 pttm -57.26 13.6 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.015 0.436 . . . . 0.0 111.779 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.746 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.5 pt-20 -144.45 -2.69 0.85 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.955 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.97 178.89 2.06 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 122.315 1.055 . . . . 0.0 113.059 -177.051 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.609 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.47 146.09 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.042 0 CA-C-N 113.312 -1.767 . . . . 0.0 106.587 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.467 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 2.3 ptt? -154.06 149.84 27.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 117.09 -1.844 . . . . 0.0 114.324 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -94.51 107.7 19.66 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.645 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.628 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.34 149.84 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.124 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' B' ' 344' ' ' THR . 32.0 t0 -89.53 92.6 9.17 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.884 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.56 -28.58 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.732 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 14.8 mttp -75.0 -43.79 51.86 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.73 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.554 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.41 -12.84 14.68 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 11.5 tttt 66.54 -0.75 1.45 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.048 0.452 . . . . 0.0 110.049 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.8 mt-10 -85.15 152.22 23.53 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.311 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 82.5 t -83.83 135.14 25.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.528 0.68 . . . . 0.0 112.253 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -104.55 -30.93 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.414 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.467 ' O ' ' CB ' ' B' ' 338' ' ' MET . 7.4 tt0 -138.01 154.9 49.29 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.516 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -145.32 149.83 35.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.37 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.549 ' O ' ' N ' ' B' ' 337' ' ' VAL . 63.0 t-105 -161.99 135.06 6.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.753 177.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.78 139.1 27.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.424 0.631 . . . . 0.0 111.32 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.8 tt -79.47 -35.6 40.06 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.83 11.28 1.11 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.888 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.7 m-20 -114.65 -4.19 12.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.191 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 74.0 mt -57.99 148.53 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.155 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 10.3 tttt -106.42 -45.12 4.35 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.1 ptt180 -175.64 136.52 0.33 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.365 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.45 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.5 p90 -119.53 174.14 6.57 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.224 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.02 98.83 1.78 Allowed 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.039 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.68 147.09 30.78 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.803 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -136.36 173.78 5.22 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -77.24 -8.26 17.4 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.038 1.825 . . . . 0.0 112.205 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.6 mttt -130.6 -21.43 2.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.073 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.563 ' HA ' ' H ' ' B' ' 382' ' ' THR . 94.4 p -151.74 168.75 24.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.658 0.742 . . . . 0.0 111.858 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.456 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -140.64 157.07 45.99 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.84 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.453 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 62.7 m -146.79 158.64 43.96 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.848 -174.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.453 ' N ' ' CG2' ' B' ' 367' ' ' THR . 5.6 mt -132.41 140.11 48.32 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.519 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 19.7 t0 -117.0 96.03 5.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.634 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' B' ' 370' ' ' PHE . 5.9 p90 -137.25 94.11 2.9 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.555 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.58 12.68 1.74 Allowed Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 8.8 t0 -41.97 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.108 -0.546 . . . . 0.0 111.682 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.3 m-85 -54.43 -37.24 64.9 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.51 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -126.09 -92.67 0.5 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.093 176.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.51 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.3 t70 -129.32 96.21 4.24 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -99.98 -3.13 55.96 Favored Glycine 0 C--N 1.315 -0.605 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.223 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.25 105.68 16.79 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -175.581 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.18 127.68 54.35 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.557 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.553 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 22.6 t -137.48 157.83 45.71 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.313 0.578 . . . . 0.0 112.23 -177.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.532 ' N ' ' HG ' ' B' ' 379' ' ' SER . 2.5 m -142.09 171.86 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.047 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -100.84 125.99 47.4 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.964 0.887 . . . . 0.0 110.991 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.667 ' HG1' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -156.01 137.59 14.13 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.876 179.046 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.43 15.54 6.44 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.132 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . 0.667 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.2 OUTLIER -143.93 84.54 1.78 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.065 175.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -56.35 2.32 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.4 pt-20 -45.07 -20.18 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 114.797 -0.702 . . . . 0.0 111.025 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' B' ' 385' ' ' GLY . 2.5 mm-40 -82.96 -39.39 21.46 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' B' ' 385' ' ' GLY . 46.3 mt -76.85 -42.44 33.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.669 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.37 -42.18 62.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.665 -177.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.436 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -63.93 -34.89 78.99 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.032 0.92 . . . . 0.0 110.965 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.599 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.8 -53.69 10.84 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.783 -179.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.599 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.14 -56.1 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.59 -33.8 47.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 112.819 -1.991 . . . . 0.0 110.662 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.98 -17.87 62.29 Favored Glycine 0 CA--C 1.507 -0.444 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.3 m-30 -87.01 -36.79 18.02 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -13.21 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-O 122.157 0.98 . . . . 0.0 109.258 176.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.64 -22.54 46.74 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.712 -1.585 . . . . 0.0 109.459 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.8 mt -91.82 -62.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.968 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.442 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.43 -20.43 27.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.347 -177.026 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.442 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.765 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 9' ' ' ASP . 2.7 mp -41.37 164.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.271 0.558 . . . . 0.0 110.709 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.435 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 14.9 t0 70.63 -47.61 0.64 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.268 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.477 ' C ' ' HG1' ' A' ' 14' ' ' THR . 14.4 mt-30 -82.48 -46.09 13.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.7 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.471 ' C ' ' O ' ' A' ' 10' ' ' GLN . 56.9 mtp -22.76 -67.88 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 124.058 0.849 . . . . 0.0 112.023 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' MET . 12.3 m-85 -39.83 -58.24 1.41 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.056 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -67.27 -34.03 76.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.945 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.485 ' H ' ' HG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -61.48 -26.89 68.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.547 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.07 -39.75 9.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -42.67 94.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.708 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.22 92.86 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.04 -39.7 75.59 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.501 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 5.2 mtp -56.82 -31.25 64.52 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.905 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.3 -27.8 16.6 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.228 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.527 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -77.34 -8.06 57.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.309 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.483 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -93.07 -10.16 37.08 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.149 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' SER . 58.4 m -124.93 -9.47 7.19 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.172 0.511 . . . . 0.0 110.391 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 19.5 mp0 53.99 -83.55 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.905 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -154.22 -11.62 0.14 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.253 -178.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -21.18 63.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.646 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.572 ' C ' ' H ' ' A' ' 29' ' ' ASP . . . -46.76 -32.39 5.85 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.4 t 56.6 2.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.833 0.349 . . . . 0.0 110.618 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' A' ' 27' ' ' GLY . 34.3 t70 -161.59 -78.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.581 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.572 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . 0.59 ' N ' ' CD1' ' B' ' 308' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' B' ' 308' ' ' TYR . . . -60.17 -138.3 0.01 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.2 t -40.76 137.65 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.776 0.322 . . . . 0.0 110.72 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.58 153.45 26.28 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.221 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -130.04 134.08 47.16 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.042 0.214 . . . . 0.0 111.46 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -139.26 128.48 23.99 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.656 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.558 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.84 107.15 13.4 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 123.769 1.747 . . . . 0.0 109.396 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' B' ' 328' ' ' ARG . 30.3 m -119.13 160.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.096 -176.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -102.11 145.25 29.62 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.524 ' CD ' ' HE ' ' B' ' 339' ' ' ARG . 26.6 tt0 -133.36 149.99 51.85 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.005 0.907 . . . . 0.0 112.708 -178.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . 0.534 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 6.3 tptm -81.68 101.93 10.39 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.233 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 38.7 mmt -94.1 178.93 5.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.177 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.665 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -100.1 150.97 21.93 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.155 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 114.96 -22.46 12.48 Favored Glycine 0 C--N 1.313 -0.701 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.61 -143.81 0.17 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.535 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.534 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.4 OUTLIER -140.48 -20.38 0.84 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.499 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.46 -176.38 5.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.959 0.409 . . . . 0.0 110.938 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 31.4 mt -93.39 164.15 13.31 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.274 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' B' ' 317' ' ' GLU . 5.7 t -123.46 123.88 26.39 Favored Pre-proline 0 N--CA 1.44 -0.965 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.993 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' B' ' 326' ' ' VAL . 68.1 Cg_exo -44.18 144.14 3.01 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 N-CA-C 108.096 -1.54 . . . . 0.0 108.096 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.626 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 13.9 ttt180 -150.41 -173.23 4.39 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.71 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -141.41 120.76 13.11 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.103 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 32.0 tp -98.67 158.17 15.79 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.223 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.56 108.5 0.53 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 29.4 mm -87.98 123.58 40.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.724 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.98 138.05 52.45 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.423 ' O ' HG21 ' B' ' 399' ' ' ILE . 0.0 OUTLIER -57.55 14.65 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.697 0.284 . . . . 0.0 111.442 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.724 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.5 pt-20 -144.53 -4.36 0.78 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.561 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.48 177.35 2.19 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.412 1.101 . . . . 0.0 112.915 -176.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.0 t -132.5 145.4 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 113.148 -1.842 . . . . 0.0 106.401 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.2 ptt? -152.93 150.61 29.44 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 117.199 -1.801 . . . . 0.0 114.568 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . 0.524 ' HE ' ' CD ' ' B' ' 317' ' ' GLU . 0.4 OUTLIER -96.24 106.86 19.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.515 176.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.13 150.1 4.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.299 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.5 t0 -87.97 91.62 8.83 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.694 -178.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.43 -28.32 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.619 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 24.0 mttp -75.52 -43.94 46.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.725 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.556 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.61 -13.7 14.77 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 15.3 tttt 68.0 -0.41 2.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.98 0.419 . . . . 0.0 109.933 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.9 mt-10 -86.66 152.9 22.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 89.7 t -81.61 133.96 28.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.5 0.667 . . . . 0.0 112.276 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 1.2 mm -104.14 -30.76 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.225 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' B' ' 338' ' ' MET . 15.7 tt0 -138.74 157.23 46.47 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.489 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -143.4 150.55 39.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.233 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.52 124.31 4.01 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.942 177.644 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.529 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -45.69 140.92 3.14 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.42 0.628 . . . . 0.0 111.612 -178.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' B' ' 355' ' ' ASN . 2.0 tt -84.36 -36.32 22.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 354' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' B' ' 400' ' ' LEU . 6.0 t -73.5 9.54 1.33 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.906 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.571 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 1.0 OUTLIER -111.13 -7.28 14.49 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.0 178.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 78.0 mt -56.91 146.41 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 120.444 -0.503 . . . . 0.0 111.766 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . 0.512 ' NZ ' ' OH ' ' B' ' 373' ' ' TYR . 9.0 tttp -107.6 -46.03 3.92 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.5 ptt-85 -172.97 135.76 0.63 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.454 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.1 p90 -119.15 176.56 5.25 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.186 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.37 98.94 1.59 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 119.176 -1.009 . . . . 0.0 111.877 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.64 145.73 31.52 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.563 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.537 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -134.09 173.73 5.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.735 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.38 -8.21 17.23 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.175 1.917 . . . . 0.0 112.069 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' B' ' 382' ' ' THR . 26.0 mttt -130.51 -21.3 2.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.942 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.566 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.3 p -151.94 167.79 27.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.601 0.715 . . . . 0.0 111.883 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.439 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -139.19 156.49 47.07 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.549 179.557 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.432 ' OG1' ' OG ' ' B' ' 379' ' ' SER . 25.1 m -148.43 154.81 40.39 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 118.947 -1.101 . . . . 0.0 113.068 -174.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.419 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.6 mt -125.64 140.09 53.02 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.329 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 9.7 t0 -117.56 95.5 4.98 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.875 176.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 27.6 t80 -137.75 95.16 3.0 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.89 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.96 12.17 1.96 Allowed Glycine 0 C--O 1.225 -0.413 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.6 t0 -41.73 -16.36 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.911 -0.645 . . . . 0.0 112.057 -178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.539 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.0 m-85 -54.35 -37.83 65.37 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.502 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.66 -92.16 0.51 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.522 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.502 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 7.5 t0 -130.02 96.29 4.16 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.14 -3.31 54.39 Favored Glycine 0 C--N 1.306 -1.131 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.405 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.68 107.11 16.71 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -175.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -115.39 120.66 40.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.742 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.586 ' HG ' ' H ' ' B' ' 380' ' ' VAL . 35.2 t -138.49 163.35 32.19 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.788 0.804 . . . . 0.0 113.103 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.586 ' H ' ' HG ' ' B' ' 379' ' ' SER . 1.6 m -149.97 175.56 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.299 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -101.74 124.4 47.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.039 0.923 . . . . 0.0 110.728 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.566 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.46 136.86 14.97 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.883 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.62 17.59 4.55 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.251 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . 0.517 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.4 OUTLIER -144.16 83.58 1.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.949 174.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -58.85 1.92 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.0 pt-20 -44.49 -20.08 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.904 -0.648 . . . . 0.0 111.022 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.437 ' N ' ' C ' ' B' ' 385' ' ' GLY . 23.5 mt-30 -83.13 -39.55 20.93 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.9 mt -76.54 -42.02 34.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.654 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.63 -42.69 61.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.503 -177.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -63.63 -34.62 78.24 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 122.036 0.922 . . . . 0.0 111.05 -177.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.596 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.96 -53.16 10.7 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.811 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.596 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -49.12 -55.12 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.19 -34.32 44.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.657 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.86 -17.99 62.31 Favored Glycine 0 CA--C 1.504 -0.611 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.4 m-30 -86.72 -36.65 18.54 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -13.02 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-O 122.123 0.963 . . . . 0.0 109.226 176.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.51 -23.07 43.18 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.465 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . 0.419 ' O ' ' CD1' ' B' ' 400' ' ' LEU . 74.2 mt -90.34 -59.95 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.573 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.493 ' O ' ' C ' ' B' ' 400' ' ' LEU . 0.7 OUTLIER -69.1 -19.58 23.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.266 -177.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.493 ' C ' ' O ' ' B' ' 399' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.381 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mt -145.88 149.26 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.425 0.631 . . . . 0.0 110.619 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.53 -35.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.327 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.496 ' O ' ' C ' ' A' ' 11' ' ' MET . 49.2 mt-30 -128.43 -26.92 2.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.773 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.496 ' C ' ' O ' ' A' ' 10' ' ' GLN . 43.5 mtp -17.79 -69.4 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.412 0 O-C-N 124.286 0.991 . . . . 0.0 112.069 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -43.51 -64.1 0.71 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.918 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 10' ' ' GLN . 3.0 t -56.17 -39.88 73.05 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.766 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.451 ' H ' ' HG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -52.21 -48.81 64.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.829 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -74.66 -43.5 55.02 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -37.35 64.61 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.12 -50.68 61.19 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -55.5 -41.33 72.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.986 0.422 . . . . 0.0 110.023 178.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.519 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 6.7 mtp -57.19 -34.39 68.44 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.013 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -49.19 -32.16 9.86 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.192 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.543 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.0 mm? -73.35 -16.88 61.34 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.267 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.483 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -84.0 -11.26 57.06 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 25' ' ' SER . 3.8 m -126.96 -9.19 6.0 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.134 0.492 . . . . 0.0 110.372 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 15.2 mp0 54.45 -82.49 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.902 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -153.97 -12.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.269 -178.545 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 mp -41.24 -85.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.589 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.53 -96.28 0.13 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.65 -32.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.88 0.372 . . . . 0.0 110.582 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 54.55 94.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.529 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.587 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . 0.598 ' N ' ' CD1' ' B' ' 308' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 56.06 -81.47 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' B' ' 308' ' ' TYR . 74.9 t -127.31 134.05 66.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.761 0.315 . . . . 0.0 110.771 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.5 153.65 24.78 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.113 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -127.7 135.42 50.16 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.158 0.286 . . . . 0.0 111.587 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -139.96 127.36 21.4 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.572 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.555 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.77 107.72 13.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 123.751 1.739 . . . . 0.0 109.314 178.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' B' ' 328' ' ' ARG . 31.3 m -120.18 162.6 18.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 112.658 -2.065 . . . . 0.0 110.097 -176.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -104.0 145.61 29.9 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.474 ' O ' ' SD ' ' B' ' 319' ' ' MET . 44.0 tt0 -136.38 152.42 50.61 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.033 0.92 . . . . 0.0 112.627 -178.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . 0.553 ' HZ1' HD21 ' B' ' 323' ' ' ASN . 6.2 tptm -79.87 100.57 8.09 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.536 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.68 ' N ' ' SD ' ' B' ' 319' ' ' MET . 0.0 OUTLIER -89.88 178.9 6.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.987 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.67 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.86 147.54 26.39 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.04 178.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 117.93 -25.29 8.48 Favored Glycine 0 C--N 1.313 -0.703 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -133.97 -143.06 0.2 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.637 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.553 HD21 ' HZ1' ' B' ' 318' ' ' LYS . 0.1 OUTLIER -140.85 -17.2 0.86 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.549 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.65 -176.73 4.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 110.952 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 27.1 mt -91.26 163.37 14.26 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.327 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' B' ' 317' ' ' GLU . 14.4 t -124.69 126.12 25.41 Favored Pre-proline 0 N--CA 1.44 -0.929 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.91 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.409 ' C ' ' O ' ' B' ' 326' ' ' VAL . 68.0 Cg_exo -44.39 144.11 3.28 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.629 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 11.2 ttm-85 -150.08 -173.59 4.48 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.696 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.16 120.49 13.07 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.145 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 31.7 tp -99.04 157.9 16.03 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.249 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.2 108.04 0.52 Allowed Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.7 mm -87.82 122.91 40.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.715 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.9 p -117.09 138.55 51.55 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.414 ' O ' HG21 ' B' ' 399' ' ' ILE . 1.0 OUTLIER -57.79 15.83 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.747 0.308 . . . . 0.0 111.354 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.715 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.1 pt-20 -145.72 -4.5 0.66 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.528 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.46 177.39 2.19 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.362 1.077 . . . . 0.0 113.011 -176.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.61 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 9.9 t -132.81 145.29 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 CA-C-N 113.16 -1.836 . . . . 0.0 106.254 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.475 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.0 OUTLIER -152.54 150.88 30.04 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 117.143 -1.823 . . . . 0.0 114.468 -175.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . 0.506 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 62.6 mtm180 -96.13 106.77 19.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.524 176.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.7 t -96.76 150.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.278 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' B' ' 344' ' ' THR . 28.8 t0 -88.04 91.74 8.88 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.76 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.48 -28.38 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.617 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.8 mttm -75.18 -43.78 50.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.691 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.7 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 1.3 p -108.77 -13.98 14.68 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 14.7 tttp 68.29 -0.77 2.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.026 0.441 . . . . 0.0 109.958 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.7 ' H ' ' HG1' ' B' ' 344' ' ' THR . 3.9 mt-10 -86.3 152.83 22.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.35 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 86.6 t -81.6 133.55 29.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.485 0.66 . . . . 0.0 112.178 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 11.9 mt -102.98 -31.02 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.319 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.506 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 21.8 tt0 -139.58 158.15 44.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.595 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -143.06 150.08 39.06 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.135 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.556 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.0 122.38 4.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.938 177.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.551 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -44.93 139.79 2.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.443 0.639 . . . . 0.0 111.624 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.7 tt -82.24 -37.28 26.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 19.7 m -70.67 6.76 1.32 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.799 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.587 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 0.9 OUTLIER -108.37 -4.84 17.06 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.106 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.9 144.42 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.753 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -107.3 -45.95 3.99 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 7.2 ptt180 -172.43 135.7 0.74 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.443 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.6 p90 -119.08 176.35 5.34 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.208 -177.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.24 99.21 1.62 Allowed 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.961 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.25 145.4 30.96 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.573 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -133.71 173.96 5.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -77.39 -7.95 17.12 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.136 1.891 . . . . 0.0 112.131 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' B' ' 382' ' ' THR . 4.0 mtpp -130.61 -21.27 2.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.046 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.565 ' HA ' ' H ' ' B' ' 382' ' ' THR . 61.1 p -152.25 167.36 28.85 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.528 0.68 . . . . 0.0 111.903 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.437 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -138.79 156.63 47.18 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.504 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.428 ' OG1' ' OG ' ' B' ' 379' ' ' SER . 24.2 m -148.57 154.47 39.81 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.014 -1.075 . . . . 0.0 113.02 -174.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.8 mt -125.32 140.77 52.53 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.355 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.8 t0 -118.06 95.6 4.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.464 -0.895 . . . . 0.0 110.821 176.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 18.6 t80 -137.38 94.85 2.98 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.936 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.01 12.41 1.91 Allowed Glycine 0 C--O 1.226 -0.405 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.2 t0 -41.89 -16.12 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.02 -0.59 . . . . 0.0 111.887 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.542 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.34 -37.94 65.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.501 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.32 -92.37 0.51 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.895 -1.502 . . . . 0.0 107.358 176.691 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.501 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 7.8 t70 -129.93 96.16 4.14 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.16 -2.92 54.48 Favored Glycine 0 C--N 1.31 -0.883 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.28 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.673 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.45 107.06 16.5 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -175.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . 0.422 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.7 OUTLIER -114.71 120.95 41.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.677 175.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.608 ' HG ' ' H ' ' B' ' 380' ' ' VAL . 35.7 t -138.67 163.21 32.69 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.608 ' H ' ' HG ' ' B' ' 379' ' ' SER . 0.8 OUTLIER -149.95 175.18 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.209 178.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -101.44 124.57 47.32 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.955 0.883 . . . . 0.0 110.863 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.565 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.88 136.91 14.66 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.937 179.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.75 17.42 4.77 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.207 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.06 83.88 1.75 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.902 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.96 -58.19 2.04 Favored Glycine 0 C--O 1.223 -0.578 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.5 pt-20 -44.58 -20.06 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.814 -0.693 . . . . 0.0 111.083 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.439 ' N ' ' C ' ' B' ' 385' ' ' GLY . 41.5 mt-30 -83.04 -39.78 20.78 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' B' ' 385' ' ' GLY . 50.2 mt -76.74 -41.99 33.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.611 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.68 -42.37 61.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.293 -1.321 . . . . 0.0 113.532 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.462 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.3 pt20 -64.02 -34.65 78.5 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.076 0.941 . . . . 0.0 111.063 -177.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.598 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.96 -53.11 10.8 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.753 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.598 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -49.09 -55.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.98 -33.69 52.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.736 -2.029 . . . . 0.0 110.511 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.06 -17.71 62.45 Favored Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.3 m-30 -86.91 -37.18 17.88 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -13.15 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.112 0.958 . . . . 0.0 109.297 176.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.96 -22.67 45.33 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.437 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 69.6 mt -91.95 -61.9 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.126 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.441 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.64 -20.37 27.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.324 -176.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.441 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.637 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.9 mt -144.6 150.25 16.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.652 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.34 -48.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.195 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.496 ' O ' ' C ' ' A' ' 11' ' ' MET . 9.7 mt-30 -122.7 -22.99 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.86 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.496 ' C ' ' O ' ' A' ' 10' ' ' GLN . 61.4 mtp -17.58 -66.4 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.412 0 O-C-N 124.23 0.957 . . . . 0.0 112.102 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' MET . 14.4 m-85 -41.11 -62.48 0.82 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.981 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 10' ' ' GLN . 4.7 t -63.2 -34.13 76.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.831 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.26 -29.13 69.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.32 -38.47 10.51 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.03 -43.26 99.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.619 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.26 89.2 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.67 -40.64 76.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.508 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 4.6 mtp -56.78 -31.0 64.2 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.932 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -28.63 16.7 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.247 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.525 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -75.82 -8.93 58.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.292 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.464 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -93.47 -8.6 41.1 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.117 0.484 . . . . 0.0 109.762 179.198 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.46 ' CG2' ' O ' ' A' ' 23' ' ' THR . 14.0 m -129.8 -5.47 4.58 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.697 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 13.8 mp0 44.99 -93.72 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.667 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -142.34 -7.65 0.89 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.381 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.4 mp -47.71 -90.6 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.605 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.48 96.5 1.18 Allowed Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 174.91 129.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 121.369 0.604 . . . . 0.0 110.377 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 30' ' ' THR . 6.8 t70 -90.35 -91.87 0.14 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.721 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.518 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 10.8 t . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.539 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 41.05 -155.12 0.06 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 85.3 t -40.57 137.33 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.781 0.324 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.68 153.29 26.64 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.202 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -130.09 134.64 47.49 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.052 0.22 . . . . 0.0 111.436 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -138.93 129.3 25.69 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.533 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.573 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.39 102.32 10.41 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 123.902 1.811 . . . . 0.0 109.503 178.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.613 ' O ' ' N ' ' B' ' 328' ' ' ARG . 26.2 m -114.33 158.08 14.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 112.76 -2.018 . . . . 0.0 110.187 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . 0.462 ' NZ ' ' CG ' ' A' ' 29' ' ' ASP . 12.2 mtpt -98.35 145.22 26.91 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' B' ' 326' ' ' VAL . 30.1 tt0 -127.29 145.55 50.75 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.927 0.87 . . . . 0.0 112.435 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 5.7 tptm -75.56 101.13 4.79 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.599 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 34.5 mmt -104.2 168.97 8.76 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.74 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.66 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -102.03 143.52 31.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.205 178.517 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 125.31 -20.2 6.64 Favored Glycine 0 C--N 1.311 -0.839 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' B' ' 323' ' ' ASN . 14.9 ptpt -136.75 -21.13 1.29 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.331 -0.435 . . . . 0.0 111.022 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.543 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 2.3 t-20 85.97 -28.63 0.07 Allowed 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.643 0.59 . . . . 0.0 110.67 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.17 -174.96 5.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.114 0.483 . . . . 0.0 111.033 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 19.2 mt -85.71 163.45 18.23 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.421 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.6 t -127.33 126.1 24.1 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.132 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.417 ' C ' ' O ' ' B' ' 326' ' ' VAL . 71.2 Cg_exo -44.14 143.03 3.63 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 N-CA-C 107.939 -1.6 . . . . 0.0 107.939 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.617 HH21 ' CD1' ' B' ' 348' ' ' ILE . 2.2 tpt180 -148.52 -172.59 4.12 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.629 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.66 121.11 11.0 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 31.9 tp -99.4 158.61 15.6 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.198 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.34 108.34 0.52 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 29.9 mm -88.19 123.26 40.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.718 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.88 138.37 52.17 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.412 ' O ' HG21 ' B' ' 399' ' ' ILE . 1.0 OUTLIER -58.06 15.73 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.752 0.31 . . . . 0.0 111.251 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.718 ' H ' ' C ' ' B' ' 333' ' ' THR . 11.2 pt-20 -145.12 -4.75 0.71 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.525 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.62 177.28 2.15 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.425 1.107 . . . . 0.0 112.89 -176.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.61 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.9 t -132.56 145.3 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 CA-C-N 113.065 -1.88 . . . . 0.0 106.315 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.472 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.2 ptt? -152.63 150.61 29.67 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 117.175 -1.81 . . . . 0.0 114.423 -175.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . 0.507 ' NH1' ' OE1' ' B' ' 317' ' ' GLU . 26.3 mtm105 -95.74 107.01 19.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.481 176.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.629 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -96.57 150.04 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.274 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.6 t0 -88.19 91.4 8.77 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.668 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.4 -28.49 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.678 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.9 mttm -75.19 -43.96 49.18 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.704 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.74 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 1.3 p -108.95 -13.27 14.76 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 17.4 tttp 67.72 -0.9 1.8 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 109.988 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.74 ' H ' ' HG1' ' B' ' 344' ' ' THR . 3.5 mt-10 -85.69 152.07 23.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.346 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 85.6 t -81.38 133.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.514 0.673 . . . . 0.0 112.209 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . 0.617 ' CD1' HH21 ' B' ' 328' ' ' ARG . 48.8 mt -103.83 -30.24 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.335 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.472 ' O ' ' CB ' ' B' ' 338' ' ' MET . 21.4 tt0 -139.72 157.41 45.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.639 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -143.35 149.98 38.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.321 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.554 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.87 124.12 4.27 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.102 177.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.516 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.54 140.63 3.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.394 0.616 . . . . 0.0 111.606 -178.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' B' ' 355' ' ' ASN . 2.0 tt -84.16 -35.89 23.26 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -74.26 9.87 1.49 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.824 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.575 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.0 m-20 -111.46 -7.56 14.34 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.069 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 81.3 mt -55.95 146.9 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.805 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -107.83 -45.9 3.9 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.502 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.9 ptt-85 -173.02 135.72 0.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.457 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.0 p90 -119.61 176.28 5.45 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.195 -177.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.93 99.59 1.54 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.017 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.34 147.7 30.97 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.574 -1.193 . . . . 0.0 110.682 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.541 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -135.32 174.17 4.9 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -77.81 -8.13 16.74 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.137 1.892 . . . . 0.0 112.122 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' B' ' 382' ' ' THR . 5.6 mttm -130.74 -20.36 2.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.056 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.566 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.1 p -153.11 167.98 27.43 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.594 0.711 . . . . 0.0 111.934 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.437 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -139.42 156.46 46.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.618 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.424 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 26.0 m -148.51 154.81 40.32 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.03 -1.068 . . . . 0.0 113.081 -174.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.424 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.8 mt -125.82 140.0 53.03 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.362 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.6 t0 -117.4 95.6 5.04 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.654 176.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 30.5 t80 -137.93 94.94 2.95 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.985 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.85 12.11 1.99 Allowed Glycine 0 C--O 1.224 -0.51 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.3 t0 -41.61 -16.42 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.977 -0.612 . . . . 0.0 111.745 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.38 -37.33 64.88 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.513 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.06 -92.31 0.51 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.283 176.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.513 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.5 t70 -129.59 96.36 4.24 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.5 -3.34 53.28 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.21 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.677 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.21 106.79 16.11 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . 0.4 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.9 OUTLIER -114.53 120.3 39.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.748 176.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.508 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 34.8 t -138.68 163.91 30.9 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.54 175.81 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.15 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.76 124.29 47.15 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.904 0.859 . . . . 0.0 110.754 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.566 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.69 136.85 14.77 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.87 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.74 17.42 4.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.247 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . 0.552 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.1 OUTLIER -144.06 83.74 1.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.996 175.031 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.53 -58.24 1.97 Allowed Glycine 0 C--N 1.317 -0.498 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.1 pt-20 -44.81 -20.17 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 114.949 -0.625 . . . . 0.0 111.032 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 6.7 mm-40 -83.47 -38.87 21.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.2 mt -76.68 -42.2 34.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.613 177.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.69 -42.58 61.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.363 -1.289 . . . . 0.0 113.541 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.443 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.9 pt20 -63.55 -34.45 77.83 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.051 0.929 . . . . 0.0 111.069 -177.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.599 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.02 -53.32 10.29 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.81 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.599 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.6 mt -49.21 -55.09 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 176.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.38 -34.1 46.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.55 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.79 -17.95 62.54 Favored Glycine 0 CA--C 1.506 -0.529 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.5 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.4 m-30 -86.91 -36.93 18.1 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -13.29 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 CA-C-O 122.151 0.976 . . . . 0.0 109.283 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.49 -22.62 47.19 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.741 -1.572 . . . . 0.0 109.447 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.7 mt -91.94 -61.85 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.901 -1.499 . . . . 0.0 112.037 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -65.12 -20.17 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.357 -176.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.454 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.838 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 mt -145.05 149.7 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.997 0.427 . . . . 0.0 110.644 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.61 -64.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.142 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.516 ' O ' ' C ' ' A' ' 11' ' ' MET . 8.9 mt-30 -122.5 -21.35 5.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.88 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.516 ' C ' ' O ' ' A' ' 10' ' ' GLN . 12.5 mtm -15.58 -63.38 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 124.277 0.986 . . . . 0.0 112.106 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -42.63 -66.8 0.33 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.101 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -59.33 -34.26 72.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.874 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.465 ' H ' ' HG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -61.67 -45.2 95.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.016 -179.59 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.19 -38.16 60.91 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.84 -40.33 83.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.3 -42.03 99.72 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.491 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.4 mt-10 -65.39 -37.67 87.69 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.507 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 8.6 mtp -58.88 -32.52 69.56 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.855 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -50.98 -30.23 14.49 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.158 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.5 mm? -70.61 -11.84 61.19 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.269 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.509 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -90.6 -9.38 47.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.98 0.419 . . . . 0.0 109.986 179.462 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.469 ' HG1' ' CD2' ' A' ' 22' ' ' LEU . 4.4 m -118.55 -8.7 10.41 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.338 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.453 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER -56.09 -160.27 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.724 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.659 ' HG ' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -52.73 -166.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.85 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.659 ' N ' ' HG ' ' A' ' 25' ' ' SER . 10.4 mp -40.6 -88.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.618 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.43 97.9 0.01 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.459 ' CG2' ' H ' ' A' ' 29' ' ' ASP . 2.5 m -69.58 -104.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.802 0.334 . . . . 0.0 110.514 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.459 ' H ' ' CG2' ' A' ' 28' ' ' VAL . 9.3 t70 -72.76 53.21 0.32 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.551 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.1 m . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.579 -179.939 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 48.54 -95.14 0.01 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.93 134.74 65.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.772 0.32 . . . . 0.0 110.786 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.02 153.7 25.22 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.099 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -127.79 135.57 50.28 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.1 0.25 . . . . 0.0 111.56 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -140.31 128.11 21.86 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.568 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.557 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.58 107.99 13.84 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 123.653 1.692 . . . . 0.0 109.477 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' B' ' 328' ' ' ARG . 31.1 m -119.85 161.28 19.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 112.706 -2.043 . . . . 0.0 110.072 -176.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -102.58 146.02 28.78 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' B' ' 326' ' ' VAL . 20.5 tt0 -130.32 147.24 52.01 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.993 0.902 . . . . 0.0 112.275 -178.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 5.5 tptm -75.49 101.86 5.01 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.095 -1.412 . . . . 0.0 111.758 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 34.1 mmt -105.08 169.24 8.55 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.654 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.66 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.96 142.35 33.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.335 178.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 126.62 -20.61 6.09 Favored Glycine 0 C--N 1.312 -0.802 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' B' ' 323' ' ' ASN . 15.5 ptpt -136.4 -21.58 1.34 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.354 -0.423 . . . . 0.0 111.147 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.536 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.2 OUTLIER 86.84 -29.57 0.05 Allowed 'General case' 0 C--N 1.333 -0.136 0 O-C-N 123.698 0.624 . . . . 0.0 110.814 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.98 -175.2 5.47 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.045 0.45 . . . . 0.0 111.136 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 20.7 mt -84.45 163.16 19.64 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.46 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.2 t -126.86 124.25 23.96 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.139 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' B' ' 326' ' ' VAL . 64.0 Cg_exo -44.87 145.09 3.13 Favored 'Trans proline' 0 C--N 1.32 -0.937 0 N-CA-C 108.088 -1.543 . . . . 0.0 108.088 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.632 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 12.5 ttm-85 -151.68 -172.89 4.35 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.62 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.21 121.13 13.59 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 31.9 tp -99.17 157.95 16.01 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -178.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.01 108.04 0.52 Allowed Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.96 122.19 39.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.737 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.2 p -116.56 138.2 51.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.43 ' O ' HG21 ' B' ' 399' ' ' ILE . 22.1 pttm -57.59 14.09 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.031 0.443 . . . . 0.0 111.647 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.737 ' H ' ' C ' ' B' ' 333' ' ' THR . 16.2 pt-20 -144.2 -3.63 0.84 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.758 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.618 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.59 178.18 1.98 Allowed 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.386 1.089 . . . . 0.0 112.898 -176.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.618 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.0 t -134.18 144.72 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 113.106 -1.861 . . . . 0.0 106.386 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.488 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.6 ptt? -152.71 151.46 30.56 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 117.175 -1.81 . . . . 0.0 114.42 -175.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.18 106.69 18.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.385 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.651 ' N ' ' O ' ' B' ' 329' ' ' LEU . 3.0 t -96.1 149.26 4.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.293 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' B' ' 343' ' ' LYS . 46.0 t0 -87.26 90.49 8.38 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.854 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.8 OUTLIER -35.84 -28.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.686 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' B' ' 341' ' ' ASP . 15.9 mttp -70.49 -44.01 68.55 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.613 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.624 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 0.5 OUTLIER -114.21 -17.55 11.84 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' B' ' 344' ' ' THR . 8.3 tttp 77.46 -0.0 2.87 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.624 ' H ' ' HG1' ' B' ' 344' ' ' THR . 8.1 pt-20 -82.47 157.82 23.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 90.3 t -87.38 131.69 34.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.363 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 59.3 mt -101.35 -29.99 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.455 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.488 ' O ' ' CB ' ' B' ' 338' ' ' MET . 18.0 tt0 -140.81 158.23 44.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.626 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -143.79 151.25 39.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.232 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -160.31 124.83 3.75 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.19 177.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.539 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -47.09 139.42 5.86 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.448 0.642 . . . . 0.0 111.493 -178.803 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.9 tt -82.99 -35.67 25.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.2 t -74.15 9.69 1.52 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.935 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.57 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.1 m-20 -111.29 -7.67 14.4 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.992 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 78.9 mt -56.55 146.69 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.826 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -107.76 -45.12 4.08 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.503 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 10.3 ptt180 -173.79 136.1 0.54 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.476 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 7.9 p90 -119.09 177.24 4.94 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.23 -177.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.58 99.23 1.57 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.101 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.13 147.13 30.21 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.647 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.554 ' HG ' ' H ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -135.69 173.71 5.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -76.98 -8.39 17.74 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.088 1.858 . . . . 0.0 112.297 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.9 mttm -130.66 -20.76 2.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.057 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.56 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.3 p -152.47 167.67 28.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.572 0.701 . . . . 0.0 111.852 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.443 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -139.2 156.79 46.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.815 179.619 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.437 ' OG1' ' OG ' ' B' ' 379' ' ' SER . 24.9 m -148.65 155.52 41.16 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.11 -1.036 . . . . 0.0 113.17 -174.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.432 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.8 mt -126.05 140.15 52.83 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.168 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 9.2 t0 -117.69 95.6 5.01 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.547 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 31.0 t80 -137.63 94.71 2.95 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.937 176.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.85 12.17 1.98 Allowed Glycine 0 C--O 1.225 -0.421 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.7 t0 -41.6 -16.16 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.953 -0.624 . . . . 0.0 111.818 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.45 -37.44 65.19 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.514 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.87 -92.59 0.5 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.909 -1.496 . . . . 0.0 107.187 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.514 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.5 t70 -129.34 96.18 4.23 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.24 -3.37 54.05 Favored Glycine 0 C--N 1.311 -0.851 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.256 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.02 106.73 15.9 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -175.605 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . 0.403 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.9 OUTLIER -114.05 120.38 40.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.759 175.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.636 ' HG ' ' H ' ' B' ' 380' ' ' VAL . 34.7 t -138.46 163.87 30.83 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.679 0.752 . . . . 0.0 112.909 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.636 ' H ' ' HG ' ' B' ' 379' ' ' SER . 1.6 m -150.76 175.56 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.101 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -101.53 125.08 48.13 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.12 0.962 . . . . 0.0 110.799 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.56 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.22 136.51 14.0 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.831 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.22 17.35 4.38 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.175 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.04 83.94 1.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.936 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.98 -58.78 1.95 Allowed Glycine 0 C--O 1.223 -0.557 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.501 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.7 pt-20 -44.45 -20.87 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 114.787 -0.706 . . . . 0.0 111.027 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' B' ' 385' ' ' GLY . 22.3 mt-30 -82.37 -39.35 22.86 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 51.6 mt -76.59 -42.2 34.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.579 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.89 -42.57 60.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.534 -177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 5.0 pp0? -63.81 -34.44 77.91 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.075 0.941 . . . . 0.0 111.105 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.6 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.05 -53.42 10.02 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.73 -179.581 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.6 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -48.97 -55.56 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -51.96 -34.01 40.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.777 -2.01 . . . . 0.0 110.635 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.89 -18.16 61.9 Favored Glycine 0 CA--C 1.506 -0.491 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.5 m-30 -86.79 -36.82 18.34 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.42 -13.3 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 CA-C-O 122.195 0.998 . . . . 0.0 109.29 176.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.42 -22.6 47.5 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.512 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.5 mt -91.9 -62.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.003 -178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.44 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.68 -20.24 26.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.359 -1.746 . . . . 0.0 112.393 -176.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.44 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.715 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.8 OUTLIER 39.86 -161.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.711 179.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 50.9 t0 58.16 -78.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.376 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 13' ' ' SER . 81.2 mt-30 -76.83 -41.86 42.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.962 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 14' ' ' THR . 62.3 mtp -19.18 -72.27 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 124.121 0.888 . . . . 0.0 112.099 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.426 ' C ' ' O ' ' A' ' 11' ' ' MET . 10.9 m-85 -39.42 -57.38 1.43 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.928 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 10' ' ' GLN . 1.8 t -67.27 -24.54 65.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.779 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 11' ' ' MET . 0.2 OUTLIER -75.39 -19.95 59.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -109.98 -41.02 4.58 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.08 -43.75 98.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.79 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.35 -36.08 81.92 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.83 -41.74 67.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.516 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 6.1 mtp -52.33 -32.54 38.54 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.891 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -26.49 12.79 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.317 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.519 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.2 mm? -79.59 -6.85 57.92 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.376 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.525 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -93.72 -10.33 34.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.901 0.381 . . . . 0.0 110.028 179.61 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 m -118.68 -15.75 9.47 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.006 0.431 . . . . 0.0 110.315 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.3 -72.52 0.05 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.243 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.565 ' HG ' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -178.1 -47.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.213 -178.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.565 ' N ' ' HG ' ' A' ' 25' ' ' SER . 11.0 mp -63.84 -99.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.568 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.81 88.1 0.01 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.459 ' CG1' ' N ' ' A' ' 29' ' ' ASP . 3.4 p -74.51 -41.13 49.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.007 0.432 . . . . 0.0 110.71 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.459 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 29.5 t70 55.03 95.21 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.555 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 29' ' ' ASP . 1.3 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.558 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . 0.422 ' O ' ' OH ' ' B' ' 395' ' ' TYR . 50.9 m-85 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -80.58 -155.03 10.9 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 95.2 t -40.71 137.26 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.736 0.303 . . . . 0.0 110.769 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.58 153.59 27.31 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -129.58 134.13 47.56 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.14 0.275 . . . . 0.0 111.45 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -138.93 128.01 23.88 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.615 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.561 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.06 106.09 12.78 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 123.762 1.744 . . . . 0.0 109.284 178.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' B' ' 328' ' ' ARG . 28.5 m -118.55 162.68 16.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 112.669 -2.059 . . . . 0.0 110.12 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -103.83 145.98 29.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.49 ' O ' ' SD ' ' B' ' 319' ' ' MET . 38.1 tt0 -135.43 152.27 51.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.059 0.933 . . . . 0.0 112.538 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -79.29 101.44 8.05 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.636 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.687 ' N ' ' SD ' ' B' ' 319' ' ' MET . 0.0 OUTLIER -92.27 179.38 5.57 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.989 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.675 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -98.52 142.33 30.25 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.914 178.494 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 126.25 -26.19 5.31 Favored Glycine 0 C--N 1.31 -0.882 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' B' ' 324' ' ' LYS . 20.4 pttp -146.51 -157.87 0.85 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.456 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -117.71 -27.22 6.32 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.822 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.511 ' O ' ' NZ ' ' B' ' 322' ' ' LYS . 0.0 OUTLIER -73.55 -176.74 2.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.058 0.456 . . . . 0.0 111.045 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 31.3 mt -99.4 167.16 10.81 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.34 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' B' ' 317' ' ' GLU . 19.6 t -123.69 126.55 25.72 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.018 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.405 ' C ' ' O ' ' B' ' 326' ' ' VAL . 67.8 Cg_exo -44.52 144.73 3.01 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 N-CA-C 108.117 -1.532 . . . . 0.0 108.117 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.636 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 8.1 ttm180 -151.18 -173.09 4.39 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 119.577 -0.849 . . . . 0.0 108.712 -177.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.12 121.47 13.99 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 33.3 tp -99.41 158.42 15.74 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.213 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.83 108.44 0.52 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.0 mm -87.91 123.96 40.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.73 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.42 138.38 52.5 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.417 ' O ' HG22 ' B' ' 399' ' ' ILE . 0.5 OUTLIER -57.83 14.71 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.122 0.487 . . . . 0.0 111.562 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.73 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.2 pt-20 -144.59 -4.11 0.78 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.805 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.13 176.77 2.03 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.323 1.059 . . . . 0.0 112.989 -176.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.615 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 9.5 t -132.58 145.8 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 CA-C-N 113.209 -1.814 . . . . 0.0 106.269 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.477 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 1.2 ptt? -152.66 151.16 30.25 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 117.167 -1.813 . . . . 0.0 114.549 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . 0.554 ' NH1' ' NE2' ' B' ' 349' ' ' GLN . 2.7 mtm180 -95.76 106.8 18.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.436 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.46 149.5 4.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.29 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' B' ' 343' ' ' LYS . 42.9 t0 -87.63 90.83 8.52 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.862 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.8 OUTLIER -36.24 -27.27 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.654 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.1 mttp -70.64 -43.17 69.78 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.672 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.533 ' N ' ' O ' ' B' ' 341' ' ' ASP . 26.6 p -115.59 -17.86 11.05 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' B' ' 344' ' ' THR . 10.3 tttm 78.16 1.19 2.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 110.126 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -84.97 156.98 20.93 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 91.7 t -86.69 132.87 31.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.508 0.67 . . . . 0.0 112.394 -178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 22.0 mm -102.6 -30.6 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.267 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.554 ' NE2' ' NH1' ' B' ' 339' ' ' ARG . 2.7 tt0 -140.45 157.87 44.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.622 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -142.28 150.29 40.67 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.19 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -157.16 122.32 4.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.136 177.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.528 ' H ' ' HG ' ' B' ' 352' ' ' SER . 0.0 OUTLIER -45.48 138.95 4.02 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.403 0.621 . . . . 0.0 111.503 -178.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.7 tt -81.66 -36.99 28.18 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 17.4 m -70.97 6.9 1.34 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.892 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.569 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.7 m-20 -108.55 -4.95 16.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.93 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 70.8 mt -60.65 144.16 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.743 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -107.3 -45.63 4.06 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.4 ptt-85 -172.43 135.77 0.74 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.451 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 8.7 p90 -118.95 175.51 5.72 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.119 -177.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.87 98.94 1.66 Allowed 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 119.199 -1.001 . . . . 0.0 111.891 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.16 149.54 29.07 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.839 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.522 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -137.86 174.99 3.72 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -78.42 -7.0 15.83 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.266 1.977 . . . . 0.0 112.134 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' B' ' 382' ' ' THR . 47.6 mttt -130.84 -22.53 2.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.001 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.55 ' HA ' ' H ' ' B' ' 382' ' ' THR . 63.8 p -152.74 165.94 33.74 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.653 0.74 . . . . 0.0 111.85 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.431 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -137.36 156.98 47.58 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.737 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.441 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 27.7 m -148.52 156.29 42.25 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.065 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.441 ' N ' ' CG2' ' B' ' 367' ' ' THR . 7.1 mt -126.71 141.45 51.84 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.435 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.4 t0 -118.44 95.41 4.86 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.691 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 17.6 t80 -137.18 94.85 3.0 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.951 176.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.79 12.24 1.98 Allowed Glycine 0 C--O 1.225 -0.412 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -41.73 -16.15 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.857 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.52 -37.51 65.45 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.506 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.82 -92.27 0.51 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.958 -1.473 . . . . 0.0 107.345 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.506 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 12.9 t0 -129.75 96.37 4.22 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.46 -2.7 53.56 Favored Glycine 0 C--N 1.311 -0.82 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.271 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.81 106.87 16.67 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -175.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.11 122.69 46.87 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.663 176.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.516 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 34.3 t -139.03 163.69 31.73 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.35 173.66 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.113 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -99.92 125.29 45.89 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.976 0.893 . . . . 0.0 110.872 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.55 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.21 136.39 13.91 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.912 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.09 16.83 4.66 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.296 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.19 84.1 1.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.992 175.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.76 -58.26 2.05 Favored Glycine 0 C--N 1.317 -0.487 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.9 pt-20 -44.73 -20.09 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 114.893 -0.653 . . . . 0.0 111.047 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.434 ' N ' ' C ' ' B' ' 385' ' ' GLY . 46.7 mt-30 -82.89 -39.76 21.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' B' ' 385' ' ' GLY . 51.4 mt -76.66 -41.84 34.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.687 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.86 -42.19 61.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.362 -1.29 . . . . 0.0 113.604 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.462 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.4 pt20 -64.19 -34.44 78.08 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.06 0.933 . . . . 0.0 111.047 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.598 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.09 -53.47 9.87 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.759 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.598 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -48.93 -55.28 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.6 -33.9 48.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 112.801 -2.0 . . . . 0.0 110.506 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.75 -17.98 62.55 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.4 m-30 -86.91 -37.07 17.98 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -13.14 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.911 0 CA-C-O 122.102 0.953 . . . . 0.0 109.325 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.04 -22.6 45.15 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.507 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.9 mt -91.83 -61.96 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-N 113.865 -1.516 . . . . 0.0 112.105 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.54 -20.54 27.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.38 -176.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.462 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.801 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.3 mt -101.0 151.15 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.567 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.502 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 54.3 t0 -172.91 -116.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.575 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 11' ' ' MET . 25.9 mt-30 -37.74 -33.53 0.08 Allowed 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.399 0.437 . . . . 0.0 110.764 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.488 ' C ' ' O ' ' A' ' 10' ' ' GLN . 6.7 mmm -21.2 -56.72 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 124.222 0.951 . . . . 0.0 111.848 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.502 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 9.6 m-85 -54.96 -71.96 0.07 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.047 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.0 t -46.35 -26.17 0.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.708 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -67.88 -54.63 17.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.644 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.9 -41.15 52.83 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -39.34 81.73 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.57 -45.52 96.15 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.518 ' OE2' ' CD2' ' B' ' 377' ' ' TYR . 82.5 mt-10 -61.36 -34.14 74.81 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.554 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 7.4 mtp -70.01 -32.63 70.9 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.191 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.2 OUTLIER -55.42 -19.47 9.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.191 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.519 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -71.45 -38.39 71.31 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.085 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.419 ' C ' ' CD1' ' A' ' 22' ' ' LEU . 4.0 pp -100.92 6.06 43.49 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.461 -0.495 . . . . 0.0 109.961 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 25' ' ' SER . 1.3 m -124.77 -25.29 3.97 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.171 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.9 mp0 35.11 -91.34 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.098 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 23' ' ' THR . 6.6 p -139.89 -139.68 0.13 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.213 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -101.35 -116.71 0.18 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.449 -179.299 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.51 -57.72 4.45 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.6 t -102.93 -3.43 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.802 0.334 . . . . 0.0 110.59 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.76 -89.87 0.35 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.533 180.0 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 136.24 -86.21 0.24 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 69.2 t -126.73 133.62 68.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.835 0.35 . . . . 0.0 110.712 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.44 153.1 25.49 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.081 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -128.99 134.76 48.29 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.037 0.211 . . . . 0.0 111.405 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -138.35 129.76 27.55 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.763 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.568 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.12 104.02 12.16 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 123.666 1.698 . . . . 0.0 109.283 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.598 ' O ' ' N ' ' B' ' 328' ' ' ARG . 34.7 m -120.27 157.27 22.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 112.867 -1.97 . . . . 0.0 110.167 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' B' ' 380' ' ' VAL . 7.0 mtmt -96.6 139.5 32.59 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.454 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.529 ' OE1' ' NE ' ' B' ' 339' ' ' ARG . 3.2 tt0 -126.43 154.32 43.82 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 122.007 0.908 . . . . 0.0 113.061 -177.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . 0.455 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 6.3 tptm -75.92 103.01 5.78 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.335 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 36.1 mmt -102.31 179.26 4.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.972 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.672 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -96.78 146.12 25.2 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.037 178.63 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 123.56 -26.24 6.04 Favored Glycine 0 C--N 1.312 -0.757 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -140.46 -142.04 0.14 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.59 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.455 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.8 OUTLIER -137.38 -20.76 1.19 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.527 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.484 ' HD2' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -89.48 -179.54 5.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.017 0.437 . . . . 0.0 111.052 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . 0.442 HD21 ' N ' ' B' ' 318' ' ' LYS . 15.1 mt -85.14 160.96 19.83 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.241 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' B' ' 327' ' ' PRO . 3.4 t -122.81 129.8 24.87 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.99 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.542 ' O ' ' NE ' ' B' ' 328' ' ' ARG . 80.1 Cg_exo -38.05 144.62 0.17 Allowed 'Trans proline' 0 CA--C 1.508 -0.816 0 N-CA-C 108.701 -1.307 . . . . 0.0 108.701 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' B' ' 315' ' ' VAL . 0.3 OUTLIER -157.15 -171.54 3.67 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.82 -176.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.643 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -142.81 124.38 14.88 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 27.9 tp -103.95 158.18 16.59 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.41 107.84 0.52 Allowed Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 31.6 mm -88.35 123.59 40.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.745 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.4 p -118.19 137.91 52.67 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.43 ' O ' HG21 ' B' ' 399' ' ' ILE . 20.9 pttm -57.36 13.64 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.004 0.43 . . . . 0.0 111.793 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.745 ' H ' ' C ' ' B' ' 333' ' ' THR . 12.7 pt-20 -144.32 -2.85 0.86 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.991 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.643 ' H ' ' HG1' ' B' ' 333' ' ' THR . 0.1 OUTLIER -173.9 178.72 2.12 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.307 1.051 . . . . 0.0 112.982 -177.07 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.601 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.38 145.6 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-N 113.338 -1.756 . . . . 0.0 106.682 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.473 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 3.2 ptt? -153.95 149.49 27.33 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 117.062 -1.855 . . . . 0.0 114.356 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . 0.529 ' NE ' ' OE1' ' B' ' 317' ' ' GLU . 12.1 mtp180 -94.14 107.65 19.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.666 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -98.73 149.71 5.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.2 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.9 t0 -89.6 92.27 9.02 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.815 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 341' ' ' ASP . 1.1 tt0 -35.46 -28.83 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.65 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' B' ' 341' ' ' ASP . 14.8 mttp -75.17 -43.62 51.19 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.704 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.61 ' HG1' ' H ' ' B' ' 346' ' ' GLU . 1.2 p -109.2 -12.55 14.78 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt 66.67 -1.15 1.38 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.029 0.442 . . . . 0.0 109.961 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.61 ' H ' ' HG1' ' B' ' 344' ' ' THR . 2.5 mt-10 -84.71 153.53 23.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.322 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 79.2 t -82.83 135.29 25.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.454 0.645 . . . . 0.0 112.288 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 66.0 mt -103.67 -30.39 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.424 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.473 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.9 tt0 -140.55 156.63 46.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.715 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -145.74 149.61 34.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.495 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' B' ' 337' ' ' VAL . 63.5 t-105 -162.79 135.15 5.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.892 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.503 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.57 138.75 27.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.411 -178.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.9 tt -79.03 -35.82 42.05 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.64 10.92 1.16 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.98 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.503 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.4 m-20 -114.23 -4.43 13.06 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.217 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 71.6 mt -57.48 147.81 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.068 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 26.8 tttt -105.84 -45.84 4.28 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 0.2 OUTLIER -174.45 136.3 0.46 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.405 177.272 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.439 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 10.0 p90 -119.99 173.64 6.95 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.256 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.73 99.72 1.73 Allowed 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 119.153 -1.019 . . . . 0.0 112.252 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -81.49 144.29 31.45 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.797 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.549 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -132.14 174.28 4.89 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -77.66 -8.63 17.06 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.165 1.91 . . . . 0.0 112.019 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.0 mtpp -130.95 -19.24 2.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.121 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.592 ' HA ' ' H ' ' B' ' 382' ' ' THR . 92.8 p -152.78 168.5 25.5 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.552 0.691 . . . . 0.0 112.062 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.452 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.2 OUTLIER -140.84 156.94 46.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.914 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.461 ' CG2' ' N ' ' B' ' 368' ' ' LEU . 64.1 m -147.3 158.99 44.17 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.003 -174.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.461 ' N ' ' CG2' ' B' ' 367' ' ' THR . 5.8 mt -133.23 140.29 47.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.515 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 19.5 t0 -117.33 96.13 5.28 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.615 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 9.5 p90 -136.9 93.92 2.9 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.352 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.66 12.49 1.76 Allowed Glycine 0 C--O 1.227 -0.294 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -41.73 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.18 -0.51 . . . . 0.0 111.769 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.562 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.46 -37.44 65.2 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.51 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.5 OUTLIER -125.76 -92.87 0.5 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.111 176.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.51 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.4 t0 -129.05 96.27 4.29 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.13 -2.66 55.87 Favored Glycine 0 C--N 1.312 -0.78 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.245 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.38 105.44 16.71 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.79 127.44 54.34 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.554 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 23.2 t -137.67 158.35 44.55 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.348 0.594 . . . . 0.0 112.349 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.541 ' N ' ' HG ' ' B' ' 379' ' ' SER . 2.4 m -141.72 172.63 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.004 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -103.35 124.62 49.03 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.896 0.855 . . . . 0.0 110.796 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.592 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.89 139.17 16.64 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.183 179.336 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.09 16.08 6.58 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.313 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.98 84.48 1.78 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.075 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.37 -56.93 2.18 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.7 pt-20 -44.98 -20.22 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 114.615 -0.792 . . . . 0.0 110.945 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' B' ' 385' ' ' GLY . 3.2 mm-40 -82.62 -39.76 21.71 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' B' ' 385' ' ' GLY . 45.0 mt -76.6 -42.38 34.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.763 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.4 -42.01 62.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.255 -1.339 . . . . 0.0 113.68 -177.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.437 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -64.06 -34.83 78.92 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.975 -177.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.596 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.85 -53.75 10.61 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.664 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.596 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.2 -55.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.7 -33.69 48.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.852 -1.976 . . . . 0.0 110.697 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.01 -17.84 62.3 Favored Glycine 0 CA--C 1.506 -0.471 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -178.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.3 m-30 -87.04 -36.99 17.88 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -13.18 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 CA-C-O 122.18 0.99 . . . . 0.0 109.236 176.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.48 -22.62 47.23 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.511 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.7 mt -91.78 -62.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.978 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.441 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.39 -20.56 27.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.379 -177.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.441 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.82 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 8.2 p30 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.562 ' CG1' ' H ' ' A' ' 9' ' ' ASP . 1.2 tt -54.13 -168.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.478 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.562 ' H ' ' CG1' ' A' ' 8' ' ' ILE . 9.9 t0 62.06 -65.79 0.08 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.932 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 8' ' ' ILE . 9.6 mt-30 -67.51 -54.77 17.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.516 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.468 ' C ' ' O ' ' A' ' 10' ' ' GLN . 29.8 mtp -22.92 -69.15 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 123.974 0.796 . . . . 0.0 112.079 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -42.98 -57.77 2.71 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.976 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -62.58 -39.37 93.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.974 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.501 ' H ' ' HG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -53.71 -44.56 69.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.978 -179.649 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.65 -40.42 49.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -39.63 80.03 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.09 -43.4 98.8 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.484 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.6 mt-10 -63.3 -37.93 89.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.475 -0.362 . . . . 0.0 110.036 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.531 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 13.5 mtp -58.7 -35.1 72.09 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.853 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.57 -29.21 6.64 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.421 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 4.0 mm? -77.72 -18.05 56.96 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.172 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.504 ' CD2' ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -76.65 -13.29 60.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 24' ' ' GLN . 1.2 m -111.52 -44.23 3.55 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.561 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.574 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER 47.27 -179.72 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.395 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER 38.86 -88.75 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.83 179.572 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' A' ' 24' ' ' GLN . 1.1 tp -41.57 -39.8 1.69 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.665 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.03 -32.45 9.83 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.45 ' O ' ' CG1' ' A' ' 28' ' ' VAL . 53.6 t -71.94 -4.82 5.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.814 0.34 . . . . 0.0 110.571 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.92 -1.56 27.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.53 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.544 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . 0.427 ' O ' ' OH ' ' B' ' 395' ' ' TYR . 1.3 t80 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -80.31 -152.84 8.32 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 94.2 t -40.9 137.54 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.728 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.03 153.59 27.87 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.162 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -129.54 134.36 47.72 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.042 0.214 . . . . 0.0 111.439 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -139.22 127.78 23.09 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.596 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.56 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.75 106.85 13.07 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 123.712 1.72 . . . . 0.0 109.272 178.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.622 ' O ' ' N ' ' B' ' 328' ' ' ARG . 28.0 m -119.8 162.82 17.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 112.755 -2.02 . . . . 0.0 110.187 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -103.72 145.58 29.86 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.491 ' O ' ' SD ' ' B' ' 319' ' ' MET . 44.2 tt0 -135.73 152.32 51.04 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.023 0.916 . . . . 0.0 112.558 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . 0.543 ' HZ3' HD21 ' B' ' 323' ' ' ASN . 6.3 tptm -79.36 100.74 7.74 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.46 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 319' ' ' MET . . . . . 0.673 ' N ' ' SD ' ' B' ' 319' ' ' MET . 0.0 OUTLIER -90.74 179.03 5.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.944 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.66 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.64 147.38 26.5 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.059 178.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 118.11 -25.03 8.5 Favored Glycine 0 C--N 1.313 -0.718 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -134.74 -143.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.651 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . 0.543 HD21 ' HZ3' ' B' ' 318' ' ' LYS . 0.1 OUTLIER -140.16 -18.97 0.89 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.582 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.48 ' HD2' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -89.48 -176.75 5.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.944 0.402 . . . . 0.0 111.067 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 30.3 mt -92.0 162.16 14.5 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.164 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.7 t -123.01 126.88 25.88 Favored Pre-proline 0 N--CA 1.442 -0.86 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.089 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.407 ' C ' ' O ' ' B' ' 326' ' ' VAL . 68.9 Cg_exo -43.9 144.51 2.47 Favored 'Trans proline' 0 C--N 1.321 -0.917 0 N-CA-C 108.209 -1.496 . . . . 0.0 108.209 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.631 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 7.6 ttm180 -151.55 -173.02 4.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 119.496 -0.881 . . . . 0.0 108.628 -177.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.636 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.68 121.32 13.38 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.113 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 31.5 tp -99.47 158.72 15.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.175 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -142.95 108.7 0.53 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.2 mm -87.91 124.4 41.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.737 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.5 p -118.59 138.25 52.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.327 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.431 ' O ' HG23 ' B' ' 399' ' ' ILE . 4.1 ptpp? -57.96 14.4 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.115 0.484 . . . . 0.0 111.769 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.737 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -144.66 -3.06 0.81 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.981 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.62 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.64 176.95 1.82 Allowed 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.43 1.11 . . . . 0.0 112.833 -176.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.62 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.4 t -132.28 145.84 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-N 113.071 -1.877 . . . . 0.0 106.215 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.477 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 0.9 OUTLIER -152.63 150.78 29.86 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 117.179 -1.808 . . . . 0.0 114.415 -175.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . 0.516 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 60.0 mtm180 -95.85 106.94 19.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.397 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.65 149.93 4.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.278 -178.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.0 t0 -88.07 91.6 8.83 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.736 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.9 OUTLIER -35.42 -28.38 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.671 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' B' ' 341' ' ' ASP . 28.1 mttp -75.39 -43.92 47.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.641 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.558 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.68 -13.47 14.79 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm 67.71 -1.11 1.74 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' B' ' 344' ' ' THR . 4.4 mt-10 -85.95 152.08 23.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.337 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 86.9 t -80.99 133.26 29.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.527 0.68 . . . . 0.0 112.176 -178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 55.0 mt -102.91 -30.29 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.323 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.516 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 22.1 tt0 -140.27 158.06 44.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 45.6 mt-10 -142.85 150.69 40.22 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.296 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.02 122.47 4.23 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.227 177.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.511 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.01 140.1 2.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.51 0.672 . . . . 0.0 111.632 -178.755 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.5 tt -82.46 -36.48 26.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 354' ' ' THR . . . . . 0.475 ' CG2' ' O ' ' B' ' 354' ' ' THR . 99.5 m -71.17 7.07 1.36 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.831 177.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.571 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.2 m-20 -108.12 -5.26 17.06 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.828 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 72.1 mt -61.19 143.23 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.672 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -107.3 -45.29 4.13 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.501 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.0 ptt-85 -172.17 136.27 0.83 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.474 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 7.8 p90 -119.14 176.33 5.36 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.234 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.63 98.62 1.67 Allowed 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 119.066 -1.054 . . . . 0.0 112.044 -178.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -80.81 145.01 31.64 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.747 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.532 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -133.76 174.15 5.02 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -77.69 -7.61 16.7 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.12 1.88 . . . . 0.0 112.158 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.4 mtpt -130.86 -21.42 2.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.011 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.556 ' HA ' ' H ' ' B' ' 382' ' ' THR . 61.3 p -152.65 166.63 31.51 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.56 0.695 . . . . 0.0 111.908 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.453 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -137.68 156.84 47.58 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.823 179.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.433 ' OG1' ' OG ' ' B' ' 379' ' ' SER . 29.1 m -148.81 155.06 40.4 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.215 -174.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.425 ' N ' ' CG2' ' B' ' 367' ' ' THR . 7.4 mt -125.81 139.83 53.17 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.181 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.1 t0 -117.6 95.65 5.04 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.569 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 15.1 t80 -137.45 94.43 2.92 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.955 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.92 11.98 2.0 Allowed Glycine 0 C--O 1.225 -0.407 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 8.9 t0 -41.47 -16.01 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.087 -0.556 . . . . 0.0 111.777 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.56 -37.08 65.03 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.517 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.0 -92.94 0.49 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.876 -1.511 . . . . 0.0 107.072 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.517 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 16.3 t0 -128.9 96.38 4.34 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.53 -2.9 53.38 Favored Glycine 0 C--N 1.313 -0.7 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.339 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -83.79 106.65 15.66 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -175.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . 0.426 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.6 OUTLIER -114.06 120.8 41.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.6 176.066 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.664 ' HG ' ' N ' ' B' ' 380' ' ' VAL . 38.4 t -138.88 164.09 30.6 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.587 0.708 . . . . 0.0 112.818 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.664 ' N ' ' HG ' ' B' ' 379' ' ' SER . 0.9 OUTLIER -150.84 174.1 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.874 179.079 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -100.47 125.49 46.78 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 122.0 0.905 . . . . 0.0 110.835 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.556 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.56 136.78 13.88 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.832 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.25 17.0 4.62 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.147 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . 0.502 ' H ' ' HG1' ' B' ' 382' ' ' THR . 0.3 OUTLIER -144.01 84.19 1.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.092 175.121 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.88 -58.45 2.01 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.463 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.2 pt-20 -44.3 -20.19 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 114.814 -0.693 . . . . 0.0 111.026 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' B' ' 385' ' ' GLY . 67.5 mt-30 -82.75 -40.15 20.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.578 0.704 . . . . 0.0 109.102 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' B' ' 385' ' ' GLY . 49.5 mt -76.41 -42.04 35.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.719 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.46 -42.32 62.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.6 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.463 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -64.14 -34.79 78.87 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.023 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.64 -53.67 9.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.727 -179.509 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.597 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -48.59 -55.7 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 176.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.8 45.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 112.761 -2.018 . . . . 0.0 110.578 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.12 -17.83 62.11 Favored Glycine 0 CA--C 1.505 -0.539 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.1 m-30 -86.88 -36.45 18.41 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -13.23 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 CA-C-O 122.166 0.984 . . . . 0.0 109.308 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.77 -22.62 42.96 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.52 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 74.8 mt -91.23 -62.15 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.17 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.431 HG23 ' O ' ' B' ' 334' ' ' LYS . 0.9 OUTLIER -61.4 -25.84 37.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 113.409 -1.723 . . . . 0.0 112.291 -176.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 C--O 1.218 -0.581 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.693 -179.703 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 8' ' ' ILE . 1.4 p-10 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.513 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 8.7 mt 58.35 148.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.585 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 10' ' ' GLN . 4.6 t70 -175.95 -85.88 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.917 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 4.6 mt-30 -104.19 -19.22 14.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.944 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.503 ' C ' ' O ' ' A' ' 10' ' ' GLN . 27.1 mtm -14.81 -61.43 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 124.279 0.987 . . . . 0.0 112.044 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -41.17 -62.29 0.86 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.205 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 10' ' ' GLN . 19.2 t -67.9 -25.05 65.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.748 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.428 ' H ' ' HG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER -74.14 -22.07 59.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 -179.396 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.09 -33.47 10.46 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -43.38 96.59 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.7 -36.42 89.67 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 92.6 mt-10 -70.77 -39.52 73.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.326 -0.437 . . . . 0.0 109.843 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.511 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 9.9 mtp -56.16 -31.67 63.59 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.77 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.99 -29.52 21.11 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.458 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.466 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 4.1 mm? -73.48 -10.37 59.65 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.241 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.528 ' CD2' ' HG1' ' A' ' 23' ' ' THR . 0.0 OUTLIER -88.89 -9.01 53.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.019 0.438 . . . . 0.0 110.0 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.528 ' HG1' ' CD2' ' A' ' 22' ' ' LEU . 17.1 m -105.77 -34.72 7.59 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.21 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.529 HE21 ' C ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -108.49 136.3 48.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.773 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER 166.71 -9.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.721 -179.643 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.581 ' C ' ' H ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -41.12 -17.4 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.592 0.71 . . . . 0.0 112.42 179.109 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 25' ' ' SER . . . -60.53 3.51 0.36 Allowed Glycine 0 C--N 1.305 -1.176 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.731 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.581 ' H ' ' C ' ' A' ' 26' ' ' LEU . 3.8 p -168.86 -41.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.092 0.472 . . . . 0.0 110.543 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.472 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 21.5 t70 -70.13 2.27 3.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.669 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.423 ' O ' ' O ' ' B' ' 322' ' ' LYS . 24.3 p . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.593 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 308' ' ' TYR . . . . . 0.616 ' N ' ' CD1' ' B' ' 308' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 134.66 -93.06 0.24 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 70.8 t -126.33 133.19 69.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.742 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.83 153.26 24.65 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.123 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -129.69 135.45 48.51 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.03 0.206 . . . . 0.0 111.483 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -138.83 129.89 26.7 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.565 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.561 ' O ' ' CD1' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.61 104.72 13.09 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 123.918 1.818 . . . . 0.0 109.368 178.368 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 315' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.9 m -115.71 161.19 14.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 112.523 -2.126 . . . . 0.0 110.086 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -103.57 145.0 30.69 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 317' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' B' ' 326' ' ' VAL . 27.8 tt0 -132.37 152.07 51.6 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.102 0.953 . . . . 0.0 112.729 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -80.95 102.19 9.96 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.204 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 33.8 mmt -99.64 178.59 4.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.984 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 320' ' ' LYS . . . . . 0.562 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.57 158.02 16.39 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.639 178.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 110.94 -23.25 19.71 Favored Glycine 0 C--N 1.309 -0.958 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 30' ' ' THR . 6.4 ptpt -135.5 -139.74 0.16 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.603 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.98 -16.76 0.59 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.571 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.54 -176.91 3.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 111.013 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 31.8 mt -86.84 165.2 16.15 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.209 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 326' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' B' ' 317' ' ' GLU . 9.5 t -124.15 126.21 25.61 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.016 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' B' ' 326' ' ' VAL . 61.0 Cg_exo -44.56 145.22 2.76 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 N-CA-C 108.099 -1.539 . . . . 0.0 108.099 178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 328' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' B' ' 315' ' ' VAL . 5.6 ttm-85 -150.2 -173.21 4.37 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.776 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 329' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.95 122.72 12.64 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.07 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 330' ' ' LEU . . . . . . . . . . . . . 26.4 tp -101.96 158.32 16.22 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 331' ' ' GLY . . . . . . . . . . . . . . . -141.44 107.94 0.53 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 332' ' ' ILE . . . . . . . . . . . . . 30.8 mm -88.46 123.83 41.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 333' ' ' THR . . . . . 0.745 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.6 p -118.31 137.75 52.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 334' ' ' LYS . . . . . 0.42 ' O ' HG23 ' B' ' 399' ' ' ILE . 0.0 OUTLIER -57.26 13.23 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.05 0.452 . . . . 0.0 111.741 -179.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 335' ' ' GLU . . . . . 0.745 ' H ' ' C ' ' B' ' 333' ' ' THR . 11.3 pt-20 -144.15 -2.52 0.89 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.844 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 336' ' ' CYS . . . . . 0.611 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.86 179.36 2.0 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 122.158 0.98 . . . . 0.0 113.045 -177.194 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 337' ' ' VAL . . . . . 0.611 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.3 t -137.08 145.31 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 CA-C-N 113.365 -1.743 . . . . 0.0 106.677 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 338' ' ' MET . . . . . 0.479 ' CB ' ' O ' ' B' ' 349' ' ' GLN . 3.9 ptt? -154.08 149.95 27.69 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 117.028 -1.869 . . . . 0.0 114.318 -176.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 339' ' ' ARG . . . . . 0.497 ' NH1' ' OE2' ' B' ' 317' ' ' GLU . 44.7 mtm180 -94.66 107.79 19.78 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.778 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . 0.626 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.24 149.84 5.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.228 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 344' ' ' THR . 29.0 t0 -89.93 92.15 8.89 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.784 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.51 -28.95 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.76 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 35.8 mttt -74.7 -43.67 53.97 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.672 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 344' ' ' THR . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.3 -12.72 14.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 7.4 tttp 66.73 -0.91 1.46 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.977 0.418 . . . . 0.0 109.918 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.6 mt-10 -84.88 152.73 23.36 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.388 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 347' ' ' VAL . . . . . . . . . . . . . 81.9 t -82.92 135.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.449 0.642 . . . . 0.0 112.352 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mt -104.03 -30.13 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.386 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 349' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' B' ' 338' ' ' MET . 6.9 tt0 -140.49 156.05 46.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.677 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -145.66 149.43 34.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.451 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 351' ' ' TRP . . . . . 0.554 ' O ' ' N ' ' B' ' 337' ' ' VAL . 68.6 t-105 -162.34 135.95 6.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.828 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 352' ' ' SER . . . . . 0.509 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -54.01 138.32 37.51 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.541 -178.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' B' ' 355' ' ' ASN . 1.8 tt -78.51 -35.69 45.97 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.97 11.1 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.97 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 355' ' ' ASN . . . . . 0.509 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -115.04 -3.99 12.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.171 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 356' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.12 148.54 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.951 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 357' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 11.5 tptt -106.45 -45.64 4.21 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.2 ptt180 -174.88 136.3 0.4 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.399 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 359' ' ' TRP . . . . . 0.462 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 8.6 p90 -118.74 174.53 6.22 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.35 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -156.88 97.99 1.73 Allowed 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.936 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -79.77 147.85 31.69 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.855 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 362' ' ' SER . . . . . 0.535 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -136.21 173.04 6.06 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -76.63 -8.61 18.26 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.033 1.822 . . . . 0.0 112.092 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 6.4 mttm -130.79 -22.08 2.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.96 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 365' ' ' SER . . . . . 0.569 ' HA ' ' H ' ' B' ' 382' ' ' THR . 89.8 p -149.73 170.02 19.7 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.617 0.723 . . . . 0.0 111.815 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 366' ' ' PHE . . . . . 0.468 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -142.79 156.56 44.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.802 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 367' ' ' THR . . . . . 0.472 ' HG1' ' CG ' ' A' ' 19' ' ' MET . 33.9 m -148.1 156.44 42.61 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.734 -174.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 368' ' ' LEU . . . . . 0.442 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.0 mt -129.11 143.4 50.85 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.479 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.7 t0 -119.74 95.86 4.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.652 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 370' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 10.3 p90 -136.6 93.52 2.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.371 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.58 12.22 1.81 Allowed Glycine 0 C--O 1.226 -0.397 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -41.77 -15.74 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.117 -0.542 . . . . 0.0 111.776 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.61 -37.3 65.42 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 374' ' ' GLN . . . . . 0.514 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.85 -92.94 0.5 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 375' ' ' ASP . . . . . 0.514 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.5 t70 -129.02 96.4 4.33 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.5 -2.45 55.49 Favored Glycine 0 C--N 1.311 -0.859 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.218 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 377' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.32 106.11 17.15 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -175.547 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.21 125.98 52.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.783 175.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 379' ' ' SER . . . . . 0.674 ' HG ' ' H ' ' B' ' 380' ' ' VAL . 35.9 t -138.19 164.27 29.62 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.519 0.676 . . . . 0.0 112.667 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 380' ' ' VAL . . . . . 0.674 ' H ' ' HG ' ' B' ' 379' ' ' SER . 1.8 m -150.4 172.89 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.942 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -99.77 126.51 45.85 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.891 0.853 . . . . 0.0 111.114 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 382' ' ' THR . . . . . 0.569 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.11 136.05 13.73 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.651 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.27 16.66 4.22 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.103 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.95 84.04 1.77 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.91 175.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.9 -58.84 1.95 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.509 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.1 pt-20 -44.66 -20.73 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.746 -0.727 . . . . 0.0 110.976 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 387' ' ' GLN . . . . . 0.429 ' N ' ' C ' ' B' ' 385' ' ' GLY . 78.2 mt-30 -82.06 -39.38 23.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 48.1 mt -76.93 -42.33 32.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.712 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.87 -42.29 60.96 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.185 -1.37 . . . . 0.0 113.618 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . 0.509 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.79 -34.99 79.13 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.116 0.96 . . . . 0.0 110.992 -177.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 391' ' ' LEU . . . . . 0.599 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.93 -53.59 10.91 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.814 -179.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 392' ' ' ILE . . . . . 0.599 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.09 -56.12 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 393' ' ' ALA . . . . . . . . . . . . . . . -52.29 -33.77 43.67 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.792 -2.004 . . . . 0.0 110.743 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 394' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.2 -17.86 61.92 Favored Glycine 0 CA--C 1.507 -0.454 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 395' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' B' ' 391' ' ' LEU . 5.3 m-30 -87.15 -36.95 17.77 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -13.33 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 122.237 1.017 . . . . 0.0 109.365 176.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.54 -22.7 46.89 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.513 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 398' ' ' ILE . . . . . . . . . . . . . 68.5 mt -91.8 -62.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 113.899 -1.501 . . . . 0.0 112.042 -178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 399' ' ' ILE . . . . . 0.443 ' O ' ' OXT' ' B' ' 400' ' ' LEU . 0.8 OUTLIER -64.29 -20.6 27.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 113.404 -1.725 . . . . 0.0 112.384 -177.048 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 400' ' ' LEU . . . . . 0.443 ' OXT' ' O ' ' B' ' 399' ' ' ILE . 1.1 pp . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.773 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.555 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? . . . . . 0 N--CA 1.462 0.129 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -43.41 98.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.582 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.87 -37.27 90.45 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.457 -0.371 . . . . 0.0 110.035 178.632 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 89.1 t . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.736 0.303 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.56 153.62 27.22 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.202 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.22 134.29 47.16 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.054 0.221 . . . . 0.0 111.471 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -139.82 128.42 23.03 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.663 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.904 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.58 107.17 13.16 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 123.685 1.707 . . . . 0.0 109.358 178.583 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.648 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.7 m -118.96 160.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.174 -176.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -104.78 144.93 31.08 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' B' ' 326' ' ' VAL . 60.6 tt0 . . . . . 0 C--N 1.315 -0.923 0 CA-C-O 122.126 0.965 . . . . 0.0 112.596 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' B' ' 317' ' ' GLU . 12.2 t . . . . . 0 N--CA 1.44 -0.965 0 CA-C-O 119.156 -0.45 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.424 ' O ' HG12 ' B' ' 326' ' ' VAL . 56.7 Cg_exo -44.74 144.75 3.23 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.621 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 10.5 ttm-85 -151.58 -173.06 4.4 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 119.48 -0.888 . . . . 0.0 108.682 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.81 120.79 12.83 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.105 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.845 HD12 ' O ' ' B' ' 338' ' ' MET . 32.0 tp -98.17 158.74 15.38 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.214 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.436 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -143.0 108.76 0.53 Allowed Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.725 HD11 HD21 ' B' ' 330' ' ' LEU . 30.0 mm -87.97 124.34 41.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.721 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.5 p -118.47 138.34 52.56 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.426 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 334' ' ' LYS . . . . . 0.602 ' NZ ' ' CE1' ' B' ' 395' ' ' TYR . 1.1 mtmm -57.68 14.55 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.813 0.34 . . . . 0.0 111.306 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.721 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.1 pt-20 -144.96 -3.56 0.77 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.15 177.7 1.86 Allowed 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.351 1.072 . . . . 0.0 112.991 -176.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.613 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.3 t -132.8 145.56 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 CA-C-N 113.093 -1.867 . . . . 0.0 106.236 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.845 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.5 ptt? -152.88 151.83 30.83 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.334 -175.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.51 HH12 HD13 ' B' ' 330' ' ' LEU . 5.4 mmt-85 -96.96 106.68 19.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.277 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -95.73 149.44 4.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.517 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' B' ' 343' ' ' LYS . 41.0 t0 -86.64 89.95 8.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.673 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.7 OUTLIER -35.88 -27.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.6 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 31.6 mttm -71.21 -44.16 65.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.582 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.54 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -113.61 -17.34 12.18 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.746 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 345' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' B' ' 344' ' ' THR . 6.8 tttm 77.26 0.22 2.96 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.445 ' O ' HG13 ' B' ' 340' ' ' VAL . 8.0 pt-20 -82.84 157.98 22.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.603 HG21 ' SD ' ' B' ' 338' ' ' MET . 89.8 t -87.29 131.94 33.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.331 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 6.7 mt -102.64 -30.67 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.498 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.484 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.8 tt0 -138.13 158.31 44.57 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.662 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -144.48 149.75 36.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.258 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.13 123.14 3.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.318 177.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.5 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.48 139.58 3.67 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.513 0.673 . . . . 0.0 111.627 -178.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.598 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -82.26 -36.64 26.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 354' ' ' THR . . . . . 0.536 HG22 ' O ' ' B' ' 354' ' ' THR . 19.6 m -71.74 7.37 1.53 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.882 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.4 m-20 -108.51 -5.02 16.75 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.825 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.535 HD12 HD23 ' B' ' 353' ' ' LEU . 72.1 mt -60.81 144.19 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.725 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -107.42 -46.18 3.91 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 7.5 ptt180 -171.54 136.03 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.542 ' CH2' HD12 ' B' ' 396' ' ' ILE . 7.5 p90 -119.31 176.45 5.32 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.315 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.7 98.27 1.64 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.188 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.38 145.77 31.84 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.741 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.523 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -134.23 174.17 4.97 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -77.57 -7.87 16.91 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.027 1.818 . . . . 0.0 112.123 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' B' ' 382' ' ' THR . 10.4 mtpt -130.86 -21.49 2.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.016 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.654 ' HA ' ' H ' ' B' ' 382' ' ' THR . 58.1 p -152.21 167.15 29.52 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.526 0.679 . . . . 0.0 111.874 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.468 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -138.55 156.74 47.23 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.826 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.555 ' CG2' HD12 ' A' ' 15' ' ' LEU . 31.8 m -148.56 154.72 40.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.146 -1.022 . . . . 0.0 113.185 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.4 mt -125.89 139.64 53.3 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.142 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.9 t0 -117.72 95.58 5.0 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.485 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 17.3 t80 -137.33 94.48 2.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.89 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.87 11.97 2.01 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 372' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.6 t0 -41.41 -16.12 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.067 -0.566 . . . . 0.0 111.797 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.556 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.59 -37.03 65.06 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.469 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.3 OUTLIER -125.93 -93.06 0.49 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.853 -1.521 . . . . 0.0 106.946 176.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.469 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 8.2 t70 -128.96 96.41 4.34 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.56 -2.64 53.27 Favored Glycine 0 C--N 1.312 -0.775 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.292 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.67 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.26 107.13 16.39 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.637 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 378' ' ' TYR . . . . . 0.413 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.7 OUTLIER -114.65 120.43 40.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.737 176.03 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.1 t -138.73 163.59 31.76 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.581 0.705 . . . . 0.0 112.78 -177.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.2 m -151.08 175.41 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.792 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -100.78 125.57 47.27 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.96 0.885 . . . . 0.0 110.931 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.654 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.28 136.49 13.93 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.753 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.32 17.01 4.68 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.143 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.99 84.04 1.76 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.022 175.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.99 -58.84 1.94 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.458 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.4 pt-20 -44.41 -20.21 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.748 -0.726 . . . . 0.0 111.038 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.437 ' N ' ' C ' ' B' ' 385' ' ' GLY . 63.6 mt-30 -83.04 -39.71 20.87 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.1 mt -76.39 -42.22 36.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.683 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.47 -42.53 61.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.267 -1.333 . . . . 0.0 113.718 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.458 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 12.2 pt20 -63.88 -34.76 78.66 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.04 0.924 . . . . 0.0 110.98 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.657 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.84 -53.47 10.14 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 113.877 -1.51 . . . . 0.0 108.765 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.657 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.4 mt -48.67 -55.29 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 176.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.49 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.79 -33.68 49.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.708 -2.042 . . . . 0.0 110.552 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.96 -18.0 62.06 Favored Glycine 0 CA--C 1.507 -0.456 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.68 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -86.84 -37.18 17.99 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.542 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.38 -13.39 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 122.153 0.978 . . . . 0.0 109.284 176.21 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.82 -22.69 45.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.506 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.8 mt -91.89 -61.88 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 113.895 -1.502 . . . . 0.0 112.033 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.85 -20.51 27.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.374 -1.739 . . . . 0.0 112.307 -176.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.56 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.83 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.553 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? . . . . . 0 N--CA 1.463 0.187 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -42.94 98.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.24 -36.86 90.59 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 . . . . . 0 C--N 1.327 -0.379 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.707 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.775 0.322 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.55 153.56 23.96 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.15 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -129.95 134.58 47.55 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.153 0.283 . . . . 0.0 111.496 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -139.84 128.52 23.13 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.582 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.907 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.86 107.27 13.53 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.745 1.736 . . . . 0.0 109.334 178.586 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' B' ' 382' ' ' THR . 30.7 m -118.74 160.57 18.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 112.63 -2.077 . . . . 0.0 110.096 -176.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -102.94 145.53 29.7 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' B' ' 326' ' ' VAL . 31.0 tt0 . . . . . 0 C--N 1.315 -0.897 0 CA-C-O 122.164 0.983 . . . . 0.0 112.575 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t . . . . . 0 N--CA 1.44 -0.952 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.425 ' O ' HG12 ' B' ' 326' ' ' VAL . 63.9 Cg_exo -44.15 144.06 3.03 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 N-CA-C 108.085 -1.544 . . . . 0.0 108.085 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.62 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 8.4 ttm180 -150.26 -173.3 4.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.8 120.65 12.72 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.05 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.835 HD12 ' O ' ' B' ' 338' ' ' MET . 31.3 tp -98.45 158.43 15.6 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.09 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.435 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.45 108.4 0.52 Allowed Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 177.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.735 HD11 HD21 ' B' ' 330' ' ' LEU . 29.7 mm -87.98 123.02 40.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.722 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.37 138.25 51.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -57.86 15.2 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.173 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.722 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.0 pt-20 -144.99 -4.25 0.74 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.62 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.6 177.22 2.17 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 122.448 1.118 . . . . 0.0 112.892 -176.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.613 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.8 t -132.32 145.25 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-N 113.132 -1.849 . . . . 0.0 106.201 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.835 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.1 ptt? -152.77 151.01 29.99 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 117.089 -1.845 . . . . 0.0 114.419 -175.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.525 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 61.4 mtm180 -96.01 106.91 19.13 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.443 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.46 149.81 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.284 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.0 t0 -87.83 91.57 8.8 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.712 -178.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.37 -28.46 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.62 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.5 mttp -75.54 -44.0 45.76 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.714 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.555 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.63 -13.07 14.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 30.7 tttp 67.38 -0.67 1.76 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 109.986 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.7 mt-10 -85.99 152.56 22.82 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.317 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.622 HG21 ' SD ' ' B' ' 338' ' ' MET . 87.5 t -81.36 133.6 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.498 0.666 . . . . 0.0 112.299 -178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 348' ' ' ILE . . . . . 0.436 HD11 ' HB2' ' B' ' 341' ' ' ASP . 56.1 mt -103.21 -30.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.369 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.525 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 19.7 tt0 -140.23 157.86 44.93 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.678 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 350' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 44.9 mt-10 -143.32 150.15 38.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.349 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.562 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.49 124.02 4.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.118 177.513 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.404 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.59 140.44 3.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.439 0.638 . . . . 0.0 111.566 -178.557 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.585 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -84.2 -36.12 23.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -73.74 9.39 1.48 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.889 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.57 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 4.3 m-20 -111.04 -7.21 14.53 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.055 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.495 HD12 HD23 ' B' ' 353' ' ' LEU . 79.2 mt -56.75 146.6 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.686 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 10.0 tttm -107.78 -46.35 3.82 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.3 ptt-85 -172.05 135.91 0.83 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.513 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.7 p90 -119.53 175.94 5.6 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.288 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.37 99.49 1.62 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.085 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.63 146.83 30.98 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.747 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.529 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -134.55 173.75 5.43 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -77.49 -7.98 17.03 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.119 1.879 . . . . 0.0 112.038 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' B' ' 382' ' ' THR . 4.1 mtpp -130.87 -21.16 2.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.038 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.657 ' HA ' ' H ' ' B' ' 382' ' ' THR . 58.6 p -152.13 167.7 27.66 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.566 0.698 . . . . 0.0 111.942 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.46 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.06 156.64 47.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.651 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.553 ' CG2' HD12 ' A' ' 15' ' ' LEU . 27.9 m -148.53 154.74 40.2 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.151 -174.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.0 mt -126.12 140.03 52.9 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.08 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.0 t0 -117.75 95.84 5.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.533 176.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 27.6 t80 -137.93 94.72 2.93 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.89 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.8 12.02 2.02 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 372' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.9 t0 -41.39 -16.43 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.045 -0.577 . . . . 0.0 111.829 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.548 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.46 -37.25 64.99 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.468 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.2 pt20 -125.85 -92.74 0.5 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.941 -1.482 . . . . 0.0 107.222 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.468 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.6 t70 -129.14 96.3 4.29 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.24 -2.91 54.24 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.376 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.681 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.57 106.75 16.37 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -175.583 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 378' ' ' TYR . . . . . 0.41 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.8 OUTLIER -114.3 120.13 39.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.717 176.106 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.4 t -138.66 163.45 32.06 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.673 0.749 . . . . 0.0 112.773 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.3 m -150.62 175.61 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.93 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -101.42 124.89 47.83 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.938 0.875 . . . . 0.0 110.807 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.657 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.95 136.68 14.4 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.772 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.41 17.2 4.63 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.271 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.03 83.92 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.989 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.02 -59.15 1.9 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.497 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.6 pt-20 -44.33 -20.69 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.758 -0.721 . . . . 0.0 111.009 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 55.6 mt-30 -82.43 -39.59 22.39 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.0 mt -76.55 -42.01 34.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.661 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.87 -42.71 60.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.651 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.76 -34.3 77.58 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.055 0.931 . . . . 0.0 110.969 -177.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.31 -53.4 9.77 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.705 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -48.77 -55.38 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.487 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.06 -34.53 43.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.737 -2.029 . . . . 0.0 110.593 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.46 -18.06 62.98 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.679 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.7 -37.0 18.37 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.513 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.31 -13.29 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.097 0.951 . . . . 0.0 109.221 176.277 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.39 -22.62 47.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.563 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' B' ' 395' ' ' TYR . 67.2 mt -91.99 -61.96 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.057 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.81 -20.28 27.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.396 -1.729 . . . . 0.0 112.335 -176.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.555 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.858 -1.067 . . . . 0.0 110.731 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? . . . . . 0 CA--C 1.518 -0.256 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -39.26 80.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.724 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.35 -43.21 99.4 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 C--N 1.326 -0.423 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.397 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.832 0.348 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.09 153.43 26.94 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.229 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -130.47 134.26 46.95 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.113 0.258 . . . . 0.0 111.423 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -139.31 129.01 24.63 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.625 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.9 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.52 105.9 13.04 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 123.749 1.737 . . . . 0.0 109.42 178.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.649 HG12 ' HB ' ' B' ' 382' ' ' THR . 30.8 m -117.36 160.82 16.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 112.703 -2.044 . . . . 0.0 110.078 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -102.55 145.5 29.52 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.563 ' CD ' ' HE ' ' B' ' 339' ' ' ARG . 26.6 tt0 . . . . . 0 C--N 1.315 -0.929 0 CA-C-O 121.955 0.884 . . . . 0.0 112.627 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' B' ' 317' ' ' GLU . 6.5 t . . . . . 0 N--CA 1.438 -1.049 0 CA-C-O 119.116 -0.468 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' B' ' 326' ' ' VAL . 66.5 Cg_exo -43.9 143.89 2.81 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 N-CA-C 108.196 -1.502 . . . . 0.0 108.196 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.615 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.7 ttt180 -149.71 -173.33 4.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 119.476 -0.89 . . . . 0.0 108.699 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.662 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -141.83 120.73 12.77 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.162 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.832 HD12 ' O ' ' B' ' 338' ' ' MET . 32.2 tp -98.5 158.11 15.8 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.177 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.52 108.46 0.53 Allowed Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.719 HD11 HD21 ' B' ' 330' ' ' LEU . 29.5 mm -88.1 123.04 40.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.72 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.47 138.43 51.86 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 16.0 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.191 0.307 . . . . 0.0 111.268 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.72 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -145.48 -4.76 0.68 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.482 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.42 177.14 2.26 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 122.368 1.08 . . . . 0.0 112.883 -176.83 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.1 t -132.01 145.14 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 CA-C-N 113.13 -1.85 . . . . 0.0 106.33 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.832 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.79 150.84 29.79 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 117.124 -1.831 . . . . 0.0 114.519 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.563 ' HE ' ' CD ' ' B' ' 317' ' ' GLU . 0.2 OUTLIER -96.3 106.79 19.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.496 176.677 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.662 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.16 149.98 4.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.244 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.1 t0 -87.87 91.6 8.82 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.736 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.36 -28.45 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.685 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' B' ' 341' ' ' ASP . 44.4 mttt -75.5 -43.9 46.62 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.69 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.557 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.76 -13.33 14.8 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -177.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 20.6 tttt 67.77 -0.87 1.83 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.942 0.401 . . . . 0.0 109.943 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.432 ' H ' ' C ' ' B' ' 344' ' ' THR . 4.1 mt-10 -86.05 152.59 22.77 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.618 HG21 ' SD ' ' B' ' 338' ' ' MET . 87.7 t -81.37 134.05 27.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.5 0.667 . . . . 0.0 112.237 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 348' ' ' ILE . . . . . 0.482 HG21 HH22 ' B' ' 328' ' ' ARG . 7.4 mt -104.11 -30.69 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.186 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.474 ' O ' ' CB ' ' B' ' 338' ' ' MET . 15.6 tt0 -139.04 157.4 46.05 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.554 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -143.64 149.84 37.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.232 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.15 123.98 4.1 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.976 177.571 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.521 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -44.86 141.77 2.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.388 0.613 . . . . 0.0 111.661 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.6 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -85.25 -36.27 21.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -73.91 9.99 1.32 Allowed 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.908 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.574 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.1 m-20 -111.81 -7.04 14.22 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.973 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.51 HD12 HD23 ' B' ' 353' ' ' LEU . 80.1 mt -56.44 147.04 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.748 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 357' ' ' LYS . . . . . 0.509 ' NZ ' ' OH ' ' B' ' 373' ' ' TYR . 9.4 tttp -107.71 -46.29 3.84 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 6.0 ptt180 -172.77 135.71 0.67 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.482 ' CH2' HD12 ' B' ' 396' ' ' ILE . 10.4 p90 -119.28 175.78 5.64 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.226 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.14 100.38 1.7 Allowed 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.84 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -82.86 142.56 31.4 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.66 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.538 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -130.27 174.51 4.55 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -77.82 -8.31 16.77 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.145 1.896 . . . . 0.0 112.063 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' B' ' 382' ' ' THR . 3.2 mttp -130.33 -20.81 2.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.965 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.662 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.1 p -152.03 167.69 27.61 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.55 0.691 . . . . 0.0 111.951 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.441 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -138.87 156.39 47.33 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.541 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.549 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.7 m -148.46 154.53 39.98 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.021 -1.072 . . . . 0.0 113.107 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.5 mt -125.61 140.0 53.11 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.336 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.9 t0 -117.36 95.61 5.04 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.892 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 29.7 t80 -137.99 95.24 3.0 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.955 176.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.77 12.38 1.96 Allowed Glycine 0 C--O 1.225 -0.419 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 372' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 10.0 t0 -41.88 -16.35 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.935 -0.633 . . . . 0.0 112.07 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.27 -38.09 65.45 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.463 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.32 -92.17 0.52 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.881 -1.509 . . . . 0.0 107.553 176.76 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 15.1 t0 -130.06 96.27 4.15 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.82 -3.58 54.88 Favored Glycine 0 C--N 1.303 -1.287 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.425 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.5 106.99 16.5 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -175.586 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -115.09 120.45 39.85 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.691 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.1 t -138.54 163.28 32.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.5 m -149.98 176.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.367 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -102.13 124.24 47.39 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-O 122.012 0.911 . . . . 0.0 110.829 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.662 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.55 137.19 15.17 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.929 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.15 17.69 4.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.23 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.18 83.64 1.74 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.973 174.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.42 -58.52 1.95 Allowed Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.449 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.3 pt-20 -44.82 -20.08 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.783 -0.708 . . . . 0.0 111.03 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.433 ' N ' ' C ' ' B' ' 385' ' ' GLY . 4.1 mm-40 -83.37 -38.87 21.42 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.8 mt -76.91 -41.99 32.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.623 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.95 -42.51 60.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.566 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.449 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -63.65 -34.2 77.31 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.064 0.935 . . . . 0.0 111.091 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.22 -53.26 10.17 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.738 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -49.02 -55.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.485 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.13 -34.44 44.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.663 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.68 -18.01 62.63 Favored Glycine 0 CA--C 1.505 -0.56 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.675 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.65 -37.04 18.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.322 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.482 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.24 -13.34 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-O 122.121 0.962 . . . . 0.0 109.288 176.204 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.36 -22.65 47.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.715 -1.584 . . . . 0.0 109.512 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.675 HD12 ' HA ' ' B' ' 395' ' ' TYR . 67.3 mt -92.05 -61.95 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.119 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.82 -20.11 26.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 113.394 -1.73 . . . . 0.0 112.373 -176.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.554 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.219 -0.508 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.723 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.3 mm? . . . . . 0 CA--C 1.52 -0.18 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -41.42 93.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.586 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.27 -41.48 98.35 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.15 178.687 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 73.9 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.839 0.352 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.87 153.18 25.8 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.082 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -129.49 135.64 48.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.452 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -138.5 129.83 27.33 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.588 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.863 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.42 101.39 10.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 123.869 1.795 . . . . 0.0 109.541 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' B' ' 328' ' ' ARG . 31.4 m -112.88 157.79 13.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 112.654 -2.066 . . . . 0.0 109.986 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -99.57 144.14 29.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' B' ' 326' ' ' VAL . 38.8 tt0 . . . . . 0 C--N 1.314 -0.961 0 CA-C-O 122.091 0.948 . . . . 0.0 112.714 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' B' ' 317' ' ' GLU . 11.2 t . . . . . 0 N--CA 1.439 -0.984 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.859 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.445 ' O ' HG12 ' B' ' 326' ' ' VAL . 76.7 Cg_exo -43.13 142.86 2.25 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 N-CA-C 107.915 -1.61 . . . . 0.0 107.915 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' B' ' 315' ' ' VAL . 2.0 tpt180 -146.7 -173.16 4.14 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -145.93 122.92 11.38 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.318 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.838 HD12 ' O ' ' B' ' 338' ' ' MET . 26.7 tp -102.5 158.39 16.25 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.421 ' N ' ' HG ' ' B' ' 330' ' ' LEU . . . -141.01 107.51 0.52 Allowed Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.761 HD11 HD21 ' B' ' 330' ' ' LEU . 31.5 mm -88.62 122.72 40.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.733 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.5 p -117.66 137.78 52.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -57.54 13.78 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.059 0.457 . . . . 0.0 111.727 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.733 ' H ' ' C ' ' B' ' 333' ' ' THR . 15.8 pt-20 -144.25 -2.69 0.87 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.839 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.83 179.05 2.08 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.318 1.056 . . . . 0.0 112.989 -177.112 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.612 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 15.0 t -137.13 144.33 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 CA-C-N 113.266 -1.788 . . . . 0.0 106.752 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.838 ' O ' HD12 ' B' ' 330' ' ' LEU . 4.2 ptt? -153.44 150.12 28.46 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 117.053 -1.859 . . . . 0.0 114.263 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.654 HH12 HD13 ' B' ' 330' ' ' LEU . 6.5 mmt-85 -94.9 107.19 19.22 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.665 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.63 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.53 149.7 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.275 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.1 t0 -89.92 92.18 8.9 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.765 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.58 -28.7 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.697 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 20.2 mttp -75.42 -43.6 48.98 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.705 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.556 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.39 -12.58 14.72 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 345' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' B' ' 341' ' ' ASP . 6.3 ttmm 66.76 -0.52 1.59 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.032 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.5 mt-10 -84.9 153.17 23.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.274 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.58 HG21 ' SD ' ' B' ' 338' ' ' MET . 74.2 t -83.17 134.35 27.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.481 0.658 . . . . 0.0 112.334 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 21.6 mm -102.89 -31.85 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.353 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' B' ' 338' ' ' MET . 32.2 tt0 -137.64 156.89 47.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.703 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -146.42 148.78 32.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.348 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.556 ' O ' ' N ' ' B' ' 337' ' ' VAL . 67.0 t-105 -163.73 135.74 4.95 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.905 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -53.87 138.25 36.71 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.344 -178.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.631 HD12 ' O ' ' B' ' 333' ' ' THR . 1.7 tt -78.26 -35.38 48.23 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -75.59 11.72 1.23 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.999 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -115.58 -4.01 12.28 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.139 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.501 HD12 HD23 ' B' ' 353' ' ' LEU . 75.8 mt -57.7 149.39 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.097 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 357' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 10.8 tptt -107.33 -44.71 4.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.1 ptt180 -175.88 136.22 0.31 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.407 177.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.457 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.3 p90 -118.84 174.54 6.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.344 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.31 99.21 1.76 Allowed 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 119.233 -0.987 . . . . 0.0 112.002 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.53 144.25 31.45 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.773 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.539 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -131.9 174.27 4.9 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -77.31 -8.94 17.57 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.14 1.893 . . . . 0.0 112.102 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 17.1 mttt -130.69 -21.37 2.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.97 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.654 ' HA ' ' H ' ' B' ' 382' ' ' THR . 78.7 p -149.85 168.88 22.48 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.487 0.661 . . . . 0.0 111.938 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.503 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -141.16 156.87 45.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.796 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.549 ' CG2' HD12 ' A' ' 15' ' ' LEU . 44.8 m -147.78 156.85 43.17 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.093 -1.043 . . . . 0.0 112.913 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.466 ' N ' HG22 ' B' ' 367' ' ' THR . 5.9 mt -130.04 140.65 50.82 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.546 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.4 t0 -117.28 95.86 5.16 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.697 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.52 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 11.6 p90 -136.56 93.64 2.9 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.443 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.45 12.36 1.82 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 372' ' ' ASP . . . . . 0.401 ' CG ' ' OH ' ' B' ' 377' ' ' TYR . 8.3 t0 -41.84 -15.78 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.034 -0.583 . . . . 0.0 111.756 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.6 -37.27 65.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.478 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.89 -92.78 0.5 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.132 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.478 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.0 t70 -129.05 96.27 4.29 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.38 -3.03 55.6 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.306 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.682 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.95 106.06 16.86 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -175.545 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.14 125.86 51.89 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.736 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 46.6 t -138.38 163.67 31.27 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.532 0.682 . . . . 0.0 112.559 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -148.89 175.02 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.883 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.07 125.41 48.76 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.897 0.855 . . . . 0.0 111.098 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.654 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.54 136.44 14.56 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.814 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.78 16.85 4.4 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.243 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.97 84.0 1.76 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.938 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.79 -58.24 2.05 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.6 pt-20 -44.79 -20.69 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.811 -0.695 . . . . 0.0 110.962 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' B' ' 385' ' ' GLY . 68.9 mt-30 -82.11 -39.29 23.55 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 45.9 mt -77.05 -42.43 31.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.614 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.63 -42.38 61.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.569 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.77 -34.91 78.96 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.1 0.952 . . . . 0.0 110.95 -177.374 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.01 -53.78 10.28 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.723 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -48.97 -56.06 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 176.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.41 -33.74 45.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 112.874 -1.966 . . . . 0.0 110.671 177.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.18 -17.81 62.05 Favored Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.674 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.04 -36.92 17.91 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.47 ' HA ' HD11 ' B' ' 399' ' ' ILE . 0.0 OUTLIER -68.59 -13.31 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 122.203 1.002 . . . . 0.0 109.285 176.17 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.6 -22.68 46.67 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.459 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 395' ' ' TYR . 69.2 mt -91.82 -62.01 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 113.894 -1.503 . . . . 0.0 112.038 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.22 -20.58 27.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 113.449 -1.705 . . . . 0.0 112.323 -177.061 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.222 -0.384 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.812 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.559 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? . . . . . 0 CA--C 1.521 -0.145 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -41.19 88.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.432 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.68 -41.82 99.66 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.508 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 90.0 mt-10 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.042 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.846 0.355 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.76 153.4 26.57 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.166 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -129.73 134.52 47.66 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.085 0.24 . . . . 0.0 111.475 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -139.33 128.72 24.21 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.612 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.892 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.3 105.86 12.83 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 123.733 1.73 . . . . 0.0 109.446 178.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.657 HG12 ' HB ' ' B' ' 382' ' ' THR . 29.5 m -118.34 161.95 16.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 112.709 -2.041 . . . . 0.0 110.145 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -103.41 145.3 30.19 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' B' ' 326' ' ' VAL . 44.4 tt0 . . . . . 0 C--N 1.314 -0.951 0 CA-C-O 121.972 0.891 . . . . 0.0 112.462 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.2 t . . . . . 0 N--CA 1.443 -0.824 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.448 ' O ' HG12 ' B' ' 326' ' ' VAL . 70.0 Cg_exo -43.9 144.44 2.51 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 N-CA-C 108.166 -1.513 . . . . 0.0 108.166 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' B' ' 315' ' ' VAL . 7.3 ttm-85 -151.44 -172.61 4.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.708 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -142.1 122.39 13.93 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.175 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.851 HD12 ' O ' ' B' ' 338' ' ' MET . 31.2 tp -100.41 158.58 15.8 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.43 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.32 108.3 0.52 Allowed Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.735 HD11 HD21 ' B' ' 330' ' ' LEU . 30.1 mm -88.09 123.4 40.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.724 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.83 138.51 52.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 334' ' ' LYS . . . . . 0.617 ' NZ ' ' CE1' ' B' ' 395' ' ' TYR . 0.4 OUTLIER -57.76 15.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.311 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.724 ' H ' ' C ' ' B' ' 333' ' ' THR . 10.9 pt-20 -144.88 -4.65 0.74 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.701 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.08 177.84 2.25 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 122.398 1.094 . . . . 0.0 112.947 -176.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.8 t -132.94 145.22 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 CA-C-N 113.113 -1.858 . . . . 0.0 106.219 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.851 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.4 ptt? -153.05 151.34 30.12 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 117.258 -1.777 . . . . 0.0 114.429 -175.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.422 HH12 HG21 ' B' ' 380' ' ' VAL . 8.7 mmt180 -96.24 106.85 19.12 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.456 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.641 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -97.07 149.7 4.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.235 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 343' ' ' LYS . 25.5 t0 -88.47 91.98 9.01 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.773 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.42 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.734 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 61.8 mttt -76.12 -44.08 40.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.756 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.551 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -108.72 -12.59 14.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 345' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' B' ' 341' ' ' ASP . 32.4 tttp 66.9 -0.53 1.63 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.955 0.407 . . . . 0.0 109.976 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.3 mt-10 -85.37 153.0 22.82 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.284 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.61 HG21 ' SD ' ' B' ' 338' ' ' MET . 83.4 t -81.9 133.47 29.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.524 0.678 . . . . 0.0 112.314 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 11.6 mt -103.4 -31.86 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.449 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.474 ' O ' ' CB ' ' B' ' 338' ' ' MET . 24.4 tt0 -136.6 158.48 44.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.782 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 350' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 39.1 mt-10 -144.97 149.3 34.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.286 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.562 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.88 124.74 3.94 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.151 177.624 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.401 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -46.59 140.37 4.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.435 0.636 . . . . 0.0 111.527 -178.721 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.585 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -83.74 -36.04 23.96 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.2 t -74.18 9.82 1.48 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.913 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.569 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 4.3 m-20 -111.64 -7.98 14.24 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.052 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.479 HD12 HD23 ' B' ' 353' ' ' LEU . 81.4 mt -56.01 146.92 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.692 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -107.86 -46.08 3.86 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.493 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 2.2 ptt-85 -172.55 136.38 0.75 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.53 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.3 p90 -119.44 176.49 5.33 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.275 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.39 99.2 1.75 Allowed 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.041 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.97 140.15 34.15 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.68 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.531 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -128.32 174.5 4.36 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.79 -7.78 16.66 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.118 1.878 . . . . 0.0 112.193 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.1 mttp -130.91 -20.39 2.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.04 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.672 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.5 p -152.85 166.49 32.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.423 0.63 . . . . 0.0 111.931 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.48 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -137.04 156.52 48.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.61 179.369 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.559 ' CG2' HD12 ' A' ' 15' ' ' LEU . 25.3 m -148.54 154.58 39.98 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.104 -1.038 . . . . 0.0 113.091 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.0 mt -125.66 139.45 53.55 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.118 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.8 t0 -117.07 95.83 5.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.457 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 33.4 t80 -137.77 94.51 2.91 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.896 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.67 12.12 2.03 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 372' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.0 t0 -41.47 -16.0 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.035 -0.582 . . . . 0.0 111.826 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.52 -37.33 65.24 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.474 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.69 -92.84 0.5 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.474 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.3 t70 -128.88 96.34 4.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.11 -2.97 54.66 Favored Glycine 0 C--N 1.315 -0.629 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.243 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.07 106.4 15.69 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.666 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 378' ' ' TYR . . . . . 0.415 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.8 OUTLIER -113.88 120.4 40.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.598 176.178 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 37.3 t -138.88 164.59 29.27 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.651 0.738 . . . . 0.0 112.757 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 380' ' ' VAL . . . . . 0.422 HG21 HH12 ' B' ' 339' ' ' ARG . 1.0 OUTLIER -151.07 174.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.858 179.03 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.39 124.59 46.07 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.973 0.892 . . . . 0.0 111.024 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.672 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.82 137.69 14.42 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.824 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 383' ' ' THR . . . . . 0.439 ' N ' ' OE2' ' B' ' 384' ' ' GLU . 0.8 OUTLIER -85.43 -1.2 56.79 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.972 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 384' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -123.81 84.05 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.096 0.95 . . . . 0.0 108.727 175.25 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.99 -59.54 1.86 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.4 pt-20 -45.59 -21.04 0.08 Allowed 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 114.697 -0.752 . . . . 0.0 111.074 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.406 ' N ' ' C ' ' B' ' 385' ' ' GLY . 68.6 mt-30 -81.04 -38.62 27.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.3 mt -77.36 -41.97 30.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.588 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -74.18 -42.68 59.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.507 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.65 -34.59 78.19 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.991 0.9 . . . . 0.0 111.035 -177.443 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.94 -53.45 10.08 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.781 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -48.89 -55.55 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 176.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.485 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -51.96 -34.06 40.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.764 -2.017 . . . . 0.0 110.569 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.06 -18.12 61.66 Favored Glycine 0 CA--C 1.506 -0.524 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.682 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.68 -36.88 18.47 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.53 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.29 -13.36 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 122.108 0.956 . . . . 0.0 109.189 176.326 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.34 -22.68 47.67 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.506 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.0 mt -91.99 -61.92 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 113.869 -1.514 . . . . 0.0 112.022 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.9 -20.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 113.415 -1.721 . . . . 0.0 112.311 -176.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.557 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.221 -0.437 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.775 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.552 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? . . . . . 0 CA--C 1.521 -0.159 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -40.98 86.32 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.8 -41.63 99.65 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.513 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.1 mt-10 . . . . . 0 C--N 1.327 -0.398 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.784 0.326 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.13 153.4 23.21 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.132 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -128.14 135.29 49.57 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -140.06 128.79 23.14 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.598 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.907 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.86 107.45 13.68 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 123.728 1.728 . . . . 0.0 109.349 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.65 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.0 m -119.88 159.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 112.647 -2.07 . . . . 0.0 110.066 -177.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -100.79 145.05 29.01 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' B' ' 326' ' ' VAL . 47.1 tt0 . . . . . 0 C--N 1.312 -1.023 0 CA-C-O 121.995 0.903 . . . . 0.0 112.617 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.0 t . . . . . 0 N--CA 1.441 -0.911 0 CA-C-O 119.092 -0.48 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.434 ' O ' HG12 ' B' ' 326' ' ' VAL . 67.0 Cg_exo -44.33 143.74 3.45 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 N-CA-C 108.093 -1.541 . . . . 0.0 108.093 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.631 ' N ' ' O ' ' B' ' 315' ' ' VAL . 0.3 OUTLIER -149.99 -172.92 4.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.759 -177.129 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.646 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -142.31 122.05 13.45 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.061 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.84 HD12 ' O ' ' B' ' 338' ' ' MET . 30.3 tp -100.37 158.3 15.99 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.118 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.434 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.94 108.11 0.52 Allowed Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.74 HD11 HD21 ' B' ' 330' ' ' LEU . 30.4 mm -87.99 121.63 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.72 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.3 p -115.83 138.62 50.97 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -57.92 14.95 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.364 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.72 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.4 pt-20 -145.14 -3.79 0.74 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.476 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.5 178.42 1.97 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.343 1.068 . . . . 0.0 112.993 -176.655 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.7 t -134.38 145.0 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 113.147 -1.842 . . . . 0.0 106.308 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.84 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.5 ptt? -152.8 151.99 31.09 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 117.145 -1.822 . . . . 0.0 114.546 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.787 HH12 HD13 ' B' ' 330' ' ' LEU . 6.5 mmt-85 -96.28 107.36 19.7 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.466 176.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.646 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.06 149.8 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.219 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' B' ' 343' ' ' LYS . 0.3 OUTLIER -87.94 92.0 8.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.859 -178.515 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -36.55 -27.34 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.637 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' B' ' 341' ' ' ASP . 54.3 mttt -74.79 -42.61 57.79 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.731 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 341' ' ' ASP . 64.5 p -112.0 -16.91 12.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 345' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' B' ' 344' ' ' THR . 5.8 ttmm 73.73 1.8 4.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.94 0.4 . . . . 0.0 110.174 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.468 ' O ' HG13 ' B' ' 340' ' ' VAL . 5.5 pt-20 -86.52 158.65 19.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.617 HG21 ' SD ' ' B' ' 338' ' ' MET . 89.4 t -88.4 132.78 32.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.567 0.698 . . . . 0.0 112.36 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.21 -31.34 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.241 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.0 tt0 -136.74 157.5 46.61 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.601 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -144.25 149.65 36.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.003 -0.998 . . . . 0.0 111.215 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.61 124.52 4.02 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.125 177.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.501 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -46.73 140.47 4.53 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.358 0.599 . . . . 0.0 111.511 -178.673 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.591 HD12 ' O ' ' B' ' 333' ' ' THR . 1.9 tt -83.79 -35.74 24.09 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.6 t -74.52 10.22 1.43 Allowed 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.909 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.573 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.8 m-20 -112.11 -7.63 14.06 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.004 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.481 HD12 HD23 ' B' ' 353' ' ' LEU . 80.8 mt -55.98 147.4 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.775 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.77 -45.44 4.01 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.7 ptt-85 -173.9 135.93 0.51 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.466 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.8 p90 -118.74 176.54 5.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.206 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.43 99.42 1.6 Allowed 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.887 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.783 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.21 147.22 30.09 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.699 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.529 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -135.63 173.87 5.2 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -77.35 -8.36 17.31 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.113 1.875 . . . . 0.0 112.15 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' B' ' 382' ' ' THR . 3.9 mttp -130.66 -20.55 2.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.977 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.646 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.6 p -152.69 167.29 29.43 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.59 0.71 . . . . 0.0 111.993 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.467 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -138.81 156.92 46.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.638 179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.552 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.3 m -148.53 155.73 41.52 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.041 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.436 ' N ' HG22 ' B' ' 367' ' ' THR . 6.8 mt -126.29 139.73 53.08 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.375 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.1 t0 -116.96 95.75 5.15 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.68 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 32.6 t80 -138.1 94.87 2.93 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.971 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.12 12.04 1.94 Allowed Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 372' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.4 t0 -41.79 -16.37 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.044 -0.578 . . . . 0.0 111.778 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.0 m-85 -54.33 -37.27 64.67 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.466 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.98 -92.37 0.51 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.335 176.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.466 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.7 t70 -129.78 96.28 4.19 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 174.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.15 -3.52 54.27 Favored Glycine 0 C--N 1.31 -0.872 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.313 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.25 106.33 15.79 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.06 120.43 40.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.703 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 34.5 t -138.43 163.67 31.32 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.674 0.75 . . . . 0.0 112.952 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -150.42 175.56 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.199 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -101.23 125.06 47.82 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.968 0.89 . . . . 0.0 110.899 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.65 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -155.08 136.23 13.92 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.878 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.09 17.07 4.44 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.13 83.69 1.74 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.044 174.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.25 -57.72 2.08 Favored Glycine 0 C--N 1.317 -0.51 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.451 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.5 pt-20 -45.26 -20.27 0.05 Allowed 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 114.898 -0.651 . . . . 0.0 110.991 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.425 ' N ' ' C ' ' B' ' 385' ' ' GLY . 6.7 mm-40 -83.36 -38.55 21.87 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.0 mt -77.23 -41.89 30.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.538 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.783 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.88 -42.46 60.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.344 -1.298 . . . . 0.0 113.509 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.451 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -64.08 -34.14 77.37 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.051 0.929 . . . . 0.0 111.022 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.07 -53.43 9.98 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.898 -1.501 . . . . 0.0 108.725 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -49.16 -55.55 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.487 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -51.89 -34.15 39.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 112.756 -2.02 . . . . 0.0 110.69 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.8 -18.11 62.19 Favored Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.682 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.5 m-30 -86.66 -36.98 18.43 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.467 ' HA ' HD11 ' B' ' 399' ' ' ILE . 0.0 OUTLIER -68.12 -13.29 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 CA-C-O 122.114 0.959 . . . . 0.0 109.282 176.204 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.67 -22.77 46.29 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.519 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' B' ' 395' ' ' TYR . 69.3 mt -91.9 -61.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.052 -178.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.97 -20.34 27.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 113.458 -1.701 . . . . 0.0 112.329 -176.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.557 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.463 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.767 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.545 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -40.56 91.27 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.92 -38.19 95.61 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.508 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 91.4 mt-10 . . . . . 0 C--N 1.328 -0.346 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 74.0 t . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.735 0.302 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.59 153.25 24.44 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -129.72 135.68 48.76 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.058 0.224 . . . . 0.0 111.434 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -139.2 129.49 25.47 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.648 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.873 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.37 104.45 12.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.933 1.825 . . . . 0.0 109.403 178.349 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.645 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.6 m -115.6 160.93 14.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 112.583 -2.099 . . . . 0.0 110.101 -176.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -103.89 144.49 31.43 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' B' ' 326' ' ' VAL . 27.1 tt0 . . . . . 0 C--N 1.317 -0.825 0 CA-C-O 122.088 0.947 . . . . 0.0 112.767 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' B' ' 317' ' ' GLU . 9.4 t . . . . . 0 N--CA 1.439 -0.993 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.47 ' O ' HG12 ' B' ' 326' ' ' VAL . 65.5 Cg_exo -44.49 145.32 2.63 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 N-CA-C 108.121 -1.53 . . . . 0.0 108.121 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' B' ' 315' ' ' VAL . 9.9 ttm-85 -150.13 -173.21 4.37 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.787 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.64 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -143.89 122.1 12.24 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.839 HD12 ' O ' ' B' ' 338' ' ' MET . 26.2 tp -101.34 158.01 16.36 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.432 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.53 107.51 0.51 Allowed Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.708 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -88.22 124.0 41.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.725 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.6 p -118.23 137.74 52.81 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -56.93 12.8 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.908 0.385 . . . . 0.0 111.724 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.725 ' H ' ' C ' ' B' ' 333' ' ' THR . 10.8 pt-20 -144.06 -2.49 0.9 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.712 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.2 OUTLIER -174.03 -179.28 1.66 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.357 1.075 . . . . 0.0 113.372 -177.372 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.597 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.6 t -137.95 144.84 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.106 0 CA-C-N 113.257 -1.792 . . . . 0.0 107.036 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.839 ' O ' HD12 ' B' ' 330' ' ' LEU . 5.8 ptp -153.03 151.33 30.13 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 117.178 -1.809 . . . . 0.0 114.347 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.51 ' NH1' ' OE2' ' B' ' 317' ' ' GLU . 38.8 mtm180 -96.15 107.67 20.02 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.539 176.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.64 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.76 149.03 5.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.43 -178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' B' ' 344' ' ' THR . 44.6 t0 -88.75 90.5 8.43 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.962 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.79 -28.39 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.66 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.3 mttp -68.99 -43.98 73.77 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.441 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.546 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -115.73 -16.39 11.24 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 345' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' B' ' 344' ' ' THR . 2.7 tttp 77.11 -0.75 2.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.013 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.455 ' O ' HG13 ' B' ' 340' ' ' VAL . 8.7 pt-20 -80.12 158.01 26.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.509 HG22 HG22 ' B' ' 340' ' ' VAL . 86.4 t -88.64 133.77 30.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.432 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 61.0 mt -102.18 -29.36 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.3 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.447 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 26.2 tt0 -143.46 157.89 44.09 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.938 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 350' ' ' GLU . . . . . 0.408 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 36.3 mt-10 -146.13 149.45 34.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.996 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.576 ' O ' ' N ' ' B' ' 337' ' ' VAL . 70.1 t-105 -161.14 136.78 7.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.994 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 352' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.71 137.95 48.5 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.515 0.674 . . . . 0.0 111.554 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.627 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -78.66 -35.38 45.36 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 4.9 t -75.37 11.22 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.874 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' B' ' 353' ' ' LEU . 4.7 m-20 -115.08 -3.71 12.57 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.289 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.499 HD12 HD23 ' B' ' 353' ' ' LEU . 75.6 mt -58.71 148.92 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.854 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 357' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 6.9 tttp -106.96 -45.36 4.18 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.492 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 1.7 ptt180 -174.84 136.41 0.41 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.518 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.492 ' CH2' HD12 ' B' ' 396' ' ' ILE . 6.8 p90 -118.71 175.46 5.73 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.246 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.34 97.7 1.65 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.909 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.795 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.81 142.29 33.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.785 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.519 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -129.91 174.08 5.02 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -77.43 -8.47 17.26 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.156 1.904 . . . . 0.0 112.121 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' B' ' 382' ' ' THR . 20.3 mtpt -130.66 -21.84 2.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.855 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.653 ' HA ' ' H ' ' B' ' 382' ' ' THR . 86.3 p -149.81 169.74 20.39 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.507 0.67 . . . . 0.0 111.743 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.499 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -142.35 156.43 45.23 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.885 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.545 ' CG2' HD12 ' A' ' 15' ' ' LEU . 44.0 m -147.77 156.76 43.08 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.711 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.468 ' N ' HG22 ' B' ' 367' ' ' THR . 5.7 mt -129.92 142.45 50.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.495 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.2 t0 -119.14 95.64 4.9 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.743 176.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 12.6 p90 -136.07 93.43 2.91 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.235 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.95 11.7 1.8 Allowed Glycine 0 N--CA 1.462 0.391 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -41.74 -15.53 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.21 -0.495 . . . . 0.0 111.856 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.9 -36.55 65.3 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.495 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.06 -93.25 0.49 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.495 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.8 t0 -129.01 96.43 4.34 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.8 -1.81 55.17 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.315 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.31 105.96 17.04 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -175.738 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.96 125.77 51.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.645 176.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.8 t -138.19 164.12 30.0 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.575 0.702 . . . . 0.0 112.458 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -150.39 174.08 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.867 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -100.92 126.17 47.54 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.954 0.883 . . . . 0.0 111.072 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.653 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.93 136.49 14.26 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.404 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.02 16.66 4.77 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.142 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.55 84.33 1.8 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.119 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.88 -59.15 1.91 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.504 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 15.4 pt-20 -44.17 -20.72 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.625 -0.787 . . . . 0.0 111.029 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 5.0 mm-40 -82.85 -38.7 22.64 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 47.1 mt -77.23 -42.38 31.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.526 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.795 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.41 -42.9 61.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.676 -177.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.54 -34.81 78.61 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 122.093 0.949 . . . . 0.0 110.892 -177.434 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.06 -53.89 9.94 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.771 -1.559 . . . . 0.0 108.713 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.9 mt -48.83 -55.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.482 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.62 -33.75 48.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.742 -2.026 . . . . 0.0 110.639 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.13 -17.93 61.89 Favored Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.676 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.1 -36.66 17.98 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.492 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.8 -13.2 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 122.178 0.99 . . . . 0.0 109.264 176.027 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -22.61 46.45 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.503 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.4 mt -91.63 -62.07 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 113.899 -1.5 . . . . 0.0 112.067 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.21 -20.69 27.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.437 -177.068 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.565 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.487 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.89 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.591 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.6 mm? . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 16' ' ' LEU . 59.1 mt -61.01 -41.22 96.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.569 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.39 -37.91 93.91 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.779 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 97.2 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.753 0.311 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.27 152.91 29.25 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.138 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -130.58 134.3 46.89 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.994 0.184 . . . . 0.0 111.413 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -137.59 130.14 29.73 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.565 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.874 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -83.98 101.78 11.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 123.965 1.84 . . . . 0.0 109.309 178.189 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.662 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.7 m -112.16 161.93 10.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 112.645 -2.071 . . . . 0.0 110.175 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -105.04 145.97 29.74 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' B' ' 326' ' ' VAL . 24.4 tt0 . . . . . 0 C--N 1.315 -0.923 0 CA-C-O 122.037 0.922 . . . . 0.0 112.665 -178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.6 t . . . . . 0 N--CA 1.439 -1.019 0 CA-C-O 119.1 -0.476 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.429 ' O ' HG12 ' B' ' 326' ' ' VAL . 66.2 Cg_exo -44.58 145.62 2.57 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 N-CA-C 107.956 -1.594 . . . . 0.0 107.956 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.662 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.8 ttt180 -149.91 -174.1 4.61 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.725 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.35 123.44 12.87 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.081 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.831 HD12 ' O ' ' B' ' 338' ' ' MET . 26.7 tp -102.13 159.03 15.74 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.442 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.07 108.07 0.52 Allowed Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.746 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -89.04 123.7 41.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.726 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.48 138.1 52.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.63 13.84 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.114 0.483 . . . . 0.0 111.793 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.726 ' H ' ' C ' ' B' ' 333' ' ' THR . 8.9 pt-20 -144.4 -3.16 0.84 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.868 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.88 178.52 2.17 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 122.272 1.034 . . . . 0.0 113.003 -177.125 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.5 t -135.79 145.96 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-N 113.4 -1.727 . . . . 0.0 106.573 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.831 ' O ' HD12 ' B' ' 330' ' ' LEU . 2.2 ptt? -153.93 150.31 28.2 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 117.044 -1.863 . . . . 0.0 114.262 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.553 ' NH2' HG21 ' B' ' 315' ' ' VAL . 3.2 mtp85 -94.89 107.6 19.63 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.669 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.11 149.94 5.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.371 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' B' ' 344' ' ' THR . 3.2 t70 -90.46 92.62 8.96 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.755 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.7 OUTLIER -35.87 -28.76 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.626 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' B' ' 341' ' ' ASP . 41.9 mttt -73.2 -43.49 61.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.691 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.7 p -111.43 -12.82 13.96 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt 67.63 -0.85 1.79 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 109.999 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.3 mt-10 -84.55 151.97 24.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.311 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.626 HG21 ' SD ' ' B' ' 338' ' ' MET . 77.7 t -82.94 135.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.526 0.679 . . . . 0.0 112.308 -178.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 348' ' ' ILE . . . . . 0.641 HD12 ' NH2' ' B' ' 328' ' ' ARG . 70.9 mt -103.82 -30.99 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.438 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.466 ' O ' ' CB ' ' B' ' 338' ' ' MET . 37.4 tt0 -138.85 156.04 47.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.584 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -145.51 149.6 34.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.336 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.552 ' O ' ' N ' ' B' ' 337' ' ' VAL . 64.1 t-105 -161.83 134.95 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.838 177.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.508 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.52 138.77 27.06 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.477 -178.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.622 HD12 ' O ' ' B' ' 333' ' ' THR . 1.8 tt -79.08 -35.74 41.95 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 4.7 t -74.86 11.24 1.12 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.895 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.508 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.5 m-20 -114.75 -4.16 12.74 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.14 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.484 HD12 HD23 ' B' ' 353' ' ' LEU . 73.5 mt -57.86 147.97 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.088 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 357' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 8.1 tttp -105.9 -45.48 4.36 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.8 ptt180 -174.69 136.4 0.43 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.462 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.467 ' CH2' HD12 ' B' ' 396' ' ' ILE . 10.1 p90 -119.45 173.14 7.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.174 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.0 99.11 1.8 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.086 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.16 148.6 30.85 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.951 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -136.69 173.43 5.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -76.82 -8.81 18.12 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.122 1.882 . . . . 0.0 112.073 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' B' ' 382' ' ' THR . 12.6 mtpp -130.68 -21.64 2.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.968 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.659 ' HA ' ' H ' ' B' ' 382' ' ' THR . 89.8 p -150.35 169.23 21.91 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.606 0.717 . . . . 0.0 111.852 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.506 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -141.78 156.88 45.56 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.888 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.591 ' CG2' HD12 ' A' ' 15' ' ' LEU . 34.2 m -148.06 156.68 42.91 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.091 -1.043 . . . . 0.0 112.809 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.459 ' N ' HG22 ' B' ' 367' ' ' THR . 6.0 mt -129.21 144.51 51.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.567 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 22.2 t0 -120.51 95.82 4.88 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.837 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.517 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 11.0 p90 -136.71 93.71 2.9 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.369 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.81 12.51 1.72 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -41.9 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.159 -0.521 . . . . 0.0 111.719 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.62 -37.32 65.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.476 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.77 -92.8 0.5 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.934 -1.484 . . . . 0.0 107.097 176.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.476 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.6 t70 -129.12 96.34 4.3 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.24 -2.81 55.75 Favored Glycine 0 C--N 1.312 -0.75 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.217 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.686 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.96 106.3 17.04 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -175.57 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.81 125.57 51.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.747 175.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.9 t -138.49 162.63 34.03 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.482 0.658 . . . . 0.0 112.646 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.05 172.6 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.022 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.23 126.3 45.01 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.886 0.851 . . . . 0.0 111.074 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.659 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.02 135.97 13.76 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.698 179.265 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.57 17.95 3.6 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.178 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.05 83.89 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.049 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.91 -59.34 1.89 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.9 pt-20 -45.01 -19.85 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 114.754 -0.723 . . . . 0.0 111.016 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.436 ' N ' ' C ' ' B' ' 385' ' ' GLY . 73.1 mt-30 -82.96 -39.56 21.23 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' B' ' 385' ' ' GLY . 40.6 mt -76.95 -41.86 32.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.731 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -74.11 -41.97 60.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.651 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.438 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 15.5 pt20 -63.93 -34.77 78.71 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.059 0.933 . . . . 0.0 111.023 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.656 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.92 -53.82 10.31 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.813 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.656 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.11 -55.98 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.476 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.42 -33.74 45.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.663 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.19 -17.79 62.07 Favored Glycine 0 CA--C 1.506 -0.469 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.676 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.11 -37.0 17.78 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.467 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.6 -13.27 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-O 122.187 0.994 . . . . 0.0 109.281 176.182 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.64 -22.67 46.54 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.473 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.4 mt -91.76 -62.07 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 113.897 -1.502 . . . . 0.0 112.035 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.3 -20.51 27.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.396 -177.075 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.877 -1.059 . . . . 0.0 110.797 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.546 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.3 mm? . . . . . 0 N--CA 1.462 0.135 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -38.61 77.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.513 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.32 97.99 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 89.1 mt-10 . . . . . 0 C--N 1.328 -0.345 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.718 0.294 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.47 153.19 27.78 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.192 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -130.09 134.39 47.33 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 123.059 0.224 . . . . 0.0 111.465 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -138.74 129.02 25.68 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.499 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.878 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.23 105.05 13.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.834 1.778 . . . . 0.0 109.446 178.469 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.631 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.6 m -115.79 160.92 14.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 112.596 -2.093 . . . . 0.0 110.1 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -103.52 145.67 29.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' B' ' 326' ' ' VAL . 25.3 tt0 . . . . . 0 C--N 1.315 -0.925 0 CA-C-O 122.071 0.938 . . . . 0.0 112.601 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' B' ' 317' ' ' GLU . 5.2 t . . . . . 0 N--CA 1.44 -0.953 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.423 ' O ' HG12 ' B' ' 326' ' ' VAL . 63.1 Cg_exo -44.27 145.18 2.49 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.107 -1.536 . . . . 0.0 108.107 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.631 ' N ' ' O ' ' B' ' 315' ' ' VAL . 10.6 ttm-85 -149.96 -173.5 4.45 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 119.498 -0.881 . . . . 0.0 108.658 -177.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.4 121.7 12.29 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.052 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.83 HD12 ' O ' ' B' ' 338' ' ' MET . 28.0 tp -100.15 158.31 15.95 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.44 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.81 108.38 0.54 Allowed Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.725 HD11 HD21 ' B' ' 330' ' ' LEU . 31.0 mm -88.75 124.61 41.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.723 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.94 138.13 53.0 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 334' ' ' LYS . . . . . 0.41 ' NZ ' ' CZ ' ' B' ' 395' ' ' TYR . 0.0 OUTLIER -57.34 14.71 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.74 0.305 . . . . 0.0 111.301 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -145.15 -3.66 0.75 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.497 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.81 179.98 1.88 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.287 1.041 . . . . 0.0 113.073 -176.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.67 146.53 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 CA-C-N 113.293 -1.776 . . . . 0.0 106.493 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.83 ' O ' HD12 ' B' ' 330' ' ' LEU . 2.0 ptt? -154.56 150.33 27.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 117.086 -1.845 . . . . 0.0 114.303 -176.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.658 HH21 ' NE2' ' B' ' 349' ' ' GLN . 18.3 mtt-85 -95.12 107.94 20.03 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.561 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.6 149.74 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.259 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' B' ' 344' ' ' THR . 24.7 t0 -88.97 91.91 9.02 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.724 -178.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 1.0 OUTLIER -35.38 -28.63 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.692 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 341' ' ' ASP . 32.9 mttt -75.64 -43.81 45.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.749 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.554 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -108.9 -12.64 14.86 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -177.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 345' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' B' ' 341' ' ' ASP . 13.3 ttmt 66.81 -0.29 1.68 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.017 0.436 . . . . 0.0 109.994 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.5 mt-10 -85.45 153.59 22.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.314 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.602 HG21 ' SD ' ' B' ' 338' ' ' MET . 81.6 t -83.4 134.31 27.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.493 0.663 . . . . 0.0 112.363 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 66.4 mt -102.72 -30.15 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.335 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.658 ' NE2' HH21 ' B' ' 339' ' ' ARG . 38.5 tt0 -140.41 156.84 46.25 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.627 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -145.27 149.7 35.34 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.387 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.577 ' O ' ' N ' ' B' ' 337' ' ' VAL . 70.9 t-105 -160.93 135.37 7.23 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.696 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.4 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -54.84 138.53 42.54 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.461 0.648 . . . . 0.0 111.492 -178.717 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.638 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -78.57 -35.58 45.7 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 354' ' ' THR . . . . . 0.556 HG22 ' O ' ' B' ' 354' ' ' THR . 21.8 m -73.68 8.81 1.69 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.882 177.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' B' ' 353' ' ' LEU . 4.8 m-20 -112.75 -2.35 14.48 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.147 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.525 HD12 HD23 ' B' ' 353' ' ' LEU . 68.0 mt -61.32 146.82 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.211 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 357' ' ' LYS . . . . . 0.48 ' HZ2' ' HB3' ' B' ' 372' ' ' ASP . 4.9 tttt -106.62 -45.24 4.28 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 0.1 OUTLIER -174.88 136.08 0.39 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.388 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.497 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.1 p90 -119.72 175.33 5.92 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.212 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.62 99.99 1.6 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.239 -0.984 . . . . 0.0 112.057 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.761 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.09 143.81 32.17 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.752 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.544 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -131.0 174.05 5.15 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -77.11 -9.05 17.84 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.043 1.829 . . . . 0.0 112.036 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.0 mttt -130.79 -21.1 2.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.972 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.664 ' HA ' ' H ' ' B' ' 382' ' ' THR . 78.6 p -149.81 169.54 20.86 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.513 0.673 . . . . 0.0 111.866 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.49 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.2 OUTLIER -141.09 156.32 46.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.583 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.546 ' CG2' HD12 ' A' ' 15' ' ' LEU . 54.8 m -146.31 156.89 43.67 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.885 -174.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.472 ' N ' HG22 ' B' ' 367' ' ' THR . 5.7 mt -130.79 139.68 50.23 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.54 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 22.5 t0 -116.6 95.86 5.24 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.779 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.534 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 11.2 p90 -135.93 94.01 3.0 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.532 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.77 12.51 1.73 Allowed Glycine 0 C--O 1.225 -0.427 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 372' ' ' ASP . . . . . 0.48 ' HB3' ' HZ2' ' B' ' 357' ' ' LYS . 8.4 t0 -41.74 -16.13 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.054 -0.573 . . . . 0.0 111.774 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.554 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.42 -37.28 64.93 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.477 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.98 -92.38 0.51 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.942 -1.481 . . . . 0.0 107.183 176.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.477 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.6 t0 -129.47 96.42 4.27 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.14 -3.46 55.67 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.149 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.697 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.03 106.7 17.38 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -175.649 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 378' ' ' TYR . . . . . 0.649 ' CG ' ' NH2' ' B' ' 339' ' ' ARG . 0.3 OUTLIER -120.04 127.4 52.55 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.835 175.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 33.1 t -138.64 166.52 24.14 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.621 0.724 . . . . 0.0 112.61 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.18 174.26 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.893 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -101.14 125.38 47.75 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.964 0.888 . . . . 0.0 111.092 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.664 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.83 136.82 14.62 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.84 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.27 16.88 4.77 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.211 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.07 83.88 1.75 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.021 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.38 -57.44 2.1 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.8 pt-20 -45.04 -20.2 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 114.82 -0.69 . . . . 0.0 111.091 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.426 ' N ' ' C ' ' B' ' 385' ' ' GLY . 4.6 mm-40 -83.05 -39.16 21.58 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' B' ' 385' ' ' GLY . 49.1 mt -76.58 -42.55 34.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.634 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.761 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.46 -42.53 61.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.306 -1.315 . . . . 0.0 113.604 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.453 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 12.3 pt20 -63.56 -34.72 78.43 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.001 0.905 . . . . 0.0 111.04 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.33 -53.6 10.4 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.85 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -49.02 -55.61 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.485 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -53.14 -33.61 53.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.684 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.05 -17.71 62.46 Favored Glycine 0 CA--C 1.505 -0.538 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.669 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.2 m-30 -87.07 -37.15 17.7 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.497 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.58 -13.36 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-O 122.211 1.005 . . . . 0.0 109.371 176.121 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.01 -22.62 45.23 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.525 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' B' ' 395' ' ' TYR . 71.4 mt -91.76 -62.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.998 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.31 -20.75 27.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.322 -176.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.79 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.55 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.3 mm? . . . . . 0 CA--C 1.522 -0.133 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -39.22 79.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.462 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.06 -43.86 98.16 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.516 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 88.8 mt-10 . . . . . 0 C--N 1.328 -0.335 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 71.3 t . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.778 0.323 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.28 153.26 25.1 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.1 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -129.39 135.44 48.71 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -139.1 129.43 25.55 Favored 'General case' 0 C--N 1.347 0.485 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.522 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.886 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.33 105.73 13.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 123.825 1.774 . . . . 0.0 109.402 178.348 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' B' ' 328' ' ' ARG . 33.0 m -116.98 161.11 15.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 112.564 -2.107 . . . . 0.0 110.122 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -103.5 145.34 30.15 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' B' ' 326' ' ' VAL . 27.1 tt0 . . . . . 0 C--N 1.314 -0.943 0 CA-C-O 122.119 0.961 . . . . 0.0 112.606 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t . . . . . 0 N--CA 1.441 -0.903 0 CA-C-O 119.143 -0.456 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.453 ' O ' HG12 ' B' ' 326' ' ' VAL . 62.4 Cg_exo -44.76 145.56 2.77 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 N-CA-C 108.029 -1.566 . . . . 0.0 108.029 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.649 ' N ' ' O ' ' B' ' 315' ' ' VAL . 4.2 ttm180 -150.59 -173.45 4.47 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 119.518 -0.873 . . . . 0.0 108.76 -177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.65 122.38 12.62 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.829 HD12 ' O ' ' B' ' 338' ' ' MET . 27.7 tp -101.69 157.87 16.52 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.434 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.29 107.92 0.53 Allowed Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 330' ' ' LEU . 31.1 mm -88.56 124.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.723 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.4 p -118.44 138.2 52.63 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.34 14.58 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.872 0.368 . . . . 0.0 111.331 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' B' ' 333' ' ' THR . 12.9 pt-20 -145.37 -2.88 0.75 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.459 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.88 179.66 1.93 Allowed 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.322 1.058 . . . . 0.0 113.088 -176.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.593 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.1 t -137.36 146.43 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 113.276 -1.784 . . . . 0.0 106.535 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.829 ' O ' HD12 ' B' ' 330' ' ' LEU . 4.0 ptt? -154.76 149.63 26.7 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 117.056 -1.857 . . . . 0.0 114.274 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.528 ' NH2' ' OE2' ' B' ' 317' ' ' GLU . 15.6 mtp180 -94.55 107.73 19.71 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.633 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.89 149.88 5.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.207 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 28.7 t0 -89.45 92.02 8.95 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.729 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.49 -28.79 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.745 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.7 mttm -75.21 -43.61 50.88 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.732 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.555 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.32 -12.34 14.77 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm 66.58 -1.09 1.37 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 109.962 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.4 mt-10 -84.55 153.33 23.32 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.36 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.589 HG21 ' SD ' ' B' ' 338' ' ' MET . 82.3 t -83.29 135.16 25.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.497 0.665 . . . . 0.0 112.285 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 67.2 mt -103.54 -30.17 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.407 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.468 ' O ' ' CB ' ' B' ' 338' ' ' MET . 23.5 tt0 -140.6 156.46 46.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.675 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -145.66 149.87 35.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.517 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.548 ' O ' ' N ' ' B' ' 337' ' ' VAL . 65.3 t-105 -162.82 134.87 5.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.711 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.499 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -53.13 139.39 28.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.496 0.665 . . . . 0.0 111.425 -178.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.639 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -78.77 -36.04 43.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 354' ' ' THR . . . . . 0.563 HG22 ' O ' ' B' ' 354' ' ' THR . 21.6 m -73.16 9.13 1.33 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.901 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.499 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.2 m-20 -113.52 -1.99 13.98 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.157 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.515 HD12 HD23 ' B' ' 353' ' ' LEU . 66.1 mt -61.17 145.6 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.182 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 357' ' ' LYS . . . . . 0.457 ' HZ2' ' HB3' ' B' ' 372' ' ' ASP . 5.6 tttt -104.38 -45.72 4.59 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.515 0.674 . . . . 0.0 109.21 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.7 ptt180 -174.92 136.19 0.39 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.514 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.4 p90 -118.89 174.71 6.13 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.227 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.64 99.38 1.72 Allowed 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 119.28 -0.968 . . . . 0.0 112.11 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.771 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.83 146.99 30.62 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.856 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.536 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -135.35 173.64 5.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -77.02 -8.15 17.6 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.003 1.802 . . . . 0.0 112.221 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' B' ' 382' ' ' THR . 23.0 mttt -131.02 -21.91 2.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.048 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.677 ' HA ' ' H ' ' B' ' 382' ' ' THR . 79.0 p -150.33 168.88 22.79 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.6 0.714 . . . . 0.0 111.895 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.504 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -141.09 156.79 45.93 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.75 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.55 ' CG2' HD12 ' A' ' 15' ' ' LEU . 39.7 m -147.54 156.55 42.94 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.942 -174.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.46 ' N ' HG22 ' B' ' 367' ' ' THR . 5.6 mt -129.56 141.87 50.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.628 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 21.1 t0 -118.19 95.59 4.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.677 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.524 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 11.3 p90 -136.23 93.98 2.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.657 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.49 12.45 1.8 Allowed Glycine 0 C--O 1.226 -0.349 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 372' ' ' ASP . . . . . 0.457 ' HB3' ' HZ2' ' B' ' 357' ' ' LYS . 9.2 t0 -41.79 -16.15 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.12 -0.54 . . . . 0.0 111.721 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.5 -37.38 65.24 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.48 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.5 OUTLIER -125.76 -92.5 0.51 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.169 176.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.48 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.6 t70 -129.41 96.3 4.25 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.37 -3.01 55.61 Favored Glycine 0 C--N 1.313 -0.714 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.217 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.689 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.93 106.16 16.92 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -175.655 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.54 126.66 52.96 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.77 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 47.2 t -138.47 164.55 29.1 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.6 0.714 . . . . 0.0 112.679 -177.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.64 174.13 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.971 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -100.91 125.12 47.44 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.94 0.876 . . . . 0.0 111.128 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.677 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.41 137.45 14.62 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.827 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 383' ' ' THR . . . . . 0.415 ' N ' ' OE2' ' B' ' 384' ' ' GLU . 0.8 OUTLIER -84.83 -1.13 56.06 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.975 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 384' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -123.93 84.0 2.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.038 0.923 . . . . 0.0 108.71 175.016 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.24 -58.5 1.97 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.507 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.8 pt-20 -46.81 -20.6 0.14 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 114.696 -0.752 . . . . 0.0 110.982 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 387' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -80.95 -39.09 26.64 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.504 HG21 ' CE2' ' B' ' 366' ' ' PHE . 49.4 mt -77.06 -42.42 31.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.615 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.771 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.97 -42.4 60.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.308 -1.314 . . . . 0.0 113.506 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.57 -34.74 78.47 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.049 0.928 . . . . 0.0 111.047 -177.485 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.25 -53.49 10.74 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.894 -1.503 . . . . 0.0 108.815 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.9 mt -48.94 -55.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.483 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.84 -34.06 52.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 112.732 -2.031 . . . . 0.0 110.651 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.95 -17.58 62.91 Favored Glycine 0 CA--C 1.505 -0.543 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.667 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.2 m-30 -87.14 -37.2 17.57 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.514 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.51 -13.16 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 CA-C-O 122.1 0.952 . . . . 0.0 109.236 176.222 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -79.26 -22.73 44.32 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.51 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' B' ' 395' ' ' TYR . 70.9 mt -91.62 -61.76 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 114.001 -1.454 . . . . 0.0 112.051 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.75 -20.51 27.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.419 -1.719 . . . . 0.0 112.375 -176.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.56 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 N--CA 1.467 0.424 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.802 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.551 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.2 mm? . . . . . 0 CA--C 1.52 -0.194 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -58.81 -39.1 80.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.636 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.41 -43.3 99.25 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.979 0.419 . . . . 0.0 109.97 178.402 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 68.9 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.773 0.321 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.07 153.3 24.84 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -130.2 135.17 47.86 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.012 0.195 . . . . 0.0 111.514 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -138.14 130.0 28.35 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.519 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.87 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -83.49 103.56 12.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 123.92 1.819 . . . . 0.0 109.308 178.413 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.7 m -113.7 162.05 12.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 112.579 -2.101 . . . . 0.0 110.309 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -105.32 147.1 28.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' B' ' 326' ' ' VAL . 26.3 tt0 . . . . . 0 C--N 1.312 -1.059 0 CA-C-O 122.02 0.914 . . . . 0.0 112.639 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t . . . . . 0 N--CA 1.44 -0.95 0 CA-C-O 119.166 -0.445 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.432 ' O ' HG12 ' B' ' 326' ' ' VAL . 61.2 Cg_exo -44.8 145.95 2.6 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 N-CA-C 108.07 -1.55 . . . . 0.0 108.07 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.67 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.2 ttt180 -149.92 -174.21 4.64 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 119.529 -0.868 . . . . 0.0 108.689 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.616 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.34 122.64 12.29 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -176.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.831 HD12 ' O ' ' B' ' 338' ' ' MET . 25.8 tp -102.12 158.13 16.39 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.435 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.16 108.1 0.54 Allowed Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.744 HD11 HD21 ' B' ' 330' ' ' LEU . 31.3 mm -88.64 123.97 41.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.725 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.8 p -118.52 137.45 53.2 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.99 13.65 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.944 0.402 . . . . 0.0 111.667 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.725 ' H ' ' C ' ' B' ' 333' ' ' THR . 7.9 pt-20 -144.61 -2.68 0.84 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.711 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.89 179.0 2.06 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.404 1.097 . . . . 0.0 113.072 -176.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.602 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.3 t -136.84 146.17 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 CA-C-N 113.252 -1.795 . . . . 0.0 106.4 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.831 ' O ' HD12 ' B' ' 330' ' ' LEU . 4.0 ptt? -154.24 150.08 27.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 117.153 -1.819 . . . . 0.0 114.409 -176.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.538 ' NH2' HG21 ' B' ' 315' ' ' VAL . 2.8 mtp85 -95.08 107.86 19.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.54 176.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.7 t -99.49 150.22 5.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.304 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 344' ' ' THR . 32.8 t0 -90.72 92.35 8.78 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.767 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.54 -28.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.599 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' B' ' 341' ' ' ASP . 20.5 mttp -74.66 -43.56 54.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.688 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.45 -12.53 14.7 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 345' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.3 OUTLIER 66.34 -1.21 1.27 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.035 0.445 . . . . 0.0 110.023 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.6 mt-10 -84.79 152.1 23.89 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.332 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.613 HG21 ' SD ' ' B' ' 338' ' ' MET . 76.7 t -82.76 134.75 26.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.51 0.671 . . . . 0.0 112.305 -178.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 20.9 mm -102.71 -31.12 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.276 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.466 ' O ' ' CB ' ' B' ' 338' ' ' MET . 30.7 tt0 -139.79 156.86 46.53 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.611 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -145.75 149.41 34.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.249 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.539 ' O ' ' N ' ' B' ' 337' ' ' VAL . 64.2 t-105 -162.08 135.05 6.02 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.057 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.514 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.39 139.42 24.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.432 0.634 . . . . 0.0 111.379 -178.704 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.63 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -79.57 -35.79 39.2 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.53 11.08 1.09 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.825 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.514 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -114.41 -4.5 12.94 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.027 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.474 HD12 HD23 ' B' ' 353' ' ' LEU . 69.6 mt -57.62 147.8 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.468 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 357' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 11.7 tptt -105.46 -45.7 4.38 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.502 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.6 ptt180 -175.38 135.98 0.34 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.481 ' CH2' HD12 ' B' ' 396' ' ' ILE . 12.2 p90 -118.91 173.66 6.75 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.172 -177.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.46 99.74 1.77 Allowed 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.018 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.776 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.04 147.66 30.05 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.783 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.535 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -135.99 173.56 5.51 Favored Pre-proline 0 N--CA 1.453 -0.282 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -77.06 -8.68 17.77 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.133 1.888 . . . . 0.0 112.022 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 20.6 mtpt -130.77 -21.38 2.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.96 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.659 ' HA ' ' H ' ' B' ' 382' ' ' THR . 88.9 p -150.47 169.57 21.16 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.574 0.702 . . . . 0.0 111.932 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.496 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -142.12 156.61 45.38 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.566 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.551 ' CG2' HD12 ' A' ' 15' ' ' LEU . 44.1 m -147.3 156.72 43.18 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.877 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.462 ' N ' HG22 ' B' ' 367' ' ' THR . 5.7 mt -129.78 141.35 50.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.544 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 21.9 t0 -117.66 95.72 5.07 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.722 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.508 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 8.1 p90 -136.78 94.27 2.96 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.581 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 133.02 12.77 1.64 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 372' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.5 t0 -42.08 -15.92 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.979 -0.61 . . . . 0.0 111.852 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.41 -37.68 65.36 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.47 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.57 -92.11 0.52 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.356 176.679 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.47 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.4 t70 -129.91 96.16 4.14 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -99.93 -3.52 55.88 Favored Glycine 0 C--N 1.311 -0.812 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.261 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.69 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.09 106.17 17.03 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -175.71 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.69 126.07 51.82 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.647 176.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 47.1 t -138.55 163.45 31.97 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.676 0.751 . . . . 0.0 112.849 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.51 172.89 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.196 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -99.45 125.91 45.27 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.764 0.792 . . . . 0.0 111.192 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.659 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.59 136.28 14.38 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.976 -1.465 . . . . 0.0 109.868 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.67 16.63 4.54 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.185 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.08 83.54 1.74 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.943 174.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -57.89 2.06 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.4 pt-20 -45.12 -20.58 0.05 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 114.905 -0.648 . . . . 0.0 110.964 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.422 ' N ' ' C ' ' B' ' 385' ' ' GLY . 5.6 mm-40 -82.26 -39.27 23.23 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' B' ' 385' ' ' GLY . 47.5 mt -76.54 -42.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.609 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.776 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.33 -42.36 62.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.559 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.412 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 12.5 pt20 -63.56 -34.88 78.79 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 122.082 0.944 . . . . 0.0 111.029 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.648 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.85 -53.49 11.29 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.819 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.648 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.35 -55.98 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.477 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.37 -33.74 44.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 112.761 -2.018 . . . . 0.0 110.701 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.26 -17.8 61.92 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.674 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -87.15 -36.96 17.76 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.481 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.72 -13.19 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 CA-C-O 122.175 0.988 . . . . 0.0 109.297 176.104 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.56 -22.65 46.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.475 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.1 mt -91.8 -61.98 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.067 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.54 -20.41 27.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.338 -1.756 . . . . 0.0 112.315 -176.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.557 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.494 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.793 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.553 HD12 ' CG2' ' B' ' 367' ' ' THR . 3.8 mm? . . . . . 0 N--CA 1.461 0.089 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -41.17 87.66 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.99 -44.36 97.28 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.515 ' OE2' ' CD2' ' B' ' 377' ' ' TYR . 85.6 mt-10 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 120.995 0.426 . . . . 0.0 109.933 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 72.2 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.794 0.33 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.47 153.04 25.6 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.064 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -128.87 135.18 48.73 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.125 0.266 . . . . 0.0 111.42 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -139.15 129.52 25.59 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.795 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.883 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.47 104.86 12.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 123.717 1.723 . . . . 0.0 109.154 178.242 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.621 HG12 ' HB ' ' B' ' 382' ' ' THR . 34.1 m -120.82 156.02 24.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 112.815 -1.993 . . . . 0.0 110.278 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -93.37 138.34 31.8 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.27 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' B' ' 326' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.314 -0.973 0 CA-C-O 121.918 0.866 . . . . 0.0 112.881 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.0 t . . . . . 0 N--CA 1.445 -0.678 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.482 ' C ' ' O ' ' B' ' 326' ' ' VAL . 78.1 Cg_exo -37.89 140.26 0.29 Allowed 'Trans proline' 0 CA--C 1.506 -0.882 0 N-CA-C 108.535 -1.371 . . . . 0.0 108.535 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' B' ' 315' ' ' VAL . 1.6 tpt180 -152.98 -172.22 4.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.574 -0.85 . . . . 0.0 108.731 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.628 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.33 123.63 13.82 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.089 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 338' ' ' MET . 27.7 tp -103.11 158.27 16.42 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.151 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.427 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.24 107.71 0.52 Allowed Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.769 HD11 HD21 ' B' ' 330' ' ' LEU . 31.6 mm -88.33 123.03 40.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.729 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.2 p -117.28 138.02 52.02 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -57.26 13.6 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.015 0.436 . . . . 0.0 111.779 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.729 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.5 pt-20 -144.45 -2.69 0.85 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.955 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.97 178.89 2.06 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 122.315 1.055 . . . . 0.0 113.059 -177.051 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.609 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.47 146.09 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.042 0 CA-C-N 113.312 -1.767 . . . . 0.0 106.587 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.836 ' O ' HD12 ' B' ' 330' ' ' LEU . 2.3 ptt? -154.06 149.84 27.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 117.09 -1.844 . . . . 0.0 114.324 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.43 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 45.8 mtm180 -94.51 107.7 19.66 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.645 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.628 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.34 149.84 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.124 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' B' ' 344' ' ' THR . 32.0 t0 -89.53 92.6 9.17 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.884 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.56 -28.58 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.732 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 14.8 mttp -75.0 -43.79 51.86 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.73 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.554 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.41 -12.84 14.68 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 11.5 tttt 66.54 -0.75 1.45 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.048 0.452 . . . . 0.0 110.049 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.8 mt-10 -85.15 152.22 23.53 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.311 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.631 HG21 ' SD ' ' B' ' 338' ' ' MET . 82.5 t -83.83 135.14 25.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.528 0.68 . . . . 0.0 112.253 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -104.55 -30.93 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.414 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.467 ' O ' ' CB ' ' B' ' 338' ' ' MET . 38.2 tt0 -138.01 154.9 49.29 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.516 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -145.32 149.83 35.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.37 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.549 ' O ' ' N ' ' B' ' 337' ' ' VAL . 63.0 t-105 -161.99 135.06 6.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.753 177.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.78 139.1 27.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.424 0.631 . . . . 0.0 111.32 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.625 HD12 ' O ' ' B' ' 333' ' ' THR . 1.8 tt -79.47 -35.6 40.06 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.83 11.28 1.11 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.888 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.7 m-20 -114.65 -4.19 12.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.191 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.494 HD12 HD23 ' B' ' 353' ' ' LEU . 74.0 mt -57.99 148.53 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.155 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 357' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 10.3 tttt -106.42 -45.12 4.35 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.1 ptt180 -175.64 136.52 0.33 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.365 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.475 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.5 p90 -119.53 174.14 6.57 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.224 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.02 98.83 1.78 Allowed 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.039 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.784 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.68 147.09 30.78 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.803 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -136.36 173.78 5.22 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.724 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -77.24 -8.26 17.4 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.038 1.825 . . . . 0.0 112.205 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.6 mttt -130.6 -21.43 2.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.073 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.657 ' HA ' ' H ' ' B' ' 382' ' ' THR . 94.4 p -151.74 168.75 24.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.658 0.742 . . . . 0.0 111.858 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -140.64 157.07 45.99 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.84 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.553 ' CG2' HD12 ' A' ' 15' ' ' LEU . 62.7 m -146.79 158.64 43.96 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.848 -174.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.524 ' N ' HG22 ' B' ' 367' ' ' THR . 5.6 mt -132.41 140.11 48.32 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.519 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 19.7 t0 -117.0 96.03 5.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.634 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' B' ' 370' ' ' PHE . 5.9 p90 -137.25 94.11 2.9 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.555 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.58 12.68 1.74 Allowed Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 372' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 8.8 t0 -41.97 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.108 -0.546 . . . . 0.0 111.682 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.3 m-85 -54.43 -37.24 64.9 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.471 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -126.09 -92.67 0.5 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.093 176.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.471 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.3 t70 -129.32 96.21 4.24 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -99.98 -3.13 55.96 Favored Glycine 0 C--N 1.315 -0.605 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.223 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.25 105.68 16.79 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -175.581 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.18 127.68 54.35 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.557 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.434 ' OG ' ' OG1' ' B' ' 367' ' ' THR . 22.6 t -137.48 157.83 45.71 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.313 0.578 . . . . 0.0 112.23 -177.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 380' ' ' VAL . . . . . 0.433 ' CG1' ' CD ' ' B' ' 317' ' ' GLU . 2.5 m -142.09 171.86 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.047 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -100.84 125.99 47.4 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.964 0.887 . . . . 0.0 110.991 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.657 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -156.01 137.59 14.13 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.876 179.046 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.43 15.54 6.44 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.132 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.93 84.54 1.78 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.065 175.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -56.35 2.32 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.4 pt-20 -45.07 -20.18 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 114.797 -0.702 . . . . 0.0 111.025 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' B' ' 385' ' ' GLY . 2.5 mm-40 -82.96 -39.39 21.46 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' B' ' 385' ' ' GLY . 46.3 mt -76.85 -42.44 33.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.669 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.784 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.37 -42.18 62.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.665 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.436 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 15.7 pt20 -63.93 -34.89 78.99 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.032 0.92 . . . . 0.0 110.965 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.8 -53.69 10.84 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.783 -179.322 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.14 -56.1 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.59 -33.8 47.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 112.819 -1.991 . . . . 0.0 110.662 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.98 -17.87 62.29 Favored Glycine 0 CA--C 1.507 -0.444 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.675 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.01 -36.79 18.02 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.475 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.74 -13.21 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-O 122.157 0.98 . . . . 0.0 109.258 176.101 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.64 -22.54 46.74 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.712 -1.585 . . . . 0.0 109.459 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.675 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.8 mt -91.82 -62.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.968 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.43 -20.43 27.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.347 -177.026 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.56 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.765 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.556 HD12 HG21 ' B' ' 367' ' ' THR . 4.4 mm? . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -42.67 94.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.708 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.22 92.86 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 C--N 1.326 -0.42 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.683 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.776 0.322 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.58 153.45 26.28 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.221 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -130.04 134.08 47.16 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.042 0.214 . . . . 0.0 111.46 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -139.26 128.48 23.99 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.656 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.84 107.15 13.4 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 123.769 1.747 . . . . 0.0 109.396 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.666 HG12 ' HB ' ' B' ' 382' ' ' THR . 30.3 m -119.13 160.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.096 -176.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -102.11 145.25 29.62 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.559 ' CD ' ' HE ' ' B' ' 339' ' ' ARG . 26.6 tt0 . . . . . 0 C--N 1.312 -1.038 0 CA-C-O 122.005 0.907 . . . . 0.0 112.708 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' B' ' 317' ' ' GLU . 5.7 t . . . . . 0 N--CA 1.44 -0.965 0 CA-C-O 119.112 -0.471 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.421 ' O ' HG12 ' B' ' 326' ' ' VAL . 68.1 Cg_exo -44.18 144.14 3.01 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 N-CA-C 108.096 -1.54 . . . . 0.0 108.096 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' B' ' 315' ' ' VAL . 13.9 ttt180 -150.41 -173.23 4.39 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.71 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -141.41 120.76 13.11 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.103 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.835 HD12 ' O ' ' B' ' 338' ' ' MET . 32.0 tp -98.67 158.17 15.79 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.223 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.56 108.5 0.53 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.73 HD11 HD21 ' B' ' 330' ' ' LEU . 29.4 mm -87.98 123.58 40.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.723 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.98 138.05 52.45 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 14.65 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.697 0.284 . . . . 0.0 111.442 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.5 pt-20 -144.53 -4.36 0.78 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.561 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.48 177.35 2.19 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.412 1.101 . . . . 0.0 112.915 -176.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.0 t -132.5 145.4 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 113.148 -1.842 . . . . 0.0 106.401 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.835 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.93 150.61 29.44 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 117.199 -1.801 . . . . 0.0 114.568 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.559 ' HE ' ' CD ' ' B' ' 317' ' ' GLU . 0.4 OUTLIER -96.24 106.86 19.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.515 176.589 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.13 150.1 4.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.299 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.5 t0 -87.97 91.62 8.83 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.694 -178.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.43 -28.32 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.619 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 24.0 mttp -75.52 -43.94 46.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.725 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.556 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.61 -13.7 14.77 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 15.3 tttt 68.0 -0.41 2.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.98 0.419 . . . . 0.0 109.933 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.9 mt-10 -86.66 152.9 22.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.619 HG21 ' SD ' ' B' ' 338' ' ' MET . 89.7 t -81.61 133.96 28.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.5 0.667 . . . . 0.0 112.276 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 348' ' ' ILE . . . . . 0.54 HG21 HH22 ' B' ' 328' ' ' ARG . 1.2 mm -104.14 -30.76 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.225 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' B' ' 338' ' ' MET . 15.7 tt0 -138.74 157.23 46.47 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.489 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -143.4 150.55 39.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.233 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.52 124.31 4.01 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.942 177.644 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.403 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.69 140.92 3.14 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.42 0.628 . . . . 0.0 111.612 -178.506 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.594 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -84.36 -36.32 22.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 354' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' B' ' 400' ' ' LEU . 6.0 t -73.5 9.54 1.33 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.906 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.571 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 4.3 m-20 -111.13 -7.28 14.49 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.0 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.487 HD12 HD23 ' B' ' 353' ' ' LEU . 78.0 mt -56.91 146.41 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 120.444 -0.503 . . . . 0.0 111.766 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 357' ' ' LYS . . . . . 0.506 ' NZ ' ' OH ' ' B' ' 373' ' ' TYR . 9.0 tttp -107.6 -46.03 3.92 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.5 ptt-85 -172.97 135.76 0.63 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.522 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.1 p90 -119.15 176.56 5.25 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.186 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.37 98.94 1.59 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 119.176 -1.009 . . . . 0.0 111.877 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.64 145.73 31.52 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.563 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -134.09 173.73 5.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.735 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.38 -8.21 17.23 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.175 1.917 . . . . 0.0 112.069 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' B' ' 382' ' ' THR . 26.0 mttt -130.51 -21.3 2.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.942 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.66 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.3 p -151.94 167.79 27.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.601 0.715 . . . . 0.0 111.883 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.453 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.19 156.49 47.07 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.549 179.557 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.556 HG21 HD12 ' A' ' 15' ' ' LEU . 25.1 m -148.43 154.81 40.39 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 118.947 -1.101 . . . . 0.0 113.068 -174.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.6 mt -125.64 140.09 53.02 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.329 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 9.7 t0 -117.56 95.5 4.98 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.875 176.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 27.6 t80 -137.75 95.16 3.0 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.89 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.96 12.17 1.96 Allowed Glycine 0 C--O 1.225 -0.413 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 372' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.6 t0 -41.73 -16.36 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.911 -0.645 . . . . 0.0 112.057 -178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.539 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.0 m-85 -54.35 -37.83 65.37 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.468 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.66 -92.16 0.51 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.522 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.468 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 7.5 t0 -130.02 96.29 4.16 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.14 -3.31 54.39 Favored Glycine 0 C--N 1.306 -1.131 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.405 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.68 107.11 16.71 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -175.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -115.39 120.66 40.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.742 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.2 t -138.49 163.35 32.19 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.788 0.804 . . . . 0.0 113.103 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.97 175.56 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.299 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -101.74 124.4 47.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.039 0.923 . . . . 0.0 110.728 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.666 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -154.46 136.86 14.97 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.883 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.62 17.59 4.55 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.251 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.16 83.58 1.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.949 174.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -58.85 1.92 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.0 pt-20 -44.49 -20.08 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.904 -0.648 . . . . 0.0 111.022 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.437 ' N ' ' C ' ' B' ' 385' ' ' GLY . 62.4 mt-30 -83.13 -39.55 20.93 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.9 mt -76.54 -42.02 34.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.654 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.63 -42.69 61.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.503 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 15.7 pt20 -63.63 -34.62 78.24 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 122.036 0.922 . . . . 0.0 111.05 -177.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.96 -53.16 10.7 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.811 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -49.12 -55.12 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.484 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.19 -34.32 44.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.657 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.86 -17.99 62.31 Favored Glycine 0 CA--C 1.504 -0.611 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.692 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.72 -36.65 18.54 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.522 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.32 -13.02 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-O 122.123 0.963 . . . . 0.0 109.226 176.202 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.51 -23.07 43.18 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.465 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' B' ' 395' ' ' TYR . 74.2 mt -90.34 -59.95 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.573 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.493 ' O ' ' C ' ' B' ' 400' ' ' LEU . 0.7 OUTLIER -69.1 -19.58 23.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.266 -177.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.493 ' C ' ' O ' ' B' ' 399' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.381 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.551 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? . . . . . 0 N--CA 1.463 0.186 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -37.35 64.61 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.12 -50.68 61.19 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 120.986 0.422 . . . . 0.0 110.023 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 74.9 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.761 0.315 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.5 153.65 24.78 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.113 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -127.7 135.42 50.16 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.158 0.286 . . . . 0.0 111.587 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -139.96 127.36 21.4 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.572 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.911 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.77 107.72 13.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 123.751 1.739 . . . . 0.0 109.314 178.505 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.692 HG12 ' HB ' ' B' ' 382' ' ' THR . 31.3 m -120.18 162.6 18.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 112.658 -2.065 . . . . 0.0 110.097 -176.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -104.0 145.61 29.9 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' B' ' 326' ' ' VAL . 44.0 tt0 . . . . . 0 C--N 1.314 -0.951 0 CA-C-O 122.033 0.92 . . . . 0.0 112.627 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' B' ' 317' ' ' GLU . 14.4 t . . . . . 0 N--CA 1.44 -0.929 0 CA-C-O 119.113 -0.47 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.426 ' O ' HG12 ' B' ' 326' ' ' VAL . 68.0 Cg_exo -44.39 144.11 3.28 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.618 ' N ' ' O ' ' B' ' 315' ' ' VAL . 11.2 ttm-85 -150.08 -173.59 4.48 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.696 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.16 120.49 13.07 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.145 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.835 HD12 ' O ' ' B' ' 338' ' ' MET . 31.7 tp -99.04 157.9 16.03 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.249 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.2 108.04 0.52 Allowed Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.711 HD11 HD21 ' B' ' 330' ' ' LEU . 30.7 mm -87.82 122.91 40.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.722 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.9 p -117.09 138.55 51.55 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.79 15.83 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.747 0.308 . . . . 0.0 111.354 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.722 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.1 pt-20 -145.72 -4.5 0.66 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.528 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.46 177.39 2.19 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.362 1.077 . . . . 0.0 113.011 -176.593 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.61 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 9.9 t -132.81 145.29 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 CA-C-N 113.16 -1.836 . . . . 0.0 106.254 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.835 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.0 OUTLIER -152.54 150.88 30.04 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 117.143 -1.823 . . . . 0.0 114.468 -175.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.532 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 62.6 mtm180 -96.13 106.77 19.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.524 176.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.7 t -96.76 150.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.278 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' B' ' 344' ' ' THR . 28.8 t0 -88.04 91.74 8.88 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.76 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.48 -28.38 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.617 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.8 mttm -75.18 -43.78 50.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.691 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.56 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.77 -13.98 14.68 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 14.7 tttp 68.29 -0.77 2.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.026 0.441 . . . . 0.0 109.958 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.9 mt-10 -86.3 152.83 22.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.35 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.623 HG21 ' SD ' ' B' ' 338' ' ' MET . 86.6 t -81.6 133.55 29.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.485 0.66 . . . . 0.0 112.178 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 11.9 mt -102.98 -31.02 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.319 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.532 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 21.8 tt0 -139.58 158.15 44.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.595 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -143.06 150.08 39.06 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.135 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.556 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.0 122.38 4.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.938 177.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 352' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.93 139.79 2.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.443 0.639 . . . . 0.0 111.624 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.6 HD12 ' O ' ' B' ' 333' ' ' THR . 1.7 tt -82.24 -37.28 26.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 354' ' ' THR . . . . . 0.523 HG22 ' O ' ' B' ' 354' ' ' THR . 19.7 m -70.67 6.76 1.32 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.799 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.587 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 5.2 m-20 -108.37 -4.84 17.06 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.106 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.534 HD12 HD23 ' B' ' 353' ' ' LEU . 70.5 mt -60.9 144.42 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.753 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -107.3 -45.95 3.99 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 7.2 ptt180 -172.43 135.7 0.74 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.546 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.6 p90 -119.08 176.35 5.34 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.208 -177.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.24 99.21 1.62 Allowed 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.961 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.787 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.25 145.4 30.96 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.573 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -133.71 173.96 5.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -77.39 -7.95 17.12 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.136 1.891 . . . . 0.0 112.131 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' B' ' 382' ' ' THR . 4.0 mtpp -130.61 -21.27 2.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.046 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.659 ' HA ' ' H ' ' B' ' 382' ' ' THR . 61.1 p -152.25 167.36 28.85 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.528 0.68 . . . . 0.0 111.903 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.469 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -138.79 156.63 47.18 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.504 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.551 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.2 m -148.57 154.47 39.81 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.014 -1.075 . . . . 0.0 113.02 -174.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.8 mt -125.32 140.77 52.53 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.355 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.8 t0 -118.06 95.6 4.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.464 -0.895 . . . . 0.0 110.821 176.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 18.6 t80 -137.38 94.85 2.98 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.936 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.01 12.41 1.91 Allowed Glycine 0 C--O 1.226 -0.405 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 372' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.2 t0 -41.89 -16.12 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.02 -0.59 . . . . 0.0 111.887 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.542 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.34 -37.94 65.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.463 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.32 -92.37 0.51 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.895 -1.502 . . . . 0.0 107.358 176.691 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 7.8 t70 -129.93 96.16 4.14 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.16 -2.92 54.48 Favored Glycine 0 C--N 1.31 -0.883 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.28 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.673 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.45 107.06 16.5 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -175.635 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 378' ' ' TYR . . . . . 0.422 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.7 OUTLIER -114.71 120.95 41.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.677 175.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.7 t -138.67 163.21 32.69 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.95 175.18 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.209 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -101.44 124.57 47.32 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.955 0.883 . . . . 0.0 110.863 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.692 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -154.88 136.91 14.66 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.937 179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.75 17.42 4.77 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.207 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.06 83.88 1.75 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.902 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.96 -58.19 2.04 Favored Glycine 0 C--O 1.223 -0.578 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.5 pt-20 -44.58 -20.06 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.814 -0.693 . . . . 0.0 111.083 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.439 ' N ' ' C ' ' B' ' 385' ' ' GLY . 41.5 mt-30 -83.04 -39.78 20.78 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' B' ' 385' ' ' GLY . 50.2 mt -76.74 -41.99 33.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.611 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.787 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.68 -42.37 61.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.293 -1.321 . . . . 0.0 113.532 -177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.462 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.3 pt20 -64.02 -34.65 78.5 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.076 0.941 . . . . 0.0 111.063 -177.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.96 -53.11 10.8 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.753 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -49.09 -55.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.492 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.98 -33.69 52.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.736 -2.029 . . . . 0.0 110.511 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.06 -17.71 62.45 Favored Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.677 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -86.91 -37.18 17.88 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.546 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.48 -13.15 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.112 0.958 . . . . 0.0 109.297 176.214 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.96 -22.67 45.33 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.437 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' B' ' 395' ' ' TYR . 69.6 mt -91.95 -61.9 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.126 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.64 -20.37 27.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.324 -176.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.565 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.637 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.546 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? . . . . . 0 N--CA 1.463 0.199 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.03 -43.26 99.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.619 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.26 89.2 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.724 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 85.3 t . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.781 0.324 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.68 153.29 26.64 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.202 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -130.09 134.64 47.49 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.052 0.22 . . . . 0.0 111.436 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -138.93 129.3 25.69 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.533 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.878 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.39 102.32 10.41 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 123.902 1.811 . . . . 0.0 109.503 178.544 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.647 HG12 ' HB ' ' B' ' 382' ' ' THR . 26.2 m -114.33 158.08 14.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 112.76 -2.018 . . . . 0.0 110.187 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -98.35 145.22 26.91 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' B' ' 326' ' ' VAL . 30.1 tt0 . . . . . 0 C--N 1.31 -1.121 0 CA-C-O 121.927 0.87 . . . . 0.0 112.435 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.6 t . . . . . 0 N--CA 1.44 -0.952 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.442 ' O ' HG12 ' B' ' 326' ' ' VAL . 71.2 Cg_exo -44.14 143.03 3.63 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 N-CA-C 107.939 -1.6 . . . . 0.0 107.939 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.637 HH21 ' CD1' ' B' ' 348' ' ' ILE . 2.2 tpt180 -148.52 -172.59 4.12 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.629 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.66 121.11 11.0 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.291 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 338' ' ' MET . 31.9 tp -99.4 158.61 15.6 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.198 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.432 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.34 108.34 0.52 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.767 HD11 HD21 ' B' ' 330' ' ' LEU . 29.9 mm -88.19 123.26 40.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.722 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.88 138.37 52.17 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.06 15.73 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.752 0.31 . . . . 0.0 111.251 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.722 ' H ' ' C ' ' B' ' 333' ' ' THR . 11.2 pt-20 -145.12 -4.75 0.71 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.525 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.62 177.28 2.15 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.425 1.107 . . . . 0.0 112.89 -176.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.61 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.9 t -132.56 145.3 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 CA-C-N 113.065 -1.88 . . . . 0.0 106.315 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.836 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.63 150.61 29.67 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 117.175 -1.81 . . . . 0.0 114.423 -175.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.507 ' NH1' ' OE1' ' B' ' 317' ' ' GLU . 26.3 mtm105 -95.74 107.01 19.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.481 176.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.629 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -96.57 150.04 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.274 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.6 t0 -88.19 91.4 8.77 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.668 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.4 -28.49 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.678 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.9 mttm -75.19 -43.96 49.18 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.704 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.559 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.95 -13.27 14.76 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 17.4 tttp 67.72 -0.9 1.8 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 109.988 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.5 mt-10 -85.69 152.07 23.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.346 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.624 HG21 ' SD ' ' B' ' 338' ' ' MET . 85.6 t -81.38 133.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.514 0.673 . . . . 0.0 112.209 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 348' ' ' ILE . . . . . 0.637 ' CD1' HH21 ' B' ' 328' ' ' ARG . 48.8 mt -103.83 -30.24 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.335 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.472 ' O ' ' CB ' ' B' ' 338' ' ' MET . 21.4 tt0 -139.72 157.41 45.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.639 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -143.35 149.98 38.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.321 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.554 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.87 124.12 4.27 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.102 177.601 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.516 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.54 140.63 3.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.394 0.616 . . . . 0.0 111.606 -178.537 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.595 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -84.16 -35.89 23.26 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -74.26 9.87 1.49 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.824 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.575 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.0 m-20 -111.46 -7.56 14.34 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.069 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.5 HD12 HD23 ' B' ' 353' ' ' LEU . 81.3 mt -55.95 146.9 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.805 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -107.83 -45.9 3.9 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.502 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.9 ptt-85 -173.02 135.72 0.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.479 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.0 p90 -119.61 176.28 5.45 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.195 -177.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.93 99.59 1.54 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.017 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.34 147.7 30.97 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.574 -1.193 . . . . 0.0 110.682 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -135.32 174.17 4.9 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -77.81 -8.13 16.74 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.137 1.892 . . . . 0.0 112.122 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' B' ' 382' ' ' THR . 5.6 mttm -130.74 -20.36 2.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.056 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.658 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.1 p -153.11 167.98 27.43 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.594 0.711 . . . . 0.0 111.934 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.42 156.46 46.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.618 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.546 ' CG2' HD12 ' A' ' 15' ' ' LEU . 26.0 m -148.51 154.81 40.32 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.03 -1.068 . . . . 0.0 113.081 -174.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.447 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.8 mt -125.82 140.0 53.03 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.362 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.6 t0 -117.4 95.6 5.04 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.654 176.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 30.5 t80 -137.93 94.94 2.95 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.985 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.85 12.11 1.99 Allowed Glycine 0 C--O 1.224 -0.51 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 372' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.3 t0 -41.61 -16.42 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.977 -0.612 . . . . 0.0 111.745 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.38 -37.33 64.88 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.47 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.06 -92.31 0.51 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.283 176.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.47 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.5 t70 -129.59 96.36 4.24 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.5 -3.34 53.28 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.21 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.677 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.21 106.79 16.11 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.752 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 378' ' ' TYR . . . . . 0.4 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.9 OUTLIER -114.53 120.3 39.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.748 176.104 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 34.8 t -138.68 163.91 30.9 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.54 175.81 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.15 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.76 124.29 47.15 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.904 0.859 . . . . 0.0 110.754 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.658 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.69 136.85 14.77 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.87 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.74 17.42 4.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.247 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.06 83.74 1.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.996 175.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.53 -58.24 1.97 Allowed Glycine 0 C--N 1.317 -0.498 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.1 pt-20 -44.81 -20.17 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 114.949 -0.625 . . . . 0.0 111.032 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 6.7 mm-40 -83.47 -38.87 21.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.2 mt -76.68 -42.2 34.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.613 177.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.69 -42.58 61.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.363 -1.289 . . . . 0.0 113.541 -177.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.443 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.9 pt20 -63.55 -34.45 77.83 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.051 0.929 . . . . 0.0 111.069 -177.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.02 -53.32 10.29 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.81 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.6 mt -49.21 -55.09 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 176.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.486 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.38 -34.1 46.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.55 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.79 -17.95 62.54 Favored Glycine 0 CA--C 1.506 -0.529 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.681 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.91 -36.93 18.1 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.479 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.28 -13.29 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 CA-C-O 122.151 0.976 . . . . 0.0 109.283 176.142 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.49 -22.62 47.19 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.741 -1.572 . . . . 0.0 109.447 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.7 mt -91.94 -61.85 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.901 -1.499 . . . . 0.0 112.037 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -65.12 -20.17 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.357 -176.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.555 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.454 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.838 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.559 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? . . . . . 0 CA--C 1.519 -0.243 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.84 -40.33 83.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.3 -42.03 99.72 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.491 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.4 mt-10 . . . . . 0 C--N 1.327 -0.381 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.772 0.32 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.02 153.7 25.22 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.099 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -127.79 135.57 50.28 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.1 0.25 . . . . 0.0 111.56 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -140.31 128.11 21.86 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.568 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.912 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.58 107.99 13.84 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 123.653 1.692 . . . . 0.0 109.477 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.649 HG12 ' HB ' ' B' ' 382' ' ' THR . 31.1 m -119.85 161.28 19.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 112.706 -2.043 . . . . 0.0 110.072 -176.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -102.58 146.02 28.78 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' B' ' 326' ' ' VAL . 20.5 tt0 . . . . . 0 C--N 1.313 -0.99 0 CA-C-O 121.993 0.902 . . . . 0.0 112.275 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.2 t . . . . . 0 N--CA 1.442 -0.873 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.434 ' O ' HG12 ' B' ' 326' ' ' VAL . 64.0 Cg_exo -44.87 145.09 3.13 Favored 'Trans proline' 0 C--N 1.32 -0.937 0 N-CA-C 108.088 -1.543 . . . . 0.0 108.088 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' B' ' 315' ' ' VAL . 12.5 ttm-85 -151.68 -172.89 4.35 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.62 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.21 121.13 13.59 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.094 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.834 HD12 ' O ' ' B' ' 338' ' ' MET . 31.9 tp -99.17 157.95 16.01 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.01 108.04 0.52 Allowed Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -87.96 122.19 39.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.727 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.2 p -116.56 138.2 51.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -57.59 14.09 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.031 0.443 . . . . 0.0 111.647 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.727 ' H ' ' C ' ' B' ' 333' ' ' THR . 16.2 pt-20 -144.2 -3.63 0.84 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.758 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.618 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.59 178.18 1.98 Allowed 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.386 1.089 . . . . 0.0 112.898 -176.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.618 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.0 t -134.18 144.72 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 113.106 -1.861 . . . . 0.0 106.386 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.834 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.6 ptt? -152.71 151.46 30.56 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 117.175 -1.81 . . . . 0.0 114.42 -175.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.18 106.69 18.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.385 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.651 ' N ' ' O ' ' B' ' 329' ' ' LEU . 3.0 t -96.1 149.26 4.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.293 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' B' ' 343' ' ' LYS . 46.0 t0 -87.26 90.49 8.38 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.854 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.8 OUTLIER -35.84 -28.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.686 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' B' ' 341' ' ' ASP . 15.9 mttp -70.49 -44.01 68.55 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.613 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -114.21 -17.55 11.84 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.729 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 345' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' B' ' 344' ' ' THR . 8.3 tttp 77.46 -0.0 2.87 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.458 ' O ' HG13 ' B' ' 340' ' ' VAL . 8.1 pt-20 -82.47 157.82 23.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.593 HG21 ' SD ' ' B' ' 338' ' ' MET . 90.3 t -87.38 131.69 34.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.363 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 348' ' ' ILE . . . . . 0.417 HD11 ' HB2' ' B' ' 341' ' ' ASP . 59.3 mt -101.35 -29.99 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.455 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.488 ' O ' ' CB ' ' B' ' 338' ' ' MET . 18.0 tt0 -140.81 158.23 44.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.626 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -143.79 151.25 39.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.232 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -160.31 124.83 3.75 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.19 177.768 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.502 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -47.09 139.42 5.86 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.448 0.642 . . . . 0.0 111.493 -178.803 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.583 HD12 ' O ' ' B' ' 333' ' ' THR . 1.9 tt -82.99 -35.67 25.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.2 t -74.15 9.69 1.52 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.935 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.57 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.1 m-20 -111.29 -7.67 14.4 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.992 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.467 HD12 HD23 ' B' ' 353' ' ' LEU . 78.9 mt -56.55 146.69 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.826 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -107.76 -45.12 4.08 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.503 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 10.3 ptt180 -173.79 136.1 0.54 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.513 ' CH2' HD12 ' B' ' 396' ' ' ILE . 7.9 p90 -119.09 177.24 4.94 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.23 -177.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.58 99.23 1.57 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.101 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.13 147.13 30.21 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.647 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -135.69 173.71 5.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -76.98 -8.39 17.74 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.088 1.858 . . . . 0.0 112.297 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.9 mttm -130.66 -20.76 2.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.057 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.652 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.3 p -152.47 167.67 28.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.572 0.701 . . . . 0.0 111.852 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.478 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.2 156.79 46.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.815 179.619 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.559 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.9 m -148.65 155.52 41.16 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.11 -1.036 . . . . 0.0 113.17 -174.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.8 mt -126.05 140.15 52.83 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.168 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 9.2 t0 -117.69 95.6 5.01 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.547 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 31.0 t80 -137.63 94.71 2.95 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.937 176.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.85 12.17 1.98 Allowed Glycine 0 C--O 1.225 -0.421 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 372' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.7 t0 -41.6 -16.16 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.953 -0.624 . . . . 0.0 111.818 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.45 -37.44 65.19 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.473 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.87 -92.59 0.5 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.909 -1.496 . . . . 0.0 107.187 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.473 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.5 t70 -129.34 96.18 4.23 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.24 -3.37 54.05 Favored Glycine 0 C--N 1.311 -0.851 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.256 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.02 106.73 15.9 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -175.605 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 378' ' ' TYR . . . . . 0.403 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.9 OUTLIER -114.05 120.38 40.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.759 175.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 34.7 t -138.46 163.87 30.83 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.679 0.752 . . . . 0.0 112.909 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -150.76 175.56 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.101 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -101.53 125.08 48.13 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.12 0.962 . . . . 0.0 110.799 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.652 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.22 136.51 14.0 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.831 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.22 17.35 4.38 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.175 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.04 83.94 1.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.936 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.98 -58.78 1.95 Allowed Glycine 0 C--O 1.223 -0.557 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.501 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.7 pt-20 -44.45 -20.87 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 114.787 -0.706 . . . . 0.0 111.027 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' B' ' 385' ' ' GLY . 51.1 mt-30 -82.37 -39.35 22.86 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 51.6 mt -76.59 -42.2 34.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.579 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.89 -42.57 60.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.534 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.81 -34.44 77.91 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.075 0.941 . . . . 0.0 111.105 -177.504 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.05 -53.42 10.02 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.73 -179.581 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -48.97 -55.56 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.487 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -51.96 -34.01 40.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.777 -2.01 . . . . 0.0 110.635 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.89 -18.16 61.9 Favored Glycine 0 CA--C 1.506 -0.491 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.684 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.5 m-30 -86.79 -36.82 18.34 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.513 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.42 -13.3 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 CA-C-O 122.195 0.998 . . . . 0.0 109.29 176.165 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.42 -22.6 47.5 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.512 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.5 mt -91.9 -62.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.003 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.68 -20.24 26.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.359 -1.746 . . . . 0.0 112.393 -176.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.715 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.558 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.6 mm? . . . . . 0 CA--C 1.521 -0.152 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 16' ' ' LEU . 74.5 mt -62.08 -43.75 98.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.79 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.35 -36.08 81.92 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.752 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 95.2 t . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.736 0.303 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.58 153.59 27.31 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -129.58 134.13 47.56 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.14 0.275 . . . . 0.0 111.45 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -138.93 128.01 23.88 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.615 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.896 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.06 106.09 12.78 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 123.762 1.744 . . . . 0.0 109.284 178.567 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.7 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.5 m -118.55 162.68 16.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 112.669 -2.059 . . . . 0.0 110.12 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -103.83 145.98 29.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' B' ' 326' ' ' VAL . 38.1 tt0 . . . . . 0 C--N 1.314 -0.942 0 CA-C-O 122.059 0.933 . . . . 0.0 112.538 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' B' ' 317' ' ' GLU . 19.6 t . . . . . 0 N--CA 1.44 -0.967 0 CA-C-O 119.158 -0.449 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.427 ' O ' HG12 ' B' ' 326' ' ' VAL . 67.8 Cg_exo -44.52 144.73 3.01 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 N-CA-C 108.117 -1.532 . . . . 0.0 108.117 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' B' ' 315' ' ' VAL . 8.1 ttm180 -151.18 -173.09 4.39 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 119.577 -0.849 . . . . 0.0 108.712 -177.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.12 121.47 13.99 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.209 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.832 HD12 ' O ' ' B' ' 338' ' ' MET . 33.3 tp -99.41 158.42 15.74 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.213 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.83 108.44 0.52 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 177.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.719 HD11 HD21 ' B' ' 330' ' ' LEU . 30.0 mm -87.91 123.96 40.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.728 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.42 138.38 52.5 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.83 14.71 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.122 0.487 . . . . 0.0 111.562 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.728 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.2 pt-20 -144.59 -4.11 0.78 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.805 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.13 176.77 2.03 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.323 1.059 . . . . 0.0 112.989 -176.696 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.615 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 9.5 t -132.58 145.8 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 CA-C-N 113.209 -1.814 . . . . 0.0 106.269 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.832 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.66 151.16 30.25 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 117.167 -1.813 . . . . 0.0 114.549 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -95.76 106.8 18.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.436 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.46 149.5 4.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.29 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' B' ' 343' ' ' LYS . 42.9 t0 -87.63 90.83 8.52 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.862 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.8 OUTLIER -36.24 -27.27 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.654 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.1 mttp -70.64 -43.17 69.78 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.672 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.533 ' N ' ' O ' ' B' ' 341' ' ' ASP . 26.6 p -115.59 -17.86 11.05 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 345' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' B' ' 344' ' ' THR . 10.3 tttm 78.16 1.19 2.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 110.126 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.445 ' O ' HG13 ' B' ' 340' ' ' VAL . 6.3 pt-20 -84.97 156.98 20.93 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.616 HG21 ' SD ' ' B' ' 338' ' ' MET . 91.7 t -86.69 132.87 31.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.508 0.67 . . . . 0.0 112.394 -178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 22.0 mm -102.6 -30.6 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.267 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.482 ' NE2' ' CZ3' ' B' ' 351' ' ' TRP . 6.8 tt0 -140.45 157.87 44.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.622 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -142.28 150.29 40.67 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.19 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -157.16 122.32 4.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.136 177.743 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.499 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.48 138.95 4.02 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.403 0.621 . . . . 0.0 111.503 -178.671 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.601 HD12 ' O ' ' B' ' 333' ' ' THR . 1.7 tt -81.66 -36.99 28.18 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 354' ' ' THR . . . . . 0.514 HG22 ' O ' ' B' ' 354' ' ' THR . 17.4 m -70.97 6.9 1.34 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.892 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.569 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.7 m-20 -108.55 -4.95 16.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.93 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.538 HD12 HD23 ' B' ' 353' ' ' LEU . 70.8 mt -60.65 144.16 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.743 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -107.3 -45.63 4.06 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.4 ptt-85 -172.43 135.77 0.74 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.541 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.7 p90 -118.95 175.51 5.72 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.119 -177.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.87 98.94 1.66 Allowed 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 119.199 -1.001 . . . . 0.0 111.891 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.79 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.16 149.54 29.07 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.839 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.522 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -137.86 174.99 3.72 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -78.42 -7.0 15.83 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.266 1.977 . . . . 0.0 112.134 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' B' ' 382' ' ' THR . 47.6 mttt -130.84 -22.53 2.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.001 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.644 ' HA ' ' H ' ' B' ' 382' ' ' THR . 63.8 p -152.74 165.94 33.74 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.653 0.74 . . . . 0.0 111.85 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.485 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -137.36 156.98 47.58 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.737 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.558 ' CG2' HD12 ' A' ' 15' ' ' LEU . 27.7 m -148.52 156.29 42.25 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.065 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.45 ' N ' HG22 ' B' ' 367' ' ' THR . 7.1 mt -126.71 141.45 51.84 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.435 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.4 t0 -118.44 95.41 4.86 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.691 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 17.6 t80 -137.18 94.85 3.0 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.951 176.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.79 12.24 1.98 Allowed Glycine 0 C--O 1.225 -0.412 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -41.73 -16.15 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.857 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.52 -37.51 65.45 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.466 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.82 -92.27 0.51 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.958 -1.473 . . . . 0.0 107.345 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.466 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 12.9 t0 -129.75 96.37 4.22 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.46 -2.7 53.56 Favored Glycine 0 C--N 1.311 -0.82 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.271 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.81 106.87 16.67 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -175.648 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.11 122.69 46.87 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.663 176.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 34.3 t -139.03 163.69 31.73 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.35 173.66 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.113 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -99.92 125.29 45.89 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.976 0.893 . . . . 0.0 110.872 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.7 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -155.21 136.39 13.91 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.912 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.09 16.83 4.66 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.296 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.19 84.1 1.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.992 175.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.76 -58.26 2.05 Favored Glycine 0 C--N 1.317 -0.487 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.9 pt-20 -44.73 -20.09 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 114.893 -0.653 . . . . 0.0 111.047 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.434 ' N ' ' C ' ' B' ' 385' ' ' GLY . 46.7 mt-30 -82.89 -39.76 21.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' B' ' 385' ' ' GLY . 51.4 mt -76.66 -41.84 34.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.687 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.79 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.86 -42.19 61.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.362 -1.29 . . . . 0.0 113.604 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.462 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.4 pt20 -64.19 -34.44 78.08 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.06 0.933 . . . . 0.0 111.047 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.09 -53.47 9.87 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.759 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -48.93 -55.28 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.491 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.6 -33.9 48.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 112.801 -2.0 . . . . 0.0 110.506 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.75 -17.98 62.55 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.68 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.91 -37.07 17.98 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.541 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.44 -13.14 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.911 0 CA-C-O 122.102 0.953 . . . . 0.0 109.325 176.191 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.04 -22.6 45.15 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.507 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.9 mt -91.83 -61.96 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-N 113.865 -1.516 . . . . 0.0 112.105 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.54 -20.54 27.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.38 -176.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.561 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.462 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.801 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.564 HD12 HG21 ' B' ' 367' ' ' THR . 4.3 mm? . . . . . 0 N--CA 1.463 0.206 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -39.34 81.73 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.57 -45.52 96.15 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.518 ' OE2' ' CD2' ' B' ' 377' ' ' TYR . 82.5 mt-10 . . . . . 0 C--O 1.222 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 69.2 t . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 120.835 0.35 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.44 153.1 25.49 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.081 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -128.99 134.76 48.29 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.037 0.211 . . . . 0.0 111.405 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -138.35 129.76 27.55 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.763 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.871 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.12 104.02 12.16 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 123.666 1.698 . . . . 0.0 109.283 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.598 ' O ' ' N ' ' B' ' 328' ' ' ARG . 34.7 m -120.27 157.27 22.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 112.867 -1.97 . . . . 0.0 110.167 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 316' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' B' ' 380' ' ' VAL . 7.0 mtmt -96.6 139.5 32.59 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.454 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' B' ' 326' ' ' VAL . 3.2 tt0 . . . . . 0 C--N 1.316 -0.866 0 CA-C-O 122.007 0.908 . . . . 0.0 113.061 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.4 t . . . . . 0 N--CA 1.444 -0.743 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.542 ' O ' ' NE ' ' B' ' 328' ' ' ARG . 80.1 Cg_exo -38.05 144.62 0.17 Allowed 'Trans proline' 0 CA--C 1.508 -0.816 0 N-CA-C 108.701 -1.307 . . . . 0.0 108.701 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' B' ' 315' ' ' VAL . 0.3 OUTLIER -157.15 -171.54 3.67 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.82 -176.572 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.643 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -142.81 124.38 14.88 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.155 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.832 HD12 ' O ' ' B' ' 338' ' ' MET . 27.9 tp -103.95 158.18 16.59 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.427 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.41 107.84 0.52 Allowed Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.758 HD11 HD21 ' B' ' 330' ' ' LEU . 31.6 mm -88.35 123.59 40.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.73 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.4 p -118.19 137.91 52.67 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -57.36 13.64 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.004 0.43 . . . . 0.0 111.793 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.73 ' H ' ' C ' ' B' ' 333' ' ' THR . 12.7 pt-20 -144.32 -2.85 0.86 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.991 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.601 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.9 178.72 2.12 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.307 1.051 . . . . 0.0 112.982 -177.07 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.601 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.38 145.6 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-N 113.338 -1.756 . . . . 0.0 106.682 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.832 ' O ' HD12 ' B' ' 330' ' ' LEU . 3.2 ptt? -153.95 149.49 27.33 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 117.062 -1.855 . . . . 0.0 114.356 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.529 ' NE ' ' OE1' ' B' ' 317' ' ' GLU . 12.1 mtp180 -94.14 107.65 19.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.666 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -98.73 149.71 5.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.2 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.9 t0 -89.6 92.27 9.02 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.815 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 341' ' ' ASP . 1.1 tt0 -35.46 -28.83 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.65 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' B' ' 341' ' ' ASP . 14.8 mttp -75.17 -43.62 51.19 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.704 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.555 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.2 -12.55 14.78 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 345' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' B' ' 341' ' ' ASP . 6.1 ttmt 66.67 -1.15 1.38 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.029 0.442 . . . . 0.0 109.961 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.459 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.5 mt-10 -84.71 153.53 23.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.322 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.596 HG21 ' SD ' ' B' ' 338' ' ' MET . 79.2 t -82.83 135.29 25.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.454 0.645 . . . . 0.0 112.288 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 66.0 mt -103.67 -30.39 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.424 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.473 ' O ' ' CB ' ' B' ' 338' ' ' MET . 10.2 tt0 -140.55 156.63 46.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.715 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -145.74 149.61 34.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.495 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' B' ' 337' ' ' VAL . 63.5 t-105 -162.79 135.15 5.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.892 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.503 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.57 138.75 27.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.411 -178.682 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.626 HD12 ' O ' ' B' ' 333' ' ' THR . 1.9 tt -79.03 -35.82 42.05 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.64 10.92 1.16 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.98 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.503 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.4 m-20 -114.23 -4.43 13.06 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.217 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.499 HD12 HD23 ' B' ' 353' ' ' LEU . 71.6 mt -57.48 147.81 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.068 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 357' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 26.8 tttt -105.84 -45.84 4.28 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 0.2 OUTLIER -174.45 136.3 0.46 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.405 177.272 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.478 ' CH2' HD12 ' B' ' 396' ' ' ILE . 10.0 p90 -119.99 173.64 6.95 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.256 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.73 99.72 1.73 Allowed 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 119.153 -1.019 . . . . 0.0 112.252 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.49 144.29 31.45 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.797 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.549 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -132.14 174.28 4.89 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -77.66 -8.63 17.06 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.165 1.91 . . . . 0.0 112.019 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.0 mtpp -130.95 -19.24 2.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.121 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.683 ' HA ' ' H ' ' B' ' 382' ' ' THR . 92.8 p -152.78 168.5 25.5 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.552 0.691 . . . . 0.0 112.062 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.506 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.2 OUTLIER -140.84 156.94 46.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.914 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.564 HG21 HD12 ' A' ' 15' ' ' LEU . 64.1 m -147.3 158.99 44.17 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.003 -174.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.534 ' N ' HG22 ' B' ' 367' ' ' THR . 5.8 mt -133.23 140.29 47.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.515 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 19.5 t0 -117.33 96.13 5.28 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.615 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.497 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 9.5 p90 -136.9 93.92 2.9 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.352 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.66 12.49 1.76 Allowed Glycine 0 C--O 1.227 -0.294 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -41.73 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.18 -0.51 . . . . 0.0 111.769 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.562 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.46 -37.44 65.2 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.47 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.5 OUTLIER -125.76 -92.87 0.5 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.111 176.889 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.47 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.4 t0 -129.05 96.27 4.29 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.13 -2.66 55.87 Favored Glycine 0 C--N 1.312 -0.78 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.245 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.38 105.44 16.71 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.463 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.79 127.44 54.34 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.431 ' OG ' ' OG1' ' B' ' 367' ' ' THR . 23.2 t -137.67 158.35 44.55 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.348 0.594 . . . . 0.0 112.349 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 380' ' ' VAL . . . . . 0.401 ' CB ' ' O ' ' B' ' 316' ' ' LYS . 2.4 m -141.72 172.63 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.004 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -103.35 124.62 49.03 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.896 0.855 . . . . 0.0 110.796 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.683 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.89 139.17 16.64 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.183 179.336 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.09 16.08 6.58 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.313 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.98 84.48 1.78 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.075 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.37 -56.93 2.18 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.7 pt-20 -44.98 -20.22 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 114.615 -0.792 . . . . 0.0 110.945 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' B' ' 385' ' ' GLY . 3.2 mm-40 -82.62 -39.76 21.71 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' B' ' 385' ' ' GLY . 45.0 mt -76.6 -42.38 34.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.763 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.4 -42.01 62.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.255 -1.339 . . . . 0.0 113.68 -177.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.437 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 15.6 pt20 -64.06 -34.83 78.92 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.975 -177.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.649 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.85 -53.75 10.61 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.664 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.649 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.2 -55.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.479 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.7 -33.69 48.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.852 -1.976 . . . . 0.0 110.697 178.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.01 -17.84 62.3 Favored Glycine 0 CA--C 1.506 -0.471 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -178.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.674 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.04 -36.99 17.88 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.478 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.65 -13.18 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 CA-C-O 122.18 0.99 . . . . 0.0 109.236 176.183 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.48 -22.62 47.23 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.511 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.7 mt -91.78 -62.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.978 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.39 -20.56 27.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.379 -177.058 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.558 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.82 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.561 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? . . . . . 0 CA--C 1.52 -0.186 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -39.63 80.03 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.09 -43.4 98.8 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.484 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.6 mt-10 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.475 -0.362 . . . . 0.0 110.036 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.797 0.332 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.03 153.59 27.87 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.162 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -129.54 134.36 47.72 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.042 0.214 . . . . 0.0 111.439 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -139.22 127.78 23.09 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.596 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.906 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.75 106.85 13.07 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 123.712 1.72 . . . . 0.0 109.272 178.528 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.697 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.0 m -119.8 162.82 17.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 112.755 -2.02 . . . . 0.0 110.187 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -103.72 145.58 29.86 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' B' ' 326' ' ' VAL . 44.2 tt0 . . . . . 0 C--N 1.315 -0.905 0 CA-C-O 122.023 0.916 . . . . 0.0 112.558 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.7 t . . . . . 0 N--CA 1.442 -0.86 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.449 ' O ' HG12 ' B' ' 326' ' ' VAL . 68.9 Cg_exo -43.9 144.51 2.47 Favored 'Trans proline' 0 C--N 1.321 -0.917 0 N-CA-C 108.209 -1.496 . . . . 0.0 108.209 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' B' ' 315' ' ' VAL . 7.6 ttm180 -151.55 -173.02 4.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 119.496 -0.881 . . . . 0.0 108.628 -177.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.636 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.68 121.32 13.38 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.113 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.841 HD12 ' O ' ' B' ' 338' ' ' MET . 31.5 tp -99.47 158.72 15.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.175 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.435 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.95 108.7 0.53 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.727 HD11 HD21 ' B' ' 330' ' ' LEU . 30.2 mm -87.91 124.4 41.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.729 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.5 p -118.59 138.25 52.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.327 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -57.96 14.4 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.115 0.484 . . . . 0.0 111.769 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.729 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -144.66 -3.06 0.81 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.981 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.62 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.64 176.95 1.82 Allowed 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.43 1.11 . . . . 0.0 112.833 -176.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.62 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.4 t -132.28 145.84 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-N 113.071 -1.877 . . . . 0.0 106.215 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.841 ' O ' HD12 ' B' ' 330' ' ' LEU . 0.9 OUTLIER -152.63 150.78 29.86 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 117.179 -1.808 . . . . 0.0 114.415 -175.843 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.54 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 60.0 mtm180 -95.85 106.94 19.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.397 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.65 149.93 4.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.278 -178.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.0 t0 -88.07 91.6 8.83 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.736 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.9 OUTLIER -35.42 -28.38 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.671 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' B' ' 341' ' ' ASP . 28.1 mttp -75.39 -43.92 47.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.641 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.558 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.68 -13.47 14.79 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm 67.71 -1.11 1.74 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' B' ' 344' ' ' THR . 4.4 mt-10 -85.95 152.08 23.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.337 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.629 HG21 ' SD ' ' B' ' 338' ' ' MET . 86.9 t -80.99 133.26 29.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.527 0.68 . . . . 0.0 112.176 -178.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 348' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' B' ' 341' ' ' ASP . 55.0 mt -102.91 -30.29 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.323 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.54 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 22.1 tt0 -140.27 158.06 44.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 350' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 45.6 mt-10 -142.85 150.69 40.22 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.296 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.02 122.47 4.23 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.227 177.685 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.511 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.01 140.1 2.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.51 0.672 . . . . 0.0 111.632 -178.755 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.614 HD12 ' O ' ' B' ' 333' ' ' THR . 1.5 tt -82.46 -36.48 26.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 354' ' ' THR . . . . . 0.703 HG22 ' O ' ' B' ' 354' ' ' THR . 99.5 m -71.17 7.07 1.36 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.831 177.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.571 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.2 m-20 -108.12 -5.26 17.06 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.828 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.555 HD12 HD23 ' B' ' 353' ' ' LEU . 72.1 mt -61.19 143.23 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.672 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -107.3 -45.29 4.13 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.501 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.0 ptt-85 -172.17 136.27 0.83 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.497 ' CH2' HD12 ' B' ' 396' ' ' ILE . 7.8 p90 -119.14 176.33 5.36 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.234 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.63 98.62 1.67 Allowed 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 119.066 -1.054 . . . . 0.0 112.044 -178.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.793 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.81 145.01 31.64 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.747 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.522 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -133.76 174.15 5.02 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -77.69 -7.61 16.7 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.12 1.88 . . . . 0.0 112.158 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.4 mtpt -130.86 -21.42 2.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.011 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.65 ' HA ' ' H ' ' B' ' 382' ' ' THR . 61.3 p -152.65 166.63 31.51 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.56 0.695 . . . . 0.0 111.908 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.484 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -137.68 156.84 47.58 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.823 179.573 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.561 ' CG2' HD12 ' A' ' 15' ' ' LEU . 29.1 m -148.81 155.06 40.4 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.215 -174.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.4 mt -125.81 139.83 53.17 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.181 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.1 t0 -117.6 95.65 5.04 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.569 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 15.1 t80 -137.45 94.43 2.92 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.955 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.92 11.98 2.0 Allowed Glycine 0 C--O 1.225 -0.407 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 372' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 8.9 t0 -41.47 -16.01 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.087 -0.556 . . . . 0.0 111.777 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.56 -37.08 65.03 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.473 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.0 -92.94 0.49 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.876 -1.511 . . . . 0.0 107.072 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.473 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 16.3 t0 -128.9 96.38 4.34 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.53 -2.9 53.38 Favored Glycine 0 C--N 1.313 -0.7 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.339 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -83.79 106.65 15.66 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -175.68 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 378' ' ' TYR . . . . . 0.426 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.6 OUTLIER -114.06 120.8 41.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.6 176.066 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 38.4 t -138.88 164.09 30.6 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.587 0.708 . . . . 0.0 112.818 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.84 174.1 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.874 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -100.47 125.49 46.78 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 122.0 0.905 . . . . 0.0 110.835 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.697 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -155.56 136.78 13.88 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.832 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.25 17.0 4.62 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.147 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.01 84.19 1.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.092 175.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.88 -58.45 2.01 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.463 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.2 pt-20 -44.3 -20.19 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 114.814 -0.693 . . . . 0.0 111.026 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' B' ' 385' ' ' GLY . 67.5 mt-30 -82.75 -40.15 20.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.578 0.704 . . . . 0.0 109.102 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' B' ' 385' ' ' GLY . 49.5 mt -76.41 -42.04 35.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.719 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.793 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.46 -42.32 62.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.6 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.463 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -64.14 -34.79 78.87 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.023 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.64 -53.67 9.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.727 -179.509 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -48.59 -55.7 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 176.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.492 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.42 -33.8 45.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 112.761 -2.018 . . . . 0.0 110.578 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.12 -17.83 62.11 Favored Glycine 0 CA--C 1.505 -0.539 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.68 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.1 m-30 -86.88 -36.45 18.41 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.538 ' O ' HD12 ' B' ' 400' ' ' LEU . 0.0 OUTLIER -69.23 -13.23 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 CA-C-O 122.166 0.984 . . . . 0.0 109.308 176.023 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.77 -22.62 42.96 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.52 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' B' ' 395' ' ' TYR . 74.8 mt -91.23 -62.15 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.17 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.9 OUTLIER -61.4 -25.84 37.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 113.409 -1.723 . . . . 0.0 112.291 -176.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.538 HD12 ' O ' ' B' ' 396' ' ' ILE . 42.4 mt . . . . . 0 C--O 1.218 -0.581 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.693 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.564 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? . . . . . 0 N--CA 1.463 0.191 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -43.38 96.59 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.7 -36.42 89.67 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.516 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 92.6 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.326 -0.437 . . . . 0.0 109.843 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 70.8 t . . . . . 0 CA--C 1.529 0.164 0 CA-C-O 120.738 0.304 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.83 153.26 24.65 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.123 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -129.69 135.45 48.51 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.03 0.206 . . . . 0.0 111.483 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -138.83 129.89 26.7 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.565 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.875 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.61 104.72 13.09 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 123.918 1.818 . . . . 0.0 109.368 178.368 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 315' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.9 m -115.71 161.19 14.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 112.523 -2.126 . . . . 0.0 110.086 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -103.57 145.0 30.69 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 317' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' B' ' 326' ' ' VAL . 27.8 tt0 . . . . . 0 C--N 1.316 -0.88 0 CA-C-O 122.102 0.953 . . . . 0.0 112.729 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 326' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' B' ' 317' ' ' GLU . 9.5 t . . . . . 0 N--CA 1.44 -0.967 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 327' ' ' PRO . . . . . 0.461 ' O ' HG12 ' B' ' 326' ' ' VAL . 61.0 Cg_exo -44.56 145.22 2.76 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 N-CA-C 108.099 -1.539 . . . . 0.0 108.099 178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 328' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' B' ' 315' ' ' VAL . 5.6 ttm-85 -150.2 -173.21 4.37 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.776 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 329' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.95 122.72 12.64 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.07 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 330' ' ' LEU . . . . . 0.833 HD12 ' O ' ' B' ' 338' ' ' MET . 26.4 tp -101.96 158.32 16.22 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 331' ' ' GLY . . . . . 0.428 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.44 107.94 0.53 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 332' ' ' ILE . . . . . 0.736 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -88.46 123.83 41.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 333' ' ' THR . . . . . 0.729 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.6 p -118.31 137.75 52.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.26 13.23 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.05 0.452 . . . . 0.0 111.741 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 335' ' ' GLU . . . . . 0.729 ' H ' ' C ' ' B' ' 333' ' ' THR . 11.3 pt-20 -144.15 -2.52 0.89 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.844 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 336' ' ' CYS . . . . . 0.611 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.86 179.36 2.0 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 122.158 0.98 . . . . 0.0 113.045 -177.194 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 337' ' ' VAL . . . . . 0.611 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.3 t -137.08 145.31 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 CA-C-N 113.365 -1.743 . . . . 0.0 106.677 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 338' ' ' MET . . . . . 0.833 ' O ' HD12 ' B' ' 330' ' ' LEU . 3.9 ptt? -154.08 149.95 27.69 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 117.028 -1.869 . . . . 0.0 114.318 -176.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 339' ' ' ARG . . . . . 0.497 ' NH1' ' OE2' ' B' ' 317' ' ' GLU . 44.7 mtm180 -94.66 107.79 19.78 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.778 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 340' ' ' VAL . . . . . 0.626 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.24 149.84 5.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.228 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 344' ' ' THR . 29.0 t0 -89.93 92.15 8.89 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.784 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.51 -28.95 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.76 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 343' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 35.8 mttt -74.7 -43.67 53.97 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.672 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 344' ' ' THR . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.3 -12.72 14.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 7.4 tttp 66.73 -0.91 1.46 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.977 0.418 . . . . 0.0 109.918 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 346' ' ' GLU . . . . . 0.456 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.6 mt-10 -84.88 152.73 23.36 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.388 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 347' ' ' VAL . . . . . 0.597 HG21 ' SD ' ' B' ' 338' ' ' MET . 81.9 t -82.92 135.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.449 0.642 . . . . 0.0 112.352 -178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mt -104.03 -30.13 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.386 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 349' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' B' ' 338' ' ' MET . 36.0 tt0 -140.49 156.05 46.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.677 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -145.66 149.43 34.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.451 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 351' ' ' TRP . . . . . 0.554 ' O ' ' N ' ' B' ' 337' ' ' VAL . 68.6 t-105 -162.34 135.95 6.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.828 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 352' ' ' SER . . . . . 0.509 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -54.01 138.32 37.51 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.541 -178.788 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.623 HD12 ' O ' ' B' ' 333' ' ' THR . 1.8 tt -78.51 -35.69 45.97 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.97 11.1 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.97 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 355' ' ' ASN . . . . . 0.509 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -115.04 -3.99 12.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.171 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 356' ' ' ILE . . . . . 0.477 HD12 HD23 ' B' ' 353' ' ' LEU . 72.5 mt -58.12 148.54 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.951 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 357' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 11.5 tptt -106.45 -45.64 4.21 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.2 ptt180 -174.88 136.3 0.4 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.399 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 359' ' ' TRP . . . . . 0.489 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.6 p90 -118.74 174.53 6.22 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.35 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -156.88 97.99 1.73 Allowed 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.936 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 361' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -79.77 147.85 31.69 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.855 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 362' ' ' SER . . . . . 0.535 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -136.21 173.04 6.06 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -76.63 -8.61 18.26 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.033 1.822 . . . . 0.0 112.092 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 6.4 mttm -130.79 -22.08 2.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.96 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 365' ' ' SER . . . . . 0.657 ' HA ' ' H ' ' B' ' 382' ' ' THR . 89.8 p -149.73 170.02 19.7 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.617 0.723 . . . . 0.0 111.815 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 366' ' ' PHE . . . . . 0.505 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -142.79 156.56 44.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.802 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 367' ' ' THR . . . . . 0.564 ' CG2' HD12 ' A' ' 15' ' ' LEU . 33.9 m -148.1 156.44 42.61 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.734 -174.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 368' ' ' LEU . . . . . 0.454 ' N ' HG22 ' B' ' 367' ' ' THR . 6.0 mt -129.11 143.4 50.85 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.479 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.7 t0 -119.74 95.86 4.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.652 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 370' ' ' PHE . . . . . 0.491 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 10.3 p90 -136.6 93.52 2.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.371 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 371' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.58 12.22 1.81 Allowed Glycine 0 C--O 1.226 -0.397 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -41.77 -15.74 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.117 -0.542 . . . . 0.0 111.776 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 373' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.61 -37.3 65.42 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 374' ' ' GLN . . . . . 0.479 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.85 -92.94 0.5 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.946 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 375' ' ' ASP . . . . . 0.479 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.5 t70 -129.02 96.4 4.33 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.5 -2.45 55.49 Favored Glycine 0 C--N 1.311 -0.859 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.218 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 377' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.32 106.11 17.15 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -175.547 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.21 125.98 52.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.783 175.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 379' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.9 t -138.19 164.27 29.62 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.519 0.676 . . . . 0.0 112.667 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.4 172.89 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.942 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -99.77 126.51 45.85 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.891 0.853 . . . . 0.0 111.114 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 382' ' ' THR . . . . . 0.657 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.11 136.05 13.73 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.651 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.27 16.66 4.22 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.103 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.95 84.04 1.77 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.91 175.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.9 -58.84 1.95 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 386' ' ' GLU . . . . . 0.509 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.1 pt-20 -44.66 -20.73 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.746 -0.727 . . . . 0.0 110.976 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 387' ' ' GLN . . . . . 0.429 ' N ' ' C ' ' B' ' 385' ' ' GLY . 78.2 mt-30 -82.06 -39.38 23.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 48.1 mt -76.93 -42.33 32.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.712 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 389' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.87 -42.29 60.96 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.185 -1.37 . . . . 0.0 113.618 -177.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 390' ' ' GLN . . . . . 0.509 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.79 -34.99 79.13 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.116 0.96 . . . . 0.0 110.992 -177.498 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.93 -53.59 10.91 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.814 -179.441 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.09 -56.12 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 393' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.29 -33.77 43.67 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.792 -2.004 . . . . 0.0 110.743 177.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 394' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.2 -17.86 61.92 Favored Glycine 0 CA--C 1.507 -0.454 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 395' ' ' TYR . . . . . 0.677 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.15 -36.95 17.77 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 396' ' ' ILE . . . . . 0.489 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.44 -13.33 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 122.237 1.017 . . . . 0.0 109.365 176.029 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.54 -22.7 46.89 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.513 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 398' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.5 mt -91.8 -62.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 113.899 -1.501 . . . . 0.0 112.042 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 399' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.29 -20.6 27.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 113.404 -1.725 . . . . 0.0 112.384 -177.048 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 400' ' ' LEU . . . . . 0.561 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.773 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.2 mt -100.2 150.85 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.543 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.71 -67.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.895 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 13' ' ' SER . 32.5 mt-30 -120.95 -21.61 6.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.518 ' C ' ' O ' ' A' ' 10' ' ' GLN . 15.6 mtm -14.47 -63.54 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 124.2 0.937 . . . . 0.0 112.044 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -41.96 -62.73 0.86 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.101 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -65.24 -27.86 68.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.71 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.01 -24.54 63.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.966 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.555 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? -98.97 -36.87 9.6 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -43.41 98.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.582 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.87 -37.27 90.45 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.74 -40.6 72.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.457 -0.371 . . . . 0.0 110.035 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.501 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 9.9 mtp -54.49 -31.81 56.69 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.936 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.9 -28.8 17.51 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.335 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.4 mm? -73.59 -11.32 60.39 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.287 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.733 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -89.58 -11.26 43.22 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.555 ' N ' HD23 ' A' ' 22' ' ' LEU . 2.9 m -113.4 -14.97 12.71 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.961 0.41 . . . . 0.0 110.267 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.46 -74.1 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.179 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.94 -36.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.188 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 26' ' ' LEU . 8.4 mp -63.05 -99.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.548 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.67 -82.71 0.27 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.577 ' O ' HG12 ' A' ' 28' ' ' VAL . 63.6 t -136.47 -1.53 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.744 0.307 . . . . 0.0 110.665 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' O ' ' OXT' ' A' ' 30' ' ' THR . 45.7 t0 48.13 15.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.671 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.446 ' N ' ' C ' ' A' ' 28' ' ' VAL . 41.8 p . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.554 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -137.15 -145.47 4.96 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 89.1 t -40.8 138.31 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 110.703 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.56 153.62 27.22 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.202 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.22 134.29 47.16 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.054 0.221 . . . . 0.0 111.471 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -139.82 128.42 23.03 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.663 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.904 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.58 107.17 13.16 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 123.685 1.707 . . . . 0.0 109.358 178.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.648 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.7 m -118.96 160.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.174 -176.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -104.78 144.93 31.08 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' B' ' 326' ' ' VAL . 60.6 tt0 -134.04 152.38 51.82 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 122.126 0.965 . . . . 0.0 112.596 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 318' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 6.7 tptm -81.24 102.37 10.32 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.163 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 35.2 mmt -96.81 178.78 5.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.067 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.75 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -99.38 150.52 22.06 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.067 178.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 117.02 -23.34 10.0 Favored Glycine 0 C--N 1.315 -0.59 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -138.56 -142.27 0.16 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.285 -0.457 . . . . 0.0 110.646 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 323' ' ' ASN . . . . . 0.525 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.4 OUTLIER -141.28 -17.88 0.8 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.532 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.443 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -91.1 -176.79 4.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.935 0.398 . . . . 0.0 110.956 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 29.0 mt -90.17 162.78 15.1 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.192 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' B' ' 317' ' ' GLU . 12.2 t -121.58 123.81 27.41 Favored Pre-proline 0 N--CA 1.44 -0.965 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.088 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.424 ' O ' HG12 ' B' ' 326' ' ' VAL . 56.7 Cg_exo -44.74 144.75 3.23 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.621 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 10.5 ttm-85 -151.58 -173.06 4.4 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 119.48 -0.888 . . . . 0.0 108.682 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.81 120.79 12.83 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.105 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.845 HD12 ' O ' ' B' ' 338' ' ' MET . 32.0 tp -98.17 158.74 15.38 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.214 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.436 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -143.0 108.76 0.53 Allowed Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.725 HD11 HD21 ' B' ' 330' ' ' LEU . 30.0 mm -87.97 124.34 41.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.721 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.5 p -118.47 138.34 52.56 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.426 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 334' ' ' LYS . . . . . 0.602 ' NZ ' ' CE1' ' B' ' 395' ' ' TYR . 1.1 mtmm -57.68 14.55 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.813 0.34 . . . . 0.0 111.306 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.721 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.1 pt-20 -144.96 -3.56 0.77 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.15 177.7 1.86 Allowed 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.351 1.072 . . . . 0.0 112.991 -176.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.613 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.3 t -132.8 145.56 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 CA-C-N 113.093 -1.867 . . . . 0.0 106.236 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.845 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.5 ptt? -152.88 151.83 30.83 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.334 -175.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.51 HH12 HD13 ' B' ' 330' ' ' LEU . 5.4 mmt-85 -96.96 106.68 19.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.277 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -95.73 149.44 4.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.517 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' B' ' 343' ' ' LYS . 41.0 t0 -86.64 89.95 8.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.673 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.7 OUTLIER -35.88 -27.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.6 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 31.6 mttm -71.21 -44.16 65.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.582 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.54 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -113.61 -17.34 12.18 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 345' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' B' ' 344' ' ' THR . 6.8 tttm 77.26 0.22 2.96 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.445 ' O ' HG13 ' B' ' 340' ' ' VAL . 8.0 pt-20 -82.84 157.98 22.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.603 HG21 ' SD ' ' B' ' 338' ' ' MET . 89.8 t -87.29 131.94 33.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.331 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 6.7 mt -102.64 -30.67 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.498 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.484 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.8 tt0 -138.13 158.31 44.57 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.662 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -144.48 149.75 36.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.258 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.13 123.14 3.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.318 177.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.5 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.48 139.58 3.67 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.513 0.673 . . . . 0.0 111.627 -178.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.598 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -82.26 -36.64 26.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 354' ' ' THR . . . . . 0.536 HG22 ' O ' ' B' ' 354' ' ' THR . 19.6 m -71.74 7.37 1.53 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.882 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.4 m-20 -108.51 -5.02 16.75 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.825 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.535 HD12 HD23 ' B' ' 353' ' ' LEU . 72.1 mt -60.81 144.19 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.725 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -107.42 -46.18 3.91 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 7.5 ptt180 -171.54 136.03 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.542 ' CH2' HD12 ' B' ' 396' ' ' ILE . 7.5 p90 -119.31 176.45 5.32 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.315 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.7 98.27 1.64 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.188 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.38 145.77 31.84 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.741 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.523 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -134.23 174.17 4.97 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -77.57 -7.87 16.91 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.027 1.818 . . . . 0.0 112.123 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' B' ' 382' ' ' THR . 10.4 mtpt -130.86 -21.49 2.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.016 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.654 ' HA ' ' H ' ' B' ' 382' ' ' THR . 58.1 p -152.21 167.15 29.52 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.526 0.679 . . . . 0.0 111.874 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.468 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -138.55 156.74 47.23 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.826 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.555 ' CG2' HD12 ' A' ' 15' ' ' LEU . 31.8 m -148.56 154.72 40.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.146 -1.022 . . . . 0.0 113.185 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.4 mt -125.89 139.64 53.3 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.142 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.9 t0 -117.72 95.58 5.0 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.485 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 17.3 t80 -137.33 94.48 2.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.89 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.87 11.97 2.01 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 372' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.6 t0 -41.41 -16.12 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.067 -0.566 . . . . 0.0 111.797 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.556 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.59 -37.03 65.06 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.469 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.3 OUTLIER -125.93 -93.06 0.49 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.853 -1.521 . . . . 0.0 106.946 176.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.469 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 8.2 t70 -128.96 96.41 4.34 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.56 -2.64 53.27 Favored Glycine 0 C--N 1.312 -0.775 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.292 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.67 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.26 107.13 16.39 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 378' ' ' TYR . . . . . 0.413 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.7 OUTLIER -114.65 120.43 40.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.737 176.03 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.501 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.1 t -138.73 163.59 31.76 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.581 0.705 . . . . 0.0 112.78 -177.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.2 m -151.08 175.41 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.792 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -100.78 125.57 47.27 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.96 0.885 . . . . 0.0 110.931 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.654 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.28 136.49 13.93 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.753 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.32 17.01 4.68 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.143 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.99 84.04 1.76 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.022 175.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.99 -58.84 1.94 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.458 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.4 pt-20 -44.41 -20.21 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.748 -0.726 . . . . 0.0 111.038 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.437 ' N ' ' C ' ' B' ' 385' ' ' GLY . 63.6 mt-30 -83.04 -39.71 20.87 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.1 mt -76.39 -42.22 36.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.683 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.47 -42.53 61.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.267 -1.333 . . . . 0.0 113.718 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.458 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 12.2 pt20 -63.88 -34.76 78.66 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.04 0.924 . . . . 0.0 110.98 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.657 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.84 -53.47 10.14 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 113.877 -1.51 . . . . 0.0 108.765 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.657 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.4 mt -48.67 -55.29 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 176.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.49 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.79 -33.68 49.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.708 -2.042 . . . . 0.0 110.552 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.96 -18.0 62.06 Favored Glycine 0 CA--C 1.507 -0.456 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.68 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -86.84 -37.18 17.99 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.542 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.38 -13.39 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 122.153 0.978 . . . . 0.0 109.284 176.21 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.82 -22.69 45.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.506 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.8 mt -91.89 -61.88 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 113.895 -1.502 . . . . 0.0 112.033 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.85 -20.51 27.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.374 -1.739 . . . . 0.0 112.307 -176.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.56 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.83 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.806 HG23 ' SD ' ' A' ' 11' ' ' MET . 2.1 mp -101.07 151.96 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.631 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.18 -43.62 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.092 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 11' ' ' MET . 37.4 mt-30 -120.78 -24.67 5.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.934 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.806 ' SD ' HG23 ' A' ' 8' ' ' ILE . 58.2 mtp -19.42 -64.72 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 124.109 0.88 . . . . 0.0 112.02 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.412 ' C ' ' O ' ' A' ' 11' ' ' MET . 11.4 m-85 -41.09 -62.1 0.89 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.081 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' GLN . 2.9 t -64.51 -33.79 76.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.813 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.78 -27.25 68.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.553 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? -96.79 -38.58 9.82 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -42.94 98.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.24 -36.86 90.59 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.47 -39.79 70.69 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.501 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 4.8 mtp -55.62 -30.61 61.23 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.893 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.11 -26.71 17.45 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.262 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.8 mm? -76.17 -6.5 51.56 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.234 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.699 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -93.85 -10.55 33.61 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.178 0.513 . . . . 0.0 109.811 179.104 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 25' ' ' SER . 44.3 m -123.29 -24.61 4.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.153 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 7.0 mp0 42.64 17.22 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.286 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.3 OUTLIER 74.97 -60.33 0.52 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.024 178.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.5 ' N ' ' OG ' ' A' ' 25' ' ' SER . 1.4 mp -89.37 -23.74 22.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.476 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.5 11.1 59.84 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 29' ' ' ASP . 3.8 p -45.01 -41.42 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.156 0.503 . . . . 0.0 110.821 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.467 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 2.0 t70 40.96 86.71 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.531 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.631 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 41.1 -108.72 0.13 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 94.8 t -86.47 136.41 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.322 . . . . 0.0 110.702 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.55 153.56 23.96 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.15 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -129.95 134.58 47.55 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.153 0.283 . . . . 0.0 111.496 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -139.84 128.52 23.13 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.582 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.907 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.86 107.27 13.53 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.745 1.736 . . . . 0.0 109.334 178.586 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' B' ' 382' ' ' THR . 30.7 m -118.74 160.57 18.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 112.63 -2.077 . . . . 0.0 110.096 -176.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -102.94 145.53 29.7 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' B' ' 326' ' ' VAL . 31.0 tt0 -133.18 149.95 52.02 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.164 0.983 . . . . 0.0 112.575 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -81.68 101.87 10.34 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.157 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 38.1 mmt -95.05 178.89 5.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.072 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.768 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.36 150.93 22.51 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.103 178.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.12 -22.53 12.23 Favored Glycine 0 C--N 1.315 -0.586 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.19 -141.63 0.17 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.642 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.48 -21.1 0.68 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.523 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.45 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -89.3 -176.31 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.924 0.392 . . . . 0.0 111.001 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 325' ' ' LEU . . . . . 0.459 HD11 HD21 ' A' ' 22' ' ' LEU . 32.9 mt -91.24 164.63 13.82 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.161 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t -122.84 122.34 27.13 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.154 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.425 ' O ' HG12 ' B' ' 326' ' ' VAL . 63.9 Cg_exo -44.15 144.06 3.03 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 N-CA-C 108.085 -1.544 . . . . 0.0 108.085 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.62 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 8.4 ttm180 -150.26 -173.3 4.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.8 120.65 12.72 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.05 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.835 HD12 ' O ' ' B' ' 338' ' ' MET . 31.3 tp -98.45 158.43 15.6 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.09 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.435 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.45 108.4 0.52 Allowed Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 177.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.735 HD11 HD21 ' B' ' 330' ' ' LEU . 29.7 mm -87.98 123.02 40.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.722 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.37 138.25 51.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -57.86 15.2 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.173 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.722 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.0 pt-20 -144.99 -4.25 0.74 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.62 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.6 177.22 2.17 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 122.448 1.118 . . . . 0.0 112.892 -176.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.613 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.8 t -132.32 145.25 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-N 113.132 -1.849 . . . . 0.0 106.201 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.835 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.1 ptt? -152.77 151.01 29.99 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 117.089 -1.845 . . . . 0.0 114.419 -175.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.525 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 61.4 mtm180 -96.01 106.91 19.13 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.443 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.46 149.81 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.284 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.0 t0 -87.83 91.57 8.8 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.712 -178.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.37 -28.46 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.62 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.5 mttp -75.54 -44.0 45.76 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.714 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.555 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.63 -13.07 14.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 30.7 tttp 67.38 -0.67 1.76 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 109.986 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.7 mt-10 -85.99 152.56 22.82 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.317 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.622 HG21 ' SD ' ' B' ' 338' ' ' MET . 87.5 t -81.36 133.6 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.498 0.666 . . . . 0.0 112.299 -178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.436 HD11 ' HB2' ' B' ' 341' ' ' ASP . 56.1 mt -103.21 -30.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.369 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.525 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 19.7 tt0 -140.23 157.86 44.93 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.678 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 350' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 44.9 mt-10 -143.32 150.15 38.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.349 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.562 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.49 124.02 4.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.118 177.513 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.404 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.59 140.44 3.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.439 0.638 . . . . 0.0 111.566 -178.557 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.585 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -84.2 -36.12 23.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -73.74 9.39 1.48 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.889 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.57 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 4.3 m-20 -111.04 -7.21 14.53 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.055 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.495 HD12 HD23 ' B' ' 353' ' ' LEU . 79.2 mt -56.75 146.6 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.686 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 10.0 tttm -107.78 -46.35 3.82 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.3 ptt-85 -172.05 135.91 0.83 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.513 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.7 p90 -119.53 175.94 5.6 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.288 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.37 99.49 1.62 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.085 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.63 146.83 30.98 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.747 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.529 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -134.55 173.75 5.43 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -77.49 -7.98 17.03 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.119 1.879 . . . . 0.0 112.038 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' B' ' 382' ' ' THR . 4.1 mtpp -130.87 -21.16 2.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.038 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.657 ' HA ' ' H ' ' B' ' 382' ' ' THR . 58.6 p -152.13 167.7 27.66 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.566 0.698 . . . . 0.0 111.942 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.46 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.06 156.64 47.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.651 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.553 ' CG2' HD12 ' A' ' 15' ' ' LEU . 27.9 m -148.53 154.74 40.2 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.151 -174.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.0 mt -126.12 140.03 52.9 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.08 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.0 t0 -117.75 95.84 5.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.533 176.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 27.6 t80 -137.93 94.72 2.93 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.89 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.8 12.02 2.02 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 372' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.9 t0 -41.39 -16.43 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.045 -0.577 . . . . 0.0 111.829 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.548 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.46 -37.25 64.99 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.468 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.2 pt20 -125.85 -92.74 0.5 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.941 -1.482 . . . . 0.0 107.222 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.468 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.6 t70 -129.14 96.3 4.29 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.24 -2.91 54.24 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.376 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.681 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.57 106.75 16.37 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -175.583 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 378' ' ' TYR . . . . . 0.41 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.8 OUTLIER -114.3 120.13 39.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.717 176.106 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.501 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.4 t -138.66 163.45 32.06 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.673 0.749 . . . . 0.0 112.773 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.3 m -150.62 175.61 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.93 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -101.42 124.89 47.83 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.938 0.875 . . . . 0.0 110.807 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.657 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.95 136.68 14.4 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.772 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.41 17.2 4.63 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.271 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.03 83.92 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.989 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.02 -59.15 1.9 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.497 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.6 pt-20 -44.33 -20.69 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.758 -0.721 . . . . 0.0 111.009 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 55.6 mt-30 -82.43 -39.59 22.39 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.0 mt -76.55 -42.01 34.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.661 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.87 -42.71 60.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.651 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.76 -34.3 77.58 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.055 0.931 . . . . 0.0 110.969 -177.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.31 -53.4 9.77 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.705 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -48.77 -55.38 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.487 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.06 -34.53 43.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.737 -2.029 . . . . 0.0 110.593 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.46 -18.06 62.98 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.679 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.7 -37.0 18.37 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.513 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.31 -13.29 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.097 0.951 . . . . 0.0 109.221 176.277 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.39 -22.62 47.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.563 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' B' ' 395' ' ' TYR . 67.2 mt -91.99 -61.96 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.057 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.81 -20.28 27.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.396 -1.729 . . . . 0.0 112.335 -176.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.555 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.858 -1.067 . . . . 0.0 110.731 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.558 HG21 ' SD ' ' A' ' 11' ' ' MET . 3.5 mt -78.21 152.49 5.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.323 0.582 . . . . 0.0 110.748 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.48 -41.05 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.374 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 11' ' ' MET . 34.1 mt-30 -69.41 -55.14 11.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.756 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.558 ' SD ' HG21 ' A' ' 8' ' ' ILE . 40.1 mtp -17.91 -71.8 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.475 0 O-C-N 124.264 0.977 . . . . 0.0 112.157 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -42.99 -60.95 1.43 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.917 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -59.15 -37.1 76.49 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.878 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -47.0 76.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 110.838 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? -75.57 -41.05 55.76 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -39.26 80.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.724 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.35 -43.21 99.4 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.87 -38.29 90.48 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.486 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 3.9 mtp -58.32 -32.39 68.44 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.296 -0.562 . . . . 0.0 109.882 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.17 -29.06 12.66 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.249 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.1 mm? -75.15 -9.3 58.42 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.295 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.689 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -93.16 -9.42 39.43 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.094 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 23' ' ' THR . 22.0 m -131.61 -2.41 3.8 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.318 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 14.7 mp0 42.27 -91.62 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.902 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -141.36 -10.54 0.95 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.332 -178.454 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mp -45.64 -74.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.669 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.3 79.44 1.41 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.66 HG12 ' N ' ' A' ' 29' ' ' ASP . 58.7 t -95.51 -110.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.679 0.276 . . . . 0.0 110.458 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.66 ' N ' HG12 ' A' ' 28' ' ' VAL . 30.5 t70 55.09 60.26 3.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.519 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.579 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.44 -154.36 52.93 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.6 t -40.62 138.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.832 0.348 . . . . 0.0 110.731 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.09 153.43 26.94 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.229 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -130.47 134.26 46.95 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.113 0.258 . . . . 0.0 111.423 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -139.31 129.01 24.63 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.625 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.9 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.52 105.9 13.04 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 123.749 1.737 . . . . 0.0 109.42 178.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.649 HG12 ' HB ' ' B' ' 382' ' ' THR . 30.8 m -117.36 160.82 16.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 112.703 -2.044 . . . . 0.0 110.078 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -102.55 145.5 29.52 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.563 ' CD ' ' HE ' ' B' ' 339' ' ' ARG . 26.6 tt0 -132.92 149.5 52.24 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.955 0.884 . . . . 0.0 112.627 -178.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 318' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 6.1 tptm -81.83 100.76 9.76 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.425 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.603 ' SD ' ' NZ ' ' B' ' 320' ' ' LYS . 38.7 mmt -93.62 178.68 5.62 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.115 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.634 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.34 157.59 16.68 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.101 179.128 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 107.98 -21.74 28.94 Favored Glycine 0 C--N 1.312 -0.804 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.12 -140.21 0.16 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.45 -0.375 . . . . 0.0 110.603 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 323' ' ' ASN . . . . . 0.513 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 1.1 m-20 -145.83 -17.91 0.46 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.56 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.443 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -91.63 -176.62 4.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.966 0.412 . . . . 0.0 110.937 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 325' ' ' LEU . . . . . 0.497 HD11 HD21 ' A' ' 22' ' ' LEU . 34.3 mt -90.85 164.81 13.92 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.4 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' B' ' 317' ' ' GLU . 6.5 t -124.44 122.72 25.88 Favored Pre-proline 0 N--CA 1.438 -1.049 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.038 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' B' ' 326' ' ' VAL . 66.5 Cg_exo -43.9 143.89 2.81 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 N-CA-C 108.196 -1.502 . . . . 0.0 108.196 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.615 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.7 ttt180 -149.71 -173.33 4.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 119.476 -0.89 . . . . 0.0 108.699 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.662 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -141.83 120.73 12.77 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.162 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.832 HD12 ' O ' ' B' ' 338' ' ' MET . 32.2 tp -98.5 158.11 15.8 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.177 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.52 108.46 0.53 Allowed Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.719 HD11 HD21 ' B' ' 330' ' ' LEU . 29.5 mm -88.1 123.04 40.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.72 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.47 138.43 51.86 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 16.0 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.191 0.307 . . . . 0.0 111.268 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.72 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -145.48 -4.76 0.68 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.482 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.42 177.14 2.26 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 122.368 1.08 . . . . 0.0 112.883 -176.83 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.1 t -132.01 145.14 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 CA-C-N 113.13 -1.85 . . . . 0.0 106.33 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.832 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.79 150.84 29.79 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 117.124 -1.831 . . . . 0.0 114.519 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.563 ' HE ' ' CD ' ' B' ' 317' ' ' GLU . 0.2 OUTLIER -96.3 106.79 19.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.496 176.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.662 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.16 149.98 4.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.244 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.1 t0 -87.87 91.6 8.82 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.736 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.36 -28.45 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.685 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' B' ' 341' ' ' ASP . 44.4 mttt -75.5 -43.9 46.62 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.69 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.557 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.76 -13.33 14.8 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -177.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 20.6 tttt 67.77 -0.87 1.83 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.942 0.401 . . . . 0.0 109.943 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.432 ' H ' ' C ' ' B' ' 344' ' ' THR . 4.1 mt-10 -86.05 152.59 22.77 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.618 HG21 ' SD ' ' B' ' 338' ' ' MET . 87.7 t -81.37 134.05 27.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.5 0.667 . . . . 0.0 112.237 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.482 HG21 HH22 ' B' ' 328' ' ' ARG . 7.4 mt -104.11 -30.69 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.186 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.474 ' O ' ' CB ' ' B' ' 338' ' ' MET . 15.6 tt0 -139.04 157.4 46.05 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.554 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -143.64 149.84 37.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.232 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.15 123.98 4.1 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.976 177.571 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.521 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -44.86 141.77 2.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.388 0.613 . . . . 0.0 111.661 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.6 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -85.25 -36.27 21.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -73.91 9.99 1.32 Allowed 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.908 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.574 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.1 m-20 -111.81 -7.04 14.22 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.973 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.51 HD12 HD23 ' B' ' 353' ' ' LEU . 80.1 mt -56.44 147.04 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.748 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 357' ' ' LYS . . . . . 0.509 ' NZ ' ' OH ' ' B' ' 373' ' ' TYR . 9.4 tttp -107.71 -46.29 3.84 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 6.0 ptt180 -172.77 135.71 0.67 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.482 ' CH2' HD12 ' B' ' 396' ' ' ILE . 10.4 p90 -119.28 175.78 5.64 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.226 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.14 100.38 1.7 Allowed 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.84 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -82.86 142.56 31.4 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.66 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.538 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -130.27 174.51 4.55 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -77.82 -8.31 16.77 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.145 1.896 . . . . 0.0 112.063 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' B' ' 382' ' ' THR . 3.2 mttp -130.33 -20.81 2.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.965 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.662 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.1 p -152.03 167.69 27.61 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.55 0.691 . . . . 0.0 111.951 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.445 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -138.87 156.39 47.33 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.541 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.549 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.7 m -148.46 154.53 39.98 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.021 -1.072 . . . . 0.0 113.107 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.5 mt -125.61 140.0 53.11 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.336 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.9 t0 -117.36 95.61 5.04 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.892 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 29.7 t80 -137.99 95.24 3.0 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.955 176.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.77 12.38 1.96 Allowed Glycine 0 C--O 1.225 -0.419 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 372' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 10.0 t0 -41.88 -16.35 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.935 -0.633 . . . . 0.0 112.07 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.27 -38.09 65.45 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.463 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.32 -92.17 0.52 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.881 -1.509 . . . . 0.0 107.553 176.76 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 15.1 t0 -130.06 96.27 4.15 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.82 -3.58 54.88 Favored Glycine 0 C--N 1.303 -1.287 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.425 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.5 106.99 16.5 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -175.586 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -115.09 120.45 39.85 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.691 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.486 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.1 t -138.54 163.28 32.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.5 m -149.98 176.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.367 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -102.13 124.24 47.39 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-O 122.012 0.911 . . . . 0.0 110.829 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.662 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.55 137.19 15.17 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.929 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.15 17.69 4.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.23 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.18 83.64 1.74 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.973 174.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.42 -58.52 1.95 Allowed Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.449 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.3 pt-20 -44.82 -20.08 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.783 -0.708 . . . . 0.0 111.03 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.433 ' N ' ' C ' ' B' ' 385' ' ' GLY . 4.1 mm-40 -83.37 -38.87 21.42 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.8 mt -76.91 -41.99 32.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.623 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.95 -42.51 60.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.566 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.449 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -63.65 -34.2 77.31 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.064 0.935 . . . . 0.0 111.091 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.22 -53.26 10.17 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.738 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -49.02 -55.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.485 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.13 -34.44 44.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.663 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.68 -18.01 62.63 Favored Glycine 0 CA--C 1.505 -0.56 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.675 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.65 -37.04 18.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.322 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.482 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.24 -13.34 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-O 122.121 0.962 . . . . 0.0 109.288 176.204 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.36 -22.65 47.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.715 -1.584 . . . . 0.0 109.512 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.675 HD12 ' HA ' ' B' ' 395' ' ' TYR . 67.3 mt -92.05 -61.95 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.119 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.82 -20.11 26.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 113.394 -1.73 . . . . 0.0 112.373 -176.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.554 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.219 -0.508 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.723 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 9' ' ' ASP . 9.9 p30 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 8' ' ' ILE . 59.6 mt -72.61 10.86 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.436 0.636 . . . . 0.0 110.727 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -103.74 -31.95 9.59 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.399 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.502 ' O ' ' C ' ' A' ' 11' ' ' MET . 78.5 mt-30 -100.17 -35.16 9.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.599 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.502 ' C ' ' O ' ' A' ' 10' ' ' GLN . 24.6 mtp -18.33 -74.12 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 124.026 0.829 . . . . 0.0 112.163 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 11' ' ' MET . 10.0 m-85 -40.44 -62.51 0.76 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.118 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 10' ' ' GLN . 5.5 t -58.3 -32.85 68.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.796 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -47.15 87.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.975 0.416 . . . . 0.0 110.975 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.3 mm? -75.84 -41.25 53.01 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -41.42 93.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.586 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.27 -41.48 98.35 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.22 -39.61 89.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.15 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.516 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 5.9 mtp -56.61 -31.72 64.57 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.664 -0.414 . . . . 0.0 109.993 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.46 -28.55 20.69 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.15 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.529 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.1 mm? -79.72 -0.15 32.97 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.422 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.726 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -101.75 -9.91 20.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 109.726 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 23' ' ' THR . 5.2 m -123.58 -9.23 7.94 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.992 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 12.9 mp0 40.98 -95.08 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.899 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -143.52 -162.58 1.48 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.361 -178.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.518 ' N ' ' OG ' ' A' ' 25' ' ' SER . 8.4 mp -68.82 -100.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.507 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.57 -33.44 2.31 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.666 HG12 ' N ' ' A' ' 29' ' ' ASP . 58.7 t -147.55 -112.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 110.43 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.666 ' N ' HG12 ' A' ' 28' ' ' VAL . 20.3 t70 -98.91 -111.4 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.603 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.463 ' N ' ' CG ' ' A' ' 29' ' ' ASP . 81.6 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.629 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 135.8 -91.03 0.22 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.57 134.21 66.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.839 0.352 . . . . 0.0 110.765 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.87 153.18 25.8 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.082 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -129.49 135.64 48.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.452 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -138.5 129.83 27.33 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.588 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.863 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.42 101.39 10.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 123.869 1.795 . . . . 0.0 109.541 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' B' ' 328' ' ' ARG . 31.4 m -112.88 157.79 13.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 112.654 -2.066 . . . . 0.0 109.986 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -99.57 144.14 29.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' B' ' 326' ' ' VAL . 38.8 tt0 -131.14 151.34 51.56 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 122.091 0.948 . . . . 0.0 112.714 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -81.23 102.57 10.44 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.975 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 34.1 mmt -98.65 178.65 4.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.039 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.755 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -99.87 151.33 21.42 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.009 178.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 117.4 -23.13 9.87 Favored Glycine 0 C--N 1.316 -0.57 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -140.18 -146.64 0.2 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.553 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.18 -18.08 1.79 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.521 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.461 ' HD2' HG11 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -90.86 -176.67 4.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.89 0.376 . . . . 0.0 110.919 -179.451 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 325' ' ' LEU . . . . . 0.418 HD11 HD21 ' A' ' 22' ' ' LEU . 35.2 mt -90.52 166.25 13.33 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.213 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' B' ' 317' ' ' GLU . 11.2 t -124.4 126.73 25.43 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.859 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.445 ' O ' HG12 ' B' ' 326' ' ' VAL . 76.7 Cg_exo -43.13 142.86 2.25 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 N-CA-C 107.915 -1.61 . . . . 0.0 107.915 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' B' ' 315' ' ' VAL . 2.0 tpt180 -146.7 -173.16 4.14 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -145.93 122.92 11.38 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.318 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.838 HD12 ' O ' ' B' ' 338' ' ' MET . 26.7 tp -102.5 158.39 16.25 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.421 ' N ' ' HG ' ' B' ' 330' ' ' LEU . . . -141.01 107.51 0.52 Allowed Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.761 HD11 HD21 ' B' ' 330' ' ' LEU . 31.5 mm -88.62 122.72 40.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.733 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.5 p -117.66 137.78 52.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -57.54 13.78 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.059 0.457 . . . . 0.0 111.727 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.733 ' H ' ' C ' ' B' ' 333' ' ' THR . 15.8 pt-20 -144.25 -2.69 0.87 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.839 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.83 179.05 2.08 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.318 1.056 . . . . 0.0 112.989 -177.112 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.612 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 15.0 t -137.13 144.33 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 CA-C-N 113.266 -1.788 . . . . 0.0 106.752 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.838 ' O ' HD12 ' B' ' 330' ' ' LEU . 4.2 ptt? -153.44 150.12 28.46 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 117.053 -1.859 . . . . 0.0 114.263 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.654 HH12 HD13 ' B' ' 330' ' ' LEU . 6.5 mmt-85 -94.9 107.19 19.22 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.665 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.63 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.53 149.7 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.275 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.1 t0 -89.92 92.18 8.9 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.765 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.58 -28.7 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.697 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 20.2 mttp -75.42 -43.6 48.98 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.705 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.556 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.39 -12.58 14.72 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 345' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' B' ' 341' ' ' ASP . 6.3 ttmm 66.76 -0.52 1.59 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.032 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.5 mt-10 -84.9 153.17 23.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.274 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.58 HG21 ' SD ' ' B' ' 338' ' ' MET . 74.2 t -83.17 134.35 27.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.481 0.658 . . . . 0.0 112.334 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 21.6 mm -102.89 -31.85 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.353 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' B' ' 338' ' ' MET . 32.2 tt0 -137.64 156.89 47.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.703 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -146.42 148.78 32.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.348 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.556 ' O ' ' N ' ' B' ' 337' ' ' VAL . 67.0 t-105 -163.73 135.74 4.95 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.905 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -53.87 138.25 36.71 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.344 -178.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.631 HD12 ' O ' ' B' ' 333' ' ' THR . 1.7 tt -78.26 -35.38 48.23 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -75.59 11.72 1.23 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.999 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -115.58 -4.01 12.28 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.139 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.501 HD12 HD23 ' B' ' 353' ' ' LEU . 75.8 mt -57.7 149.39 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.097 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 357' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 10.8 tptt -107.33 -44.71 4.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.1 ptt180 -175.88 136.22 0.31 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.407 177.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.457 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.3 p90 -118.84 174.54 6.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.344 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.31 99.21 1.76 Allowed 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 119.233 -0.987 . . . . 0.0 112.002 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.53 144.25 31.45 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.773 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.539 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -131.9 174.27 4.9 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -77.31 -8.94 17.57 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.14 1.893 . . . . 0.0 112.102 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 17.1 mttt -130.69 -21.37 2.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.97 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.654 ' HA ' ' H ' ' B' ' 382' ' ' THR . 78.7 p -149.85 168.88 22.48 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.487 0.661 . . . . 0.0 111.938 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.503 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -141.16 156.87 45.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.796 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.549 ' CG2' HD12 ' A' ' 15' ' ' LEU . 44.8 m -147.78 156.85 43.17 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.093 -1.043 . . . . 0.0 112.913 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.466 ' N ' HG22 ' B' ' 367' ' ' THR . 5.9 mt -130.04 140.65 50.82 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.546 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.4 t0 -117.28 95.86 5.16 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.697 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.52 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 11.6 p90 -136.56 93.64 2.9 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.443 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.45 12.36 1.82 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 372' ' ' ASP . . . . . 0.401 ' CG ' ' OH ' ' B' ' 377' ' ' TYR . 8.3 t0 -41.84 -15.78 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.034 -0.583 . . . . 0.0 111.756 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.6 -37.27 65.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.478 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.89 -92.78 0.5 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.132 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.478 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.0 t70 -129.05 96.27 4.29 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.38 -3.03 55.6 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.306 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.682 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.95 106.06 16.86 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -175.545 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.14 125.86 51.89 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.736 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.516 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 46.6 t -138.38 163.67 31.27 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.532 0.682 . . . . 0.0 112.559 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -148.89 175.02 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.883 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.07 125.41 48.76 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.897 0.855 . . . . 0.0 111.098 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.654 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.54 136.44 14.56 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.814 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.78 16.85 4.4 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.243 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.97 84.0 1.76 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.938 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.79 -58.24 2.05 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.6 pt-20 -44.79 -20.69 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.811 -0.695 . . . . 0.0 110.962 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' B' ' 385' ' ' GLY . 68.9 mt-30 -82.11 -39.29 23.55 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 45.9 mt -77.05 -42.43 31.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.614 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.63 -42.38 61.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.569 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.77 -34.91 78.96 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.1 0.952 . . . . 0.0 110.95 -177.374 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.01 -53.78 10.28 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.723 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -48.97 -56.06 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 176.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.41 -33.74 45.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 112.874 -1.966 . . . . 0.0 110.671 177.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.18 -17.81 62.05 Favored Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.674 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.04 -36.92 17.91 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.47 ' HA ' HD11 ' B' ' 399' ' ' ILE . 0.0 OUTLIER -68.59 -13.31 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 122.203 1.002 . . . . 0.0 109.285 176.17 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.6 -22.68 46.67 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.459 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 395' ' ' TYR . 69.2 mt -91.82 -62.01 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 113.894 -1.503 . . . . 0.0 112.038 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.22 -20.58 27.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 113.449 -1.705 . . . . 0.0 112.323 -177.061 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.222 -0.384 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.812 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' O ' ' A' ' 8' ' ' ILE . 76.7 mt 55.57 7.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.354 0.597 . . . . 0.0 110.608 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.6 OUTLIER -140.79 -35.26 0.49 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.314 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' SER . 45.8 mt-30 -101.06 -53.72 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.807 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.486 ' C ' ' O ' ' A' ' 10' ' ' GLN . 7.8 mmm -19.83 -71.4 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 124.146 0.903 . . . . 0.0 112.156 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -43.9 -58.41 2.78 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.065 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -60.77 -35.89 77.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.814 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.8 -46.26 81.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.836 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.559 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? -75.59 -38.97 58.67 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -41.19 88.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.432 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.68 -41.82 99.66 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.508 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 90.0 mt-10 -65.76 -38.94 90.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.042 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.547 ' HE2' HD13 ' A' ' 22' ' ' LEU . 9.9 mtp -55.92 -33.91 65.11 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.855 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.26 -31.3 13.78 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.398 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.4 mm? -73.37 -12.29 60.77 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.266 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.738 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -87.88 -11.66 47.07 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.475 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.602 ' N ' HD23 ' A' ' 22' ' ' LEU . 2.4 m -111.19 -17.63 13.16 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.085 0.469 . . . . 0.0 110.106 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.82 -73.77 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.189 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -169.8 -162.47 0.33 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.19 -178.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' N ' ' OG ' ' A' ' 25' ' ' SER . 5.2 mp -48.35 -44.93 34.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.707 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.13 -57.72 4.85 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.7 t -149.8 -41.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.926 0.393 . . . . 0.0 110.817 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -173.21 26.56 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.793 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.428 ' O ' ' O ' ' B' ' 319' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.563 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -82.05 -149.18 7.33 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 98.6 t -40.8 137.18 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 0.0 110.69 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.76 153.4 26.57 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.166 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -129.73 134.52 47.66 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.085 0.24 . . . . 0.0 111.475 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -139.33 128.72 24.21 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.612 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.892 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.3 105.86 12.83 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 123.733 1.73 . . . . 0.0 109.446 178.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.657 HG12 ' HB ' ' B' ' 382' ' ' THR . 29.5 m -118.34 161.95 16.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 112.709 -2.041 . . . . 0.0 110.145 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -103.41 145.3 30.19 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' B' ' 326' ' ' VAL . 44.4 tt0 -135.11 151.93 51.17 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.972 0.891 . . . . 0.0 112.462 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 318' ' ' LYS . . . . . 0.529 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 5.7 tptm -79.21 101.1 7.79 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.475 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.676 ' N ' ' SD ' ' B' ' 319' ' ' MET . 0.0 OUTLIER -91.25 179.0 5.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.911 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.754 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.61 149.25 24.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.007 178.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.96 -25.12 9.65 Favored Glycine 0 C--N 1.313 -0.7 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -133.47 -142.58 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.45 -0.375 . . . . 0.0 110.537 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 323' ' ' ASN . . . . . 0.529 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.3 OUTLIER -142.61 -14.55 0.75 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.808 0.337 . . . . 0.0 110.574 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.711 ' CD ' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -94.14 -176.4 3.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.188 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 28.4 mt -92.04 160.96 14.98 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.206 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.2 t -122.58 126.97 25.98 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.018 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.448 ' O ' HG12 ' B' ' 326' ' ' VAL . 70.0 Cg_exo -43.9 144.44 2.51 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 N-CA-C 108.166 -1.513 . . . . 0.0 108.166 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' B' ' 315' ' ' VAL . 7.3 ttm-85 -151.44 -172.61 4.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.708 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -142.1 122.39 13.93 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.175 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.851 HD12 ' O ' ' B' ' 338' ' ' MET . 31.2 tp -100.41 158.58 15.8 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.43 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.32 108.3 0.52 Allowed Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.735 HD11 HD21 ' B' ' 330' ' ' LEU . 30.1 mm -88.09 123.4 40.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.724 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.83 138.51 52.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 334' ' ' LYS . . . . . 0.617 ' NZ ' ' CE1' ' B' ' 395' ' ' TYR . 0.4 OUTLIER -57.76 15.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.311 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.724 ' H ' ' C ' ' B' ' 333' ' ' THR . 10.9 pt-20 -144.88 -4.65 0.74 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.701 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.08 177.84 2.25 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 122.398 1.094 . . . . 0.0 112.947 -176.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.8 t -132.94 145.22 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 CA-C-N 113.113 -1.858 . . . . 0.0 106.219 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.851 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.4 ptt? -153.05 151.34 30.12 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 117.258 -1.777 . . . . 0.0 114.429 -175.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.422 HH12 HG21 ' B' ' 380' ' ' VAL . 8.7 mmt180 -96.24 106.85 19.12 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.456 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.641 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -97.07 149.7 4.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.235 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 343' ' ' LYS . 25.5 t0 -88.47 91.98 9.01 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.773 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.42 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.734 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 61.8 mttt -76.12 -44.08 40.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.756 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.551 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -108.72 -12.59 14.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 345' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' B' ' 341' ' ' ASP . 32.4 tttp 66.9 -0.53 1.63 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.955 0.407 . . . . 0.0 109.976 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.3 mt-10 -85.37 153.0 22.82 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.284 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.61 HG21 ' SD ' ' B' ' 338' ' ' MET . 83.4 t -81.9 133.47 29.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.524 0.678 . . . . 0.0 112.314 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 11.6 mt -103.4 -31.86 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.449 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.474 ' O ' ' CB ' ' B' ' 338' ' ' MET . 24.4 tt0 -136.6 158.48 44.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.782 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 350' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 39.1 mt-10 -144.97 149.3 34.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.286 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.562 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.88 124.74 3.94 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.151 177.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.401 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -46.59 140.37 4.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.435 0.636 . . . . 0.0 111.527 -178.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.585 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -83.74 -36.04 23.96 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.2 t -74.18 9.82 1.48 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.913 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.569 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 4.3 m-20 -111.64 -7.98 14.24 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.052 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.479 HD12 HD23 ' B' ' 353' ' ' LEU . 81.4 mt -56.01 146.92 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.692 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -107.86 -46.08 3.86 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.493 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 2.2 ptt-85 -172.55 136.38 0.75 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.53 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.3 p90 -119.44 176.49 5.33 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.275 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.39 99.2 1.75 Allowed 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.041 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.97 140.15 34.15 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.68 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.531 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -128.32 174.5 4.36 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.79 -7.78 16.66 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.118 1.878 . . . . 0.0 112.193 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.1 mttp -130.91 -20.39 2.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.04 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.672 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.5 p -152.85 166.49 32.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.423 0.63 . . . . 0.0 111.931 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.48 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -137.04 156.52 48.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.61 179.369 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.559 ' CG2' HD12 ' A' ' 15' ' ' LEU . 25.3 m -148.54 154.58 39.98 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.104 -1.038 . . . . 0.0 113.091 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.0 mt -125.66 139.45 53.55 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.118 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.8 t0 -117.07 95.83 5.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.457 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 33.4 t80 -137.77 94.51 2.91 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.896 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.67 12.12 2.03 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 372' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.0 t0 -41.47 -16.0 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.035 -0.582 . . . . 0.0 111.826 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.52 -37.33 65.24 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.474 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.69 -92.84 0.5 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.474 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.3 t70 -128.88 96.34 4.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.11 -2.97 54.66 Favored Glycine 0 C--N 1.315 -0.629 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.243 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.07 106.4 15.69 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 378' ' ' TYR . . . . . 0.415 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.8 OUTLIER -113.88 120.4 40.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.598 176.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.521 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 37.3 t -138.88 164.59 29.27 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.651 0.738 . . . . 0.0 112.757 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 380' ' ' VAL . . . . . 0.422 HG21 HH12 ' B' ' 339' ' ' ARG . 1.0 OUTLIER -151.07 174.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.858 179.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.39 124.59 46.07 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.973 0.892 . . . . 0.0 111.024 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.672 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.82 137.69 14.42 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.824 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 383' ' ' THR . . . . . 0.439 ' N ' ' OE2' ' B' ' 384' ' ' GLU . 0.8 OUTLIER -85.43 -1.2 56.79 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.972 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 384' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -123.81 84.05 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.096 0.95 . . . . 0.0 108.727 175.25 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.99 -59.54 1.86 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.4 pt-20 -45.59 -21.04 0.08 Allowed 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 114.697 -0.752 . . . . 0.0 111.074 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.406 ' N ' ' C ' ' B' ' 385' ' ' GLY . 68.6 mt-30 -81.04 -38.62 27.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.3 mt -77.36 -41.97 30.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.588 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -74.18 -42.68 59.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.507 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.65 -34.59 78.19 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.991 0.9 . . . . 0.0 111.035 -177.443 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.94 -53.45 10.08 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.781 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -48.89 -55.55 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 176.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.485 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -51.96 -34.06 40.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.764 -2.017 . . . . 0.0 110.569 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.06 -18.12 61.66 Favored Glycine 0 CA--C 1.506 -0.524 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.682 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.68 -36.88 18.47 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.53 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.29 -13.36 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 122.108 0.956 . . . . 0.0 109.189 176.326 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.34 -22.68 47.67 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.506 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.0 mt -91.99 -61.92 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 113.869 -1.514 . . . . 0.0 112.022 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.9 -20.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 113.415 -1.721 . . . . 0.0 112.311 -176.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.557 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.221 -0.437 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.775 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.445 HG21 ' SD ' ' A' ' 11' ' ' MET . 3.7 mt -96.07 152.55 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.11 0.481 . . . . 0.0 110.626 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -171.38 -36.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.076 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 13' ' ' SER . 38.4 mt-30 -72.72 -54.33 9.25 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.787 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.483 ' C ' ' O ' ' A' ' 10' ' ' GLN . 49.3 mtp -20.07 -70.13 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 124.238 0.961 . . . . 0.0 112.044 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -42.95 -59.89 1.83 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.006 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -60.53 -37.33 80.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.899 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.74 -46.02 77.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.552 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? -75.65 -39.93 56.92 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -40.98 86.32 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.8 -41.63 99.65 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.513 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.1 mt-10 -65.8 -38.21 88.37 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.522 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 8.2 mtp -57.71 -33.58 68.55 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.962 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.54 -29.42 10.62 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.365 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.541 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.4 mm? -76.34 -9.18 58.45 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.399 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.738 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -91.82 -10.7 38.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.007 0.432 . . . . 0.0 110.027 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.529 ' N ' HD23 ' A' ' 22' ' ' LEU . 2.9 m -115.78 -15.36 11.31 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.085 0.469 . . . . 0.0 110.25 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -49.64 -74.05 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.264 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -178.0 -45.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.268 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 26' ' ' LEU . 8.6 mp -62.27 -98.89 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.515 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 46.66 91.57 0.01 OUTLIER Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.669 HG12 ' N ' ' A' ' 29' ' ' ASP . 91.1 t -78.53 -107.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.752 0.311 . . . . 0.0 110.469 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.669 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.6 OUTLIER 55.52 95.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.598 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.466 ' CB ' ' O ' ' A' ' 29' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.575 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 135.96 -73.4 0.44 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 77.8 t -130.12 133.5 64.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.784 0.326 . . . . 0.0 110.835 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.13 153.4 23.21 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.132 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -128.14 135.29 49.57 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -140.06 128.79 23.14 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.598 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.907 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.86 107.45 13.68 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 123.728 1.728 . . . . 0.0 109.349 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.65 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.0 m -119.88 159.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 112.647 -2.07 . . . . 0.0 110.066 -177.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -100.79 145.05 29.01 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' B' ' 326' ' ' VAL . 47.1 tt0 -131.67 150.96 51.97 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.995 0.903 . . . . 0.0 112.617 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -80.17 101.51 8.86 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.308 -1.315 . . . . 0.0 111.256 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 35.0 mmt -97.6 178.67 5.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.169 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.634 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.0 157.88 16.42 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.85 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 109.96 -22.61 23.1 Favored Glycine 0 C--N 1.309 -0.971 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -136.64 -138.69 0.15 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.347 -0.426 . . . . 0.0 110.605 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.79 -16.35 0.47 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.631 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -94.21 -174.46 3.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.924 0.392 . . . . 0.0 110.947 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 325' ' ' LEU . . . . . 0.445 HD11 HD21 ' A' ' 22' ' ' LEU . 32.1 mt -91.93 162.56 14.36 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.25 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.506 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.0 t -122.24 126.6 26.19 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.055 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.434 ' O ' HG12 ' B' ' 326' ' ' VAL . 67.0 Cg_exo -44.33 143.74 3.45 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 N-CA-C 108.093 -1.541 . . . . 0.0 108.093 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.631 ' N ' ' O ' ' B' ' 315' ' ' VAL . 0.3 OUTLIER -149.99 -172.92 4.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.759 -177.129 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.646 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -142.31 122.05 13.45 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.061 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.84 HD12 ' O ' ' B' ' 338' ' ' MET . 30.3 tp -100.37 158.3 15.99 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.118 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.434 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.94 108.11 0.52 Allowed Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.74 HD11 HD21 ' B' ' 330' ' ' LEU . 30.4 mm -87.99 121.63 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.72 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.3 p -115.83 138.62 50.97 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -57.92 14.95 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.364 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.72 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.4 pt-20 -145.14 -3.79 0.74 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.476 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.5 178.42 1.97 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.343 1.068 . . . . 0.0 112.993 -176.655 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.7 t -134.38 145.0 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 113.147 -1.842 . . . . 0.0 106.308 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.84 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.5 ptt? -152.8 151.99 31.09 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 117.145 -1.822 . . . . 0.0 114.546 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.787 HH12 HD13 ' B' ' 330' ' ' LEU . 6.5 mmt-85 -96.28 107.36 19.7 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.466 176.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.646 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.06 149.8 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.219 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' B' ' 343' ' ' LYS . 0.3 OUTLIER -87.94 92.0 8.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.859 -178.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -36.55 -27.34 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.637 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' B' ' 341' ' ' ASP . 54.3 mttt -74.79 -42.61 57.79 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.731 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 341' ' ' ASP . 64.5 p -112.0 -16.91 12.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 345' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' B' ' 344' ' ' THR . 5.8 ttmm 73.73 1.8 4.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.94 0.4 . . . . 0.0 110.174 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.468 ' O ' HG13 ' B' ' 340' ' ' VAL . 5.5 pt-20 -86.52 158.65 19.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.617 HG21 ' SD ' ' B' ' 338' ' ' MET . 89.4 t -88.4 132.78 32.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.567 0.698 . . . . 0.0 112.36 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.21 -31.34 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.241 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.0 tt0 -136.74 157.5 46.61 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.601 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -144.25 149.65 36.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.003 -0.998 . . . . 0.0 111.215 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.61 124.52 4.02 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.125 177.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.501 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -46.73 140.47 4.53 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.358 0.599 . . . . 0.0 111.511 -178.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.591 HD12 ' O ' ' B' ' 333' ' ' THR . 1.9 tt -83.79 -35.74 24.09 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.6 t -74.52 10.22 1.43 Allowed 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.909 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.573 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.8 m-20 -112.11 -7.63 14.06 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.004 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.481 HD12 HD23 ' B' ' 353' ' ' LEU . 80.8 mt -55.98 147.4 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.775 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.77 -45.44 4.01 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.7 ptt-85 -173.9 135.93 0.51 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.466 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.8 p90 -118.74 176.54 5.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.206 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.43 99.42 1.6 Allowed 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.887 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.783 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.21 147.22 30.09 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.699 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.529 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -135.63 173.87 5.2 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -77.35 -8.36 17.31 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.113 1.875 . . . . 0.0 112.15 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' B' ' 382' ' ' THR . 3.9 mttp -130.66 -20.55 2.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.977 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.646 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.6 p -152.69 167.29 29.43 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.59 0.71 . . . . 0.0 111.993 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.467 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -138.81 156.92 46.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.638 179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.552 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.3 m -148.53 155.73 41.52 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.041 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.436 ' N ' HG22 ' B' ' 367' ' ' THR . 6.8 mt -126.29 139.73 53.08 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.375 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.1 t0 -116.96 95.75 5.15 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.68 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 32.6 t80 -138.1 94.87 2.93 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.971 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.12 12.04 1.94 Allowed Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 372' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.4 t0 -41.79 -16.37 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.044 -0.578 . . . . 0.0 111.778 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.0 m-85 -54.33 -37.27 64.67 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.466 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.98 -92.37 0.51 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.335 176.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.466 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.7 t70 -129.78 96.28 4.19 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 174.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.15 -3.52 54.27 Favored Glycine 0 C--N 1.31 -0.872 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.313 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.25 106.33 15.79 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.06 120.43 40.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.703 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.522 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 34.5 t -138.43 163.67 31.32 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.674 0.75 . . . . 0.0 112.952 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -150.42 175.56 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.199 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -101.23 125.06 47.82 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.968 0.89 . . . . 0.0 110.899 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.65 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -155.08 136.23 13.92 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.878 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.09 17.07 4.44 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.13 83.69 1.74 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.044 174.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.25 -57.72 2.08 Favored Glycine 0 C--N 1.317 -0.51 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.451 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.5 pt-20 -45.26 -20.27 0.05 Allowed 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 114.898 -0.651 . . . . 0.0 110.991 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.425 ' N ' ' C ' ' B' ' 385' ' ' GLY . 6.7 mm-40 -83.36 -38.55 21.87 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.0 mt -77.23 -41.89 30.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.538 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.783 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.88 -42.46 60.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.344 -1.298 . . . . 0.0 113.509 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.451 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -64.08 -34.14 77.37 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.051 0.929 . . . . 0.0 111.022 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.07 -53.43 9.98 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.898 -1.501 . . . . 0.0 108.725 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -49.16 -55.55 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.487 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -51.89 -34.15 39.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 112.756 -2.02 . . . . 0.0 110.69 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.8 -18.11 62.19 Favored Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.682 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.5 m-30 -86.66 -36.98 18.43 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.467 ' HA ' HD11 ' B' ' 399' ' ' ILE . 0.0 OUTLIER -68.12 -13.29 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 CA-C-O 122.114 0.959 . . . . 0.0 109.282 176.204 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.67 -22.77 46.29 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.519 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' B' ' 395' ' ' TYR . 69.3 mt -91.9 -61.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.052 -178.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.97 -20.34 27.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 113.458 -1.701 . . . . 0.0 112.329 -176.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.557 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.463 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.767 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.48 ' O ' ' SD ' ' A' ' 11' ' ' MET . 10.0 p-10 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.569 ' CG1' ' H ' ' A' ' 9' ' ' ASP . 0.9 OUTLIER -155.8 -166.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.532 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.569 ' H ' ' CG1' ' A' ' 8' ' ' ILE . 6.7 t70 68.89 -54.16 0.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.951 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 13' ' ' SER . 34.0 mt-30 -74.19 -56.35 5.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.614 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.492 ' C ' ' O ' ' A' ' 10' ' ' GLN . 48.5 mtp -20.54 -70.87 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 O-C-N 124.183 0.927 . . . . 0.0 111.941 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' MET . 16.9 m-85 -38.88 -57.1 1.28 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.227 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -68.41 -36.16 78.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.705 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.75 -24.99 66.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.095 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.545 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? -98.14 -38.42 9.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -40.56 91.27 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.92 -38.19 95.61 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.508 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 91.4 mt-10 -69.74 -37.87 76.64 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.5 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 9.0 mtp -58.34 -32.36 68.45 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.921 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 0.2 OUTLIER -52.01 -27.3 13.07 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.418 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 21' ' ' LEU . 4.2 mm? -77.44 -11.16 59.81 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.437 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.738 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -86.04 -9.42 56.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.14 0.495 . . . . 0.0 109.901 179.629 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.619 HG21 ' H ' ' A' ' 28' ' ' VAL . 1.3 m -120.25 -42.77 2.55 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.114 0.483 . . . . 0.0 110.737 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER 47.53 -178.23 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.714 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 26' ' ' LEU . 1.5 t 37.44 -90.13 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.219 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 24' ' ' GLN . 4.5 mm? -42.68 -34.89 0.98 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.527 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 40.56 71.9 0.27 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.619 ' H ' HG21 ' A' ' 23' ' ' THR . 92.5 t -69.76 -2.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.339 . . . . 0.0 110.565 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.65 22.18 3.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.402 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.431 ' HG1' ' CG ' ' A' ' 20' ' ' ASP . 1.8 m . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.57 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 308' ' ' TYR . . . . . 0.409 ' O ' ' N ' ' B' ' 310' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 68.22 -65.61 0.38 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' B' ' 308' ' ' TYR . 74.0 t -126.56 133.45 68.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.735 0.302 . . . . 0.0 110.755 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.59 153.25 24.44 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -129.72 135.68 48.76 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.058 0.224 . . . . 0.0 111.434 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -139.2 129.49 25.47 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.648 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.873 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.37 104.45 12.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.933 1.825 . . . . 0.0 109.403 178.349 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.645 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.6 m -115.6 160.93 14.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 112.583 -2.099 . . . . 0.0 110.101 -176.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -103.89 144.49 31.43 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' B' ' 326' ' ' VAL . 27.1 tt0 -132.66 152.77 51.59 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.088 0.947 . . . . 0.0 112.767 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -81.37 103.25 10.99 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.891 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.4 ' HE3' ' OE2' ' B' ' 317' ' ' GLU . 33.7 mmt -99.71 178.78 4.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.118 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.748 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -99.77 150.38 22.39 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.238 178.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 118.22 -23.84 9.0 Favored Glycine 0 C--N 1.315 -0.607 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -139.0 -142.82 0.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.265 -0.467 . . . . 0.0 110.59 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -139.25 -20.32 0.96 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.428 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.528 ' H ' ' HD2' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -88.99 -176.85 5.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 110.92 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 31.6 mt -89.77 165.24 14.28 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.147 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' B' ' 317' ' ' GLU . 9.4 t -123.67 126.21 25.81 Favored Pre-proline 0 N--CA 1.439 -0.993 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.056 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.47 ' O ' HG12 ' B' ' 326' ' ' VAL . 65.5 Cg_exo -44.49 145.32 2.63 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 N-CA-C 108.121 -1.53 . . . . 0.0 108.121 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' B' ' 315' ' ' VAL . 9.9 ttm-85 -150.13 -173.21 4.37 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.787 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.64 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -143.89 122.1 12.24 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.839 HD12 ' O ' ' B' ' 338' ' ' MET . 26.2 tp -101.34 158.01 16.36 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.432 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.53 107.51 0.51 Allowed Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.708 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -88.22 124.0 41.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.725 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.6 p -118.23 137.74 52.81 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -56.93 12.8 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.908 0.385 . . . . 0.0 111.724 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.725 ' H ' ' C ' ' B' ' 333' ' ' THR . 10.8 pt-20 -144.06 -2.49 0.9 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.712 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.2 OUTLIER -174.03 -179.28 1.66 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.357 1.075 . . . . 0.0 113.372 -177.372 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.597 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.6 t -137.95 144.84 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.106 0 CA-C-N 113.257 -1.792 . . . . 0.0 107.036 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.839 ' O ' HD12 ' B' ' 330' ' ' LEU . 5.8 ptp -153.03 151.33 30.13 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 117.178 -1.809 . . . . 0.0 114.347 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.51 ' NH1' ' OE2' ' B' ' 317' ' ' GLU . 38.8 mtm180 -96.15 107.67 20.02 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.539 176.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.64 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.76 149.03 5.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.43 -178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' B' ' 344' ' ' THR . 44.6 t0 -88.75 90.5 8.43 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.962 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.79 -28.39 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.66 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.3 mttp -68.99 -43.98 73.77 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.441 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.546 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -115.73 -16.39 11.24 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 345' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' B' ' 344' ' ' THR . 2.7 tttp 77.11 -0.75 2.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.013 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.455 ' O ' HG13 ' B' ' 340' ' ' VAL . 8.7 pt-20 -80.12 158.01 26.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.509 HG22 HG22 ' B' ' 340' ' ' VAL . 86.4 t -88.64 133.77 30.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.432 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 61.0 mt -102.18 -29.36 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.3 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.447 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 26.2 tt0 -143.46 157.89 44.09 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.938 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 350' ' ' GLU . . . . . 0.408 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 36.3 mt-10 -146.13 149.45 34.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.996 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.576 ' O ' ' N ' ' B' ' 337' ' ' VAL . 70.1 t-105 -161.14 136.78 7.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.994 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 352' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.71 137.95 48.5 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.515 0.674 . . . . 0.0 111.554 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.627 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -78.66 -35.38 45.36 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 4.9 t -75.37 11.22 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.874 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' B' ' 353' ' ' LEU . 4.7 m-20 -115.08 -3.71 12.57 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.289 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.499 HD12 HD23 ' B' ' 353' ' ' LEU . 75.6 mt -58.71 148.92 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.854 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 357' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 6.9 tttp -106.96 -45.36 4.18 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.492 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 1.7 ptt180 -174.84 136.41 0.41 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.518 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.492 ' CH2' HD12 ' B' ' 396' ' ' ILE . 6.8 p90 -118.71 175.46 5.73 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.246 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.34 97.7 1.65 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.909 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.795 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.81 142.29 33.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.785 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.519 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -129.91 174.08 5.02 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -77.43 -8.47 17.26 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.156 1.904 . . . . 0.0 112.121 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' B' ' 382' ' ' THR . 20.3 mtpt -130.66 -21.84 2.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.855 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.653 ' HA ' ' H ' ' B' ' 382' ' ' THR . 86.3 p -149.81 169.74 20.39 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.507 0.67 . . . . 0.0 111.743 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.499 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -142.35 156.43 45.23 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.885 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.545 ' CG2' HD12 ' A' ' 15' ' ' LEU . 44.0 m -147.77 156.76 43.08 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.711 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.468 ' N ' HG22 ' B' ' 367' ' ' THR . 5.7 mt -129.92 142.45 50.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.495 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.2 t0 -119.14 95.64 4.9 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.743 176.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.525 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 12.6 p90 -136.07 93.43 2.91 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.235 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.95 11.7 1.8 Allowed Glycine 0 N--CA 1.462 0.391 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -41.74 -15.53 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.21 -0.495 . . . . 0.0 111.856 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.9 -36.55 65.3 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.495 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.06 -93.25 0.49 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.495 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.8 t0 -129.01 96.43 4.34 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.8 -1.81 55.17 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.315 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.31 105.96 17.04 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -175.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.96 125.77 51.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.645 176.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.5 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.8 t -138.19 164.12 30.0 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.575 0.702 . . . . 0.0 112.458 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -150.39 174.08 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.867 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -100.92 126.17 47.54 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.954 0.883 . . . . 0.0 111.072 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.653 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.93 136.49 14.26 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.404 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.02 16.66 4.77 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.142 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.55 84.33 1.8 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.119 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.88 -59.15 1.91 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.504 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 15.4 pt-20 -44.17 -20.72 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.625 -0.787 . . . . 0.0 111.029 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 5.0 mm-40 -82.85 -38.7 22.64 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 47.1 mt -77.23 -42.38 31.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.526 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.795 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.41 -42.9 61.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.676 -177.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.54 -34.81 78.61 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 122.093 0.949 . . . . 0.0 110.892 -177.434 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.06 -53.89 9.94 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.771 -1.559 . . . . 0.0 108.713 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.9 mt -48.83 -55.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.482 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.62 -33.75 48.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.742 -2.026 . . . . 0.0 110.639 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.13 -17.93 61.89 Favored Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.676 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.1 -36.66 17.98 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.492 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.8 -13.2 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 122.178 0.99 . . . . 0.0 109.264 176.027 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -22.61 46.45 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.503 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.4 mt -91.63 -62.07 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 113.899 -1.5 . . . . 0.0 112.067 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.21 -20.69 27.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.437 -177.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.565 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.487 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.89 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.589 ' N ' ' SD ' ' A' ' 11' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 8' ' ' ILE . 58.3 mt 52.33 11.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.211 0.529 . . . . 0.0 110.667 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.449 ' N ' ' C ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -124.73 -33.13 3.01 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.49 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.473 ' O ' ' C ' ' A' ' 11' ' ' MET . 78.6 mt-30 -126.72 -36.14 2.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.63 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' A' ' 7' ' ' ASP . 20.3 mtm -22.73 -70.9 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 123.981 0.801 . . . . 0.0 112.049 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 11' ' ' MET . 10.9 m-85 -36.48 -56.16 0.81 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.146 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 10' ' ' GLN . 2.0 t -69.82 -28.71 65.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.912 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 11' ' ' MET . 0.2 OUTLIER -72.54 -17.37 61.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.591 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.6 mm? -110.69 -41.31 4.33 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 16' ' ' LEU . 59.1 mt -61.01 -41.22 96.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.569 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.39 -37.91 93.91 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -69.84 -39.3 76.5 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.525 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 4.4 mtp -56.56 -31.75 64.49 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.959 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.4 -27.8 17.25 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.329 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.54 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.1 mm? -75.95 -9.02 58.27 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.251 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.668 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -93.05 -9.06 41.03 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.244 0.545 . . . . 0.0 109.8 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 23' ' ' THR . 21.3 m -133.71 -3.17 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.044 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 12.1 mp0 39.85 -92.18 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.933 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -142.14 -7.86 0.91 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.299 -178.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' B' ' 323' ' ' ASN . 5.4 mp -40.33 -84.49 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.647 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.08 -95.52 0.12 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.646 HG12 ' N ' ' A' ' 29' ' ' ASP . 47.4 t -142.83 -113.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.694 0.283 . . . . 0.0 110.452 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.646 ' N ' HG12 ' A' ' 28' ' ' VAL . 8.2 t70 -97.16 44.79 1.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.624 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.534 -179.979 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 308' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' B' ' 309' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 309' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' B' ' 308' ' ' TYR . . . 43.31 -168.52 0.01 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 97.2 t -41.6 137.62 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 0.0 110.809 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.27 152.91 29.25 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.138 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -130.58 134.3 46.89 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.994 0.184 . . . . 0.0 111.413 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -137.59 130.14 29.73 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.565 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.874 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -83.98 101.78 11.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 123.965 1.84 . . . . 0.0 109.309 178.189 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.662 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.7 m -112.16 161.93 10.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 112.645 -2.071 . . . . 0.0 110.175 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -105.04 145.97 29.74 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' B' ' 326' ' ' VAL . 24.4 tt0 -133.62 151.43 51.68 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 122.037 0.922 . . . . 0.0 112.665 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -81.82 101.77 10.39 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.176 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 33.6 mmt -98.76 178.62 4.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.029 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.648 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.43 158.16 16.27 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.733 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 110.88 -22.95 20.58 Favored Glycine 0 C--N 1.308 -0.988 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -136.51 -139.65 0.16 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.255 -0.472 . . . . 0.0 110.634 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 323' ' ' ASN . . . . . 0.544 ' HB3' HD21 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -143.98 -18.4 0.58 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.473 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.536 ' H ' ' HD2' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -93.82 -176.52 4.07 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.031 0.443 . . . . 0.0 110.968 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 325' ' ' LEU . . . . . 0.454 HD11 HD21 ' A' ' 22' ' ' LEU . 30.7 mt -87.87 165.6 15.16 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.174 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.6 t -124.21 124.12 25.91 Favored Pre-proline 0 N--CA 1.439 -1.019 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.887 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.429 ' O ' HG12 ' B' ' 326' ' ' VAL . 66.2 Cg_exo -44.58 145.62 2.57 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 N-CA-C 107.956 -1.594 . . . . 0.0 107.956 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.662 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.8 ttt180 -149.91 -174.1 4.61 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.725 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.35 123.44 12.87 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.081 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.831 HD12 ' O ' ' B' ' 338' ' ' MET . 26.7 tp -102.13 159.03 15.74 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.442 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.07 108.07 0.52 Allowed Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.746 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -89.04 123.7 41.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.726 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.48 138.1 52.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.63 13.84 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.114 0.483 . . . . 0.0 111.793 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.726 ' H ' ' C ' ' B' ' 333' ' ' THR . 8.9 pt-20 -144.4 -3.16 0.84 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.868 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.88 178.52 2.17 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 122.272 1.034 . . . . 0.0 113.003 -177.125 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.5 t -135.79 145.96 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-N 113.4 -1.727 . . . . 0.0 106.573 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.831 ' O ' HD12 ' B' ' 330' ' ' LEU . 2.2 ptt? -153.93 150.31 28.2 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 117.044 -1.863 . . . . 0.0 114.262 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.553 ' NH2' HG21 ' B' ' 315' ' ' VAL . 3.2 mtp85 -94.89 107.6 19.63 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.669 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.11 149.94 5.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.371 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' B' ' 344' ' ' THR . 3.2 t70 -90.46 92.62 8.96 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.755 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.7 OUTLIER -35.87 -28.76 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.626 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' B' ' 341' ' ' ASP . 41.9 mttt -73.2 -43.49 61.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.691 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.7 p -111.43 -12.82 13.96 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt 67.63 -0.85 1.79 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 109.999 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.3 mt-10 -84.55 151.97 24.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.311 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.626 HG21 ' SD ' ' B' ' 338' ' ' MET . 77.7 t -82.94 135.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.526 0.679 . . . . 0.0 112.308 -178.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.641 HD12 ' NH2' ' B' ' 328' ' ' ARG . 70.9 mt -103.82 -30.99 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.438 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.466 ' O ' ' CB ' ' B' ' 338' ' ' MET . 37.4 tt0 -138.85 156.04 47.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.584 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -145.51 149.6 34.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.336 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.552 ' O ' ' N ' ' B' ' 337' ' ' VAL . 64.1 t-105 -161.83 134.95 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.838 177.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.508 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.52 138.77 27.06 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.477 -178.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.622 HD12 ' O ' ' B' ' 333' ' ' THR . 1.8 tt -79.08 -35.74 41.95 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 4.7 t -74.86 11.24 1.12 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.895 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.508 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.5 m-20 -114.75 -4.16 12.74 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.14 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.484 HD12 HD23 ' B' ' 353' ' ' LEU . 73.5 mt -57.86 147.97 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.088 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 357' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 8.1 tttp -105.9 -45.48 4.36 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.8 ptt180 -174.69 136.4 0.43 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.462 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.467 ' CH2' HD12 ' B' ' 396' ' ' ILE . 10.1 p90 -119.45 173.14 7.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.174 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.0 99.11 1.8 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.086 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.16 148.6 30.85 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.951 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -136.69 173.43 5.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -76.82 -8.81 18.12 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.122 1.882 . . . . 0.0 112.073 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' B' ' 382' ' ' THR . 12.6 mtpp -130.68 -21.64 2.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.968 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.659 ' HA ' ' H ' ' B' ' 382' ' ' THR . 89.8 p -150.35 169.23 21.91 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.606 0.717 . . . . 0.0 111.852 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.506 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -141.78 156.88 45.56 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.888 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.591 ' CG2' HD12 ' A' ' 15' ' ' LEU . 34.2 m -148.06 156.68 42.91 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.091 -1.043 . . . . 0.0 112.809 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.459 ' N ' HG22 ' B' ' 367' ' ' THR . 6.0 mt -129.21 144.51 51.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.567 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 22.2 t0 -120.51 95.82 4.88 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.837 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.517 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 11.0 p90 -136.71 93.71 2.9 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.369 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.81 12.51 1.72 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -41.9 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.159 -0.521 . . . . 0.0 111.719 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.62 -37.32 65.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.476 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.77 -92.8 0.5 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.934 -1.484 . . . . 0.0 107.097 176.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.476 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.6 t70 -129.12 96.34 4.3 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.24 -2.81 55.75 Favored Glycine 0 C--N 1.312 -0.75 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.217 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.686 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.96 106.3 17.04 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -175.57 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.81 125.57 51.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.747 175.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.525 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.9 t -138.49 162.63 34.03 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.482 0.658 . . . . 0.0 112.646 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.05 172.6 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.022 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.23 126.3 45.01 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.886 0.851 . . . . 0.0 111.074 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.659 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.02 135.97 13.76 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.698 179.265 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.57 17.95 3.6 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.178 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.05 83.89 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.049 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.91 -59.34 1.89 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.9 pt-20 -45.01 -19.85 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 114.754 -0.723 . . . . 0.0 111.016 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.436 ' N ' ' C ' ' B' ' 385' ' ' GLY . 73.1 mt-30 -82.96 -39.56 21.23 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' B' ' 385' ' ' GLY . 40.6 mt -76.95 -41.86 32.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.731 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -74.11 -41.97 60.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.651 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.438 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 15.5 pt20 -63.93 -34.77 78.71 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.059 0.933 . . . . 0.0 111.023 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.656 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.92 -53.82 10.31 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.813 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.656 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.11 -55.98 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.476 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.42 -33.74 45.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.663 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.19 -17.79 62.07 Favored Glycine 0 CA--C 1.506 -0.469 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.676 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.11 -37.0 17.78 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.467 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.6 -13.27 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-O 122.187 0.994 . . . . 0.0 109.281 176.182 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.64 -22.67 46.54 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.473 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.4 mt -91.76 -62.07 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 113.897 -1.502 . . . . 0.0 112.035 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.3 -20.51 27.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.396 -177.075 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.877 -1.059 . . . . 0.0 110.797 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.623 HG22 ' O ' ' A' ' 8' ' ' ILE . 61.1 mt -78.78 10.37 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.325 0.583 . . . . 0.0 110.739 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.81 -32.28 8.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.315 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 11' ' ' MET . 78.2 mt-30 -101.06 -35.11 9.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.546 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.487 ' C ' ' O ' ' A' ' 10' ' ' GLN . 6.1 mmm -18.97 -72.59 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 124.153 0.908 . . . . 0.0 112.146 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -42.76 -62.63 0.95 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.968 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 10' ' ' GLN . 6.4 t -56.6 -35.4 68.22 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.811 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -47.94 79.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.031 0.444 . . . . 0.0 110.773 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.546 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.3 mm? -76.49 -41.56 46.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -38.61 77.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.513 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.32 97.99 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 89.1 mt-10 -63.67 -36.42 83.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.512 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 4.7 mtp -61.82 -31.88 72.16 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.883 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.63 -28.78 15.4 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.23 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -75.12 -9.41 58.51 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.311 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.684 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -93.18 -8.88 41.18 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.119 0.485 . . . . 0.0 109.82 179.207 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 23' ' ' THR . 24.4 m -131.95 -1.52 3.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.803 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 14.9 mp0 41.58 -91.21 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.894 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -140.71 -11.18 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.417 -178.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tp -47.02 -36.49 7.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.757 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 41.29 80.43 0.04 OUTLIER Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.505 HG23 ' H ' ' A' ' 29' ' ' ASP . 3.8 m -88.94 -109.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.724 0.297 . . . . 0.0 110.444 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.505 ' H ' HG23 ' A' ' 28' ' ' VAL . 4.8 t70 51.41 81.38 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.659 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.578 -179.922 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 308' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' B' ' 309' ' ' GLY . 1.7 p90 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 309' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 308' ' ' TYR . . . -60.21 -135.53 0.01 OUTLIER Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.5 t -40.8 137.14 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.718 0.294 . . . . 0.0 110.805 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.47 153.19 27.78 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.192 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -130.09 134.39 47.33 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 123.059 0.224 . . . . 0.0 111.465 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -138.74 129.02 25.68 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.499 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.878 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.23 105.05 13.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.834 1.778 . . . . 0.0 109.446 178.469 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.631 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.6 m -115.79 160.92 14.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 112.596 -2.093 . . . . 0.0 110.1 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -103.52 145.67 29.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' B' ' 326' ' ' VAL . 25.3 tt0 -132.46 150.64 52.12 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 122.071 0.938 . . . . 0.0 112.601 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 318' ' ' LYS . . . . . 0.435 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 6.2 tptm -82.37 101.45 10.61 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.205 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.601 ' SD ' ' NZ ' ' B' ' 320' ' ' LYS . 38.3 mmt -94.91 179.09 5.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.173 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.635 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.48 157.92 16.45 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.89 179.116 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 108.51 -21.88 27.52 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 -141.66 0.16 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.561 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 323' ' ' ASN . . . . . 0.435 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.7 OUTLIER -143.57 -18.86 0.61 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.482 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.439 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -90.07 -176.52 4.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.976 0.417 . . . . 0.0 110.911 -179.365 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 325' ' ' LEU . . . . . 0.468 HD11 HD21 ' A' ' 22' ' ' LEU . 31.7 mt -91.85 165.02 13.46 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.219 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' B' ' 317' ' ' GLU . 5.2 t -123.88 123.71 26.16 Favored Pre-proline 0 N--CA 1.44 -0.953 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.909 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.423 ' O ' HG12 ' B' ' 326' ' ' VAL . 63.1 Cg_exo -44.27 145.18 2.49 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.107 -1.536 . . . . 0.0 108.107 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.631 ' N ' ' O ' ' B' ' 315' ' ' VAL . 10.6 ttm-85 -149.96 -173.5 4.45 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 119.498 -0.881 . . . . 0.0 108.658 -177.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.4 121.7 12.29 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.052 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.83 HD12 ' O ' ' B' ' 338' ' ' MET . 28.0 tp -100.15 158.31 15.95 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.44 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.81 108.38 0.54 Allowed Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.725 HD11 HD21 ' B' ' 330' ' ' LEU . 31.0 mm -88.75 124.61 41.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.723 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.94 138.13 53.0 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 334' ' ' LYS . . . . . 0.41 ' NZ ' ' CZ ' ' B' ' 395' ' ' TYR . 0.0 OUTLIER -57.34 14.71 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.74 0.305 . . . . 0.0 111.301 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -145.15 -3.66 0.75 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.497 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.81 179.98 1.88 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.287 1.041 . . . . 0.0 113.073 -176.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.67 146.53 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 CA-C-N 113.293 -1.776 . . . . 0.0 106.493 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.83 ' O ' HD12 ' B' ' 330' ' ' LEU . 2.0 ptt? -154.56 150.33 27.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 117.086 -1.845 . . . . 0.0 114.303 -176.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.658 HH21 ' NE2' ' B' ' 349' ' ' GLN . 18.3 mtt-85 -95.12 107.94 20.03 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.561 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.6 149.74 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.259 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' B' ' 344' ' ' THR . 24.7 t0 -88.97 91.91 9.02 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.724 -178.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 1.0 OUTLIER -35.38 -28.63 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.692 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 341' ' ' ASP . 32.9 mttt -75.64 -43.81 45.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.749 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.554 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -108.9 -12.64 14.86 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -177.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 345' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' B' ' 341' ' ' ASP . 13.3 ttmt 66.81 -0.29 1.68 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.017 0.436 . . . . 0.0 109.994 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.5 mt-10 -85.45 153.59 22.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.314 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.602 HG21 ' SD ' ' B' ' 338' ' ' MET . 81.6 t -83.4 134.31 27.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.493 0.663 . . . . 0.0 112.363 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 66.4 mt -102.72 -30.15 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.335 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.658 ' NE2' HH21 ' B' ' 339' ' ' ARG . 38.5 tt0 -140.41 156.84 46.25 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.627 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -145.27 149.7 35.34 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.387 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.577 ' O ' ' N ' ' B' ' 337' ' ' VAL . 70.9 t-105 -160.93 135.37 7.23 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.696 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.4 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -54.84 138.53 42.54 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.461 0.648 . . . . 0.0 111.492 -178.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.638 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -78.57 -35.58 45.7 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 354' ' ' THR . . . . . 0.556 HG22 ' O ' ' B' ' 354' ' ' THR . 21.8 m -73.68 8.81 1.69 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.882 177.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' B' ' 353' ' ' LEU . 4.8 m-20 -112.75 -2.35 14.48 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.147 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.525 HD12 HD23 ' B' ' 353' ' ' LEU . 68.0 mt -61.32 146.82 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.211 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 357' ' ' LYS . . . . . 0.48 ' HZ2' ' HB3' ' B' ' 372' ' ' ASP . 4.9 tttt -106.62 -45.24 4.28 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 0.1 OUTLIER -174.88 136.08 0.39 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.388 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.497 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.1 p90 -119.72 175.33 5.92 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.212 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.62 99.99 1.6 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.239 -0.984 . . . . 0.0 112.057 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.761 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.09 143.81 32.17 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.752 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.544 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -131.0 174.05 5.15 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -77.11 -9.05 17.84 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.043 1.829 . . . . 0.0 112.036 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.0 mttt -130.79 -21.1 2.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.972 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.664 ' HA ' ' H ' ' B' ' 382' ' ' THR . 78.6 p -149.81 169.54 20.86 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.513 0.673 . . . . 0.0 111.866 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.49 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.2 OUTLIER -141.09 156.32 46.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.583 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.546 ' CG2' HD12 ' A' ' 15' ' ' LEU . 54.8 m -146.31 156.89 43.67 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.885 -174.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.472 ' N ' HG22 ' B' ' 367' ' ' THR . 5.7 mt -130.79 139.68 50.23 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.54 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 22.5 t0 -116.6 95.86 5.24 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.779 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.534 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 11.2 p90 -135.93 94.01 3.0 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.532 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.77 12.51 1.73 Allowed Glycine 0 C--O 1.225 -0.427 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 372' ' ' ASP . . . . . 0.48 ' HB3' ' HZ2' ' B' ' 357' ' ' LYS . 8.4 t0 -41.74 -16.13 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.054 -0.573 . . . . 0.0 111.774 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.554 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.42 -37.28 64.93 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.477 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.98 -92.38 0.51 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.942 -1.481 . . . . 0.0 107.183 176.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.477 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.6 t0 -129.47 96.42 4.27 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.14 -3.46 55.67 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.149 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.697 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.03 106.7 17.38 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -175.649 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 378' ' ' TYR . . . . . 0.649 ' CG ' ' NH2' ' B' ' 339' ' ' ARG . 0.3 OUTLIER -120.04 127.4 52.55 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.835 175.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.512 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 33.1 t -138.64 166.52 24.14 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.621 0.724 . . . . 0.0 112.61 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.18 174.26 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.893 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -101.14 125.38 47.75 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.964 0.888 . . . . 0.0 111.092 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.664 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.83 136.82 14.62 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.84 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.27 16.88 4.77 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.211 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.07 83.88 1.75 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.021 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.38 -57.44 2.1 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.8 pt-20 -45.04 -20.2 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 114.82 -0.69 . . . . 0.0 111.091 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.426 ' N ' ' C ' ' B' ' 385' ' ' GLY . 4.6 mm-40 -83.05 -39.16 21.58 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' B' ' 385' ' ' GLY . 49.1 mt -76.58 -42.55 34.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.634 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.761 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.46 -42.53 61.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.306 -1.315 . . . . 0.0 113.604 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.453 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 12.3 pt20 -63.56 -34.72 78.43 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.001 0.905 . . . . 0.0 111.04 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.33 -53.6 10.4 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.85 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -49.02 -55.61 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.485 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -53.14 -33.61 53.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.684 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.05 -17.71 62.46 Favored Glycine 0 CA--C 1.505 -0.538 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.669 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.2 m-30 -87.07 -37.15 17.7 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.497 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.58 -13.36 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-O 122.211 1.005 . . . . 0.0 109.371 176.121 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.01 -22.62 45.23 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.525 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' B' ' 395' ' ' TYR . 71.4 mt -91.76 -62.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.998 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.31 -20.75 27.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.322 -176.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.79 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 9' ' ' ASP . 13.1 p30 . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 8' ' ' ILE . 60.9 mt -72.68 10.87 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.4 0.619 . . . . 0.0 110.698 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -103.54 -32.01 9.66 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.394 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.502 ' O ' ' C ' ' A' ' 11' ' ' MET . 78.5 mt-30 -100.39 -35.23 9.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.578 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.502 ' C ' ' O ' ' A' ' 10' ' ' GLN . 24.6 mtp -18.18 -73.67 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 124.122 0.889 . . . . 0.0 112.159 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' MET . 10.1 m-85 -40.66 -63.38 0.66 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.998 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 10' ' ' GLN . 5.1 t -57.15 -34.45 68.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.845 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -46.77 86.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.55 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.3 mm? -77.39 -42.24 37.1 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -39.22 79.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.462 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.06 -43.86 98.16 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 88.8 mt-10 -62.97 -37.45 87.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.523 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 6.4 mtp -60.85 -33.22 72.72 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.003 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.16 -29.96 15.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.169 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 21' ' ' LEU . 4.2 mm? -75.69 -13.97 60.33 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.294 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.732 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -86.38 -12.88 48.01 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.977 0.417 . . . . 0.0 109.932 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 24' ' ' GLN . 1.4 m -124.98 -27.51 3.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.958 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.7 OUTLIER 39.37 -161.13 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.367 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -26.95 66.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.19 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.4 mm? -47.51 -35.79 9.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.939 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -45.37 -31.63 3.45 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.63 -22.62 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.642 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.65 -1.23 53.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.557 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.578 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -77.19 -40.18 25.05 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 71.3 t -126.33 133.99 67.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.778 0.323 . . . . 0.0 110.822 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.28 153.26 25.1 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.1 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -129.39 135.44 48.71 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -139.1 129.43 25.55 Favored 'General case' 0 C--N 1.347 0.485 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.522 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.886 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.33 105.73 13.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 123.825 1.774 . . . . 0.0 109.402 178.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' B' ' 328' ' ' ARG . 33.0 m -116.98 161.11 15.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 112.564 -2.107 . . . . 0.0 110.122 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -103.5 145.34 30.15 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' B' ' 339' ' ' ARG . 27.1 tt0 -132.76 152.04 51.86 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.119 0.961 . . . . 0.0 112.606 -178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -82.19 101.92 10.77 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.118 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.54 ' SD ' ' NH2' ' B' ' 328' ' ' ARG . 36.6 mmt -95.92 179.31 5.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.067 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.638 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.18 157.99 16.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.849 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 108.55 -21.3 28.51 Favored Glycine 0 C--N 1.308 -1.003 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.38 -141.23 0.15 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.299 -0.451 . . . . 0.0 110.609 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -143.24 -21.73 0.62 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.486 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.537 ' H ' ' HD2' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -86.91 -176.61 5.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.944 0.402 . . . . 0.0 110.99 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 325' ' ' LEU . . . . . 0.469 HD11 HD21 ' A' ' 22' ' ' LEU . 28.1 mt -91.79 165.15 13.42 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.202 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t -124.31 125.8 25.62 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.971 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.453 ' O ' HG12 ' B' ' 326' ' ' VAL . 62.4 Cg_exo -44.76 145.56 2.77 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 N-CA-C 108.029 -1.566 . . . . 0.0 108.029 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.649 ' N ' ' O ' ' B' ' 315' ' ' VAL . 4.2 ttm180 -150.59 -173.45 4.47 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 119.518 -0.873 . . . . 0.0 108.76 -177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.65 122.38 12.62 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.829 HD12 ' O ' ' B' ' 338' ' ' MET . 27.7 tp -101.69 157.87 16.52 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.434 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.29 107.92 0.53 Allowed Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 330' ' ' LEU . 31.1 mm -88.56 124.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.723 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.4 p -118.44 138.2 52.63 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.34 14.58 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.872 0.368 . . . . 0.0 111.331 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' B' ' 333' ' ' THR . 12.9 pt-20 -145.37 -2.88 0.75 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.459 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.88 179.66 1.93 Allowed 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.322 1.058 . . . . 0.0 113.088 -176.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.593 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.1 t -137.36 146.43 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 113.276 -1.784 . . . . 0.0 106.535 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.829 ' O ' HD12 ' B' ' 330' ' ' LEU . 4.0 ptt? -154.76 149.63 26.7 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 117.056 -1.857 . . . . 0.0 114.274 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.528 ' NH2' ' OE2' ' B' ' 317' ' ' GLU . 15.6 mtp180 -94.55 107.73 19.71 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.633 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.89 149.88 5.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.207 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 28.7 t0 -89.45 92.02 8.95 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.729 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.49 -28.79 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.745 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.7 mttm -75.21 -43.61 50.88 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.732 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.555 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.32 -12.34 14.77 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm 66.58 -1.09 1.37 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 109.962 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.4 mt-10 -84.55 153.33 23.32 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.36 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.589 HG21 ' SD ' ' B' ' 338' ' ' MET . 82.3 t -83.29 135.16 25.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.497 0.665 . . . . 0.0 112.285 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 67.2 mt -103.54 -30.17 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.407 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.468 ' O ' ' CB ' ' B' ' 338' ' ' MET . 23.5 tt0 -140.6 156.46 46.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.675 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -145.66 149.87 35.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.517 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.548 ' O ' ' N ' ' B' ' 337' ' ' VAL . 65.3 t-105 -162.82 134.87 5.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.711 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.499 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -53.13 139.39 28.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.496 0.665 . . . . 0.0 111.425 -178.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.639 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -78.77 -36.04 43.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 354' ' ' THR . . . . . 0.563 HG22 ' O ' ' B' ' 354' ' ' THR . 21.6 m -73.16 9.13 1.33 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.901 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.499 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.2 m-20 -113.52 -1.99 13.98 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.157 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.515 HD12 HD23 ' B' ' 353' ' ' LEU . 66.1 mt -61.17 145.6 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.182 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 357' ' ' LYS . . . . . 0.457 ' HZ2' ' HB3' ' B' ' 372' ' ' ASP . 5.6 tttt -104.38 -45.72 4.59 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.515 0.674 . . . . 0.0 109.21 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.7 ptt180 -174.92 136.19 0.39 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.514 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.4 p90 -118.89 174.71 6.13 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.227 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.64 99.38 1.72 Allowed 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 119.28 -0.968 . . . . 0.0 112.11 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.771 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.83 146.99 30.62 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.856 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.536 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -135.35 173.64 5.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -77.02 -8.15 17.6 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.003 1.802 . . . . 0.0 112.221 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' B' ' 382' ' ' THR . 23.0 mttt -131.02 -21.91 2.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.048 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.677 ' HA ' ' H ' ' B' ' 382' ' ' THR . 79.0 p -150.33 168.88 22.79 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.6 0.714 . . . . 0.0 111.895 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.504 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -141.09 156.79 45.93 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.75 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.55 ' CG2' HD12 ' A' ' 15' ' ' LEU . 39.7 m -147.54 156.55 42.94 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.942 -174.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.46 ' N ' HG22 ' B' ' 367' ' ' THR . 5.6 mt -129.56 141.87 50.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.628 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 21.1 t0 -118.19 95.59 4.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.677 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.524 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 11.3 p90 -136.23 93.98 2.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.657 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.49 12.45 1.8 Allowed Glycine 0 C--O 1.226 -0.349 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 372' ' ' ASP . . . . . 0.457 ' HB3' ' HZ2' ' B' ' 357' ' ' LYS . 9.2 t0 -41.79 -16.15 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.12 -0.54 . . . . 0.0 111.721 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.5 -37.38 65.24 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.48 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.5 OUTLIER -125.76 -92.5 0.51 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.169 176.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.48 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.6 t70 -129.41 96.3 4.25 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.37 -3.01 55.61 Favored Glycine 0 C--N 1.313 -0.714 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.217 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.689 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.93 106.16 16.92 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -175.655 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.54 126.66 52.96 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.77 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.523 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 47.2 t -138.47 164.55 29.1 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.6 0.714 . . . . 0.0 112.679 -177.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.64 174.13 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.971 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -100.91 125.12 47.44 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.94 0.876 . . . . 0.0 111.128 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.677 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.41 137.45 14.62 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.827 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 383' ' ' THR . . . . . 0.415 ' N ' ' OE2' ' B' ' 384' ' ' GLU . 0.8 OUTLIER -84.83 -1.13 56.06 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.975 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 384' ' ' GLU . . . . . 0.533 ' H ' ' CD ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -123.93 84.0 2.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.038 0.923 . . . . 0.0 108.71 175.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.24 -58.5 1.97 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.507 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.8 pt-20 -46.81 -20.6 0.14 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 114.696 -0.752 . . . . 0.0 110.982 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 387' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -80.95 -39.09 26.64 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.504 HG21 ' CE2' ' B' ' 366' ' ' PHE . 49.4 mt -77.06 -42.42 31.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.615 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.771 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.97 -42.4 60.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.308 -1.314 . . . . 0.0 113.506 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.57 -34.74 78.47 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.049 0.928 . . . . 0.0 111.047 -177.485 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.25 -53.49 10.74 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.894 -1.503 . . . . 0.0 108.815 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.9 mt -48.94 -55.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.483 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.84 -34.06 52.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 112.732 -2.031 . . . . 0.0 110.651 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.95 -17.58 62.91 Favored Glycine 0 CA--C 1.505 -0.543 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.667 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.2 m-30 -87.14 -37.2 17.57 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.514 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.51 -13.16 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 CA-C-O 122.1 0.952 . . . . 0.0 109.236 176.222 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -79.26 -22.73 44.32 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.51 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' B' ' 395' ' ' TYR . 70.9 mt -91.62 -61.76 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 114.001 -1.454 . . . . 0.0 112.051 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.75 -20.51 27.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.419 -1.719 . . . . 0.0 112.375 -176.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.56 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 N--CA 1.467 0.424 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.802 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 8' ' ' ILE . 61.0 m-20 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 7' ' ' ASP . 15.1 mt 58.4 151.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.688 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.91 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.146 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.529 ' O ' ' C ' ' A' ' 11' ' ' MET . 66.3 mt-30 -96.6 -47.55 5.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.849 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.529 ' C ' ' O ' ' A' ' 10' ' ' GLN . 24.7 mtp -11.45 -77.73 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.46 0 O-C-N 124.326 1.016 . . . . 0.0 112.209 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 11' ' ' MET . 11.9 m-85 -41.2 -62.67 0.8 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.045 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 10' ' ' GLN . 1.2 t -58.41 -34.26 70.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.912 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -58.69 -47.04 85.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.551 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.2 mm? -76.43 -42.7 43.18 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -58.81 -39.1 80.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.636 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.41 -43.3 99.25 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.46 -37.63 88.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.979 0.419 . . . . 0.0 109.97 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.507 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 4.4 mtp -60.03 -32.14 70.62 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.027 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.58 -29.17 16.26 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.287 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.544 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -74.11 -10.45 59.64 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.286 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.668 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -92.37 -9.17 42.75 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.122 0.487 . . . . 0.0 109.723 179.196 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.586 ' OG1' HD23 ' A' ' 22' ' ' LEU . 22.9 m -134.15 -2.06 2.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.62 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 13.1 mp0 40.94 -91.94 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.729 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -140.85 -9.89 1.02 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.316 -178.562 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mp -46.27 -73.51 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.669 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.63 89.59 0.4 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.568 ' O ' HG12 ' A' ' 28' ' ' VAL . 53.4 t -75.12 -3.27 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.883 0.373 . . . . 0.0 110.526 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 61.9 t0 46.55 69.69 0.46 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.629 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.545 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 308' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' B' ' 310' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 68.57 -65.96 0.42 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' B' ' 308' ' ' TYR . 68.9 t -126.31 133.43 68.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.773 0.321 . . . . 0.0 110.715 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.07 153.3 24.84 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -130.2 135.17 47.86 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.012 0.195 . . . . 0.0 111.514 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -138.14 130.0 28.35 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.519 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.87 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -83.49 103.56 12.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 123.92 1.819 . . . . 0.0 109.308 178.413 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.7 m -113.7 162.05 12.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 112.579 -2.101 . . . . 0.0 110.309 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -105.32 147.1 28.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' B' ' 326' ' ' VAL . 26.3 tt0 -134.74 152.73 51.99 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.02 0.914 . . . . 0.0 112.639 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 318' ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 7.1 tptm -84.27 102.11 12.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.422 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 38.7 mmt -94.66 179.09 5.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.188 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.772 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -100.72 151.25 21.88 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.091 178.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.05 -22.16 12.66 Favored Glycine 0 C--N 1.315 -0.637 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.99 -146.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.548 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 323' ' ' ASN . . . . . 0.463 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.5 OUTLIER -137.52 -20.01 1.2 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.572 179.608 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.443 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -87.26 -176.67 5.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 111.024 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 325' ' ' LEU . . . . . 0.475 HD11 HD21 ' A' ' 22' ' ' LEU . 28.9 mt -93.13 166.29 12.41 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.348 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t -124.4 124.75 25.73 Favored Pre-proline 0 N--CA 1.44 -0.95 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.888 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.432 ' O ' HG12 ' B' ' 326' ' ' VAL . 61.2 Cg_exo -44.8 145.95 2.6 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 N-CA-C 108.07 -1.55 . . . . 0.0 108.07 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.67 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.2 ttt180 -149.92 -174.21 4.64 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 119.529 -0.868 . . . . 0.0 108.689 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.616 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.34 122.64 12.29 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -176.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.831 HD12 ' O ' ' B' ' 338' ' ' MET . 25.8 tp -102.12 158.13 16.39 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.435 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.16 108.1 0.54 Allowed Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.744 HD11 HD21 ' B' ' 330' ' ' LEU . 31.3 mm -88.64 123.97 41.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.725 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.8 p -118.52 137.45 53.2 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.99 13.65 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.944 0.402 . . . . 0.0 111.667 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.725 ' H ' ' C ' ' B' ' 333' ' ' THR . 7.9 pt-20 -144.61 -2.68 0.84 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.711 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.89 179.0 2.06 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.404 1.097 . . . . 0.0 113.072 -176.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.602 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.3 t -136.84 146.17 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 CA-C-N 113.252 -1.795 . . . . 0.0 106.4 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.831 ' O ' HD12 ' B' ' 330' ' ' LEU . 4.0 ptt? -154.24 150.08 27.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 117.153 -1.819 . . . . 0.0 114.409 -176.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.538 ' NH2' HG21 ' B' ' 315' ' ' VAL . 2.8 mtp85 -95.08 107.86 19.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.54 176.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.7 t -99.49 150.22 5.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.304 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 344' ' ' THR . 32.8 t0 -90.72 92.35 8.78 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.767 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.54 -28.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.599 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' B' ' 341' ' ' ASP . 20.5 mttp -74.66 -43.56 54.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.688 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.45 -12.53 14.7 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 345' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.3 OUTLIER 66.34 -1.21 1.27 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.035 0.445 . . . . 0.0 110.023 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.6 mt-10 -84.79 152.1 23.89 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.332 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.613 HG21 ' SD ' ' B' ' 338' ' ' MET . 76.7 t -82.76 134.75 26.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.51 0.671 . . . . 0.0 112.305 -178.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 20.9 mm -102.71 -31.12 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.276 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.466 ' O ' ' CB ' ' B' ' 338' ' ' MET . 30.7 tt0 -139.79 156.86 46.53 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.611 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -145.75 149.41 34.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.249 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.539 ' O ' ' N ' ' B' ' 337' ' ' VAL . 64.2 t-105 -162.08 135.05 6.02 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.057 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.514 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.39 139.42 24.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.432 0.634 . . . . 0.0 111.379 -178.704 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.63 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -79.57 -35.79 39.2 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.53 11.08 1.09 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.825 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.514 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -114.41 -4.5 12.94 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.027 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.474 HD12 HD23 ' B' ' 353' ' ' LEU . 69.6 mt -57.62 147.8 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.468 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 357' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 11.7 tptt -105.46 -45.7 4.38 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.502 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.6 ptt180 -175.38 135.98 0.34 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.481 ' CH2' HD12 ' B' ' 396' ' ' ILE . 12.2 p90 -118.91 173.66 6.75 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.172 -177.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.46 99.74 1.77 Allowed 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.018 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.776 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.04 147.66 30.05 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.783 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.535 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -135.99 173.56 5.51 Favored Pre-proline 0 N--CA 1.453 -0.282 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -77.06 -8.68 17.77 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.133 1.888 . . . . 0.0 112.022 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 20.6 mtpt -130.77 -21.38 2.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.96 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.659 ' HA ' ' H ' ' B' ' 382' ' ' THR . 88.9 p -150.47 169.57 21.16 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.574 0.702 . . . . 0.0 111.932 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.496 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -142.12 156.61 45.38 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.566 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.551 ' CG2' HD12 ' A' ' 15' ' ' LEU . 44.1 m -147.3 156.72 43.18 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.877 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.462 ' N ' HG22 ' B' ' 367' ' ' THR . 5.7 mt -129.78 141.35 50.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.544 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 21.9 t0 -117.66 95.72 5.07 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.722 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.508 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 8.1 p90 -136.78 94.27 2.96 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.581 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 133.02 12.77 1.64 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 372' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.5 t0 -42.08 -15.92 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.979 -0.61 . . . . 0.0 111.852 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.41 -37.68 65.36 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.47 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.57 -92.11 0.52 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.356 176.679 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.47 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.4 t70 -129.91 96.16 4.14 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -99.93 -3.52 55.88 Favored Glycine 0 C--N 1.311 -0.812 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.261 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.69 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.09 106.17 17.03 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -175.71 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.69 126.07 51.82 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.647 176.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.507 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 47.1 t -138.55 163.45 31.97 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.676 0.751 . . . . 0.0 112.849 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.51 172.89 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.196 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -99.45 125.91 45.27 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.764 0.792 . . . . 0.0 111.192 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.659 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.59 136.28 14.38 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.976 -1.465 . . . . 0.0 109.868 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.67 16.63 4.54 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.185 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.08 83.54 1.74 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.943 174.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -57.89 2.06 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.4 pt-20 -45.12 -20.58 0.05 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 114.905 -0.648 . . . . 0.0 110.964 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.422 ' N ' ' C ' ' B' ' 385' ' ' GLY . 5.6 mm-40 -82.26 -39.27 23.23 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' B' ' 385' ' ' GLY . 47.5 mt -76.54 -42.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.609 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.776 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.33 -42.36 62.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.559 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.412 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 12.5 pt20 -63.56 -34.88 78.79 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 122.082 0.944 . . . . 0.0 111.029 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.648 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.85 -53.49 11.29 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.819 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.648 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.35 -55.98 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.477 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.37 -33.74 44.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 112.761 -2.018 . . . . 0.0 110.701 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.26 -17.8 61.92 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.674 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -87.15 -36.96 17.76 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.481 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.72 -13.19 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 CA-C-O 122.175 0.988 . . . . 0.0 109.297 176.104 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.56 -22.65 46.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.475 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.1 mt -91.8 -61.98 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.067 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.54 -20.41 27.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.338 -1.756 . . . . 0.0 112.315 -176.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.557 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.494 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.793 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' ILE . 1.2 m-20 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.617 HG21 ' SD ' ' A' ' 11' ' ' MET . 5.5 mt 57.64 151.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.664 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.12 -28.0 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.051 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.509 ' O ' ' C ' ' A' ' 11' ' ' MET . 57.1 mt-30 -85.69 -44.46 12.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.864 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.617 ' SD ' HG21 ' A' ' 8' ' ' ILE . 15.7 mtp -15.73 -80.19 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 124.252 0.97 . . . . 0.0 111.986 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.444 ' C ' ' O ' ' A' ' 11' ' ' MET . 11.0 m-85 -38.01 -63.53 0.47 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.1 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 10' ' ' GLN . 1.1 t -56.17 -27.42 54.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.85 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 11' ' ' MET . 0.2 OUTLIER -65.4 -49.47 69.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.7 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.553 HD12 ' CG2' ' B' ' 367' ' ' THR . 3.8 mm? -77.27 -43.38 33.51 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -41.17 87.66 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.99 -44.36 97.28 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.515 ' OE2' ' CD2' ' B' ' 377' ' ' TYR . 85.6 mt-10 -62.77 -34.03 76.39 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 120.995 0.426 . . . . 0.0 109.933 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.553 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 7.3 mtp -69.49 -33.11 72.38 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.061 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -54.68 -20.44 8.23 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.107 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.518 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -72.12 -37.91 69.38 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.177 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.903 HD13 HD11 ' B' ' 325' ' ' LEU . 4.3 pp -100.48 6.6 44.36 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 25' ' ' SER . 1.3 m -126.03 -26.5 3.41 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.069 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 8.7 mp0 37.29 -91.54 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.88 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -141.81 -7.71 0.95 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.23 -178.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 28' ' ' VAL . 7.9 mp -64.23 -89.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.699 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.62 33.44 26.25 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.665 HG12 ' N ' ' A' ' 29' ' ' ASP . 51.7 t -101.64 -112.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.729 0.3 . . . . 0.0 110.452 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.665 ' N ' HG12 ' A' ' 28' ' ' VAL . 27.3 t70 42.0 24.06 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.646 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' VAL . 2.5 m . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.6 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 308' ' ' TYR . . . . . 0.48 ' O ' ' N ' ' B' ' 310' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 63.0 -73.68 0.03 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' B' ' 308' ' ' TYR . 72.2 t -126.48 134.13 67.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.794 0.33 . . . . 0.0 110.776 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.47 153.04 25.6 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.064 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -128.87 135.18 48.73 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.125 0.266 . . . . 0.0 111.42 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -139.15 129.52 25.59 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.795 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.883 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.47 104.86 12.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 123.717 1.723 . . . . 0.0 109.154 178.242 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.621 HG12 ' HB ' ' B' ' 382' ' ' THR . 34.1 m -120.82 156.02 24.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 112.815 -1.993 . . . . 0.0 110.278 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -93.37 138.34 31.8 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.27 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' B' ' 326' ' ' VAL . 1.0 OUTLIER -125.67 152.5 45.15 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.918 0.866 . . . . 0.0 112.881 -178.04 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -75.81 102.66 5.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.245 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 35.8 mmt -102.29 179.42 4.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.023 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.768 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -96.5 146.19 25.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.998 178.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 123.54 -26.18 6.06 Favored Glycine 0 C--N 1.313 -0.744 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -140.76 -142.81 0.15 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.527 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.94 -19.37 1.31 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.567 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.44 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -90.5 -178.82 5.43 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.936 0.398 . . . . 0.0 110.937 -179.327 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 325' ' ' LEU . . . . . 0.903 HD11 HD13 ' A' ' 22' ' ' LEU . 13.5 mt -85.88 161.2 19.17 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.379 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.0 t -122.89 130.74 24.5 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.172 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.482 ' C ' ' O ' ' B' ' 326' ' ' VAL . 78.1 Cg_exo -37.89 140.26 0.29 Allowed 'Trans proline' 0 CA--C 1.506 -0.882 0 N-CA-C 108.535 -1.371 . . . . 0.0 108.535 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' B' ' 315' ' ' VAL . 1.6 tpt180 -152.98 -172.22 4.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.574 -0.85 . . . . 0.0 108.731 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.628 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.33 123.63 13.82 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.089 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 338' ' ' MET . 27.7 tp -103.11 158.27 16.42 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.151 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.427 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.24 107.71 0.52 Allowed Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.769 HD11 HD21 ' B' ' 330' ' ' LEU . 31.6 mm -88.33 123.03 40.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.729 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.2 p -117.28 138.02 52.02 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -57.26 13.6 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.015 0.436 . . . . 0.0 111.779 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.729 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.5 pt-20 -144.45 -2.69 0.85 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.955 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.97 178.89 2.06 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 122.315 1.055 . . . . 0.0 113.059 -177.051 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.609 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.47 146.09 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.042 0 CA-C-N 113.312 -1.767 . . . . 0.0 106.587 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.836 ' O ' HD12 ' B' ' 330' ' ' LEU . 2.3 ptt? -154.06 149.84 27.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 117.09 -1.844 . . . . 0.0 114.324 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.43 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 45.8 mtm180 -94.51 107.7 19.66 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.645 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.628 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.34 149.84 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.124 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' B' ' 344' ' ' THR . 32.0 t0 -89.53 92.6 9.17 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.884 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.56 -28.58 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.732 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 14.8 mttp -75.0 -43.79 51.86 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.73 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.554 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.41 -12.84 14.68 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 11.5 tttt 66.54 -0.75 1.45 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.048 0.452 . . . . 0.0 110.049 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.8 mt-10 -85.15 152.22 23.53 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.311 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.631 HG21 ' SD ' ' B' ' 338' ' ' MET . 82.5 t -83.83 135.14 25.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.528 0.68 . . . . 0.0 112.253 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -104.55 -30.93 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.414 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.467 ' O ' ' CB ' ' B' ' 338' ' ' MET . 38.2 tt0 -138.01 154.9 49.29 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.516 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -145.32 149.83 35.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.37 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.549 ' O ' ' N ' ' B' ' 337' ' ' VAL . 63.0 t-105 -161.99 135.06 6.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.753 177.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.78 139.1 27.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.424 0.631 . . . . 0.0 111.32 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.625 HD12 ' O ' ' B' ' 333' ' ' THR . 1.8 tt -79.47 -35.6 40.06 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.83 11.28 1.11 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.888 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.7 m-20 -114.65 -4.19 12.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.191 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.494 HD12 HD23 ' B' ' 353' ' ' LEU . 74.0 mt -57.99 148.53 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.155 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 357' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 10.3 tttt -106.42 -45.12 4.35 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.1 ptt180 -175.64 136.52 0.33 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.365 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.475 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.5 p90 -119.53 174.14 6.57 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.224 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.02 98.83 1.78 Allowed 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.039 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.784 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.68 147.09 30.78 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.803 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -136.36 173.78 5.22 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.724 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -77.24 -8.26 17.4 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.038 1.825 . . . . 0.0 112.205 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.6 mttt -130.6 -21.43 2.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.073 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.657 ' HA ' ' H ' ' B' ' 382' ' ' THR . 94.4 p -151.74 168.75 24.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.658 0.742 . . . . 0.0 111.858 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -140.64 157.07 45.99 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.84 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.603 ' HG1' ' HG ' ' B' ' 379' ' ' SER . 62.7 m -146.79 158.64 43.96 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.848 -174.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.524 ' N ' HG22 ' B' ' 367' ' ' THR . 5.6 mt -132.41 140.11 48.32 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.519 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 19.7 t0 -117.0 96.03 5.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.634 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' B' ' 370' ' ' PHE . 5.9 p90 -137.25 94.11 2.9 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.555 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.58 12.68 1.74 Allowed Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 372' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 8.8 t0 -41.97 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.108 -0.546 . . . . 0.0 111.682 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.3 m-85 -54.43 -37.24 64.9 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.471 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -126.09 -92.67 0.5 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.093 176.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.471 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.3 t70 -129.32 96.21 4.24 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -99.98 -3.13 55.96 Favored Glycine 0 C--N 1.315 -0.605 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.223 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.25 105.68 16.79 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -175.581 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.18 127.68 54.35 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.557 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.603 ' HG ' ' HG1' ' B' ' 367' ' ' THR . 22.6 t -137.48 157.83 45.71 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.313 0.578 . . . . 0.0 112.23 -177.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 380' ' ' VAL . . . . . 0.433 ' CG1' ' CD ' ' B' ' 317' ' ' GLU . 2.5 m -142.09 171.86 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.047 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 381' ' ' GLN . . . . . 0.689 ' HB2' HD12 ' B' ' 325' ' ' LEU . 3.6 tt0 -100.84 125.99 47.4 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.964 0.887 . . . . 0.0 110.991 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.657 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -156.01 137.59 14.13 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.876 179.046 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.43 15.54 6.44 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.132 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.93 84.54 1.78 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.065 175.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -56.35 2.32 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.4 pt-20 -45.07 -20.18 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 114.797 -0.702 . . . . 0.0 111.025 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' B' ' 385' ' ' GLY . 2.5 mm-40 -82.96 -39.39 21.46 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' B' ' 385' ' ' GLY . 46.3 mt -76.85 -42.44 33.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.669 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.784 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.37 -42.18 62.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.665 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.436 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 15.7 pt20 -63.93 -34.89 78.99 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.032 0.92 . . . . 0.0 110.965 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.8 -53.69 10.84 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.783 -179.322 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.14 -56.1 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.59 -33.8 47.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 112.819 -1.991 . . . . 0.0 110.662 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.98 -17.87 62.29 Favored Glycine 0 CA--C 1.507 -0.444 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.675 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.01 -36.79 18.02 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.475 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.74 -13.21 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-O 122.157 0.98 . . . . 0.0 109.258 176.101 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.64 -22.54 46.74 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.712 -1.585 . . . . 0.0 109.459 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.675 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.8 mt -91.82 -62.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.968 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.43 -20.43 27.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.347 -177.026 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.56 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.765 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.608 HG22 ' N ' ' A' ' 9' ' ' ASP . 2.7 mp -41.37 164.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.271 0.558 . . . . 0.0 110.709 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.608 ' N ' HG22 ' A' ' 8' ' ' ILE . 14.9 t0 70.63 -47.61 0.64 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.268 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.471 ' O ' ' C ' ' A' ' 11' ' ' MET . 46.3 mt-30 -82.48 -46.09 13.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.7 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.471 ' C ' ' O ' ' A' ' 10' ' ' GLN . 56.9 mtp -22.76 -67.88 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 124.058 0.849 . . . . 0.0 112.023 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' MET . 12.3 m-85 -39.83 -58.24 1.41 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.056 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -67.27 -34.03 76.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.945 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.402 ' OG1' ' C ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -61.48 -26.89 68.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.547 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.556 HD12 HG21 ' B' ' 367' ' ' THR . 4.4 mm? -96.07 -39.75 9.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -42.67 94.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.708 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.22 92.86 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.04 -39.7 75.59 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.497 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 5.2 mtp -56.82 -31.25 64.52 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.905 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.3 -27.8 16.6 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.228 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.527 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -77.34 -8.06 57.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.309 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.72 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -93.07 -10.16 37.08 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.149 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.556 ' OG1' HD23 ' A' ' 22' ' ' LEU . 58.4 m -124.93 -9.47 7.19 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.172 0.511 . . . . 0.0 110.391 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 19.5 mp0 53.99 -83.55 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.905 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -154.22 -11.62 0.14 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.253 -178.397 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.861 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -61.01 -21.18 63.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.646 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 29' ' ' ASP . . . -46.76 -32.39 5.85 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 26' ' ' LEU . 58.4 t 56.6 2.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.833 0.349 . . . . 0.0 110.618 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 27' ' ' GLY . 34.3 t70 -161.59 -78.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.581 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.572 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 308' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' B' ' 308' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 309' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' B' ' 308' ' ' TYR . . . -60.17 -138.3 0.01 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.2 t -40.76 137.65 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.776 0.322 . . . . 0.0 110.72 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.58 153.45 26.28 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.221 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -130.04 134.08 47.16 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.042 0.214 . . . . 0.0 111.46 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -139.26 128.48 23.99 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.656 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.84 107.15 13.4 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 123.769 1.747 . . . . 0.0 109.396 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.666 HG12 ' HB ' ' B' ' 382' ' ' THR . 30.3 m -119.13 160.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.096 -176.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -102.11 145.25 29.62 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.559 ' CD ' ' HE ' ' B' ' 339' ' ' ARG . 26.6 tt0 -133.36 149.99 51.85 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.005 0.907 . . . . 0.0 112.708 -178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 318' ' ' LYS . . . . . 0.485 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 6.3 tptm -81.68 101.93 10.39 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.233 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 38.7 mmt -94.1 178.93 5.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.177 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.756 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -100.1 150.97 21.93 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.155 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 114.96 -22.46 12.48 Favored Glycine 0 C--N 1.313 -0.701 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.61 -143.81 0.17 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.535 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 323' ' ' ASN . . . . . 0.531 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.6 m-20 -140.48 -20.38 0.84 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.499 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -86.46 -176.38 5.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.959 0.409 . . . . 0.0 110.938 -179.399 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 325' ' ' LEU . . . . . 0.529 HD11 HD21 ' A' ' 22' ' ' LEU . 31.4 mt -93.39 164.15 13.31 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.274 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' B' ' 317' ' ' GLU . 5.7 t -123.46 123.88 26.39 Favored Pre-proline 0 N--CA 1.44 -0.965 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.993 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.421 ' O ' HG12 ' B' ' 326' ' ' VAL . 68.1 Cg_exo -44.18 144.14 3.01 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 N-CA-C 108.096 -1.54 . . . . 0.0 108.096 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' B' ' 315' ' ' VAL . 13.9 ttt180 -150.41 -173.23 4.39 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.71 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -141.41 120.76 13.11 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.103 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.835 HD12 ' O ' ' B' ' 338' ' ' MET . 32.0 tp -98.67 158.17 15.79 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.223 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.56 108.5 0.53 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.73 HD11 HD21 ' B' ' 330' ' ' LEU . 29.4 mm -87.98 123.58 40.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.723 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.98 138.05 52.45 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 14.65 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.697 0.284 . . . . 0.0 111.442 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.5 pt-20 -144.53 -4.36 0.78 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.561 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.48 177.35 2.19 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.412 1.101 . . . . 0.0 112.915 -176.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.0 t -132.5 145.4 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 113.148 -1.842 . . . . 0.0 106.401 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.835 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.93 150.61 29.44 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 117.199 -1.801 . . . . 0.0 114.568 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.559 ' HE ' ' CD ' ' B' ' 317' ' ' GLU . 0.4 OUTLIER -96.24 106.86 19.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.515 176.589 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.13 150.1 4.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.299 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.5 t0 -87.97 91.62 8.83 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.694 -178.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.43 -28.32 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.619 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 24.0 mttp -75.52 -43.94 46.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.725 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.556 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.61 -13.7 14.77 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 15.3 tttt 68.0 -0.41 2.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.98 0.419 . . . . 0.0 109.933 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.9 mt-10 -86.66 152.9 22.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.619 HG21 ' SD ' ' B' ' 338' ' ' MET . 89.7 t -81.61 133.96 28.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.5 0.667 . . . . 0.0 112.276 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.54 HG21 HH22 ' B' ' 328' ' ' ARG . 1.2 mm -104.14 -30.76 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.225 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' B' ' 338' ' ' MET . 15.7 tt0 -138.74 157.23 46.47 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.489 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -143.4 150.55 39.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.233 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.52 124.31 4.01 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.942 177.644 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.403 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.69 140.92 3.14 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.42 0.628 . . . . 0.0 111.612 -178.506 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.594 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -84.36 -36.32 22.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 354' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' B' ' 400' ' ' LEU . 6.0 t -73.5 9.54 1.33 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.906 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.571 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 4.3 m-20 -111.13 -7.28 14.49 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.0 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.487 HD12 HD23 ' B' ' 353' ' ' LEU . 78.0 mt -56.91 146.41 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 120.444 -0.503 . . . . 0.0 111.766 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 357' ' ' LYS . . . . . 0.506 ' NZ ' ' OH ' ' B' ' 373' ' ' TYR . 9.0 tttp -107.6 -46.03 3.92 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.5 ptt-85 -172.97 135.76 0.63 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.522 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.1 p90 -119.15 176.56 5.25 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.186 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.37 98.94 1.59 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 119.176 -1.009 . . . . 0.0 111.877 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.64 145.73 31.52 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.563 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -134.09 173.73 5.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.735 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.38 -8.21 17.23 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.175 1.917 . . . . 0.0 112.069 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' B' ' 382' ' ' THR . 26.0 mttt -130.51 -21.3 2.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.942 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.66 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.3 p -151.94 167.79 27.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.601 0.715 . . . . 0.0 111.883 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.453 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.19 156.49 47.07 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.549 179.557 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.556 HG21 HD12 ' A' ' 15' ' ' LEU . 25.1 m -148.43 154.81 40.39 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 118.947 -1.101 . . . . 0.0 113.068 -174.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.6 mt -125.64 140.09 53.02 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.329 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 9.7 t0 -117.56 95.5 4.98 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.875 176.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 27.6 t80 -137.75 95.16 3.0 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.89 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.96 12.17 1.96 Allowed Glycine 0 C--O 1.225 -0.413 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 372' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.6 t0 -41.73 -16.36 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.911 -0.645 . . . . 0.0 112.057 -178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.539 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.0 m-85 -54.35 -37.83 65.37 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.468 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.66 -92.16 0.51 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.522 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.468 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 7.5 t0 -130.02 96.29 4.16 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.14 -3.31 54.39 Favored Glycine 0 C--N 1.306 -1.131 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.405 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.68 107.11 16.71 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -175.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -115.39 120.66 40.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.742 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.497 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.2 t -138.49 163.35 32.19 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.788 0.804 . . . . 0.0 113.103 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.97 175.56 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.299 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -101.74 124.4 47.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.039 0.923 . . . . 0.0 110.728 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.666 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -154.46 136.86 14.97 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.883 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.62 17.59 4.55 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.251 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.16 83.58 1.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.949 174.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -58.85 1.92 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.0 pt-20 -44.49 -20.08 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.904 -0.648 . . . . 0.0 111.022 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.437 ' N ' ' C ' ' B' ' 385' ' ' GLY . 62.4 mt-30 -83.13 -39.55 20.93 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.9 mt -76.54 -42.02 34.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.654 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.63 -42.69 61.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.503 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 15.7 pt20 -63.63 -34.62 78.24 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 122.036 0.922 . . . . 0.0 111.05 -177.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.96 -53.16 10.7 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.811 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -49.12 -55.12 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.484 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.19 -34.32 44.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.657 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.86 -17.99 62.31 Favored Glycine 0 CA--C 1.504 -0.611 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.692 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.72 -36.65 18.54 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.522 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.32 -13.02 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-O 122.123 0.963 . . . . 0.0 109.226 176.202 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.51 -23.07 43.18 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.465 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' B' ' 395' ' ' TYR . 74.2 mt -90.34 -59.95 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.573 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.493 ' O ' ' C ' ' B' ' 400' ' ' LEU . 0.7 OUTLIER -69.1 -19.58 23.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.266 -177.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.493 ' C ' ' O ' ' B' ' 399' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.381 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mt -145.88 149.26 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.425 0.631 . . . . 0.0 110.619 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.53 -35.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.327 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.496 ' O ' ' C ' ' A' ' 11' ' ' MET . 49.2 mt-30 -128.43 -26.92 2.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.773 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.496 ' C ' ' O ' ' A' ' 10' ' ' GLN . 43.5 mtp -17.79 -69.4 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.412 0 O-C-N 124.286 0.991 . . . . 0.0 112.069 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -43.51 -64.1 0.71 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.918 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 10' ' ' GLN . 3.0 t -56.17 -39.88 73.05 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.766 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.445 ' O ' ' OE2' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -52.21 -48.81 64.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.829 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.551 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? -74.66 -43.5 55.02 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -37.35 64.61 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.12 -50.68 61.19 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -55.5 -41.33 72.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.986 0.422 . . . . 0.0 110.023 178.168 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.508 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 6.7 mtp -57.19 -34.39 68.44 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.013 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -49.19 -32.16 9.86 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.192 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 21' ' ' LEU . 4.0 mm? -73.35 -16.88 61.34 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.267 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.723 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -84.0 -11.26 57.06 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 25' ' ' SER . 3.8 m -126.96 -9.19 6.0 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.134 0.492 . . . . 0.0 110.372 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 15.2 mp0 54.45 -82.49 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.902 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -153.97 -12.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.269 -178.545 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 mp -41.24 -85.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.589 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.53 -96.28 0.13 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.65 -32.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.88 0.372 . . . . 0.0 110.582 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 54.55 94.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.529 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.587 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 308' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' B' ' 308' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 56.06 -81.47 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 310' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' B' ' 308' ' ' TYR . 74.9 t -127.31 134.05 66.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.761 0.315 . . . . 0.0 110.771 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.5 153.65 24.78 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.113 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -127.7 135.42 50.16 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.158 0.286 . . . . 0.0 111.587 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -139.96 127.36 21.4 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.572 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.911 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.77 107.72 13.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 123.751 1.739 . . . . 0.0 109.314 178.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.692 HG12 ' HB ' ' B' ' 382' ' ' THR . 31.3 m -120.18 162.6 18.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 112.658 -2.065 . . . . 0.0 110.097 -176.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -104.0 145.61 29.9 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' B' ' 326' ' ' VAL . 44.0 tt0 -136.38 152.42 50.61 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.033 0.92 . . . . 0.0 112.627 -178.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 318' ' ' LYS . . . . . 0.458 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 6.2 tptm -79.87 100.57 8.09 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.536 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.68 ' N ' ' SD ' ' B' ' 319' ' ' MET . 0.0 OUTLIER -89.88 178.9 6.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.987 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.756 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.86 147.54 26.39 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.04 178.614 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 117.93 -25.29 8.48 Favored Glycine 0 C--N 1.313 -0.703 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -133.97 -143.06 0.2 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.637 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 323' ' ' ASN . . . . . 0.458 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 1.1 m-20 -140.85 -17.2 0.86 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.549 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -91.65 -176.73 4.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 110.952 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 325' ' ' LEU . . . . . 0.491 HD11 HD21 ' A' ' 22' ' ' LEU . 27.1 mt -91.26 163.37 14.26 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.327 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' B' ' 317' ' ' GLU . 14.4 t -124.69 126.12 25.41 Favored Pre-proline 0 N--CA 1.44 -0.929 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.91 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.426 ' O ' HG12 ' B' ' 326' ' ' VAL . 68.0 Cg_exo -44.39 144.11 3.28 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.618 ' N ' ' O ' ' B' ' 315' ' ' VAL . 11.2 ttm-85 -150.08 -173.59 4.48 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.696 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.16 120.49 13.07 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.145 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.835 HD12 ' O ' ' B' ' 338' ' ' MET . 31.7 tp -99.04 157.9 16.03 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.249 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.2 108.04 0.52 Allowed Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.711 HD11 HD21 ' B' ' 330' ' ' LEU . 30.7 mm -87.82 122.91 40.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.722 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.9 p -117.09 138.55 51.55 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.79 15.83 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.747 0.308 . . . . 0.0 111.354 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.722 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.1 pt-20 -145.72 -4.5 0.66 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.528 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.46 177.39 2.19 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.362 1.077 . . . . 0.0 113.011 -176.593 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.61 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 9.9 t -132.81 145.29 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 CA-C-N 113.16 -1.836 . . . . 0.0 106.254 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.835 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.0 OUTLIER -152.54 150.88 30.04 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 117.143 -1.823 . . . . 0.0 114.468 -175.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.532 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 62.6 mtm180 -96.13 106.77 19.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.524 176.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.7 t -96.76 150.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.278 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' B' ' 344' ' ' THR . 28.8 t0 -88.04 91.74 8.88 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.76 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.48 -28.38 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.617 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.8 mttm -75.18 -43.78 50.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.691 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.56 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.77 -13.98 14.68 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 14.7 tttp 68.29 -0.77 2.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.026 0.441 . . . . 0.0 109.958 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.9 mt-10 -86.3 152.83 22.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.35 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.623 HG21 ' SD ' ' B' ' 338' ' ' MET . 86.6 t -81.6 133.55 29.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.485 0.66 . . . . 0.0 112.178 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 11.9 mt -102.98 -31.02 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.319 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.532 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 21.8 tt0 -139.58 158.15 44.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.595 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -143.06 150.08 39.06 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.135 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.556 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.0 122.38 4.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.938 177.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 352' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.93 139.79 2.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.443 0.639 . . . . 0.0 111.624 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.6 HD12 ' O ' ' B' ' 333' ' ' THR . 1.7 tt -82.24 -37.28 26.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 354' ' ' THR . . . . . 0.523 HG22 ' O ' ' B' ' 354' ' ' THR . 19.7 m -70.67 6.76 1.32 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.799 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.587 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 5.2 m-20 -108.37 -4.84 17.06 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.106 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.534 HD12 HD23 ' B' ' 353' ' ' LEU . 70.5 mt -60.9 144.42 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.753 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -107.3 -45.95 3.99 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 7.2 ptt180 -172.43 135.7 0.74 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.546 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.6 p90 -119.08 176.35 5.34 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.208 -177.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.24 99.21 1.62 Allowed 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.961 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.787 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.25 145.4 30.96 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.573 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -133.71 173.96 5.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -77.39 -7.95 17.12 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.136 1.891 . . . . 0.0 112.131 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' B' ' 382' ' ' THR . 4.0 mtpp -130.61 -21.27 2.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.046 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.659 ' HA ' ' H ' ' B' ' 382' ' ' THR . 61.1 p -152.25 167.36 28.85 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.528 0.68 . . . . 0.0 111.903 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.469 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -138.79 156.63 47.18 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.504 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.551 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.2 m -148.57 154.47 39.81 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.014 -1.075 . . . . 0.0 113.02 -174.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.8 mt -125.32 140.77 52.53 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.355 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.8 t0 -118.06 95.6 4.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.464 -0.895 . . . . 0.0 110.821 176.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 18.6 t80 -137.38 94.85 2.98 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.936 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.01 12.41 1.91 Allowed Glycine 0 C--O 1.226 -0.405 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 372' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.2 t0 -41.89 -16.12 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.02 -0.59 . . . . 0.0 111.887 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.542 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.34 -37.94 65.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.463 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.32 -92.37 0.51 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.895 -1.502 . . . . 0.0 107.358 176.691 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 7.8 t70 -129.93 96.16 4.14 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.16 -2.92 54.48 Favored Glycine 0 C--N 1.31 -0.883 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.28 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.673 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.45 107.06 16.5 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -175.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 378' ' ' TYR . . . . . 0.422 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.7 OUTLIER -114.71 120.95 41.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.677 175.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.508 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.7 t -138.67 163.21 32.69 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.95 175.18 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.209 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.44 124.57 47.32 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.955 0.883 . . . . 0.0 110.863 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.692 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -154.88 136.91 14.66 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.937 179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.75 17.42 4.77 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.207 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.06 83.88 1.75 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.902 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.96 -58.19 2.04 Favored Glycine 0 C--O 1.223 -0.578 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.5 pt-20 -44.58 -20.06 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.814 -0.693 . . . . 0.0 111.083 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.439 ' N ' ' C ' ' B' ' 385' ' ' GLY . 41.5 mt-30 -83.04 -39.78 20.78 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' B' ' 385' ' ' GLY . 50.2 mt -76.74 -41.99 33.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.611 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.787 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.68 -42.37 61.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.293 -1.321 . . . . 0.0 113.532 -177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.462 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.3 pt20 -64.02 -34.65 78.5 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.076 0.941 . . . . 0.0 111.063 -177.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.96 -53.11 10.8 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.753 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -49.09 -55.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.492 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.98 -33.69 52.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.736 -2.029 . . . . 0.0 110.511 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.06 -17.71 62.45 Favored Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.677 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -86.91 -37.18 17.88 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.546 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.48 -13.15 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.112 0.958 . . . . 0.0 109.297 176.214 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.96 -22.67 45.33 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.437 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' B' ' 395' ' ' TYR . 69.6 mt -91.95 -61.9 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.126 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.64 -20.37 27.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.324 -176.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.565 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.637 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.649 HG23 ' SD ' ' A' ' 11' ' ' MET . 5.9 mt -144.6 150.25 16.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.652 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.34 -48.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.195 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.496 ' O ' ' C ' ' A' ' 11' ' ' MET . 36.6 mt-30 -122.7 -22.99 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.86 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.649 ' SD ' HG23 ' A' ' 8' ' ' ILE . 61.4 mtp -17.58 -66.4 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.412 0 O-C-N 124.23 0.957 . . . . 0.0 112.102 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' MET . 14.4 m-85 -41.11 -62.48 0.82 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.981 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 10' ' ' GLN . 4.7 t -63.2 -34.13 76.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.831 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.26 -29.13 69.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.546 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? -95.32 -38.47 10.51 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.03 -43.26 99.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.619 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.26 89.2 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.67 -40.64 76.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.501 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 4.6 mtp -56.78 -31.0 64.2 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.932 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -28.63 16.7 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.247 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.525 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -75.82 -8.93 58.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.292 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.693 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -93.47 -8.6 41.1 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.117 0.484 . . . . 0.0 109.762 179.198 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 23' ' ' THR . 14.0 m -129.8 -5.47 4.58 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.697 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 13.8 mp0 44.99 -93.72 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.667 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -142.34 -7.65 0.89 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.381 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.49 HD23 ' HG3' ' B' ' 324' ' ' LYS . 9.4 mp -47.71 -90.6 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.605 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' C ' HG12 ' A' ' 28' ' ' VAL . . . 90.48 96.5 1.18 Allowed Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.526 HG12 ' C ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER 174.91 129.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 121.369 0.604 . . . . 0.0 110.377 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.794 ' OD1' HG22 ' A' ' 30' ' ' THR . 6.8 t70 -90.35 -91.87 0.14 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.721 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.794 HG22 ' OD1' ' A' ' 29' ' ' ASP . 10.8 t . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.539 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 41.05 -155.12 0.06 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 85.3 t -40.57 137.33 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.781 0.324 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.68 153.29 26.64 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.202 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -130.09 134.64 47.49 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.052 0.22 . . . . 0.0 111.436 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -138.93 129.3 25.69 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.533 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.878 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.39 102.32 10.41 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 123.902 1.811 . . . . 0.0 109.503 178.544 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.647 HG12 ' HB ' ' B' ' 382' ' ' THR . 26.2 m -114.33 158.08 14.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 112.76 -2.018 . . . . 0.0 110.187 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 316' ' ' LYS . . . . . 0.462 ' NZ ' ' CG ' ' A' ' 29' ' ' ASP . 12.2 mtpt -98.35 145.22 26.91 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' B' ' 326' ' ' VAL . 30.1 tt0 -127.29 145.55 50.75 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.927 0.87 . . . . 0.0 112.435 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 318' ' ' LYS . . . . . 0.502 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 5.7 tptm -75.56 101.13 4.79 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.599 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 34.5 mmt -104.2 168.97 8.76 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.74 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.759 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -102.03 143.52 31.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.205 178.517 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 125.31 -20.2 6.64 Favored Glycine 0 C--N 1.311 -0.839 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 322' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' B' ' 323' ' ' ASN . 14.9 ptpt -136.75 -21.13 1.29 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.331 -0.435 . . . . 0.0 111.022 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 323' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' B' ' 322' ' ' LYS . 2.3 t-20 85.97 -28.63 0.07 Allowed 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.643 0.59 . . . . 0.0 110.67 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.49 ' HG3' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -86.17 -174.96 5.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.114 0.483 . . . . 0.0 111.033 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 325' ' ' LEU . . . . . 0.444 HD11 HD21 ' A' ' 22' ' ' LEU . 19.2 mt -85.71 163.45 18.23 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.421 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.6 t -127.33 126.1 24.1 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.132 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.442 ' O ' HG12 ' B' ' 326' ' ' VAL . 71.2 Cg_exo -44.14 143.03 3.63 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 N-CA-C 107.939 -1.6 . . . . 0.0 107.939 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.637 HH21 ' CD1' ' B' ' 348' ' ' ILE . 2.2 tpt180 -148.52 -172.59 4.12 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.629 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.66 121.11 11.0 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.291 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 338' ' ' MET . 31.9 tp -99.4 158.61 15.6 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.198 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.432 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.34 108.34 0.52 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.767 HD11 HD21 ' B' ' 330' ' ' LEU . 29.9 mm -88.19 123.26 40.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.722 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.88 138.37 52.17 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.06 15.73 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.752 0.31 . . . . 0.0 111.251 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.722 ' H ' ' C ' ' B' ' 333' ' ' THR . 11.2 pt-20 -145.12 -4.75 0.71 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.525 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.62 177.28 2.15 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.425 1.107 . . . . 0.0 112.89 -176.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.61 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.9 t -132.56 145.3 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 CA-C-N 113.065 -1.88 . . . . 0.0 106.315 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.836 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.63 150.61 29.67 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 117.175 -1.81 . . . . 0.0 114.423 -175.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.507 ' NH1' ' OE1' ' B' ' 317' ' ' GLU . 26.3 mtm105 -95.74 107.01 19.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.481 176.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.629 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -96.57 150.04 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.274 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.6 t0 -88.19 91.4 8.77 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.668 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.4 -28.49 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.678 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.9 mttm -75.19 -43.96 49.18 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.704 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.559 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.95 -13.27 14.76 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 17.4 tttp 67.72 -0.9 1.8 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 109.988 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.5 mt-10 -85.69 152.07 23.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.346 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.624 HG21 ' SD ' ' B' ' 338' ' ' MET . 85.6 t -81.38 133.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.514 0.673 . . . . 0.0 112.209 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.637 ' CD1' HH21 ' B' ' 328' ' ' ARG . 48.8 mt -103.83 -30.24 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.335 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.472 ' O ' ' CB ' ' B' ' 338' ' ' MET . 21.4 tt0 -139.72 157.41 45.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.639 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -143.35 149.98 38.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.321 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.554 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.87 124.12 4.27 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.102 177.601 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.516 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.54 140.63 3.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.394 0.616 . . . . 0.0 111.606 -178.537 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.595 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -84.16 -35.89 23.26 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -74.26 9.87 1.49 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.824 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.575 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.0 m-20 -111.46 -7.56 14.34 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.069 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.5 HD12 HD23 ' B' ' 353' ' ' LEU . 81.3 mt -55.95 146.9 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.805 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -107.83 -45.9 3.9 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.502 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.9 ptt-85 -173.02 135.72 0.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.479 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.0 p90 -119.61 176.28 5.45 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.195 -177.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.93 99.59 1.54 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.017 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.34 147.7 30.97 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.574 -1.193 . . . . 0.0 110.682 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -135.32 174.17 4.9 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -77.81 -8.13 16.74 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.137 1.892 . . . . 0.0 112.122 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' B' ' 382' ' ' THR . 5.6 mttm -130.74 -20.36 2.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.056 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.658 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.1 p -153.11 167.98 27.43 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.594 0.711 . . . . 0.0 111.934 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.42 156.46 46.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.618 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.546 ' CG2' HD12 ' A' ' 15' ' ' LEU . 26.0 m -148.51 154.81 40.32 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.03 -1.068 . . . . 0.0 113.081 -174.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.447 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.8 mt -125.82 140.0 53.03 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.362 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.6 t0 -117.4 95.6 5.04 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.654 176.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 30.5 t80 -137.93 94.94 2.95 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.985 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.85 12.11 1.99 Allowed Glycine 0 C--O 1.224 -0.51 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 372' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.3 t0 -41.61 -16.42 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.977 -0.612 . . . . 0.0 111.745 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.38 -37.33 64.88 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.47 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.06 -92.31 0.51 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.283 176.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.47 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.5 t70 -129.59 96.36 4.24 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.5 -3.34 53.28 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.21 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.677 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.21 106.79 16.11 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.752 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 378' ' ' TYR . . . . . 0.4 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.9 OUTLIER -114.53 120.3 39.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.748 176.104 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.501 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 34.8 t -138.68 163.91 30.9 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.54 175.81 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.15 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.76 124.29 47.15 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.904 0.859 . . . . 0.0 110.754 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.658 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.69 136.85 14.77 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.87 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.74 17.42 4.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.247 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.06 83.74 1.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.996 175.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.53 -58.24 1.97 Allowed Glycine 0 C--N 1.317 -0.498 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.1 pt-20 -44.81 -20.17 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 114.949 -0.625 . . . . 0.0 111.032 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 6.7 mm-40 -83.47 -38.87 21.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.2 mt -76.68 -42.2 34.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.613 177.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.69 -42.58 61.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.363 -1.289 . . . . 0.0 113.541 -177.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.443 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.9 pt20 -63.55 -34.45 77.83 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.051 0.929 . . . . 0.0 111.069 -177.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.02 -53.32 10.29 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.81 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.6 mt -49.21 -55.09 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 176.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.486 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.38 -34.1 46.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.55 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.79 -17.95 62.54 Favored Glycine 0 CA--C 1.506 -0.529 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.681 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.91 -36.93 18.1 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.479 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.28 -13.29 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 CA-C-O 122.151 0.976 . . . . 0.0 109.283 176.142 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.49 -22.62 47.19 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.741 -1.572 . . . . 0.0 109.447 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.7 mt -91.94 -61.85 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.901 -1.499 . . . . 0.0 112.037 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -65.12 -20.17 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.357 -176.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.555 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.454 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.838 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 8' ' ' ILE . 5.4 mt -145.05 149.7 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.997 0.427 . . . . 0.0 110.644 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.61 -64.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.142 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.516 ' O ' ' C ' ' A' ' 11' ' ' MET . 33.6 mt-30 -122.5 -21.35 5.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.88 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.516 ' C ' ' O ' ' A' ' 10' ' ' GLN . 12.5 mtm -15.58 -63.38 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 124.277 0.986 . . . . 0.0 112.106 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -42.63 -66.8 0.33 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.101 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -59.33 -34.26 72.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.874 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -45.2 95.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.016 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.559 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? -75.19 -38.16 60.91 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.84 -40.33 83.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.3 -42.03 99.72 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.491 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.4 mt-10 -65.39 -37.67 87.69 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.493 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 8.6 mtp -58.88 -32.52 69.56 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.855 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -50.98 -30.23 14.49 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.158 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.5 mm? -70.61 -11.84 61.19 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.269 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.745 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -90.6 -9.38 47.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.98 0.419 . . . . 0.0 109.986 179.462 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.484 ' N ' HD23 ' A' ' 22' ' ' LEU . 4.4 m -118.55 -8.7 10.41 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.338 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.453 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER -56.09 -160.27 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.724 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -52.73 -166.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.85 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.524 ' N ' ' OG ' ' A' ' 25' ' ' SER . 10.4 mp -40.6 -88.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.618 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.43 97.9 0.01 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.533 HG23 ' H ' ' A' ' 29' ' ' ASP . 2.5 m -69.58 -104.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.802 0.334 . . . . 0.0 110.514 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.533 ' H ' HG23 ' A' ' 28' ' ' VAL . 9.3 t70 -72.76 53.21 0.32 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.551 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.1 m . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.579 -179.939 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 48.54 -95.14 0.01 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.93 134.74 65.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.772 0.32 . . . . 0.0 110.786 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.02 153.7 25.22 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.099 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -127.79 135.57 50.28 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.1 0.25 . . . . 0.0 111.56 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -140.31 128.11 21.86 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.568 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.912 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.58 107.99 13.84 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 123.653 1.692 . . . . 0.0 109.477 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.649 HG12 ' HB ' ' B' ' 382' ' ' THR . 31.1 m -119.85 161.28 19.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 112.706 -2.043 . . . . 0.0 110.072 -176.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -102.58 146.02 28.78 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' B' ' 326' ' ' VAL . 20.5 tt0 -130.32 147.24 52.01 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.993 0.902 . . . . 0.0 112.275 -178.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 318' ' ' LYS . . . . . 0.468 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 5.5 tptm -75.49 101.86 5.01 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.095 -1.412 . . . . 0.0 111.758 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 34.1 mmt -105.08 169.24 8.55 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.654 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.759 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.96 142.35 33.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.335 178.54 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 126.62 -20.61 6.09 Favored Glycine 0 C--N 1.312 -0.802 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 322' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' B' ' 323' ' ' ASN . 15.5 ptpt -136.4 -21.58 1.34 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.354 -0.423 . . . . 0.0 111.147 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 323' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' B' ' 322' ' ' LYS . 7.3 t-20 86.84 -29.57 0.05 Allowed 'General case' 0 C--N 1.333 -0.136 0 O-C-N 123.698 0.624 . . . . 0.0 110.814 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.98 -175.2 5.47 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.045 0.45 . . . . 0.0 111.136 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 20.7 mt -84.45 163.16 19.64 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.46 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.2 t -126.86 124.25 23.96 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.139 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.434 ' O ' HG12 ' B' ' 326' ' ' VAL . 64.0 Cg_exo -44.87 145.09 3.13 Favored 'Trans proline' 0 C--N 1.32 -0.937 0 N-CA-C 108.088 -1.543 . . . . 0.0 108.088 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' B' ' 315' ' ' VAL . 12.5 ttm-85 -151.68 -172.89 4.35 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.62 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.21 121.13 13.59 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.094 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.834 HD12 ' O ' ' B' ' 338' ' ' MET . 31.9 tp -99.17 157.95 16.01 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.01 108.04 0.52 Allowed Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -87.96 122.19 39.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.727 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.2 p -116.56 138.2 51.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -57.59 14.09 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.031 0.443 . . . . 0.0 111.647 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.727 ' H ' ' C ' ' B' ' 333' ' ' THR . 16.2 pt-20 -144.2 -3.63 0.84 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.758 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.618 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.59 178.18 1.98 Allowed 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.386 1.089 . . . . 0.0 112.898 -176.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.618 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.0 t -134.18 144.72 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 113.106 -1.861 . . . . 0.0 106.386 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.834 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.6 ptt? -152.71 151.46 30.56 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 117.175 -1.81 . . . . 0.0 114.42 -175.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.18 106.69 18.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.385 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.651 ' N ' ' O ' ' B' ' 329' ' ' LEU . 3.0 t -96.1 149.26 4.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.293 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' B' ' 343' ' ' LYS . 46.0 t0 -87.26 90.49 8.38 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.854 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.8 OUTLIER -35.84 -28.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.686 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' B' ' 341' ' ' ASP . 15.9 mttp -70.49 -44.01 68.55 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.613 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -114.21 -17.55 11.84 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.729 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 345' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' B' ' 344' ' ' THR . 8.3 tttp 77.46 -0.0 2.87 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.458 ' O ' HG13 ' B' ' 340' ' ' VAL . 8.1 pt-20 -82.47 157.82 23.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.593 HG21 ' SD ' ' B' ' 338' ' ' MET . 90.3 t -87.38 131.69 34.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.363 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.417 HD11 ' HB2' ' B' ' 341' ' ' ASP . 59.3 mt -101.35 -29.99 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.455 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.488 ' O ' ' CB ' ' B' ' 338' ' ' MET . 18.0 tt0 -140.81 158.23 44.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.626 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -143.79 151.25 39.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.232 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -160.31 124.83 3.75 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.19 177.768 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.502 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -47.09 139.42 5.86 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.448 0.642 . . . . 0.0 111.493 -178.803 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.583 HD12 ' O ' ' B' ' 333' ' ' THR . 1.9 tt -82.99 -35.67 25.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.2 t -74.15 9.69 1.52 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.935 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.57 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.1 m-20 -111.29 -7.67 14.4 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.992 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.467 HD12 HD23 ' B' ' 353' ' ' LEU . 78.9 mt -56.55 146.69 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.826 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -107.76 -45.12 4.08 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.503 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 10.3 ptt180 -173.79 136.1 0.54 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.513 ' CH2' HD12 ' B' ' 396' ' ' ILE . 7.9 p90 -119.09 177.24 4.94 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.23 -177.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.58 99.23 1.57 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.101 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.13 147.13 30.21 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.647 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -135.69 173.71 5.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -76.98 -8.39 17.74 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.088 1.858 . . . . 0.0 112.297 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.9 mttm -130.66 -20.76 2.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.057 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.652 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.3 p -152.47 167.67 28.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.572 0.701 . . . . 0.0 111.852 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.478 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.2 156.79 46.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.815 179.619 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.559 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.9 m -148.65 155.52 41.16 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.11 -1.036 . . . . 0.0 113.17 -174.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.8 mt -126.05 140.15 52.83 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.168 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 9.2 t0 -117.69 95.6 5.01 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.547 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 31.0 t80 -137.63 94.71 2.95 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.937 176.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.85 12.17 1.98 Allowed Glycine 0 C--O 1.225 -0.421 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 372' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' B' ' 372' ' ' ASP . 9.7 t0 -41.6 -16.16 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.953 -0.624 . . . . 0.0 111.818 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.45 -37.44 65.19 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.473 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.87 -92.59 0.5 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.909 -1.496 . . . . 0.0 107.187 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.473 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.5 t70 -129.34 96.18 4.23 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.24 -3.37 54.05 Favored Glycine 0 C--N 1.311 -0.851 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.256 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.02 106.73 15.9 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -175.605 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 378' ' ' TYR . . . . . 0.403 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.9 OUTLIER -114.05 120.38 40.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.759 175.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.493 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 34.7 t -138.46 163.87 30.83 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.679 0.752 . . . . 0.0 112.909 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -150.76 175.56 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.101 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -101.53 125.08 48.13 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.12 0.962 . . . . 0.0 110.799 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.652 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.22 136.51 14.0 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.831 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.22 17.35 4.38 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.175 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.04 83.94 1.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.936 174.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.98 -58.78 1.95 Allowed Glycine 0 C--O 1.223 -0.557 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.501 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.7 pt-20 -44.45 -20.87 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 114.787 -0.706 . . . . 0.0 111.027 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' B' ' 385' ' ' GLY . 51.1 mt-30 -82.37 -39.35 22.86 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 51.6 mt -76.59 -42.2 34.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.579 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.89 -42.57 60.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.534 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.81 -34.44 77.91 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.075 0.941 . . . . 0.0 111.105 -177.504 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.05 -53.42 10.02 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.73 -179.581 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -48.97 -55.56 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.487 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -51.96 -34.01 40.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.777 -2.01 . . . . 0.0 110.635 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.89 -18.16 61.9 Favored Glycine 0 CA--C 1.506 -0.491 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.684 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.5 m-30 -86.79 -36.82 18.34 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.513 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.42 -13.3 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 CA-C-O 122.195 0.998 . . . . 0.0 109.29 176.165 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.42 -22.6 47.5 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.512 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.5 mt -91.9 -62.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.003 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.68 -20.24 26.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.359 -1.746 . . . . 0.0 112.393 -176.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.715 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.578 HG22 ' H ' ' A' ' 9' ' ' ASP . 0.8 OUTLIER 39.86 -161.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.711 179.851 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.578 ' H ' HG22 ' A' ' 8' ' ' ILE . 50.9 t0 58.16 -78.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.376 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 13' ' ' SER . 81.2 mt-30 -76.83 -41.86 42.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.962 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 14' ' ' THR . 62.3 mtp -19.18 -72.27 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 124.121 0.888 . . . . 0.0 112.099 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.426 ' C ' ' O ' ' A' ' 11' ' ' MET . 10.9 m-85 -39.42 -57.38 1.43 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.928 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 10' ' ' GLN . 1.8 t -67.27 -24.54 65.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.779 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 11' ' ' MET . 0.2 OUTLIER -75.39 -19.95 59.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.558 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.6 mm? -109.98 -41.02 4.58 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 16' ' ' LEU . 74.5 mt -62.08 -43.75 98.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.79 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.35 -36.08 81.92 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.83 -41.74 67.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.511 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 6.1 mtp -52.33 -32.54 38.54 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.891 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -26.49 12.79 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.317 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.2 mm? -79.59 -6.85 57.92 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.376 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.736 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -93.72 -10.33 34.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.901 0.381 . . . . 0.0 110.028 179.61 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.494 ' N ' HD23 ' A' ' 22' ' ' LEU . 2.9 m -118.68 -15.75 9.47 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.006 0.431 . . . . 0.0 110.315 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.3 -72.52 0.05 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.243 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -178.1 -47.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.213 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 26' ' ' LEU . 11.0 mp -63.84 -99.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.568 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.81 88.1 0.01 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.459 ' CG1' ' N ' ' A' ' 29' ' ' ASP . 3.4 p -74.51 -41.13 49.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.007 0.432 . . . . 0.0 110.71 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.459 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 29.5 t70 55.03 95.21 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.555 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 29' ' ' ASP . 1.3 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.558 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -80.58 -155.03 10.9 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 95.2 t -40.71 137.26 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.736 0.303 . . . . 0.0 110.769 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.58 153.59 27.31 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -129.58 134.13 47.56 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.14 0.275 . . . . 0.0 111.45 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -138.93 128.01 23.88 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.615 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.896 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.06 106.09 12.78 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 123.762 1.744 . . . . 0.0 109.284 178.567 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.7 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.5 m -118.55 162.68 16.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 112.669 -2.059 . . . . 0.0 110.12 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -103.83 145.98 29.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' B' ' 326' ' ' VAL . 38.1 tt0 -135.43 152.27 51.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.059 0.933 . . . . 0.0 112.538 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -79.29 101.44 8.05 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.636 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.687 ' N ' ' SD ' ' B' ' 319' ' ' MET . 0.0 OUTLIER -92.27 179.38 5.57 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.989 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.768 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -98.52 142.33 30.25 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.914 178.494 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 126.25 -26.19 5.31 Favored Glycine 0 C--N 1.31 -0.882 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 322' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' B' ' 324' ' ' LYS . 20.4 pttp -146.51 -157.87 0.85 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.456 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -117.71 -27.22 6.32 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.822 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.523 ' H ' ' HD2' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -73.55 -176.74 2.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.058 0.456 . . . . 0.0 111.045 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 325' ' ' LEU . . . . . 0.511 HD11 HD21 ' A' ' 22' ' ' LEU . 31.3 mt -99.4 167.16 10.81 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.34 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' B' ' 317' ' ' GLU . 19.6 t -123.69 126.55 25.72 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.018 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.427 ' O ' HG12 ' B' ' 326' ' ' VAL . 67.8 Cg_exo -44.52 144.73 3.01 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 N-CA-C 108.117 -1.532 . . . . 0.0 108.117 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' B' ' 315' ' ' VAL . 8.1 ttm180 -151.18 -173.09 4.39 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 119.577 -0.849 . . . . 0.0 108.712 -177.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.12 121.47 13.99 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.209 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.832 HD12 ' O ' ' B' ' 338' ' ' MET . 33.3 tp -99.41 158.42 15.74 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.213 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.83 108.44 0.52 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 177.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.719 HD11 HD21 ' B' ' 330' ' ' LEU . 30.0 mm -87.91 123.96 40.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.728 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.42 138.38 52.5 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.83 14.71 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.122 0.487 . . . . 0.0 111.562 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.728 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.2 pt-20 -144.59 -4.11 0.78 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.805 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.13 176.77 2.03 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.323 1.059 . . . . 0.0 112.989 -176.696 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.615 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 9.5 t -132.58 145.8 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 CA-C-N 113.209 -1.814 . . . . 0.0 106.269 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.832 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.66 151.16 30.25 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 117.167 -1.813 . . . . 0.0 114.549 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -95.76 106.8 18.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.436 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.46 149.5 4.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.29 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' B' ' 343' ' ' LYS . 42.9 t0 -87.63 90.83 8.52 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.862 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.8 OUTLIER -36.24 -27.27 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.654 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.1 mttp -70.64 -43.17 69.78 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.672 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.533 ' N ' ' O ' ' B' ' 341' ' ' ASP . 26.6 p -115.59 -17.86 11.05 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 345' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' B' ' 344' ' ' THR . 10.3 tttm 78.16 1.19 2.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 110.126 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.445 ' O ' HG13 ' B' ' 340' ' ' VAL . 6.3 pt-20 -84.97 156.98 20.93 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.616 HG21 ' SD ' ' B' ' 338' ' ' MET . 91.7 t -86.69 132.87 31.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.508 0.67 . . . . 0.0 112.394 -178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 22.0 mm -102.6 -30.6 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.267 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.482 ' NE2' ' CZ3' ' B' ' 351' ' ' TRP . 6.8 tt0 -140.45 157.87 44.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.622 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -142.28 150.29 40.67 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.19 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -157.16 122.32 4.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.136 177.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.499 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.48 138.95 4.02 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.403 0.621 . . . . 0.0 111.503 -178.671 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.601 HD12 ' O ' ' B' ' 333' ' ' THR . 1.7 tt -81.66 -36.99 28.18 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 354' ' ' THR . . . . . 0.514 HG22 ' O ' ' B' ' 354' ' ' THR . 17.4 m -70.97 6.9 1.34 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.892 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.569 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.7 m-20 -108.55 -4.95 16.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.93 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.538 HD12 HD23 ' B' ' 353' ' ' LEU . 70.8 mt -60.65 144.16 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.743 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -107.3 -45.63 4.06 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.4 ptt-85 -172.43 135.77 0.74 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.541 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.7 p90 -118.95 175.51 5.72 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.119 -177.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.87 98.94 1.66 Allowed 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 119.199 -1.001 . . . . 0.0 111.891 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.79 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.16 149.54 29.07 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.839 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.522 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -137.86 174.99 3.72 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -78.42 -7.0 15.83 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.266 1.977 . . . . 0.0 112.134 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' B' ' 382' ' ' THR . 47.6 mttt -130.84 -22.53 2.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.001 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.644 ' HA ' ' H ' ' B' ' 382' ' ' THR . 63.8 p -152.74 165.94 33.74 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.653 0.74 . . . . 0.0 111.85 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.485 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -137.36 156.98 47.58 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.737 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.558 ' CG2' HD12 ' A' ' 15' ' ' LEU . 27.7 m -148.52 156.29 42.25 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.065 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.45 ' N ' HG22 ' B' ' 367' ' ' THR . 7.1 mt -126.71 141.45 51.84 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.435 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.4 t0 -118.44 95.41 4.86 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.691 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 17.6 t80 -137.18 94.85 3.0 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.951 176.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.79 12.24 1.98 Allowed Glycine 0 C--O 1.225 -0.412 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -41.73 -16.15 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.857 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.52 -37.51 65.45 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.466 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.82 -92.27 0.51 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.958 -1.473 . . . . 0.0 107.345 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.466 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 12.9 t0 -129.75 96.37 4.22 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.46 -2.7 53.56 Favored Glycine 0 C--N 1.311 -0.82 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.271 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.81 106.87 16.67 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -175.648 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.11 122.69 46.87 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.663 176.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.511 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 34.3 t -139.03 163.69 31.73 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.35 173.66 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.113 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -99.92 125.29 45.89 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.976 0.893 . . . . 0.0 110.872 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.7 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -155.21 136.39 13.91 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.912 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.09 16.83 4.66 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.296 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.19 84.1 1.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.992 175.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.76 -58.26 2.05 Favored Glycine 0 C--N 1.317 -0.487 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.9 pt-20 -44.73 -20.09 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 114.893 -0.653 . . . . 0.0 111.047 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.434 ' N ' ' C ' ' B' ' 385' ' ' GLY . 46.7 mt-30 -82.89 -39.76 21.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' B' ' 385' ' ' GLY . 51.4 mt -76.66 -41.84 34.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.687 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.79 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.86 -42.19 61.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.362 -1.29 . . . . 0.0 113.604 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.462 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.4 pt20 -64.19 -34.44 78.08 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.06 0.933 . . . . 0.0 111.047 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.09 -53.47 9.87 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.759 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -48.93 -55.28 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.491 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.6 -33.9 48.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 112.801 -2.0 . . . . 0.0 110.506 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.75 -17.98 62.55 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.68 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.91 -37.07 17.98 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.541 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.44 -13.14 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.911 0 CA-C-O 122.102 0.953 . . . . 0.0 109.325 176.191 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.04 -22.6 45.15 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.507 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.9 mt -91.83 -61.96 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-N 113.865 -1.516 . . . . 0.0 112.105 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.54 -20.54 27.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.38 -176.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.561 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.462 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.801 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.3 mt -101.0 151.15 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.567 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.502 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 54.3 t0 -172.91 -116.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.575 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 11' ' ' MET . 81.9 mt-30 -37.74 -33.53 0.08 Allowed 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.399 0.437 . . . . 0.0 110.764 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.488 ' C ' ' O ' ' A' ' 10' ' ' GLN . 6.7 mmm -21.2 -56.72 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 124.222 0.951 . . . . 0.0 111.848 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.502 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 9.6 m-85 -54.96 -71.96 0.07 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.047 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.0 t -46.35 -26.17 0.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.708 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -67.88 -54.63 17.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.644 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.564 HD12 HG21 ' B' ' 367' ' ' THR . 4.3 mm? -75.9 -41.15 52.83 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -39.34 81.73 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.57 -45.52 96.15 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.518 ' OE2' ' CD2' ' B' ' 377' ' ' TYR . 82.5 mt-10 -61.36 -34.14 74.81 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.554 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 7.4 mtp -70.01 -32.63 70.9 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.191 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.2 OUTLIER -55.42 -19.47 9.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.191 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.519 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -71.45 -38.39 71.31 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.085 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.829 HD13 HD11 ' B' ' 325' ' ' LEU . 4.0 pp -100.92 6.06 43.49 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.461 -0.495 . . . . 0.0 109.961 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 25' ' ' SER . 1.3 m -124.77 -25.29 3.97 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.171 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.9 mp0 35.11 -91.34 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.098 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 23' ' ' THR . 6.6 p -139.89 -139.68 0.13 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.213 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.84 HD22 ' N ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -101.35 -116.71 0.18 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.449 -179.299 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.51 -57.72 4.45 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.759 HG21 ' NZ ' ' B' ' 324' ' ' LYS . 96.6 t -102.93 -3.43 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.802 0.334 . . . . 0.0 110.59 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.76 -89.87 0.35 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.533 180.0 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 136.24 -86.21 0.24 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 69.2 t -126.73 133.62 68.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.835 0.35 . . . . 0.0 110.712 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.44 153.1 25.49 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.081 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -128.99 134.76 48.29 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.037 0.211 . . . . 0.0 111.405 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -138.35 129.76 27.55 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.763 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.871 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.12 104.02 12.16 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 123.666 1.698 . . . . 0.0 109.283 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.598 ' O ' ' N ' ' B' ' 328' ' ' ARG . 34.7 m -120.27 157.27 22.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 112.867 -1.97 . . . . 0.0 110.167 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 316' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' B' ' 380' ' ' VAL . 7.0 mtmt -96.6 139.5 32.59 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.454 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' B' ' 326' ' ' VAL . 3.2 tt0 -126.43 154.32 43.82 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 122.007 0.908 . . . . 0.0 113.061 -177.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -75.92 103.01 5.78 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.335 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 36.1 mmt -102.31 179.26 4.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.972 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.766 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -96.78 146.12 25.2 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.037 178.63 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 123.56 -26.24 6.04 Favored Glycine 0 C--N 1.312 -0.757 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -140.46 -142.04 0.14 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.59 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.38 -20.76 1.19 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.527 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.759 ' NZ ' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -89.48 -179.54 5.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.017 0.437 . . . . 0.0 111.052 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 325' ' ' LEU . . . . . 0.829 HD11 HD13 ' A' ' 22' ' ' LEU . 15.1 mt -85.14 160.96 19.83 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.241 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.4 t -122.81 129.8 24.87 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.99 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.542 ' O ' ' NE ' ' B' ' 328' ' ' ARG . 80.1 Cg_exo -38.05 144.62 0.17 Allowed 'Trans proline' 0 CA--C 1.508 -0.816 0 N-CA-C 108.701 -1.307 . . . . 0.0 108.701 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' B' ' 315' ' ' VAL . 0.3 OUTLIER -157.15 -171.54 3.67 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.82 -176.572 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.643 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -142.81 124.38 14.88 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.155 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.832 HD12 ' O ' ' B' ' 338' ' ' MET . 27.9 tp -103.95 158.18 16.59 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.427 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.41 107.84 0.52 Allowed Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.758 HD11 HD21 ' B' ' 330' ' ' LEU . 31.6 mm -88.35 123.59 40.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.73 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.4 p -118.19 137.91 52.67 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -57.36 13.64 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.004 0.43 . . . . 0.0 111.793 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.73 ' H ' ' C ' ' B' ' 333' ' ' THR . 12.7 pt-20 -144.32 -2.85 0.86 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.991 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.601 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.9 178.72 2.12 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.307 1.051 . . . . 0.0 112.982 -177.07 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.601 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.38 145.6 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-N 113.338 -1.756 . . . . 0.0 106.682 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.832 ' O ' HD12 ' B' ' 330' ' ' LEU . 3.2 ptt? -153.95 149.49 27.33 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 117.062 -1.855 . . . . 0.0 114.356 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.529 ' NE ' ' OE1' ' B' ' 317' ' ' GLU . 12.1 mtp180 -94.14 107.65 19.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.666 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -98.73 149.71 5.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.2 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.9 t0 -89.6 92.27 9.02 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.815 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 341' ' ' ASP . 1.1 tt0 -35.46 -28.83 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.65 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' B' ' 341' ' ' ASP . 14.8 mttp -75.17 -43.62 51.19 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.704 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.555 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.2 -12.55 14.78 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 345' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' B' ' 341' ' ' ASP . 6.1 ttmt 66.67 -1.15 1.38 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.029 0.442 . . . . 0.0 109.961 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.459 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.5 mt-10 -84.71 153.53 23.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.322 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.596 HG21 ' SD ' ' B' ' 338' ' ' MET . 79.2 t -82.83 135.29 25.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.454 0.645 . . . . 0.0 112.288 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 66.0 mt -103.67 -30.39 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.424 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.473 ' O ' ' CB ' ' B' ' 338' ' ' MET . 10.2 tt0 -140.55 156.63 46.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.715 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -145.74 149.61 34.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.495 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' B' ' 337' ' ' VAL . 63.5 t-105 -162.79 135.15 5.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.892 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.503 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.57 138.75 27.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.411 -178.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.626 HD12 ' O ' ' B' ' 333' ' ' THR . 1.9 tt -79.03 -35.82 42.05 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.64 10.92 1.16 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.98 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.503 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.4 m-20 -114.23 -4.43 13.06 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.217 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.499 HD12 HD23 ' B' ' 353' ' ' LEU . 71.6 mt -57.48 147.81 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.068 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 357' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 26.8 tttt -105.84 -45.84 4.28 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 0.2 OUTLIER -174.45 136.3 0.46 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.405 177.272 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.478 ' CH2' HD12 ' B' ' 396' ' ' ILE . 10.0 p90 -119.99 173.64 6.95 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.256 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.73 99.72 1.73 Allowed 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 119.153 -1.019 . . . . 0.0 112.252 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.49 144.29 31.45 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.797 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.549 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -132.14 174.28 4.89 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -77.66 -8.63 17.06 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.165 1.91 . . . . 0.0 112.019 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.0 mtpp -130.95 -19.24 2.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.121 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.683 ' HA ' ' H ' ' B' ' 382' ' ' THR . 92.8 p -152.78 168.5 25.5 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.552 0.691 . . . . 0.0 112.062 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.506 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.2 OUTLIER -140.84 156.94 46.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.914 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.564 HG21 HD12 ' A' ' 15' ' ' LEU . 64.1 m -147.3 158.99 44.17 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.003 -174.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.534 ' N ' HG22 ' B' ' 367' ' ' THR . 5.8 mt -133.23 140.29 47.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.515 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 19.5 t0 -117.33 96.13 5.28 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.615 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.497 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 9.5 p90 -136.9 93.92 2.9 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.352 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.66 12.49 1.76 Allowed Glycine 0 C--O 1.227 -0.294 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -41.73 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.18 -0.51 . . . . 0.0 111.769 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.562 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.46 -37.44 65.2 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.47 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.5 OUTLIER -125.76 -92.87 0.5 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.111 176.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.47 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.4 t0 -129.05 96.27 4.29 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.13 -2.66 55.87 Favored Glycine 0 C--N 1.312 -0.78 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.245 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.38 105.44 16.71 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.463 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.79 127.44 54.34 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.554 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 23.2 t -137.67 158.35 44.55 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.348 0.594 . . . . 0.0 112.349 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 380' ' ' VAL . . . . . 0.401 ' CB ' ' O ' ' B' ' 316' ' ' LYS . 2.4 m -141.72 172.63 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.004 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 381' ' ' GLN . . . . . 0.673 ' HB2' HD12 ' B' ' 325' ' ' LEU . 2.1 mt-30 -103.35 124.62 49.03 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.896 0.855 . . . . 0.0 110.796 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.683 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.89 139.17 16.64 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.183 179.336 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.09 16.08 6.58 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.313 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.98 84.48 1.78 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.075 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.37 -56.93 2.18 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.7 pt-20 -44.98 -20.22 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 114.615 -0.792 . . . . 0.0 110.945 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' B' ' 385' ' ' GLY . 3.2 mm-40 -82.62 -39.76 21.71 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' B' ' 385' ' ' GLY . 45.0 mt -76.6 -42.38 34.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.763 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.4 -42.01 62.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.255 -1.339 . . . . 0.0 113.68 -177.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.437 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 15.6 pt20 -64.06 -34.83 78.92 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.975 -177.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.649 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.85 -53.75 10.61 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.664 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.649 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.2 -55.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.479 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.7 -33.69 48.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.852 -1.976 . . . . 0.0 110.697 178.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.01 -17.84 62.3 Favored Glycine 0 CA--C 1.506 -0.471 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -178.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.674 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.04 -36.99 17.88 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.478 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.65 -13.18 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 CA-C-O 122.18 0.99 . . . . 0.0 109.236 176.183 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.48 -22.62 47.23 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.511 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.7 mt -91.78 -62.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.978 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.39 -20.56 27.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.379 -177.058 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.558 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.82 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 8.2 p30 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 9' ' ' ASP . 1.2 tt -54.13 -168.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.478 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.548 ' N ' HG23 ' A' ' 8' ' ' ILE . 9.9 t0 62.06 -65.79 0.08 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.932 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 8' ' ' ILE . 36.6 mt-30 -67.51 -54.77 17.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.516 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.468 ' C ' ' O ' ' A' ' 10' ' ' GLN . 29.8 mtp -22.92 -69.15 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 123.974 0.796 . . . . 0.0 112.079 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -42.98 -57.77 2.71 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.976 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -62.58 -39.37 93.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.974 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.71 -44.56 69.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.978 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.561 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? -76.65 -40.42 49.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -39.63 80.03 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.09 -43.4 98.8 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.484 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.6 mt-10 -63.3 -37.93 89.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.475 -0.362 . . . . 0.0 110.036 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.674 ' HE2' HD13 ' A' ' 22' ' ' LEU . 13.5 mtp -58.7 -35.1 72.09 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.853 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.57 -29.21 6.64 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.421 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.548 HD22 ' N ' ' A' ' 21' ' ' LEU . 4.0 mm? -77.72 -18.05 56.96 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.172 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.714 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -76.65 -13.29 60.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.65 ' N ' HD23 ' A' ' 22' ' ' LEU . 1.2 m -111.52 -44.23 3.55 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.561 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.574 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER 47.27 -179.72 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.395 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER 38.86 -88.75 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.83 179.572 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' A' ' 24' ' ' GLN . 1.1 tp -41.57 -39.8 1.69 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.665 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.03 -32.45 9.83 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' ' 28' ' ' VAL . 53.6 t -71.94 -4.82 5.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.814 0.34 . . . . 0.0 110.571 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.92 -1.56 27.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.53 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.544 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -80.31 -152.84 8.32 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 94.2 t -40.9 137.54 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.728 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.03 153.59 27.87 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.162 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -129.54 134.36 47.72 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.042 0.214 . . . . 0.0 111.439 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -139.22 127.78 23.09 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.596 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.906 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.75 106.85 13.07 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 123.712 1.72 . . . . 0.0 109.272 178.528 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.697 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.0 m -119.8 162.82 17.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 112.755 -2.02 . . . . 0.0 110.187 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -103.72 145.58 29.86 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' B' ' 326' ' ' VAL . 44.2 tt0 -135.73 152.32 51.04 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.023 0.916 . . . . 0.0 112.558 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 318' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 6.3 tptm -79.36 100.74 7.74 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.46 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.673 ' N ' ' SD ' ' B' ' 319' ' ' MET . 0.0 OUTLIER -90.74 179.03 5.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.944 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.755 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.64 147.38 26.5 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.059 178.541 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 118.11 -25.03 8.5 Favored Glycine 0 C--N 1.313 -0.718 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -134.74 -143.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.651 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 323' ' ' ASN . . . . . 0.464 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 1.2 m-20 -140.16 -18.97 0.89 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.582 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.529 ' H ' ' HD2' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -89.48 -176.75 5.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.944 0.402 . . . . 0.0 111.067 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 325' ' ' LEU . . . . . 0.403 HD11 HD21 ' A' ' 22' ' ' LEU . 30.3 mt -92.0 162.16 14.5 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.164 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.7 t -123.01 126.88 25.88 Favored Pre-proline 0 N--CA 1.442 -0.86 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.089 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.449 ' O ' HG12 ' B' ' 326' ' ' VAL . 68.9 Cg_exo -43.9 144.51 2.47 Favored 'Trans proline' 0 C--N 1.321 -0.917 0 N-CA-C 108.209 -1.496 . . . . 0.0 108.209 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' B' ' 315' ' ' VAL . 7.6 ttm180 -151.55 -173.02 4.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 119.496 -0.881 . . . . 0.0 108.628 -177.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.636 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.68 121.32 13.38 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.113 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.841 HD12 ' O ' ' B' ' 338' ' ' MET . 31.5 tp -99.47 158.72 15.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.175 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.435 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.95 108.7 0.53 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.727 HD11 HD21 ' B' ' 330' ' ' LEU . 30.2 mm -87.91 124.4 41.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.729 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.5 p -118.59 138.25 52.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.327 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -57.96 14.4 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.115 0.484 . . . . 0.0 111.769 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.729 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -144.66 -3.06 0.81 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.981 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.62 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.64 176.95 1.82 Allowed 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.43 1.11 . . . . 0.0 112.833 -176.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.62 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.4 t -132.28 145.84 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-N 113.071 -1.877 . . . . 0.0 106.215 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.841 ' O ' HD12 ' B' ' 330' ' ' LEU . 0.9 OUTLIER -152.63 150.78 29.86 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 117.179 -1.808 . . . . 0.0 114.415 -175.843 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.54 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 60.0 mtm180 -95.85 106.94 19.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.397 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.65 149.93 4.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.278 -178.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.0 t0 -88.07 91.6 8.83 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.736 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.9 OUTLIER -35.42 -28.38 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.671 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' B' ' 341' ' ' ASP . 28.1 mttp -75.39 -43.92 47.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.641 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.558 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.68 -13.47 14.79 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm 67.71 -1.11 1.74 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' B' ' 344' ' ' THR . 4.4 mt-10 -85.95 152.08 23.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.337 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.629 HG21 ' SD ' ' B' ' 338' ' ' MET . 86.9 t -80.99 133.26 29.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.527 0.68 . . . . 0.0 112.176 -178.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' B' ' 341' ' ' ASP . 55.0 mt -102.91 -30.29 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.323 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.54 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 22.1 tt0 -140.27 158.06 44.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 350' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 45.6 mt-10 -142.85 150.69 40.22 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.296 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.02 122.47 4.23 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.227 177.685 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.511 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.01 140.1 2.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.51 0.672 . . . . 0.0 111.632 -178.755 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.614 HD12 ' O ' ' B' ' 333' ' ' THR . 1.5 tt -82.46 -36.48 26.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 354' ' ' THR . . . . . 0.703 HG22 ' O ' ' B' ' 354' ' ' THR . 99.5 m -71.17 7.07 1.36 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.831 177.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.571 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.2 m-20 -108.12 -5.26 17.06 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.828 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.555 HD12 HD23 ' B' ' 353' ' ' LEU . 72.1 mt -61.19 143.23 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.672 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -107.3 -45.29 4.13 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.501 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.0 ptt-85 -172.17 136.27 0.83 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.497 ' CH2' HD12 ' B' ' 396' ' ' ILE . 7.8 p90 -119.14 176.33 5.36 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.234 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.63 98.62 1.67 Allowed 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 119.066 -1.054 . . . . 0.0 112.044 -178.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.793 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.81 145.01 31.64 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.747 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.522 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -133.76 174.15 5.02 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -77.69 -7.61 16.7 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.12 1.88 . . . . 0.0 112.158 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.4 mtpt -130.86 -21.42 2.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.011 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.65 ' HA ' ' H ' ' B' ' 382' ' ' THR . 61.3 p -152.65 166.63 31.51 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.56 0.695 . . . . 0.0 111.908 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.484 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -137.68 156.84 47.58 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.823 179.573 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.561 ' CG2' HD12 ' A' ' 15' ' ' LEU . 29.1 m -148.81 155.06 40.4 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.215 -174.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.4 mt -125.81 139.83 53.17 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.181 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.1 t0 -117.6 95.65 5.04 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.569 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 15.1 t80 -137.45 94.43 2.92 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.955 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.92 11.98 2.0 Allowed Glycine 0 C--O 1.225 -0.407 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 372' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 8.9 t0 -41.47 -16.01 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.087 -0.556 . . . . 0.0 111.777 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.56 -37.08 65.03 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.473 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.0 -92.94 0.49 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.876 -1.511 . . . . 0.0 107.072 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.473 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 16.3 t0 -128.9 96.38 4.34 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.53 -2.9 53.38 Favored Glycine 0 C--N 1.313 -0.7 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.339 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -83.79 106.65 15.66 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -175.68 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 378' ' ' TYR . . . . . 0.426 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.6 OUTLIER -114.06 120.8 41.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.6 176.066 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.531 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 38.4 t -138.88 164.09 30.6 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.587 0.708 . . . . 0.0 112.818 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.84 174.1 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.874 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -100.47 125.49 46.78 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 122.0 0.905 . . . . 0.0 110.835 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.697 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -155.56 136.78 13.88 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.832 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.25 17.0 4.62 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.147 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.01 84.19 1.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.092 175.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.88 -58.45 2.01 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.463 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.2 pt-20 -44.3 -20.19 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 114.814 -0.693 . . . . 0.0 111.026 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' B' ' 385' ' ' GLY . 67.5 mt-30 -82.75 -40.15 20.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.578 0.704 . . . . 0.0 109.102 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' B' ' 385' ' ' GLY . 49.5 mt -76.41 -42.04 35.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.719 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.793 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.46 -42.32 62.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.6 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.463 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -64.14 -34.79 78.87 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.023 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.64 -53.67 9.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.727 -179.509 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -48.59 -55.7 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 176.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.492 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.42 -33.8 45.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 112.761 -2.018 . . . . 0.0 110.578 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.12 -17.83 62.11 Favored Glycine 0 CA--C 1.505 -0.539 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.68 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.1 m-30 -86.88 -36.45 18.41 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.538 ' O ' HD12 ' B' ' 400' ' ' LEU . 0.0 OUTLIER -69.23 -13.23 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 CA-C-O 122.166 0.984 . . . . 0.0 109.308 176.023 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.77 -22.62 42.96 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.52 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' B' ' 395' ' ' TYR . 74.8 mt -91.23 -62.15 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.17 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.9 OUTLIER -61.4 -25.84 37.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 113.409 -1.723 . . . . 0.0 112.291 -176.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.538 HD12 ' O ' ' B' ' 396' ' ' ILE . 42.4 mt . . . . . 0 C--O 1.218 -0.581 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.693 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 8' ' ' ILE . 1.4 p-10 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.485 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 8.7 mt 58.35 148.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.585 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 10' ' ' GLN . 4.6 t70 -175.95 -85.88 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.917 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 14.2 mt-30 -104.19 -19.22 14.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.944 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.503 ' C ' ' O ' ' A' ' 10' ' ' GLN . 27.1 mtm -14.81 -61.43 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 124.279 0.987 . . . . 0.0 112.044 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -41.17 -62.29 0.86 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.205 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 10' ' ' GLN . 19.2 t -67.9 -25.05 65.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.748 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.14 -22.07 59.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.564 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? -100.09 -33.47 10.46 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -43.38 96.59 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.7 -36.42 89.67 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 92.6 mt-10 -70.77 -39.52 73.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.326 -0.437 . . . . 0.0 109.843 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.501 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 9.9 mtp -56.16 -31.67 63.59 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.77 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.99 -29.52 21.11 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.458 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 21' ' ' LEU . 4.1 mm? -73.48 -10.37 59.65 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.241 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.731 ' C ' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -88.89 -9.01 53.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.019 0.438 . . . . 0.0 110.0 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.537 ' N ' HD23 ' A' ' 22' ' ' LEU . 17.1 m -105.77 -34.72 7.59 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.21 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.449 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -108.49 136.3 48.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.773 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER 166.71 -9.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.721 -179.643 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.673 ' C ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -41.12 -17.4 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.592 0.71 . . . . 0.0 112.42 179.109 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.609 ' N ' HD22 ' A' ' 26' ' ' LEU . . . -60.53 3.51 0.36 Allowed Glycine 0 C--N 1.305 -1.176 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.731 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.565 ' H ' ' C ' ' A' ' 26' ' ' LEU . 3.8 p -168.86 -41.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.092 0.472 . . . . 0.0 110.543 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.472 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 21.5 t70 -70.13 2.27 3.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.669 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.423 ' O ' ' O ' ' B' ' 322' ' ' LYS . 24.3 p . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.593 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 308' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' B' ' 308' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 134.66 -93.06 0.24 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 70.8 t -126.33 133.19 69.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.742 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.83 153.26 24.65 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.123 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -129.69 135.45 48.51 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.03 0.206 . . . . 0.0 111.483 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -138.83 129.89 26.7 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.565 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.875 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.61 104.72 13.09 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 123.918 1.818 . . . . 0.0 109.368 178.368 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 315' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.9 m -115.71 161.19 14.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 112.523 -2.126 . . . . 0.0 110.086 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -103.57 145.0 30.69 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 317' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' B' ' 326' ' ' VAL . 27.8 tt0 -132.37 152.07 51.6 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.102 0.953 . . . . 0.0 112.729 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -80.95 102.19 9.96 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.204 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 319' ' ' MET . . . . . 0.416 ' HE3' ' OE2' ' B' ' 317' ' ' GLU . 33.8 mmt -99.64 178.59 4.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.984 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 320' ' ' LYS . . . . . 0.642 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.57 158.02 16.39 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.639 178.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 110.94 -23.25 19.71 Favored Glycine 0 C--N 1.309 -0.958 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 322' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 30' ' ' THR . 6.4 ptpt -135.5 -139.74 0.16 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.603 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.98 -16.76 0.59 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.571 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.452 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -96.54 -176.91 3.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 111.013 -179.222 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 31.8 mt -86.84 165.2 16.15 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.209 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 326' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' B' ' 317' ' ' GLU . 9.5 t -124.15 126.21 25.61 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.016 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.461 ' O ' HG12 ' B' ' 326' ' ' VAL . 61.0 Cg_exo -44.56 145.22 2.76 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 N-CA-C 108.099 -1.539 . . . . 0.0 108.099 178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 328' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' B' ' 315' ' ' VAL . 5.6 ttm-85 -150.2 -173.21 4.37 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.776 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 329' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.95 122.72 12.64 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.07 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 330' ' ' LEU . . . . . 0.833 HD12 ' O ' ' B' ' 338' ' ' MET . 26.4 tp -101.96 158.32 16.22 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 331' ' ' GLY . . . . . 0.428 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.44 107.94 0.53 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 332' ' ' ILE . . . . . 0.736 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -88.46 123.83 41.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 333' ' ' THR . . . . . 0.729 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.6 p -118.31 137.75 52.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.26 13.23 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.05 0.452 . . . . 0.0 111.741 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 335' ' ' GLU . . . . . 0.729 ' H ' ' C ' ' B' ' 333' ' ' THR . 11.3 pt-20 -144.15 -2.52 0.89 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.844 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 336' ' ' CYS . . . . . 0.611 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.86 179.36 2.0 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 122.158 0.98 . . . . 0.0 113.045 -177.194 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 337' ' ' VAL . . . . . 0.611 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.3 t -137.08 145.31 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 CA-C-N 113.365 -1.743 . . . . 0.0 106.677 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 338' ' ' MET . . . . . 0.833 ' O ' HD12 ' B' ' 330' ' ' LEU . 3.9 ptt? -154.08 149.95 27.69 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 117.028 -1.869 . . . . 0.0 114.318 -176.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 339' ' ' ARG . . . . . 0.497 ' NH1' ' OE2' ' B' ' 317' ' ' GLU . 44.7 mtm180 -94.66 107.79 19.78 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.778 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.626 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.24 149.84 5.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.228 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 344' ' ' THR . 29.0 t0 -89.93 92.15 8.89 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.784 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.51 -28.95 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.76 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 35.8 mttt -74.7 -43.67 53.97 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.672 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 344' ' ' THR . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.3 -12.72 14.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 7.4 tttp 66.73 -0.91 1.46 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.977 0.418 . . . . 0.0 109.918 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 346' ' ' GLU . . . . . 0.456 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.6 mt-10 -84.88 152.73 23.36 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.388 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 347' ' ' VAL . . . . . 0.597 HG21 ' SD ' ' B' ' 338' ' ' MET . 81.9 t -82.92 135.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.449 0.642 . . . . 0.0 112.352 -178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mt -104.03 -30.13 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.386 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 349' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' B' ' 338' ' ' MET . 36.0 tt0 -140.49 156.05 46.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.677 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -145.66 149.43 34.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.451 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 351' ' ' TRP . . . . . 0.554 ' O ' ' N ' ' B' ' 337' ' ' VAL . 68.6 t-105 -162.34 135.95 6.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.828 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 352' ' ' SER . . . . . 0.509 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -54.01 138.32 37.51 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.541 -178.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.623 HD12 ' O ' ' B' ' 333' ' ' THR . 1.8 tt -78.51 -35.69 45.97 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.97 11.1 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.97 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 355' ' ' ASN . . . . . 0.509 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -115.04 -3.99 12.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.171 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 356' ' ' ILE . . . . . 0.477 HD12 HD23 ' B' ' 353' ' ' LEU . 72.5 mt -58.12 148.54 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.951 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 357' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 11.5 tptt -106.45 -45.64 4.21 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.2 ptt180 -174.88 136.3 0.4 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.399 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 359' ' ' TRP . . . . . 0.489 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.6 p90 -118.74 174.53 6.22 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.35 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -156.88 97.99 1.73 Allowed 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.936 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 361' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -79.77 147.85 31.69 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.855 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 362' ' ' SER . . . . . 0.535 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -136.21 173.04 6.06 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -76.63 -8.61 18.26 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.033 1.822 . . . . 0.0 112.092 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 6.4 mttm -130.79 -22.08 2.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.96 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 365' ' ' SER . . . . . 0.657 ' HA ' ' H ' ' B' ' 382' ' ' THR . 89.8 p -149.73 170.02 19.7 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.617 0.723 . . . . 0.0 111.815 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 366' ' ' PHE . . . . . 0.505 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -142.79 156.56 44.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.802 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 367' ' ' THR . . . . . 0.564 ' CG2' HD12 ' A' ' 15' ' ' LEU . 33.9 m -148.1 156.44 42.61 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.734 -174.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 368' ' ' LEU . . . . . 0.454 ' N ' HG22 ' B' ' 367' ' ' THR . 6.0 mt -129.11 143.4 50.85 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.479 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.7 t0 -119.74 95.86 4.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.652 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 370' ' ' PHE . . . . . 0.491 ' O ' ' CD2' ' B' ' 370' ' ' PHE . 10.3 p90 -136.6 93.52 2.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.371 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 371' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.58 12.22 1.81 Allowed Glycine 0 C--O 1.226 -0.397 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -41.77 -15.74 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.117 -0.542 . . . . 0.0 111.776 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.61 -37.3 65.42 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 374' ' ' GLN . . . . . 0.479 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.85 -92.94 0.5 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 375' ' ' ASP . . . . . 0.479 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.5 t70 -129.02 96.4 4.33 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.5 -2.45 55.49 Favored Glycine 0 C--N 1.311 -0.859 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.218 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 377' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.32 106.11 17.15 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -175.547 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.21 125.98 52.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.783 175.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 379' ' ' SER . . . . . 0.501 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.9 t -138.19 164.27 29.62 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.519 0.676 . . . . 0.0 112.667 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.4 172.89 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.942 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -99.77 126.51 45.85 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.891 0.853 . . . . 0.0 111.114 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 382' ' ' THR . . . . . 0.657 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.11 136.05 13.73 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.651 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.27 16.66 4.22 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.103 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.95 84.04 1.77 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.91 175.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.9 -58.84 1.95 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.509 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.1 pt-20 -44.66 -20.73 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.746 -0.727 . . . . 0.0 110.976 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 387' ' ' GLN . . . . . 0.429 ' N ' ' C ' ' B' ' 385' ' ' GLY . 78.2 mt-30 -82.06 -39.38 23.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 48.1 mt -76.93 -42.33 32.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.712 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 389' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.87 -42.29 60.96 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.185 -1.37 . . . . 0.0 113.618 -177.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.509 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.79 -34.99 79.13 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.116 0.96 . . . . 0.0 110.992 -177.498 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.93 -53.59 10.91 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.814 -179.441 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.09 -56.12 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 393' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.29 -33.77 43.67 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.792 -2.004 . . . . 0.0 110.743 177.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 394' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.2 -17.86 61.92 Favored Glycine 0 CA--C 1.507 -0.454 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 395' ' ' TYR . . . . . 0.677 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.15 -36.95 17.77 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.489 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.44 -13.33 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 122.237 1.017 . . . . 0.0 109.365 176.029 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.54 -22.7 46.89 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.513 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 398' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.5 mt -91.8 -62.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 113.899 -1.501 . . . . 0.0 112.042 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 399' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.29 -20.6 27.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 113.404 -1.725 . . . . 0.0 112.384 -177.048 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 400' ' ' LEU . . . . . 0.561 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.773 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.555 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? . . . . . 0 N--CA 1.462 0.129 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -43.41 98.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.582 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.87 -37.27 90.45 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.457 -0.371 . . . . 0.0 110.035 178.632 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 89.1 t . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.736 0.303 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.56 153.62 27.22 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.202 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.22 134.29 47.16 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.054 0.221 . . . . 0.0 111.471 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -139.82 128.42 23.03 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.663 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.904 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.58 107.17 13.16 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 123.685 1.707 . . . . 0.0 109.358 178.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.648 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.7 m -118.96 160.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.174 -176.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -104.78 144.93 31.08 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' B' ' 326' ' ' VAL . 60.6 tt0 . . . . . 0 C--N 1.315 -0.923 0 CA-C-O 122.126 0.965 . . . . 0.0 112.596 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' B' ' 317' ' ' GLU . 12.2 t . . . . . 0 N--CA 1.44 -0.965 0 CA-C-O 119.156 -0.45 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.424 ' O ' HG12 ' B' ' 326' ' ' VAL . 56.7 Cg_exo -44.74 144.75 3.23 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.621 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 10.5 ttm-85 -151.58 -173.06 4.4 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 119.48 -0.888 . . . . 0.0 108.682 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.81 120.79 12.83 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.845 HD12 ' O ' ' B' ' 338' ' ' MET . 32.0 tp -98.17 158.74 15.38 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.214 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.436 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -143.0 108.76 0.53 Allowed Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.725 HD11 HD21 ' B' ' 330' ' ' LEU . 30.0 mm -87.97 124.34 41.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.721 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.5 p -118.47 138.34 52.56 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.426 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . 0.602 ' NZ ' ' CE1' ' B' ' 395' ' ' TYR . 1.1 mtmm -57.68 14.55 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.813 0.34 . . . . 0.0 111.306 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.721 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.1 pt-20 -144.96 -3.56 0.77 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.15 177.7 1.86 Allowed 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.351 1.072 . . . . 0.0 112.991 -176.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.613 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.3 t -132.8 145.56 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 CA-C-N 113.093 -1.867 . . . . 0.0 106.236 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.845 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.5 ptt? -152.88 151.83 30.83 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.334 -175.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.51 HH12 HD13 ' B' ' 330' ' ' LEU . 5.4 mmt-85 -96.96 106.68 19.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.277 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -95.73 149.44 4.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.517 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' B' ' 343' ' ' LYS . 41.0 t0 -86.64 89.95 8.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.673 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.7 OUTLIER -35.88 -27.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.6 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 31.6 mttm -71.21 -44.16 65.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.582 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.54 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -113.61 -17.34 12.18 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' B' ' 344' ' ' THR . 6.8 tttm 77.26 0.22 2.96 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.445 ' O ' HG13 ' B' ' 340' ' ' VAL . 8.0 pt-20 -82.84 157.98 22.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.603 HG21 ' SD ' ' B' ' 338' ' ' MET . 89.8 t -87.29 131.94 33.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.331 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 6.7 mt -102.64 -30.67 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.498 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.484 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.8 tt0 -138.13 158.31 44.57 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.662 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -144.48 149.75 36.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.258 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.13 123.14 3.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.318 177.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.5 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.48 139.58 3.67 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.513 0.673 . . . . 0.0 111.627 -178.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.598 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -82.26 -36.64 26.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . 0.536 ' O ' HG22 ' B' ' 354' ' ' THR . 19.6 m -71.74 7.37 1.53 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.882 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.4 m-20 -108.51 -5.02 16.75 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.825 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.535 HD12 HD23 ' B' ' 353' ' ' LEU . 72.1 mt -60.81 144.19 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.725 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -107.42 -46.18 3.91 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 7.5 ptt180 -171.54 136.03 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.542 ' CH2' HD12 ' B' ' 396' ' ' ILE . 7.5 p90 -119.31 176.45 5.32 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.315 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.7 98.27 1.64 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.188 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.38 145.77 31.84 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.741 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.523 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -134.23 174.17 4.97 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -77.57 -7.87 16.91 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.027 1.818 . . . . 0.0 112.123 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' B' ' 382' ' ' THR . 10.4 mtpt -130.86 -21.49 2.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.016 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.654 ' HA ' ' H ' ' B' ' 382' ' ' THR . 58.1 p -152.21 167.15 29.52 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.526 0.679 . . . . 0.0 111.874 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.468 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -138.55 156.74 47.23 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.826 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.555 ' CG2' HD12 ' A' ' 15' ' ' LEU . 31.8 m -148.56 154.72 40.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.146 -1.022 . . . . 0.0 113.185 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.4 mt -125.89 139.64 53.3 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.142 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.9 t0 -117.72 95.58 5.0 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.485 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 17.3 t80 -137.33 94.48 2.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.89 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.87 11.97 2.01 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.6 t0 -41.41 -16.12 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.067 -0.566 . . . . 0.0 111.797 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.556 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.59 -37.03 65.06 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.469 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.3 OUTLIER -125.93 -93.06 0.49 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.853 -1.521 . . . . 0.0 106.946 176.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.469 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 8.2 t70 -128.96 96.41 4.34 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.56 -2.64 53.27 Favored Glycine 0 C--N 1.312 -0.775 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.292 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.67 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.26 107.13 16.39 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . 0.413 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.7 OUTLIER -114.65 120.43 40.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.737 176.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.1 t -138.73 163.59 31.76 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.581 0.705 . . . . 0.0 112.78 -177.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.2 m -151.08 175.41 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.792 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -100.78 125.57 47.27 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.96 0.885 . . . . 0.0 110.931 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.654 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.28 136.49 13.93 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.753 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.32 17.01 4.68 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.143 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.99 84.04 1.76 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.022 175.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.99 -58.84 1.94 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.458 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.4 pt-20 -44.41 -20.21 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.748 -0.726 . . . . 0.0 111.038 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.437 ' N ' ' C ' ' B' ' 385' ' ' GLY . 63.6 mt-30 -83.04 -39.71 20.87 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.1 mt -76.39 -42.22 36.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.683 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.47 -42.53 61.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.267 -1.333 . . . . 0.0 113.718 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.458 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 12.2 pt20 -63.88 -34.76 78.66 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.04 0.924 . . . . 0.0 110.98 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.657 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.84 -53.47 10.14 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 113.877 -1.51 . . . . 0.0 108.765 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.657 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.4 mt -48.67 -55.29 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 176.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.49 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.79 -33.68 49.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.708 -2.042 . . . . 0.0 110.552 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.96 -18.0 62.06 Favored Glycine 0 CA--C 1.507 -0.456 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.68 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -86.84 -37.18 17.99 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.542 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.38 -13.39 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 122.153 0.978 . . . . 0.0 109.284 176.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.82 -22.69 45.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.506 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.8 mt -91.89 -61.88 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 113.895 -1.502 . . . . 0.0 112.033 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.85 -20.51 27.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.374 -1.739 . . . . 0.0 112.307 -176.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.56 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.83 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.553 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? . . . . . 0 N--CA 1.463 0.187 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -42.94 98.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.24 -36.86 90.59 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 . . . . . 0 C--N 1.327 -0.379 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.707 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.775 0.322 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.55 153.56 23.96 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.15 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -129.95 134.58 47.55 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.153 0.283 . . . . 0.0 111.496 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -139.84 128.52 23.13 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.582 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.907 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.86 107.27 13.53 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.745 1.736 . . . . 0.0 109.334 178.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' B' ' 382' ' ' THR . 30.7 m -118.74 160.57 18.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 112.63 -2.077 . . . . 0.0 110.096 -176.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -102.94 145.53 29.7 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' B' ' 326' ' ' VAL . 31.0 tt0 . . . . . 0 C--N 1.315 -0.897 0 CA-C-O 122.164 0.983 . . . . 0.0 112.575 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t . . . . . 0 N--CA 1.44 -0.952 0 CA-C-O 119.04 -0.505 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.425 ' O ' HG12 ' B' ' 326' ' ' VAL . 63.9 Cg_exo -44.15 144.06 3.03 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 N-CA-C 108.085 -1.544 . . . . 0.0 108.085 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.62 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 8.4 ttm180 -150.26 -173.3 4.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.8 120.65 12.72 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.835 HD12 ' O ' ' B' ' 338' ' ' MET . 31.3 tp -98.45 158.43 15.6 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.09 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.435 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.45 108.4 0.52 Allowed Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 177.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.735 HD11 HD21 ' B' ' 330' ' ' LEU . 29.7 mm -87.98 123.02 40.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.722 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.37 138.25 51.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -57.86 15.2 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.173 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.722 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.0 pt-20 -144.99 -4.25 0.74 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.62 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.6 177.22 2.17 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 122.448 1.118 . . . . 0.0 112.892 -176.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.613 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.8 t -132.32 145.25 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-N 113.132 -1.849 . . . . 0.0 106.201 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.835 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.1 ptt? -152.77 151.01 29.99 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 117.089 -1.845 . . . . 0.0 114.419 -175.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.525 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 61.4 mtm180 -96.01 106.91 19.13 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.443 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.46 149.81 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.284 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.0 t0 -87.83 91.57 8.8 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.712 -178.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.37 -28.46 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.62 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.5 mttp -75.54 -44.0 45.76 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.714 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.555 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.63 -13.07 14.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 30.7 tttp 67.38 -0.67 1.76 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 109.986 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.7 mt-10 -85.99 152.56 22.82 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.317 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.622 HG21 ' SD ' ' B' ' 338' ' ' MET . 87.5 t -81.36 133.6 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.498 0.666 . . . . 0.0 112.299 -178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . 0.436 HD11 ' HB2' ' B' ' 341' ' ' ASP . 56.1 mt -103.21 -30.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.369 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.525 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 19.7 tt0 -140.23 157.86 44.93 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.678 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 44.9 mt-10 -143.32 150.15 38.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.349 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.562 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.49 124.02 4.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.118 177.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.404 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.59 140.44 3.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.439 0.638 . . . . 0.0 111.566 -178.557 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.585 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -84.2 -36.12 23.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . 0.467 HG23 HD22 ' B' ' 355' ' ' ASN . 5.7 t -73.74 9.39 1.48 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.889 177.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.57 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 1.0 OUTLIER -111.04 -7.21 14.53 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.055 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.495 HD12 HD23 ' B' ' 353' ' ' LEU . 79.2 mt -56.75 146.6 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.686 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 10.0 tttm -107.78 -46.35 3.82 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.3 ptt-85 -172.05 135.91 0.83 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.513 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.7 p90 -119.53 175.94 5.6 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.288 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.37 99.49 1.62 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.085 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.63 146.83 30.98 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.747 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.529 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -134.55 173.75 5.43 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -77.49 -7.98 17.03 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.119 1.879 . . . . 0.0 112.038 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' B' ' 382' ' ' THR . 4.1 mtpp -130.87 -21.16 2.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.038 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.657 ' HA ' ' H ' ' B' ' 382' ' ' THR . 58.6 p -152.13 167.7 27.66 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.566 0.698 . . . . 0.0 111.942 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.46 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.06 156.64 47.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.651 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.553 ' CG2' HD12 ' A' ' 15' ' ' LEU . 27.9 m -148.53 154.74 40.2 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.151 -174.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.0 mt -126.12 140.03 52.9 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.08 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.0 t0 -117.75 95.84 5.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.533 176.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 27.6 t80 -137.93 94.72 2.93 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.89 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.8 12.02 2.02 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.9 t0 -41.39 -16.43 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.045 -0.577 . . . . 0.0 111.829 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.548 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.46 -37.25 64.99 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.468 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.2 pt20 -125.85 -92.74 0.5 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.941 -1.482 . . . . 0.0 107.222 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.468 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.6 t70 -129.14 96.3 4.29 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.24 -2.91 54.24 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.376 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.681 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.57 106.75 16.37 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -175.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . 0.41 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.8 OUTLIER -114.3 120.13 39.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.717 176.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.4 t -138.66 163.45 32.06 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.673 0.749 . . . . 0.0 112.773 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.3 m -150.62 175.61 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.93 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -101.42 124.89 47.83 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.938 0.875 . . . . 0.0 110.807 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.657 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.95 136.68 14.4 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.772 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.41 17.2 4.63 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.271 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.03 83.92 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.989 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.02 -59.15 1.9 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.497 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.6 pt-20 -44.33 -20.69 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.758 -0.721 . . . . 0.0 111.009 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 22.9 mt-30 -82.43 -39.59 22.39 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.0 mt -76.55 -42.01 34.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.661 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.87 -42.71 60.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.651 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 5.1 pp0? -63.76 -34.3 77.58 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.055 0.931 . . . . 0.0 110.969 -177.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.31 -53.4 9.77 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.705 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -48.77 -55.38 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.487 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.06 -34.53 43.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.737 -2.029 . . . . 0.0 110.593 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.46 -18.06 62.98 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.679 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.7 -37.0 18.37 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.513 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.31 -13.29 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.097 0.951 . . . . 0.0 109.221 176.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.39 -22.62 47.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.563 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' B' ' 395' ' ' TYR . 67.2 mt -91.99 -61.96 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.057 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.81 -20.28 27.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.396 -1.729 . . . . 0.0 112.335 -176.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.555 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.858 -1.067 . . . . 0.0 110.731 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? . . . . . 0 CA--C 1.518 -0.256 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -39.26 80.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.724 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.35 -43.21 99.4 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 C--N 1.326 -0.423 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.397 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.832 0.348 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.09 153.43 26.94 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.229 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -130.47 134.26 46.95 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.113 0.258 . . . . 0.0 111.423 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -139.31 129.01 24.63 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.625 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.9 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.52 105.9 13.04 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 123.749 1.737 . . . . 0.0 109.42 178.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.649 HG12 ' HB ' ' B' ' 382' ' ' THR . 30.8 m -117.36 160.82 16.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 112.703 -2.044 . . . . 0.0 110.078 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -102.55 145.5 29.52 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.563 ' CD ' ' HE ' ' B' ' 339' ' ' ARG . 26.6 tt0 . . . . . 0 C--N 1.315 -0.929 0 CA-C-O 121.955 0.884 . . . . 0.0 112.627 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' B' ' 317' ' ' GLU . 6.5 t . . . . . 0 N--CA 1.438 -1.049 0 CA-C-O 119.116 -0.468 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' B' ' 326' ' ' VAL . 66.5 Cg_exo -43.9 143.89 2.81 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 N-CA-C 108.196 -1.502 . . . . 0.0 108.196 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.615 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.7 ttt180 -149.71 -173.33 4.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 119.476 -0.89 . . . . 0.0 108.699 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.662 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -141.83 120.73 12.77 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.832 HD12 ' O ' ' B' ' 338' ' ' MET . 32.2 tp -98.5 158.11 15.8 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.177 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.52 108.46 0.53 Allowed Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.719 HD11 HD21 ' B' ' 330' ' ' LEU . 29.5 mm -88.1 123.04 40.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.72 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.47 138.43 51.86 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 16.0 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.191 0.307 . . . . 0.0 111.268 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.72 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -145.48 -4.76 0.68 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.482 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.42 177.14 2.26 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 122.368 1.08 . . . . 0.0 112.883 -176.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.1 t -132.01 145.14 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 CA-C-N 113.13 -1.85 . . . . 0.0 106.33 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.832 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.79 150.84 29.79 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 117.124 -1.831 . . . . 0.0 114.519 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.563 ' HE ' ' CD ' ' B' ' 317' ' ' GLU . 0.2 OUTLIER -96.3 106.79 19.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.496 176.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.662 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.16 149.98 4.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.244 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.1 t0 -87.87 91.6 8.82 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.736 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.36 -28.45 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.685 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' B' ' 341' ' ' ASP . 44.4 mttt -75.5 -43.9 46.62 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.69 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.557 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.76 -13.33 14.8 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -177.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 20.6 tttt 67.77 -0.87 1.83 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.942 0.401 . . . . 0.0 109.943 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.432 ' H ' ' C ' ' B' ' 344' ' ' THR . 4.1 mt-10 -86.05 152.59 22.77 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.618 HG21 ' SD ' ' B' ' 338' ' ' MET . 87.7 t -81.37 134.05 27.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.5 0.667 . . . . 0.0 112.237 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . 0.482 HG21 HH22 ' B' ' 328' ' ' ARG . 7.4 mt -104.11 -30.69 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.186 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.474 ' O ' ' CB ' ' B' ' 338' ' ' MET . 15.6 tt0 -139.04 157.4 46.05 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.554 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -143.64 149.84 37.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.232 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.15 123.98 4.1 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.976 177.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.521 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -44.86 141.77 2.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.388 0.613 . . . . 0.0 111.661 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.6 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -85.25 -36.27 21.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -73.91 9.99 1.32 Allowed 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.908 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.574 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.1 m-20 -111.81 -7.04 14.22 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.973 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.51 HD12 HD23 ' B' ' 353' ' ' LEU . 80.1 mt -56.44 147.04 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.748 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . 0.509 ' NZ ' ' OH ' ' B' ' 373' ' ' TYR . 9.4 tttp -107.71 -46.29 3.84 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 6.0 ptt180 -172.77 135.71 0.67 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.482 ' CH2' HD12 ' B' ' 396' ' ' ILE . 10.4 p90 -119.28 175.78 5.64 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.226 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.14 100.38 1.7 Allowed 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.84 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -82.86 142.56 31.4 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.66 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.538 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -130.27 174.51 4.55 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -77.82 -8.31 16.77 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.145 1.896 . . . . 0.0 112.063 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' B' ' 382' ' ' THR . 3.2 mttp -130.33 -20.81 2.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.965 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.662 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.1 p -152.03 167.69 27.61 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.55 0.691 . . . . 0.0 111.951 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.441 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -138.87 156.39 47.33 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.541 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.549 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.7 m -148.46 154.53 39.98 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.021 -1.072 . . . . 0.0 113.107 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.5 mt -125.61 140.0 53.11 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.336 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.9 t0 -117.36 95.61 5.04 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.892 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 29.7 t80 -137.99 95.24 3.0 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.955 176.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.77 12.38 1.96 Allowed Glycine 0 C--O 1.225 -0.419 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 10.0 t0 -41.88 -16.35 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.935 -0.633 . . . . 0.0 112.07 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.27 -38.09 65.45 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.463 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.32 -92.17 0.52 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.881 -1.509 . . . . 0.0 107.553 176.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 15.1 t0 -130.06 96.27 4.15 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.82 -3.58 54.88 Favored Glycine 0 C--N 1.303 -1.287 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.425 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.5 106.99 16.5 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -175.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -115.09 120.45 39.85 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.691 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.1 t -138.54 163.28 32.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.5 m -149.98 176.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.367 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -102.13 124.24 47.39 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-O 122.012 0.911 . . . . 0.0 110.829 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.662 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.55 137.19 15.17 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.929 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.15 17.69 4.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.23 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.18 83.64 1.74 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.973 174.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.42 -58.52 1.95 Allowed Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.449 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.3 pt-20 -44.82 -20.08 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.783 -0.708 . . . . 0.0 111.03 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.433 ' N ' ' C ' ' B' ' 385' ' ' GLY . 4.1 mm-40 -83.37 -38.87 21.42 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.8 mt -76.91 -41.99 32.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.623 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.95 -42.51 60.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.566 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.449 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -63.65 -34.2 77.31 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.064 0.935 . . . . 0.0 111.091 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.22 -53.26 10.17 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.738 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -49.02 -55.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.485 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.13 -34.44 44.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.663 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.68 -18.01 62.63 Favored Glycine 0 CA--C 1.505 -0.56 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.675 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.65 -37.04 18.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.322 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.482 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.24 -13.34 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-O 122.121 0.962 . . . . 0.0 109.288 176.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.36 -22.65 47.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.715 -1.584 . . . . 0.0 109.512 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.675 HD12 ' HA ' ' B' ' 395' ' ' TYR . 67.3 mt -92.05 -61.95 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.119 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.82 -20.11 26.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 113.394 -1.73 . . . . 0.0 112.373 -176.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.554 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.219 -0.508 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.723 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.3 mm? . . . . . 0 CA--C 1.52 -0.18 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -41.42 93.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.586 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.27 -41.48 98.35 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.15 178.687 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 73.9 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.839 0.352 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.87 153.18 25.8 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.082 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -129.49 135.64 48.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.452 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -138.5 129.83 27.33 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.588 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.863 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.42 101.39 10.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 123.869 1.795 . . . . 0.0 109.541 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' B' ' 328' ' ' ARG . 31.4 m -112.88 157.79 13.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 112.654 -2.066 . . . . 0.0 109.986 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -99.57 144.14 29.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.53 ' O ' ' N ' ' B' ' 326' ' ' VAL . 38.8 tt0 . . . . . 0 C--N 1.314 -0.961 0 CA-C-O 122.091 0.948 . . . . 0.0 112.714 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' B' ' 317' ' ' GLU . 11.2 t . . . . . 0 N--CA 1.439 -0.984 0 CA-C-O 118.901 -0.571 . . . . 0.0 109.859 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.445 ' O ' HG12 ' B' ' 326' ' ' VAL . 76.7 Cg_exo -43.13 142.86 2.25 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 N-CA-C 107.915 -1.61 . . . . 0.0 107.915 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' B' ' 315' ' ' VAL . 2.0 tpt180 -146.7 -173.16 4.14 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -145.93 122.92 11.38 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.838 HD12 ' O ' ' B' ' 338' ' ' MET . 26.7 tp -102.5 158.39 16.25 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.421 ' N ' ' HG ' ' B' ' 330' ' ' LEU . . . -141.01 107.51 0.52 Allowed Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.761 HD11 HD21 ' B' ' 330' ' ' LEU . 31.5 mm -88.62 122.72 40.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.733 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.5 p -117.66 137.78 52.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -57.54 13.78 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.059 0.457 . . . . 0.0 111.727 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.733 ' H ' ' C ' ' B' ' 333' ' ' THR . 15.8 pt-20 -144.25 -2.69 0.87 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.839 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.83 179.05 2.08 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.318 1.056 . . . . 0.0 112.989 -177.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.612 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 15.0 t -137.13 144.33 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 CA-C-N 113.266 -1.788 . . . . 0.0 106.752 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.838 ' O ' HD12 ' B' ' 330' ' ' LEU . 4.2 ptt? -153.44 150.12 28.46 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 117.053 -1.859 . . . . 0.0 114.263 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.654 HH12 HD13 ' B' ' 330' ' ' LEU . 6.5 mmt-85 -94.9 107.19 19.22 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.665 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.63 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.53 149.7 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.275 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.1 t0 -89.92 92.18 8.9 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.765 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.58 -28.7 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.697 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 20.2 mttp -75.42 -43.6 48.98 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.705 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.556 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.39 -12.58 14.72 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' B' ' 341' ' ' ASP . 6.3 ttmm 66.76 -0.52 1.59 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.032 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.5 mt-10 -84.9 153.17 23.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.274 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.58 HG21 ' SD ' ' B' ' 338' ' ' MET . 74.2 t -83.17 134.35 27.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.481 0.658 . . . . 0.0 112.334 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 21.6 mm -102.89 -31.85 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.353 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' B' ' 338' ' ' MET . 17.1 tt0 -137.64 156.89 47.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.703 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -146.42 148.78 32.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.348 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.556 ' O ' ' N ' ' B' ' 337' ' ' VAL . 67.0 t-105 -163.73 135.74 4.95 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.905 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -53.87 138.25 36.71 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.344 -178.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.631 HD12 ' O ' ' B' ' 333' ' ' THR . 1.7 tt -78.26 -35.38 48.23 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -75.59 11.72 1.23 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.999 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -115.58 -4.01 12.28 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.139 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.501 HD12 HD23 ' B' ' 353' ' ' LEU . 75.8 mt -57.7 149.39 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.097 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 10.8 tptt -107.33 -44.71 4.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.1 ptt180 -175.88 136.22 0.31 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.407 177.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.457 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.3 p90 -118.84 174.54 6.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.344 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.31 99.21 1.76 Allowed 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 119.233 -0.987 . . . . 0.0 112.002 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.53 144.25 31.45 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.773 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.539 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -131.9 174.27 4.9 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -77.31 -8.94 17.57 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.14 1.893 . . . . 0.0 112.102 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 17.1 mttt -130.69 -21.37 2.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.97 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.654 ' HA ' ' H ' ' B' ' 382' ' ' THR . 78.7 p -149.85 168.88 22.48 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.487 0.661 . . . . 0.0 111.938 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.503 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -141.16 156.87 45.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.796 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.549 ' CG2' HD12 ' A' ' 15' ' ' LEU . 44.8 m -147.78 156.85 43.17 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.093 -1.043 . . . . 0.0 112.913 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.466 ' N ' HG22 ' B' ' 367' ' ' THR . 5.9 mt -130.04 140.65 50.82 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.546 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.4 t0 -117.28 95.86 5.16 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.697 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.6 p90 -136.56 93.64 2.9 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.443 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.45 12.36 1.82 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . 0.401 ' CG ' ' OH ' ' B' ' 377' ' ' TYR . 8.3 t0 -41.84 -15.78 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.034 -0.583 . . . . 0.0 111.756 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.6 -37.27 65.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.478 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.89 -92.78 0.5 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.132 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.478 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.0 t70 -129.05 96.27 4.29 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.38 -3.03 55.6 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.306 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.682 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.95 106.06 16.86 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -175.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.14 125.86 51.89 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.736 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 46.6 t -138.38 163.67 31.27 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.532 0.682 . . . . 0.0 112.559 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -148.89 175.02 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.883 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.07 125.41 48.76 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.897 0.855 . . . . 0.0 111.098 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.654 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.54 136.44 14.56 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.814 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.78 16.85 4.4 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.243 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.97 84.0 1.76 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.938 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.79 -58.24 2.05 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.6 pt-20 -44.79 -20.69 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.811 -0.695 . . . . 0.0 110.962 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' B' ' 385' ' ' GLY . 68.9 mt-30 -82.11 -39.29 23.55 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 45.9 mt -77.05 -42.43 31.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.614 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.63 -42.38 61.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.569 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 5.1 pp0? -63.77 -34.91 78.96 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.1 0.952 . . . . 0.0 110.95 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.01 -53.78 10.28 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.723 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -48.97 -56.06 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 176.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.41 -33.74 45.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 112.874 -1.966 . . . . 0.0 110.671 177.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.18 -17.81 62.05 Favored Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.674 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.04 -36.92 17.91 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.47 ' HA ' HD11 ' B' ' 399' ' ' ILE . 0.0 OUTLIER -68.59 -13.31 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 122.203 1.002 . . . . 0.0 109.285 176.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.6 -22.68 46.67 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.459 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 395' ' ' TYR . 69.2 mt -91.82 -62.01 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 113.894 -1.503 . . . . 0.0 112.038 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.22 -20.58 27.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 113.449 -1.705 . . . . 0.0 112.323 -177.061 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.222 -0.384 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.812 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.559 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? . . . . . 0 CA--C 1.521 -0.145 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -41.19 88.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.432 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.68 -41.82 99.66 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.508 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 90.0 mt-10 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.042 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.846 0.355 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.76 153.4 26.57 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.166 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -129.73 134.52 47.66 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.085 0.24 . . . . 0.0 111.475 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -139.33 128.72 24.21 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.612 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.892 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.3 105.86 12.83 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 123.733 1.73 . . . . 0.0 109.446 178.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.657 HG12 ' HB ' ' B' ' 382' ' ' THR . 29.5 m -118.34 161.95 16.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 112.709 -2.041 . . . . 0.0 110.145 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -103.41 145.3 30.19 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' B' ' 326' ' ' VAL . 44.4 tt0 . . . . . 0 C--N 1.314 -0.951 0 CA-C-O 121.972 0.891 . . . . 0.0 112.462 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.2 t . . . . . 0 N--CA 1.443 -0.824 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.448 ' O ' HG12 ' B' ' 326' ' ' VAL . 70.0 Cg_exo -43.9 144.44 2.51 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 N-CA-C 108.166 -1.513 . . . . 0.0 108.166 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' B' ' 315' ' ' VAL . 7.3 ttm-85 -151.44 -172.61 4.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.708 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -142.1 122.39 13.93 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.851 HD12 ' O ' ' B' ' 338' ' ' MET . 31.2 tp -100.41 158.58 15.8 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.43 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.32 108.3 0.52 Allowed Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.735 HD11 HD21 ' B' ' 330' ' ' LEU . 30.1 mm -88.09 123.4 40.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.724 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.83 138.51 52.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . 0.617 ' NZ ' ' CE1' ' B' ' 395' ' ' TYR . 0.4 OUTLIER -57.76 15.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.311 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.724 ' H ' ' C ' ' B' ' 333' ' ' THR . 10.9 pt-20 -144.88 -4.65 0.74 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.701 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.08 177.84 2.25 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 122.398 1.094 . . . . 0.0 112.947 -176.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.8 t -132.94 145.22 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 CA-C-N 113.113 -1.858 . . . . 0.0 106.219 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.851 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.4 ptt? -153.05 151.34 30.12 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 117.258 -1.777 . . . . 0.0 114.429 -175.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.422 HH12 HG21 ' B' ' 380' ' ' VAL . 8.7 mmt180 -96.24 106.85 19.12 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.456 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.641 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -97.07 149.7 4.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.235 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 343' ' ' LYS . 25.5 t0 -88.47 91.98 9.01 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.773 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.42 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.734 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 61.8 mttt -76.12 -44.08 40.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.756 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.551 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -108.72 -12.59 14.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' B' ' 341' ' ' ASP . 32.4 tttp 66.9 -0.53 1.63 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.955 0.407 . . . . 0.0 109.976 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.3 mt-10 -85.37 153.0 22.82 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.284 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.61 HG21 ' SD ' ' B' ' 338' ' ' MET . 83.4 t -81.9 133.47 29.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.524 0.678 . . . . 0.0 112.314 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 11.6 mt -103.4 -31.86 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.449 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.474 ' O ' ' CB ' ' B' ' 338' ' ' MET . 24.4 tt0 -136.6 158.48 44.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.782 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 39.1 mt-10 -144.97 149.3 34.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.286 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.562 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.88 124.74 3.94 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.151 177.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.401 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -46.59 140.37 4.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.435 0.636 . . . . 0.0 111.527 -178.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.585 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -83.74 -36.04 23.96 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . 0.462 HG23 HD22 ' B' ' 355' ' ' ASN . 5.2 t -74.18 9.82 1.48 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.913 177.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.569 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 1.0 OUTLIER -111.64 -7.98 14.24 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.052 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.479 HD12 HD23 ' B' ' 353' ' ' LEU . 81.4 mt -56.01 146.92 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.692 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -107.86 -46.08 3.86 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.493 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 2.2 ptt-85 -172.55 136.38 0.75 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.53 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.3 p90 -119.44 176.49 5.33 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.275 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.39 99.2 1.75 Allowed 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.041 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.97 140.15 34.15 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.68 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.531 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -128.32 174.5 4.36 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.79 -7.78 16.66 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.118 1.878 . . . . 0.0 112.193 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.1 mttp -130.91 -20.39 2.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.04 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.672 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.5 p -152.85 166.49 32.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.423 0.63 . . . . 0.0 111.931 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.48 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -137.04 156.52 48.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.61 179.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.559 ' CG2' HD12 ' A' ' 15' ' ' LEU . 25.3 m -148.54 154.58 39.98 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.104 -1.038 . . . . 0.0 113.091 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.0 mt -125.66 139.45 53.55 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.118 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.8 t0 -117.07 95.83 5.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.457 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 33.4 t80 -137.77 94.51 2.91 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.896 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.67 12.12 2.03 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.0 t0 -41.47 -16.0 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.035 -0.582 . . . . 0.0 111.826 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.52 -37.33 65.24 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.474 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.69 -92.84 0.5 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.474 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.3 t70 -128.88 96.34 4.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.11 -2.97 54.66 Favored Glycine 0 C--N 1.315 -0.629 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.243 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.07 106.4 15.69 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . 0.415 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.8 OUTLIER -113.88 120.4 40.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.598 176.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 37.3 t -138.88 164.59 29.27 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.651 0.738 . . . . 0.0 112.757 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . 0.422 HG21 HH12 ' B' ' 339' ' ' ARG . 1.0 OUTLIER -151.07 174.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.858 179.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.39 124.59 46.07 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.973 0.892 . . . . 0.0 111.024 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.672 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.82 137.69 14.42 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.824 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . 0.439 ' N ' ' OE2' ' B' ' 384' ' ' GLU . 0.8 OUTLIER -85.43 -1.2 56.79 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.972 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -123.81 84.05 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.096 0.95 . . . . 0.0 108.727 175.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.99 -59.54 1.86 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.4 pt-20 -45.59 -21.04 0.08 Allowed 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 114.697 -0.752 . . . . 0.0 111.074 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.406 ' N ' ' C ' ' B' ' 385' ' ' GLY . 68.6 mt-30 -81.04 -38.62 27.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.3 mt -77.36 -41.97 30.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.588 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -74.18 -42.68 59.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.507 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.65 -34.59 78.19 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.991 0.9 . . . . 0.0 111.035 -177.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.94 -53.45 10.08 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.781 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -48.89 -55.55 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 176.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.485 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -51.96 -34.06 40.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.764 -2.017 . . . . 0.0 110.569 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.06 -18.12 61.66 Favored Glycine 0 CA--C 1.506 -0.524 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.682 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.68 -36.88 18.47 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.53 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.29 -13.36 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 122.108 0.956 . . . . 0.0 109.189 176.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.34 -22.68 47.67 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.506 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.0 mt -91.99 -61.92 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 113.869 -1.514 . . . . 0.0 112.022 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.9 -20.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 113.415 -1.721 . . . . 0.0 112.311 -176.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.557 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.221 -0.437 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.775 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.552 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? . . . . . 0 CA--C 1.521 -0.159 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -40.98 86.32 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.8 -41.63 99.65 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.513 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.1 mt-10 . . . . . 0 C--N 1.327 -0.398 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.784 0.326 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.13 153.4 23.21 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.132 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -128.14 135.29 49.57 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -140.06 128.79 23.14 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.598 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.907 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.86 107.45 13.68 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 123.728 1.728 . . . . 0.0 109.349 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.65 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.0 m -119.88 159.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 112.647 -2.07 . . . . 0.0 110.066 -177.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -100.79 145.05 29.01 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' B' ' 326' ' ' VAL . 47.1 tt0 . . . . . 0 C--N 1.312 -1.023 0 CA-C-O 121.995 0.903 . . . . 0.0 112.617 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.0 t . . . . . 0 N--CA 1.441 -0.911 0 CA-C-O 119.092 -0.48 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.434 ' O ' HG12 ' B' ' 326' ' ' VAL . 67.0 Cg_exo -44.33 143.74 3.45 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 N-CA-C 108.093 -1.541 . . . . 0.0 108.093 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.631 ' N ' ' O ' ' B' ' 315' ' ' VAL . 0.3 OUTLIER -149.99 -172.92 4.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.759 -177.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.646 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -142.31 122.05 13.45 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.84 HD12 ' O ' ' B' ' 338' ' ' MET . 30.3 tp -100.37 158.3 15.99 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.118 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.434 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.94 108.11 0.52 Allowed Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.74 HD11 HD21 ' B' ' 330' ' ' LEU . 30.4 mm -87.99 121.63 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.72 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.3 p -115.83 138.62 50.97 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -57.92 14.95 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.364 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.72 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.4 pt-20 -145.14 -3.79 0.74 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.476 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.5 178.42 1.97 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.343 1.068 . . . . 0.0 112.993 -176.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.7 t -134.38 145.0 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 113.147 -1.842 . . . . 0.0 106.308 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.84 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.5 ptt? -152.8 151.99 31.09 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 117.145 -1.822 . . . . 0.0 114.546 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.787 HH12 HD13 ' B' ' 330' ' ' LEU . 6.5 mmt-85 -96.28 107.36 19.7 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.466 176.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.646 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.06 149.8 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.219 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' B' ' 343' ' ' LYS . 0.3 OUTLIER -87.94 92.0 8.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.859 -178.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -36.55 -27.34 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.637 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' B' ' 341' ' ' ASP . 54.3 mttt -74.79 -42.61 57.79 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.731 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 341' ' ' ASP . 64.5 p -112.0 -16.91 12.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' B' ' 344' ' ' THR . 5.8 ttmm 73.73 1.8 4.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.94 0.4 . . . . 0.0 110.174 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.468 ' O ' HG13 ' B' ' 340' ' ' VAL . 5.5 pt-20 -86.52 158.65 19.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.617 HG21 ' SD ' ' B' ' 338' ' ' MET . 89.4 t -88.4 132.78 32.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.567 0.698 . . . . 0.0 112.36 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.21 -31.34 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.241 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.0 tt0 -136.74 157.5 46.61 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.601 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -144.25 149.65 36.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.003 -0.998 . . . . 0.0 111.215 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.61 124.52 4.02 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.125 177.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.501 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -46.73 140.47 4.53 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.358 0.599 . . . . 0.0 111.511 -178.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.591 HD12 ' O ' ' B' ' 333' ' ' THR . 1.9 tt -83.79 -35.74 24.09 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.6 t -74.52 10.22 1.43 Allowed 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.909 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.573 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.8 m-20 -112.11 -7.63 14.06 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.004 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.481 HD12 HD23 ' B' ' 353' ' ' LEU . 80.8 mt -55.98 147.4 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.775 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.77 -45.44 4.01 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.7 ptt-85 -173.9 135.93 0.51 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.466 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.8 p90 -118.74 176.54 5.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.206 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.43 99.42 1.6 Allowed 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.887 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.783 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.21 147.22 30.09 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.699 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.529 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -135.63 173.87 5.2 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -77.35 -8.36 17.31 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.113 1.875 . . . . 0.0 112.15 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' B' ' 382' ' ' THR . 3.9 mttp -130.66 -20.55 2.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.977 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.646 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.6 p -152.69 167.29 29.43 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.59 0.71 . . . . 0.0 111.993 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.467 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -138.81 156.92 46.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.638 179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.552 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.3 m -148.53 155.73 41.52 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.041 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.436 ' N ' HG22 ' B' ' 367' ' ' THR . 6.8 mt -126.29 139.73 53.08 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.375 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.1 t0 -116.96 95.75 5.15 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.68 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 32.6 t80 -138.1 94.87 2.93 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.971 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.12 12.04 1.94 Allowed Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.4 t0 -41.79 -16.37 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.044 -0.578 . . . . 0.0 111.778 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.0 m-85 -54.33 -37.27 64.67 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.466 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.98 -92.37 0.51 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.335 176.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.466 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.7 t70 -129.78 96.28 4.19 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 174.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.15 -3.52 54.27 Favored Glycine 0 C--N 1.31 -0.872 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.313 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.25 106.33 15.79 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.06 120.43 40.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.703 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 34.5 t -138.43 163.67 31.32 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.674 0.75 . . . . 0.0 112.952 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -150.42 175.56 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.199 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -101.23 125.06 47.82 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.968 0.89 . . . . 0.0 110.899 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.65 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -155.08 136.23 13.92 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.878 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.09 17.07 4.44 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.13 83.69 1.74 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.044 174.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.25 -57.72 2.08 Favored Glycine 0 C--N 1.317 -0.51 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.451 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.5 pt-20 -45.26 -20.27 0.05 Allowed 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 114.898 -0.651 . . . . 0.0 110.991 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.425 ' N ' ' C ' ' B' ' 385' ' ' GLY . 6.7 mm-40 -83.36 -38.55 21.87 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.0 mt -77.23 -41.89 30.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.538 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.783 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.88 -42.46 60.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.344 -1.298 . . . . 0.0 113.509 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.451 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -64.08 -34.14 77.37 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.051 0.929 . . . . 0.0 111.022 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.07 -53.43 9.98 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.898 -1.501 . . . . 0.0 108.725 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -49.16 -55.55 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.487 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -51.89 -34.15 39.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 112.756 -2.02 . . . . 0.0 110.69 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.8 -18.11 62.19 Favored Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.682 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.5 m-30 -86.66 -36.98 18.43 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.467 ' HA ' HD11 ' B' ' 399' ' ' ILE . 0.0 OUTLIER -68.12 -13.29 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 CA-C-O 122.114 0.959 . . . . 0.0 109.282 176.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.67 -22.77 46.29 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.519 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' B' ' 395' ' ' TYR . 69.3 mt -91.9 -61.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.052 -178.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.97 -20.34 27.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 113.458 -1.701 . . . . 0.0 112.329 -176.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.557 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.463 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.767 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.545 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -40.56 91.27 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.92 -38.19 95.61 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.508 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 91.4 mt-10 . . . . . 0 C--N 1.328 -0.346 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 74.0 t . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.735 0.302 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.59 153.25 24.44 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -129.72 135.68 48.76 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.058 0.224 . . . . 0.0 111.434 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -139.2 129.49 25.47 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.648 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.873 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.37 104.45 12.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.933 1.825 . . . . 0.0 109.403 178.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.645 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.6 m -115.6 160.93 14.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 112.583 -2.099 . . . . 0.0 110.101 -176.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -103.89 144.49 31.43 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' B' ' 326' ' ' VAL . 27.1 tt0 . . . . . 0 C--N 1.317 -0.825 0 CA-C-O 122.088 0.947 . . . . 0.0 112.767 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' B' ' 317' ' ' GLU . 9.4 t . . . . . 0 N--CA 1.439 -0.993 0 CA-C-O 119.124 -0.465 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.47 ' O ' HG12 ' B' ' 326' ' ' VAL . 65.5 Cg_exo -44.49 145.32 2.63 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 N-CA-C 108.121 -1.53 . . . . 0.0 108.121 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' B' ' 315' ' ' VAL . 9.9 ttm-85 -150.13 -173.21 4.37 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.787 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.64 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -143.89 122.1 12.24 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.839 HD12 ' O ' ' B' ' 338' ' ' MET . 26.2 tp -101.34 158.01 16.36 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.432 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.53 107.51 0.51 Allowed Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.708 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -88.22 124.0 41.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.725 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.6 p -118.23 137.74 52.81 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -56.93 12.8 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.908 0.385 . . . . 0.0 111.724 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.725 ' H ' ' C ' ' B' ' 333' ' ' THR . 10.8 pt-20 -144.06 -2.49 0.9 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.712 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.2 OUTLIER -174.03 -179.28 1.66 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.357 1.075 . . . . 0.0 113.372 -177.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.597 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.6 t -137.95 144.84 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.106 0 CA-C-N 113.257 -1.792 . . . . 0.0 107.036 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.839 ' O ' HD12 ' B' ' 330' ' ' LEU . 5.8 ptp -153.03 151.33 30.13 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 117.178 -1.809 . . . . 0.0 114.347 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.51 ' NH1' ' OE2' ' B' ' 317' ' ' GLU . 38.8 mtm180 -96.15 107.67 20.02 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.539 176.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.64 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.76 149.03 5.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.43 -178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' B' ' 344' ' ' THR . 44.6 t0 -88.75 90.5 8.43 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.962 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.79 -28.39 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.66 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.3 mttp -68.99 -43.98 73.77 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.441 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.546 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -115.73 -16.39 11.24 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' B' ' 344' ' ' THR . 2.7 tttp 77.11 -0.75 2.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.013 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.455 ' O ' HG13 ' B' ' 340' ' ' VAL . 8.7 pt-20 -80.12 158.01 26.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.509 HG22 HG22 ' B' ' 340' ' ' VAL . 86.4 t -88.64 133.77 30.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.432 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 61.0 mt -102.18 -29.36 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.3 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.447 ' O ' ' CB ' ' B' ' 338' ' ' MET . 17.6 tt0 -143.46 157.89 44.09 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.938 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . 0.408 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 36.3 mt-10 -146.13 149.45 34.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.996 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.576 ' O ' ' N ' ' B' ' 337' ' ' VAL . 70.1 t-105 -161.14 136.78 7.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.994 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.71 137.95 48.5 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.515 0.674 . . . . 0.0 111.554 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.627 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -78.66 -35.38 45.36 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . 0.473 ' C ' HD22 ' B' ' 355' ' ' ASN . 4.9 t -75.37 11.22 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.874 177.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.473 HD22 ' C ' ' B' ' 354' ' ' THR . 0.9 OUTLIER -115.08 -3.71 12.57 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.289 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.499 HD12 HD23 ' B' ' 353' ' ' LEU . 75.6 mt -58.71 148.92 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.854 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 6.9 tttp -106.96 -45.36 4.18 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.492 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 1.7 ptt180 -174.84 136.41 0.41 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.518 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.492 ' CH2' HD12 ' B' ' 396' ' ' ILE . 6.8 p90 -118.71 175.46 5.73 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.246 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.34 97.7 1.65 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.909 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.795 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.81 142.29 33.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.785 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.519 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -129.91 174.08 5.02 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -77.43 -8.47 17.26 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.156 1.904 . . . . 0.0 112.121 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' B' ' 382' ' ' THR . 20.3 mtpt -130.66 -21.84 2.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.855 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.653 ' HA ' ' H ' ' B' ' 382' ' ' THR . 86.3 p -149.81 169.74 20.39 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.507 0.67 . . . . 0.0 111.743 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.499 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -142.35 156.43 45.23 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.885 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.545 ' CG2' HD12 ' A' ' 15' ' ' LEU . 44.0 m -147.77 156.76 43.08 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.711 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.468 ' N ' HG22 ' B' ' 367' ' ' THR . 5.7 mt -129.92 142.45 50.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.495 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.2 t0 -119.14 95.64 4.9 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.743 176.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 12.6 p90 -136.07 93.43 2.91 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.235 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.95 11.7 1.8 Allowed Glycine 0 N--CA 1.462 0.391 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -41.74 -15.53 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.21 -0.495 . . . . 0.0 111.856 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.9 -36.55 65.3 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.495 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.06 -93.25 0.49 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.495 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.8 t0 -129.01 96.43 4.34 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.8 -1.81 55.17 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.315 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.31 105.96 17.04 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -175.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.96 125.77 51.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.645 176.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.8 t -138.19 164.12 30.0 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.575 0.702 . . . . 0.0 112.458 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -150.39 174.08 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.867 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -100.92 126.17 47.54 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.954 0.883 . . . . 0.0 111.072 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.653 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.93 136.49 14.26 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.404 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.02 16.66 4.77 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.142 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.55 84.33 1.8 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.119 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.88 -59.15 1.91 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.504 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 15.4 pt-20 -44.17 -20.72 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.625 -0.787 . . . . 0.0 111.029 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 5.0 mm-40 -82.85 -38.7 22.64 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 47.1 mt -77.23 -42.38 31.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.526 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.795 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.41 -42.9 61.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.676 -177.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.54 -34.81 78.61 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 122.093 0.949 . . . . 0.0 110.892 -177.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.06 -53.89 9.94 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.771 -1.559 . . . . 0.0 108.713 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.9 mt -48.83 -55.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.482 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.62 -33.75 48.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.742 -2.026 . . . . 0.0 110.639 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.13 -17.93 61.89 Favored Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.676 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.1 -36.66 17.98 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.492 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.8 -13.2 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 122.178 0.99 . . . . 0.0 109.264 176.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -22.61 46.45 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.503 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.4 mt -91.63 -62.07 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 113.899 -1.5 . . . . 0.0 112.067 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.21 -20.69 27.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.437 -177.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.565 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.487 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.89 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.591 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.6 mm? . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 16' ' ' LEU . 59.1 mt -61.01 -41.22 96.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.569 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.39 -37.91 93.91 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.779 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 97.2 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.753 0.311 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.27 152.91 29.25 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.138 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -130.58 134.3 46.89 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.994 0.184 . . . . 0.0 111.413 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -137.59 130.14 29.73 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.565 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.874 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -83.98 101.78 11.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 123.965 1.84 . . . . 0.0 109.309 178.189 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.662 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.7 m -112.16 161.93 10.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 112.645 -2.071 . . . . 0.0 110.175 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -105.04 145.97 29.74 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' B' ' 326' ' ' VAL . 24.4 tt0 . . . . . 0 C--N 1.315 -0.923 0 CA-C-O 122.037 0.922 . . . . 0.0 112.665 -178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.6 t . . . . . 0 N--CA 1.439 -1.019 0 CA-C-O 119.1 -0.476 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.429 ' O ' HG12 ' B' ' 326' ' ' VAL . 66.2 Cg_exo -44.58 145.62 2.57 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 N-CA-C 107.956 -1.594 . . . . 0.0 107.956 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.662 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.8 ttt180 -149.91 -174.1 4.61 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.725 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.35 123.44 12.87 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.081 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.831 HD12 ' O ' ' B' ' 338' ' ' MET . 26.7 tp -102.13 159.03 15.74 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.442 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.07 108.07 0.52 Allowed Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.746 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -89.04 123.7 41.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.726 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.48 138.1 52.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.63 13.84 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.114 0.483 . . . . 0.0 111.793 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.726 ' H ' ' C ' ' B' ' 333' ' ' THR . 8.9 pt-20 -144.4 -3.16 0.84 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.868 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.88 178.52 2.17 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 122.272 1.034 . . . . 0.0 113.003 -177.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.5 t -135.79 145.96 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-N 113.4 -1.727 . . . . 0.0 106.573 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.831 ' O ' HD12 ' B' ' 330' ' ' LEU . 2.2 ptt? -153.93 150.31 28.2 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 117.044 -1.863 . . . . 0.0 114.262 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.553 ' NH2' HG21 ' B' ' 315' ' ' VAL . 3.2 mtp85 -94.89 107.6 19.63 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.669 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.11 149.94 5.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.371 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' B' ' 344' ' ' THR . 3.2 t70 -90.46 92.62 8.96 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.755 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.7 OUTLIER -35.87 -28.76 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.626 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' B' ' 341' ' ' ASP . 41.9 mttt -73.2 -43.49 61.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.691 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.7 p -111.43 -12.82 13.96 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt 67.63 -0.85 1.79 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 109.999 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.3 mt-10 -84.55 151.97 24.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.311 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.626 HG21 ' SD ' ' B' ' 338' ' ' MET . 77.7 t -82.94 135.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.526 0.679 . . . . 0.0 112.308 -178.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . 0.641 HD12 ' NH2' ' B' ' 328' ' ' ARG . 70.9 mt -103.82 -30.99 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.438 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.466 ' O ' ' CB ' ' B' ' 338' ' ' MET . 7.2 tt0 -138.85 156.04 47.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.584 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -145.51 149.6 34.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.336 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.552 ' O ' ' N ' ' B' ' 337' ' ' VAL . 64.1 t-105 -161.83 134.95 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.838 177.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.508 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.52 138.77 27.06 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.477 -178.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.622 HD12 ' O ' ' B' ' 333' ' ' THR . 1.8 tt -79.08 -35.74 41.95 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 4.7 t -74.86 11.24 1.12 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.895 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.508 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.5 m-20 -114.75 -4.16 12.74 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.14 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.484 HD12 HD23 ' B' ' 353' ' ' LEU . 73.5 mt -57.86 147.97 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.088 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 8.1 tttp -105.9 -45.48 4.36 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.8 ptt180 -174.69 136.4 0.43 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.462 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.467 ' CH2' HD12 ' B' ' 396' ' ' ILE . 10.1 p90 -119.45 173.14 7.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.174 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.0 99.11 1.8 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.086 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.16 148.6 30.85 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.951 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -136.69 173.43 5.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -76.82 -8.81 18.12 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.122 1.882 . . . . 0.0 112.073 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' B' ' 382' ' ' THR . 12.6 mtpp -130.68 -21.64 2.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.968 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.659 ' HA ' ' H ' ' B' ' 382' ' ' THR . 89.8 p -150.35 169.23 21.91 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.606 0.717 . . . . 0.0 111.852 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.506 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -141.78 156.88 45.56 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.888 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.591 ' CG2' HD12 ' A' ' 15' ' ' LEU . 34.2 m -148.06 156.68 42.91 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.091 -1.043 . . . . 0.0 112.809 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.459 ' N ' HG22 ' B' ' 367' ' ' THR . 6.0 mt -129.21 144.51 51.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.567 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 22.2 t0 -120.51 95.82 4.88 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.837 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.0 p90 -136.71 93.71 2.9 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.369 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.81 12.51 1.72 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -41.9 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.159 -0.521 . . . . 0.0 111.719 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.62 -37.32 65.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.476 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.77 -92.8 0.5 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.934 -1.484 . . . . 0.0 107.097 176.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.476 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.6 t70 -129.12 96.34 4.3 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.24 -2.81 55.75 Favored Glycine 0 C--N 1.312 -0.75 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.217 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.686 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.96 106.3 17.04 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -175.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.81 125.57 51.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.747 175.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.9 t -138.49 162.63 34.03 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.482 0.658 . . . . 0.0 112.646 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.05 172.6 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.022 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -99.23 126.3 45.01 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.886 0.851 . . . . 0.0 111.074 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.659 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.02 135.97 13.76 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.698 179.265 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.57 17.95 3.6 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.178 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.05 83.89 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.049 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.91 -59.34 1.89 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.9 pt-20 -45.01 -19.85 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 114.754 -0.723 . . . . 0.0 111.016 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.436 ' N ' ' C ' ' B' ' 385' ' ' GLY . 24.3 mt-30 -82.96 -39.56 21.23 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' B' ' 385' ' ' GLY . 40.6 mt -76.95 -41.86 32.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.731 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -74.11 -41.97 60.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.651 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.438 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -63.93 -34.77 78.71 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.059 0.933 . . . . 0.0 111.023 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.656 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.92 -53.82 10.31 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.813 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.656 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.11 -55.98 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.476 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.42 -33.74 45.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.663 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.19 -17.79 62.07 Favored Glycine 0 CA--C 1.506 -0.469 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.676 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.11 -37.0 17.78 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.467 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.6 -13.27 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-O 122.187 0.994 . . . . 0.0 109.281 176.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.64 -22.67 46.54 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.473 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.4 mt -91.76 -62.07 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 113.897 -1.502 . . . . 0.0 112.035 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.3 -20.51 27.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.396 -177.075 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.877 -1.059 . . . . 0.0 110.797 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.546 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.3 mm? . . . . . 0 N--CA 1.462 0.135 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -38.61 77.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.513 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.32 97.99 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 89.1 mt-10 . . . . . 0 C--N 1.328 -0.345 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.718 0.294 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.47 153.19 27.78 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.192 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -130.09 134.39 47.33 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 123.059 0.224 . . . . 0.0 111.465 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -138.74 129.02 25.68 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.499 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.878 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.23 105.05 13.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.834 1.778 . . . . 0.0 109.446 178.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.631 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.6 m -115.79 160.92 14.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 112.596 -2.093 . . . . 0.0 110.1 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -103.52 145.67 29.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' B' ' 326' ' ' VAL . 25.3 tt0 . . . . . 0 C--N 1.315 -0.925 0 CA-C-O 122.071 0.938 . . . . 0.0 112.601 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' B' ' 317' ' ' GLU . 5.2 t . . . . . 0 N--CA 1.44 -0.953 0 CA-C-O 119.138 -0.458 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.423 ' O ' HG12 ' B' ' 326' ' ' VAL . 63.1 Cg_exo -44.27 145.18 2.49 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.107 -1.536 . . . . 0.0 108.107 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.631 ' N ' ' O ' ' B' ' 315' ' ' VAL . 10.6 ttm-85 -149.96 -173.5 4.45 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 119.498 -0.881 . . . . 0.0 108.658 -177.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.4 121.7 12.29 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.83 HD12 ' O ' ' B' ' 338' ' ' MET . 28.0 tp -100.15 158.31 15.95 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.44 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.81 108.38 0.54 Allowed Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.725 HD11 HD21 ' B' ' 330' ' ' LEU . 31.0 mm -88.75 124.61 41.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.723 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.94 138.13 53.0 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . 0.41 ' NZ ' ' CZ ' ' B' ' 395' ' ' TYR . 0.0 OUTLIER -57.34 14.71 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.74 0.305 . . . . 0.0 111.301 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -145.15 -3.66 0.75 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.497 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.81 179.98 1.88 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.287 1.041 . . . . 0.0 113.073 -176.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.67 146.53 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 CA-C-N 113.293 -1.776 . . . . 0.0 106.493 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.83 ' O ' HD12 ' B' ' 330' ' ' LEU . 2.0 ptt? -154.56 150.33 27.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 117.086 -1.845 . . . . 0.0 114.303 -176.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.658 HH21 ' NE2' ' B' ' 349' ' ' GLN . 18.3 mtt-85 -95.12 107.94 20.03 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.561 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.6 149.74 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.259 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' B' ' 344' ' ' THR . 24.7 t0 -88.97 91.91 9.02 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.724 -178.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 1.0 OUTLIER -35.38 -28.63 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.692 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 341' ' ' ASP . 32.9 mttt -75.64 -43.81 45.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.749 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.554 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -108.9 -12.64 14.86 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -177.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' B' ' 341' ' ' ASP . 13.3 ttmt 66.81 -0.29 1.68 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.017 0.436 . . . . 0.0 109.994 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.5 mt-10 -85.45 153.59 22.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.314 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.602 HG21 ' SD ' ' B' ' 338' ' ' MET . 81.6 t -83.4 134.31 27.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.493 0.663 . . . . 0.0 112.363 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 66.4 mt -102.72 -30.15 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.335 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.658 ' NE2' HH21 ' B' ' 339' ' ' ARG . 38.5 tt0 -140.41 156.84 46.25 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.627 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -145.27 149.7 35.34 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.387 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.577 ' O ' ' N ' ' B' ' 337' ' ' VAL . 70.9 t-105 -160.93 135.37 7.23 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.696 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.4 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -54.84 138.53 42.54 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.461 0.648 . . . . 0.0 111.492 -178.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.638 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -78.57 -35.58 45.7 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . 0.556 ' O ' HG22 ' B' ' 354' ' ' THR . 21.8 m -73.68 8.81 1.69 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.882 177.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.434 HD22 ' C ' ' B' ' 354' ' ' THR . 0.9 OUTLIER -112.75 -2.35 14.48 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.147 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.525 HD12 HD23 ' B' ' 353' ' ' LEU . 68.0 mt -61.32 146.82 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.211 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . 0.48 ' HZ2' ' HB3' ' B' ' 372' ' ' ASP . 4.9 tttt -106.62 -45.24 4.28 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 0.1 OUTLIER -174.88 136.08 0.39 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.497 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.1 p90 -119.72 175.33 5.92 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.212 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.62 99.99 1.6 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.239 -0.984 . . . . 0.0 112.057 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.761 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.09 143.81 32.17 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.752 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.544 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -131.0 174.05 5.15 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -77.11 -9.05 17.84 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.043 1.829 . . . . 0.0 112.036 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.0 mttt -130.79 -21.1 2.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.972 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.664 ' HA ' ' H ' ' B' ' 382' ' ' THR . 78.6 p -149.81 169.54 20.86 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.513 0.673 . . . . 0.0 111.866 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.49 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.2 OUTLIER -141.09 156.32 46.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.583 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.546 ' CG2' HD12 ' A' ' 15' ' ' LEU . 54.8 m -146.31 156.89 43.67 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.885 -174.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.472 ' N ' HG22 ' B' ' 367' ' ' THR . 5.7 mt -130.79 139.68 50.23 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.54 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 22.5 t0 -116.6 95.86 5.24 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.779 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.2 p90 -135.93 94.01 3.0 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.532 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.77 12.51 1.73 Allowed Glycine 0 C--O 1.225 -0.427 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . 0.48 ' HB3' ' HZ2' ' B' ' 357' ' ' LYS . 8.4 t0 -41.74 -16.13 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.054 -0.573 . . . . 0.0 111.774 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.554 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.42 -37.28 64.93 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.477 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.98 -92.38 0.51 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.942 -1.481 . . . . 0.0 107.183 176.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.477 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.6 t0 -129.47 96.42 4.27 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.14 -3.46 55.67 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.149 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.697 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.03 106.7 17.38 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -175.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . 0.649 ' CG ' ' NH2' ' B' ' 339' ' ' ARG . 0.3 OUTLIER -120.04 127.4 52.55 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.835 175.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 33.1 t -138.64 166.52 24.14 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.621 0.724 . . . . 0.0 112.61 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.18 174.26 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.893 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -101.14 125.38 47.75 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.964 0.888 . . . . 0.0 111.092 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.664 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.83 136.82 14.62 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.84 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.27 16.88 4.77 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.211 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.07 83.88 1.75 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.021 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.38 -57.44 2.1 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.8 pt-20 -45.04 -20.2 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 114.82 -0.69 . . . . 0.0 111.091 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.426 ' N ' ' C ' ' B' ' 385' ' ' GLY . 4.6 mm-40 -83.05 -39.16 21.58 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' B' ' 385' ' ' GLY . 49.1 mt -76.58 -42.55 34.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.634 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.761 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.46 -42.53 61.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.306 -1.315 . . . . 0.0 113.604 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.453 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 12.3 pt20 -63.56 -34.72 78.43 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.001 0.905 . . . . 0.0 111.04 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.33 -53.6 10.4 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.85 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -49.02 -55.61 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.485 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -53.14 -33.61 53.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.684 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.05 -17.71 62.46 Favored Glycine 0 CA--C 1.505 -0.538 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.669 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.2 m-30 -87.07 -37.15 17.7 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.497 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.58 -13.36 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-O 122.211 1.005 . . . . 0.0 109.371 176.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.01 -22.62 45.23 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.525 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' B' ' 395' ' ' TYR . 71.4 mt -91.76 -62.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.998 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.31 -20.75 27.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.322 -176.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.79 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.55 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.3 mm? . . . . . 0 CA--C 1.522 -0.133 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -39.22 79.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.462 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.06 -43.86 98.16 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.516 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 88.8 mt-10 . . . . . 0 C--N 1.328 -0.335 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 71.3 t . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.778 0.323 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.28 153.26 25.1 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.1 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -129.39 135.44 48.71 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -139.1 129.43 25.55 Favored 'General case' 0 C--N 1.347 0.485 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.522 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.886 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.33 105.73 13.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 123.825 1.774 . . . . 0.0 109.402 178.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' B' ' 328' ' ' ARG . 33.0 m -116.98 161.11 15.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 112.564 -2.107 . . . . 0.0 110.122 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -103.5 145.34 30.15 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' B' ' 326' ' ' VAL . 27.1 tt0 . . . . . 0 C--N 1.314 -0.943 0 CA-C-O 122.119 0.961 . . . . 0.0 112.606 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t . . . . . 0 N--CA 1.441 -0.903 0 CA-C-O 119.143 -0.456 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.453 ' O ' HG12 ' B' ' 326' ' ' VAL . 62.4 Cg_exo -44.76 145.56 2.77 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 N-CA-C 108.029 -1.566 . . . . 0.0 108.029 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.649 ' N ' ' O ' ' B' ' 315' ' ' VAL . 4.2 ttm180 -150.59 -173.45 4.47 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 119.518 -0.873 . . . . 0.0 108.76 -177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.65 122.38 12.62 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.829 HD12 ' O ' ' B' ' 338' ' ' MET . 27.7 tp -101.69 157.87 16.52 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.434 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.29 107.92 0.53 Allowed Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 330' ' ' LEU . 31.1 mm -88.56 124.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.723 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.4 p -118.44 138.2 52.63 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.34 14.58 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.872 0.368 . . . . 0.0 111.331 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' B' ' 333' ' ' THR . 12.9 pt-20 -145.37 -2.88 0.75 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.459 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.88 179.66 1.93 Allowed 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.322 1.058 . . . . 0.0 113.088 -176.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.593 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.1 t -137.36 146.43 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 113.276 -1.784 . . . . 0.0 106.535 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.829 ' O ' HD12 ' B' ' 330' ' ' LEU . 4.0 ptt? -154.76 149.63 26.7 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 117.056 -1.857 . . . . 0.0 114.274 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.528 ' NH2' ' OE2' ' B' ' 317' ' ' GLU . 15.6 mtp180 -94.55 107.73 19.71 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.633 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.89 149.88 5.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.207 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 28.7 t0 -89.45 92.02 8.95 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.729 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.49 -28.79 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.745 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.7 mttm -75.21 -43.61 50.88 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.732 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.555 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.32 -12.34 14.77 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm 66.58 -1.09 1.37 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 109.962 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.4 mt-10 -84.55 153.33 23.32 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.36 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.589 HG21 ' SD ' ' B' ' 338' ' ' MET . 82.3 t -83.29 135.16 25.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.497 0.665 . . . . 0.0 112.285 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 67.2 mt -103.54 -30.17 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.407 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.468 ' O ' ' CB ' ' B' ' 338' ' ' MET . 23.5 tt0 -140.6 156.46 46.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.675 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -145.66 149.87 35.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.517 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.548 ' O ' ' N ' ' B' ' 337' ' ' VAL . 65.3 t-105 -162.82 134.87 5.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.711 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.499 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -53.13 139.39 28.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.496 0.665 . . . . 0.0 111.425 -178.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.639 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -78.77 -36.04 43.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . 0.563 ' O ' HG22 ' B' ' 354' ' ' THR . 21.6 m -73.16 9.13 1.33 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.901 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.499 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.2 m-20 -113.52 -1.99 13.98 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.157 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.515 HD12 HD23 ' B' ' 353' ' ' LEU . 66.1 mt -61.17 145.6 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.182 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . 0.457 ' HZ2' ' HB3' ' B' ' 372' ' ' ASP . 5.6 tttt -104.38 -45.72 4.59 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.515 0.674 . . . . 0.0 109.21 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.7 ptt180 -174.92 136.19 0.39 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.514 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.4 p90 -118.89 174.71 6.13 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.227 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.64 99.38 1.72 Allowed 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 119.28 -0.968 . . . . 0.0 112.11 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.771 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.83 146.99 30.62 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.856 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.536 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -135.35 173.64 5.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -77.02 -8.15 17.6 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.003 1.802 . . . . 0.0 112.221 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' B' ' 382' ' ' THR . 23.0 mttt -131.02 -21.91 2.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.048 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.677 ' HA ' ' H ' ' B' ' 382' ' ' THR . 79.0 p -150.33 168.88 22.79 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.6 0.714 . . . . 0.0 111.895 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.504 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -141.09 156.79 45.93 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.75 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.55 ' CG2' HD12 ' A' ' 15' ' ' LEU . 39.7 m -147.54 156.55 42.94 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.942 -174.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.46 ' N ' HG22 ' B' ' 367' ' ' THR . 5.6 mt -129.56 141.87 50.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.628 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 21.1 t0 -118.19 95.59 4.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.677 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.3 p90 -136.23 93.98 2.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.657 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.49 12.45 1.8 Allowed Glycine 0 C--O 1.226 -0.349 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . 0.457 ' HB3' ' HZ2' ' B' ' 357' ' ' LYS . 9.2 t0 -41.79 -16.15 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.12 -0.54 . . . . 0.0 111.721 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.5 -37.38 65.24 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.48 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.5 OUTLIER -125.76 -92.5 0.51 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.169 176.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.48 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.6 t70 -129.41 96.3 4.25 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.37 -3.01 55.61 Favored Glycine 0 C--N 1.313 -0.714 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.217 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.689 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.93 106.16 16.92 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -175.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.54 126.66 52.96 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.77 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 47.2 t -138.47 164.55 29.1 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.6 0.714 . . . . 0.0 112.679 -177.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.64 174.13 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.971 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -100.91 125.12 47.44 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.94 0.876 . . . . 0.0 111.128 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.677 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.41 137.45 14.62 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.827 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . 0.415 ' N ' ' OE2' ' B' ' 384' ' ' GLU . 0.8 OUTLIER -84.83 -1.13 56.06 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.975 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -123.93 84.0 2.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.038 0.923 . . . . 0.0 108.71 175.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.24 -58.5 1.97 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.507 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.8 pt-20 -46.81 -20.6 0.14 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 114.696 -0.752 . . . . 0.0 110.982 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -80.95 -39.09 26.64 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.504 HG21 ' CE2' ' B' ' 366' ' ' PHE . 49.4 mt -77.06 -42.42 31.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.615 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.771 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.97 -42.4 60.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.308 -1.314 . . . . 0.0 113.506 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.57 -34.74 78.47 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.049 0.928 . . . . 0.0 111.047 -177.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.25 -53.49 10.74 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.894 -1.503 . . . . 0.0 108.815 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.9 mt -48.94 -55.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.483 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.84 -34.06 52.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 112.732 -2.031 . . . . 0.0 110.651 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.95 -17.58 62.91 Favored Glycine 0 CA--C 1.505 -0.543 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.667 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.2 m-30 -87.14 -37.2 17.57 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.514 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.51 -13.16 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 CA-C-O 122.1 0.952 . . . . 0.0 109.236 176.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -79.26 -22.73 44.32 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.51 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' B' ' 395' ' ' TYR . 70.9 mt -91.62 -61.76 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 114.001 -1.454 . . . . 0.0 112.051 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.75 -20.51 27.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.419 -1.719 . . . . 0.0 112.375 -176.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.56 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 N--CA 1.467 0.424 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.802 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.551 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.2 mm? . . . . . 0 CA--C 1.52 -0.194 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -58.81 -39.1 80.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.636 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.41 -43.3 99.25 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.979 0.419 . . . . 0.0 109.97 178.402 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 68.9 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.773 0.321 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.07 153.3 24.84 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -130.2 135.17 47.86 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.012 0.195 . . . . 0.0 111.514 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -138.14 130.0 28.35 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.519 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.87 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -83.49 103.56 12.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 123.92 1.819 . . . . 0.0 109.308 178.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.7 m -113.7 162.05 12.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 112.579 -2.101 . . . . 0.0 110.309 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -105.32 147.1 28.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' B' ' 326' ' ' VAL . 26.3 tt0 . . . . . 0 C--N 1.312 -1.059 0 CA-C-O 122.02 0.914 . . . . 0.0 112.639 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t . . . . . 0 N--CA 1.44 -0.95 0 CA-C-O 119.166 -0.445 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.432 ' O ' HG12 ' B' ' 326' ' ' VAL . 61.2 Cg_exo -44.8 145.95 2.6 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 N-CA-C 108.07 -1.55 . . . . 0.0 108.07 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.67 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.2 ttt180 -149.92 -174.21 4.64 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 119.529 -0.868 . . . . 0.0 108.689 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.616 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.34 122.64 12.29 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -176.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.831 HD12 ' O ' ' B' ' 338' ' ' MET . 25.8 tp -102.12 158.13 16.39 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.435 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.16 108.1 0.54 Allowed Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.744 HD11 HD21 ' B' ' 330' ' ' LEU . 31.3 mm -88.64 123.97 41.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.725 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.8 p -118.52 137.45 53.2 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.99 13.65 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.944 0.402 . . . . 0.0 111.667 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.725 ' H ' ' C ' ' B' ' 333' ' ' THR . 7.9 pt-20 -144.61 -2.68 0.84 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.711 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.89 179.0 2.06 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.404 1.097 . . . . 0.0 113.072 -176.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.602 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.3 t -136.84 146.17 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 CA-C-N 113.252 -1.795 . . . . 0.0 106.4 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.831 ' O ' HD12 ' B' ' 330' ' ' LEU . 4.0 ptt? -154.24 150.08 27.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 117.153 -1.819 . . . . 0.0 114.409 -176.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.538 ' NH2' HG21 ' B' ' 315' ' ' VAL . 2.8 mtp85 -95.08 107.86 19.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.54 176.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.7 t -99.49 150.22 5.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.304 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 344' ' ' THR . 32.8 t0 -90.72 92.35 8.78 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.767 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.54 -28.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.599 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' B' ' 341' ' ' ASP . 20.5 mttp -74.66 -43.56 54.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.688 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.45 -12.53 14.7 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.3 OUTLIER 66.34 -1.21 1.27 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.035 0.445 . . . . 0.0 110.023 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.6 mt-10 -84.79 152.1 23.89 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.332 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.613 HG21 ' SD ' ' B' ' 338' ' ' MET . 76.7 t -82.76 134.75 26.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.51 0.671 . . . . 0.0 112.305 -178.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 20.9 mm -102.71 -31.12 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.276 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.466 ' O ' ' CB ' ' B' ' 338' ' ' MET . 17.1 tt0 -139.79 156.86 46.53 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.611 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -145.75 149.41 34.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.249 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.539 ' O ' ' N ' ' B' ' 337' ' ' VAL . 64.2 t-105 -162.08 135.05 6.02 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.057 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.514 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.39 139.42 24.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.432 0.634 . . . . 0.0 111.379 -178.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.63 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -79.57 -35.79 39.2 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.53 11.08 1.09 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.825 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.514 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -114.41 -4.5 12.94 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.027 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.474 HD12 HD23 ' B' ' 353' ' ' LEU . 69.6 mt -57.62 147.8 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.468 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 11.7 tptt -105.46 -45.7 4.38 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.502 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.6 ptt180 -175.38 135.98 0.34 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.481 ' CH2' HD12 ' B' ' 396' ' ' ILE . 12.2 p90 -118.91 173.66 6.75 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.172 -177.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.46 99.74 1.77 Allowed 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.018 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.776 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.04 147.66 30.05 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.783 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.535 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -135.99 173.56 5.51 Favored Pre-proline 0 N--CA 1.453 -0.282 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -77.06 -8.68 17.77 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.133 1.888 . . . . 0.0 112.022 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 20.6 mtpt -130.77 -21.38 2.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.96 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.659 ' HA ' ' H ' ' B' ' 382' ' ' THR . 88.9 p -150.47 169.57 21.16 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.574 0.702 . . . . 0.0 111.932 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.496 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -142.12 156.61 45.38 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.566 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.551 ' CG2' HD12 ' A' ' 15' ' ' LEU . 44.1 m -147.3 156.72 43.18 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.877 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.462 ' N ' HG22 ' B' ' 367' ' ' THR . 5.7 mt -129.78 141.35 50.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.544 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 21.9 t0 -117.66 95.72 5.07 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.722 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 8.1 p90 -136.78 94.27 2.96 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.581 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 133.02 12.77 1.64 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.5 t0 -42.08 -15.92 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.979 -0.61 . . . . 0.0 111.852 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.41 -37.68 65.36 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.47 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.57 -92.11 0.52 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.356 176.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.47 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.4 t70 -129.91 96.16 4.14 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -99.93 -3.52 55.88 Favored Glycine 0 C--N 1.311 -0.812 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.261 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.69 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.09 106.17 17.03 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -175.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.69 126.07 51.82 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.647 176.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 47.1 t -138.55 163.45 31.97 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.676 0.751 . . . . 0.0 112.849 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.51 172.89 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.196 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -99.45 125.91 45.27 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.764 0.792 . . . . 0.0 111.192 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.659 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.59 136.28 14.38 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.976 -1.465 . . . . 0.0 109.868 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.67 16.63 4.54 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.185 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.08 83.54 1.74 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.943 174.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -57.89 2.06 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.531 ' O ' ' NE2' ' B' ' 390' ' ' GLN . 7.4 pt-20 -45.12 -20.58 0.05 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 114.905 -0.648 . . . . 0.0 110.964 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.422 ' N ' ' C ' ' B' ' 385' ' ' GLY . 5.6 mm-40 -82.26 -39.27 23.23 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' B' ' 385' ' ' GLY . 47.5 mt -76.54 -42.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.609 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.776 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.33 -42.36 62.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.559 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' B' ' 386' ' ' GLU . 2.2 pt20 -63.56 -34.88 78.79 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 122.082 0.944 . . . . 0.0 111.029 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.648 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.85 -53.49 11.29 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.819 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.648 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.35 -55.98 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.477 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.37 -33.74 44.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 112.761 -2.018 . . . . 0.0 110.701 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.26 -17.8 61.92 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.674 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -87.15 -36.96 17.76 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.481 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.72 -13.19 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 CA-C-O 122.175 0.988 . . . . 0.0 109.297 176.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.56 -22.65 46.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.475 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.1 mt -91.8 -61.98 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.067 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.54 -20.41 27.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.338 -1.756 . . . . 0.0 112.315 -176.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.557 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.494 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.793 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.553 HD12 ' CG2' ' B' ' 367' ' ' THR . 3.8 mm? . . . . . 0 N--CA 1.461 0.089 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -41.17 87.66 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.99 -44.36 97.28 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.515 ' OE2' ' CD2' ' B' ' 377' ' ' TYR . 85.6 mt-10 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 120.995 0.426 . . . . 0.0 109.933 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 72.2 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.794 0.33 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.47 153.04 25.6 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.064 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -128.87 135.18 48.73 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.125 0.266 . . . . 0.0 111.42 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -139.15 129.52 25.59 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.795 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.883 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.47 104.86 12.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 123.717 1.723 . . . . 0.0 109.154 178.242 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.621 HG12 ' HB ' ' B' ' 382' ' ' THR . 34.1 m -120.82 156.02 24.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 112.815 -1.993 . . . . 0.0 110.278 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -93.37 138.34 31.8 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.27 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' B' ' 326' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.314 -0.973 0 CA-C-O 121.918 0.866 . . . . 0.0 112.881 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.0 t . . . . . 0 N--CA 1.445 -0.678 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.482 ' C ' ' O ' ' B' ' 326' ' ' VAL . 78.1 Cg_exo -37.89 140.26 0.29 Allowed 'Trans proline' 0 CA--C 1.506 -0.882 0 N-CA-C 108.535 -1.371 . . . . 0.0 108.535 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' B' ' 315' ' ' VAL . 1.6 tpt180 -152.98 -172.22 4.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.574 -0.85 . . . . 0.0 108.731 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.628 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.33 123.63 13.82 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 338' ' ' MET . 27.7 tp -103.11 158.27 16.42 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.151 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.427 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.24 107.71 0.52 Allowed Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.769 HD11 HD21 ' B' ' 330' ' ' LEU . 31.6 mm -88.33 123.03 40.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.729 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.2 p -117.28 138.02 52.02 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -57.26 13.6 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.015 0.436 . . . . 0.0 111.779 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.729 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.5 pt-20 -144.45 -2.69 0.85 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.955 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.97 178.89 2.06 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 122.315 1.055 . . . . 0.0 113.059 -177.051 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.609 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.47 146.09 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.042 0 CA-C-N 113.312 -1.767 . . . . 0.0 106.587 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.836 ' O ' HD12 ' B' ' 330' ' ' LEU . 2.3 ptt? -154.06 149.84 27.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 117.09 -1.844 . . . . 0.0 114.324 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.43 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 45.8 mtm180 -94.51 107.7 19.66 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.645 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.628 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.34 149.84 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.124 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' B' ' 344' ' ' THR . 32.0 t0 -89.53 92.6 9.17 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.884 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.56 -28.58 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.732 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 14.8 mttp -75.0 -43.79 51.86 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.73 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.554 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.41 -12.84 14.68 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 11.5 tttt 66.54 -0.75 1.45 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.048 0.452 . . . . 0.0 110.049 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.8 mt-10 -85.15 152.22 23.53 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.311 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.631 HG21 ' SD ' ' B' ' 338' ' ' MET . 82.5 t -83.83 135.14 25.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.528 0.68 . . . . 0.0 112.253 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -104.55 -30.93 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.414 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.467 ' O ' ' CB ' ' B' ' 338' ' ' MET . 7.4 tt0 -138.01 154.9 49.29 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.516 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -145.32 149.83 35.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.37 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.549 ' O ' ' N ' ' B' ' 337' ' ' VAL . 63.0 t-105 -161.99 135.06 6.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.753 177.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.78 139.1 27.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.424 0.631 . . . . 0.0 111.32 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.625 HD12 ' O ' ' B' ' 333' ' ' THR . 1.8 tt -79.47 -35.6 40.06 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.83 11.28 1.11 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.888 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.7 m-20 -114.65 -4.19 12.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.191 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.494 HD12 HD23 ' B' ' 353' ' ' LEU . 74.0 mt -57.99 148.53 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.155 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 10.3 tttt -106.42 -45.12 4.35 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.1 ptt180 -175.64 136.52 0.33 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.365 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.475 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.5 p90 -119.53 174.14 6.57 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.224 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.02 98.83 1.78 Allowed 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.039 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.784 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.68 147.09 30.78 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.803 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -136.36 173.78 5.22 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -77.24 -8.26 17.4 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.038 1.825 . . . . 0.0 112.205 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.6 mttt -130.6 -21.43 2.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.073 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.657 ' HA ' ' H ' ' B' ' 382' ' ' THR . 94.4 p -151.74 168.75 24.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.658 0.742 . . . . 0.0 111.858 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -140.64 157.07 45.99 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.84 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.553 ' CG2' HD12 ' A' ' 15' ' ' LEU . 62.7 m -146.79 158.64 43.96 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.848 -174.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.524 ' N ' HG22 ' B' ' 367' ' ' THR . 5.6 mt -132.41 140.11 48.32 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.519 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 19.7 t0 -117.0 96.03 5.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.634 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' B' ' 370' ' ' PHE . 5.9 p90 -137.25 94.11 2.9 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.555 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.58 12.68 1.74 Allowed Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 8.8 t0 -41.97 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.108 -0.546 . . . . 0.0 111.682 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.3 m-85 -54.43 -37.24 64.9 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.471 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -126.09 -92.67 0.5 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.093 176.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.471 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.3 t70 -129.32 96.21 4.24 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -99.98 -3.13 55.96 Favored Glycine 0 C--N 1.315 -0.605 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.223 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.25 105.68 16.79 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -175.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.18 127.68 54.35 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.557 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.434 ' OG ' ' OG1' ' B' ' 367' ' ' THR . 22.6 t -137.48 157.83 45.71 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.313 0.578 . . . . 0.0 112.23 -177.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . 0.433 ' CG1' ' CD ' ' B' ' 317' ' ' GLU . 2.5 m -142.09 171.86 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.047 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -100.84 125.99 47.4 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.964 0.887 . . . . 0.0 110.991 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.657 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -156.01 137.59 14.13 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.876 179.046 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.43 15.54 6.44 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.132 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.93 84.54 1.78 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.065 175.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -56.35 2.32 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.4 pt-20 -45.07 -20.18 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 114.797 -0.702 . . . . 0.0 111.025 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' B' ' 385' ' ' GLY . 2.5 mm-40 -82.96 -39.39 21.46 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' B' ' 385' ' ' GLY . 46.3 mt -76.85 -42.44 33.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.669 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.784 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.37 -42.18 62.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.665 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.436 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -63.93 -34.89 78.99 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.032 0.92 . . . . 0.0 110.965 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.8 -53.69 10.84 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.783 -179.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.14 -56.1 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.59 -33.8 47.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 112.819 -1.991 . . . . 0.0 110.662 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.98 -17.87 62.29 Favored Glycine 0 CA--C 1.507 -0.444 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.675 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.01 -36.79 18.02 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.475 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.74 -13.21 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-O 122.157 0.98 . . . . 0.0 109.258 176.101 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.64 -22.54 46.74 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.712 -1.585 . . . . 0.0 109.459 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.675 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.8 mt -91.82 -62.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.968 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.43 -20.43 27.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.347 -177.026 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.56 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.765 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.556 HD12 HG21 ' B' ' 367' ' ' THR . 4.4 mm? . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -42.67 94.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.708 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.22 92.86 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 . . . . . 0 C--N 1.326 -0.42 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.683 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 CA--C 1.527 0.085 0 CA-C-O 120.776 0.322 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.58 153.45 26.28 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.221 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -130.04 134.08 47.16 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.042 0.214 . . . . 0.0 111.46 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -139.26 128.48 23.99 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.656 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.84 107.15 13.4 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 123.769 1.747 . . . . 0.0 109.396 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.666 HG12 ' HB ' ' B' ' 382' ' ' THR . 30.3 m -119.13 160.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.096 -176.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -102.11 145.25 29.62 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.559 ' CD ' ' HE ' ' B' ' 339' ' ' ARG . 26.6 tt0 . . . . . 0 C--N 1.312 -1.038 0 CA-C-O 122.005 0.907 . . . . 0.0 112.708 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.53 ' N ' ' O ' ' B' ' 317' ' ' GLU . 5.7 t . . . . . 0 N--CA 1.44 -0.965 0 CA-C-O 119.112 -0.471 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.421 ' O ' HG12 ' B' ' 326' ' ' VAL . 68.1 Cg_exo -44.18 144.14 3.01 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 N-CA-C 108.096 -1.54 . . . . 0.0 108.096 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' B' ' 315' ' ' VAL . 13.9 ttt180 -150.41 -173.23 4.39 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.71 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -141.41 120.76 13.11 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.103 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.835 HD12 ' O ' ' B' ' 338' ' ' MET . 32.0 tp -98.67 158.17 15.79 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.223 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.56 108.5 0.53 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.73 HD11 HD21 ' B' ' 330' ' ' LEU . 29.4 mm -87.98 123.58 40.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.723 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.98 138.05 52.45 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 14.65 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.697 0.284 . . . . 0.0 111.442 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.5 pt-20 -144.53 -4.36 0.78 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.561 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.48 177.35 2.19 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.412 1.101 . . . . 0.0 112.915 -176.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.0 t -132.5 145.4 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 113.148 -1.842 . . . . 0.0 106.401 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.835 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.93 150.61 29.44 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 117.199 -1.801 . . . . 0.0 114.568 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.559 ' HE ' ' CD ' ' B' ' 317' ' ' GLU . 0.4 OUTLIER -96.24 106.86 19.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.515 176.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.13 150.1 4.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.299 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.5 t0 -87.97 91.62 8.83 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.694 -178.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.43 -28.32 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.619 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 24.0 mttp -75.52 -43.94 46.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.725 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.556 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.61 -13.7 14.77 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 15.3 tttt 68.0 -0.41 2.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.98 0.419 . . . . 0.0 109.933 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.9 mt-10 -86.66 152.9 22.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.619 HG21 ' SD ' ' B' ' 338' ' ' MET . 89.7 t -81.61 133.96 28.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.5 0.667 . . . . 0.0 112.276 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . 0.54 HG21 HH22 ' B' ' 328' ' ' ARG . 1.2 mm -104.14 -30.76 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.225 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' B' ' 338' ' ' MET . 15.7 tt0 -138.74 157.23 46.47 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.489 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -143.4 150.55 39.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.233 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.52 124.31 4.01 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.942 177.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.403 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.69 140.92 3.14 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.42 0.628 . . . . 0.0 111.612 -178.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.594 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -84.36 -36.32 22.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . 0.475 HG23 HD22 ' B' ' 355' ' ' ASN . 6.0 t -73.5 9.54 1.33 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.906 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.571 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 1.0 OUTLIER -111.13 -7.28 14.49 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.0 178.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.487 HD12 HD23 ' B' ' 353' ' ' LEU . 78.0 mt -56.91 146.41 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 120.444 -0.503 . . . . 0.0 111.766 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . 0.506 ' NZ ' ' OH ' ' B' ' 373' ' ' TYR . 9.0 tttp -107.6 -46.03 3.92 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.5 ptt-85 -172.97 135.76 0.63 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.522 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.1 p90 -119.15 176.56 5.25 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.186 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.37 98.94 1.59 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 119.176 -1.009 . . . . 0.0 111.877 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.64 145.73 31.52 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.563 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -134.09 173.73 5.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.38 -8.21 17.23 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.175 1.917 . . . . 0.0 112.069 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' B' ' 382' ' ' THR . 26.0 mttt -130.51 -21.3 2.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.942 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.66 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.3 p -151.94 167.79 27.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.601 0.715 . . . . 0.0 111.883 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.453 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.19 156.49 47.07 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.549 179.557 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.556 HG21 HD12 ' A' ' 15' ' ' LEU . 25.1 m -148.43 154.81 40.39 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 118.947 -1.101 . . . . 0.0 113.068 -174.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.6 mt -125.64 140.09 53.02 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.329 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 9.7 t0 -117.56 95.5 4.98 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.875 176.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 27.6 t80 -137.75 95.16 3.0 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.89 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.96 12.17 1.96 Allowed Glycine 0 C--O 1.225 -0.413 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.6 t0 -41.73 -16.36 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.911 -0.645 . . . . 0.0 112.057 -178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.539 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.0 m-85 -54.35 -37.83 65.37 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.468 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.66 -92.16 0.51 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.522 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.468 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 7.5 t0 -130.02 96.29 4.16 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.14 -3.31 54.39 Favored Glycine 0 C--N 1.306 -1.131 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.405 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.68 107.11 16.71 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -175.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -115.39 120.66 40.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.742 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.2 t -138.49 163.35 32.19 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.788 0.804 . . . . 0.0 113.103 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.97 175.56 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.299 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -101.74 124.4 47.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.039 0.923 . . . . 0.0 110.728 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.666 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -154.46 136.86 14.97 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.883 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.62 17.59 4.55 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.251 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.16 83.58 1.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.949 174.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -58.85 1.92 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.0 pt-20 -44.49 -20.08 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.904 -0.648 . . . . 0.0 111.022 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.437 ' N ' ' C ' ' B' ' 385' ' ' GLY . 23.5 mt-30 -83.13 -39.55 20.93 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.9 mt -76.54 -42.02 34.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.654 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.63 -42.69 61.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.503 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -63.63 -34.62 78.24 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 122.036 0.922 . . . . 0.0 111.05 -177.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.96 -53.16 10.7 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.811 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -49.12 -55.12 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.484 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.19 -34.32 44.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.657 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.86 -17.99 62.31 Favored Glycine 0 CA--C 1.504 -0.611 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.692 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.72 -36.65 18.54 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.522 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.32 -13.02 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-O 122.123 0.963 . . . . 0.0 109.226 176.202 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.51 -23.07 43.18 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.465 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' B' ' 395' ' ' TYR . 74.2 mt -90.34 -59.95 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.573 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.493 ' O ' ' C ' ' B' ' 400' ' ' LEU . 0.7 OUTLIER -69.1 -19.58 23.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.266 -177.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.493 ' C ' ' O ' ' B' ' 399' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.381 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.551 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? . . . . . 0 N--CA 1.463 0.186 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -37.35 64.61 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.12 -50.68 61.19 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 120.986 0.422 . . . . 0.0 110.023 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 74.9 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.761 0.315 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.5 153.65 24.78 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.113 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -127.7 135.42 50.16 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.158 0.286 . . . . 0.0 111.587 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -139.96 127.36 21.4 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.572 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.911 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.77 107.72 13.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 123.751 1.739 . . . . 0.0 109.314 178.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.692 HG12 ' HB ' ' B' ' 382' ' ' THR . 31.3 m -120.18 162.6 18.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 112.658 -2.065 . . . . 0.0 110.097 -176.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -104.0 145.61 29.9 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' B' ' 326' ' ' VAL . 44.0 tt0 . . . . . 0 C--N 1.314 -0.951 0 CA-C-O 122.033 0.92 . . . . 0.0 112.627 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' B' ' 317' ' ' GLU . 14.4 t . . . . . 0 N--CA 1.44 -0.929 0 CA-C-O 119.113 -0.47 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.426 ' O ' HG12 ' B' ' 326' ' ' VAL . 68.0 Cg_exo -44.39 144.11 3.28 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.618 ' N ' ' O ' ' B' ' 315' ' ' VAL . 11.2 ttm-85 -150.08 -173.59 4.48 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.696 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.16 120.49 13.07 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.145 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.835 HD12 ' O ' ' B' ' 338' ' ' MET . 31.7 tp -99.04 157.9 16.03 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.249 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.2 108.04 0.52 Allowed Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.711 HD11 HD21 ' B' ' 330' ' ' LEU . 30.7 mm -87.82 122.91 40.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.722 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.9 p -117.09 138.55 51.55 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.79 15.83 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.747 0.308 . . . . 0.0 111.354 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.722 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.1 pt-20 -145.72 -4.5 0.66 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.528 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.46 177.39 2.19 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.362 1.077 . . . . 0.0 113.011 -176.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.61 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 9.9 t -132.81 145.29 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 CA-C-N 113.16 -1.836 . . . . 0.0 106.254 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.835 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.0 OUTLIER -152.54 150.88 30.04 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 117.143 -1.823 . . . . 0.0 114.468 -175.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.532 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 62.6 mtm180 -96.13 106.77 19.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.524 176.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.7 t -96.76 150.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.278 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' B' ' 344' ' ' THR . 28.8 t0 -88.04 91.74 8.88 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.76 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.48 -28.38 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.617 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.8 mttm -75.18 -43.78 50.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.691 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.56 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.77 -13.98 14.68 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 14.7 tttp 68.29 -0.77 2.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.026 0.441 . . . . 0.0 109.958 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.9 mt-10 -86.3 152.83 22.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.35 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.623 HG21 ' SD ' ' B' ' 338' ' ' MET . 86.6 t -81.6 133.55 29.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.485 0.66 . . . . 0.0 112.178 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 11.9 mt -102.98 -31.02 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.319 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.532 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 21.8 tt0 -139.58 158.15 44.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.595 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -143.06 150.08 39.06 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.135 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.556 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.0 122.38 4.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.938 177.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.93 139.79 2.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.443 0.639 . . . . 0.0 111.624 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.6 HD12 ' O ' ' B' ' 333' ' ' THR . 1.7 tt -82.24 -37.28 26.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . 0.523 ' O ' HG22 ' B' ' 354' ' ' THR . 19.7 m -70.67 6.76 1.32 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.799 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.587 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 0.9 OUTLIER -108.37 -4.84 17.06 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.106 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.534 HD12 HD23 ' B' ' 353' ' ' LEU . 70.5 mt -60.9 144.42 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.753 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -107.3 -45.95 3.99 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 7.2 ptt180 -172.43 135.7 0.74 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.546 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.6 p90 -119.08 176.35 5.34 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.208 -177.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.24 99.21 1.62 Allowed 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.961 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.787 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.25 145.4 30.96 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.573 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -133.71 173.96 5.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -77.39 -7.95 17.12 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.136 1.891 . . . . 0.0 112.131 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' B' ' 382' ' ' THR . 4.0 mtpp -130.61 -21.27 2.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.046 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.659 ' HA ' ' H ' ' B' ' 382' ' ' THR . 61.1 p -152.25 167.36 28.85 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.528 0.68 . . . . 0.0 111.903 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.469 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -138.79 156.63 47.18 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.504 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.551 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.2 m -148.57 154.47 39.81 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.014 -1.075 . . . . 0.0 113.02 -174.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.8 mt -125.32 140.77 52.53 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.355 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.8 t0 -118.06 95.6 4.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.464 -0.895 . . . . 0.0 110.821 176.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 18.6 t80 -137.38 94.85 2.98 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.936 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.01 12.41 1.91 Allowed Glycine 0 C--O 1.226 -0.405 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.2 t0 -41.89 -16.12 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.02 -0.59 . . . . 0.0 111.887 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.542 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.34 -37.94 65.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.463 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.32 -92.37 0.51 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.895 -1.502 . . . . 0.0 107.358 176.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 7.8 t70 -129.93 96.16 4.14 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.16 -2.92 54.48 Favored Glycine 0 C--N 1.31 -0.883 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.28 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.673 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.45 107.06 16.5 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -175.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . 0.422 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.7 OUTLIER -114.71 120.95 41.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.677 175.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.7 t -138.67 163.21 32.69 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.95 175.18 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.209 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -101.44 124.57 47.32 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.955 0.883 . . . . 0.0 110.863 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.692 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -154.88 136.91 14.66 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.937 179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.75 17.42 4.77 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.207 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.06 83.88 1.75 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.902 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.96 -58.19 2.04 Favored Glycine 0 C--O 1.223 -0.578 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.5 pt-20 -44.58 -20.06 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.814 -0.693 . . . . 0.0 111.083 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.439 ' N ' ' C ' ' B' ' 385' ' ' GLY . 41.5 mt-30 -83.04 -39.78 20.78 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' B' ' 385' ' ' GLY . 50.2 mt -76.74 -41.99 33.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.611 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.787 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.68 -42.37 61.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.293 -1.321 . . . . 0.0 113.532 -177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.462 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.3 pt20 -64.02 -34.65 78.5 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.076 0.941 . . . . 0.0 111.063 -177.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.96 -53.11 10.8 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.753 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -49.09 -55.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.492 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.98 -33.69 52.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.736 -2.029 . . . . 0.0 110.511 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.06 -17.71 62.45 Favored Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.677 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -86.91 -37.18 17.88 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.546 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.48 -13.15 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.112 0.958 . . . . 0.0 109.297 176.214 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.96 -22.67 45.33 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.437 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' B' ' 395' ' ' TYR . 69.6 mt -91.95 -61.9 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.126 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.64 -20.37 27.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.324 -176.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.565 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.637 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.546 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? . . . . . 0 N--CA 1.463 0.199 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.03 -43.26 99.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.619 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.26 89.2 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.724 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 85.3 t . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.781 0.324 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.68 153.29 26.64 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.202 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -130.09 134.64 47.49 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.052 0.22 . . . . 0.0 111.436 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -138.93 129.3 25.69 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.533 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.878 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.39 102.32 10.41 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 123.902 1.811 . . . . 0.0 109.503 178.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.647 HG12 ' HB ' ' B' ' 382' ' ' THR . 26.2 m -114.33 158.08 14.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 112.76 -2.018 . . . . 0.0 110.187 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -98.35 145.22 26.91 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' B' ' 326' ' ' VAL . 30.1 tt0 . . . . . 0 C--N 1.31 -1.121 0 CA-C-O 121.927 0.87 . . . . 0.0 112.435 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.6 t . . . . . 0 N--CA 1.44 -0.952 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.442 ' O ' HG12 ' B' ' 326' ' ' VAL . 71.2 Cg_exo -44.14 143.03 3.63 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 N-CA-C 107.939 -1.6 . . . . 0.0 107.939 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.637 HH21 ' CD1' ' B' ' 348' ' ' ILE . 2.2 tpt180 -148.52 -172.59 4.12 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.629 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.66 121.11 11.0 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 338' ' ' MET . 31.9 tp -99.4 158.61 15.6 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.198 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.432 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.34 108.34 0.52 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.767 HD11 HD21 ' B' ' 330' ' ' LEU . 29.9 mm -88.19 123.26 40.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.722 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.88 138.37 52.17 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.06 15.73 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.752 0.31 . . . . 0.0 111.251 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.722 ' H ' ' C ' ' B' ' 333' ' ' THR . 11.2 pt-20 -145.12 -4.75 0.71 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.525 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.62 177.28 2.15 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.425 1.107 . . . . 0.0 112.89 -176.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.61 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.9 t -132.56 145.3 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 CA-C-N 113.065 -1.88 . . . . 0.0 106.315 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.836 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.63 150.61 29.67 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 117.175 -1.81 . . . . 0.0 114.423 -175.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.507 ' NH1' ' OE1' ' B' ' 317' ' ' GLU . 26.3 mtm105 -95.74 107.01 19.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.481 176.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.629 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -96.57 150.04 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.274 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.6 t0 -88.19 91.4 8.77 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.668 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.4 -28.49 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.678 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.9 mttm -75.19 -43.96 49.18 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.704 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.559 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.95 -13.27 14.76 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 17.4 tttp 67.72 -0.9 1.8 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 109.988 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.5 mt-10 -85.69 152.07 23.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.346 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.624 HG21 ' SD ' ' B' ' 338' ' ' MET . 85.6 t -81.38 133.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.514 0.673 . . . . 0.0 112.209 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . 0.637 ' CD1' HH21 ' B' ' 328' ' ' ARG . 48.8 mt -103.83 -30.24 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.335 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.472 ' O ' ' CB ' ' B' ' 338' ' ' MET . 21.4 tt0 -139.72 157.41 45.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.639 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -143.35 149.98 38.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.321 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.554 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.87 124.12 4.27 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.102 177.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.516 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.54 140.63 3.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.394 0.616 . . . . 0.0 111.606 -178.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.595 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -84.16 -35.89 23.26 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -74.26 9.87 1.49 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.824 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.575 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.0 m-20 -111.46 -7.56 14.34 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.069 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.5 HD12 HD23 ' B' ' 353' ' ' LEU . 81.3 mt -55.95 146.9 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.805 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -107.83 -45.9 3.9 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.502 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.9 ptt-85 -173.02 135.72 0.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.479 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.0 p90 -119.61 176.28 5.45 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.195 -177.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.93 99.59 1.54 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.017 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.34 147.7 30.97 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.574 -1.193 . . . . 0.0 110.682 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -135.32 174.17 4.9 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -77.81 -8.13 16.74 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.137 1.892 . . . . 0.0 112.122 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' B' ' 382' ' ' THR . 5.6 mttm -130.74 -20.36 2.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.056 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.658 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.1 p -153.11 167.98 27.43 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.594 0.711 . . . . 0.0 111.934 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.42 156.46 46.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.618 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.546 ' CG2' HD12 ' A' ' 15' ' ' LEU . 26.0 m -148.51 154.81 40.32 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.03 -1.068 . . . . 0.0 113.081 -174.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.447 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.8 mt -125.82 140.0 53.03 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.362 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.6 t0 -117.4 95.6 5.04 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.654 176.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 30.5 t80 -137.93 94.94 2.95 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.985 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.85 12.11 1.99 Allowed Glycine 0 C--O 1.224 -0.51 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.3 t0 -41.61 -16.42 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.977 -0.612 . . . . 0.0 111.745 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.38 -37.33 64.88 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.47 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.06 -92.31 0.51 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.283 176.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.47 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.5 t70 -129.59 96.36 4.24 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.5 -3.34 53.28 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.21 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.677 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.21 106.79 16.11 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . 0.4 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.9 OUTLIER -114.53 120.3 39.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.748 176.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 34.8 t -138.68 163.91 30.9 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.54 175.81 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.15 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.76 124.29 47.15 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.904 0.859 . . . . 0.0 110.754 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.658 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.69 136.85 14.77 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.87 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.74 17.42 4.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.247 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.06 83.74 1.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.996 175.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.53 -58.24 1.97 Allowed Glycine 0 C--N 1.317 -0.498 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.1 pt-20 -44.81 -20.17 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 114.949 -0.625 . . . . 0.0 111.032 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 6.7 mm-40 -83.47 -38.87 21.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.2 mt -76.68 -42.2 34.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.613 177.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.69 -42.58 61.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.363 -1.289 . . . . 0.0 113.541 -177.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.443 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.9 pt20 -63.55 -34.45 77.83 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.051 0.929 . . . . 0.0 111.069 -177.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.02 -53.32 10.29 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.81 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.6 mt -49.21 -55.09 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 176.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.486 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.38 -34.1 46.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.55 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.79 -17.95 62.54 Favored Glycine 0 CA--C 1.506 -0.529 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.681 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.91 -36.93 18.1 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.479 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.28 -13.29 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 CA-C-O 122.151 0.976 . . . . 0.0 109.283 176.142 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.49 -22.62 47.19 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.741 -1.572 . . . . 0.0 109.447 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.7 mt -91.94 -61.85 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.901 -1.499 . . . . 0.0 112.037 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -65.12 -20.17 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.357 -176.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.555 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.454 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.838 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.559 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? . . . . . 0 CA--C 1.519 -0.243 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.84 -40.33 83.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.3 -42.03 99.72 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.491 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.4 mt-10 . . . . . 0 C--N 1.327 -0.381 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.772 0.32 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.02 153.7 25.22 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.099 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -127.79 135.57 50.28 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.1 0.25 . . . . 0.0 111.56 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -140.31 128.11 21.86 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.568 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.912 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.58 107.99 13.84 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 123.653 1.692 . . . . 0.0 109.477 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.649 HG12 ' HB ' ' B' ' 382' ' ' THR . 31.1 m -119.85 161.28 19.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 112.706 -2.043 . . . . 0.0 110.072 -176.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -102.58 146.02 28.78 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' B' ' 326' ' ' VAL . 20.5 tt0 . . . . . 0 C--N 1.313 -0.99 0 CA-C-O 121.993 0.902 . . . . 0.0 112.275 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.2 t . . . . . 0 N--CA 1.442 -0.873 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.434 ' O ' HG12 ' B' ' 326' ' ' VAL . 64.0 Cg_exo -44.87 145.09 3.13 Favored 'Trans proline' 0 C--N 1.32 -0.937 0 N-CA-C 108.088 -1.543 . . . . 0.0 108.088 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' B' ' 315' ' ' VAL . 12.5 ttm-85 -151.68 -172.89 4.35 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.62 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.21 121.13 13.59 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.834 HD12 ' O ' ' B' ' 338' ' ' MET . 31.9 tp -99.17 157.95 16.01 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.01 108.04 0.52 Allowed Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -87.96 122.19 39.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.727 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.2 p -116.56 138.2 51.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -57.59 14.09 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.031 0.443 . . . . 0.0 111.647 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.727 ' H ' ' C ' ' B' ' 333' ' ' THR . 16.2 pt-20 -144.2 -3.63 0.84 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.758 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.618 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.59 178.18 1.98 Allowed 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.386 1.089 . . . . 0.0 112.898 -176.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.618 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.0 t -134.18 144.72 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 113.106 -1.861 . . . . 0.0 106.386 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.834 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.6 ptt? -152.71 151.46 30.56 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 117.175 -1.81 . . . . 0.0 114.42 -175.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.18 106.69 18.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.385 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.651 ' N ' ' O ' ' B' ' 329' ' ' LEU . 3.0 t -96.1 149.26 4.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.293 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' B' ' 343' ' ' LYS . 46.0 t0 -87.26 90.49 8.38 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.854 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.8 OUTLIER -35.84 -28.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.686 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' B' ' 341' ' ' ASP . 15.9 mttp -70.49 -44.01 68.55 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.613 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -114.21 -17.55 11.84 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' B' ' 344' ' ' THR . 8.3 tttp 77.46 -0.0 2.87 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.458 ' O ' HG13 ' B' ' 340' ' ' VAL . 8.1 pt-20 -82.47 157.82 23.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.593 HG21 ' SD ' ' B' ' 338' ' ' MET . 90.3 t -87.38 131.69 34.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.363 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . 0.417 HD11 ' HB2' ' B' ' 341' ' ' ASP . 59.3 mt -101.35 -29.99 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.455 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.488 ' O ' ' CB ' ' B' ' 338' ' ' MET . 18.0 tt0 -140.81 158.23 44.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.626 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -143.79 151.25 39.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.232 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -160.31 124.83 3.75 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.19 177.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.502 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -47.09 139.42 5.86 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.448 0.642 . . . . 0.0 111.493 -178.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.583 HD12 ' O ' ' B' ' 333' ' ' THR . 1.9 tt -82.99 -35.67 25.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.2 t -74.15 9.69 1.52 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.935 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.57 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.1 m-20 -111.29 -7.67 14.4 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.992 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.467 HD12 HD23 ' B' ' 353' ' ' LEU . 78.9 mt -56.55 146.69 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.826 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -107.76 -45.12 4.08 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.503 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 10.3 ptt180 -173.79 136.1 0.54 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.513 ' CH2' HD12 ' B' ' 396' ' ' ILE . 7.9 p90 -119.09 177.24 4.94 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.23 -177.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.58 99.23 1.57 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.101 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.13 147.13 30.21 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.647 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -135.69 173.71 5.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -76.98 -8.39 17.74 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.088 1.858 . . . . 0.0 112.297 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.9 mttm -130.66 -20.76 2.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.057 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.652 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.3 p -152.47 167.67 28.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.572 0.701 . . . . 0.0 111.852 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.478 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.2 156.79 46.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.815 179.619 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.559 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.9 m -148.65 155.52 41.16 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.11 -1.036 . . . . 0.0 113.17 -174.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.8 mt -126.05 140.15 52.83 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.168 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 9.2 t0 -117.69 95.6 5.01 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.547 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 31.0 t80 -137.63 94.71 2.95 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.937 176.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.85 12.17 1.98 Allowed Glycine 0 C--O 1.225 -0.421 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.7 t0 -41.6 -16.16 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.953 -0.624 . . . . 0.0 111.818 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.45 -37.44 65.19 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.473 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.87 -92.59 0.5 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.909 -1.496 . . . . 0.0 107.187 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.473 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.5 t70 -129.34 96.18 4.23 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.24 -3.37 54.05 Favored Glycine 0 C--N 1.311 -0.851 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.256 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.02 106.73 15.9 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -175.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . 0.403 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.9 OUTLIER -114.05 120.38 40.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.759 175.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 34.7 t -138.46 163.87 30.83 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.679 0.752 . . . . 0.0 112.909 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -150.76 175.56 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.101 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -101.53 125.08 48.13 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.12 0.962 . . . . 0.0 110.799 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.652 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.22 136.51 14.0 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.831 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.22 17.35 4.38 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.175 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . 0.425 ' CB ' HE21 ' B' ' 387' ' ' GLN . 0.2 OUTLIER -144.04 83.94 1.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.936 174.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.98 -58.78 1.95 Allowed Glycine 0 C--O 1.223 -0.557 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.501 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.7 pt-20 -44.45 -20.87 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 114.787 -0.706 . . . . 0.0 111.027 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' B' ' 385' ' ' GLY . 22.3 mt-30 -82.37 -39.35 22.86 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 51.6 mt -76.59 -42.2 34.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.579 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.89 -42.57 60.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.534 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 5.0 pp0? -63.81 -34.44 77.91 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.075 0.941 . . . . 0.0 111.105 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.05 -53.42 10.02 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.73 -179.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -48.97 -55.56 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.487 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -51.96 -34.01 40.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.777 -2.01 . . . . 0.0 110.635 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.89 -18.16 61.9 Favored Glycine 0 CA--C 1.506 -0.491 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.684 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.5 m-30 -86.79 -36.82 18.34 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.513 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.42 -13.3 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 CA-C-O 122.195 0.998 . . . . 0.0 109.29 176.165 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.42 -22.6 47.5 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.512 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.5 mt -91.9 -62.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.003 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.68 -20.24 26.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.359 -1.746 . . . . 0.0 112.393 -176.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.715 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.558 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.6 mm? . . . . . 0 CA--C 1.521 -0.152 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 16' ' ' LEU . 74.5 mt -62.08 -43.75 98.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.79 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.35 -36.08 81.92 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.752 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 95.2 t . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.736 0.303 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.58 153.59 27.31 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -129.58 134.13 47.56 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.14 0.275 . . . . 0.0 111.45 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -138.93 128.01 23.88 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.615 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.896 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.06 106.09 12.78 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 123.762 1.744 . . . . 0.0 109.284 178.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.7 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.5 m -118.55 162.68 16.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 112.669 -2.059 . . . . 0.0 110.12 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -103.83 145.98 29.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' B' ' 326' ' ' VAL . 38.1 tt0 . . . . . 0 C--N 1.314 -0.942 0 CA-C-O 122.059 0.933 . . . . 0.0 112.538 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' B' ' 317' ' ' GLU . 19.6 t . . . . . 0 N--CA 1.44 -0.967 0 CA-C-O 119.158 -0.449 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.427 ' O ' HG12 ' B' ' 326' ' ' VAL . 67.8 Cg_exo -44.52 144.73 3.01 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 N-CA-C 108.117 -1.532 . . . . 0.0 108.117 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' B' ' 315' ' ' VAL . 8.1 ttm180 -151.18 -173.09 4.39 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 119.577 -0.849 . . . . 0.0 108.712 -177.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.12 121.47 13.99 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.832 HD12 ' O ' ' B' ' 338' ' ' MET . 33.3 tp -99.41 158.42 15.74 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.213 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.83 108.44 0.52 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 177.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.719 HD11 HD21 ' B' ' 330' ' ' LEU . 30.0 mm -87.91 123.96 40.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.728 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.42 138.38 52.5 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.83 14.71 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.122 0.487 . . . . 0.0 111.562 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.728 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.2 pt-20 -144.59 -4.11 0.78 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.805 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.13 176.77 2.03 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.323 1.059 . . . . 0.0 112.989 -176.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.615 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 9.5 t -132.58 145.8 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 CA-C-N 113.209 -1.814 . . . . 0.0 106.269 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.832 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.66 151.16 30.25 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 117.167 -1.813 . . . . 0.0 114.549 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.554 ' NH1' ' NE2' ' B' ' 349' ' ' GLN . 2.7 mtm180 -95.76 106.8 18.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.436 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.46 149.5 4.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.29 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' B' ' 343' ' ' LYS . 42.9 t0 -87.63 90.83 8.52 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.862 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.8 OUTLIER -36.24 -27.27 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.654 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.1 mttp -70.64 -43.17 69.78 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.672 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.533 ' N ' ' O ' ' B' ' 341' ' ' ASP . 26.6 p -115.59 -17.86 11.05 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' B' ' 344' ' ' THR . 10.3 tttm 78.16 1.19 2.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 110.126 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.445 ' O ' HG13 ' B' ' 340' ' ' VAL . 6.3 pt-20 -84.97 156.98 20.93 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.616 HG21 ' SD ' ' B' ' 338' ' ' MET . 91.7 t -86.69 132.87 31.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.508 0.67 . . . . 0.0 112.394 -178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 22.0 mm -102.6 -30.6 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.267 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.554 ' NE2' ' NH1' ' B' ' 339' ' ' ARG . 2.7 tt0 -140.45 157.87 44.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.622 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -142.28 150.29 40.67 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.19 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -157.16 122.32 4.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.136 177.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.499 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.48 138.95 4.02 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.403 0.621 . . . . 0.0 111.503 -178.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.601 HD12 ' O ' ' B' ' 333' ' ' THR . 1.7 tt -81.66 -36.99 28.18 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . 0.514 ' O ' HG22 ' B' ' 354' ' ' THR . 17.4 m -70.97 6.9 1.34 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.892 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.569 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.7 m-20 -108.55 -4.95 16.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.93 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.538 HD12 HD23 ' B' ' 353' ' ' LEU . 70.8 mt -60.65 144.16 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.743 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -107.3 -45.63 4.06 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.4 ptt-85 -172.43 135.77 0.74 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.541 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.7 p90 -118.95 175.51 5.72 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.119 -177.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.87 98.94 1.66 Allowed 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 119.199 -1.001 . . . . 0.0 111.891 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.79 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.16 149.54 29.07 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.839 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.522 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -137.86 174.99 3.72 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -78.42 -7.0 15.83 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.266 1.977 . . . . 0.0 112.134 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' B' ' 382' ' ' THR . 47.6 mttt -130.84 -22.53 2.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.001 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.644 ' HA ' ' H ' ' B' ' 382' ' ' THR . 63.8 p -152.74 165.94 33.74 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.653 0.74 . . . . 0.0 111.85 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.485 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -137.36 156.98 47.58 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.737 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.558 ' CG2' HD12 ' A' ' 15' ' ' LEU . 27.7 m -148.52 156.29 42.25 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.065 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.45 ' N ' HG22 ' B' ' 367' ' ' THR . 7.1 mt -126.71 141.45 51.84 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.435 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.4 t0 -118.44 95.41 4.86 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.691 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 17.6 t80 -137.18 94.85 3.0 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.951 176.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.79 12.24 1.98 Allowed Glycine 0 C--O 1.225 -0.412 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -41.73 -16.15 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.857 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.52 -37.51 65.45 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.466 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.82 -92.27 0.51 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.958 -1.473 . . . . 0.0 107.345 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.466 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 12.9 t0 -129.75 96.37 4.22 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.46 -2.7 53.56 Favored Glycine 0 C--N 1.311 -0.82 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.271 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.81 106.87 16.67 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -175.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.11 122.69 46.87 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.663 176.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 34.3 t -139.03 163.69 31.73 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.35 173.66 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.113 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -99.92 125.29 45.89 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.976 0.893 . . . . 0.0 110.872 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.7 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -155.21 136.39 13.91 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.912 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.09 16.83 4.66 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.296 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.19 84.1 1.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.992 175.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.76 -58.26 2.05 Favored Glycine 0 C--N 1.317 -0.487 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.9 pt-20 -44.73 -20.09 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 114.893 -0.653 . . . . 0.0 111.047 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.434 ' N ' ' C ' ' B' ' 385' ' ' GLY . 46.7 mt-30 -82.89 -39.76 21.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' B' ' 385' ' ' GLY . 51.4 mt -76.66 -41.84 34.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.687 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.79 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.86 -42.19 61.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.362 -1.29 . . . . 0.0 113.604 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.462 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.4 pt20 -64.19 -34.44 78.08 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.06 0.933 . . . . 0.0 111.047 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.09 -53.47 9.87 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.759 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -48.93 -55.28 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.491 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.6 -33.9 48.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 112.801 -2.0 . . . . 0.0 110.506 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.75 -17.98 62.55 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.68 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.91 -37.07 17.98 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.541 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.44 -13.14 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.911 0 CA-C-O 122.102 0.953 . . . . 0.0 109.325 176.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.04 -22.6 45.15 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.507 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.9 mt -91.83 -61.96 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-N 113.865 -1.516 . . . . 0.0 112.105 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.54 -20.54 27.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.38 -176.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.561 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.462 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.801 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.564 HD12 HG21 ' B' ' 367' ' ' THR . 4.3 mm? . . . . . 0 N--CA 1.463 0.206 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -39.34 81.73 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.57 -45.52 96.15 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.518 ' OE2' ' CD2' ' B' ' 377' ' ' TYR . 82.5 mt-10 . . . . . 0 C--O 1.222 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 69.2 t . . . . . 0 CA--C 1.529 0.142 0 CA-C-O 120.835 0.35 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.44 153.1 25.49 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.081 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -128.99 134.76 48.29 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.037 0.211 . . . . 0.0 111.405 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -138.35 129.76 27.55 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.763 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.871 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.12 104.02 12.16 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 123.666 1.698 . . . . 0.0 109.283 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.598 ' O ' ' N ' ' B' ' 328' ' ' ARG . 34.7 m -120.27 157.27 22.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 112.867 -1.97 . . . . 0.0 110.167 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' B' ' 380' ' ' VAL . 7.0 mtmt -96.6 139.5 32.59 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.454 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' B' ' 326' ' ' VAL . 3.2 tt0 . . . . . 0 C--N 1.316 -0.866 0 CA-C-O 122.007 0.908 . . . . 0.0 113.061 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.4 t . . . . . 0 N--CA 1.444 -0.743 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.542 ' O ' ' NE ' ' B' ' 328' ' ' ARG . 80.1 Cg_exo -38.05 144.62 0.17 Allowed 'Trans proline' 0 CA--C 1.508 -0.816 0 N-CA-C 108.701 -1.307 . . . . 0.0 108.701 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' B' ' 315' ' ' VAL . 0.3 OUTLIER -157.15 -171.54 3.67 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.82 -176.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.643 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -142.81 124.38 14.88 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.832 HD12 ' O ' ' B' ' 338' ' ' MET . 27.9 tp -103.95 158.18 16.59 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.427 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.41 107.84 0.52 Allowed Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.758 HD11 HD21 ' B' ' 330' ' ' LEU . 31.6 mm -88.35 123.59 40.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.73 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.4 p -118.19 137.91 52.67 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -57.36 13.64 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.004 0.43 . . . . 0.0 111.793 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.73 ' H ' ' C ' ' B' ' 333' ' ' THR . 12.7 pt-20 -144.32 -2.85 0.86 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.991 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.601 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.9 178.72 2.12 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.307 1.051 . . . . 0.0 112.982 -177.07 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.601 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.38 145.6 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-N 113.338 -1.756 . . . . 0.0 106.682 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.832 ' O ' HD12 ' B' ' 330' ' ' LEU . 3.2 ptt? -153.95 149.49 27.33 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 117.062 -1.855 . . . . 0.0 114.356 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.529 ' NE ' ' OE1' ' B' ' 317' ' ' GLU . 12.1 mtp180 -94.14 107.65 19.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.666 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -98.73 149.71 5.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.2 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.9 t0 -89.6 92.27 9.02 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.815 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 341' ' ' ASP . 1.1 tt0 -35.46 -28.83 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.65 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' B' ' 341' ' ' ASP . 14.8 mttp -75.17 -43.62 51.19 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.704 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.555 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.2 -12.55 14.78 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' B' ' 341' ' ' ASP . 6.1 ttmt 66.67 -1.15 1.38 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.029 0.442 . . . . 0.0 109.961 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.459 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.5 mt-10 -84.71 153.53 23.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.322 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.596 HG21 ' SD ' ' B' ' 338' ' ' MET . 79.2 t -82.83 135.29 25.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.454 0.645 . . . . 0.0 112.288 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 66.0 mt -103.67 -30.39 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.424 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.473 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.9 tt0 -140.55 156.63 46.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.715 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -145.74 149.61 34.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.495 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' B' ' 337' ' ' VAL . 63.5 t-105 -162.79 135.15 5.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.892 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.503 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.57 138.75 27.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.411 -178.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.626 HD12 ' O ' ' B' ' 333' ' ' THR . 1.9 tt -79.03 -35.82 42.05 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.64 10.92 1.16 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.98 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.503 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.4 m-20 -114.23 -4.43 13.06 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.217 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.499 HD12 HD23 ' B' ' 353' ' ' LEU . 71.6 mt -57.48 147.81 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.068 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 26.8 tttt -105.84 -45.84 4.28 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 0.2 OUTLIER -174.45 136.3 0.46 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.405 177.272 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.478 ' CH2' HD12 ' B' ' 396' ' ' ILE . 10.0 p90 -119.99 173.64 6.95 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.256 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.73 99.72 1.73 Allowed 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 119.153 -1.019 . . . . 0.0 112.252 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.49 144.29 31.45 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.797 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.549 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -132.14 174.28 4.89 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -77.66 -8.63 17.06 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.165 1.91 . . . . 0.0 112.019 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.0 mtpp -130.95 -19.24 2.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.121 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.683 ' HA ' ' H ' ' B' ' 382' ' ' THR . 92.8 p -152.78 168.5 25.5 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.552 0.691 . . . . 0.0 112.062 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.506 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.2 OUTLIER -140.84 156.94 46.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.914 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.564 HG21 HD12 ' A' ' 15' ' ' LEU . 64.1 m -147.3 158.99 44.17 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.003 -174.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.534 ' N ' HG22 ' B' ' 367' ' ' THR . 5.8 mt -133.23 140.29 47.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.515 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 19.5 t0 -117.33 96.13 5.28 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.615 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 9.5 p90 -136.9 93.92 2.9 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.352 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.66 12.49 1.76 Allowed Glycine 0 C--O 1.227 -0.294 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -41.73 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.18 -0.51 . . . . 0.0 111.769 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.562 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.46 -37.44 65.2 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.47 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.5 OUTLIER -125.76 -92.87 0.5 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.111 176.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.47 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.4 t0 -129.05 96.27 4.29 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.13 -2.66 55.87 Favored Glycine 0 C--N 1.312 -0.78 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.245 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.38 105.44 16.71 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.79 127.44 54.34 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.431 ' OG ' ' OG1' ' B' ' 367' ' ' THR . 23.2 t -137.67 158.35 44.55 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.348 0.594 . . . . 0.0 112.349 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . 0.401 ' CB ' ' O ' ' B' ' 316' ' ' LYS . 2.4 m -141.72 172.63 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.004 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -103.35 124.62 49.03 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.896 0.855 . . . . 0.0 110.796 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.683 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.89 139.17 16.64 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.183 179.336 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.09 16.08 6.58 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.313 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.98 84.48 1.78 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.075 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.37 -56.93 2.18 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.7 pt-20 -44.98 -20.22 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 114.615 -0.792 . . . . 0.0 110.945 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' B' ' 385' ' ' GLY . 3.2 mm-40 -82.62 -39.76 21.71 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' B' ' 385' ' ' GLY . 45.0 mt -76.6 -42.38 34.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.763 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.4 -42.01 62.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.255 -1.339 . . . . 0.0 113.68 -177.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.437 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -64.06 -34.83 78.92 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.975 -177.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.649 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.85 -53.75 10.61 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.664 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.649 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.2 -55.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.479 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.7 -33.69 48.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.852 -1.976 . . . . 0.0 110.697 178.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.01 -17.84 62.3 Favored Glycine 0 CA--C 1.506 -0.471 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -178.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.674 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.04 -36.99 17.88 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.478 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.65 -13.18 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 CA-C-O 122.18 0.99 . . . . 0.0 109.236 176.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.48 -22.62 47.23 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.511 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.7 mt -91.78 -62.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.978 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.39 -20.56 27.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.379 -177.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.558 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.82 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.561 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? . . . . . 0 CA--C 1.52 -0.186 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -39.63 80.03 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.09 -43.4 98.8 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.484 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.6 mt-10 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.475 -0.362 . . . . 0.0 110.036 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.797 0.332 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.03 153.59 27.87 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.162 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -129.54 134.36 47.72 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.042 0.214 . . . . 0.0 111.439 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -139.22 127.78 23.09 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.596 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.906 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.75 106.85 13.07 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 123.712 1.72 . . . . 0.0 109.272 178.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.697 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.0 m -119.8 162.82 17.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 112.755 -2.02 . . . . 0.0 110.187 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -103.72 145.58 29.86 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' B' ' 326' ' ' VAL . 44.2 tt0 . . . . . 0 C--N 1.315 -0.905 0 CA-C-O 122.023 0.916 . . . . 0.0 112.558 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.7 t . . . . . 0 N--CA 1.442 -0.86 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.449 ' O ' HG12 ' B' ' 326' ' ' VAL . 68.9 Cg_exo -43.9 144.51 2.47 Favored 'Trans proline' 0 C--N 1.321 -0.917 0 N-CA-C 108.209 -1.496 . . . . 0.0 108.209 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' B' ' 315' ' ' VAL . 7.6 ttm180 -151.55 -173.02 4.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 119.496 -0.881 . . . . 0.0 108.628 -177.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.636 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.68 121.32 13.38 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.113 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.841 HD12 ' O ' ' B' ' 338' ' ' MET . 31.5 tp -99.47 158.72 15.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.175 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.435 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.95 108.7 0.53 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.727 HD11 HD21 ' B' ' 330' ' ' LEU . 30.2 mm -87.91 124.4 41.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.729 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.5 p -118.59 138.25 52.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.327 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -57.96 14.4 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.115 0.484 . . . . 0.0 111.769 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.729 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -144.66 -3.06 0.81 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.981 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.62 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.64 176.95 1.82 Allowed 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.43 1.11 . . . . 0.0 112.833 -176.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.62 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.4 t -132.28 145.84 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-N 113.071 -1.877 . . . . 0.0 106.215 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.841 ' O ' HD12 ' B' ' 330' ' ' LEU . 0.9 OUTLIER -152.63 150.78 29.86 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 117.179 -1.808 . . . . 0.0 114.415 -175.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.54 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 60.0 mtm180 -95.85 106.94 19.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.397 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.65 149.93 4.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.278 -178.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.0 t0 -88.07 91.6 8.83 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.736 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.9 OUTLIER -35.42 -28.38 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.671 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' B' ' 341' ' ' ASP . 28.1 mttp -75.39 -43.92 47.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.641 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.558 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.68 -13.47 14.79 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm 67.71 -1.11 1.74 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' B' ' 344' ' ' THR . 4.4 mt-10 -85.95 152.08 23.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.337 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.629 HG21 ' SD ' ' B' ' 338' ' ' MET . 86.9 t -80.99 133.26 29.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.527 0.68 . . . . 0.0 112.176 -178.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' B' ' 341' ' ' ASP . 55.0 mt -102.91 -30.29 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.323 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.54 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 22.1 tt0 -140.27 158.06 44.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 45.6 mt-10 -142.85 150.69 40.22 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.296 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.02 122.47 4.23 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.227 177.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.511 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.01 140.1 2.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.51 0.672 . . . . 0.0 111.632 -178.755 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.614 HD12 ' O ' ' B' ' 333' ' ' THR . 1.5 tt -82.46 -36.48 26.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . 0.703 ' O ' HG22 ' B' ' 354' ' ' THR . 99.5 m -71.17 7.07 1.36 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.831 177.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.571 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.2 m-20 -108.12 -5.26 17.06 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.828 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.555 HD12 HD23 ' B' ' 353' ' ' LEU . 72.1 mt -61.19 143.23 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.672 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -107.3 -45.29 4.13 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.501 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.0 ptt-85 -172.17 136.27 0.83 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.497 ' CH2' HD12 ' B' ' 396' ' ' ILE . 7.8 p90 -119.14 176.33 5.36 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.234 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.63 98.62 1.67 Allowed 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 119.066 -1.054 . . . . 0.0 112.044 -178.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.793 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.81 145.01 31.64 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.747 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.522 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -133.76 174.15 5.02 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -77.69 -7.61 16.7 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.12 1.88 . . . . 0.0 112.158 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.4 mtpt -130.86 -21.42 2.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.011 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.65 ' HA ' ' H ' ' B' ' 382' ' ' THR . 61.3 p -152.65 166.63 31.51 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.56 0.695 . . . . 0.0 111.908 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.484 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -137.68 156.84 47.58 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.823 179.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.561 ' CG2' HD12 ' A' ' 15' ' ' LEU . 29.1 m -148.81 155.06 40.4 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.215 -174.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.4 mt -125.81 139.83 53.17 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.181 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.1 t0 -117.6 95.65 5.04 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.569 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 15.1 t80 -137.45 94.43 2.92 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.955 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.92 11.98 2.0 Allowed Glycine 0 C--O 1.225 -0.407 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 8.9 t0 -41.47 -16.01 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.087 -0.556 . . . . 0.0 111.777 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.56 -37.08 65.03 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.473 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.0 -92.94 0.49 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.876 -1.511 . . . . 0.0 107.072 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.473 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 16.3 t0 -128.9 96.38 4.34 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.53 -2.9 53.38 Favored Glycine 0 C--N 1.313 -0.7 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.339 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -83.79 106.65 15.66 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -175.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . 0.426 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.6 OUTLIER -114.06 120.8 41.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.6 176.066 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 38.4 t -138.88 164.09 30.6 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.587 0.708 . . . . 0.0 112.818 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.84 174.1 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.874 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -100.47 125.49 46.78 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 122.0 0.905 . . . . 0.0 110.835 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.697 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -155.56 136.78 13.88 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.832 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.25 17.0 4.62 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.147 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.01 84.19 1.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.092 175.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.88 -58.45 2.01 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.463 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.2 pt-20 -44.3 -20.19 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 114.814 -0.693 . . . . 0.0 111.026 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' B' ' 385' ' ' GLY . 67.5 mt-30 -82.75 -40.15 20.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.578 0.704 . . . . 0.0 109.102 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' B' ' 385' ' ' GLY . 49.5 mt -76.41 -42.04 35.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.719 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.793 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.46 -42.32 62.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.6 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.463 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -64.14 -34.79 78.87 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.023 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.64 -53.67 9.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.727 -179.509 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -48.59 -55.7 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 176.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.492 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.42 -33.8 45.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 112.761 -2.018 . . . . 0.0 110.578 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.12 -17.83 62.11 Favored Glycine 0 CA--C 1.505 -0.539 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.68 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.1 m-30 -86.88 -36.45 18.41 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.538 ' O ' HD12 ' B' ' 400' ' ' LEU . 0.0 OUTLIER -69.23 -13.23 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 CA-C-O 122.166 0.984 . . . . 0.0 109.308 176.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.77 -22.62 42.96 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.52 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' B' ' 395' ' ' TYR . 74.8 mt -91.23 -62.15 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.17 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.9 OUTLIER -61.4 -25.84 37.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 113.409 -1.723 . . . . 0.0 112.291 -176.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.538 HD12 ' O ' ' B' ' 396' ' ' ILE . 42.4 mt . . . . . 0 C--O 1.218 -0.581 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.693 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.564 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? . . . . . 0 N--CA 1.463 0.191 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -43.38 96.59 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.7 -36.42 89.67 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.516 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 92.6 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 115.326 -0.437 . . . . 0.0 109.843 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 70.8 t . . . . . 0 CA--C 1.529 0.164 0 CA-C-O 120.738 0.304 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.83 153.26 24.65 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.123 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -129.69 135.45 48.51 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.03 0.206 . . . . 0.0 111.483 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -138.83 129.89 26.7 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.565 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.875 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.61 104.72 13.09 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 123.918 1.818 . . . . 0.0 109.368 178.368 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 315' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.9 m -115.71 161.19 14.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 112.523 -2.126 . . . . 0.0 110.086 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -103.57 145.0 30.69 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 317' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' B' ' 326' ' ' VAL . 27.8 tt0 . . . . . 0 C--N 1.316 -0.88 0 CA-C-O 122.102 0.953 . . . . 0.0 112.729 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 326' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' B' ' 317' ' ' GLU . 9.5 t . . . . . 0 N--CA 1.44 -0.967 0 CA-C-O 119.142 -0.456 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 327' ' ' PRO . . . . . 0.461 ' O ' HG12 ' B' ' 326' ' ' VAL . 61.0 Cg_exo -44.56 145.22 2.76 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 N-CA-C 108.099 -1.539 . . . . 0.0 108.099 178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 328' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' B' ' 315' ' ' VAL . 5.6 ttm-85 -150.2 -173.21 4.37 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.776 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 329' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.95 122.72 12.64 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.07 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 330' ' ' LEU . . . . . 0.833 HD12 ' O ' ' B' ' 338' ' ' MET . 26.4 tp -101.96 158.32 16.22 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 331' ' ' GLY . . . . . 0.428 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.44 107.94 0.53 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 332' ' ' ILE . . . . . 0.736 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -88.46 123.83 41.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 333' ' ' THR . . . . . 0.729 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.6 p -118.31 137.75 52.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.26 13.23 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.05 0.452 . . . . 0.0 111.741 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 335' ' ' GLU . . . . . 0.729 ' H ' ' C ' ' B' ' 333' ' ' THR . 11.3 pt-20 -144.15 -2.52 0.89 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.844 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 336' ' ' CYS . . . . . 0.611 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.86 179.36 2.0 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 122.158 0.98 . . . . 0.0 113.045 -177.194 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 337' ' ' VAL . . . . . 0.611 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.3 t -137.08 145.31 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 CA-C-N 113.365 -1.743 . . . . 0.0 106.677 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 338' ' ' MET . . . . . 0.833 ' O ' HD12 ' B' ' 330' ' ' LEU . 3.9 ptt? -154.08 149.95 27.69 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 117.028 -1.869 . . . . 0.0 114.318 -176.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 339' ' ' ARG . . . . . 0.497 ' NH1' ' OE2' ' B' ' 317' ' ' GLU . 44.7 mtm180 -94.66 107.79 19.78 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.778 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 340' ' ' VAL . . . . . 0.626 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.24 149.84 5.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.228 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 344' ' ' THR . 29.0 t0 -89.93 92.15 8.89 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.784 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.51 -28.95 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.76 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 343' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 35.8 mttt -74.7 -43.67 53.97 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.672 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 344' ' ' THR . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.3 -12.72 14.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 7.4 tttp 66.73 -0.91 1.46 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.977 0.418 . . . . 0.0 109.918 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 346' ' ' GLU . . . . . 0.456 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.6 mt-10 -84.88 152.73 23.36 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.388 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 347' ' ' VAL . . . . . 0.597 HG21 ' SD ' ' B' ' 338' ' ' MET . 81.9 t -82.92 135.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.449 0.642 . . . . 0.0 112.352 -178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mt -104.03 -30.13 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.386 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 349' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' B' ' 338' ' ' MET . 6.9 tt0 -140.49 156.05 46.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.677 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -145.66 149.43 34.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.451 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 351' ' ' TRP . . . . . 0.554 ' O ' ' N ' ' B' ' 337' ' ' VAL . 68.6 t-105 -162.34 135.95 6.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.828 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 352' ' ' SER . . . . . 0.509 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -54.01 138.32 37.51 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.541 -178.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.623 HD12 ' O ' ' B' ' 333' ' ' THR . 1.8 tt -78.51 -35.69 45.97 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.97 11.1 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.97 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 355' ' ' ASN . . . . . 0.509 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -115.04 -3.99 12.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.171 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 356' ' ' ILE . . . . . 0.477 HD12 HD23 ' B' ' 353' ' ' LEU . 72.5 mt -58.12 148.54 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.951 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 357' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 11.5 tptt -106.45 -45.64 4.21 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.2 ptt180 -174.88 136.3 0.4 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.399 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 359' ' ' TRP . . . . . 0.489 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.6 p90 -118.74 174.53 6.22 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.35 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -156.88 97.99 1.73 Allowed 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.936 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 361' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -79.77 147.85 31.69 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.855 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 362' ' ' SER . . . . . 0.535 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -136.21 173.04 6.06 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -76.63 -8.61 18.26 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.033 1.822 . . . . 0.0 112.092 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 6.4 mttm -130.79 -22.08 2.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.96 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 365' ' ' SER . . . . . 0.657 ' HA ' ' H ' ' B' ' 382' ' ' THR . 89.8 p -149.73 170.02 19.7 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.617 0.723 . . . . 0.0 111.815 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 366' ' ' PHE . . . . . 0.505 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -142.79 156.56 44.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.802 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 367' ' ' THR . . . . . 0.564 ' CG2' HD12 ' A' ' 15' ' ' LEU . 33.9 m -148.1 156.44 42.61 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.734 -174.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 368' ' ' LEU . . . . . 0.454 ' N ' HG22 ' B' ' 367' ' ' THR . 6.0 mt -129.11 143.4 50.85 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.479 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.7 t0 -119.74 95.86 4.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.652 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 370' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 10.3 p90 -136.6 93.52 2.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.371 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 371' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.58 12.22 1.81 Allowed Glycine 0 C--O 1.226 -0.397 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -41.77 -15.74 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.117 -0.542 . . . . 0.0 111.776 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 373' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.61 -37.3 65.42 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 374' ' ' GLN . . . . . 0.479 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.85 -92.94 0.5 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 375' ' ' ASP . . . . . 0.479 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.5 t70 -129.02 96.4 4.33 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.5 -2.45 55.49 Favored Glycine 0 C--N 1.311 -0.859 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.218 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 377' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.32 106.11 17.15 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -175.547 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.21 125.98 52.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.783 175.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 379' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' B' ' 366' ' ' PHE . 35.9 t -138.19 164.27 29.62 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.519 0.676 . . . . 0.0 112.667 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.4 172.89 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.942 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -99.77 126.51 45.85 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.891 0.853 . . . . 0.0 111.114 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 382' ' ' THR . . . . . 0.657 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.11 136.05 13.73 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.651 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.27 16.66 4.22 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.103 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.95 84.04 1.77 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.91 175.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.9 -58.84 1.95 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 386' ' ' GLU . . . . . 0.509 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.1 pt-20 -44.66 -20.73 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.746 -0.727 . . . . 0.0 110.976 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 387' ' ' GLN . . . . . 0.429 ' N ' ' C ' ' B' ' 385' ' ' GLY . 78.2 mt-30 -82.06 -39.38 23.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 48.1 mt -76.93 -42.33 32.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.712 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 389' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.87 -42.29 60.96 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.185 -1.37 . . . . 0.0 113.618 -177.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 390' ' ' GLN . . . . . 0.509 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.79 -34.99 79.13 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.116 0.96 . . . . 0.0 110.992 -177.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.93 -53.59 10.91 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.814 -179.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.09 -56.12 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 393' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.29 -33.77 43.67 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.792 -2.004 . . . . 0.0 110.743 177.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 394' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.2 -17.86 61.92 Favored Glycine 0 CA--C 1.507 -0.454 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 395' ' ' TYR . . . . . 0.677 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.15 -36.95 17.77 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 396' ' ' ILE . . . . . 0.489 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.44 -13.33 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 122.237 1.017 . . . . 0.0 109.365 176.029 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.54 -22.7 46.89 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.513 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 398' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.5 mt -91.8 -62.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 113.899 -1.501 . . . . 0.0 112.042 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 399' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.29 -20.6 27.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 113.404 -1.725 . . . . 0.0 112.384 -177.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 400' ' ' LEU . . . . . 0.561 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.773 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.2 mt -100.2 150.85 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.543 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.71 -67.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.895 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 13' ' ' SER . 8.3 mt-30 -120.95 -21.61 6.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.102 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.518 ' C ' ' O ' ' A' ' 10' ' ' GLN . 15.6 mtm -14.47 -63.54 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 124.2 0.937 . . . . 0.0 112.044 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -41.96 -62.73 0.86 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.101 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -65.24 -27.86 68.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.71 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.01 -24.54 63.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.966 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.555 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? -98.97 -36.87 9.6 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -43.41 98.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.582 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.87 -37.27 90.45 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -70.74 -40.6 72.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.457 -0.371 . . . . 0.0 110.035 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.501 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 9.9 mtp -54.49 -31.81 56.69 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.936 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.9 -28.8 17.51 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.335 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.527 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.4 mm? -73.59 -11.32 60.39 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.287 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.733 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -89.58 -11.26 43.22 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.555 ' N ' HD23 ' A' ' 22' ' ' LEU . 2.9 m -113.4 -14.97 12.71 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.961 0.41 . . . . 0.0 110.267 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.46 -74.1 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.179 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.94 -36.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.188 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 26' ' ' LEU . 8.4 mp -63.05 -99.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.548 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.67 -82.71 0.27 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.577 ' O ' HG12 ' A' ' 28' ' ' VAL . 63.6 t -136.47 -1.53 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.744 0.307 . . . . 0.0 110.665 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' O ' ' OXT' ' A' ' 30' ' ' THR . 45.7 t0 48.13 15.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.671 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.446 ' N ' ' C ' ' A' ' 28' ' ' VAL . 41.8 p . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.554 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -137.15 -145.47 4.96 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 89.1 t -40.8 138.31 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.736 0.303 . . . . 0.0 110.703 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.56 153.62 27.22 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.202 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.22 134.29 47.16 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.054 0.221 . . . . 0.0 111.471 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -139.82 128.42 23.03 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.663 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.904 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.58 107.17 13.16 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 123.685 1.707 . . . . 0.0 109.358 178.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.648 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.7 m -118.96 160.64 18.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.174 -176.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -104.78 144.93 31.08 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' B' ' 326' ' ' VAL . 60.6 tt0 -134.04 152.38 51.82 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 122.126 0.965 . . . . 0.0 112.596 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 6.7 tptm -81.24 102.37 10.32 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.163 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 35.2 mmt -96.81 178.78 5.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.067 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.75 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -99.38 150.52 22.06 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.067 178.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 117.02 -23.34 10.0 Favored Glycine 0 C--N 1.315 -0.59 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -138.56 -142.27 0.16 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.285 -0.457 . . . . 0.0 110.646 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . 0.525 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.4 OUTLIER -141.28 -17.88 0.8 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.532 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.443 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -91.1 -176.79 4.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.935 0.398 . . . . 0.0 110.956 -179.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 29.0 mt -90.17 162.78 15.1 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.192 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' B' ' 317' ' ' GLU . 12.2 t -121.58 123.81 27.41 Favored Pre-proline 0 N--CA 1.44 -0.965 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.088 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.424 ' O ' HG12 ' B' ' 326' ' ' VAL . 56.7 Cg_exo -44.74 144.75 3.23 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 N-CA-C 108.226 -1.49 . . . . 0.0 108.226 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.621 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 10.5 ttm-85 -151.58 -173.06 4.4 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 119.48 -0.888 . . . . 0.0 108.682 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.81 120.79 12.83 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.845 HD12 ' O ' ' B' ' 338' ' ' MET . 32.0 tp -98.17 158.74 15.38 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.214 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.436 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -143.0 108.76 0.53 Allowed Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.725 HD11 HD21 ' B' ' 330' ' ' LEU . 30.0 mm -87.97 124.34 41.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.721 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.5 p -118.47 138.34 52.56 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.426 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . 0.602 ' NZ ' ' CE1' ' B' ' 395' ' ' TYR . 1.1 mtmm -57.68 14.55 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.813 0.34 . . . . 0.0 111.306 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.721 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.1 pt-20 -144.96 -3.56 0.77 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.65 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.15 177.7 1.86 Allowed 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.351 1.072 . . . . 0.0 112.991 -176.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.613 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.3 t -132.8 145.56 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.033 0 CA-C-N 113.093 -1.867 . . . . 0.0 106.236 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.845 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.5 ptt? -152.88 151.83 30.83 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 117.098 -1.841 . . . . 0.0 114.334 -175.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.51 HH12 HD13 ' B' ' 330' ' ' LEU . 5.4 mmt-85 -96.96 106.68 19.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.277 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -95.73 149.44 4.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.517 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' B' ' 343' ' ' LYS . 41.0 t0 -86.64 89.95 8.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.673 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.7 OUTLIER -35.88 -27.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.6 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 31.6 mttm -71.21 -44.16 65.96 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.582 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.54 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -113.61 -17.34 12.18 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -177.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' B' ' 344' ' ' THR . 6.8 tttm 77.26 0.22 2.96 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.445 ' O ' HG13 ' B' ' 340' ' ' VAL . 8.0 pt-20 -82.84 157.98 22.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.603 HG21 ' SD ' ' B' ' 338' ' ' MET . 89.8 t -87.29 131.94 33.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.331 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 6.7 mt -102.64 -30.67 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.498 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.484 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.8 tt0 -138.13 158.31 44.57 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.662 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -144.48 149.75 36.47 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.258 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.13 123.14 3.89 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.318 177.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.5 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.48 139.58 3.67 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.513 0.673 . . . . 0.0 111.627 -178.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.598 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -82.26 -36.64 26.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . 0.536 ' O ' HG22 ' B' ' 354' ' ' THR . 19.6 m -71.74 7.37 1.53 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.882 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.4 m-20 -108.51 -5.02 16.75 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.825 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.535 HD12 HD23 ' B' ' 353' ' ' LEU . 72.1 mt -60.81 144.19 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.725 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -107.42 -46.18 3.91 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 7.5 ptt180 -171.54 136.03 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.542 ' CH2' HD12 ' B' ' 396' ' ' ILE . 7.5 p90 -119.31 176.45 5.32 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.315 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.7 98.27 1.64 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 119.06 -1.056 . . . . 0.0 112.188 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.38 145.77 31.84 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.741 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.523 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -134.23 174.17 4.97 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -77.57 -7.87 16.91 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.027 1.818 . . . . 0.0 112.123 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' B' ' 382' ' ' THR . 10.4 mtpt -130.86 -21.49 2.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.016 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.654 ' HA ' ' H ' ' B' ' 382' ' ' THR . 58.1 p -152.21 167.15 29.52 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.526 0.679 . . . . 0.0 111.874 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.468 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -138.55 156.74 47.23 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.826 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.555 ' CG2' HD12 ' A' ' 15' ' ' LEU . 31.8 m -148.56 154.72 40.15 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.146 -1.022 . . . . 0.0 113.185 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.4 mt -125.89 139.64 53.3 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.142 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.9 t0 -117.72 95.58 5.0 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.485 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 17.3 t80 -137.33 94.48 2.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.89 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.87 11.97 2.01 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.6 t0 -41.41 -16.12 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.067 -0.566 . . . . 0.0 111.797 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.556 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.59 -37.03 65.06 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.469 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.3 OUTLIER -125.93 -93.06 0.49 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.853 -1.521 . . . . 0.0 106.946 176.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.469 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 8.2 t70 -128.96 96.41 4.34 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.56 -2.64 53.27 Favored Glycine 0 C--N 1.312 -0.775 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.292 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.67 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.26 107.13 16.39 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -175.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . 0.413 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.7 OUTLIER -114.65 120.43 40.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.737 176.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.501 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.1 t -138.73 163.59 31.76 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.581 0.705 . . . . 0.0 112.78 -177.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.2 m -151.08 175.41 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.792 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -100.78 125.57 47.27 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.96 0.885 . . . . 0.0 110.931 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.654 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.28 136.49 13.93 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.753 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.32 17.01 4.68 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.143 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.99 84.04 1.76 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.022 175.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.99 -58.84 1.94 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.458 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.4 pt-20 -44.41 -20.21 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.748 -0.726 . . . . 0.0 111.038 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.437 ' N ' ' C ' ' B' ' 385' ' ' GLY . 63.6 mt-30 -83.04 -39.71 20.87 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.1 mt -76.39 -42.22 36.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.683 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.47 -42.53 61.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.267 -1.333 . . . . 0.0 113.718 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.458 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 12.2 pt20 -63.88 -34.76 78.66 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.04 0.924 . . . . 0.0 110.98 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.657 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.84 -53.47 10.14 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 113.877 -1.51 . . . . 0.0 108.765 -179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.657 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.4 mt -48.67 -55.29 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 176.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.49 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.79 -33.68 49.87 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.708 -2.042 . . . . 0.0 110.552 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.96 -18.0 62.06 Favored Glycine 0 CA--C 1.507 -0.456 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.68 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -86.84 -37.18 17.99 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.542 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.38 -13.39 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 122.153 0.978 . . . . 0.0 109.284 176.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.82 -22.69 45.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.506 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.8 mt -91.89 -61.88 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-N 113.895 -1.502 . . . . 0.0 112.033 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.85 -20.51 27.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.374 -1.739 . . . . 0.0 112.307 -176.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.56 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.882 -1.056 . . . . 0.0 110.83 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.806 HG23 ' SD ' ' A' ' 11' ' ' MET . 2.1 mp -101.07 151.96 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.631 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.18 -43.62 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.092 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 11' ' ' MET . 37.4 mt-30 -120.78 -24.67 5.63 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.934 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.806 ' SD ' HG23 ' A' ' 8' ' ' ILE . 58.2 mtp -19.42 -64.72 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 124.109 0.88 . . . . 0.0 112.02 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.412 ' C ' ' O ' ' A' ' 11' ' ' MET . 11.4 m-85 -41.09 -62.1 0.89 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.081 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' GLN . 2.9 t -64.51 -33.79 76.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.813 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.78 -27.25 68.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.553 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? -96.79 -38.58 9.82 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -42.94 98.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.24 -36.86 90.59 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.47 -39.79 70.69 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.501 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 4.8 mtp -55.62 -30.61 61.23 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.893 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.11 -26.71 17.45 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.262 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.8 mm? -76.17 -6.5 51.56 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.234 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.699 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -93.85 -10.55 33.61 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.178 0.513 . . . . 0.0 109.811 179.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 25' ' ' SER . 44.3 m -123.29 -24.61 4.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.153 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 7.0 mp0 42.64 17.22 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.286 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.3 OUTLIER 74.97 -60.33 0.52 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.024 178.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.5 ' N ' ' OG ' ' A' ' 25' ' ' SER . 1.4 mp -89.37 -23.74 22.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.476 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.5 11.1 59.84 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 29' ' ' ASP . 3.8 p -45.01 -41.42 2.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.156 0.503 . . . . 0.0 110.821 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.467 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 2.0 t70 40.96 86.71 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.531 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.631 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 41.1 -108.72 0.13 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 94.8 t -86.47 136.41 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.322 . . . . 0.0 110.702 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.55 153.56 23.96 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.15 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -129.95 134.58 47.55 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.153 0.283 . . . . 0.0 111.496 -178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -139.84 128.52 23.13 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.582 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.907 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.86 107.27 13.53 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 123.745 1.736 . . . . 0.0 109.334 178.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' B' ' 382' ' ' THR . 30.7 m -118.74 160.57 18.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 112.63 -2.077 . . . . 0.0 110.096 -176.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -102.94 145.53 29.7 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' B' ' 326' ' ' VAL . 31.0 tt0 -133.18 149.95 52.02 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.164 0.983 . . . . 0.0 112.575 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -81.68 101.87 10.34 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.038 -1.437 . . . . 0.0 111.157 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 38.1 mmt -95.05 178.89 5.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.072 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.768 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.36 150.93 22.51 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.103 178.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.12 -22.53 12.23 Favored Glycine 0 C--N 1.315 -0.586 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.19 -141.63 0.17 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.642 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . 0.404 HD21 ' HA ' ' A' ' 28' ' ' VAL . 2.3 m-20 -142.48 -21.1 0.68 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.523 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.45 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -89.3 -176.31 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.924 0.392 . . . . 0.0 111.001 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . 0.459 HD11 HD21 ' A' ' 22' ' ' LEU . 32.9 mt -91.24 164.63 13.82 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.161 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t -122.84 122.34 27.13 Favored Pre-proline 0 N--CA 1.44 -0.952 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.154 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.425 ' O ' HG12 ' B' ' 326' ' ' VAL . 63.9 Cg_exo -44.15 144.06 3.03 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 N-CA-C 108.085 -1.544 . . . . 0.0 108.085 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.62 ' CG ' ' H ' ' B' ' 329' ' ' LEU . 8.4 ttm180 -150.26 -173.3 4.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.8 120.65 12.72 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.835 HD12 ' O ' ' B' ' 338' ' ' MET . 31.3 tp -98.45 158.43 15.6 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.09 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.435 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.45 108.4 0.52 Allowed Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 177.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.735 HD11 HD21 ' B' ' 330' ' ' LEU . 29.7 mm -87.98 123.02 40.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.722 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.37 138.25 51.92 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -57.86 15.2 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.173 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.722 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.0 pt-20 -144.99 -4.25 0.74 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.62 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.6 177.22 2.17 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 122.448 1.118 . . . . 0.0 112.892 -176.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.613 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.8 t -132.32 145.25 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 CA-C-N 113.132 -1.849 . . . . 0.0 106.201 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.835 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.1 ptt? -152.77 151.01 29.99 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 117.089 -1.845 . . . . 0.0 114.419 -175.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.525 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 61.4 mtm180 -96.01 106.91 19.13 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.443 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.46 149.81 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.284 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.0 t0 -87.83 91.57 8.8 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.712 -178.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.37 -28.46 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.62 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.5 mttp -75.54 -44.0 45.76 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.714 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.555 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.63 -13.07 14.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 30.7 tttp 67.38 -0.67 1.76 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 109.986 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.7 mt-10 -85.99 152.56 22.82 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.317 178.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.622 HG21 ' SD ' ' B' ' 338' ' ' MET . 87.5 t -81.36 133.6 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.498 0.666 . . . . 0.0 112.299 -178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.436 HD11 ' HB2' ' B' ' 341' ' ' ASP . 56.1 mt -103.21 -30.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.369 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.525 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 19.7 tt0 -140.23 157.86 44.93 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.678 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 44.9 mt-10 -143.32 150.15 38.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.349 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.562 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.49 124.02 4.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.118 177.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.404 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.59 140.44 3.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.439 0.638 . . . . 0.0 111.566 -178.557 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.585 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -84.2 -36.12 23.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . 0.467 HG23 HD22 ' B' ' 355' ' ' ASN . 5.7 t -73.74 9.39 1.48 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.889 177.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.57 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 1.0 OUTLIER -111.04 -7.21 14.53 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.055 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.495 HD12 HD23 ' B' ' 353' ' ' LEU . 79.2 mt -56.75 146.6 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.686 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 10.0 tttm -107.78 -46.35 3.82 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.3 ptt-85 -172.05 135.91 0.83 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.513 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.7 p90 -119.53 175.94 5.6 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.288 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.37 99.49 1.62 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.085 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.63 146.83 30.98 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.747 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.529 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -134.55 173.75 5.43 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -77.49 -7.98 17.03 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.119 1.879 . . . . 0.0 112.038 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' B' ' 382' ' ' THR . 4.1 mtpp -130.87 -21.16 2.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.038 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.657 ' HA ' ' H ' ' B' ' 382' ' ' THR . 58.6 p -152.13 167.7 27.66 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.566 0.698 . . . . 0.0 111.942 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.46 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.06 156.64 47.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.651 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.553 ' CG2' HD12 ' A' ' 15' ' ' LEU . 27.9 m -148.53 154.74 40.2 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.151 -174.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.434 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.0 mt -126.12 140.03 52.9 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.08 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.0 t0 -117.75 95.84 5.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.533 176.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 27.6 t80 -137.93 94.72 2.93 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.89 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.8 12.02 2.02 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.9 t0 -41.39 -16.43 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.045 -0.577 . . . . 0.0 111.829 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.548 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.46 -37.25 64.99 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.468 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.2 pt20 -125.85 -92.74 0.5 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.941 -1.482 . . . . 0.0 107.222 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.468 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.6 t70 -129.14 96.3 4.29 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 174.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.24 -2.91 54.24 Favored Glycine 0 C--N 1.312 -0.796 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.376 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.681 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.57 106.75 16.37 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -175.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . 0.41 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.8 OUTLIER -114.3 120.13 39.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.717 176.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.501 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.4 t -138.66 163.45 32.06 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.673 0.749 . . . . 0.0 112.773 -177.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.3 m -150.62 175.61 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.93 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -101.42 124.89 47.83 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.938 0.875 . . . . 0.0 110.807 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.657 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.95 136.68 14.4 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.772 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.41 17.2 4.63 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.271 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.03 83.92 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.989 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.55 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.02 -59.15 1.9 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.497 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.6 pt-20 -44.33 -20.69 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 114.758 -0.721 . . . . 0.0 111.009 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 22.9 mt-30 -82.43 -39.59 22.39 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.55 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.0 mt -76.55 -42.01 34.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.661 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.87 -42.71 60.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.651 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 5.1 pp0? -63.76 -34.3 77.58 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 122.055 0.931 . . . . 0.0 110.969 -177.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.31 -53.4 9.77 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.949 -1.478 . . . . 0.0 108.705 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -48.77 -55.38 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.487 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.06 -34.53 43.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.737 -2.029 . . . . 0.0 110.593 178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.46 -18.06 62.98 Favored Glycine 0 CA--C 1.507 -0.445 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.679 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.7 -37.0 18.37 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.513 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.31 -13.29 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.097 0.951 . . . . 0.0 109.221 176.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.39 -22.62 47.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.563 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.679 HD12 ' HA ' ' B' ' 395' ' ' TYR . 67.2 mt -91.99 -61.96 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 113.872 -1.513 . . . . 0.0 112.057 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.81 -20.28 27.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 113.396 -1.729 . . . . 0.0 112.335 -176.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.555 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.858 -1.067 . . . . 0.0 110.731 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.558 HG21 ' SD ' ' A' ' 11' ' ' MET . 3.5 mt -78.21 152.49 5.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.323 0.582 . . . . 0.0 110.748 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.48 -41.05 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.374 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 11' ' ' MET . 8.9 mt-30 -69.41 -55.14 11.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.756 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.558 ' SD ' HG21 ' A' ' 8' ' ' ILE . 40.1 mtp -17.91 -71.8 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.475 0 O-C-N 124.264 0.977 . . . . 0.0 112.157 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -42.99 -60.95 1.43 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.917 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -59.15 -37.1 76.49 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.878 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.52 -47.0 76.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 110.838 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? -75.57 -41.05 55.76 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.91 -39.26 80.96 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.724 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.35 -43.21 99.4 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.87 -38.29 90.48 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.486 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 3.9 mtp -58.32 -32.39 68.44 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.296 -0.562 . . . . 0.0 109.882 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.17 -29.06 12.66 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.249 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.1 mm? -75.15 -9.3 58.42 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.295 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.689 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -93.16 -9.42 39.43 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 23' ' ' THR . 22.0 m -131.61 -2.41 3.8 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.318 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 14.7 mp0 42.27 -91.62 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.902 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -141.36 -10.54 0.95 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.332 -178.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mp -45.64 -74.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.669 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.3 79.44 1.41 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.66 HG12 ' N ' ' A' ' 29' ' ' ASP . 58.7 t -95.51 -110.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.679 0.276 . . . . 0.0 110.458 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.66 ' N ' HG12 ' A' ' 28' ' ' VAL . 30.5 t70 55.09 60.26 3.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.519 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.579 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 67.44 -154.36 52.93 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.6 t -40.62 138.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.832 0.348 . . . . 0.0 110.731 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.09 153.43 26.94 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.229 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -130.47 134.26 46.95 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.113 0.258 . . . . 0.0 111.423 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -139.31 129.01 24.63 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.625 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.9 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.52 105.9 13.04 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 123.749 1.737 . . . . 0.0 109.42 178.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.649 HG12 ' HB ' ' B' ' 382' ' ' THR . 30.8 m -117.36 160.82 16.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 112.703 -2.044 . . . . 0.0 110.078 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -102.55 145.5 29.52 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.563 ' CD ' ' HE ' ' B' ' 339' ' ' ARG . 26.6 tt0 -132.92 149.5 52.24 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.955 0.884 . . . . 0.0 112.627 -178.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -81.83 100.76 9.76 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.425 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.603 ' SD ' ' NZ ' ' B' ' 320' ' ' LYS . 38.7 mmt -93.62 178.68 5.62 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.115 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.634 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.34 157.59 16.68 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.101 179.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 107.98 -21.74 28.94 Favored Glycine 0 C--N 1.312 -0.804 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.12 -140.21 0.16 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.45 -0.375 . . . . 0.0 110.603 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.83 -17.91 0.46 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.56 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.443 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -91.63 -176.62 4.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.966 0.412 . . . . 0.0 110.937 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . 0.497 HD11 HD21 ' A' ' 22' ' ' LEU . 34.3 mt -90.85 164.81 13.92 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.4 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' B' ' 317' ' ' GLU . 6.5 t -124.44 122.72 25.88 Favored Pre-proline 0 N--CA 1.438 -1.049 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.038 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' B' ' 326' ' ' VAL . 66.5 Cg_exo -43.9 143.89 2.81 Favored 'Trans proline' 0 C--N 1.321 -0.878 0 N-CA-C 108.196 -1.502 . . . . 0.0 108.196 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.615 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.7 ttt180 -149.71 -173.33 4.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 119.476 -0.89 . . . . 0.0 108.699 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.662 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -141.83 120.73 12.77 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.832 HD12 ' O ' ' B' ' 338' ' ' MET . 32.2 tp -98.5 158.11 15.8 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.177 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.52 108.46 0.53 Allowed Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.719 HD11 HD21 ' B' ' 330' ' ' LEU . 29.5 mm -88.1 123.04 40.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.72 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.47 138.43 51.86 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 16.0 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.191 0.307 . . . . 0.0 111.268 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.72 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -145.48 -4.76 0.68 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.482 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.42 177.14 2.26 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-O 122.368 1.08 . . . . 0.0 112.883 -176.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.608 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.1 t -132.01 145.14 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 CA-C-N 113.13 -1.85 . . . . 0.0 106.33 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.832 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.79 150.84 29.79 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 117.124 -1.831 . . . . 0.0 114.519 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.563 ' HE ' ' CD ' ' B' ' 317' ' ' GLU . 0.2 OUTLIER -96.3 106.79 19.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.496 176.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.662 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.16 149.98 4.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.244 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.1 t0 -87.87 91.6 8.82 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.736 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.36 -28.45 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.685 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' B' ' 341' ' ' ASP . 44.4 mttt -75.5 -43.9 46.62 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.69 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.557 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.76 -13.33 14.8 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -177.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 20.6 tttt 67.77 -0.87 1.83 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.942 0.401 . . . . 0.0 109.943 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.432 ' H ' ' C ' ' B' ' 344' ' ' THR . 4.1 mt-10 -86.05 152.59 22.77 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.618 HG21 ' SD ' ' B' ' 338' ' ' MET . 87.7 t -81.37 134.05 27.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.5 0.667 . . . . 0.0 112.237 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.482 HG21 HH22 ' B' ' 328' ' ' ARG . 7.4 mt -104.11 -30.69 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.186 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.474 ' O ' ' CB ' ' B' ' 338' ' ' MET . 15.6 tt0 -139.04 157.4 46.05 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.554 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -143.64 149.84 37.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.232 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.15 123.98 4.1 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.976 177.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.521 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -44.86 141.77 2.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.388 0.613 . . . . 0.0 111.661 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.6 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -85.25 -36.27 21.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -73.91 9.99 1.32 Allowed 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.908 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.574 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.1 m-20 -111.81 -7.04 14.22 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.973 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.51 HD12 HD23 ' B' ' 353' ' ' LEU . 80.1 mt -56.44 147.04 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.748 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . 0.509 ' NZ ' ' OH ' ' B' ' 373' ' ' TYR . 9.4 tttp -107.71 -46.29 3.84 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 6.0 ptt180 -172.77 135.71 0.67 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.482 ' CH2' HD12 ' B' ' 396' ' ' ILE . 10.4 p90 -119.28 175.78 5.64 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.226 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.14 100.38 1.7 Allowed 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.84 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -82.86 142.56 31.4 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.66 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.538 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -130.27 174.51 4.55 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -77.82 -8.31 16.77 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.145 1.896 . . . . 0.0 112.063 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' B' ' 382' ' ' THR . 3.2 mttp -130.33 -20.81 2.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.965 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.662 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.1 p -152.03 167.69 27.61 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.55 0.691 . . . . 0.0 111.951 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.445 ' O ' ' OG ' ' B' ' 379' ' ' SER . 0.1 OUTLIER -138.87 156.39 47.33 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.541 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.549 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.7 m -148.46 154.53 39.98 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.021 -1.072 . . . . 0.0 113.107 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.42 ' N ' ' CG2' ' B' ' 367' ' ' THR . 6.5 mt -125.61 140.0 53.11 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.336 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.9 t0 -117.36 95.61 5.04 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.892 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 29.7 t80 -137.99 95.24 3.0 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.955 176.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.77 12.38 1.96 Allowed Glycine 0 C--O 1.225 -0.419 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 10.0 t0 -41.88 -16.35 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.935 -0.633 . . . . 0.0 112.07 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.27 -38.09 65.45 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.463 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.32 -92.17 0.52 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.881 -1.509 . . . . 0.0 107.553 176.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 15.1 t0 -130.06 96.27 4.15 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.82 -3.58 54.88 Favored Glycine 0 C--N 1.303 -1.287 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.425 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.5 106.99 16.5 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -175.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -115.09 120.45 39.85 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.691 176.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.486 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.1 t -138.54 163.28 32.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.5 m -149.98 176.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.367 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -102.13 124.24 47.39 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-O 122.012 0.911 . . . . 0.0 110.829 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.662 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.55 137.19 15.17 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.929 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.15 17.69 4.89 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.23 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.18 83.64 1.74 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.973 174.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.42 -58.52 1.95 Allowed Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.449 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.3 pt-20 -44.82 -20.08 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 114.783 -0.708 . . . . 0.0 111.03 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.433 ' N ' ' C ' ' B' ' 385' ' ' GLY . 4.1 mm-40 -83.37 -38.87 21.42 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.8 mt -76.91 -41.99 32.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.623 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.95 -42.51 60.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.566 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.449 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -63.65 -34.2 77.31 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.064 0.935 . . . . 0.0 111.091 -177.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.22 -53.26 10.17 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.738 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -49.02 -55.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.485 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.13 -34.44 44.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.663 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.68 -18.01 62.63 Favored Glycine 0 CA--C 1.505 -0.56 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.675 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.65 -37.04 18.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.322 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.482 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.24 -13.34 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.909 0 CA-C-O 122.121 0.962 . . . . 0.0 109.288 176.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.36 -22.65 47.63 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.715 -1.584 . . . . 0.0 109.512 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.675 HD12 ' HA ' ' B' ' 395' ' ' TYR . 67.3 mt -92.05 -61.95 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.119 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.82 -20.11 26.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 113.394 -1.73 . . . . 0.0 112.373 -176.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.554 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.219 -0.508 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.723 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 9' ' ' ASP . 9.9 p30 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 8' ' ' ILE . 59.6 mt -72.61 10.86 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.436 0.636 . . . . 0.0 110.727 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -103.74 -31.95 9.59 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.399 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.502 ' O ' ' C ' ' A' ' 11' ' ' MET . 23.6 mt-30 -100.17 -35.16 9.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.599 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.502 ' C ' ' O ' ' A' ' 10' ' ' GLN . 24.6 mtp -18.33 -74.12 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 124.026 0.829 . . . . 0.0 112.163 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 11' ' ' MET . 10.0 m-85 -40.44 -62.51 0.76 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.118 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 10' ' ' GLN . 5.5 t -58.3 -32.85 68.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.796 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -47.15 87.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.975 0.416 . . . . 0.0 110.975 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.3 mm? -75.84 -41.25 53.01 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -41.42 93.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.586 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.27 -41.48 98.35 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -66.22 -39.61 89.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.15 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.516 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 5.9 mtp -56.61 -31.72 64.57 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.664 -0.414 . . . . 0.0 109.993 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.46 -28.55 20.69 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.15 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.529 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.1 mm? -79.72 -0.15 32.97 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.422 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.726 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -101.75 -9.91 20.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 109.726 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 23' ' ' THR . 5.2 m -123.58 -9.23 7.94 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.992 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 12.9 mp0 40.98 -95.08 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.899 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -143.52 -162.58 1.48 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.361 -178.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.518 ' N ' ' OG ' ' A' ' 25' ' ' SER . 8.4 mp -68.82 -100.53 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.507 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.57 -33.44 2.31 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.666 HG12 ' N ' ' A' ' 29' ' ' ASP . 58.7 t -147.55 -112.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 110.43 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.666 ' N ' HG12 ' A' ' 28' ' ' VAL . 20.3 t70 -98.91 -111.4 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.603 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.463 ' N ' ' CG ' ' A' ' 29' ' ' ASP . 81.6 p . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.629 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 135.8 -91.03 0.22 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.57 134.21 66.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.839 0.352 . . . . 0.0 110.765 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.87 153.18 25.8 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.082 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -129.49 135.64 48.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.452 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -138.5 129.83 27.33 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.588 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.863 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.42 101.39 10.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 123.869 1.795 . . . . 0.0 109.541 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' B' ' 328' ' ' ARG . 31.4 m -112.88 157.79 13.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 112.654 -2.066 . . . . 0.0 109.986 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -99.57 144.14 29.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' B' ' 326' ' ' VAL . 38.8 tt0 -131.14 151.34 51.56 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 122.091 0.948 . . . . 0.0 112.714 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -81.23 102.57 10.44 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.975 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 34.1 mmt -98.65 178.65 4.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.039 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.755 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -99.87 151.33 21.42 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.009 178.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 117.4 -23.13 9.87 Favored Glycine 0 C--N 1.316 -0.57 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -140.18 -146.64 0.2 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.553 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.18 -18.08 1.79 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.521 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.461 ' HD2' HG11 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -90.86 -176.67 4.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.89 0.376 . . . . 0.0 110.919 -179.451 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . 0.418 HD11 HD21 ' A' ' 22' ' ' LEU . 35.2 mt -90.52 166.25 13.33 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.213 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' B' ' 317' ' ' GLU . 11.2 t -124.4 126.73 25.43 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.859 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.445 ' O ' HG12 ' B' ' 326' ' ' VAL . 76.7 Cg_exo -43.13 142.86 2.25 Favored 'Trans proline' 0 C--N 1.321 -0.896 0 N-CA-C 107.915 -1.61 . . . . 0.0 107.915 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' B' ' 315' ' ' VAL . 2.0 tpt180 -146.7 -173.16 4.14 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -145.93 122.92 11.38 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.838 HD12 ' O ' ' B' ' 338' ' ' MET . 26.7 tp -102.5 158.39 16.25 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.421 ' N ' ' HG ' ' B' ' 330' ' ' LEU . . . -141.01 107.51 0.52 Allowed Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.761 HD11 HD21 ' B' ' 330' ' ' LEU . 31.5 mm -88.62 122.72 40.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.733 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.5 p -117.66 137.78 52.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -57.54 13.78 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.059 0.457 . . . . 0.0 111.727 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.733 ' H ' ' C ' ' B' ' 333' ' ' THR . 15.8 pt-20 -144.25 -2.69 0.87 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.839 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.83 179.05 2.08 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.318 1.056 . . . . 0.0 112.989 -177.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.612 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 15.0 t -137.13 144.33 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.111 0 CA-C-N 113.266 -1.788 . . . . 0.0 106.752 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.838 ' O ' HD12 ' B' ' 330' ' ' LEU . 4.2 ptt? -153.44 150.12 28.46 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 117.053 -1.859 . . . . 0.0 114.263 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.654 HH12 HD13 ' B' ' 330' ' ' LEU . 6.5 mmt-85 -94.9 107.19 19.22 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.665 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.63 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.53 149.7 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.275 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.1 t0 -89.92 92.18 8.9 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.765 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.58 -28.7 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.697 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 20.2 mttp -75.42 -43.6 48.98 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.705 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.556 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.39 -12.58 14.72 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' B' ' 341' ' ' ASP . 6.3 ttmm 66.76 -0.52 1.59 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.032 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.5 mt-10 -84.9 153.17 23.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.274 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.58 HG21 ' SD ' ' B' ' 338' ' ' MET . 74.2 t -83.17 134.35 27.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.481 0.658 . . . . 0.0 112.334 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 21.6 mm -102.89 -31.85 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.353 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' B' ' 338' ' ' MET . 17.1 tt0 -137.64 156.89 47.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.703 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -146.42 148.78 32.65 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.348 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.556 ' O ' ' N ' ' B' ' 337' ' ' VAL . 67.0 t-105 -163.73 135.74 4.95 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.905 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -53.87 138.25 36.71 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.344 -178.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.631 HD12 ' O ' ' B' ' 333' ' ' THR . 1.7 tt -78.26 -35.38 48.23 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -75.59 11.72 1.23 Allowed 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.999 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -115.58 -4.01 12.28 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.139 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.501 HD12 HD23 ' B' ' 353' ' ' LEU . 75.8 mt -57.7 149.39 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.097 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 10.8 tptt -107.33 -44.71 4.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.1 ptt180 -175.88 136.22 0.31 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.407 177.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.457 ' CE3' ' N ' ' B' ' 359' ' ' TRP . 9.3 p90 -118.84 174.54 6.23 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.344 -177.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.31 99.21 1.76 Allowed 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 119.233 -0.987 . . . . 0.0 112.002 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.53 144.25 31.45 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.773 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.539 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -131.9 174.27 4.9 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -77.31 -8.94 17.57 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.14 1.893 . . . . 0.0 112.102 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 17.1 mttt -130.69 -21.37 2.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.97 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.654 ' HA ' ' H ' ' B' ' 382' ' ' THR . 78.7 p -149.85 168.88 22.48 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.487 0.661 . . . . 0.0 111.938 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.503 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -141.16 156.87 45.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.796 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.549 ' CG2' HD12 ' A' ' 15' ' ' LEU . 44.8 m -147.78 156.85 43.17 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.093 -1.043 . . . . 0.0 112.913 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.466 ' N ' HG22 ' B' ' 367' ' ' THR . 5.9 mt -130.04 140.65 50.82 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.546 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.4 t0 -117.28 95.86 5.16 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.697 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.6 p90 -136.56 93.64 2.9 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.443 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.45 12.36 1.82 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . 0.401 ' CG ' ' OH ' ' B' ' 377' ' ' TYR . 8.3 t0 -41.84 -15.78 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.034 -0.583 . . . . 0.0 111.756 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.6 -37.27 65.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.478 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.89 -92.78 0.5 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.132 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.478 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.0 t70 -129.05 96.27 4.29 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.38 -3.03 55.6 Favored Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.306 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.682 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.95 106.06 16.86 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -175.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.14 125.86 51.89 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.118 -0.947 . . . . 0.0 108.736 175.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.516 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 46.6 t -138.38 163.67 31.27 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.532 0.682 . . . . 0.0 112.559 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -148.89 175.02 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.883 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.07 125.41 48.76 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.897 0.855 . . . . 0.0 111.098 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.654 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.54 136.44 14.56 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.814 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.78 16.85 4.4 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.243 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.97 84.0 1.76 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.938 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.79 -58.24 2.05 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.056 -1.217 . . . . 0.0 110.056 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.6 pt-20 -44.79 -20.69 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.811 -0.695 . . . . 0.0 110.962 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' B' ' 385' ' ' GLY . 68.9 mt-30 -82.11 -39.29 23.55 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 45.9 mt -77.05 -42.43 31.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.614 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.777 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.63 -42.38 61.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.305 -1.316 . . . . 0.0 113.569 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 5.1 pp0? -63.77 -34.91 78.96 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.1 0.952 . . . . 0.0 110.95 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.01 -53.78 10.28 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.723 -179.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -48.97 -56.06 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 176.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.41 -33.74 45.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 112.874 -1.966 . . . . 0.0 110.671 177.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.18 -17.81 62.05 Favored Glycine 0 CA--C 1.505 -0.555 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.674 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.04 -36.92 17.91 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.47 ' HA ' HD11 ' B' ' 399' ' ' ILE . 0.0 OUTLIER -68.59 -13.31 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 122.203 1.002 . . . . 0.0 109.285 176.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.6 -22.68 46.67 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.459 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 395' ' ' TYR . 69.2 mt -91.82 -62.01 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 113.894 -1.503 . . . . 0.0 112.038 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.22 -20.58 27.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 113.449 -1.705 . . . . 0.0 112.323 -177.061 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.222 -0.384 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.812 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' O ' ' A' ' 8' ' ' ILE . 76.7 mt 55.57 7.76 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.354 0.597 . . . . 0.0 110.608 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.6 OUTLIER -140.79 -35.26 0.49 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.314 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' SER . 12.5 mt-30 -101.06 -53.72 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.807 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.486 ' C ' ' O ' ' A' ' 10' ' ' GLN . 7.8 mmm -19.83 -71.4 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 124.146 0.903 . . . . 0.0 112.156 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -43.9 -58.41 2.78 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.065 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -60.77 -35.89 77.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.814 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.8 -46.26 81.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.836 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.559 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? -75.59 -38.97 58.67 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -41.19 88.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.432 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.68 -41.82 99.66 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.508 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 90.0 mt-10 -65.76 -38.94 90.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.042 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.547 ' HE2' HD13 ' A' ' 22' ' ' LEU . 9.9 mtp -55.92 -33.91 65.11 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.855 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.26 -31.3 13.78 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.398 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.54 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.4 mm? -73.37 -12.29 60.77 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.266 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.738 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -87.88 -11.66 47.07 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.602 ' N ' HD23 ' A' ' 22' ' ' LEU . 2.4 m -111.19 -17.63 13.16 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.085 0.469 . . . . 0.0 110.106 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.82 -73.77 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.189 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -169.8 -162.47 0.33 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.19 -178.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' N ' ' OG ' ' A' ' 25' ' ' SER . 5.2 mp -48.35 -44.93 34.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.707 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.13 -57.72 4.85 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.7 t -149.8 -41.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.926 0.393 . . . . 0.0 110.817 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -173.21 26.56 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.793 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.428 ' O ' ' O ' ' B' ' 319' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.563 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -82.05 -149.18 7.33 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 98.6 t -40.8 137.18 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 0.0 110.69 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.76 153.4 26.57 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.166 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -129.73 134.52 47.66 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.085 0.24 . . . . 0.0 111.475 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -139.33 128.72 24.21 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.612 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.892 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.3 105.86 12.83 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 123.733 1.73 . . . . 0.0 109.446 178.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.657 HG12 ' HB ' ' B' ' 382' ' ' THR . 29.5 m -118.34 161.95 16.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 112.709 -2.041 . . . . 0.0 110.145 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 9.4 mtpt -103.41 145.3 30.19 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.5 ' O ' ' N ' ' B' ' 326' ' ' VAL . 44.4 tt0 -135.11 151.93 51.17 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.972 0.891 . . . . 0.0 112.462 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . 0.529 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 5.7 tptm -79.21 101.1 7.79 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.475 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.676 ' N ' ' SD ' ' B' ' 319' ' ' MET . 0.0 OUTLIER -91.25 179.0 5.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.911 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.754 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.61 149.25 24.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.007 178.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.96 -25.12 9.65 Favored Glycine 0 C--N 1.313 -0.7 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -133.47 -142.58 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.45 -0.375 . . . . 0.0 110.537 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . 0.529 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.8 OUTLIER -142.61 -14.55 0.75 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.808 0.337 . . . . 0.0 110.574 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.711 ' H ' ' CD ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -94.14 -176.4 3.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.188 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 28.4 mt -92.04 160.96 14.98 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.206 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.2 t -122.58 126.97 25.98 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.018 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.448 ' O ' HG12 ' B' ' 326' ' ' VAL . 70.0 Cg_exo -43.9 144.44 2.51 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 N-CA-C 108.166 -1.513 . . . . 0.0 108.166 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' B' ' 315' ' ' VAL . 7.3 ttm-85 -151.44 -172.61 4.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.708 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -142.1 122.39 13.93 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.851 HD12 ' O ' ' B' ' 338' ' ' MET . 31.2 tp -100.41 158.58 15.8 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.43 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.32 108.3 0.52 Allowed Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.735 HD11 HD21 ' B' ' 330' ' ' LEU . 30.1 mm -88.09 123.4 40.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.724 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.83 138.51 52.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . 0.617 ' NZ ' ' CE1' ' B' ' 395' ' ' TYR . 0.4 OUTLIER -57.76 15.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.311 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.724 ' H ' ' C ' ' B' ' 333' ' ' THR . 10.9 pt-20 -144.88 -4.65 0.74 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.701 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.08 177.84 2.25 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 122.398 1.094 . . . . 0.0 112.947 -176.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.8 t -132.94 145.22 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 CA-C-N 113.113 -1.858 . . . . 0.0 106.219 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.851 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.4 ptt? -153.05 151.34 30.12 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 117.258 -1.777 . . . . 0.0 114.429 -175.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.422 HH12 HG21 ' B' ' 380' ' ' VAL . 8.7 mmt180 -96.24 106.85 19.12 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.456 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.641 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -97.07 149.7 4.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.235 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 343' ' ' LYS . 25.5 t0 -88.47 91.98 9.01 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.773 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.42 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.734 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 61.8 mttt -76.12 -44.08 40.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.756 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.551 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -108.72 -12.59 14.92 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' B' ' 341' ' ' ASP . 32.4 tttp 66.9 -0.53 1.63 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.955 0.407 . . . . 0.0 109.976 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.3 mt-10 -85.37 153.0 22.82 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.284 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.61 HG21 ' SD ' ' B' ' 338' ' ' MET . 83.4 t -81.9 133.47 29.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.524 0.678 . . . . 0.0 112.314 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 11.6 mt -103.4 -31.86 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.449 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.474 ' O ' ' CB ' ' B' ' 338' ' ' MET . 24.4 tt0 -136.6 158.48 44.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.782 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . 0.404 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 39.1 mt-10 -144.97 149.3 34.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.286 177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.562 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.88 124.74 3.94 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.151 177.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.401 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -46.59 140.37 4.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.435 0.636 . . . . 0.0 111.527 -178.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.585 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -83.74 -36.04 23.96 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . 0.462 HG23 HD22 ' B' ' 355' ' ' ASN . 5.2 t -74.18 9.82 1.48 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.913 177.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.569 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 1.0 OUTLIER -111.64 -7.98 14.24 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.052 178.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.479 HD12 HD23 ' B' ' 353' ' ' LEU . 81.4 mt -56.01 146.92 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.692 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -107.86 -46.08 3.86 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.493 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 2.2 ptt-85 -172.55 136.38 0.75 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.53 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.3 p90 -119.44 176.49 5.33 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.275 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.39 99.2 1.75 Allowed 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.041 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.97 140.15 34.15 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.68 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.531 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -128.32 174.5 4.36 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.79 -7.78 16.66 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.118 1.878 . . . . 0.0 112.193 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.1 mttp -130.91 -20.39 2.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.04 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.672 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.5 p -152.85 166.49 32.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.423 0.63 . . . . 0.0 111.931 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.48 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -137.04 156.52 48.32 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.61 179.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.559 ' CG2' HD12 ' A' ' 15' ' ' LEU . 25.3 m -148.54 154.58 39.98 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.104 -1.038 . . . . 0.0 113.091 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.0 mt -125.66 139.45 53.55 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.118 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.8 t0 -117.07 95.83 5.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.457 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 33.4 t80 -137.77 94.51 2.91 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.896 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.67 12.12 2.03 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.0 t0 -41.47 -16.0 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.035 -0.582 . . . . 0.0 111.826 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.52 -37.33 65.24 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.474 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.69 -92.84 0.5 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.474 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.3 t70 -128.88 96.34 4.33 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.11 -2.97 54.66 Favored Glycine 0 C--N 1.315 -0.629 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.243 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.671 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.07 106.4 15.69 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -175.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . 0.415 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.8 OUTLIER -113.88 120.4 40.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.598 176.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.521 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 37.3 t -138.88 164.59 29.27 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.651 0.738 . . . . 0.0 112.757 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . 0.422 HG21 HH12 ' B' ' 339' ' ' ARG . 1.0 OUTLIER -151.07 174.98 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.858 179.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -100.39 124.59 46.07 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.973 0.892 . . . . 0.0 111.024 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.672 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.82 137.69 14.42 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.824 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . 0.439 ' N ' ' OE2' ' B' ' 384' ' ' GLU . 0.8 OUTLIER -85.43 -1.2 56.79 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.972 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -123.81 84.05 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 122.096 0.95 . . . . 0.0 108.727 175.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.99 -59.54 1.86 Allowed Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.4 pt-20 -45.59 -21.04 0.08 Allowed 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 114.697 -0.752 . . . . 0.0 111.074 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.406 ' N ' ' C ' ' B' ' 385' ' ' GLY . 68.6 mt-30 -81.04 -38.62 27.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.3 mt -77.36 -41.97 30.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.588 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -74.18 -42.68 59.5 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.507 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.65 -34.59 78.19 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.991 0.9 . . . . 0.0 111.035 -177.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.94 -53.45 10.08 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.781 -179.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -48.89 -55.55 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 176.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.485 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -51.96 -34.06 40.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.764 -2.017 . . . . 0.0 110.569 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.06 -18.12 61.66 Favored Glycine 0 CA--C 1.506 -0.524 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.682 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.68 -36.88 18.47 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.53 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.29 -13.36 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 122.108 0.956 . . . . 0.0 109.189 176.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.34 -22.68 47.67 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.506 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.0 mt -91.99 -61.92 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 113.869 -1.514 . . . . 0.0 112.022 -178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.9 -20.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 113.415 -1.721 . . . . 0.0 112.311 -176.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.557 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.221 -0.437 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.775 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.445 HG21 ' SD ' ' A' ' 11' ' ' MET . 3.7 mt -96.07 152.55 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.11 0.481 . . . . 0.0 110.626 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -171.38 -36.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.076 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 13' ' ' SER . 38.4 mt-30 -72.72 -54.33 9.25 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.787 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.483 ' C ' ' O ' ' A' ' 10' ' ' GLN . 49.3 mtp -20.07 -70.13 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 124.238 0.961 . . . . 0.0 112.044 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -42.95 -59.89 1.83 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.006 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -60.53 -37.33 80.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.899 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.74 -46.02 77.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.552 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? -75.65 -39.93 56.92 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -40.98 86.32 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.8 -41.63 99.65 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.513 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.1 mt-10 -65.8 -38.21 88.37 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.522 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 8.2 mtp -57.71 -33.58 68.55 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.962 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.54 -29.42 10.62 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.365 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.541 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.4 mm? -76.34 -9.18 58.45 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.399 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.738 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -91.82 -10.7 38.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.007 0.432 . . . . 0.0 110.027 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.529 ' N ' HD23 ' A' ' 22' ' ' LEU . 2.9 m -115.78 -15.36 11.31 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.085 0.469 . . . . 0.0 110.25 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -49.64 -74.05 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.264 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -178.0 -45.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.268 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 26' ' ' LEU . 8.6 mp -62.27 -98.89 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.515 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 46.66 91.57 0.01 OUTLIER Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.669 HG12 ' N ' ' A' ' 29' ' ' ASP . 91.1 t -78.53 -107.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.752 0.311 . . . . 0.0 110.469 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.669 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.6 OUTLIER 55.52 95.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.598 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.466 ' CB ' ' O ' ' A' ' 29' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.575 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 135.96 -73.4 0.44 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 77.8 t -130.12 133.5 64.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.784 0.326 . . . . 0.0 110.835 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.13 153.4 23.21 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.132 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -128.14 135.29 49.57 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -140.06 128.79 23.14 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.598 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.907 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.86 107.45 13.68 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 123.728 1.728 . . . . 0.0 109.349 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.65 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.0 m -119.88 159.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 112.647 -2.07 . . . . 0.0 110.066 -177.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -100.79 145.05 29.01 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' B' ' 326' ' ' VAL . 47.1 tt0 -131.67 150.96 51.97 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.995 0.903 . . . . 0.0 112.617 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -80.17 101.51 8.86 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.308 -1.315 . . . . 0.0 111.256 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 35.0 mmt -97.6 178.67 5.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.169 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.634 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.0 157.88 16.42 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.85 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 109.96 -22.61 23.1 Favored Glycine 0 C--N 1.309 -0.971 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -136.64 -138.69 0.15 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.347 -0.426 . . . . 0.0 110.605 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.79 -16.35 0.47 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.631 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -94.21 -174.46 3.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.924 0.392 . . . . 0.0 110.947 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . 0.445 HD11 HD21 ' A' ' 22' ' ' LEU . 32.1 mt -91.93 162.56 14.36 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.25 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.506 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.0 t -122.24 126.6 26.19 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.055 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.434 ' O ' HG12 ' B' ' 326' ' ' VAL . 67.0 Cg_exo -44.33 143.74 3.45 Favored 'Trans proline' 0 C--N 1.32 -0.951 0 N-CA-C 108.093 -1.541 . . . . 0.0 108.093 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.631 ' N ' ' O ' ' B' ' 315' ' ' VAL . 0.3 OUTLIER -149.99 -172.92 4.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.438 -0.905 . . . . 0.0 108.759 -177.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.646 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -142.31 122.05 13.45 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.84 HD12 ' O ' ' B' ' 338' ' ' MET . 30.3 tp -100.37 158.3 15.99 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.118 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.434 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.94 108.11 0.52 Allowed Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.74 HD11 HD21 ' B' ' 330' ' ' LEU . 30.4 mm -87.99 121.63 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.72 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.3 p -115.83 138.62 50.97 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -57.92 14.95 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.364 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.72 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.4 pt-20 -145.14 -3.79 0.74 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.476 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.5 178.42 1.97 Allowed 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.343 1.068 . . . . 0.0 112.993 -176.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.7 t -134.38 145.0 33.57 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 113.147 -1.842 . . . . 0.0 106.308 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.84 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.5 ptt? -152.8 151.99 31.09 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 117.145 -1.822 . . . . 0.0 114.546 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.787 HH12 HD13 ' B' ' 330' ' ' LEU . 6.5 mmt-85 -96.28 107.36 19.7 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.466 176.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.646 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.06 149.8 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.219 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' B' ' 343' ' ' LYS . 0.3 OUTLIER -87.94 92.0 8.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.859 -178.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -36.55 -27.34 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.637 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' B' ' 341' ' ' ASP . 54.3 mttt -74.79 -42.61 57.79 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.731 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 341' ' ' ASP . 64.5 p -112.0 -16.91 12.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . 0.421 ' CB ' ' O ' ' B' ' 344' ' ' THR . 5.8 ttmm 73.73 1.8 4.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.94 0.4 . . . . 0.0 110.174 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.468 ' O ' HG13 ' B' ' 340' ' ' VAL . 5.5 pt-20 -86.52 158.65 19.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.617 HG21 ' SD ' ' B' ' 338' ' ' MET . 89.4 t -88.4 132.78 32.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.567 0.698 . . . . 0.0 112.36 -178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -103.21 -31.34 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.241 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.0 tt0 -136.74 157.5 46.61 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.601 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -144.25 149.65 36.67 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.003 -0.998 . . . . 0.0 111.215 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.61 124.52 4.02 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.125 177.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.501 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -46.73 140.47 4.53 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.358 0.599 . . . . 0.0 111.511 -178.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.591 HD12 ' O ' ' B' ' 333' ' ' THR . 1.9 tt -83.79 -35.74 24.09 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.6 t -74.52 10.22 1.43 Allowed 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.506 -1.225 . . . . 0.0 109.909 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.573 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.8 m-20 -112.11 -7.63 14.06 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.004 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.481 HD12 HD23 ' B' ' 353' ' ' LEU . 80.8 mt -55.98 147.4 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.775 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.77 -45.44 4.01 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.7 ptt-85 -173.9 135.93 0.51 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.466 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.8 p90 -118.74 176.54 5.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.206 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.43 99.42 1.6 Allowed 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.887 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.783 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.21 147.22 30.09 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.699 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.529 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -135.63 173.87 5.2 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -77.35 -8.36 17.31 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.113 1.875 . . . . 0.0 112.15 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' B' ' 382' ' ' THR . 3.9 mttp -130.66 -20.55 2.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.977 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.646 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.6 p -152.69 167.29 29.43 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.59 0.71 . . . . 0.0 111.993 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.467 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -138.81 156.92 46.94 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.638 179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.552 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.3 m -148.53 155.73 41.52 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.041 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.436 ' N ' HG22 ' B' ' 367' ' ' THR . 6.8 mt -126.29 139.73 53.08 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.375 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.1 t0 -116.96 95.75 5.15 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.68 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 32.6 t80 -138.1 94.87 2.93 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.971 176.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.12 12.04 1.94 Allowed Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.4 t0 -41.79 -16.37 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.044 -0.578 . . . . 0.0 111.778 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.0 m-85 -54.33 -37.27 64.67 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.466 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.98 -92.37 0.51 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.335 176.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.466 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.7 t70 -129.78 96.28 4.19 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 174.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.15 -3.52 54.27 Favored Glycine 0 C--N 1.31 -0.872 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.313 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.25 106.33 15.79 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -175.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -114.06 120.43 40.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.703 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.522 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 34.5 t -138.43 163.67 31.32 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.674 0.75 . . . . 0.0 112.952 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -150.42 175.56 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.199 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -101.23 125.06 47.82 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.968 0.89 . . . . 0.0 110.899 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.65 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -155.08 136.23 13.92 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.878 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.09 17.07 4.44 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.177 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -144.13 83.69 1.74 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.044 174.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.25 -57.72 2.08 Favored Glycine 0 C--N 1.317 -0.51 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.451 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.5 pt-20 -45.26 -20.27 0.05 Allowed 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 114.898 -0.651 . . . . 0.0 110.991 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.425 ' N ' ' C ' ' B' ' 385' ' ' GLY . 6.7 mm-40 -83.36 -38.55 21.87 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.0 mt -77.23 -41.89 30.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.538 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.783 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.88 -42.46 60.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.344 -1.298 . . . . 0.0 113.509 -177.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.451 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -64.08 -34.14 77.37 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.051 0.929 . . . . 0.0 111.022 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.07 -53.43 9.98 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 113.898 -1.501 . . . . 0.0 108.725 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -49.16 -55.55 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.487 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -51.89 -34.15 39.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 112.756 -2.02 . . . . 0.0 110.69 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.8 -18.11 62.19 Favored Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.682 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.5 m-30 -86.66 -36.98 18.43 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.467 ' HA ' HD11 ' B' ' 399' ' ' ILE . 0.0 OUTLIER -68.12 -13.29 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 CA-C-O 122.114 0.959 . . . . 0.0 109.282 176.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.67 -22.77 46.29 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.519 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' B' ' 395' ' ' TYR . 69.3 mt -91.9 -61.75 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.052 -178.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.97 -20.34 27.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 113.458 -1.701 . . . . 0.0 112.329 -176.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.557 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.463 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.767 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.48 ' O ' ' SD ' ' A' ' 11' ' ' MET . 10.0 p-10 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.569 ' CG1' ' H ' ' A' ' 9' ' ' ASP . 0.9 OUTLIER -155.8 -166.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.532 179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.569 ' H ' ' CG1' ' A' ' 8' ' ' ILE . 6.7 t70 68.89 -54.16 0.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.951 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 13' ' ' SER . 8.9 mt-30 -74.19 -56.35 5.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.614 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.492 ' C ' ' O ' ' A' ' 10' ' ' GLN . 48.5 mtp -20.54 -70.87 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 O-C-N 124.183 0.927 . . . . 0.0 111.941 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' MET . 16.9 m-85 -38.88 -57.1 1.28 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.227 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -68.41 -36.16 78.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.705 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.75 -24.99 66.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.095 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.545 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? -98.14 -38.42 9.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -40.56 91.27 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.92 -38.19 95.61 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.508 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 91.4 mt-10 -69.74 -37.87 76.64 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.5 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 9.0 mtp -58.34 -32.36 68.45 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.921 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 0.2 OUTLIER -52.01 -27.3 13.07 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.418 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.492 ' N ' HD22 ' A' ' 21' ' ' LEU . 4.2 mm? -77.44 -11.16 59.81 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.437 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.738 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -86.04 -9.42 56.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.14 0.495 . . . . 0.0 109.901 179.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.619 HG21 ' H ' ' A' ' 28' ' ' VAL . 1.3 m -120.25 -42.77 2.55 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.114 0.483 . . . . 0.0 110.737 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 26' ' ' LEU . 1.4 tt0 47.53 -178.23 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.714 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 26' ' ' LEU . 1.5 t 37.44 -90.13 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.219 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 24' ' ' GLN . 4.5 mm? -42.68 -34.89 0.98 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.527 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 40.56 71.9 0.27 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.619 ' H ' HG21 ' A' ' 23' ' ' THR . 92.5 t -69.76 -2.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.339 . . . . 0.0 110.565 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.65 22.18 3.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.402 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.431 ' HG1' ' CG ' ' A' ' 20' ' ' ASP . 1.8 m . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.57 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . 0.409 ' O ' ' N ' ' B' ' 310' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 68.22 -65.61 0.38 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' B' ' 308' ' ' TYR . 74.0 t -126.56 133.45 68.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.735 0.302 . . . . 0.0 110.755 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.59 153.25 24.44 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -129.72 135.68 48.76 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.058 0.224 . . . . 0.0 111.434 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -139.2 129.49 25.47 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.648 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.873 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.37 104.45 12.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.933 1.825 . . . . 0.0 109.403 178.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.645 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.6 m -115.6 160.93 14.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 112.583 -2.099 . . . . 0.0 110.101 -176.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -103.89 144.49 31.43 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' B' ' 326' ' ' VAL . 27.1 tt0 -132.66 152.77 51.59 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.088 0.947 . . . . 0.0 112.767 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -81.37 103.25 10.99 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.891 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.4 ' HE3' ' OE2' ' B' ' 317' ' ' GLU . 33.7 mmt -99.71 178.78 4.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.118 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.748 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -99.77 150.38 22.39 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.238 178.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 118.22 -23.84 9.0 Favored Glycine 0 C--N 1.315 -0.607 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -139.0 -142.82 0.16 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.265 -0.467 . . . . 0.0 110.59 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.25 -20.32 0.96 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.428 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.528 ' HD2' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -88.99 -176.85 5.3 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 110.92 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 31.6 mt -89.77 165.24 14.28 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.147 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' B' ' 317' ' ' GLU . 9.4 t -123.67 126.21 25.81 Favored Pre-proline 0 N--CA 1.439 -0.993 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.056 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.47 ' O ' HG12 ' B' ' 326' ' ' VAL . 65.5 Cg_exo -44.49 145.32 2.63 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 N-CA-C 108.121 -1.53 . . . . 0.0 108.121 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.645 ' N ' ' O ' ' B' ' 315' ' ' VAL . 9.9 ttm-85 -150.13 -173.21 4.37 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.643 -0.823 . . . . 0.0 108.787 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.64 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -143.89 122.1 12.24 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.839 HD12 ' O ' ' B' ' 338' ' ' MET . 26.2 tp -101.34 158.01 16.36 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.432 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.53 107.51 0.51 Allowed Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.708 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -88.22 124.0 41.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.725 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.6 p -118.23 137.74 52.81 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -56.93 12.8 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.908 0.385 . . . . 0.0 111.724 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.725 ' H ' ' C ' ' B' ' 333' ' ' THR . 10.8 pt-20 -144.06 -2.49 0.9 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.712 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.2 OUTLIER -174.03 -179.28 1.66 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.357 1.075 . . . . 0.0 113.372 -177.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.597 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.6 t -137.95 144.84 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.106 0 CA-C-N 113.257 -1.792 . . . . 0.0 107.036 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.839 ' O ' HD12 ' B' ' 330' ' ' LEU . 5.8 ptp -153.03 151.33 30.13 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 117.178 -1.809 . . . . 0.0 114.347 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.51 ' NH1' ' OE2' ' B' ' 317' ' ' GLU . 38.8 mtm180 -96.15 107.67 20.02 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.539 176.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.64 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.76 149.03 5.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.43 -178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' B' ' 344' ' ' THR . 44.6 t0 -88.75 90.5 8.43 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.962 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.79 -28.39 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.66 179.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.3 mttp -68.99 -43.98 73.77 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.441 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.546 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -115.73 -16.39 11.24 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' B' ' 344' ' ' THR . 2.7 tttp 77.11 -0.75 2.89 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.013 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.455 ' O ' HG13 ' B' ' 340' ' ' VAL . 8.7 pt-20 -80.12 158.01 26.49 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.509 HG22 HG22 ' B' ' 340' ' ' VAL . 86.4 t -88.64 133.77 30.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.432 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 61.0 mt -102.18 -29.36 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.3 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.447 ' O ' ' CB ' ' B' ' 338' ' ' MET . 17.6 tt0 -143.46 157.89 44.09 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.938 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . 0.408 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 36.3 mt-10 -146.13 149.45 34.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.996 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.576 ' O ' ' N ' ' B' ' 337' ' ' VAL . 70.1 t-105 -161.14 136.78 7.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.994 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.71 137.95 48.5 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.515 0.674 . . . . 0.0 111.554 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.627 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -78.66 -35.38 45.36 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . 0.473 ' C ' HD22 ' B' ' 355' ' ' ASN . 4.9 t -75.37 11.22 1.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.874 177.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.473 HD22 ' C ' ' B' ' 354' ' ' THR . 0.9 OUTLIER -115.08 -3.71 12.57 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.289 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.499 HD12 HD23 ' B' ' 353' ' ' LEU . 75.6 mt -58.71 148.92 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.854 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 6.9 tttp -106.96 -45.36 4.18 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.492 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 1.7 ptt180 -174.84 136.41 0.41 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.993 -1.003 . . . . 0.0 108.518 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.492 ' CH2' HD12 ' B' ' 396' ' ' ILE . 6.8 p90 -118.71 175.46 5.73 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.246 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.34 97.7 1.65 Allowed 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 119.348 -0.941 . . . . 0.0 111.909 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.795 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.81 142.29 33.85 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.785 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.519 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -129.91 174.08 5.02 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -77.43 -8.47 17.26 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.156 1.904 . . . . 0.0 112.121 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' B' ' 382' ' ' THR . 20.3 mtpt -130.66 -21.84 2.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.855 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.653 ' HA ' ' H ' ' B' ' 382' ' ' THR . 86.3 p -149.81 169.74 20.39 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.507 0.67 . . . . 0.0 111.743 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.499 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -142.35 156.43 45.23 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.885 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.545 ' CG2' HD12 ' A' ' 15' ' ' LEU . 44.0 m -147.77 156.76 43.08 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.711 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.468 ' N ' HG22 ' B' ' 367' ' ' THR . 5.7 mt -129.92 142.45 50.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.495 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.2 t0 -119.14 95.64 4.9 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.743 176.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.525 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 12.6 p90 -136.07 93.43 2.91 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.235 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.95 11.7 1.8 Allowed Glycine 0 N--CA 1.462 0.391 0 N-CA-C 110.966 -0.853 . . . . 0.0 110.966 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -41.74 -15.53 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.21 -0.495 . . . . 0.0 111.856 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.9 -36.55 65.3 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.495 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.06 -93.25 0.49 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.495 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.8 t0 -129.01 96.43 4.34 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.8 -1.81 55.17 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.315 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.31 105.96 17.04 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -175.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.96 125.77 51.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.645 176.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.5 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.8 t -138.19 164.12 30.0 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.575 0.702 . . . . 0.0 112.458 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -150.39 174.08 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.867 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -100.92 126.17 47.54 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.954 0.883 . . . . 0.0 111.072 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.653 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.93 136.49 14.26 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.404 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.02 16.66 4.77 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.481 -0.888 . . . . 0.0 111.142 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.55 84.33 1.8 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.119 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.88 -59.15 1.91 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.504 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 15.4 pt-20 -44.17 -20.72 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.625 -0.787 . . . . 0.0 111.029 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 5.0 mm-40 -82.85 -38.7 22.64 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 47.1 mt -77.23 -42.38 31.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.526 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.795 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.41 -42.9 61.5 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.026 -1.443 . . . . 0.0 113.676 -177.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.504 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.54 -34.81 78.61 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 122.093 0.949 . . . . 0.0 110.892 -177.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.06 -53.89 9.94 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 113.771 -1.559 . . . . 0.0 108.713 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.9 mt -48.83 -55.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.482 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.62 -33.75 48.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.742 -2.026 . . . . 0.0 110.639 178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.13 -17.93 61.89 Favored Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.676 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.1 -36.66 17.98 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.492 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.8 -13.2 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 122.178 0.99 . . . . 0.0 109.264 176.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -22.61 46.45 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.724 -1.58 . . . . 0.0 109.503 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.4 mt -91.63 -62.07 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 113.899 -1.5 . . . . 0.0 112.067 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.21 -20.69 27.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 113.416 -1.72 . . . . 0.0 112.437 -177.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.565 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.487 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.89 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.589 ' N ' ' SD ' ' A' ' 11' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 8' ' ' ILE . 58.3 mt 52.33 11.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.211 0.529 . . . . 0.0 110.667 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.449 ' N ' ' C ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -124.73 -33.13 3.01 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.49 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.473 ' O ' ' C ' ' A' ' 11' ' ' MET . 78.6 mt-30 -126.72 -36.14 2.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.63 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' A' ' 7' ' ' ASP . 20.3 mtm -22.73 -70.9 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 123.981 0.801 . . . . 0.0 112.049 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 11' ' ' MET . 10.9 m-85 -36.48 -56.16 0.81 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.146 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 10' ' ' GLN . 2.0 t -69.82 -28.71 65.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.912 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 11' ' ' MET . 0.2 OUTLIER -72.54 -17.37 61.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -179.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.591 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.6 mm? -110.69 -41.31 4.33 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 16' ' ' LEU . 59.1 mt -61.01 -41.22 96.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.569 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.39 -37.91 93.91 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -69.84 -39.3 76.5 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.525 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 4.4 mtp -56.56 -31.75 64.49 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.369 -0.532 . . . . 0.0 109.959 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.4 -27.8 17.25 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.329 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.54 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.1 mm? -75.95 -9.02 58.27 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.251 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -93.05 -9.06 41.03 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.244 0.545 . . . . 0.0 109.8 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 23' ' ' THR . 21.3 m -133.71 -3.17 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.044 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.54 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 12.1 mp0 39.85 -92.18 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.933 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -142.14 -7.86 0.91 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.299 -178.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' B' ' 323' ' ' ASN . 5.4 mp -40.33 -84.49 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.647 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.08 -95.52 0.12 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.646 HG12 ' N ' ' A' ' 29' ' ' ASP . 47.4 t -142.83 -113.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.694 0.283 . . . . 0.0 110.452 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.646 ' N ' HG12 ' A' ' 28' ' ' VAL . 8.2 t70 -97.16 44.79 1.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.624 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.534 -179.979 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' B' ' 309' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' B' ' 308' ' ' TYR . . . 43.31 -168.52 0.01 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 97.2 t -41.6 137.62 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.753 0.311 . . . . 0.0 110.809 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.27 152.91 29.25 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.138 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -130.58 134.3 46.89 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 122.994 0.184 . . . . 0.0 111.413 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -137.59 130.14 29.73 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.565 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.874 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -83.98 101.78 11.98 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 123.965 1.84 . . . . 0.0 109.309 178.189 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.662 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.7 m -112.16 161.93 10.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 112.645 -2.071 . . . . 0.0 110.175 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -105.04 145.97 29.74 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' B' ' 326' ' ' VAL . 24.4 tt0 -133.62 151.43 51.68 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 122.037 0.922 . . . . 0.0 112.665 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -81.82 101.77 10.39 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.176 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 33.6 mmt -98.76 178.62 4.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.029 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.648 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.43 158.16 16.27 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.733 178.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 110.88 -22.95 20.58 Favored Glycine 0 C--N 1.308 -0.988 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -136.51 -139.65 0.16 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.255 -0.472 . . . . 0.0 110.634 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . 0.544 ' HB3' HD21 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -143.98 -18.4 0.58 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.473 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.536 ' HD2' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -93.82 -176.52 4.07 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.031 0.443 . . . . 0.0 110.968 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . 0.454 HD11 HD21 ' A' ' 22' ' ' LEU . 30.7 mt -87.87 165.6 15.16 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.174 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.6 t -124.21 124.12 25.91 Favored Pre-proline 0 N--CA 1.439 -1.019 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.887 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.429 ' O ' HG12 ' B' ' 326' ' ' VAL . 66.2 Cg_exo -44.58 145.62 2.57 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 N-CA-C 107.956 -1.594 . . . . 0.0 107.956 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.662 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.8 ttt180 -149.91 -174.1 4.61 Favored 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.725 -177.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.35 123.44 12.87 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.081 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.831 HD12 ' O ' ' B' ' 338' ' ' MET . 26.7 tp -102.13 159.03 15.74 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.442 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.07 108.07 0.52 Allowed Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.746 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -89.04 123.7 41.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.726 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.48 138.1 52.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.63 13.84 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.114 0.483 . . . . 0.0 111.793 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.726 ' H ' ' C ' ' B' ' 333' ' ' THR . 8.9 pt-20 -144.4 -3.16 0.84 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.868 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.88 178.52 2.17 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 122.272 1.034 . . . . 0.0 113.003 -177.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.5 t -135.79 145.96 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-N 113.4 -1.727 . . . . 0.0 106.573 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.831 ' O ' HD12 ' B' ' 330' ' ' LEU . 2.2 ptt? -153.93 150.31 28.2 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 117.044 -1.863 . . . . 0.0 114.262 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.553 ' NH2' HG21 ' B' ' 315' ' ' VAL . 3.2 mtp85 -94.89 107.6 19.63 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.669 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.11 149.94 5.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.371 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' B' ' 344' ' ' THR . 3.2 t70 -90.46 92.62 8.96 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.755 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.7 OUTLIER -35.87 -28.76 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.626 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' B' ' 341' ' ' ASP . 41.9 mttt -73.2 -43.49 61.23 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.691 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.7 p -111.43 -12.82 13.96 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt 67.63 -0.85 1.79 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 109.999 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.3 mt-10 -84.55 151.97 24.2 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.311 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.626 HG21 ' SD ' ' B' ' 338' ' ' MET . 77.7 t -82.94 135.28 25.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 121.526 0.679 . . . . 0.0 112.308 -178.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.641 HD12 ' NH2' ' B' ' 328' ' ' ARG . 70.9 mt -103.82 -30.99 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.438 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.466 ' O ' ' CB ' ' B' ' 338' ' ' MET . 7.2 tt0 -138.85 156.04 47.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.584 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -145.51 149.6 34.92 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.336 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.552 ' O ' ' N ' ' B' ' 337' ' ' VAL . 64.1 t-105 -161.83 134.95 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.838 177.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.508 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.52 138.77 27.06 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.477 -178.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.622 HD12 ' O ' ' B' ' 333' ' ' THR . 1.8 tt -79.08 -35.74 41.95 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 4.7 t -74.86 11.24 1.12 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.895 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.508 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.5 m-20 -114.75 -4.16 12.74 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.14 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.484 HD12 HD23 ' B' ' 353' ' ' LEU . 73.5 mt -57.86 147.97 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.088 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 8.1 tttp -105.9 -45.48 4.36 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.8 ptt180 -174.69 136.4 0.43 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.462 177.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.467 ' CH2' HD12 ' B' ' 396' ' ' ILE . 10.1 p90 -119.45 173.14 7.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.174 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.0 99.11 1.8 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.086 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.16 148.6 30.85 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.627 -1.169 . . . . 0.0 110.951 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -136.69 173.43 5.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -76.82 -8.81 18.12 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.122 1.882 . . . . 0.0 112.073 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' B' ' 382' ' ' THR . 12.6 mtpp -130.68 -21.64 2.76 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.968 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.659 ' HA ' ' H ' ' B' ' 382' ' ' THR . 89.8 p -150.35 169.23 21.91 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 121.606 0.717 . . . . 0.0 111.852 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.506 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -141.78 156.88 45.56 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.888 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.591 ' CG2' HD12 ' A' ' 15' ' ' LEU . 34.2 m -148.06 156.68 42.91 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.091 -1.043 . . . . 0.0 112.809 -174.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.459 ' N ' HG22 ' B' ' 367' ' ' THR . 6.0 mt -129.21 144.51 51.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.567 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 22.2 t0 -120.51 95.82 4.88 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.837 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.0 p90 -136.71 93.71 2.9 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.369 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.81 12.51 1.72 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -41.9 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.159 -0.521 . . . . 0.0 111.719 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.62 -37.32 65.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.476 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.77 -92.8 0.5 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.934 -1.484 . . . . 0.0 107.097 176.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.476 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.6 t70 -129.12 96.34 4.3 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.24 -2.81 55.75 Favored Glycine 0 C--N 1.312 -0.75 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.217 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.686 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.96 106.3 17.04 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -175.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.81 125.57 51.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.747 175.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.525 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.9 t -138.49 162.63 34.03 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.482 0.658 . . . . 0.0 112.646 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.05 172.6 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.022 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -99.23 126.3 45.01 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.886 0.851 . . . . 0.0 111.074 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.659 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.02 135.97 13.76 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.698 179.265 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.57 17.95 3.6 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.178 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.05 83.89 1.76 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.049 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.91 -59.34 1.89 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.9 pt-20 -45.01 -19.85 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 114.754 -0.723 . . . . 0.0 111.016 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.436 ' N ' ' C ' ' B' ' 385' ' ' GLY . 24.3 mt-30 -82.96 -39.56 21.23 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' B' ' 385' ' ' GLY . 40.6 mt -76.95 -41.86 32.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.731 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -74.11 -41.97 60.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.651 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.438 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -63.93 -34.77 78.71 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.059 0.933 . . . . 0.0 111.023 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.656 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.92 -53.82 10.31 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 113.787 -1.551 . . . . 0.0 108.813 -179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.656 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.11 -55.98 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.476 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.42 -33.74 45.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 112.781 -2.009 . . . . 0.0 110.663 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.19 -17.79 62.07 Favored Glycine 0 CA--C 1.506 -0.469 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.676 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.11 -37.0 17.78 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.467 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.6 -13.27 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-O 122.187 0.994 . . . . 0.0 109.281 176.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.64 -22.67 46.54 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.473 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.4 mt -91.76 -62.07 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-N 113.897 -1.502 . . . . 0.0 112.035 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.3 -20.51 27.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.396 -177.075 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.877 -1.059 . . . . 0.0 110.797 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.623 HG22 ' O ' ' A' ' 8' ' ' ILE . 61.1 mt -78.78 10.37 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.325 0.583 . . . . 0.0 110.739 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.81 -32.28 8.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.315 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 11' ' ' MET . 23.5 mt-30 -101.06 -35.11 9.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.546 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.487 ' C ' ' O ' ' A' ' 10' ' ' GLN . 6.1 mmm -18.97 -72.59 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 124.153 0.908 . . . . 0.0 112.146 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -42.76 -62.63 0.95 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.968 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 10' ' ' GLN . 6.4 t -56.6 -35.4 68.22 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.811 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -47.94 79.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.031 0.444 . . . . 0.0 110.773 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.546 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.3 mm? -76.49 -41.56 46.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -38.61 77.23 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.513 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.32 97.99 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 89.1 mt-10 -63.67 -36.42 83.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.512 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 4.7 mtp -61.82 -31.88 72.16 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.883 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.63 -28.78 15.4 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.23 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -75.12 -9.41 58.51 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.311 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.684 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -93.18 -8.88 41.18 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.119 0.485 . . . . 0.0 109.82 179.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 23' ' ' THR . 24.4 m -131.95 -1.52 3.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.803 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 14.9 mp0 41.58 -91.21 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.894 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -140.71 -11.18 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.417 -178.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tp -47.02 -36.49 7.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.757 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 41.29 80.43 0.04 OUTLIER Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.505 HG23 ' H ' ' A' ' 29' ' ' ASP . 3.8 m -88.94 -109.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.724 0.297 . . . . 0.0 110.444 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.505 ' H ' HG23 ' A' ' 28' ' ' VAL . 4.8 t70 51.41 81.38 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.659 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.578 -179.922 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' B' ' 309' ' ' GLY . 1.7 p90 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 308' ' ' TYR . . . -60.21 -135.53 0.01 OUTLIER Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.5 t -40.8 137.14 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.718 0.294 . . . . 0.0 110.805 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.47 153.19 27.78 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.192 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -130.09 134.39 47.33 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 123.059 0.224 . . . . 0.0 111.465 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -138.74 129.02 25.68 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.499 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.878 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.23 105.05 13.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 123.834 1.778 . . . . 0.0 109.446 178.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.631 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.6 m -115.79 160.92 14.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 112.596 -2.093 . . . . 0.0 110.1 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -103.52 145.67 29.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' B' ' 326' ' ' VAL . 25.3 tt0 -132.46 150.64 52.12 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 122.071 0.938 . . . . 0.0 112.601 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . 0.435 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 6.2 tptm -82.37 101.45 10.61 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.205 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.601 ' SD ' ' NZ ' ' B' ' 320' ' ' LYS . 38.3 mmt -94.91 179.09 5.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.173 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.635 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.48 157.92 16.45 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.89 179.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 108.51 -21.88 27.52 Favored Glycine 0 C--N 1.308 -0.984 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 -141.66 0.16 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.561 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . 0.435 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.7 OUTLIER -143.57 -18.86 0.61 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.482 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.439 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -90.07 -176.52 4.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.976 0.417 . . . . 0.0 110.911 -179.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . 0.468 HD11 HD21 ' A' ' 22' ' ' LEU . 31.7 mt -91.85 165.02 13.46 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.219 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' B' ' 317' ' ' GLU . 5.2 t -123.88 123.71 26.16 Favored Pre-proline 0 N--CA 1.44 -0.953 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.909 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.423 ' O ' HG12 ' B' ' 326' ' ' VAL . 63.1 Cg_exo -44.27 145.18 2.49 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 N-CA-C 108.107 -1.536 . . . . 0.0 108.107 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.631 ' N ' ' O ' ' B' ' 315' ' ' VAL . 10.6 ttm-85 -149.96 -173.5 4.45 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 119.498 -0.881 . . . . 0.0 108.658 -177.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.637 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.4 121.7 12.29 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.83 HD12 ' O ' ' B' ' 338' ' ' MET . 28.0 tp -100.15 158.31 15.95 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.44 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.81 108.38 0.54 Allowed Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.725 HD11 HD21 ' B' ' 330' ' ' LEU . 31.0 mm -88.75 124.61 41.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.723 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.94 138.13 53.0 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . 0.41 ' NZ ' ' CZ ' ' B' ' 395' ' ' TYR . 0.0 OUTLIER -57.34 14.71 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.74 0.305 . . . . 0.0 111.301 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -145.15 -3.66 0.75 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.497 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.81 179.98 1.88 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.287 1.041 . . . . 0.0 113.073 -176.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.67 146.53 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 CA-C-N 113.293 -1.776 . . . . 0.0 106.493 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.83 ' O ' HD12 ' B' ' 330' ' ' LEU . 2.0 ptt? -154.56 150.33 27.64 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 117.086 -1.845 . . . . 0.0 114.303 -176.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.658 HH21 ' NE2' ' B' ' 349' ' ' GLN . 18.3 mtt-85 -95.12 107.94 20.03 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.561 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.6 149.74 5.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.259 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' B' ' 344' ' ' THR . 24.7 t0 -88.97 91.91 9.02 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.724 -178.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 1.0 OUTLIER -35.38 -28.63 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.692 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 341' ' ' ASP . 32.9 mttt -75.64 -43.81 45.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.749 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.554 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -108.9 -12.64 14.86 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -177.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' B' ' 341' ' ' ASP . 13.3 ttmt 66.81 -0.29 1.68 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.017 0.436 . . . . 0.0 109.994 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.5 mt-10 -85.45 153.59 22.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.314 178.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.602 HG21 ' SD ' ' B' ' 338' ' ' MET . 81.6 t -83.4 134.31 27.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-O 121.493 0.663 . . . . 0.0 112.363 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 66.4 mt -102.72 -30.15 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.335 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.658 ' NE2' HH21 ' B' ' 339' ' ' ARG . 38.5 tt0 -140.41 156.84 46.25 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.627 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -145.27 149.7 35.34 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.387 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.577 ' O ' ' N ' ' B' ' 337' ' ' VAL . 70.9 t-105 -160.93 135.37 7.23 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.696 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.4 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -54.84 138.53 42.54 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.461 0.648 . . . . 0.0 111.492 -178.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.638 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -78.57 -35.58 45.7 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 177.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . 0.556 ' O ' HG22 ' B' ' 354' ' ' THR . 21.8 m -73.68 8.81 1.69 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.882 177.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.434 HD22 ' C ' ' B' ' 354' ' ' THR . 0.9 OUTLIER -112.75 -2.35 14.48 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.147 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.525 HD12 HD23 ' B' ' 353' ' ' LEU . 68.0 mt -61.32 146.82 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.211 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . 0.48 ' HZ2' ' HB3' ' B' ' 372' ' ' ASP . 4.9 tttt -106.62 -45.24 4.28 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 0.1 OUTLIER -174.88 136.08 0.39 Allowed 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.497 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.1 p90 -119.72 175.33 5.92 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.212 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.62 99.99 1.6 Allowed 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 119.239 -0.984 . . . . 0.0 112.057 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.761 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.09 143.81 32.17 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.752 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.544 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -131.0 174.05 5.15 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -77.11 -9.05 17.84 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.043 1.829 . . . . 0.0 112.036 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.0 mttt -130.79 -21.1 2.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.972 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.664 ' HA ' ' H ' ' B' ' 382' ' ' THR . 78.6 p -149.81 169.54 20.86 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.513 0.673 . . . . 0.0 111.866 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.49 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.2 OUTLIER -141.09 156.32 46.0 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.583 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.546 ' CG2' HD12 ' A' ' 15' ' ' LEU . 54.8 m -146.31 156.89 43.67 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.18 -1.008 . . . . 0.0 112.885 -174.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.472 ' N ' HG22 ' B' ' 367' ' ' THR . 5.7 mt -130.79 139.68 50.23 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.54 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 22.5 t0 -116.6 95.86 5.24 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.779 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.2 p90 -135.93 94.01 3.0 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.532 176.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.77 12.51 1.73 Allowed Glycine 0 C--O 1.225 -0.427 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . 0.48 ' HB3' ' HZ2' ' B' ' 357' ' ' LYS . 8.4 t0 -41.74 -16.13 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.054 -0.573 . . . . 0.0 111.774 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.554 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.42 -37.28 64.93 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.477 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.98 -92.38 0.51 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 113.942 -1.481 . . . . 0.0 107.183 176.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.477 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.6 t0 -129.47 96.42 4.27 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.14 -3.46 55.67 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.149 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.697 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.03 106.7 17.38 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -175.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . 0.649 ' CG ' ' NH2' ' B' ' 339' ' ' ARG . 0.3 OUTLIER -120.04 127.4 52.55 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.835 175.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.512 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 33.1 t -138.64 166.52 24.14 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.621 0.724 . . . . 0.0 112.61 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.18 174.26 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.893 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -101.14 125.38 47.75 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 121.964 0.888 . . . . 0.0 111.092 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.664 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.83 136.82 14.62 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.037 -1.438 . . . . 0.0 109.84 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.27 16.88 4.77 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.211 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.07 83.88 1.75 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.021 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.38 -57.44 2.1 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.8 pt-20 -45.04 -20.2 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 114.82 -0.69 . . . . 0.0 111.091 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.426 ' N ' ' C ' ' B' ' 385' ' ' GLY . 4.6 mm-40 -83.05 -39.16 21.58 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.54 ' N ' ' O ' ' B' ' 385' ' ' GLY . 49.1 mt -76.58 -42.55 34.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.634 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.761 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.46 -42.53 61.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.306 -1.315 . . . . 0.0 113.604 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.453 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 12.3 pt20 -63.56 -34.72 78.43 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.001 0.905 . . . . 0.0 111.04 -177.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.33 -53.6 10.4 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.84 -1.527 . . . . 0.0 108.85 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -49.02 -55.61 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.485 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -53.14 -33.61 53.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 112.72 -2.036 . . . . 0.0 110.684 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.05 -17.71 62.46 Favored Glycine 0 CA--C 1.505 -0.538 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.669 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.2 m-30 -87.07 -37.15 17.7 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.497 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.58 -13.36 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-O 122.211 1.005 . . . . 0.0 109.371 176.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.01 -22.62 45.23 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.525 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' B' ' 395' ' ' TYR . 71.4 mt -91.76 -62.0 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.998 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.456 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.31 -20.75 27.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.322 -176.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.886 -1.054 . . . . 0.0 110.79 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 9' ' ' ASP . 13.1 p30 . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 8' ' ' ILE . 60.9 mt -72.68 10.87 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.4 0.619 . . . . 0.0 110.698 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -103.54 -32.01 9.66 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.394 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.502 ' O ' ' C ' ' A' ' 11' ' ' MET . 23.6 mt-30 -100.39 -35.23 9.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.578 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.502 ' C ' ' O ' ' A' ' 10' ' ' GLN . 24.6 mtp -18.18 -73.67 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 124.122 0.889 . . . . 0.0 112.159 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' MET . 10.1 m-85 -40.66 -63.38 0.66 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.998 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 10' ' ' GLN . 5.1 t -57.15 -34.45 68.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.845 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.63 -46.77 86.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.55 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.3 mm? -77.39 -42.24 37.1 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -39.22 79.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.462 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.06 -43.86 98.16 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 88.8 mt-10 -62.97 -37.45 87.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.523 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 6.4 mtp -60.85 -33.22 72.72 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.003 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.16 -29.96 15.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.169 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.517 ' N ' HD22 ' A' ' 21' ' ' LEU . 4.2 mm? -75.69 -13.97 60.33 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.294 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.732 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -86.38 -12.88 48.01 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.977 0.417 . . . . 0.0 109.932 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 24' ' ' GLN . 1.4 m -124.98 -27.51 3.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.958 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.7 OUTLIER 39.37 -161.13 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.367 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.13 -26.95 66.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.19 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.4 mm? -47.51 -35.79 9.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.939 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -45.37 -31.63 3.45 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.63 -22.62 4.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.642 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.65 -1.23 53.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.557 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.578 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -77.19 -40.18 25.05 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 71.3 t -126.33 133.99 67.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.778 0.323 . . . . 0.0 110.822 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.28 153.26 25.1 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.1 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -129.39 135.44 48.71 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.579 0.214 . . . . 0.0 111.579 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -139.1 129.43 25.55 Favored 'General case' 0 C--N 1.347 0.485 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.522 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.886 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.33 105.73 13.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 123.825 1.774 . . . . 0.0 109.402 178.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.649 ' O ' ' N ' ' B' ' 328' ' ' ARG . 33.0 m -116.98 161.11 15.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 112.564 -2.107 . . . . 0.0 110.122 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -103.5 145.34 30.15 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.528 ' OE2' ' NH2' ' B' ' 339' ' ' ARG . 27.1 tt0 -132.76 152.04 51.86 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.119 0.961 . . . . 0.0 112.606 -178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -82.19 101.92 10.77 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.118 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.54 ' SD ' ' NH2' ' B' ' 328' ' ' ARG . 36.6 mmt -95.92 179.31 5.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.067 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.638 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.18 157.99 16.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.849 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 108.55 -21.3 28.51 Favored Glycine 0 C--N 1.308 -1.003 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.38 -141.23 0.15 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.299 -0.451 . . . . 0.0 110.609 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.24 -21.73 0.62 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.486 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.537 ' HD2' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -86.91 -176.61 5.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.944 0.402 . . . . 0.0 110.99 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . 0.469 HD11 HD21 ' A' ' 22' ' ' LEU . 28.1 mt -91.79 165.15 13.42 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.202 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t -124.31 125.8 25.62 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.971 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.453 ' O ' HG12 ' B' ' 326' ' ' VAL . 62.4 Cg_exo -44.76 145.56 2.77 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 N-CA-C 108.029 -1.566 . . . . 0.0 108.029 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.649 ' N ' ' O ' ' B' ' 315' ' ' VAL . 4.2 ttm180 -150.59 -173.45 4.47 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 119.518 -0.873 . . . . 0.0 108.76 -177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.65 122.38 12.62 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.829 HD12 ' O ' ' B' ' 338' ' ' MET . 27.7 tp -101.69 157.87 16.52 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.434 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.29 107.92 0.53 Allowed Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 330' ' ' LEU . 31.1 mm -88.56 124.06 41.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.723 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.4 p -118.44 138.2 52.63 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.34 14.58 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.872 0.368 . . . . 0.0 111.331 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' B' ' 333' ' ' THR . 12.9 pt-20 -145.37 -2.88 0.75 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.459 178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.88 179.66 1.93 Allowed 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 122.322 1.058 . . . . 0.0 113.088 -176.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.593 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.1 t -137.36 146.43 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 113.276 -1.784 . . . . 0.0 106.535 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.829 ' O ' HD12 ' B' ' 330' ' ' LEU . 4.0 ptt? -154.76 149.63 26.7 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 117.056 -1.857 . . . . 0.0 114.274 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.528 ' NH2' ' OE2' ' B' ' 317' ' ' GLU . 15.6 mtp180 -94.55 107.73 19.71 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.633 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -98.89 149.88 5.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.207 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 28.7 t0 -89.45 92.02 8.95 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.729 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.49 -28.79 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.745 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.7 mttm -75.21 -43.61 50.88 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.732 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.555 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.32 -12.34 14.77 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm 66.58 -1.09 1.37 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 109.962 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.4 mt-10 -84.55 153.33 23.32 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.36 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.589 HG21 ' SD ' ' B' ' 338' ' ' MET . 82.3 t -83.29 135.16 25.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.497 0.665 . . . . 0.0 112.285 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 67.2 mt -103.54 -30.17 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.407 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.468 ' O ' ' CB ' ' B' ' 338' ' ' MET . 23.5 tt0 -140.6 156.46 46.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.675 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -145.66 149.87 35.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.517 178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.548 ' O ' ' N ' ' B' ' 337' ' ' VAL . 65.3 t-105 -162.82 134.87 5.3 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.711 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.499 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -53.13 139.39 28.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.496 0.665 . . . . 0.0 111.425 -178.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.639 HD12 ' O ' ' B' ' 333' ' ' THR . 1.6 tt -78.77 -36.04 43.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . 0.563 ' O ' HG22 ' B' ' 354' ' ' THR . 21.6 m -73.16 9.13 1.33 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.901 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.499 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.2 m-20 -113.52 -1.99 13.98 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.157 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.515 HD12 HD23 ' B' ' 353' ' ' LEU . 66.1 mt -61.17 145.6 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.182 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . 0.457 ' HZ2' ' HB3' ' B' ' 372' ' ' ASP . 5.6 tttt -104.38 -45.72 4.59 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.515 0.674 . . . . 0.0 109.21 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.7 ptt180 -174.92 136.19 0.39 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.514 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.4 p90 -118.89 174.71 6.13 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.227 -177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.64 99.38 1.72 Allowed 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 119.28 -0.968 . . . . 0.0 112.11 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.771 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.83 146.99 30.62 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.856 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.536 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -135.35 173.64 5.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -77.02 -8.15 17.6 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.003 1.802 . . . . 0.0 112.221 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' B' ' 382' ' ' THR . 23.0 mttt -131.02 -21.91 2.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.048 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.677 ' HA ' ' H ' ' B' ' 382' ' ' THR . 79.0 p -150.33 168.88 22.79 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.6 0.714 . . . . 0.0 111.895 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.504 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -141.09 156.79 45.93 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.627 -1.169 . . . . 0.0 108.75 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.55 ' CG2' HD12 ' A' ' 15' ' ' LEU . 39.7 m -147.54 156.55 42.94 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.128 -1.029 . . . . 0.0 112.942 -174.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.46 ' N ' HG22 ' B' ' 367' ' ' THR . 5.6 mt -129.56 141.87 50.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.628 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 21.1 t0 -118.19 95.59 4.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.677 176.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 11.3 p90 -136.23 93.98 2.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.657 176.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.49 12.45 1.8 Allowed Glycine 0 C--O 1.226 -0.349 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . 0.457 ' HB3' ' HZ2' ' B' ' 357' ' ' LYS . 9.2 t0 -41.79 -16.15 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.12 -0.54 . . . . 0.0 111.721 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.5 -37.38 65.24 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.48 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.5 OUTLIER -125.76 -92.5 0.51 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.169 176.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.48 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.6 t70 -129.41 96.3 4.25 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.37 -3.01 55.61 Favored Glycine 0 C--N 1.313 -0.714 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.217 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.689 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -85.93 106.16 16.92 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -175.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.54 126.66 52.96 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.77 175.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.523 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 47.2 t -138.47 164.55 29.1 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.6 0.714 . . . . 0.0 112.679 -177.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.64 174.13 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.971 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -100.91 125.12 47.44 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.94 0.876 . . . . 0.0 111.128 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.677 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.41 137.45 14.62 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.827 179.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . 0.415 ' N ' ' OE2' ' B' ' 384' ' ' GLU . 0.8 OUTLIER -84.83 -1.13 56.06 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.975 179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' B' ' 384' ' ' GLU . 0.0 OUTLIER -123.93 84.0 2.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.038 0.923 . . . . 0.0 108.71 175.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.24 -58.5 1.97 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.507 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.8 pt-20 -46.81 -20.6 0.14 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 114.696 -0.752 . . . . 0.0 110.982 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -80.95 -39.09 26.64 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.504 HG21 ' CE2' ' B' ' 366' ' ' PHE . 49.4 mt -77.06 -42.42 31.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.615 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.771 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.97 -42.4 60.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.308 -1.314 . . . . 0.0 113.506 -177.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.57 -34.74 78.47 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 122.049 0.928 . . . . 0.0 111.047 -177.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.25 -53.49 10.74 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 113.894 -1.503 . . . . 0.0 108.815 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.9 mt -48.94 -55.91 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.483 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.84 -34.06 52.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 112.732 -2.031 . . . . 0.0 110.651 178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.95 -17.58 62.91 Favored Glycine 0 CA--C 1.505 -0.543 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.667 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.2 m-30 -87.14 -37.2 17.57 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.514 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.51 -13.16 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.927 0 CA-C-O 122.1 0.952 . . . . 0.0 109.236 176.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -79.26 -22.73 44.32 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 113.791 -1.549 . . . . 0.0 109.51 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.667 HD12 ' HA ' ' B' ' 395' ' ' TYR . 70.9 mt -91.62 -61.76 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 114.001 -1.454 . . . . 0.0 112.051 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.455 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.75 -20.51 27.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.419 -1.719 . . . . 0.0 112.375 -176.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.56 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 N--CA 1.467 0.424 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.802 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 8' ' ' ILE . 61.0 m-20 . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 7' ' ' ASP . 15.1 mt 58.4 151.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.688 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.91 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.146 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.529 ' O ' ' C ' ' A' ' 11' ' ' MET . 20.8 mt-30 -96.6 -47.55 5.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.849 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.529 ' C ' ' O ' ' A' ' 10' ' ' GLN . 24.7 mtp -11.45 -77.73 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.46 0 O-C-N 124.326 1.016 . . . . 0.0 112.209 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 11' ' ' MET . 11.9 m-85 -41.2 -62.67 0.8 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.045 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 10' ' ' GLN . 1.2 t -58.41 -34.26 70.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.912 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -58.69 -47.04 85.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.551 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.2 mm? -76.43 -42.7 43.18 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -58.81 -39.1 80.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.636 178.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.41 -43.3 99.25 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.46 -37.63 88.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.979 0.419 . . . . 0.0 109.97 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.507 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 4.4 mtp -60.03 -32.14 70.62 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.027 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.58 -29.17 16.26 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.287 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.544 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -74.11 -10.45 59.64 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.286 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -92.37 -9.17 42.75 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.122 0.487 . . . . 0.0 109.723 179.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.586 ' OG1' HD23 ' A' ' 22' ' ' LEU . 22.9 m -134.15 -2.06 2.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.62 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 13.1 mp0 40.94 -91.94 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.729 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -140.85 -9.89 1.02 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.316 -178.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mp -46.27 -73.51 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.669 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.63 89.59 0.4 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.568 ' O ' HG12 ' A' ' 28' ' ' VAL . 53.4 t -75.12 -3.27 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.883 0.373 . . . . 0.0 110.526 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 61.9 t0 46.55 69.69 0.46 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.629 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.545 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' B' ' 310' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 68.57 -65.96 0.42 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' B' ' 308' ' ' TYR . 68.9 t -126.31 133.43 68.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.773 0.321 . . . . 0.0 110.715 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.07 153.3 24.84 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.163 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -130.2 135.17 47.86 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.012 0.195 . . . . 0.0 111.514 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -138.14 130.0 28.35 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.519 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.87 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -83.49 103.56 12.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 123.92 1.819 . . . . 0.0 109.308 178.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.67 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.7 m -113.7 162.05 12.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 112.579 -2.101 . . . . 0.0 110.309 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -105.32 147.1 28.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' B' ' 326' ' ' VAL . 26.3 tt0 -134.74 152.73 51.99 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.02 0.914 . . . . 0.0 112.639 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . 0.463 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 7.1 tptm -84.27 102.11 12.41 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.422 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 38.7 mmt -94.66 179.09 5.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.188 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.772 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -100.72 151.25 21.88 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.091 178.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.05 -22.16 12.66 Favored Glycine 0 C--N 1.315 -0.637 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.99 -146.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.548 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . 0.463 ' O ' ' NZ ' ' B' ' 318' ' ' LYS . 0.5 OUTLIER -137.52 -20.01 1.2 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.572 179.608 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.443 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -87.26 -176.67 5.75 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 111.024 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . 0.475 HD11 HD21 ' A' ' 22' ' ' LEU . 28.9 mt -93.13 166.29 12.41 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.348 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' B' ' 317' ' ' GLU . 4.8 t -124.4 124.75 25.73 Favored Pre-proline 0 N--CA 1.44 -0.95 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.888 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.432 ' O ' HG12 ' B' ' 326' ' ' VAL . 61.2 Cg_exo -44.8 145.95 2.6 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 N-CA-C 108.07 -1.55 . . . . 0.0 108.07 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.67 ' N ' ' O ' ' B' ' 315' ' ' VAL . 15.2 ttt180 -149.92 -174.21 4.64 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 119.529 -0.868 . . . . 0.0 108.689 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.616 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.34 122.64 12.29 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -176.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.831 HD12 ' O ' ' B' ' 338' ' ' MET . 25.8 tp -102.12 158.13 16.39 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.435 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.16 108.1 0.54 Allowed Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.744 HD11 HD21 ' B' ' 330' ' ' LEU . 31.3 mm -88.64 123.97 41.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.725 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.8 p -118.52 137.45 53.2 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.99 13.65 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.944 0.402 . . . . 0.0 111.667 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.725 ' H ' ' C ' ' B' ' 333' ' ' THR . 7.9 pt-20 -144.61 -2.68 0.84 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.711 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.89 179.0 2.06 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.404 1.097 . . . . 0.0 113.072 -176.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.602 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.3 t -136.84 146.17 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 CA-C-N 113.252 -1.795 . . . . 0.0 106.4 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.831 ' O ' HD12 ' B' ' 330' ' ' LEU . 4.0 ptt? -154.24 150.08 27.66 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 117.153 -1.819 . . . . 0.0 114.409 -176.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.538 ' NH2' HG21 ' B' ' 315' ' ' VAL . 2.8 mtp85 -95.08 107.86 19.93 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.54 176.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.7 t -99.49 150.22 5.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.304 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 344' ' ' THR . 32.8 t0 -90.72 92.35 8.78 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.767 -178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.54 -28.91 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.599 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' B' ' 341' ' ' ASP . 20.5 mttp -74.66 -43.56 54.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.688 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.45 -12.53 14.7 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.3 OUTLIER 66.34 -1.21 1.27 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.035 0.445 . . . . 0.0 110.023 -179.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.6 mt-10 -84.79 152.1 23.89 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.332 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.613 HG21 ' SD ' ' B' ' 338' ' ' MET . 76.7 t -82.76 134.75 26.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.51 0.671 . . . . 0.0 112.305 -178.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 20.9 mm -102.71 -31.12 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.276 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.466 ' O ' ' CB ' ' B' ' 338' ' ' MET . 17.1 tt0 -139.79 156.86 46.53 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.611 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -145.75 149.41 34.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.249 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.539 ' O ' ' N ' ' B' ' 337' ' ' VAL . 64.2 t-105 -162.08 135.05 6.02 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.057 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.514 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.39 139.42 24.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.432 0.634 . . . . 0.0 111.379 -178.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.63 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -79.57 -35.79 39.2 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.53 11.08 1.09 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.825 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.514 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -114.41 -4.5 12.94 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.027 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.474 HD12 HD23 ' B' ' 353' ' ' LEU . 69.6 mt -57.62 147.8 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.468 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 11.7 tptt -105.46 -45.7 4.38 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.502 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.6 ptt180 -175.38 135.98 0.34 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.481 ' CH2' HD12 ' B' ' 396' ' ' ILE . 12.2 p90 -118.91 173.66 6.75 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.172 -177.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.46 99.74 1.77 Allowed 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.018 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.776 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.04 147.66 30.05 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.783 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.535 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -135.99 173.56 5.51 Favored Pre-proline 0 N--CA 1.453 -0.282 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -77.06 -8.68 17.77 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.133 1.888 . . . . 0.0 112.022 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 20.6 mtpt -130.77 -21.38 2.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.96 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.659 ' HA ' ' H ' ' B' ' 382' ' ' THR . 88.9 p -150.47 169.57 21.16 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.574 0.702 . . . . 0.0 111.932 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.496 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -142.12 156.61 45.38 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.566 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.551 ' CG2' HD12 ' A' ' 15' ' ' LEU . 44.1 m -147.3 156.72 43.18 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.877 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.462 ' N ' HG22 ' B' ' 367' ' ' THR . 5.7 mt -129.78 141.35 50.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.544 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 21.9 t0 -117.66 95.72 5.07 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.722 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 8.1 p90 -136.78 94.27 2.96 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.581 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 133.02 12.77 1.64 Allowed Glycine 0 C--O 1.224 -0.495 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.5 t0 -42.08 -15.92 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.979 -0.61 . . . . 0.0 111.852 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.41 -37.68 65.36 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.47 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.57 -92.11 0.52 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.356 176.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.47 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.4 t70 -129.91 96.16 4.14 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -99.93 -3.52 55.88 Favored Glycine 0 C--N 1.311 -0.812 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.261 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.69 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.09 106.17 17.03 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -175.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.69 126.07 51.82 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.647 176.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.507 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 47.1 t -138.55 163.45 31.97 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.676 0.751 . . . . 0.0 112.849 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.51 172.89 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.196 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -99.45 125.91 45.27 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 121.764 0.792 . . . . 0.0 111.192 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.659 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.59 136.28 14.38 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.976 -1.465 . . . . 0.0 109.868 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.67 16.63 4.54 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.185 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.08 83.54 1.74 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.943 174.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -57.89 2.06 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.531 ' O ' ' NE2' ' B' ' 390' ' ' GLN . 7.4 pt-20 -45.12 -20.58 0.05 OUTLIER 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 114.905 -0.648 . . . . 0.0 110.964 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.422 ' N ' ' C ' ' B' ' 385' ' ' GLY . 5.6 mm-40 -82.26 -39.27 23.23 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' B' ' 385' ' ' GLY . 47.5 mt -76.54 -42.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.609 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.776 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.33 -42.36 62.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.356 -1.293 . . . . 0.0 113.559 -177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' B' ' 386' ' ' GLU . 2.2 pt20 -63.56 -34.88 78.79 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 122.082 0.944 . . . . 0.0 111.029 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.648 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.85 -53.49 11.29 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.819 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.648 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.35 -55.98 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.477 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.37 -33.74 44.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 112.761 -2.018 . . . . 0.0 110.701 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.26 -17.8 61.92 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.674 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -87.15 -36.96 17.76 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.481 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.72 -13.19 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 CA-C-O 122.175 0.988 . . . . 0.0 109.297 176.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.56 -22.65 46.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.475 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.1 mt -91.8 -61.98 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.067 -178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.54 -20.41 27.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.338 -1.756 . . . . 0.0 112.315 -176.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.557 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.494 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.793 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' ILE . 1.2 m-20 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.617 HG21 ' SD ' ' A' ' 11' ' ' MET . 5.5 mt 57.64 151.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.664 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.12 -28.0 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.051 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.509 ' O ' ' C ' ' A' ' 11' ' ' MET . 18.0 mt-30 -85.69 -44.46 12.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.864 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.617 ' SD ' HG21 ' A' ' 8' ' ' ILE . 15.7 mtp -15.73 -80.19 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 124.252 0.97 . . . . 0.0 111.986 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.444 ' C ' ' O ' ' A' ' 11' ' ' MET . 11.0 m-85 -38.01 -63.53 0.47 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.1 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 10' ' ' GLN . 1.1 t -56.17 -27.42 54.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.85 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.529 ' N ' ' O ' ' A' ' 11' ' ' MET . 0.2 OUTLIER -65.4 -49.47 69.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.7 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.553 HD12 ' CG2' ' B' ' 367' ' ' THR . 3.8 mm? -77.27 -43.38 33.51 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -41.17 87.66 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.99 -44.36 97.28 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.515 ' OE2' ' CD2' ' B' ' 377' ' ' TYR . 85.6 mt-10 -62.77 -34.03 76.39 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-O 120.995 0.426 . . . . 0.0 109.933 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.553 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 7.3 mtp -69.49 -33.11 72.38 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.061 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -54.68 -20.44 8.23 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.107 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.518 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -72.12 -37.91 69.38 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.177 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.903 HD13 HD11 ' B' ' 325' ' ' LEU . 4.3 pp -100.48 6.6 44.36 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 25' ' ' SER . 1.3 m -126.03 -26.5 3.41 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.069 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 8.7 mp0 37.29 -91.54 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.88 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -141.81 -7.71 0.95 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.23 -178.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 28' ' ' VAL . 7.9 mp -64.23 -89.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.699 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 50.62 33.44 26.25 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.665 HG12 ' N ' ' A' ' 29' ' ' ASP . 51.7 t -101.64 -112.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.729 0.3 . . . . 0.0 110.452 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.665 ' N ' HG12 ' A' ' 28' ' ' VAL . 27.3 t70 42.0 24.06 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.646 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' VAL . 2.5 m . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.6 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . 0.48 ' O ' ' N ' ' B' ' 310' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 63.0 -73.68 0.03 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' B' ' 308' ' ' TYR . 72.2 t -126.48 134.13 67.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.794 0.33 . . . . 0.0 110.776 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.47 153.04 25.6 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.064 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -128.87 135.18 48.73 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.125 0.266 . . . . 0.0 111.42 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -139.15 129.52 25.59 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.795 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.883 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.47 104.86 12.2 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 123.717 1.723 . . . . 0.0 109.154 178.242 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.621 HG12 ' HB ' ' B' ' 382' ' ' THR . 34.1 m -120.82 156.02 24.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 112.815 -1.993 . . . . 0.0 110.278 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -93.37 138.34 31.8 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.27 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' B' ' 326' ' ' VAL . 1.0 OUTLIER -125.67 152.5 45.15 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.918 0.866 . . . . 0.0 112.881 -178.04 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -75.81 102.66 5.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.245 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 35.8 mmt -102.29 179.42 4.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.023 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.768 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -96.5 146.19 25.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.998 178.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 123.54 -26.18 6.06 Favored Glycine 0 C--N 1.313 -0.744 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -140.76 -142.81 0.15 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.527 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.94 -19.37 1.31 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.567 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.44 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -90.5 -178.82 5.43 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.936 0.398 . . . . 0.0 110.937 -179.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . 0.903 HD11 HD13 ' A' ' 22' ' ' LEU . 13.5 mt -85.88 161.2 19.17 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.379 179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.0 t -122.89 130.74 24.5 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.172 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.482 ' C ' ' O ' ' B' ' 326' ' ' VAL . 78.1 Cg_exo -37.89 140.26 0.29 Allowed 'Trans proline' 0 CA--C 1.506 -0.882 0 N-CA-C 108.535 -1.371 . . . . 0.0 108.535 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' B' ' 315' ' ' VAL . 1.6 tpt180 -152.98 -172.22 4.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.574 -0.85 . . . . 0.0 108.731 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.628 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.33 123.63 13.82 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -177.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 338' ' ' MET . 27.7 tp -103.11 158.27 16.42 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.151 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.427 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.24 107.71 0.52 Allowed Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.769 HD11 HD21 ' B' ' 330' ' ' LEU . 31.6 mm -88.33 123.03 40.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.729 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.2 p -117.28 138.02 52.02 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -57.26 13.6 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.015 0.436 . . . . 0.0 111.779 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.729 ' H ' ' C ' ' B' ' 333' ' ' THR . 13.5 pt-20 -144.45 -2.69 0.85 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.955 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.97 178.89 2.06 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 122.315 1.055 . . . . 0.0 113.059 -177.051 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.609 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.47 146.09 29.43 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.042 0 CA-C-N 113.312 -1.767 . . . . 0.0 106.587 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.836 ' O ' HD12 ' B' ' 330' ' ' LEU . 2.3 ptt? -154.06 149.84 27.58 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 117.09 -1.844 . . . . 0.0 114.324 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.43 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 45.8 mtm180 -94.51 107.7 19.66 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.645 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.628 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.34 149.84 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.124 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' B' ' 344' ' ' THR . 32.0 t0 -89.53 92.6 9.17 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.884 -178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.56 -28.58 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.732 179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 14.8 mttp -75.0 -43.79 51.86 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.73 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.554 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.41 -12.84 14.68 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -177.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 11.5 tttt 66.54 -0.75 1.45 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.048 0.452 . . . . 0.0 110.049 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.8 mt-10 -85.15 152.22 23.53 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.311 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.631 HG21 ' SD ' ' B' ' 338' ' ' MET . 82.5 t -83.83 135.14 25.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.528 0.68 . . . . 0.0 112.253 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -104.55 -30.93 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.414 178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.467 ' O ' ' CB ' ' B' ' 338' ' ' MET . 7.4 tt0 -138.01 154.9 49.29 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.516 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -145.32 149.83 35.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.37 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.549 ' O ' ' N ' ' B' ' 337' ' ' VAL . 63.0 t-105 -161.99 135.06 6.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.753 177.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.512 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.78 139.1 27.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.424 0.631 . . . . 0.0 111.32 -178.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.625 HD12 ' O ' ' B' ' 333' ' ' THR . 1.8 tt -79.47 -35.6 40.06 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.83 11.28 1.11 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.888 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.512 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.7 m-20 -114.65 -4.19 12.8 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.191 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.494 HD12 HD23 ' B' ' 353' ' ' LEU . 74.0 mt -57.99 148.53 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.155 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 10.3 tttt -106.42 -45.12 4.35 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.1 ptt180 -175.64 136.52 0.33 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.365 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.475 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.5 p90 -119.53 174.14 6.57 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.224 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.02 98.83 1.78 Allowed 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.039 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.784 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.68 147.09 30.78 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.803 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.2 OUTLIER -136.36 173.78 5.22 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -77.24 -8.26 17.4 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.038 1.825 . . . . 0.0 112.205 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.6 mttt -130.6 -21.43 2.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.073 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.657 ' HA ' ' H ' ' B' ' 382' ' ' THR . 94.4 p -151.74 168.75 24.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.658 0.742 . . . . 0.0 111.858 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -140.64 157.07 45.99 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.84 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.603 ' HG1' ' HG ' ' B' ' 379' ' ' SER . 62.7 m -146.79 158.64 43.96 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.848 -174.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.524 ' N ' HG22 ' B' ' 367' ' ' THR . 5.6 mt -132.41 140.11 48.32 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.519 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 19.7 t0 -117.0 96.03 5.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.634 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' B' ' 370' ' ' PHE . 5.9 p90 -137.25 94.11 2.9 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.555 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.58 12.68 1.74 Allowed Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . 0.404 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 8.8 t0 -41.97 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.108 -0.546 . . . . 0.0 111.682 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.3 m-85 -54.43 -37.24 64.9 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.471 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -126.09 -92.67 0.5 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.915 -1.493 . . . . 0.0 107.093 176.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.471 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.3 t70 -129.32 96.21 4.24 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 174.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -99.98 -3.13 55.96 Favored Glycine 0 C--N 1.315 -0.605 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.223 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.25 105.68 16.79 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -175.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.18 127.68 54.35 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.557 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.603 ' HG ' ' HG1' ' B' ' 367' ' ' THR . 22.6 t -137.48 157.83 45.71 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.313 0.578 . . . . 0.0 112.23 -177.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . 0.433 ' CG1' ' CD ' ' B' ' 317' ' ' GLU . 2.5 m -142.09 171.86 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.047 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . 0.689 ' HB2' HD12 ' B' ' 325' ' ' LEU . 3.6 tt0 -100.84 125.99 47.4 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.964 0.887 . . . . 0.0 110.991 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.657 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -156.01 137.59 14.13 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.876 179.046 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.43 15.54 6.44 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.132 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.93 84.54 1.78 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.065 175.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -56.35 2.32 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.436 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.4 pt-20 -45.07 -20.18 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 114.797 -0.702 . . . . 0.0 111.025 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' B' ' 385' ' ' GLY . 2.5 mm-40 -82.96 -39.39 21.46 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.535 ' N ' ' O ' ' B' ' 385' ' ' GLY . 46.3 mt -76.85 -42.44 33.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.669 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.784 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.37 -42.18 62.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.665 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.436 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -63.93 -34.89 78.99 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 122.032 0.92 . . . . 0.0 110.965 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.8 -53.69 10.84 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.783 -179.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.14 -56.1 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.59 -33.8 47.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 112.819 -1.991 . . . . 0.0 110.662 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.98 -17.87 62.29 Favored Glycine 0 CA--C 1.507 -0.444 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.675 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.01 -36.79 18.02 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.475 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.74 -13.21 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-O 122.157 0.98 . . . . 0.0 109.258 176.101 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.64 -22.54 46.74 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.712 -1.585 . . . . 0.0 109.459 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.675 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.8 mt -91.82 -62.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.968 -178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.43 -20.43 27.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.347 -177.026 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.56 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.838 -1.077 . . . . 0.0 110.765 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.608 HG22 ' N ' ' A' ' 9' ' ' ASP . 2.7 mp -41.37 164.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.271 0.558 . . . . 0.0 110.709 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.608 ' N ' HG22 ' A' ' 8' ' ' ILE . 14.9 t0 70.63 -47.61 0.64 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.268 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.471 ' O ' ' C ' ' A' ' 11' ' ' MET . 14.4 mt-30 -82.48 -46.09 13.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.7 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.471 ' C ' ' O ' ' A' ' 10' ' ' GLN . 56.9 mtp -22.76 -67.88 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 124.058 0.849 . . . . 0.0 112.023 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' MET . 12.3 m-85 -39.83 -58.24 1.41 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.056 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -67.27 -34.03 76.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.945 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.402 ' OG1' ' C ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -61.48 -26.89 68.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.556 HD12 HG21 ' B' ' 367' ' ' THR . 4.4 mm? -96.07 -39.75 9.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -42.67 94.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.708 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.19 -38.22 92.86 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.04 -39.7 75.59 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.497 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 5.2 mtp -56.82 -31.25 64.52 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.905 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.3 -27.8 16.6 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.228 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.527 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -77.34 -8.06 57.05 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.309 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.72 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -93.07 -10.16 37.08 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.149 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.556 ' OG1' HD23 ' A' ' 22' ' ' LEU . 58.4 m -124.93 -9.47 7.19 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.172 0.511 . . . . 0.0 110.391 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 19.5 mp0 53.99 -83.55 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.905 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -154.22 -11.62 0.14 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.253 -178.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.861 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -61.01 -21.18 63.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.646 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 29' ' ' ASP . . . -46.76 -32.39 5.85 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 26' ' ' LEU . 58.4 t 56.6 2.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.833 0.349 . . . . 0.0 110.618 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 27' ' ' GLY . 34.3 t70 -161.59 -78.64 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.581 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.572 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . 0.59 ' N ' ' CD1' ' B' ' 308' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' B' ' 308' ' ' TYR . . . -60.17 -138.3 0.01 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 96.2 t -40.76 137.65 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.776 0.322 . . . . 0.0 110.72 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.58 153.45 26.28 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.221 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -130.04 134.08 47.16 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.042 0.214 . . . . 0.0 111.46 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -139.26 128.48 23.99 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.656 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.914 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.84 107.15 13.4 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 123.769 1.747 . . . . 0.0 109.396 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.666 HG12 ' HB ' ' B' ' 382' ' ' THR . 30.3 m -119.13 160.82 18.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 112.697 -2.047 . . . . 0.0 110.096 -176.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -102.11 145.25 29.62 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.559 ' CD ' ' HE ' ' B' ' 339' ' ' ARG . 26.6 tt0 -133.36 149.99 51.85 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 122.005 0.907 . . . . 0.0 112.708 -178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . 0.496 ' HZ2' ' C ' ' B' ' 323' ' ' ASN . 6.3 tptm -81.68 101.93 10.39 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.233 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 38.7 mmt -94.1 178.93 5.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.177 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.756 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -100.1 150.97 21.93 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.155 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 114.96 -22.46 12.48 Favored Glycine 0 C--N 1.313 -0.701 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.61 -143.81 0.17 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.535 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . 0.531 ' HB3' HD22 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -140.48 -20.38 0.84 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.499 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -86.46 -176.38 5.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.959 0.409 . . . . 0.0 110.938 -179.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . 0.529 HD11 HD21 ' A' ' 22' ' ' LEU . 31.4 mt -93.39 164.15 13.31 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.274 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' B' ' 317' ' ' GLU . 5.7 t -123.46 123.88 26.39 Favored Pre-proline 0 N--CA 1.44 -0.965 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.993 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.421 ' O ' HG12 ' B' ' 326' ' ' VAL . 68.1 Cg_exo -44.18 144.14 3.01 Favored 'Trans proline' 0 C--N 1.321 -0.907 0 N-CA-C 108.096 -1.54 . . . . 0.0 108.096 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.617 ' N ' ' O ' ' B' ' 315' ' ' VAL . 13.9 ttt180 -150.41 -173.23 4.39 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.504 -0.878 . . . . 0.0 108.71 -177.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -141.41 120.76 13.11 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.103 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.835 HD12 ' O ' ' B' ' 338' ' ' MET . 32.0 tp -98.67 158.17 15.79 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.223 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.56 108.5 0.53 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.73 HD11 HD21 ' B' ' 330' ' ' LEU . 29.4 mm -87.98 123.58 40.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.723 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.98 138.05 52.45 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 14.65 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.697 0.284 . . . . 0.0 111.442 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.723 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.5 pt-20 -144.53 -4.36 0.78 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.561 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.614 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.48 177.35 2.19 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.412 1.101 . . . . 0.0 112.915 -176.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.614 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.0 t -132.5 145.4 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 113.148 -1.842 . . . . 0.0 106.401 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.835 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.93 150.61 29.44 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 117.199 -1.801 . . . . 0.0 114.568 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.559 ' HE ' ' CD ' ' B' ' 317' ' ' GLU . 0.4 OUTLIER -96.24 106.86 19.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.515 176.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.13 150.1 4.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.299 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.5 t0 -87.97 91.62 8.83 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.694 -178.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.4 OUTLIER -35.43 -28.32 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.619 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 24.0 mttp -75.52 -43.94 46.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.725 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.556 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.61 -13.7 14.77 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 15.3 tttt 68.0 -0.41 2.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.98 0.419 . . . . 0.0 109.933 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.9 mt-10 -86.66 152.9 22.17 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.619 HG21 ' SD ' ' B' ' 338' ' ' MET . 89.7 t -81.61 133.96 28.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.5 0.667 . . . . 0.0 112.276 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.54 HG21 HH22 ' B' ' 328' ' ' ARG . 1.2 mm -104.14 -30.76 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.225 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' B' ' 338' ' ' MET . 15.7 tt0 -138.74 157.23 46.47 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.489 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -143.4 150.55 39.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.233 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -159.52 124.31 4.01 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.942 177.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.403 ' OG ' ' CG ' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.69 140.92 3.14 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.42 0.628 . . . . 0.0 111.612 -178.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.594 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -84.36 -36.32 22.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . 0.475 HG23 HD22 ' B' ' 355' ' ' ASN . 6.0 t -73.5 9.54 1.33 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.906 177.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.571 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 1.0 OUTLIER -111.13 -7.28 14.49 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.0 178.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.487 HD12 HD23 ' B' ' 353' ' ' LEU . 78.0 mt -56.91 146.41 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 120.444 -0.503 . . . . 0.0 111.766 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . 0.506 ' NZ ' ' OH ' ' B' ' 373' ' ' TYR . 9.0 tttp -107.6 -46.03 3.92 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.5 ptt-85 -172.97 135.76 0.63 Allowed 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.522 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.1 p90 -119.15 176.56 5.25 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.186 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.37 98.94 1.59 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 119.176 -1.009 . . . . 0.0 111.877 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.64 145.73 31.52 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.563 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -134.09 173.73 5.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.38 -8.21 17.23 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.175 1.917 . . . . 0.0 112.069 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' B' ' 382' ' ' THR . 26.0 mttt -130.51 -21.3 2.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.942 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.66 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.3 p -151.94 167.79 27.24 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.601 0.715 . . . . 0.0 111.883 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.453 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.19 156.49 47.07 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.549 179.557 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.556 HG21 HD12 ' A' ' 15' ' ' LEU . 25.1 m -148.43 154.81 40.39 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 118.947 -1.101 . . . . 0.0 113.068 -174.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.6 mt -125.64 140.09 53.02 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.329 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 9.7 t0 -117.56 95.5 4.98 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.875 176.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 27.6 t80 -137.75 95.16 3.0 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.89 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.96 12.17 1.96 Allowed Glycine 0 C--O 1.225 -0.413 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 178.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.6 t0 -41.73 -16.36 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.911 -0.645 . . . . 0.0 112.057 -178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.539 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.0 m-85 -54.35 -37.83 65.37 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.468 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.66 -92.16 0.51 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.522 176.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.468 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 7.5 t0 -130.02 96.29 4.16 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.14 -3.31 54.39 Favored Glycine 0 C--N 1.306 -1.131 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.405 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.685 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.68 107.11 16.71 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -175.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -115.39 120.66 40.33 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.742 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.497 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.2 t -138.49 163.35 32.19 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.788 0.804 . . . . 0.0 113.103 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.97 175.56 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.299 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -101.74 124.4 47.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.039 0.923 . . . . 0.0 110.728 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.666 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -154.46 136.86 14.97 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.883 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.62 17.59 4.55 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.251 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.16 83.58 1.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.949 174.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.16 -58.85 1.92 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.0 pt-20 -44.49 -20.08 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 114.904 -0.648 . . . . 0.0 111.022 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.437 ' N ' ' C ' ' B' ' 385' ' ' GLY . 23.5 mt-30 -83.13 -39.55 20.93 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.9 mt -76.54 -42.02 34.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.654 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.63 -42.69 61.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.503 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -63.63 -34.62 78.24 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 122.036 0.922 . . . . 0.0 111.05 -177.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.96 -53.16 10.7 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.811 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.65 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.7 mt -49.12 -55.12 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.484 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.19 -34.32 44.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.657 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.86 -17.99 62.31 Favored Glycine 0 CA--C 1.504 -0.611 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -178.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.692 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.72 -36.65 18.54 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.522 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.32 -13.02 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 CA-C-O 122.123 0.963 . . . . 0.0 109.226 176.202 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.51 -23.07 43.18 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.465 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.692 HD12 ' HA ' ' B' ' 395' ' ' TYR . 74.2 mt -90.34 -59.95 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 113.903 -1.499 . . . . 0.0 111.573 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.493 ' O ' ' C ' ' B' ' 400' ' ' LEU . 0.7 OUTLIER -69.1 -19.58 23.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 113.572 -1.649 . . . . 0.0 112.266 -177.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.493 ' C ' ' O ' ' B' ' 399' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.381 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 mt -145.88 149.26 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.425 0.631 . . . . 0.0 110.619 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.53 -35.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.327 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.496 ' O ' ' C ' ' A' ' 11' ' ' MET . 49.2 mt-30 -128.43 -26.92 2.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.773 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.496 ' C ' ' O ' ' A' ' 10' ' ' GLN . 43.5 mtp -17.79 -69.4 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.412 0 O-C-N 124.286 0.991 . . . . 0.0 112.069 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -43.51 -64.1 0.71 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.918 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 10' ' ' GLN . 3.0 t -56.17 -39.88 73.05 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.766 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.445 ' O ' ' OE2' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -52.21 -48.81 64.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.829 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.551 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? -74.66 -43.5 55.02 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -37.35 64.61 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.12 -50.68 61.19 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.879 -1.689 . . . . 0.0 108.879 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -55.5 -41.33 72.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.986 0.422 . . . . 0.0 110.023 178.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.508 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 6.7 mtp -57.19 -34.39 68.44 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.013 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -49.19 -32.16 9.86 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.192 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.546 ' N ' HD22 ' A' ' 21' ' ' LEU . 4.0 mm? -73.35 -16.88 61.34 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.267 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -84.0 -11.26 57.06 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.306 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 25' ' ' SER . 3.8 m -126.96 -9.19 6.0 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.134 0.492 . . . . 0.0 110.372 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 15.2 mp0 54.45 -82.49 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.902 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -153.97 -12.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.269 -178.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 mp -41.24 -85.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.589 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.53 -96.28 0.13 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.65 -32.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.88 0.372 . . . . 0.0 110.582 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 54.55 94.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.529 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.587 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . 0.598 ' N ' ' CD1' ' B' ' 308' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 56.06 -81.47 0.01 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' B' ' 308' ' ' TYR . 74.9 t -127.31 134.05 66.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.761 0.315 . . . . 0.0 110.771 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.5 153.65 24.78 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.113 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -127.7 135.42 50.16 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.158 0.286 . . . . 0.0 111.587 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -139.96 127.36 21.4 Favored 'General case' 0 C--N 1.347 0.466 0 C-N-CA 120.184 -0.607 . . . . 0.0 110.572 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.911 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.77 107.72 13.82 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 123.751 1.739 . . . . 0.0 109.314 178.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.692 HG12 ' HB ' ' B' ' 382' ' ' THR . 31.3 m -120.18 162.6 18.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 112.658 -2.065 . . . . 0.0 110.097 -176.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -104.0 145.61 29.9 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' B' ' 326' ' ' VAL . 44.0 tt0 -136.38 152.42 50.61 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.033 0.92 . . . . 0.0 112.627 -178.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . 0.563 ' HZ2' ' C ' ' B' ' 323' ' ' ASN . 6.2 tptm -79.87 100.57 8.09 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.536 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.68 ' N ' ' SD ' ' B' ' 319' ' ' MET . 0.0 OUTLIER -89.88 178.9 6.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.987 179.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.756 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.86 147.54 26.39 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.04 178.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 117.93 -25.29 8.48 Favored Glycine 0 C--N 1.313 -0.703 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -133.97 -143.06 0.2 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.637 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . 0.563 ' C ' ' HZ2' ' B' ' 318' ' ' LYS . 0.1 OUTLIER -140.85 -17.2 0.86 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.549 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -91.65 -176.73 4.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 110.952 -179.206 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . 0.491 HD11 HD21 ' A' ' 22' ' ' LEU . 27.1 mt -91.26 163.37 14.26 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.327 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' B' ' 317' ' ' GLU . 14.4 t -124.69 126.12 25.41 Favored Pre-proline 0 N--CA 1.44 -0.929 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.91 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.426 ' O ' HG12 ' B' ' 326' ' ' VAL . 68.0 Cg_exo -44.39 144.11 3.28 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 N-CA-C 108.038 -1.562 . . . . 0.0 108.038 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.618 ' N ' ' O ' ' B' ' 315' ' ' VAL . 11.2 ttm-85 -150.08 -173.59 4.48 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.696 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.16 120.49 13.07 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.145 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.835 HD12 ' O ' ' B' ' 338' ' ' MET . 31.7 tp -99.04 157.9 16.03 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.249 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.2 108.04 0.52 Allowed Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.711 HD11 HD21 ' B' ' 330' ' ' LEU . 30.7 mm -87.82 122.91 40.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.722 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.9 p -117.09 138.55 51.55 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.79 15.83 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.747 0.308 . . . . 0.0 111.354 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.722 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.1 pt-20 -145.72 -4.5 0.66 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.528 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.46 177.39 2.19 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.362 1.077 . . . . 0.0 113.011 -176.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.61 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 9.9 t -132.81 145.29 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 CA-C-N 113.16 -1.836 . . . . 0.0 106.254 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.835 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.0 OUTLIER -152.54 150.88 30.04 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 117.143 -1.823 . . . . 0.0 114.468 -175.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.532 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 62.6 mtm180 -96.13 106.77 19.0 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.524 176.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.7 t -96.76 150.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.278 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.56 ' O ' ' N ' ' B' ' 344' ' ' THR . 28.8 t0 -88.04 91.74 8.88 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.76 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.48 -28.38 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.617 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.8 mttm -75.18 -43.78 50.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.691 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.56 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.77 -13.98 14.68 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -177.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 14.7 tttp 68.29 -0.77 2.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.026 0.441 . . . . 0.0 109.958 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.9 mt-10 -86.3 152.83 22.43 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.35 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.623 HG21 ' SD ' ' B' ' 338' ' ' MET . 86.6 t -81.6 133.55 29.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.485 0.66 . . . . 0.0 112.178 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 11.9 mt -102.98 -31.02 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.319 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.532 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 21.8 tt0 -139.58 158.15 44.61 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.595 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -143.06 150.08 39.06 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.135 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.556 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.0 122.38 4.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.938 177.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.93 139.79 2.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.443 0.639 . . . . 0.0 111.624 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.6 HD12 ' O ' ' B' ' 333' ' ' THR . 1.7 tt -82.24 -37.28 26.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . 0.523 ' O ' HG22 ' B' ' 354' ' ' THR . 19.7 m -70.67 6.76 1.32 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.799 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.587 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 0.9 OUTLIER -108.37 -4.84 17.06 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.106 179.311 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.534 HD12 HD23 ' B' ' 353' ' ' LEU . 70.5 mt -60.9 144.42 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.753 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -107.3 -45.95 3.99 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 7.2 ptt180 -172.43 135.7 0.74 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.546 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.6 p90 -119.08 176.35 5.34 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.208 -177.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.24 99.21 1.62 Allowed 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.961 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.787 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.25 145.4 30.96 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.573 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -133.71 173.96 5.23 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -77.39 -7.95 17.12 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.136 1.891 . . . . 0.0 112.131 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' B' ' 382' ' ' THR . 4.0 mtpp -130.61 -21.27 2.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.046 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.659 ' HA ' ' H ' ' B' ' 382' ' ' THR . 61.1 p -152.25 167.36 28.85 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.528 0.68 . . . . 0.0 111.903 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.469 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -138.79 156.63 47.18 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.504 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.551 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.2 m -148.57 154.47 39.81 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 119.014 -1.075 . . . . 0.0 113.02 -174.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.8 mt -125.32 140.77 52.53 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.355 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.8 t0 -118.06 95.6 4.97 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.464 -0.895 . . . . 0.0 110.821 176.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 18.6 t80 -137.38 94.85 2.98 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.936 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.01 12.41 1.91 Allowed Glycine 0 C--O 1.226 -0.405 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.2 t0 -41.89 -16.12 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.02 -0.59 . . . . 0.0 111.887 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.542 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.34 -37.94 65.48 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.463 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.4 OUTLIER -125.32 -92.37 0.51 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.895 -1.502 . . . . 0.0 107.358 176.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.463 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 7.8 t70 -129.93 96.16 4.14 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.16 -2.92 54.48 Favored Glycine 0 C--N 1.31 -0.883 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.28 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.673 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.45 107.06 16.5 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -175.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . 0.422 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.7 OUTLIER -114.71 120.95 41.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.677 175.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.508 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.7 t -138.67 163.21 32.69 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -177.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.95 175.18 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.209 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -101.44 124.57 47.32 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 121.955 0.883 . . . . 0.0 110.863 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.692 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -154.88 136.91 14.66 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.937 179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.75 17.42 4.77 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.207 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.06 83.88 1.75 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.902 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.96 -58.19 2.04 Favored Glycine 0 C--O 1.223 -0.578 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.5 pt-20 -44.58 -20.06 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.814 -0.693 . . . . 0.0 111.083 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.439 ' N ' ' C ' ' B' ' 385' ' ' GLY . 41.5 mt-30 -83.04 -39.78 20.78 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' B' ' 385' ' ' GLY . 50.2 mt -76.74 -41.99 33.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.611 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.787 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.68 -42.37 61.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.293 -1.321 . . . . 0.0 113.532 -177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.462 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.3 pt20 -64.02 -34.65 78.5 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.076 0.941 . . . . 0.0 111.063 -177.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.96 -53.11 10.8 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.753 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -49.09 -55.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 176.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.492 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.98 -33.69 52.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.736 -2.029 . . . . 0.0 110.511 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.06 -17.71 62.45 Favored Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.677 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -86.91 -37.18 17.88 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.546 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.48 -13.15 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 CA-C-O 122.112 0.958 . . . . 0.0 109.297 176.214 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.96 -22.67 45.33 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.437 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' B' ' 395' ' ' TYR . 69.6 mt -91.95 -61.9 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 113.901 -1.5 . . . . 0.0 112.126 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.64 -20.37 27.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 113.44 -1.709 . . . . 0.0 112.324 -176.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.565 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.905 -1.045 . . . . 0.0 110.637 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.649 HG23 ' SD ' ' A' ' 11' ' ' MET . 5.9 mt -144.6 150.25 16.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.652 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.34 -48.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.195 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.496 ' O ' ' C ' ' A' ' 11' ' ' MET . 9.7 mt-30 -122.7 -22.99 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.86 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.649 ' SD ' HG23 ' A' ' 8' ' ' ILE . 61.4 mtp -17.58 -66.4 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.412 0 O-C-N 124.23 0.957 . . . . 0.0 112.102 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' MET . 14.4 m-85 -41.11 -62.48 0.82 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.981 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 10' ' ' GLN . 4.7 t -63.2 -34.13 76.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.831 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.26 -29.13 69.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.546 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? -95.32 -38.47 10.51 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.03 -43.26 99.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.619 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.26 89.2 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.67 -40.64 76.31 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.501 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 4.6 mtp -56.78 -31.0 64.2 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.932 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -28.63 16.7 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.247 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.525 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -75.82 -8.93 58.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.292 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.693 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -93.47 -8.6 41.1 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.117 0.484 . . . . 0.0 109.762 179.198 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 23' ' ' THR . 14.0 m -129.8 -5.47 4.58 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.697 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 21' ' ' LEU . 13.8 mp0 44.99 -93.72 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.667 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -142.34 -7.65 0.89 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.381 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.49 HD23 ' HG3' ' B' ' 324' ' ' LYS . 9.4 mp -47.71 -90.6 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.605 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' C ' HG12 ' A' ' 28' ' ' VAL . . . 90.48 96.5 1.18 Allowed Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.526 HG12 ' C ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER 174.91 129.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 121.369 0.604 . . . . 0.0 110.377 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.794 ' OD1' HG22 ' A' ' 30' ' ' THR . 6.8 t70 -90.35 -91.87 0.14 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.721 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.794 HG22 ' OD1' ' A' ' 29' ' ' ASP . 10.8 t . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.045 -0.979 . . . . 0.0 110.539 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 41.05 -155.12 0.06 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 85.3 t -40.57 137.33 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.781 0.324 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.68 153.29 26.64 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.202 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -130.09 134.64 47.49 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.052 0.22 . . . . 0.0 111.436 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -138.93 129.3 25.69 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.533 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.878 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.39 102.32 10.41 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 123.902 1.811 . . . . 0.0 109.503 178.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.647 HG12 ' HB ' ' B' ' 382' ' ' THR . 26.2 m -114.33 158.08 14.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 112.76 -2.018 . . . . 0.0 110.187 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . 0.462 ' NZ ' ' CG ' ' A' ' 29' ' ' ASP . 12.2 mtpt -98.35 145.22 26.91 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' B' ' 326' ' ' VAL . 30.1 tt0 -127.29 145.55 50.75 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.927 0.87 . . . . 0.0 112.435 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . 0.502 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 5.7 tptm -75.56 101.13 4.79 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.599 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 34.5 mmt -104.2 168.97 8.76 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.74 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.759 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -102.03 143.52 31.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.205 178.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 125.31 -20.2 6.64 Favored Glycine 0 C--N 1.311 -0.839 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' B' ' 323' ' ' ASN . 14.9 ptpt -136.75 -21.13 1.29 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.331 -0.435 . . . . 0.0 111.022 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' B' ' 322' ' ' LYS . 2.3 t-20 85.97 -28.63 0.07 Allowed 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.643 0.59 . . . . 0.0 110.67 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.49 ' HG3' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -86.17 -174.96 5.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.114 0.483 . . . . 0.0 111.033 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . 0.444 HD11 HD21 ' A' ' 22' ' ' LEU . 19.2 mt -85.71 163.45 18.23 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.421 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.6 t -127.33 126.1 24.1 Favored Pre-proline 0 C--N 1.314 -0.966 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.132 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.442 ' O ' HG12 ' B' ' 326' ' ' VAL . 71.2 Cg_exo -44.14 143.03 3.63 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 N-CA-C 107.939 -1.6 . . . . 0.0 107.939 178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.637 HH21 ' CD1' ' B' ' 348' ' ' ILE . 2.2 tpt180 -148.52 -172.59 4.12 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.629 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -144.66 121.11 11.0 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 338' ' ' MET . 31.9 tp -99.4 158.61 15.6 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.198 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.432 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.34 108.34 0.52 Allowed Glycine 0 N--CA 1.426 -1.99 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.767 HD11 HD21 ' B' ' 330' ' ' LEU . 29.9 mm -88.19 123.26 40.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.722 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -117.88 138.37 52.17 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.06 15.73 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.752 0.31 . . . . 0.0 111.251 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.722 ' H ' ' C ' ' B' ' 333' ' ' THR . 11.2 pt-20 -145.12 -4.75 0.71 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.525 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.61 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.62 177.28 2.15 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 122.425 1.107 . . . . 0.0 112.89 -176.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.61 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.9 t -132.56 145.3 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 CA-C-N 113.065 -1.88 . . . . 0.0 106.315 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.836 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.63 150.61 29.67 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 117.175 -1.81 . . . . 0.0 114.423 -175.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.507 ' NH1' ' OE1' ' B' ' 317' ' ' GLU . 26.3 mtm105 -95.74 107.01 19.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.481 176.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.629 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -96.57 150.04 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.274 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.6 t0 -88.19 91.4 8.77 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.668 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.6 OUTLIER -35.4 -28.49 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.678 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' B' ' 341' ' ' ASP . 30.9 mttm -75.19 -43.96 49.18 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.704 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.559 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.95 -13.27 14.76 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -177.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 17.4 tttp 67.72 -0.9 1.8 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 109.988 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' B' ' 344' ' ' THR . 3.5 mt-10 -85.69 152.07 23.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.346 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.624 HG21 ' SD ' ' B' ' 338' ' ' MET . 85.6 t -81.38 133.9 28.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.514 0.673 . . . . 0.0 112.209 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.637 ' CD1' HH21 ' B' ' 328' ' ' ARG . 48.8 mt -103.83 -30.24 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.335 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.472 ' O ' ' CB ' ' B' ' 338' ' ' MET . 21.4 tt0 -139.72 157.41 45.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.639 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -143.35 149.98 38.52 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.321 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.554 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.87 124.12 4.27 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.102 177.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.516 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.54 140.63 3.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.394 0.616 . . . . 0.0 111.606 -178.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.595 HD12 ' O ' ' B' ' 333' ' ' THR . 2.0 tt -84.16 -35.89 23.26 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.7 t -74.26 9.87 1.49 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.824 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.575 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.0 m-20 -111.46 -7.56 14.34 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.069 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.5 HD12 HD23 ' B' ' 353' ' ' LEU . 81.3 mt -55.95 146.9 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.805 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -107.83 -45.9 3.9 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.502 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.9 ptt-85 -173.02 135.72 0.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.479 ' CH2' HD12 ' B' ' 396' ' ' ILE . 9.0 p90 -119.61 176.28 5.45 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.195 -177.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.93 99.59 1.54 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.017 -178.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.34 147.7 30.97 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.574 -1.193 . . . . 0.0 110.682 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.533 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -135.32 174.17 4.9 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -77.81 -8.13 16.74 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.137 1.892 . . . . 0.0 112.122 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' B' ' 382' ' ' THR . 5.6 mttm -130.74 -20.36 2.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.056 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.658 ' HA ' ' H ' ' B' ' 382' ' ' THR . 57.1 p -153.11 167.98 27.43 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.594 0.711 . . . . 0.0 111.934 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.42 156.46 46.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.618 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.546 ' CG2' HD12 ' A' ' 15' ' ' LEU . 26.0 m -148.51 154.81 40.32 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.03 -1.068 . . . . 0.0 113.081 -174.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.447 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.8 mt -125.82 140.0 53.03 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.362 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 8.6 t0 -117.4 95.6 5.04 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.654 176.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 30.5 t80 -137.93 94.94 2.95 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.985 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.85 12.11 1.99 Allowed Glycine 0 C--O 1.224 -0.51 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.3 t0 -41.61 -16.42 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.977 -0.612 . . . . 0.0 111.745 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.38 -37.33 64.88 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.47 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.06 -92.31 0.51 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.89 -1.505 . . . . 0.0 107.283 176.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.47 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.5 t70 -129.59 96.36 4.24 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.5 -3.34 53.28 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.21 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.677 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.21 106.79 16.11 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . 0.4 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.9 OUTLIER -114.53 120.3 39.76 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.748 176.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.501 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 34.8 t -138.68 163.91 30.9 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.54 175.81 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.15 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.76 124.29 47.15 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.904 0.859 . . . . 0.0 110.754 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.658 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.69 136.85 14.77 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.87 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.74 17.42 4.76 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.247 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.06 83.74 1.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.996 175.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.53 -58.24 1.97 Allowed Glycine 0 C--N 1.317 -0.498 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.1 pt-20 -44.81 -20.17 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 114.949 -0.625 . . . . 0.0 111.032 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.432 ' N ' ' C ' ' B' ' 385' ' ' GLY . 6.7 mm-40 -83.47 -38.87 21.27 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' B' ' 385' ' ' GLY . 53.2 mt -76.68 -42.2 34.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.613 177.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.756 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.69 -42.58 61.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.363 -1.289 . . . . 0.0 113.541 -177.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.443 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.9 pt20 -63.55 -34.45 77.83 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.051 0.929 . . . . 0.0 111.069 -177.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.02 -53.32 10.29 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.81 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.654 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.6 mt -49.21 -55.09 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 176.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.486 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.38 -34.1 46.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.55 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.79 -17.95 62.54 Favored Glycine 0 CA--C 1.506 -0.529 0 N-CA-C 110.914 -0.875 . . . . 0.0 110.914 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.681 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.91 -36.93 18.1 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.479 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.28 -13.29 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 CA-C-O 122.151 0.976 . . . . 0.0 109.283 176.142 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.49 -22.62 47.19 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 113.741 -1.572 . . . . 0.0 109.447 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.7 mt -91.94 -61.85 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-N 113.901 -1.499 . . . . 0.0 112.037 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -65.12 -20.17 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.357 -176.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.555 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.454 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.838 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 8' ' ' ILE . 5.4 mt -145.05 149.7 16.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.997 0.427 . . . . 0.0 110.644 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.61 -64.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.142 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.516 ' O ' ' C ' ' A' ' 11' ' ' MET . 8.9 mt-30 -122.5 -21.35 5.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.88 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.516 ' C ' ' O ' ' A' ' 10' ' ' GLN . 12.5 mtm -15.58 -63.38 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 124.277 0.986 . . . . 0.0 112.106 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -42.63 -66.8 0.33 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.101 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -59.33 -34.26 72.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.874 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.67 -45.2 95.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.016 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.559 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? -75.19 -38.16 60.91 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.84 -40.33 83.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.3 -42.03 99.72 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.491 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.4 mt-10 -65.39 -37.67 87.69 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.493 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 8.6 mtp -58.88 -32.52 69.56 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.855 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -50.98 -30.23 14.49 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.158 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.537 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.5 mm? -70.61 -11.84 61.19 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.269 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.745 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -90.6 -9.38 47.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.98 0.419 . . . . 0.0 109.986 179.462 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.484 ' N ' HD23 ' A' ' 22' ' ' LEU . 4.4 m -118.55 -8.7 10.41 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.338 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.453 ' O ' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER -56.09 -160.27 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.724 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -52.73 -166.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.85 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.524 ' N ' ' OG ' ' A' ' 25' ' ' SER . 10.4 mp -40.6 -88.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.618 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.43 97.9 0.01 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.533 HG23 ' H ' ' A' ' 29' ' ' ASP . 2.5 m -69.58 -104.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.802 0.334 . . . . 0.0 110.514 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.533 ' H ' HG23 ' A' ' 28' ' ' VAL . 9.3 t70 -72.76 53.21 0.32 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.551 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.1 m . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.579 -179.939 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 48.54 -95.14 0.01 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.93 134.74 65.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.772 0.32 . . . . 0.0 110.786 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.02 153.7 25.22 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.099 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -127.79 135.57 50.28 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 123.1 0.25 . . . . 0.0 111.56 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -140.31 128.11 21.86 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.568 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.912 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.58 107.99 13.84 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 123.653 1.692 . . . . 0.0 109.477 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.649 HG12 ' HB ' ' B' ' 382' ' ' THR . 31.1 m -119.85 161.28 19.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 112.706 -2.043 . . . . 0.0 110.072 -176.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -102.58 146.02 28.78 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' B' ' 326' ' ' VAL . 20.5 tt0 -130.32 147.24 52.01 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.993 0.902 . . . . 0.0 112.275 -178.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' B' ' 323' ' ' ASN . 5.5 tptm -75.49 101.86 5.01 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.095 -1.412 . . . . 0.0 111.758 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 34.1 mmt -105.08 169.24 8.55 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.654 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.759 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.96 142.35 33.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.335 178.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 126.62 -20.61 6.09 Favored Glycine 0 C--N 1.312 -0.802 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' B' ' 323' ' ' ASN . 15.5 ptpt -136.4 -21.58 1.34 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.354 -0.423 . . . . 0.0 111.147 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' B' ' 322' ' ' LYS . 0.2 OUTLIER 86.84 -29.57 0.05 Allowed 'General case' 0 C--N 1.333 -0.136 0 O-C-N 123.698 0.624 . . . . 0.0 110.814 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.98 -175.2 5.47 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.045 0.45 . . . . 0.0 111.136 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 20.7 mt -84.45 163.16 19.64 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.46 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.2 t -126.86 124.25 23.96 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.139 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.434 ' O ' HG12 ' B' ' 326' ' ' VAL . 64.0 Cg_exo -44.87 145.09 3.13 Favored 'Trans proline' 0 C--N 1.32 -0.937 0 N-CA-C 108.088 -1.543 . . . . 0.0 108.088 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' B' ' 315' ' ' VAL . 12.5 ttm-85 -151.68 -172.89 4.35 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.62 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.21 121.13 13.59 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.834 HD12 ' O ' ' B' ' 338' ' ' MET . 31.9 tp -99.17 157.95 16.01 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.01 108.04 0.52 Allowed Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -87.96 122.19 39.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.727 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.2 p -116.56 138.2 51.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -57.59 14.09 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.031 0.443 . . . . 0.0 111.647 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.727 ' H ' ' C ' ' B' ' 333' ' ' THR . 16.2 pt-20 -144.2 -3.63 0.84 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.758 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.618 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -174.59 178.18 1.98 Allowed 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.386 1.089 . . . . 0.0 112.898 -176.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.618 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 11.0 t -134.18 144.72 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 113.106 -1.861 . . . . 0.0 106.386 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.834 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.6 ptt? -152.71 151.46 30.56 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 117.175 -1.81 . . . . 0.0 114.42 -175.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.18 106.69 18.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.385 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.651 ' N ' ' O ' ' B' ' 329' ' ' LEU . 3.0 t -96.1 149.26 4.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.293 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' B' ' 343' ' ' LYS . 46.0 t0 -87.26 90.49 8.38 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.854 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.8 OUTLIER -35.84 -28.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.686 179.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' B' ' 341' ' ' ASP . 15.9 mttp -70.49 -44.01 68.55 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.613 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -114.21 -17.55 11.84 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' B' ' 344' ' ' THR . 8.3 tttp 77.46 -0.0 2.87 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.458 ' O ' HG13 ' B' ' 340' ' ' VAL . 8.1 pt-20 -82.47 157.82 23.47 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.593 HG21 ' SD ' ' B' ' 338' ' ' MET . 90.3 t -87.38 131.69 34.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.363 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.417 HD11 ' HB2' ' B' ' 341' ' ' ASP . 59.3 mt -101.35 -29.99 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.455 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.488 ' O ' ' CB ' ' B' ' 338' ' ' MET . 18.0 tt0 -140.81 158.23 44.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.626 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -143.79 151.25 39.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.232 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -160.31 124.83 3.75 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.19 177.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.502 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -47.09 139.42 5.86 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.448 0.642 . . . . 0.0 111.493 -178.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.583 HD12 ' O ' ' B' ' 333' ' ' THR . 1.9 tt -82.99 -35.67 25.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.2 t -74.15 9.69 1.52 Allowed 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.935 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.57 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.1 m-20 -111.29 -7.67 14.4 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.992 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.467 HD12 HD23 ' B' ' 353' ' ' LEU . 78.9 mt -56.55 146.69 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.826 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -107.76 -45.12 4.08 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.503 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 10.3 ptt180 -173.79 136.1 0.54 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.513 ' CH2' HD12 ' B' ' 396' ' ' ILE . 7.9 p90 -119.09 177.24 4.94 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.23 -177.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -158.58 99.23 1.57 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 119.278 -0.969 . . . . 0.0 112.101 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.13 147.13 30.21 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.647 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.53 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -135.69 173.71 5.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -76.98 -8.39 17.74 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.088 1.858 . . . . 0.0 112.297 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.9 mttm -130.66 -20.76 2.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.057 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.652 ' HA ' ' H ' ' B' ' 382' ' ' THR . 59.3 p -152.47 167.67 28.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.572 0.701 . . . . 0.0 111.852 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.478 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -139.2 156.79 46.85 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.815 179.619 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.559 ' CG2' HD12 ' A' ' 15' ' ' LEU . 24.9 m -148.65 155.52 41.16 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.11 -1.036 . . . . 0.0 113.17 -174.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' B' ' 359' ' ' TRP . 6.8 mt -126.05 140.15 52.83 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.168 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 9.2 t0 -117.69 95.6 5.01 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.547 176.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.57 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 31.0 t80 -137.63 94.71 2.95 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.937 176.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.85 12.17 1.98 Allowed Glycine 0 C--O 1.225 -0.421 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 9.7 t0 -41.6 -16.16 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.953 -0.624 . . . . 0.0 111.818 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.45 -37.44 65.19 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.473 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.87 -92.59 0.5 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.909 -1.496 . . . . 0.0 107.187 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.473 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 4.5 t70 -129.34 96.18 4.23 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 174.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.24 -3.37 54.05 Favored Glycine 0 C--N 1.311 -0.851 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.256 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.02 106.73 15.9 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -175.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . 0.403 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.9 OUTLIER -114.05 120.38 40.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.759 175.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.493 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 34.7 t -138.46 163.87 30.83 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.679 0.752 . . . . 0.0 112.909 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.6 m -150.76 175.56 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.101 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -101.53 125.08 48.13 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 122.12 0.962 . . . . 0.0 110.799 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.652 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.22 136.51 14.0 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.831 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.22 17.35 4.38 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.175 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . 0.425 ' CB ' HE21 ' B' ' 387' ' ' GLN . 0.2 OUTLIER -144.04 83.94 1.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.936 174.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.98 -58.78 1.95 Allowed Glycine 0 C--O 1.223 -0.557 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.501 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 8.7 pt-20 -44.45 -20.87 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 114.787 -0.706 . . . . 0.0 111.027 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' B' ' 385' ' ' GLY . 22.3 mt-30 -82.37 -39.35 22.86 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' B' ' 385' ' ' GLY . 51.6 mt -76.59 -42.2 34.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.579 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.78 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.89 -42.57 60.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.534 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 5.0 pp0? -63.81 -34.44 77.91 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.075 0.941 . . . . 0.0 111.105 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.05 -53.42 10.02 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 113.918 -1.492 . . . . 0.0 108.73 -179.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.8 mt -48.97 -55.56 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.487 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -51.96 -34.01 40.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.777 -2.01 . . . . 0.0 110.635 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.89 -18.16 61.9 Favored Glycine 0 CA--C 1.506 -0.491 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.684 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.5 m-30 -86.79 -36.82 18.34 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.513 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.42 -13.3 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.893 0 CA-C-O 122.195 0.998 . . . . 0.0 109.29 176.165 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.42 -22.6 47.5 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 113.667 -1.606 . . . . 0.0 109.512 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.5 mt -91.9 -62.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 113.921 -1.49 . . . . 0.0 112.003 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.68 -20.24 26.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.359 -1.746 . . . . 0.0 112.393 -176.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.559 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.715 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.578 HG22 ' H ' ' A' ' 9' ' ' ASP . 0.8 OUTLIER 39.86 -161.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.711 179.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.578 ' H ' HG22 ' A' ' 8' ' ' ILE . 50.9 t0 58.16 -78.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.376 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 13' ' ' SER . 81.2 mt-30 -76.83 -41.86 42.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.962 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 14' ' ' THR . 62.3 mtp -19.18 -72.27 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 124.121 0.888 . . . . 0.0 112.099 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.426 ' C ' ' O ' ' A' ' 11' ' ' MET . 10.9 m-85 -39.42 -57.38 1.43 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.928 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 10' ' ' GLN . 1.8 t -67.27 -24.54 65.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.779 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 11' ' ' MET . 0.2 OUTLIER -75.39 -19.95 59.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 -179.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.558 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.6 mm? -109.98 -41.02 4.58 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 16' ' ' LEU . 74.5 mt -62.08 -43.75 98.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.79 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.35 -36.08 81.92 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.354 -1.499 . . . . 0.0 109.354 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.83 -41.74 67.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.511 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 6.1 mtp -52.33 -32.54 38.54 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.891 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.42 -26.49 12.79 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.317 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.543 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.2 mm? -79.59 -6.85 57.92 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.376 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -93.72 -10.33 34.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.901 0.381 . . . . 0.0 110.028 179.61 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.494 ' N ' HD23 ' A' ' 22' ' ' LEU . 2.9 m -118.68 -15.75 9.47 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.006 0.431 . . . . 0.0 110.315 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.3 -72.52 0.05 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.243 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -178.1 -47.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.213 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 26' ' ' LEU . 11.0 mp -63.84 -99.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.568 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 49.81 88.1 0.01 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.459 ' CG1' ' N ' ' A' ' 29' ' ' ASP . 3.4 p -74.51 -41.13 49.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.007 0.432 . . . . 0.0 110.71 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.459 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 29.5 t70 55.03 95.21 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.555 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 29' ' ' ASP . 1.3 p . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.558 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -80.58 -155.03 10.9 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 95.2 t -40.71 137.26 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.736 0.303 . . . . 0.0 110.769 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.58 153.59 27.31 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.189 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -129.58 134.13 47.56 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.14 0.275 . . . . 0.0 111.45 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -138.93 128.01 23.88 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.615 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.896 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -81.06 106.09 12.78 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 123.762 1.744 . . . . 0.0 109.284 178.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.7 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.5 m -118.55 162.68 16.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 112.669 -2.059 . . . . 0.0 110.12 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -103.83 145.98 29.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' B' ' 326' ' ' VAL . 38.1 tt0 -135.43 152.27 51.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.059 0.933 . . . . 0.0 112.538 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 9.7 tptm -79.29 101.44 8.05 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.636 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.687 ' N ' ' SD ' ' B' ' 319' ' ' MET . 0.0 OUTLIER -92.27 179.38 5.57 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.989 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.768 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -98.52 142.33 30.25 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.914 178.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 126.25 -26.19 5.31 Favored Glycine 0 C--N 1.31 -0.882 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' B' ' 324' ' ' LYS . 20.4 pttp -146.51 -157.87 0.85 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.487 -0.356 . . . . 0.0 110.456 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -117.71 -27.22 6.32 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.822 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.523 ' HD2' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -73.55 -176.74 2.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.058 0.456 . . . . 0.0 111.045 -179.279 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . 0.511 HD11 HD21 ' A' ' 22' ' ' LEU . 31.3 mt -99.4 167.16 10.81 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.34 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' B' ' 317' ' ' GLU . 19.6 t -123.69 126.55 25.72 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.018 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.427 ' O ' HG12 ' B' ' 326' ' ' VAL . 67.8 Cg_exo -44.52 144.73 3.01 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 N-CA-C 108.117 -1.532 . . . . 0.0 108.117 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.623 ' N ' ' O ' ' B' ' 315' ' ' VAL . 8.1 ttm180 -151.18 -173.09 4.39 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 119.577 -0.849 . . . . 0.0 108.712 -177.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.12 121.47 13.99 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.832 HD12 ' O ' ' B' ' 338' ' ' MET . 33.3 tp -99.41 158.42 15.74 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.213 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' B' ' 338' ' ' MET . . . -142.83 108.44 0.52 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 177.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.719 HD11 HD21 ' B' ' 330' ' ' LEU . 30.0 mm -87.91 123.96 40.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.728 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.4 p -118.42 138.38 52.5 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.83 14.71 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.122 0.487 . . . . 0.0 111.562 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.728 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.2 pt-20 -144.59 -4.11 0.78 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.805 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.13 176.77 2.03 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 122.323 1.059 . . . . 0.0 112.989 -176.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.615 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 9.5 t -132.58 145.8 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 CA-C-N 113.209 -1.814 . . . . 0.0 106.269 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.832 ' O ' HD12 ' B' ' 330' ' ' LEU . 1.2 ptt? -152.66 151.16 30.25 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 117.167 -1.813 . . . . 0.0 114.549 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.554 ' NH1' ' NE2' ' B' ' 349' ' ' GLN . 2.7 mtm180 -95.76 106.8 18.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.436 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.46 149.5 4.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.29 -178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' B' ' 343' ' ' LYS . 42.9 t0 -87.63 90.83 8.52 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.862 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.8 OUTLIER -36.24 -27.27 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.654 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' B' ' 341' ' ' ASP . 16.1 mttp -70.64 -43.17 69.78 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.672 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.533 ' N ' ' O ' ' B' ' 341' ' ' ASP . 26.6 p -115.59 -17.86 11.05 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' B' ' 344' ' ' THR . 10.3 tttm 78.16 1.19 2.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.913 0.387 . . . . 0.0 110.126 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.445 ' O ' HG13 ' B' ' 340' ' ' VAL . 6.3 pt-20 -84.97 156.98 20.93 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.616 HG21 ' SD ' ' B' ' 338' ' ' MET . 91.7 t -86.69 132.87 31.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.508 0.67 . . . . 0.0 112.394 -178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 22.0 mm -102.6 -30.6 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.267 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.554 ' NE2' ' NH1' ' B' ' 339' ' ' ARG . 2.7 tt0 -140.45 157.87 44.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.622 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -142.28 150.29 40.67 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.19 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.568 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -157.16 122.32 4.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.136 177.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.499 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.48 138.95 4.02 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.403 0.621 . . . . 0.0 111.503 -178.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.601 HD12 ' O ' ' B' ' 333' ' ' THR . 1.7 tt -81.66 -36.99 28.18 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . 0.514 ' O ' HG22 ' B' ' 354' ' ' THR . 17.4 m -70.97 6.9 1.34 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.892 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.569 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 10.7 m-20 -108.55 -4.95 16.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.93 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.538 HD12 HD23 ' B' ' 353' ' ' LEU . 70.8 mt -60.65 144.16 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.743 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -107.3 -45.63 4.06 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.4 ptt-85 -172.43 135.77 0.74 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.541 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.7 p90 -118.95 175.51 5.72 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.119 -177.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.87 98.94 1.66 Allowed 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 119.199 -1.001 . . . . 0.0 111.891 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.79 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.16 149.54 29.07 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.839 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.522 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -137.86 174.99 3.72 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -78.42 -7.0 15.83 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.266 1.977 . . . . 0.0 112.134 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' B' ' 382' ' ' THR . 47.6 mttt -130.84 -22.53 2.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.001 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.644 ' HA ' ' H ' ' B' ' 382' ' ' THR . 63.8 p -152.74 165.94 33.74 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.653 0.74 . . . . 0.0 111.85 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.485 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -137.36 156.98 47.58 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.737 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.558 ' CG2' HD12 ' A' ' 15' ' ' LEU . 27.7 m -148.52 156.29 42.25 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.065 -174.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.45 ' N ' HG22 ' B' ' 367' ' ' THR . 7.1 mt -126.71 141.45 51.84 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.435 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.4 t0 -118.44 95.41 4.86 Favored 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.691 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 17.6 t80 -137.18 94.85 3.0 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.951 176.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.545 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.79 12.24 1.98 Allowed Glycine 0 C--O 1.225 -0.412 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -41.73 -16.15 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.001 -0.6 . . . . 0.0 111.857 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.1 m-85 -54.52 -37.51 65.45 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.466 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -125.82 -92.27 0.51 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.958 -1.473 . . . . 0.0 107.345 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.466 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 12.9 t0 -129.75 96.37 4.22 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.46 -2.7 53.56 Favored Glycine 0 C--N 1.311 -0.82 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.271 -178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.666 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -84.81 106.87 16.67 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -175.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.11 122.69 46.87 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.663 176.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.511 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 34.3 t -139.03 163.69 31.73 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.35 173.66 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.113 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -99.92 125.29 45.89 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.976 0.893 . . . . 0.0 110.872 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.7 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -155.21 136.39 13.91 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.912 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.09 16.83 4.66 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.296 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.19 84.1 1.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.992 175.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.76 -58.26 2.05 Favored Glycine 0 C--N 1.317 -0.487 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 9.9 pt-20 -44.73 -20.09 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 114.893 -0.653 . . . . 0.0 111.047 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.434 ' N ' ' C ' ' B' ' 385' ' ' GLY . 46.7 mt-30 -82.89 -39.76 21.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' B' ' 385' ' ' GLY . 51.4 mt -76.66 -41.84 34.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.687 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.79 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.86 -42.19 61.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.362 -1.29 . . . . 0.0 113.604 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.462 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.4 pt20 -64.19 -34.44 78.08 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 122.06 0.933 . . . . 0.0 111.047 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -74.09 -53.47 9.87 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.759 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -48.93 -55.28 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.491 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.6 -33.9 48.45 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 112.801 -2.0 . . . . 0.0 110.506 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -84.75 -17.98 62.55 Favored Glycine 0 CA--C 1.506 -0.521 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.68 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.4 m-30 -86.91 -37.07 17.98 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.541 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.44 -13.14 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.911 0 CA-C-O 122.102 0.953 . . . . 0.0 109.325 176.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.04 -22.6 45.15 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.507 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.9 mt -91.83 -61.96 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 CA-C-N 113.865 -1.516 . . . . 0.0 112.105 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.54 -20.54 27.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.38 -176.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.561 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.462 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.801 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.3 mt -101.0 151.15 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.567 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.502 ' O ' ' CD2' ' A' ' 12' ' ' PHE . 54.3 t0 -172.91 -116.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.575 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.488 ' O ' ' C ' ' A' ' 11' ' ' MET . 25.9 mt-30 -37.74 -33.53 0.08 Allowed 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.399 0.437 . . . . 0.0 110.764 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.488 ' C ' ' O ' ' A' ' 10' ' ' GLN . 6.7 mmm -21.2 -56.72 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 124.222 0.951 . . . . 0.0 111.848 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.502 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 9.6 m-85 -54.96 -71.96 0.07 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.047 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.0 t -46.35 -26.17 0.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.708 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -67.88 -54.63 17.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.644 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.564 HD12 HG21 ' B' ' 367' ' ' THR . 4.3 mm? -75.9 -41.15 52.83 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -39.34 81.73 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.57 -45.52 96.15 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.518 ' OE2' ' CD2' ' B' ' 377' ' ' TYR . 82.5 mt-10 -61.36 -34.14 74.81 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.554 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 7.4 mtp -70.01 -32.63 70.9 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.191 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.2 OUTLIER -55.42 -19.47 9.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.191 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.519 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 4.2 mm? -71.45 -38.39 71.31 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.085 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.829 HD13 HD11 ' B' ' 325' ' ' LEU . 4.0 pp -100.92 6.06 43.49 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.461 -0.495 . . . . 0.0 109.961 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 25' ' ' SER . 1.3 m -124.77 -25.29 3.97 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.171 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 20' ' ' ASP . 8.9 mp0 35.11 -91.34 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.098 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 23' ' ' THR . 6.6 p -139.89 -139.68 0.13 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.213 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.84 HD22 ' N ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -101.35 -116.71 0.18 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.449 -179.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.51 -57.72 4.45 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.759 HG21 ' NZ ' ' B' ' 324' ' ' LYS . 96.6 t -102.93 -3.43 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.802 0.334 . . . . 0.0 110.59 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.76 -89.87 0.35 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.524 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.533 180.0 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 136.24 -86.21 0.24 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 69.2 t -126.73 133.62 68.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.835 0.35 . . . . 0.0 110.712 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.44 153.1 25.49 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.081 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -128.99 134.76 48.29 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.037 0.211 . . . . 0.0 111.405 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -138.35 129.76 27.55 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.763 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.871 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.12 104.02 12.16 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 123.666 1.698 . . . . 0.0 109.283 178.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.598 ' O ' ' N ' ' B' ' 328' ' ' ARG . 34.7 m -120.27 157.27 22.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 112.867 -1.97 . . . . 0.0 110.167 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' B' ' 380' ' ' VAL . 7.0 mtmt -96.6 139.5 32.59 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.454 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' B' ' 326' ' ' VAL . 3.2 tt0 -126.43 154.32 43.82 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 122.007 0.908 . . . . 0.0 113.061 -177.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -75.92 103.01 5.78 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.335 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . . . . . . . . . 36.1 mmt -102.31 179.26 4.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.972 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.766 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -96.78 146.12 25.2 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.037 178.63 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 123.56 -26.24 6.04 Favored Glycine 0 C--N 1.312 -0.757 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -140.46 -142.04 0.14 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.59 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.38 -20.76 1.19 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.527 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.759 ' NZ ' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -89.48 -179.54 5.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.017 0.437 . . . . 0.0 111.052 -179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . 0.829 HD11 HD13 ' A' ' 22' ' ' LEU . 15.1 mt -85.14 160.96 19.83 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.241 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' B' ' 317' ' ' GLU . 3.4 t -122.81 129.8 24.87 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.99 -178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.542 ' O ' ' NE ' ' B' ' 328' ' ' ARG . 80.1 Cg_exo -38.05 144.62 0.17 Allowed 'Trans proline' 0 CA--C 1.508 -0.816 0 N-CA-C 108.701 -1.307 . . . . 0.0 108.701 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' B' ' 315' ' ' VAL . 0.3 OUTLIER -157.15 -171.54 3.67 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.324 -0.951 . . . . 0.0 108.82 -176.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.643 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.0 OUTLIER -142.81 124.38 14.88 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.832 HD12 ' O ' ' B' ' 338' ' ' MET . 27.9 tp -103.95 158.18 16.59 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.427 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.41 107.84 0.52 Allowed Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.758 HD11 HD21 ' B' ' 330' ' ' LEU . 31.6 mm -88.35 123.59 40.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.73 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.4 p -118.19 137.91 52.67 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 20.9 pttm -57.36 13.64 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.004 0.43 . . . . 0.0 111.793 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.73 ' H ' ' C ' ' B' ' 333' ' ' THR . 12.7 pt-20 -144.32 -2.85 0.86 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.991 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.601 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.9 178.72 2.12 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.307 1.051 . . . . 0.0 112.982 -177.07 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.601 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 12.0 t -136.38 145.6 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-N 113.338 -1.756 . . . . 0.0 106.682 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.832 ' O ' HD12 ' B' ' 330' ' ' LEU . 3.2 ptt? -153.95 149.49 27.33 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 117.062 -1.855 . . . . 0.0 114.356 -176.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.529 ' NE ' ' OE1' ' B' ' 317' ' ' GLU . 12.1 mtp180 -94.14 107.65 19.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.666 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.9 t -98.73 149.71 5.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.2 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' B' ' 344' ' ' THR . 26.9 t0 -89.6 92.27 9.02 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.815 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 341' ' ' ASP . 1.1 tt0 -35.46 -28.83 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.65 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' B' ' 341' ' ' ASP . 14.8 mttp -75.17 -43.62 51.19 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.704 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.555 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.2 -12.55 14.78 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' B' ' 341' ' ' ASP . 6.1 ttmt 66.67 -1.15 1.38 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.029 0.442 . . . . 0.0 109.961 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.459 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.5 mt-10 -84.71 153.53 23.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.322 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.596 HG21 ' SD ' ' B' ' 338' ' ' MET . 79.2 t -82.83 135.29 25.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.454 0.645 . . . . 0.0 112.288 -178.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 66.0 mt -103.67 -30.39 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.424 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.473 ' O ' ' CB ' ' B' ' 338' ' ' MET . 19.9 tt0 -140.55 156.63 46.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.715 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -145.74 149.61 34.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.495 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' B' ' 337' ' ' VAL . 63.5 t-105 -162.79 135.15 5.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.892 177.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.503 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -52.57 138.75 27.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.411 -178.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.626 HD12 ' O ' ' B' ' 333' ' ' THR . 1.9 tt -79.03 -35.82 42.05 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.64 10.92 1.16 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.98 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.503 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.4 m-20 -114.23 -4.43 13.06 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.217 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.499 HD12 HD23 ' B' ' 353' ' ' LEU . 71.6 mt -57.48 147.81 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.068 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 26.8 tttt -105.84 -45.84 4.28 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 0.2 OUTLIER -174.45 136.3 0.46 Allowed 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.405 177.272 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.478 ' CH2' HD12 ' B' ' 396' ' ' ILE . 10.0 p90 -119.99 173.64 6.95 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.256 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.73 99.72 1.73 Allowed 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 119.153 -1.019 . . . . 0.0 112.252 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -81.49 144.29 31.45 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.797 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.549 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -132.14 174.28 4.89 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -77.66 -8.63 17.06 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.165 1.91 . . . . 0.0 112.019 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' B' ' 382' ' ' THR . 13.0 mtpp -130.95 -19.24 2.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.121 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.683 ' HA ' ' H ' ' B' ' 382' ' ' THR . 92.8 p -152.78 168.5 25.5 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.552 0.691 . . . . 0.0 112.062 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.506 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.2 OUTLIER -140.84 156.94 46.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.914 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.564 HG21 HD12 ' A' ' 15' ' ' LEU . 64.1 m -147.3 158.99 44.17 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.003 -174.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.534 ' N ' HG22 ' B' ' 367' ' ' THR . 5.8 mt -133.23 140.29 47.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.515 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 19.5 t0 -117.33 96.13 5.28 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.615 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 9.5 p90 -136.9 93.92 2.9 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.352 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.66 12.49 1.76 Allowed Glycine 0 C--O 1.227 -0.294 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -41.73 -15.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.18 -0.51 . . . . 0.0 111.769 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.562 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.46 -37.44 65.2 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.47 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.5 OUTLIER -125.76 -92.87 0.5 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.111 176.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.47 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 6.4 t0 -129.05 96.27 4.29 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 174.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.13 -2.66 55.87 Favored Glycine 0 C--N 1.312 -0.78 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.245 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.38 105.44 16.71 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -175.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.79 127.44 54.34 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.554 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 23.2 t -137.67 158.35 44.55 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.348 0.594 . . . . 0.0 112.349 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . 0.401 ' CB ' ' O ' ' B' ' 316' ' ' LYS . 2.4 m -141.72 172.63 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.004 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . 0.673 ' HB2' HD12 ' B' ' 325' ' ' LEU . 2.1 mt-30 -103.35 124.62 49.03 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.896 0.855 . . . . 0.0 110.796 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.683 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -154.89 139.17 16.64 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.183 179.336 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.09 16.08 6.58 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.313 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.98 84.48 1.78 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.075 175.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -86.37 -56.93 2.18 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.7 pt-20 -44.98 -20.22 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 114.615 -0.792 . . . . 0.0 110.945 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.428 ' N ' ' C ' ' B' ' 385' ' ' GLY . 3.2 mm-40 -82.62 -39.76 21.71 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' B' ' 385' ' ' GLY . 45.0 mt -76.6 -42.38 34.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.763 178.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.775 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.4 -42.01 62.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.255 -1.339 . . . . 0.0 113.68 -177.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.437 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 2.3 pt20 -64.06 -34.83 78.92 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.975 -177.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.649 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.85 -53.75 10.61 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.796 -1.547 . . . . 0.0 108.664 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.649 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.2 -55.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.479 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.7 -33.69 48.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.852 -1.976 . . . . 0.0 110.697 178.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.01 -17.84 62.3 Favored Glycine 0 CA--C 1.506 -0.471 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -178.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.674 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.04 -36.99 17.88 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.478 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.65 -13.18 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 CA-C-O 122.18 0.99 . . . . 0.0 109.236 176.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -78.48 -22.62 47.23 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 113.752 -1.567 . . . . 0.0 109.511 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.7 mt -91.78 -62.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.978 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.39 -20.56 27.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 113.423 -1.717 . . . . 0.0 112.379 -177.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.558 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.82 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 8.2 p30 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 9' ' ' ASP . 1.2 tt -54.13 -168.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.478 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.548 ' N ' HG23 ' A' ' 8' ' ' ILE . 9.9 t0 62.06 -65.79 0.08 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.932 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 8' ' ' ILE . 9.6 mt-30 -67.51 -54.77 17.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.516 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.468 ' C ' ' O ' ' A' ' 10' ' ' GLN . 29.8 mtp -22.92 -69.15 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 123.974 0.796 . . . . 0.0 112.079 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -42.98 -57.77 2.71 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.976 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -62.58 -39.37 93.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.974 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.71 -44.56 69.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.978 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.561 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.5 mm? -76.65 -40.42 49.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -39.63 80.03 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.09 -43.4 98.8 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.484 ' OE1' ' CG ' ' B' ' 377' ' ' TYR . 92.6 mt-10 -63.3 -37.93 89.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.475 -0.362 . . . . 0.0 110.036 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.674 ' HE2' HD13 ' A' ' 22' ' ' LEU . 13.5 mtp -58.7 -35.1 72.09 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.853 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.57 -29.21 6.64 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.421 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.548 ' N ' HD22 ' A' ' 21' ' ' LEU . 4.0 mm? -77.72 -18.05 56.96 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.172 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.714 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -76.65 -13.29 60.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.65 ' N ' HD23 ' A' ' 22' ' ' LEU . 1.2 m -111.52 -44.23 3.55 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.561 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.574 ' O ' ' N ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER 47.27 -179.72 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.395 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER 38.86 -88.75 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.83 179.572 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' A' ' 24' ' ' GLN . 1.1 tp -41.57 -39.8 1.69 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.665 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.03 -32.45 9.83 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' ' 28' ' ' VAL . 53.6 t -71.94 -4.82 5.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.814 0.34 . . . . 0.0 110.571 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.92 -1.56 27.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.53 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.544 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . -80.31 -152.84 8.32 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 94.2 t -40.9 137.54 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.728 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.03 153.59 27.87 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.162 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -129.54 134.36 47.72 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.042 0.214 . . . . 0.0 111.439 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -139.22 127.78 23.09 Favored 'General case' 0 C--N 1.346 0.43 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.596 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.906 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -80.75 106.85 13.07 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 123.712 1.72 . . . . 0.0 109.272 178.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.697 HG12 ' HB ' ' B' ' 382' ' ' THR . 28.0 m -119.8 162.82 17.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-N 112.755 -2.02 . . . . 0.0 110.187 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 21.8 mttm -103.72 145.58 29.86 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' B' ' 326' ' ' VAL . 44.2 tt0 -135.73 152.32 51.04 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.023 0.916 . . . . 0.0 112.558 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . 0.499 ' HZ2' ' C ' ' B' ' 323' ' ' ASN . 6.3 tptm -79.36 100.74 7.74 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.46 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.673 ' N ' ' SD ' ' B' ' 319' ' ' MET . 0.0 OUTLIER -90.74 179.03 5.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.944 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.755 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.64 147.38 26.5 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.059 178.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 118.11 -25.03 8.5 Favored Glycine 0 C--N 1.313 -0.718 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -134.74 -143.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.651 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . 0.499 ' C ' ' HZ2' ' B' ' 318' ' ' LYS . 0.1 OUTLIER -140.16 -18.97 0.89 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.582 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.529 ' HD2' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -89.48 -176.75 5.14 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.944 0.402 . . . . 0.0 111.067 -179.293 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . 0.403 HD11 HD21 ' A' ' 22' ' ' LEU . 30.3 mt -92.0 162.16 14.5 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.164 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' B' ' 317' ' ' GLU . 10.7 t -123.01 126.88 25.88 Favored Pre-proline 0 N--CA 1.442 -0.86 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.089 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.449 ' O ' HG12 ' B' ' 326' ' ' VAL . 68.9 Cg_exo -43.9 144.51 2.47 Favored 'Trans proline' 0 C--N 1.321 -0.917 0 N-CA-C 108.209 -1.496 . . . . 0.0 108.209 178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.622 ' N ' ' O ' ' B' ' 315' ' ' VAL . 7.6 ttm180 -151.55 -173.02 4.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 119.496 -0.881 . . . . 0.0 108.628 -177.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.636 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -141.68 121.32 13.38 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.113 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.841 HD12 ' O ' ' B' ' 338' ' ' MET . 31.5 tp -99.47 158.72 15.53 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.175 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.435 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -142.95 108.7 0.53 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.727 HD11 HD21 ' B' ' 330' ' ' LEU . 30.2 mm -87.91 124.4 41.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.729 ' C ' ' H ' ' B' ' 335' ' ' GLU . 1.5 p -118.59 138.25 52.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.327 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -57.96 14.4 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.115 0.484 . . . . 0.0 111.769 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.729 ' H ' ' C ' ' B' ' 333' ' ' THR . 9.6 pt-20 -144.66 -3.06 0.81 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.981 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.62 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -175.64 176.95 1.82 Allowed 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.43 1.11 . . . . 0.0 112.833 -176.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.62 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 10.4 t -132.28 145.84 34.0 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-N 113.071 -1.877 . . . . 0.0 106.215 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.841 ' O ' HD12 ' B' ' 330' ' ' LEU . 0.9 OUTLIER -152.63 150.78 29.86 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 117.179 -1.808 . . . . 0.0 114.415 -175.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.54 ' HE ' ' CB ' ' B' ' 349' ' ' GLN . 60.0 mtm180 -95.85 106.94 19.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.397 176.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -96.65 149.93 4.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.278 -178.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' B' ' 344' ' ' THR . 27.0 t0 -88.07 91.6 8.83 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.736 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.9 OUTLIER -35.42 -28.38 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.671 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' B' ' 341' ' ' ASP . 28.1 mttp -75.39 -43.92 47.53 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.641 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.558 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.3 p -108.68 -13.47 14.79 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm 67.71 -1.11 1.74 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' B' ' 344' ' ' THR . 4.4 mt-10 -85.95 152.08 23.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.337 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.629 HG21 ' SD ' ' B' ' 338' ' ' MET . 86.9 t -80.99 133.26 29.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.527 0.68 . . . . 0.0 112.176 -178.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' B' ' 341' ' ' ASP . 55.0 mt -102.91 -30.29 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.323 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.54 ' CB ' ' HE ' ' B' ' 339' ' ' ARG . 22.1 tt0 -140.27 158.06 44.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . 0.401 ' N ' ' CG ' ' B' ' 349' ' ' GLN . 45.6 mt-10 -142.85 150.69 40.22 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.296 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' B' ' 337' ' ' VAL . 0.0 OUTLIER -158.02 122.47 4.23 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.227 177.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.511 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -45.01 140.1 2.84 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.51 0.672 . . . . 0.0 111.632 -178.755 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.614 HD12 ' O ' ' B' ' 333' ' ' THR . 1.5 tt -82.46 -36.48 26.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . 0.703 ' O ' HG22 ' B' ' 354' ' ' THR . 99.5 m -71.17 7.07 1.36 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.831 177.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.571 ' O ' ' CD1' ' B' ' 370' ' ' PHE . 11.2 m-20 -108.12 -5.26 17.06 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.828 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.555 HD12 HD23 ' B' ' 353' ' ' LEU . 72.1 mt -61.19 143.23 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.672 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -107.3 -45.29 4.13 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.501 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 4.0 ptt-85 -172.17 136.27 0.83 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.497 ' CH2' HD12 ' B' ' 396' ' ' ILE . 7.8 p90 -119.14 176.33 5.36 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.234 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -157.63 98.62 1.67 Allowed 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 119.066 -1.054 . . . . 0.0 112.044 -178.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.793 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -80.81 145.01 31.64 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.747 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.522 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.3 OUTLIER -133.76 174.15 5.02 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -77.69 -7.61 16.7 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.12 1.88 . . . . 0.0 112.158 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' B' ' 382' ' ' THR . 11.4 mtpt -130.86 -21.42 2.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.011 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.65 ' HA ' ' H ' ' B' ' 382' ' ' THR . 61.3 p -152.65 166.63 31.51 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.56 0.695 . . . . 0.0 111.908 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.484 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -137.68 156.84 47.58 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.823 179.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.561 ' CG2' HD12 ' A' ' 15' ' ' LEU . 29.1 m -148.81 155.06 40.4 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.117 -1.033 . . . . 0.0 113.215 -174.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' B' ' 359' ' ' TRP . 7.4 mt -125.81 139.83 53.17 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.181 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 10.1 t0 -117.6 95.65 5.04 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.569 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' B' ' 355' ' ' ASN . 15.1 t80 -137.45 94.43 2.92 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.955 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 131.92 11.98 2.0 Allowed Glycine 0 C--O 1.225 -0.407 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' B' ' 372' ' ' ASP . 8.9 t0 -41.47 -16.01 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.087 -0.556 . . . . 0.0 111.777 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.56 -37.08 65.03 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.473 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 1.1 pt20 -126.0 -92.94 0.49 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 113.876 -1.511 . . . . 0.0 107.072 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.473 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 16.3 t0 -128.9 96.38 4.34 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 174.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -101.53 -2.9 53.38 Favored Glycine 0 C--N 1.313 -0.7 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.339 -178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -83.79 106.65 15.66 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -175.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . 0.426 ' CE2' ' CZ3' ' B' ' 351' ' ' TRP . 0.6 OUTLIER -114.06 120.8 41.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.6 176.066 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.531 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 38.4 t -138.88 164.09 30.6 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.587 0.708 . . . . 0.0 112.818 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.84 174.1 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.874 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -100.47 125.49 46.78 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 122.0 0.905 . . . . 0.0 110.835 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.697 ' HB ' HG12 ' B' ' 315' ' ' VAL . 0.0 OUTLIER -155.56 136.78 13.88 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.832 179.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.25 17.0 4.62 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.147 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.01 84.19 1.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.092 175.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.88 -58.45 2.01 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.463 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.2 pt-20 -44.3 -20.19 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 114.814 -0.693 . . . . 0.0 111.026 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.441 ' N ' ' C ' ' B' ' 385' ' ' GLY . 67.5 mt-30 -82.75 -40.15 20.9 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.578 0.704 . . . . 0.0 109.102 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' B' ' 385' ' ' GLY . 49.5 mt -76.41 -42.04 35.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.719 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.793 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.46 -42.32 62.09 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.31 -1.314 . . . . 0.0 113.6 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.463 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 10.5 pt20 -64.14 -34.79 78.87 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.023 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -73.64 -53.67 9.89 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.954 -1.475 . . . . 0.0 108.727 -179.509 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.652 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 1.5 mt -48.59 -55.7 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 105.661 -1.978 . . . . 0.0 105.661 176.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.492 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.42 -33.8 45.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 112.761 -2.018 . . . . 0.0 110.578 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.12 -17.83 62.11 Favored Glycine 0 CA--C 1.505 -0.539 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.68 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.1 m-30 -86.88 -36.45 18.41 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.538 ' O ' HD12 ' B' ' 400' ' ' LEU . 0.0 OUTLIER -69.23 -13.23 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 CA-C-O 122.166 0.984 . . . . 0.0 109.308 176.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.77 -22.62 42.96 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.52 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' B' ' 395' ' ' TYR . 74.8 mt -91.23 -62.15 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.17 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.469 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.9 OUTLIER -61.4 -25.84 37.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 113.409 -1.723 . . . . 0.0 112.291 -176.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.538 HD12 ' O ' ' B' ' 396' ' ' ILE . 42.4 mt . . . . . 0 C--O 1.218 -0.581 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.693 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 8' ' ' ILE . 1.4 p-10 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.485 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 8.7 mt 58.35 148.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.585 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 10' ' ' GLN . 4.6 t70 -175.95 -85.88 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.917 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 4.6 mt-30 -104.19 -19.22 14.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.944 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.503 ' C ' ' O ' ' A' ' 10' ' ' GLN . 27.1 mtm -14.81 -61.43 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.366 0 O-C-N 124.279 0.987 . . . . 0.0 112.044 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -41.17 -62.29 0.86 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.205 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 10' ' ' GLN . 19.2 t -67.9 -25.05 65.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.748 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.14 -22.07 59.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.564 HD12 ' CG2' ' B' ' 367' ' ' THR . 4.4 mm? -100.09 -33.47 10.46 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -43.38 96.59 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.7 -36.42 89.67 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' OE2' ' CE2' ' B' ' 377' ' ' TYR . 92.6 mt-10 -70.77 -39.52 73.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.326 -0.437 . . . . 0.0 109.843 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.501 ' SD ' ' OG ' ' B' ' 379' ' ' SER . 9.9 mtp -56.16 -31.67 63.59 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.77 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.99 -29.52 21.11 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.458 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' N ' HD22 ' A' ' 21' ' ' LEU . 4.1 mm? -73.48 -10.37 59.65 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.241 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -88.89 -9.01 53.18 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.019 0.438 . . . . 0.0 110.0 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.537 ' N ' HD23 ' A' ' 22' ' ' LEU . 17.1 m -105.77 -34.72 7.59 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.21 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.563 HE21 ' C ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -108.49 136.3 48.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.773 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER 166.71 -9.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.721 -179.643 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.673 HD22 ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -41.12 -17.4 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.592 0.71 . . . . 0.0 112.42 179.109 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.609 ' N ' HD22 ' A' ' 26' ' ' LEU . . . -60.53 3.51 0.36 Allowed Glycine 0 C--N 1.305 -1.176 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.731 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.565 ' H ' ' C ' ' A' ' 26' ' ' LEU . 3.8 p -168.86 -41.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.092 0.472 . . . . 0.0 110.543 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.472 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 21.5 t70 -70.13 2.27 3.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.669 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.423 ' O ' ' O ' ' B' ' 322' ' ' LYS . 24.3 p . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.593 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 308' ' ' TYR . . . . . 0.616 ' N ' ' CD1' ' B' ' 308' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 134.66 -93.06 0.24 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 70.8 t -126.33 133.19 69.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 110.742 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 311' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.83 153.26 24.65 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.123 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -129.69 135.45 48.51 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.03 0.206 . . . . 0.0 111.483 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 313' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -138.83 129.89 26.7 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.565 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.875 HD13 ' O ' ' B' ' 314' ' ' LEU . 0.0 OUTLIER -82.61 104.72 13.09 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 123.918 1.818 . . . . 0.0 109.368 178.368 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 315' ' ' VAL . . . . . 0.652 ' O ' ' N ' ' B' ' 328' ' ' ARG . 32.9 m -115.71 161.19 14.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 112.523 -2.126 . . . . 0.0 110.086 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 316' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -103.57 145.0 30.69 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 317' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' B' ' 326' ' ' VAL . 27.8 tt0 -132.37 152.07 51.6 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.102 0.953 . . . . 0.0 112.729 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 318' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -80.95 102.19 9.96 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.204 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 319' ' ' MET . . . . . 0.416 ' HE3' ' OE2' ' B' ' 317' ' ' GLU . 33.8 mmt -99.64 178.59 4.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.984 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 320' ' ' LYS . . . . . 0.642 ' H ' ' CD ' ' B' ' 320' ' ' LYS . 0.0 OUTLIER -101.57 158.02 16.39 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.639 178.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 321' ' ' GLY . . . . . . . . . . . . . . . 110.94 -23.25 19.71 Favored Glycine 0 C--N 1.309 -0.958 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 30' ' ' THR . 6.4 ptpt -135.5 -139.74 0.16 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.603 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 323' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.98 -16.76 0.59 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.571 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.452 ' HD3' ' H ' ' B' ' 324' ' ' LYS . 0.0 OUTLIER -96.54 -176.91 3.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 111.013 -179.222 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 325' ' ' LEU . . . . . . . . . . . . . 31.8 mt -86.84 165.2 16.15 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.209 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 326' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' B' ' 317' ' ' GLU . 9.5 t -124.15 126.21 25.61 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.016 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.461 ' O ' HG12 ' B' ' 326' ' ' VAL . 61.0 Cg_exo -44.56 145.22 2.76 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 N-CA-C 108.099 -1.539 . . . . 0.0 108.099 178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 328' ' ' ARG . . . . . 0.652 ' N ' ' O ' ' B' ' 315' ' ' VAL . 5.6 ttm-85 -150.2 -173.21 4.37 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.776 -177.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 329' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' B' ' 340' ' ' VAL . 0.1 OUTLIER -143.95 122.72 12.64 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.07 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 330' ' ' LEU . . . . . 0.833 HD12 ' O ' ' B' ' 338' ' ' MET . 26.4 tp -101.96 158.32 16.22 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 331' ' ' GLY . . . . . 0.428 ' H ' HD12 ' B' ' 330' ' ' LEU . . . -141.44 107.94 0.53 Allowed Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 332' ' ' ILE . . . . . 0.736 HD11 HD21 ' B' ' 330' ' ' LEU . 30.8 mm -88.46 123.83 41.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . 0.729 ' C ' ' H ' ' B' ' 335' ' ' GLU . 2.6 p -118.31 137.75 52.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.26 13.23 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.05 0.452 . . . . 0.0 111.741 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 335' ' ' GLU . . . . . 0.729 ' H ' ' C ' ' B' ' 333' ' ' THR . 11.3 pt-20 -144.15 -2.52 0.89 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.844 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 336' ' ' CYS . . . . . 0.611 ' SG ' ' N ' ' B' ' 337' ' ' VAL . 0.1 OUTLIER -173.86 179.36 2.0 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 122.158 0.98 . . . . 0.0 113.045 -177.194 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 337' ' ' VAL . . . . . 0.611 ' N ' ' SG ' ' B' ' 336' ' ' CYS . 13.3 t -137.08 145.31 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.072 0 CA-C-N 113.365 -1.743 . . . . 0.0 106.677 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 338' ' ' MET . . . . . 0.833 ' O ' HD12 ' B' ' 330' ' ' LEU . 3.9 ptt? -154.08 149.95 27.69 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 117.028 -1.869 . . . . 0.0 114.318 -176.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 339' ' ' ARG . . . . . 0.497 ' NH1' ' OE2' ' B' ' 317' ' ' GLU . 44.7 mtm180 -94.66 107.79 19.78 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.778 176.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.626 ' N ' ' O ' ' B' ' 329' ' ' LEU . 2.8 t -99.24 149.84 5.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.228 -178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 341' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' B' ' 344' ' ' THR . 29.0 t0 -89.93 92.15 8.89 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.784 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 342' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' B' ' 341' ' ' ASP . 0.5 OUTLIER -35.51 -28.95 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.76 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' B' ' 341' ' ' ASP . 35.8 mttt -74.7 -43.67 53.97 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.672 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 344' ' ' THR . . . . . 0.553 ' N ' ' O ' ' B' ' 341' ' ' ASP . 1.2 p -109.3 -12.72 14.73 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 7.4 tttp 66.73 -0.91 1.46 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.977 0.418 . . . . 0.0 109.918 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . 0.456 ' H ' ' C ' ' B' ' 344' ' ' THR . 2.6 mt-10 -84.88 152.73 23.36 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.388 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 347' ' ' VAL . . . . . 0.597 HG21 ' SD ' ' B' ' 338' ' ' MET . 81.9 t -82.92 135.57 24.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.449 0.642 . . . . 0.0 112.352 -178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mt -104.03 -30.13 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.386 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 349' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' B' ' 338' ' ' MET . 6.9 tt0 -140.49 156.05 46.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.677 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -145.66 149.43 34.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.451 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 351' ' ' TRP . . . . . 0.554 ' O ' ' N ' ' B' ' 337' ' ' VAL . 68.6 t-105 -162.34 135.95 6.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.828 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 352' ' ' SER . . . . . 0.509 ' OG ' ' ND2' ' B' ' 355' ' ' ASN . 0.0 OUTLIER -54.01 138.32 37.51 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.541 -178.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.623 HD12 ' O ' ' B' ' 333' ' ' THR . 1.8 tt -78.51 -35.69 45.97 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 354' ' ' THR . . . . . . . . . . . . . 5.1 t -74.97 11.1 1.18 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.97 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 355' ' ' ASN . . . . . 0.509 ' ND2' ' OG ' ' B' ' 352' ' ' SER . 11.8 m-20 -115.04 -3.99 12.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.171 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 356' ' ' ILE . . . . . 0.477 HD12 HD23 ' B' ' 353' ' ' LEU . 72.5 mt -58.12 148.54 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.951 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 357' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' B' ' 369' ' ' ASP . 11.5 tptt -106.45 -45.64 4.21 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 358' ' ' ARG . . . . . 0.489 ' O ' ' CB ' ' B' ' 369' ' ' ASP . 5.2 ptt180 -174.88 136.3 0.4 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.399 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 359' ' ' TRP . . . . . 0.489 ' CH2' HD12 ' B' ' 396' ' ' ILE . 8.6 p90 -118.74 174.53 6.22 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.35 -178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 360' ' ' ALA . . . . . . . . . . . . . . . -156.88 97.99 1.73 Allowed 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.936 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 389' ' ' ALA . . . -79.77 147.85 31.69 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.855 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 362' ' ' SER . . . . . 0.535 ' N ' ' O ' ' B' ' 365' ' ' SER . 0.1 OUTLIER -136.21 173.04 6.06 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 363' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -76.63 -8.61 18.26 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.033 1.822 . . . . 0.0 112.092 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 364' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' B' ' 382' ' ' THR . 6.4 mttm -130.79 -22.08 2.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.96 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 365' ' ' SER . . . . . 0.657 ' HA ' ' H ' ' B' ' 382' ' ' THR . 89.8 p -149.73 170.02 19.7 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.617 0.723 . . . . 0.0 111.815 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 366' ' ' PHE . . . . . 0.505 ' CE2' HG21 ' B' ' 388' ' ' ILE . 0.1 OUTLIER -142.79 156.56 44.99 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.802 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 367' ' ' THR . . . . . 0.564 ' CG2' HD12 ' A' ' 15' ' ' LEU . 33.9 m -148.1 156.44 42.61 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.05 -1.06 . . . . 0.0 112.734 -174.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 368' ' ' LEU . . . . . 0.454 ' N ' HG22 ' B' ' 367' ' ' THR . 6.0 mt -129.11 143.4 50.85 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.479 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 358' ' ' ARG . 20.7 t0 -119.74 95.86 4.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.652 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 370' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' B' ' 370' ' ' PHE . 10.3 p90 -136.6 93.52 2.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.371 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' B' ' 373' ' ' TYR . . . 132.58 12.22 1.81 Allowed Glycine 0 C--O 1.226 -0.397 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 372' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -41.77 -15.74 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.117 -0.542 . . . . 0.0 111.776 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' B' ' 371' ' ' GLY . 2.2 m-85 -54.61 -37.3 65.42 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 374' ' ' GLN . . . . . 0.479 ' CG ' ' H ' ' B' ' 375' ' ' ASP . 0.6 OUTLIER -125.85 -92.94 0.5 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 375' ' ' ASP . . . . . 0.479 ' H ' ' CG ' ' B' ' 374' ' ' GLN . 5.5 t70 -129.02 96.4 4.33 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 376' ' ' GLY . . . . . . . . . . . . . . . -100.5 -2.45 55.49 Favored Glycine 0 C--N 1.311 -0.859 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.218 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 377' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' B' ' 377' ' ' TYR . 0.1 OUTLIER -86.32 106.11 17.15 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -175.547 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 378' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.21 125.98 52.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.783 175.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 379' ' ' SER . . . . . 0.501 ' OG ' ' SD ' ' A' ' 19' ' ' MET . 35.9 t -138.19 164.27 29.62 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.519 0.676 . . . . 0.0 112.667 -177.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 380' ' ' VAL . . . . . . . . . . . . . 1.8 m -150.4 172.89 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.942 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 381' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -99.77 126.51 45.85 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.891 0.853 . . . . 0.0 111.114 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 382' ' ' THR . . . . . 0.657 ' H ' ' HA ' ' B' ' 365' ' ' SER . 0.0 OUTLIER -155.11 136.05 13.73 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.651 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 383' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.27 16.66 4.22 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.103 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 384' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.95 84.04 1.77 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.91 175.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 385' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' B' ' 388' ' ' ILE . . . -85.9 -58.84 1.95 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.509 ' O ' ' CG ' ' B' ' 390' ' ' GLN . 7.1 pt-20 -44.66 -20.73 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.746 -0.727 . . . . 0.0 110.976 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 387' ' ' GLN . . . . . 0.429 ' N ' ' C ' ' B' ' 385' ' ' GLY . 78.2 mt-30 -82.06 -39.38 23.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 388' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' B' ' 385' ' ' GLY . 48.1 mt -76.93 -42.33 32.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.712 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 389' ' ' ALA . . . . . 0.791 ' HB2' ' HB2' ' B' ' 361' ' ' ALA . . . -73.87 -42.29 60.96 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.185 -1.37 . . . . 0.0 113.618 -177.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.509 ' CG ' ' O ' ' B' ' 386' ' ' GLU . 0.0 OUTLIER -63.79 -34.99 79.13 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 122.116 0.96 . . . . 0.0 110.992 -177.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 391' ' ' LEU . . . . . 0.653 ' HG ' ' N ' ' B' ' 392' ' ' ILE . 0.1 OUTLIER -72.93 -53.59 10.91 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.814 -179.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 392' ' ' ILE . . . . . 0.653 ' N ' ' HG ' ' B' ' 391' ' ' LEU . 2.0 mt -49.09 -56.12 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 393' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 392' ' ' ILE . . . -52.29 -33.77 43.67 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.792 -2.004 . . . . 0.0 110.743 177.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 394' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' B' ' 391' ' ' LEU . . . -85.2 -17.86 61.92 Favored Glycine 0 CA--C 1.507 -0.454 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 395' ' ' TYR . . . . . 0.677 ' HA ' HD12 ' B' ' 398' ' ' ILE . 5.3 m-30 -87.15 -36.95 17.77 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.489 HD12 ' CH2' ' B' ' 359' ' ' TRP . 0.0 OUTLIER -68.44 -13.33 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-O 122.237 1.017 . . . . 0.0 109.365 176.029 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 397' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.54 -22.7 46.89 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.513 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 398' ' ' ILE . . . . . 0.677 HD12 ' HA ' ' B' ' 395' ' ' TYR . 68.5 mt -91.8 -62.06 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 113.899 -1.501 . . . . 0.0 112.042 -178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 399' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' B' ' 396' ' ' ILE . 0.8 OUTLIER -64.29 -20.6 27.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 113.404 -1.725 . . . . 0.0 112.384 -177.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 400' ' ' LEU . . . . . 0.561 ' C ' HD12 ' B' ' 400' ' ' LEU . 1.1 pp . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.773 -178.903 . . . . . . . . 1 1 . 1 stop_ save_